Clustering O 0 0.002195395063608885
of O 0 0.0008578491979278624
missense O 0 0.0014506839215755463
mutations O 0 0.00019939422782044858
in O 0 0.00012671685544773936
the O 0 0.0005473741330206394
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999927282333374
telangiectasia I-Disease 1 0.9999774694442749
gene O 0 7.77997775003314e-05
in O 0 4.060680657858029e-05
a O 0 6.754611240467057e-05
sporadic B-Disease 0 0.001573614776134491
T I-Disease 1 0.9999703168869019
- I-Disease 1 0.9972817897796631
cell I-Disease 1 0.6667177677154541
leukaemia I-Disease 1 0.9998461008071899
. O 0 0.0007945648394525051

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999855756759644
telangiectasia I-Disease 1 0.9999992847442627
( O 0 0.002272574929520488
A B-Disease 1 0.9999984502792358
- I-Disease 1 0.9993793964385986
T I-Disease 1 0.9998733997344971
) O 0 9.254766155208927e-06
is O 0 4.773016371473204e-06
a O 0 1.8032807929557748e-05
recessive B-Disease 0 0.000758601410780102
multi I-Disease 1 0.9995622038841248
- I-Disease 1 0.9999856948852539
system I-Disease 1 0.9966760873794556
disorder I-Disease 1 1.0
caused O 1 0.9988995790481567
by O 0 5.242535917204805e-05
mutations O 0 4.563016045722179e-05
in O 0 2.5087476387852803e-05
the O 0 4.056934631080367e-05
ATM O 0 0.000829448807053268
gene O 0 4.389691457618028e-05
at O 0 0.00021287091658450663
11q22 O 0 0.0013798861764371395
- O 0 0.00031473004491999745
q23 O 0 0.0007488909759558737
( O 0 5.675935608451255e-05
ref O 0 0.0016264646546915174
. O 0 3.693475082400255e-05
3 O 0 0.0001695867395028472
) O 0 6.998607568675652e-05
. O 0 0.00013644866703543812

The O 0 0.0005053296335972846
risk O 0 0.0004872991412412375
of O 0 0.0014087141025811434
cancer B-Disease 1 0.999998927116394
, O 0 0.00012621736095752567
especially O 0 0.00021722292876802385
lymphoid B-Disease 1 0.9981847405433655
neoplasias I-Disease 1 0.9960401058197021
, O 0 2.7442103601060808e-05
is O 0 8.702813829586376e-06
substantially O 0 6.224311073310673e-05
elevated O 0 0.0015098813455551863
in O 0 5.9321289882063866e-05
A B-Disease 1 0.9999955892562866
- I-Disease 1 0.9999978542327881
T I-Disease 1 1.0
patients O 0 0.0001044446398736909
and O 0 9.981866242014803e-06
has O 0 1.1718991117959376e-05
long O 0 3.194251985405572e-05
been O 0 9.848767149378546e-06
associated O 0 1.3214024875196628e-05
with O 0 6.045916597940959e-05
chromosomal O 1 1.0
instability O 1 1.0
. O 1 0.7733619809150696

By O 0 0.0002897961821872741
analysing O 0 0.0021543570328503847
tumour B-Disease 1 0.9999998807907104
DNA O 0 0.0005743359797634184
from O 0 0.00015463562158402056
patients O 0 7.090409053489566e-05
with O 0 3.2513573387404904e-05
sporadic B-Disease 0 0.00651318347081542
T I-Disease 1 0.9999732971191406
- I-Disease 0 0.3530723452568054
cell I-Disease 0 0.0016381797613576055
prolymphocytic I-Disease 1 0.9923123717308044
leukaemia I-Disease 1 0.9999831914901733
( O 0 0.0012427676701918244
T B-Disease 1 0.9997723698616028
- I-Disease 0 0.039549004286527634
PLL I-Disease 1 0.9982940554618835
) O 0 3.0411145417019725e-05
, O 0 1.4021617062098812e-05
a O 0 3.510608439682983e-05
rare O 0 0.000322869629599154
clonal B-Disease 0 0.01543695479631424
malignancy I-Disease 1 0.9980040192604065
with O 0 6.203463999554515e-05
similarities O 0 0.00017122765711974353
to O 0 7.954911416163668e-05
a O 0 0.00021698177442885935
mature B-Disease 0 0.004096393007785082
T I-Disease 1 0.9995149374008179
- I-Disease 0 0.03077665902674198
cell I-Disease 0 0.0009348756866529584
leukaemia I-Disease 0 0.373663991689682
seen O 0 0.00023700259043835104
in O 0 6.665135151706636e-05
A B-Disease 1 0.998329222202301
- I-Disease 1 0.7541483640670776
T I-Disease 1 0.9996218681335449
, O 0 1.4027876204636414e-05
we O 0 4.126947715121787e-06
demonstrate O 0 2.5255507352994755e-05
a O 0 1.6427902664872818e-05
high O 0 4.771576277562417e-05
frequency O 0 1.6125781257869676e-05
of O 0 9.785611473489553e-05
ATM O 0 0.0023673849646002054
mutations O 0 0.00024998123990371823
in O 0 0.0006794302607886493
T B-Disease 1 0.9981485605239868
- I-Disease 0 0.035973384976387024
PLL I-Disease 1 0.9921579360961914
. O 0 0.0007540950318798423

In O 0 0.0002575404359959066
marked O 0 0.00043240078957751393
contrast O 0 8.593965321779251e-05
to O 0 4.338315920904279e-05
the O 0 0.00010716638644225895
ATM O 0 0.0016024986980482936
mutation O 0 5.3406056395033374e-05
pattern O 0 0.00023290990793611854
in O 0 0.0001761596358846873
A B-Disease 1 0.9998511075973511
- I-Disease 1 0.995439350605011
T I-Disease 1 0.9999146461486816
, O 0 1.1552324394870084e-05
the O 0 1.0678763828764204e-05
most O 0 5.280968707666034e-06
frequent O 0 1.1668316801660694e-05
nucleotide O 0 1.720766340440605e-05
changes O 0 1.3983560165797826e-05
in O 0 2.9618096959893592e-05
this O 0 2.5644456400186755e-05
leukaemia B-Disease 1 0.9949118494987488
were O 0 0.00038098578806966543
missense O 0 0.0024819555692374706
mutations O 0 0.000700084026902914
. O 0 0.0005609808140434325

These O 0 0.00017994285735767335
clustered O 0 0.0005211530369706452
in O 0 4.582211477099918e-05
the O 0 3.873258538078517e-05
region O 0 5.154877362656407e-05
corresponding O 0 1.8729942894424312e-05
to O 0 3.3561565942363814e-05
the O 0 4.8284917284036055e-05
kinase O 0 6.873271195217967e-05
domain O 0 7.537963392678648e-05
, O 0 1.0004147043218836e-05
which O 0 6.790620318497531e-06
is O 0 6.822323030064581e-06
highly O 0 1.9194189007976092e-05
conserved O 0 7.115647167665884e-05
in O 0 4.422717393026687e-05
ATM O 0 0.002026510424911976
- O 0 0.0003087387012783438
related O 0 4.7150526370387524e-05
proteins O 0 2.3821628928999417e-05
in O 0 5.24283605045639e-05
mouse O 0 0.00011798240302596241
, O 0 1.7939499230124056e-05
yeast O 0 0.0001326606288785115
and O 0 7.389942766167223e-05
Drosophila O 0 0.0006607593968510628
. O 0 0.0001769545633578673

The O 0 0.000403008540160954
resulting O 0 0.0002875292848329991
amino O 0 0.00017985831073019654
- O 0 0.0003568209067452699
acid O 0 4.201314368401654e-05
substitutions O 0 3.890524385496974e-05
are O 0 5.9841281654371414e-06
predicted O 0 5.4018346418160945e-05
to O 0 1.7751970517565496e-05
interfere O 0 9.514480188954622e-05
with O 0 5.381089431466535e-05
ATP O 1 0.8698784112930298
binding O 0 0.00014599031419493258
or O 0 0.0001419524196535349
substrate O 0 0.0005517668905667961
recognition O 0 0.00077495735604316
. O 0 0.0007311346125788987

Two O 0 7.81017224653624e-05
of O 0 0.00019981464720331132
seventeen O 0 0.0012968581868335605
mutated O 0 0.0016480718040838838
T B-Disease 0 0.3366527557373047
- I-Disease 0 0.000977515708655119
PLL I-Disease 0 0.005949331447482109
samples O 0 2.3712314941803925e-05
had O 0 3.1151816074270755e-05
a O 0 1.5290370356524363e-05
previously O 0 5.6858440075302497e-05
reported O 0 0.00010437065066071227
A B-Disease 1 0.5728980302810669
- I-Disease 0 0.42156893014907837
T I-Disease 1 0.9997692704200745
allele O 0 0.00028042157646268606
. O 0 0.00032672466477379203

In O 0 0.00038220133865252137
contrast O 0 0.00022771758085582405
, O 0 3.720834502018988e-05
no O 0 2.300501728313975e-05
mutations O 0 2.8995596949243918e-05
were O 0 5.124655581312254e-05
detected O 0 7.5132331403438e-05
in O 0 1.366805281577399e-05
the O 0 1.8849696061806753e-05
p53 O 0 2.6825759050552733e-05
gene O 0 1.2237407645443454e-05
, O 0 4.773981800099136e-06
suggesting O 0 2.8969618142582476e-05
that O 0 7.517709036619635e-06
this O 0 5.558197517530061e-05
tumour B-Disease 1 1.0
suppressor O 0 0.12548841536045074
is O 0 3.413066588109359e-05
not O 0 8.752169378567487e-06
frequently O 0 1.714544850983657e-05
altered O 0 4.5930748456157744e-05
in O 0 3.982720591011457e-05
this O 0 7.923446537461132e-05
leukaemia B-Disease 1 0.9966193437576294
. O 0 0.0011017537908628583

Occasional O 0 0.001304779783822596
missense O 0 0.0016597716603428125
mutations O 0 0.00019288626208435744
in O 0 0.0001240855490323156
ATM O 0 0.0015195957385003567
were O 0 4.0049097151495516e-05
also O 0 1.3989028047944885e-05
found O 0 9.910026165016461e-06
in O 0 3.434203608776443e-05
tumour B-Disease 1 0.9999992847442627
DNA O 0 0.00010312139056622982
from O 0 3.522512997733429e-05
patients O 0 2.346137807762716e-05
with O 0 1.557416544528678e-05
B B-Disease 1 0.7316851615905762
- I-Disease 0 0.015327606350183487
cell I-Disease 0 0.0008785967947915196
non I-Disease 0 0.001119069173000753
- I-Disease 1 0.83745276927948
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9998350143432617
( O 0 0.00028835696866735816
B B-Disease 0 0.005255295429378748
- I-Disease 0 0.000368597888154909
NHL I-Disease 0 0.0006296451902016997
) O 0 1.7140413547167554e-05
and O 0 8.158694072335493e-06
a O 0 6.122198101365939e-05
B B-Disease 0 0.003657983150333166
- I-Disease 0 0.0015800880501046777
NHL I-Disease 0 0.013102957047522068
cell O 0 0.0011097709648311138
line O 0 0.0010280866408720613
. O 0 0.0003748888848349452

The O 0 0.00015992212865967304
evidence O 0 5.686017175321467e-05
of O 0 4.698136035585776e-05
a O 0 3.968817327404395e-05
significant O 0 4.40786279796157e-05
proportion O 0 5.159746797289699e-05
of O 0 8.524319855496287e-05
loss O 0 0.0038806444499641657
- O 0 0.0004969208384864032
of O 0 0.0001771973620634526
- O 0 0.0002889145107474178
function O 0 4.5671436964767054e-05
mutations O 0 2.0397974367369898e-05
and O 0 6.47055503577576e-06
a O 0 2.2595811969949864e-05
complete O 0 5.486138252308592e-05
absence O 0 0.00016572355525568128
of O 0 0.00010105291585205123
the O 0 0.00010741591540863737
normal O 0 5.9174395573791116e-05
copy O 0 5.068781320005655e-05
of O 0 5.7798955822363496e-05
ATM O 0 0.0008833727333694696
in O 0 2.1933527023065835e-05
the O 0 1.7329875845462084e-05
majority O 0 1.77570000232663e-05
of O 0 0.00023405993124470115
mutated O 0 0.0034611925948411226
tumours B-Disease 1 0.9999998807907104
establishes O 0 0.001312993816100061
somatic O 0 0.0005147576448507607
inactivation O 0 0.002254308434203267
of O 0 0.00013381842290982604
this O 0 1.5770285244798288e-05
gene O 0 9.617613613954745e-06
in O 0 8.329366210091393e-06
the O 0 2.5356068363180384e-05
pathogenesis O 0 0.28045713901519775
of O 0 0.0006275799823924899
sporadic B-Disease 1 0.9828754663467407
T I-Disease 1 0.9999971389770508
- I-Disease 1 0.6119985580444336
PLL I-Disease 1 0.9895036220550537
and O 0 2.716324888751842e-05
suggests O 0 2.9812323191436008e-05
that O 0 7.935139365145005e-06
ATM O 0 0.0004680324054788798
acts O 0 0.00010888610268011689
as O 0 0.0001697465922916308
a O 0 0.001172973308712244
tumour B-Disease 1 1.0
suppressor O 1 0.9959201812744141
. O 0 0.0008324224036186934

As O 0 0.0003326293081045151
constitutional O 0 0.00036855871439911425
DNA O 0 0.0001853667345130816
was O 0 0.00015454363892786205
not O 0 4.570967121253489e-06
available O 0 1.5482737580896355e-06
, O 0 4.027965587738436e-06
a O 0 2.318146471225191e-05
putative O 0 0.0009988861856982112
hereditary O 1 0.9999972581863403
predisposition O 1 0.9999997615814209
to O 1 0.9995087385177612
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9917207956314087
PLL I-Disease 1 0.9917231202125549
will O 0 2.2585558326682076e-05
require O 0 4.428412012202898e-06
further O 0 1.9450855688774027e-05
investigation O 0 8.614469697931781e-05
. O 0 5.6394044804619625e-05
. O 0 0.00010908814874710515

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 0.014547920785844326
kinase O 0 0.0005811420269310474
is O 0 3.0176533982739784e-05
involved O 0 2.034295721387025e-05
in O 0 6.851520538475597e-06
the O 0 7.602023742947495e-06
modulation O 0 2.8454642233555205e-05
of O 0 3.5967572330264375e-05
the O 0 6.992015551077202e-05
Ca2 O 0 0.0008055760408751667
+ O 0 0.0015959738520905375
homeostasis O 0 0.013422361575067043
in O 0 0.0019047001842409372
skeletal O 1 0.9999991655349731
muscle O 1 0.9999716281890869
cells O 0 0.024534668773412704
. O 0 0.0012901416048407555

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999818801879883
DM B-Disease 1 1.0
) O 0 0.0002989369968418032
, O 0 1.7088415916077793e-05
the O 0 2.7828773454530165e-05
most O 0 9.068557119462639e-05
prevalent O 1 0.9999134540557861
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9978169202804565
adults O 0 0.0007121316739358008
, O 0 6.357140227919444e-05
is O 0 3.543435741448775e-05
caused O 0 0.00022553198505192995
by O 0 2.0918083464493975e-05
( O 0 0.00010009969264501706
CTG O 0 0.0396183505654335
) O 0 3.789814218180254e-05
n O 0 0.00017652264796197414
- O 0 0.00013529250281862915
repeat O 0 0.0001084497562260367
expansion O 0 0.0001217616954818368
in O 0 1.07299583760323e-05
a O 0 8.242962394433562e-06
gene O 0 4.262476522853831e-06
encoding O 0 5.636666173813865e-06
a O 0 3.074084088439122e-05
protein O 0 4.922856533084996e-05
kinase O 0 0.00011129591439384967
( O 0 9.204206435242668e-05
DM B-Disease 1 0.9999680519104004
protein O 0 0.00017459261289332062
kinase O 0 0.00014310708502307534
; O 0 3.0729610443813726e-05
DMPK O 0 0.012608719989657402
) O 0 2.188847429351881e-05
and O 0 8.506924132234417e-06
involves O 0 2.724205842241645e-05
changes O 0 2.454549030517228e-05
in O 0 0.00010490647400729358
cytoarchitecture O 0 0.005533477757126093
and O 0 0.00018996413564309478
ion O 0 0.0043889801017940044
homeostasis O 1 0.6910362839698792
. O 0 0.000709878106135875

To O 0 0.0001522040256531909
obtain O 0 6.729170854669064e-05
clues O 0 0.00015202419308479875
to O 0 1.2977293408766855e-05
the O 0 3.0122506359475665e-05
normal O 0 3.216471304767765e-05
biological O 0 5.350862193154171e-05
role O 0 9.65742437983863e-05
of O 0 0.0002592946693766862
DMPK O 1 0.9997108578681946
in O 0 0.00026860853540711105
cellular O 0 0.0007302342564798892
ion O 0 0.0010686864843592048
homeostasis O 0 0.0019579932559281588
, O 0 2.6067520593642257e-05
we O 0 6.338980711007025e-06
have O 0 2.0642607978516025e-06
compared O 0 1.0084571840707213e-05
the O 0 1.7268255760427564e-05
resting O 0 0.00029624163289554417
[ O 0 0.0001803054183255881
Ca2 O 0 0.0002967510372400284
+ O 0 0.0002948041947092861
] O 0 0.0002977208059746772
i O 0 5.0316117267357185e-05
, O 0 3.832729362329701e-06
the O 0 8.066704140219372e-06
amplitude O 0 6.387273606378585e-05
and O 0 2.8109416234656237e-05
shape O 0 0.00015354013885371387
of O 0 0.0002534384257160127
depolarization O 0 0.0018567417282611132
- O 0 0.00149567611515522
induced O 0 0.0007964441319927573
Ca2 O 0 0.0004154375346843153
+ O 0 0.00036002532579004765
transients O 0 0.00036240206100046635
, O 0 1.0279529305989854e-05
and O 0 4.702201295003761e-06
the O 0 1.4303838725027163e-05
content O 0 2.5966390239773318e-05
of O 0 0.0001699488639133051
ATP O 1 0.8778004050254822
- O 0 0.0018898569978773594
driven O 0 0.0004482677613850683
ion O 0 0.0003516883007250726
pumps O 0 0.0002774547610897571
in O 0 0.00010450270201545209
cultured O 0 0.002985171275213361
skeletal O 1 0.9995331764221191
muscle O 0 0.01771094650030136
cells O 0 0.00034798402339220047
of O 0 0.0004357225261628628
wild O 0 0.0003856247931253165
- O 0 0.00035592191852629185
type O 0 0.00011524855653988197
and O 0 4.775654451805167e-05
DMPK O 1 0.993478536605835
[ O 0 0.0011781164212152362
- O 0 0.0012563025811687112
/ O 0 0.0008250090759247541
- O 0 0.0010855771834030747
] O 0 0.001294430228881538
knockout O 1 0.7839141488075256
mice O 0 0.0017697140574455261
. O 0 0.00023814789892639965

In O 0 0.0004972764872945845
vitro O 0 0.000649705296382308
- O 0 0.0007104923133738339
differentiated O 0 0.0006518833106383681
DMPK O 1 0.9901672601699829
[ O 0 0.0013905433006584644
- O 0 0.0012928673531860113
/ O 0 0.0007116764318197966
- O 0 0.0005931012565270066
] O 0 0.00039824176928959787
myotubes O 0 0.0012572093401104212
exhibit O 0 0.00014016219938639551
a O 0 7.604240818182006e-05
higher O 0 0.00014816218754276633
resting O 0 0.0007255161181092262
[ O 0 0.0001692571968305856
Ca2 O 0 0.0004230271733831614
+ O 0 0.0005408128490671515
] O 0 0.0005078889662399888
i O 0 9.582980419509113e-05
than O 0 1.4680568710900843e-05
do O 0 1.2409531336743385e-05
wild O 0 5.285844235913828e-05
- O 0 0.0001604579738341272
type O 0 0.00014233682304620743
myotubes O 0 0.002064748900011182
because O 0 2.79185642284574e-05
of O 0 4.0012295357882977e-05
an O 0 3.2413299777545035e-05
altered O 0 0.0001006576421787031
open O 0 3.853187445201911e-05
probability O 0 6.912267053849064e-06
of O 0 8.413841715082526e-05
voltage O 0 0.0011855870252475142
- O 0 0.0006435254472307861
dependent O 0 0.00012360642722342163
l O 0 0.0003430715878494084
- O 0 0.00011183486640220508
type O 0 4.824017742066644e-05
Ca2 O 0 0.00014688957890029997
+ O 0 0.00010238602408207953
and O 0 3.534600182319991e-05
Na O 0 0.004159929696470499
+ O 0 0.00030495936516672373
channels O 0 0.0002019312378251925
. O 0 0.00014561506395693868

The O 0 0.0008642176981084049
mutant O 0 0.0024919407442212105
myotubes O 0 0.006962243001908064
exhibit O 0 0.0004500612849369645
smaller O 0 5.987633630866185e-05
and O 0 1.6801521269371733e-05
slower O 0 7.78854446252808e-05
Ca2 O 0 0.00011858538346132264
+ O 0 6.859638961032033e-05
responses O 0 9.167152711597737e-06
upon O 0 5.589291686192155e-05
triggering O 0 0.00015552077093161643
by O 0 2.7798534574685618e-05
acetylcholine O 0 0.00034371952642686665
or O 0 7.124799594748765e-05
high O 0 0.0004917129408568144
external O 0 0.0002984977909363806
K O 0 0.0017316787270829082
+ O 0 0.0008030851022340357
. O 0 0.00020383490482345223

In O 0 0.00028781534638255835
addition O 0 6.172890425659716e-05
, O 0 1.8807622836902738e-05
we O 0 6.572764050361002e-06
observed O 0 7.553626801382052e-06
that O 0 2.1262274003674975e-06
these O 0 2.9841694413335063e-06
Ca2 O 0 0.0002496515808161348
+ O 0 0.0005100405542179942
transients O 0 0.0011113425716757774
partially O 0 0.00017268610827159137
result O 0 1.680700370343402e-05
from O 0 7.52369805923081e-06
an O 0 4.809002803085605e-06
influx O 0 4.653515497921035e-05
of O 0 3.1624145776731893e-05
extracellular O 0 0.00023931919713504612
Ca2 O 0 0.00027772894827649
+ O 0 8.168133354047313e-05
through O 0 1.1380950127204414e-05
the O 0 2.6810774215846322e-05
l O 0 0.0002176367270294577
- O 0 0.00010839589958777651
type O 0 6.132553244242445e-05
Ca2 O 0 0.0002387672138866037
+ O 0 0.0002992674708366394
channel O 0 0.0004931408329866827
. O 0 0.00014660005399491638

Neither O 0 0.0004470410931389779
the O 0 9.53326016315259e-05
content O 0 4.580656241159886e-05
nor O 0 1.7976695744437166e-05
the O 0 8.235262612288352e-06
activity O 0 1.25591268442804e-05
of O 0 5.017868897994049e-05
Na O 0 0.006361077539622784
+ O 0 0.00024362395924981683
/ O 0 0.00016197148943319917
K O 0 0.00024164091155398637
+ O 0 0.00014582030416931957
ATPase O 0 0.0002301904751220718
and O 0 2.1157105948077515e-05
sarcoplasmic O 0 0.0006213738233782351
reticulum O 0 0.0002801503287628293
Ca2 O 0 0.00031037814915180206
+ O 0 0.0002843004767782986
- O 0 0.00016833610425237566
ATPase O 0 8.702783816261217e-05
are O 0 2.901796960941283e-06
affected O 0 3.0118369977572e-05
by O 0 4.839924440602772e-05
DMPK O 1 0.9738247394561768
absence O 0 0.0038870235439389944
. O 0 0.0008019327651709318

In O 0 0.00043816230027005076
conclusion O 0 0.00022610838641412556
, O 0 2.656388096511364e-05
our O 0 1.593148408574052e-05
data O 0 1.4912703591107856e-05
suggest O 0 2.8259073587832972e-05
that O 0 1.452567994419951e-05
DMPK O 0 0.09451568871736526
is O 0 2.6848640118259937e-05
involved O 0 2.355643482587766e-05
in O 0 2.8418793590390123e-05
modulating O 0 0.00036127783823758364
the O 0 5.1916107622673735e-05
initial O 0 2.884160312532913e-05
events O 0 5.358209818950854e-05
of O 0 0.00013126777776051313
excitation O 0 0.0017732909182086587
- O 0 0.04946059733629227
contraction O 0 0.016745740547776222
coupling O 0 0.0015861705178394914
in O 0 0.0008619032450951636
skeletal O 1 0.9999992847442627
muscle O 1 0.9966625571250916
. O 0 0.000512927770614624
. O 0 0.0004778541042469442

Constitutional O 0 0.01597451977431774
RB1 O 1 0.9999667406082153
- O 0 0.005559773184359074
gene O 0 9.365725418319926e-05
mutations O 0 5.176903505343944e-05
in O 0 4.449428524821997e-05
patients O 0 6.265532283578068e-05
with O 0 4.0111706766765565e-05
isolated O 0 0.0010051607387140393
unilateral B-Disease 0 0.0009577847667969763
retinoblastoma I-Disease 1 0.9999568462371826
. O 0 0.0029325527139008045

In O 0 0.00038030414725653827
most O 0 8.993650408228859e-05
patients O 0 7.693335646763444e-05
with O 0 3.362756615388207e-05
isolated O 0 0.0013894332805648446
unilateral B-Disease 0 0.0007265968597494066
retinoblastoma I-Disease 1 0.9999969005584717
, O 0 0.001471833442337811
tumor B-Disease 1 0.9999886751174927
development O 0 0.0002644314372446388
is O 0 2.0958177628926933e-05
initiated O 0 9.196151950163767e-05
by O 0 3.6459612147154985e-06
somatic O 0 8.077683742158115e-05
inactivation O 0 0.00044644574518315494
of O 0 8.63868699525483e-05
both O 0 2.5716874006320722e-05
alleles O 0 1.9064193111262284e-05
of O 0 0.00016908974794205278
the O 0 0.0005958178080618382
RB1 O 1 0.9999583959579468
gene O 0 0.00036459663533605635
. O 0 0.00019175738270860165

However O 0 0.00023048100410960615
, O 0 1.9344732208992355e-05
some O 0 6.767436843801988e-06
of O 0 4.790456296177581e-05
these O 0 2.83110530290287e-05
patients O 0 0.00014186502085067332
can O 0 9.204118396155536e-05
transmit O 0 0.002195164328441024
retinoblastoma B-Disease 1 0.999194324016571
predisposition O 1 0.992209792137146
to O 0 0.0005022122641094029
their O 0 0.00019359526049811393
offspring O 0 0.0006212458829395473
. O 0 0.00022925628582015634

To O 0 8.331747812917456e-05
determine O 0 2.1560930690611713e-05
the O 0 2.5464751161052845e-05
frequency O 0 2.859975393221248e-05
and O 0 1.5491375961573794e-05
nature O 0 3.3814460039138794e-05
of O 0 0.00012266779958736151
constitutional O 0 0.0021333678159862757
RB1 O 1 0.9999960660934448
- O 0 0.002100792247802019
gene O 0 4.629445538739674e-05
mutations O 0 2.387550921412185e-05
in O 0 3.2857380574569106e-05
patients O 0 4.638624159269966e-05
with O 0 1.8829750842996873e-05
isolated O 0 0.0005971853388473392
unilateral B-Disease 0 0.0002082959545077756
retinoblastoma I-Disease 1 0.8850144147872925
, O 0 3.564935104805045e-05
we O 0 9.190122000291012e-06
analyzed O 0 1.5249245734594297e-05
DNA O 0 3.7415000406326726e-05
from O 0 3.9724076486891136e-05
peripheral O 0 0.07501507550477982
blood O 0 0.0009188437834382057
and O 0 0.00018467272457201034
from O 1 0.8597575426101685
tumor B-Disease 1 1.0
tissue O 1 0.9999576807022095
. O 0 0.0007618570234626532

The O 0 0.00012034629617119208
analysis O 0 3.928769365302287e-05
of O 0 0.0005407669232226908
tumors B-Disease 1 0.9999996423721313
from O 0 0.00022106218966655433
54 O 0 0.000201283794012852
( O 0 2.333657357667107e-05
71 O 0 5.3433825087267905e-05
% O 0 1.2596105989359785e-05
) O 0 5.433471869764617e-06
of O 0 2.516866152291186e-05
76 O 0 0.00029937364161014557
informative O 0 0.00014983696746639907
patients O 0 7.691339851589873e-05
showed O 0 0.0001118985383072868
loss O 0 0.00038202101131901145
of O 0 0.0001913074083859101
constitutional O 0 0.0008871124009601772
heterozygosity O 1 0.9996955394744873
( O 0 0.0021411047782748938
LOH O 1 0.9999998807907104
) O 0 0.00018972482939716429
at O 0 0.0007077360642142594
intragenic O 0 0.01085274200886488
loci O 0 0.0019177391659468412
. O 0 0.0005798435304313898

Three O 0 0.00018226527026854455
of O 0 0.00026440416695550084
13 O 0 0.002775775035843253
uninformative O 1 0.9907384514808655
patients O 0 0.0011346811661496758
had O 0 0.0008467964944429696
constitutional O 0 0.001018982264213264
deletions O 0 0.0033873789943754673
. O 0 0.0006881500594317913

For O 0 0.00010265732271363959
39 O 0 0.00013978261267766356
randomly O 0 3.378887413418852e-05
selected O 0 0.00024088413920253515
tumors B-Disease 1 0.9999998807907104
, O 0 0.0002877267252188176
SSCP O 1 0.9999752044677734
, O 0 0.00026635799440555274
hetero O 0 0.010351886972784996
- O 0 0.0005395847838371992
duplex O 0 0.00046612502774223685
analysis O 0 1.3341968042368535e-05
, O 0 1.244995291926898e-05
sequencing O 0 3.9250549889402464e-05
, O 0 9.125198630499654e-06
and O 0 1.1027390428353101e-05
Southern O 0 7.759231812087819e-05
blot O 0 0.00013685993326362222
analysis O 0 8.716019692656118e-06
were O 0 2.168300125049427e-05
used O 0 1.6079971828730777e-05
to O 0 6.266512355068699e-05
identify O 0 0.000248111056862399
mutations O 0 0.0005485456786118448
. O 0 0.0005692143458873034

Mutations O 0 0.0004327626375015825
were O 0 0.00015314506890717894
detected O 0 0.00018379121320322156
in O 0 2.1382133127190173e-05
21 O 0 5.8954501582775265e-05
( O 0 7.5539078352449e-06
91 O 0 4.3722819100366905e-05
% O 0 1.219138539454434e-05
) O 0 1.0931395991065074e-05
of O 0 0.0001861130294855684
23 O 1 0.9972687363624573
tumors B-Disease 1 1.0
with O 0 0.14440029859542847
LOH O 1 1.0
. O 0 0.002945544896647334

In O 0 0.00033829433959908783
6 O 0 0.0003250909794587642
( O 0 3.4656553907552734e-05
38 O 0 5.143029920873232e-05
% O 0 1.8966449715662748e-05
) O 0 1.715308644634206e-05
of O 0 0.00022105609241407365
16 O 1 0.9817032217979431
tumors B-Disease 1 1.0
without O 0 0.003360587637871504
LOH O 1 0.9999998807907104
, O 0 4.829739555134438e-05
one O 0 1.589616840647068e-05
mutation O 0 1.9791459635598585e-05
was O 0 0.00023337827587965876
detected O 0 0.00014147972979117185
, O 0 8.871345926309004e-06
and O 0 5.202616193855647e-06
in O 0 1.755474841047544e-05
9 O 0 9.287931607104838e-05
( O 0 1.4234725313144736e-05
56 O 0 3.7138503103051335e-05
% O 0 1.0090439900523052e-05
) O 0 8.179190444934648e-06
of O 0 5.723145295633003e-05
the O 0 0.0021685841493308544
tumors B-Disease 1 1.0
without O 0 0.025687621906399727
LOH O 1 1.0
, O 0 5.018587035010569e-05
both O 0 1.7871654563350603e-05
mutations O 0 5.570604480453767e-05
were O 0 0.0001394024584442377
found O 0 0.00014094878861214966
. O 0 0.0002548321499489248

Thus O 0 0.0003818719123955816
, O 0 1.8136077414965257e-05
a O 0 8.099443220999092e-06
total O 0 1.3262656466395129e-05
of O 0 5.0266571633983403e-05
45 O 0 8.401061495533213e-05
mutations O 0 4.1266550397267565e-05
were O 0 3.193429802195169e-05
identified O 0 5.55672449991107e-05
in O 0 0.0001951898302650079
tumors B-Disease 1 0.9999998807907104
of O 0 0.002388833789154887
36 O 0 0.010389815084636211
patients O 0 0.0019939288031309843
. O 0 0.0006767229060642421

Thirty O 0 0.00519578205421567
- O 0 0.00031191029120236635
nine O 0 4.273760350770317e-05
of O 0 4.129607987124473e-05
the O 0 3.53511240973603e-05
mutations O 0 3.997538078692742e-05
- O 0 0.00011848547001136467
including O 0 1.318170234299032e-05
34 O 0 9.066551137948409e-05
small O 0 3.542010017554276e-05
mutations O 0 3.3457101380918175e-05
, O 0 2.357672929065302e-05
2 O 0 0.00014971272321417928
large O 0 0.00017235349514521658
structural O 0 0.028385238721966743
alterations O 0 0.0028417245484888554
, O 0 9.239257633453235e-05
and O 0 6.009966091369279e-05
hypermethylation O 1 0.6816662549972534
in O 0 0.00039575042319484055
3 O 1 0.97809237241745
tumors O 1 1.0
- O 0 0.0010483902879059315
were O 0 3.29226822941564e-05
not O 0 4.624675966624636e-06
detected O 0 2.0811905415030196e-05
in O 0 3.96417226511403e-06
the O 0 1.0826166544575244e-05
corresponding O 0 7.508556154789403e-05
peripheral O 1 0.9951802492141724
blood O 0 0.03921715170145035
DNA O 0 0.0015765910502523184
. O 0 0.00038080039666965604

In O 0 0.0003774618962779641
6 O 0 0.0004854354483541101
( O 0 3.949385427404195e-05
17 O 0 5.535125092137605e-05
% O 0 1.2426775356289e-05
) O 0 4.808048743143445e-06
of O 0 3.329170067445375e-05
the O 0 8.162698213709518e-05
36 O 0 0.00018047296907752752
patients O 0 8.139442070387304e-05
, O 0 1.7115453374572098e-05
a O 0 2.6288329536328092e-05
mutation O 0 1.837803574744612e-05
was O 0 0.0001223648723680526
detected O 0 5.1591559895314276e-05
in O 0 1.2462637641874608e-05
constitutional O 0 3.9875125366961583e-05
DNA O 0 3.490438757580705e-05
, O 0 5.92858577874722e-06
and O 0 3.6915146210958483e-06
1 O 0 3.7755435187136754e-05
of O 0 3.023705539817456e-05
these O 0 1.4011886378284544e-05
mutations O 0 3.41546256095171e-05
is O 0 9.029869943333324e-06
known O 0 1.837230593082495e-05
to O 0 9.174692422675434e-06
be O 0 1.1285481377854012e-05
associated O 0 1.7296573787461966e-05
with O 0 1.700985012575984e-05
reduced O 0 0.0005831634043715894
expressivity O 0 0.03236723318696022
. O 0 0.0008344045490957797

The O 0 0.0005224854685366154
presence O 0 0.0001971466699615121
of O 0 0.0001315986446570605
a O 0 0.0001615525980014354
constitutional O 0 0.00023411886650137603
mutation O 0 7.90566555224359e-05
was O 0 0.00025000388268381357
not O 0 7.413527782773599e-06
associated O 0 7.91284765000455e-06
with O 0 3.090705604336108e-06
an O 0 1.2116126526962034e-05
early O 0 0.0001593583292560652
age O 0 0.00046358598046936095
at O 0 0.0021998020820319653
treatment O 0 0.001632886822335422
. O 0 0.000512028462253511

In O 0 0.0006377763347700238
1 O 0 0.0015733563341200352
patient O 0 0.0004068687267135829
, O 0 6.420531281037256e-05
somatic O 0 0.0007807918591424823
mosaicism O 1 0.9976078271865845
was O 0 0.0006128097884356976
demonstrated O 0 8.958984108176082e-05
by O 0 4.123375219933223e-06
molecular O 0 9.154722647508606e-06
analysis O 0 1.8587606973596849e-06
of O 0 1.592604530742392e-05
DNA O 0 4.277030166122131e-05
and O 0 2.333414704480674e-05
RNA O 0 0.00024815366487018764
from O 0 0.00021447037579491735
peripheral O 1 0.9903417825698853
blood O 0 0.007586752064526081
. O 0 0.0005620720330625772

In O 0 0.0005625857156701386
2 O 0 0.000940151687245816
patients O 0 8.791591972112656e-05
without O 0 4.065319080837071e-05
a O 0 9.988325473386794e-05
detectable O 0 0.0010885399533435702
mutation O 0 4.1321916796732694e-05
in O 0 7.996109343366697e-05
peripheral O 1 0.9976353645324707
blood O 0 0.01279458962380886
, O 0 0.00012681887892540544
mosaicism O 1 0.9977636337280273
was O 0 0.0008280483307316899
suggested O 0 3.296364957350306e-05
because O 0 6.176881015562685e-06
1 O 0 2.5490166080999188e-05
of O 0 2.5030791221070103e-05
the O 0 0.00012275006156414747
patients O 0 0.0010931038996204734
showed O 1 0.9389235973358154
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.000231008802074939
the O 0 9.667393169365823e-05
other O 0 1.4078939784667455e-05
later O 0 0.0001573219196870923
developed O 0 0.00042859086534008384
bilateral B-Disease 1 0.9384015798568726
retinoblastoma I-Disease 1 0.999904990196228
. O 0 0.0009520483436062932

In O 0 0.00019898152095265687
conclusion O 0 0.00010761604062281549
, O 0 1.120510478358483e-05
our O 0 7.232187272165902e-06
results O 0 5.196457550482592e-06
emphasize O 0 4.0357957914238796e-05
that O 0 6.94992377248127e-06
the O 0 4.104922845726833e-05
manifestation O 0 0.002363992854952812
and O 0 0.0001059198984876275
transmissibility O 0 0.04059730842709541
of O 0 0.0005107143661007285
retinoblastoma B-Disease 0 0.05223383009433746
depend O 0 6.899893924128264e-05
on O 0 3.6244822695152834e-05
the O 0 2.0790206690435298e-05
nature O 0 1.79942071554251e-05
of O 0 1.9469731341814622e-05
the O 0 3.1358369597001e-05
first O 0 3.898843715433031e-05
mutation O 0 8.428641194768716e-06
, O 0 2.781745934044011e-06
its O 0 2.635976215970004e-06
time O 0 8.883714144758414e-06
in O 0 9.330929060524795e-06
development O 0 2.2753793018637225e-05
, O 0 3.4401095945213456e-06
and O 0 1.8886983070842689e-06
the O 0 9.433213563170284e-06
number O 0 6.998516710154945e-06
and O 0 3.5849241157848155e-06
types O 0 1.1029599590983707e-05
of O 0 0.0001128312578657642
cells O 0 7.209472823888063e-05
that O 0 1.0847456906049047e-05
are O 0 3.5454397675493965e-06
affected O 0 4.7500390792265534e-05
. O 0 3.012655724887736e-05
. O 0 9.230926661984995e-05

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9910293817520142
the I-Disease 0 0.0016810201341286302
fifth I-Disease 0 0.0018127112416550517
component I-Disease 0 0.0002662564511410892
of I-Disease 0 0.00020049042359460145
complement I-Disease 0 0.00035790467518381774
in O 0 0.0002907210437115282
man O 0 0.0008439143421128392
. O 0 0.00017374762683175504

I O 1 0.7329893112182617
. O 0 0.0013407237129285932

Clinical O 0 0.007752975914627314
, O 0 0.0005744756199419498
immunochemical O 1 0.6651527881622314
, O 0 0.00014976327656768262
and O 0 5.470819814945571e-05
family O 0 0.00021029454364906996
studies O 0 0.00018789181194733828
. O 0 0.0003174328012391925

The O 0 0.0001750141236698255
first O 0 8.031797915464267e-05
recognized O 0 8.527556201443076e-05
human O 0 0.00010738989658420905
kindred O 0 0.046412356197834015
with O 0 0.0006124147912487388
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9999834299087524
the I-Disease 0 0.009744006209075451
fifth I-Disease 0 0.0009660420473664999
component I-Disease 0 9.325862629339099e-05
of I-Disease 0 9.495137783233076e-05
complement I-Disease 0 0.00038133826456032693
( O 0 0.0003382327558938414
C5 O 1 0.9999573230743408
) O 0 9.38311277423054e-05
is O 0 3.581256896723062e-05
described O 0 0.00013882675557397306
. O 0 0.00019945089297834784

The O 0 0.0008154052775353193
proband O 0 0.004931963514536619
, O 0 4.933270611218177e-05
a O 0 4.5989778300281614e-05
20 O 0 0.00016392048564739525
- O 0 0.00012913523823954165
year O 0 4.3256659409962595e-05
- O 0 0.00010736737021943554
old O 0 9.565387153998017e-05
black O 0 7.371847459580749e-05
female O 0 0.00013501194189302623
with O 0 0.0005804783431813121
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999995231628418
age O 1 0.9976643323898315
11 O 0 0.002125527709722519
, O 0 7.775824633426964e-05
lacked O 0 0.002804914489388466
serum O 1 0.8900597095489502
hemolytic O 1 1.0
complement O 0 0.0034113505389541388
activity O 0 0.0007529045105911791
, O 0 8.314500155393034e-05
even O 0 5.6643049902049825e-05
during O 0 0.0006057503051124513
remission O 0 0.00415043206885457
. O 0 0.0005462741246446967

C5 O 1 0.999994158744812
was O 0 0.08046302944421768
undetectable O 0 0.007825013250112534
in O 0 6.340447725960985e-05
her O 0 2.9860864742659032e-05
serum O 0 0.00011021971295122057
by O 0 1.4010094673722051e-05
both O 0 3.107434167759493e-05
immunodiffusion O 1 0.9202857613563538
and O 0 0.000580390973482281
hemolytic O 1 1.0
assays O 0 0.0033436885569244623
. O 0 0.0015940023586153984

Other O 0 4.7554593038512394e-05
complement O 0 9.906210470944643e-05
components O 0 0.00011629787331912667
were O 0 0.00010417198791401461
normal O 0 6.82289683027193e-05
during O 0 0.00019131215231027454
remission O 0 0.0012128730304539204
of O 0 0.0029259761795401573
lupus O 1 0.9999998807907104
, O 0 0.00039079698035493493
but O 0 0.00015318859368562698
C1 O 1 0.9999974966049194
, O 0 0.0007096257759258151
C4 O 1 0.9999986886978149
, O 0 0.0004214270447846502
C2 O 1 0.9991580247879028
, O 0 0.000157658287207596
and O 0 0.00014215805276762694
C3 O 1 0.9999988079071045
levels O 0 0.024963954463601112
fell O 1 0.9944884777069092
during O 0 0.0021664886735379696
exacerbations O 1 0.892086923122406
. O 0 0.0007558102952316403

A O 0 0.003843726357445121
younger O 0 0.0014666762435808778
half O 0 0.00040337213431484997
- O 0 0.0004073617747053504
sister O 0 0.00010378579463576898
, O 0 9.619246156944428e-06
who O 0 2.1825588191859424e-05
had O 0 0.00012224007514305413
no O 0 0.00014372766599990427
underlying O 1 0.9999988079071045
disease O 1 1.0
, O 0 9.663835226092488e-05
was O 0 0.0006926549249328673
also O 0 1.8258075215271674e-05
found O 0 1.0844901225937065e-05
to O 0 4.384118437883444e-05
lack O 0 0.0011765945237129927
immunochemically O 1 0.9998377561569214
detectable O 1 0.9998321533203125
C5 O 1 0.9999959468841553
. O 0 0.0015457422705367208

By O 0 0.0007060576463118196
hemolytic O 1 0.9999997615814209
assay O 0 0.0006294717313721776
, O 0 7.87755852798e-05
she O 0 2.1438730982481502e-05
exhibited O 0 0.00014199723955243826
1 O 0 0.00022646352590527385
- O 0 7.445434312103316e-05
2 O 0 2.1379339159466326e-05
% O 0 3.4416059406794375e-06
of O 0 1.4196033589541912e-05
the O 0 5.9845166106242687e-05
normal O 0 0.00018664903473109007
serum O 0 0.0010924490634351969
C5 O 1 0.8329262137413025
level O 0 0.0002962721628136933
and O 0 2.0114821381866932e-05
normal O 0 2.7709867936209776e-05
concentrations O 0 5.9660436818376184e-05
of O 0 4.698947668657638e-05
other O 0 2.696390038181562e-05
complement O 0 0.00034376472467556596
components O 0 0.0006735106580890715
. O 0 0.00035555686918087304

C5 O 1 0.9985846281051636
levels O 0 0.0007438435568474233
of O 0 0.0001545324339531362
other O 0 2.4391063561779447e-05
family O 0 3.256642594351433e-05
members O 0 9.408380719833076e-06
were O 0 3.3141110179712996e-05
either O 0 2.3995255105546676e-05
normal O 0 4.250941128702834e-05
or O 0 1.646843520575203e-05
approximately O 0 8.212636748794466e-05
half O 0 0.00011890367022715509
- O 0 0.00016903012874536216
normal O 0 1.557275390950963e-05
, O 0 3.009465444847592e-06
consistent O 0 1.494995376560837e-05
with O 0 1.2884607713203877e-05
autosomal O 0 0.001451479853130877
codominant O 1 0.9928054213523865
inheritance O 0 0.0006387075991369784
of O 0 0.00027089493232779205
the O 0 0.00019951043941546232
gene O 0 0.0005206683417782187
determining O 1 0.853392481803894
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.36393633484840393

Normal O 0 0.02525991201400757
hemolytic O 1 0.9999997615814209
titers O 0 0.04713178798556328
were O 0 0.00023142168356571347
restored O 0 0.0004915499011985958
to O 0 2.363262501603458e-05
both O 0 3.506452776491642e-05
homozygous O 0 0.001632050727494061
C5 B-Disease 1 1.0
- I-Disease 1 0.9999897480010986
deficient I-Disease 1 0.9999997615814209
( O 0 0.0008838834473863244
C5D B-Disease 1 1.0
) O 0 0.00016405120550189167
sera O 0 0.0006155874580144882
by O 0 9.763182788447011e-06
addition O 0 7.921605174487922e-06
of O 0 7.431141420966014e-05
highly O 0 0.002341636922210455
purified O 0 0.01083383895456791
human O 0 0.0015246469993144274
C5 O 1 0.9999681711196899
. O 0 0.0006814187509007752

In O 0 0.0005246363580226898
specific O 0 0.00030965666519477963
C5 O 1 0.99998939037323
titrations O 0 0.014029445126652718
, O 0 5.8755256759468466e-05
however O 0 2.0536950614769012e-05
, O 0 9.368269275000785e-06
it O 0 2.930134087364422e-06
was O 0 6.226993718883023e-05
noted O 0 1.1765036106226034e-05
that O 0 1.8196915334556252e-06
when O 0 6.00893054070184e-06
limited O 0 7.949454811750911e-06
amounts O 0 2.5713809009175748e-05
of O 0 0.00016952143050730228
C5 O 1 0.9997532963752747
were O 0 0.0001464498636778444
assayed O 0 0.00016477798635605723
in O 0 9.139586836681701e-06
the O 0 6.687835593766067e-06
presence O 0 1.5191852980933618e-05
of O 0 6.286941061262041e-05
low O 0 0.00020646225311793387
dilutions O 0 0.0006353204953484237
of O 0 0.00019923668878618628
either O 0 0.0006491290987469256
C5D B-Disease 1 1.0
serum O 0 0.0067578754387795925
, O 0 7.568114233436063e-05
curving O 0 0.0003289961314294487
rather O 0 1.4829413885308895e-05
than O 0 7.843440471333452e-06
linear O 0 0.00011375841131666675
dose O 0 0.0002845014096237719
- O 0 0.00018868246115744114
response O 0 1.1290530892438255e-05
plots O 0 4.492902007768862e-05
were O 0 2.005743226618506e-05
consistently O 0 2.5207624275935814e-05
obtained O 0 1.4519475371344015e-05
, O 0 1.0304578609066084e-05
suggesting O 0 2.7703526939149015e-05
some O 0 1.4562603610102087e-05
inhibitory O 0 0.0006154007860459387
effect O 0 0.0008203549077734351
. O 0 0.0002925485896412283

Further O 0 0.0004100735823158175
studies O 0 8.447179425274953e-05
suggested O 0 8.561125287087634e-05
that O 0 1.4737379387952387e-05
low O 0 0.00013958787894807756
dilutions O 0 0.0005719378241337836
of O 0 0.0005176231497898698
C5D B-Disease 1 1.0
serum O 0 0.0011645433260127902
contain O 0 0.00011038716183975339
a O 0 4.4285035983193666e-05
factor O 0 5.4875614296179265e-05
( O 0 1.3437429515761323e-05
or O 0 1.2892694940092042e-05
factors O 0 3.974840001319535e-05
) O 0 2.363028033869341e-05
interfering O 0 6.0267935623414814e-05
at O 0 0.00011009344598278403
some O 0 9.25021231523715e-06
step O 0 6.452399247791618e-05
in O 0 3.2287458452628925e-05
the O 0 9.600496559869498e-05
hemolytic O 1 0.9999854564666748
assay O 0 0.00030119699658825994
of O 0 0.0027816230431199074
C5 O 1 0.9999971389770508
, O 0 9.189840784529224e-05
rather O 0 1.8035114408121444e-05
than O 0 7.801218998793047e-06
a O 0 3.2311825634678826e-05
true O 0 0.00030379253439605236
C5 O 1 0.9999868869781494
inhibitor O 0 0.002776759909465909
or O 0 0.0003902400494553149
inactivator O 0 0.12234824895858765
. O 0 0.0006192348664626479

Of O 0 0.0006327257724478841
clinical O 0 0.0003411920624785125
interest O 0 0.00012756015348713845
are O 0 8.001220521691721e-06
( O 0 9.870205758488737e-06
a O 0 1.008009166980628e-05
) O 0 6.14574491919484e-06
the O 0 6.808816578995902e-06
documentation O 0 8.836786582833156e-05
of O 0 0.0010480857454240322
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999349117279053
vasculitis B-Disease 1 1.0
, O 1 0.9586291313171387
and O 1 0.9938795566558838
arthritis B-Disease 1 1.0
in O 0 0.4885670840740204
an O 0 0.00016958318883553147
individual O 0 7.09644373273477e-05
lacking O 0 0.10302217304706573
C5 O 1 0.9999984502792358
( O 0 4.950217407895252e-05
and O 0 9.463617061555851e-06
its O 0 1.6584259356022812e-05
biologic O 0 0.0005938411923125386
functions O 0 2.6214553145109676e-05
) O 0 1.318972499575466e-05
, O 0 8.004608389455825e-06
and O 0 7.659010407223832e-06
( O 0 1.4121971616987139e-05
b O 0 6.193698209244758e-05
) O 0 1.0733878298196942e-05
a O 0 1.9533632439561188e-05
remarkable O 0 0.00021072487288620323
propensity O 0 0.002680716337636113
to O 0 0.016235094517469406
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.000281291053397581
the O 0 0.00021159867173992097
proband O 0 0.003331304294988513
, O 0 1.2757327567669563e-05
even O 0 1.0875382031372283e-05
during O 0 5.8353442000225186e-05
periods O 0 8.195784175768495e-05
of O 0 0.00012222796794958413
low O 0 0.0005186929483897984
- O 0 0.00025791002553887665
dose O 0 5.118550325278193e-05
or O 0 1.0487981853657402e-05
alternate O 0 7.120907685020939e-05
- O 0 0.00036206055665388703
day O 0 0.0002868499723263085
corticosteroid O 1 0.6053826808929443
therapy O 0 0.013935134746134281
. O 0 0.0006969433161430061

Other O 0 7.020384509814903e-05
observations O 0 8.045788126764819e-05
indicate O 0 4.930937575409189e-05
that O 0 6.553636467288015e-06
the O 0 5.615780901280232e-05
C5D B-Disease 1 0.999985933303833
state O 0 4.067765985382721e-05
is O 0 1.1162569535372313e-05
compatible O 0 3.520612881402485e-05
with O 0 8.00630368757993e-06
normal O 0 8.159623394021764e-05
coagulation O 0 0.0007300432189367712
function O 0 7.138265209505334e-05
and O 0 1.688970223767683e-05
the O 0 4.139227530686185e-05
capacity O 0 0.00022205887944437563
to O 0 6.837720866315067e-05
mount O 0 0.0018366849981248379
a O 0 0.0003654378524515778
neutrophilic O 1 0.999420166015625
leukocytosis O 1 0.9997816681861877
during O 1 0.9991718530654907
pyogenic B-Disease 1 0.9999920129776001
infection I-Disease 1 0.9962433576583862
. O 0 0.00020577319082804024
. O 0 0.0002437394141452387

Susceptibility O 1 0.9991993308067322
to O 1 0.9992259740829468
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.9951159954071045
twins O 0 0.001448657363653183
: O 0 1.6400570530095138e-05
the O 0 1.0165575076825917e-05
role O 0 2.4911481887102127e-05
of O 0 5.930403494858183e-05
genes O 0 8.860226807883009e-05
, O 0 4.952484232489951e-05
HLA O 1 0.9975734353065491
, O 0 4.2640876927180216e-05
and O 0 2.672367736522574e-05
the O 0 0.00012022952432744205
environment O 0 0.00022407001233659685
. O 0 0.00013625144492834806

OBJECTIVE O 0 0.0017870670417323709
To O 0 5.3058782214066014e-05
determine O 0 1.7005666450131685e-05
the O 0 2.4421417037956417e-05
relative O 0 6.716727511957288e-05
effects O 0 0.0001390973338857293
of O 0 0.00019382170285098255
genetic O 0 0.0004121308447793126
and O 0 7.832114351913333e-05
environmental O 0 9.257213241653517e-05
factors O 0 5.2141469495836645e-05
in O 0 8.283952774945647e-05
susceptibility O 0 0.3586583733558655
to O 1 0.9974544644355774
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999839067459106
AS B-Disease 1 1.0
) O 0 0.00035791913978755474
. O 0 0.0003104603965766728

METHODS O 0 0.0014048784505575895
Twins O 0 0.0007458477048203349
with O 0 3.5329288948560134e-05
AS B-Disease 1 0.5609635710716248
were O 0 3.04327295452822e-05
identified O 0 1.555682683829218e-05
from O 0 8.070328476605937e-06
the O 0 2.6214931494905613e-05
Royal O 0 0.0005915775545872748
National O 1 0.9317765235900879
Hospital O 1 0.9999995231628418
for O 1 0.9998857975006104
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9994693398475647
. O 0 0.0016621247632429004

Clinical O 0 0.0016180651728063822
and O 0 0.00012801589036826044
radiographic O 0 0.0007815589779056609
examinations O 0 0.0004460199852474034
were O 0 0.00010367877257522196
performed O 0 9.205944661516696e-05
to O 0 5.177688581170514e-05
establish O 0 0.00022272893693298101
diagnoses O 0 0.006843809504061937
, O 0 0.0001704797614365816
and O 0 0.0007024204242043197
disease O 1 1.0
severity O 1 0.9997630715370178
was O 0 0.49066027998924255
assessed O 0 0.00011491595068946481
using O 0 9.389127626491245e-06
a O 0 1.662728755036369e-05
combination O 0 2.289348776685074e-05
of O 0 9.197590406984091e-05
validated O 0 0.00039270607521757483
scoring O 0 0.00039623642805963755
systems O 0 0.001507383189164102
. O 0 0.00033245430677197874

HLA O 1 0.984446108341217
typing O 0 0.001330946572124958
for O 0 0.00037781469291076064
HLA O 1 0.9994524121284485
- O 0 0.002833483275026083
B27 O 0 0.002270406112074852
, O 0 0.00010975237091770396
HLA O 0 0.4017050862312317
- O 0 0.0009677277994342148
B60 O 0 0.0006638156482949853
, O 0 2.750621752056759e-05
and O 0 6.52829694445245e-05
HLA O 1 0.999985933303833
- O 0 0.14061526954174042
DR1 O 1 0.9948166012763977
was O 0 0.00021814991487190127
performed O 0 3.952383849537e-05
by O 0 7.035261205601273e-06
polymerase O 0 0.00012823946599382907
chain O 0 4.353285112301819e-05
reaction O 0 7.591098892589798e-06
with O 0 4.730916316475486e-06
sequence O 0 4.5269207475939766e-05
- O 0 9.524401684757322e-05
specific O 0 7.0055079959274735e-06
primers O 0 9.676136687630787e-05
, O 0 2.0553387003019452e-05
and O 0 4.17904848291073e-05
zygosity O 0 0.0023822723887860775
was O 0 0.0006025992915965617
assessed O 0 0.00010198426753049716
using O 0 4.2518251575529575e-05
microsatellite O 0 0.00224702269770205
markers O 0 0.00294471881352365
. O 0 0.0008870810852386057

Genetic O 0 0.0014846515841782093
and O 0 6.967700755922124e-05
environmental O 0 9.469928045291454e-05
variance O 0 1.784190499165561e-05
components O 0 7.196250953711569e-05
were O 0 2.9891118174418807e-05
assessed O 0 4.1616101952968165e-05
with O 0 5.978925855743e-06
the O 0 3.025961086677853e-05
program O 0 3.945921707781963e-05
Mx O 0 0.00053878512699157
, O 0 5.2599384616769385e-06
using O 0 2.146085989807034e-06
data O 0 3.989510332758073e-06
from O 0 7.135181022022152e-06
this O 0 2.4801017843856243e-06
and O 0 2.7574674277275335e-06
previous O 0 9.910413609759416e-06
studies O 0 6.085712811909616e-06
of O 0 7.685606396989897e-05
twins O 0 0.0003506601497065276
with O 0 7.135896885301918e-05
AS B-Disease 1 0.9999951124191284
. O 0 0.0005115182138979435

RESULTS O 0 0.0004954594769515097
Six O 0 0.00012210669228807092
of O 0 0.00016409013187512755
8 O 0 0.0006255633779801428
monozygotic O 0 0.002807284239679575
( O 0 0.0005336745525710285
MZ O 1 0.9991374015808105
) O 0 0.00017014019249472767
twin O 0 0.0006015377002768219
pairs O 0 6.151236448204145e-05
were O 0 0.00019917002646252513
disease O 1 0.9990524649620056
concordant O 0 0.0012353990459814668
, O 0 3.296924478490837e-05
compared O 0 3.2538078812649474e-05
with O 0 1.2208943189762067e-05
4 O 0 0.00012624119699466974
of O 0 0.00014337370521388948
15 O 0 0.00029866292607039213
B27 O 0 0.0014442852698266506
- O 0 0.0002020469692070037
positive O 0 2.3060259991325438e-05
dizygotic O 0 0.0011646582279354334
( O 0 0.00022272660862654448
DZ O 0 0.15051083266735077
) O 0 9.347836748929694e-05
twin O 0 0.00020624324679374695
pairs O 0 2.3344164219452068e-05
( O 0 1.9834576960420236e-05
27 O 0 0.00012136538862250745
% O 0 1.865094600361772e-05
) O 0 1.297563449043082e-05
and O 0 7.83172799856402e-06
4 O 0 7.115837070159614e-05
of O 0 0.00016133152530528605
32 O 0 0.0008230683160945773
DZ O 1 0.995964765548706
twin O 0 0.0008158466662280262
pairs O 0 3.559482138371095e-05
overall O 0 7.341897435253486e-05
( O 0 2.981061697937548e-05
12 O 0 6.14382661296986e-05
. O 0 8.897594852896873e-06
5 O 0 4.2149462387897074e-05
% O 0 3.091550024691969e-05
) O 0 0.00011442050890764222
. O 0 0.0003414001257624477

Nonsignificant O 0 0.040939800441265106
increases O 0 0.00022305536549538374
in O 0 2.4105944248731248e-05
similarity O 0 4.861229899688624e-05
with O 0 1.4235457456379663e-05
regard O 0 0.00012029466597596183
to O 0 6.842808215878904e-05
age O 0 0.00282599707134068
at O 1 0.9999090433120728
disease O 1 1.0
onset O 1 0.9999949932098389
and O 0 7.329054642468691e-05
all O 0 1.8911759980255738e-05
of O 0 0.0001686286268522963
the O 0 0.0026504062116146088
disease O 1 0.9999986886978149
severity O 0 0.001396039268001914
scores O 0 8.910708129405975e-05
assessed O 0 4.595304562826641e-05
were O 0 1.841545781644527e-05
noted O 0 6.437034608097747e-05
in O 0 0.00014670996461063623
disease O 1 0.9999988079071045
- O 0 0.28561416268348694
concordant O 0 0.13495761156082153
MZ O 1 0.9999082088470459
twins O 0 0.0010576496133580804
compared O 0 0.0002638957230374217
with O 0 0.00016868636885192245
concordant O 0 0.403714656829834
DZ O 1 0.9999985694885254
twins O 0 0.08902580291032791
. O 0 0.0009825039887800813

HLA O 1 0.999984860420227
- O 0 0.019503165036439896
B27 O 0 0.002133779926225543
and O 0 4.298841304262169e-05
B60 O 0 0.00045562154264189303
were O 0 2.5307874238933437e-05
associated O 0 1.7910129827214405e-05
with O 0 1.6413730918429792e-05
the O 0 0.0006761461845599115
disease O 1 0.9999985694885254
in O 0 0.00027428881730884314
probands O 1 0.8754389882087708
, O 0 2.3370628696284257e-05
and O 0 5.283033715386409e-06
the O 0 1.416337545379065e-05
rate O 0 2.5765306418179534e-05
of O 0 9.165790106635541e-05
disease O 1 0.9996590614318848
concordance O 0 0.0003460865991655737
was O 0 0.0004872457357123494
significantly O 0 8.742501813685521e-05
increased O 0 8.995451935334131e-05
among O 0 9.473793033976108e-05
DZ O 1 0.9163287878036499
twin O 0 0.000486078584799543
pairs O 0 2.5299717890447937e-05
in O 0 2.6882918973569758e-05
which O 0 1.6432994016213343e-05
the O 0 6.831008067820221e-05
co O 0 0.0004457866307348013
- O 0 0.00028700235998257995
twin O 0 0.0001348947116639465
was O 0 5.730753036914393e-05
positive O 0 6.820787803007988e-06
for O 0 9.134793799603358e-06
both O 0 5.878507363377139e-05
B27 O 0 0.002477021189406514
and O 0 0.00024983924231491983
DR1 O 1 0.9993851184844971
. O 0 0.0007889231201261282

Additive O 0 0.0007893252768553793
genetic O 0 0.0003933805273845792
effects O 0 0.0003707737778313458
were O 0 5.2856274123769253e-05
estimated O 0 4.027783506899141e-05
to O 0 8.533394975529518e-06
contribute O 0 2.185210178140551e-05
97 O 0 8.720361074665561e-05
% O 0 1.3100344403937925e-05
of O 0 3.8175487134139985e-05
the O 0 7.2358590841759e-05
population O 0 3.287248910055496e-05
variance O 0 5.949362457613461e-05
. O 0 0.0001972459431272

CONCLUSION O 0 0.003816926619037986
Susceptibility O 0 0.0031001402530819178
to O 0 0.00022151414304971695
AS B-Disease 1 0.9883562922477722
is O 0 3.0435836379183456e-05
largely O 0 5.2596173190977424e-05
genetically O 0 1.901768882817123e-05
determined O 0 1.1921133591386024e-05
, O 0 3.7212626011751126e-06
and O 0 3.163754854540457e-06
the O 0 1.4523962818202563e-05
environmental O 0 8.250802056863904e-05
trigger O 0 6.391892384272069e-05
for O 0 2.274207872687839e-05
the O 0 0.000467267440399155
disease O 1 0.9999971389770508
is O 0 7.192148768808693e-05
probably O 0 0.0003387009783182293
ubiquitous O 0 0.0011496295919641852
. O 0 0.0002906367590185255

HLA O 1 0.9998205304145813
- O 0 0.005251420196145773
B27 O 0 0.0010179034434258938
accounts O 0 1.6268786566797644e-05
for O 0 4.962554612575332e-06
a O 0 1.011834592645755e-05
minority O 0 7.44030103305704e-06
of O 0 1.933779458340723e-05
the O 0 3.9336959162028506e-05
overall O 0 0.00018073436513077468
genetic O 0 0.00023398698249366134
susceptibility O 0 0.0009958919836208224
to O 0 0.00045007505104877055
AS B-Disease 1 0.9999927282333374
. O 0 0.0004771194653585553

Cell O 0 0.004797013010829687
cycle O 0 0.0013833979610353708
- O 0 0.0006540710455738008
dependent O 0 0.00011273167183389887
colocalization O 0 0.0013001627521589398
of O 0 0.00031519762706011534
BARD1 O 1 0.9983869791030884
and O 0 0.0001065351752913557
BRCA1 O 0 0.00026014947798103094
proteins O 0 3.0547467758879066e-05
in O 0 1.8849354091798887e-05
discrete O 0 9.233312448486686e-05
nuclear O 0 0.0020784265361726284
domains O 0 0.0011148634366691113
. O 0 0.00037698843516409397

Germ O 1 0.9999943971633911
- O 0 0.003767281537875533
line O 0 0.000397450610762462
mutations O 0 1.7908148947753944e-05
of O 0 5.8651185099733993e-05
the O 0 0.00013061838399153203
BRCA1 O 0 0.0008958366233855486
gene O 0 6.875920371385291e-05
predispose O 0 0.00029677196289412677
women O 0 1.6835205315146595e-05
to O 0 1.507377419329714e-05
early O 0 0.00018997247389052063
- O 0 0.003774981014430523
onset O 1 0.9999994039535522
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9999295473098755
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.0002904262801166624
compromising O 0 0.0007368837250396609
the O 0 9.623300866223872e-05
genes O 0 8.166015322785825e-05
presumptive O 0 0.0021467457991093397
function O 0 0.00013644555292557925
as O 0 0.00021166524675209075
a O 0 0.0007374921115115285
tumor B-Disease 1 0.9999916553497314
suppressor O 1 0.5655458569526672
. O 0 0.0010755745461210608

Although O 0 0.00011273425479885191
the O 0 6.23307132627815e-05
biochemical O 0 0.0003517239820212126
properties O 0 0.0004290337674319744
of O 0 0.0008128792978823185
BRCA1 O 0 0.003608902683481574
polypeptides O 0 0.0002957168035209179
are O 0 1.092530965252081e-05
not O 0 1.2501135643105954e-05
understood O 0 8.874398190528154e-05
, O 0 9.287675311497878e-06
their O 0 1.1807490409410093e-05
expression O 0 7.928813283797354e-05
pattern O 0 0.0003038157010450959
and O 0 8.02223730715923e-05
subcellular O 0 0.0010775118134915829
localization O 0 0.0008968281908892095
suggest O 0 8.627425268059596e-05
a O 0 3.3284813980571926e-05
role O 0 0.00010295239189872518
in O 0 0.00011904117127414793
cell O 0 0.0007776205311529338
- O 0 0.0005464155692607164
cycle O 0 0.00026541444822214544
regulation O 0 0.0002471550542395562
. O 0 0.00010150575690204278

When O 0 0.001819517812691629
resting O 0 0.3432459831237793
cells O 0 0.0003329849860165268
are O 0 3.177914550178684e-05
induced O 0 0.0005023007979616523
to O 0 6.67662316118367e-05
proliferate O 0 0.0003550069814082235
, O 0 7.260784514073748e-06
the O 0 1.7436419511795975e-05
steady O 0 0.00026728419470600784
- O 0 3.6933306546416134e-05
state O 0 4.047658876515925e-06
levels O 0 1.3755575309915002e-05
of O 0 2.0499575839494355e-05
BRCA1 O 0 0.00015623272338416427
increase O 0 2.1774672859464772e-05
in O 0 3.713255500770174e-05
late O 0 0.0003519187157507986
G1 O 0 0.002694050082936883
and O 0 1.202663315780228e-05
reach O 0 2.0470699382713065e-05
a O 0 1.4206854757503606e-05
maximum O 0 4.6762834244873375e-05
during O 0 0.0004136209608986974
S O 0 0.0027045318856835365
phase O 0 0.0030385686550289392
. O 0 0.00065815873676911

Moreover O 0 0.0010313974926248193
, O 0 8.236776920966804e-05
in O 0 6.963682972127572e-05
S O 0 0.002018810249865055
phase O 0 0.0017299040919169784
cells O 0 0.00019718239491339773
, O 0 3.54876829078421e-05
BRCA1 O 0 0.00028223017579875886
polypeptides O 0 0.00011005777196260169
are O 0 1.2380204680084717e-05
hyperphosphorylated O 0 0.0007668666075915098
and O 0 1.7441041563870385e-05
accumulate O 0 0.00010346504859626293
into O 0 3.46905471815262e-05
discrete O 0 8.562268340028822e-05
subnuclear O 0 0.005560767836868763
foci O 0 0.006463241763412952
termed O 0 0.002781779272481799
" O 0 0.0013614777708426118
BRCA1 O 0 0.00374957756139338
nuclear O 0 0.015499026514589787
dots O 0 0.005185918416827917
. O 0 0.000576735706999898

" O 0 0.0040762657299637794
BRCA1 O 0 0.002998681040480733
associates O 0 0.0005981315625831485
in O 0 6.465063052019104e-05
vivo O 0 0.00026162422727793455
with O 0 1.6612673789495602e-05
a O 0 9.521686297375709e-05
structurally O 0 0.0019413955742493272
related O 0 0.0003215395554434508
protein O 0 0.000732417858671397
termed O 0 0.006212831009179354
BARD1 O 1 0.99996018409729
. O 0 0.0008557029068470001

Here O 0 0.0004763741744682193
we O 0 1.7264173948206007e-05
show O 0 1.1614628419920336e-05
that O 0 1.4597549125028308e-06
the O 0 9.937130926118698e-06
steady O 0 0.0001909959246404469
- O 0 4.798182635568082e-05
state O 0 4.726604856841732e-06
levels O 0 1.9335360775585286e-05
of O 0 4.4934717152500525e-05
BARD1 O 1 0.9948691129684448
, O 0 2.095705713145435e-05
unlike O 0 1.2670369869738352e-05
those O 0 6.004977421980584e-06
of O 0 9.514307021163404e-05
BRCA1 O 0 0.0007781697786413133
, O 0 3.086706783506088e-05
remain O 0 9.409626363776624e-05
relatively O 0 3.6421912227524444e-05
constant O 0 0.00011642114986898378
during O 0 0.0009983029449358582
cell O 0 0.002069250913336873
cycle O 0 0.001070880563929677
progression O 1 0.886376678943634
. O 0 0.0009798490209504962

However O 0 0.000660252699162811
, O 0 0.00011700454342644662
immunostaining O 0 0.004301731940358877
revealed O 0 0.00048623824841342866
that O 0 2.6735684514278546e-05
BARD1 O 1 0.984606146812439
resides O 0 0.0003536167205311358
within O 0 9.637736366130412e-05
BRCA1 O 0 0.0007566978456452489
nuclear O 0 0.0013219316024333239
dots O 0 0.00037995766615495086
during O 0 0.0001813846902223304
S O 0 0.0003043311298824847
phase O 0 0.00014969131734687835
of O 0 4.679950143327005e-05
the O 0 0.00010419603495392948
cell O 0 0.00017365404346492141
cycle O 0 9.73435744526796e-05
, O 0 8.651028110762127e-06
but O 0 2.6838522444450064e-06
not O 0 2.3620361844223225e-06
during O 0 7.19208037480712e-05
the O 0 7.792302494635805e-05
G1 O 0 0.19059297442436218
phase O 0 0.00313303479924798
. O 0 0.0005179622676223516

Nevertheless O 0 0.007868709973990917
, O 0 0.000470435043098405
BARD1 O 1 0.954004168510437
polypeptides O 0 0.0002461945987306535
are O 0 1.182230880658608e-05
found O 0 1.0682217180146836e-05
exclusively O 0 2.2742815417586826e-05
in O 0 1.2534525012597442e-05
the O 0 2.208203477493953e-05
nuclear O 0 0.00012731735478155315
fractions O 0 3.7494046409847215e-05
of O 0 4.882377834292129e-05
both O 0 5.260645775706507e-05
G1 O 1 0.5125016570091248
- O 0 0.00036311897565610707
and O 0 4.274127059034072e-05
S O 0 0.0019617988727986813
- O 0 0.0005755992024205625
phase O 0 0.0012004777090623975
cells O 0 0.00038272052188403904
. O 0 0.00012640909699257463

Therefore O 0 0.0007484963862225413
, O 0 0.00011655421985778958
progression O 0 0.0012733424082398415
to O 0 0.00010144674160983413
S O 0 0.0018688089912757277
phase O 0 0.0005930248880758882
is O 0 2.1155008653295226e-05
accompanied O 0 3.115285653620958e-05
by O 0 2.291784539920627e-06
the O 0 3.227028173569124e-06
aggregation O 0 1.4317773093353026e-05
of O 0 7.27214792277664e-05
nuclear O 0 0.004370327573269606
BARD1 O 1 0.993937611579895
polypeptides O 0 0.00021554909471888095
into O 0 0.00015101833560038358
BRCA1 O 0 0.0014655997510999441
nuclear O 0 0.005701874848455191
dots O 0 0.0020331968553364277
. O 0 0.00027332035824656487

This O 0 0.0004104985564481467
cell O 0 0.0012703216634690762
cycle O 0 0.0005062195705249906
- O 0 0.00023121900449041277
dependent O 0 5.8805933804251254e-05
colocalization O 0 0.0006165715167298913
of O 0 0.00017881437088362873
BARD1 O 1 0.9998194575309753
and O 0 8.311116107506678e-05
BRCA1 O 0 0.00022159991203807294
indicates O 0 6.571513949893415e-05
a O 0 1.9173536202288233e-05
role O 0 5.591978697339073e-05
for O 0 3.734542042366229e-05
BARD1 O 1 0.9923698902130127
in O 0 0.0002438847004668787
BRCA1 O 0 0.013911448419094086
- O 0 0.2636500895023346
mediated O 1 0.977566659450531
tumor B-Disease 1 0.9999983310699463
suppression O 1 0.9994484782218933
. O 0 0.0016746447654441

Ethnic O 0 0.0007276910473592579
differences O 0 0.000732548302039504
in O 0 0.00021585925424005836
the O 0 0.00022994016762822866
HFE O 0 0.019440583884716034
codon O 0 0.0002449083549436182
282 O 0 0.0011802740627899766
( O 0 0.0006334328791126609
Cys O 1 0.9986042380332947
/ O 0 0.011426183395087719
Tyr O 0 0.010753448121249676
) O 0 0.00026722843176685274
polymorphism O 0 0.0006214221357367933
. O 0 0.0003664022369775921

Recent O 0 0.0001482280349591747
studies O 0 1.894273555080872e-05
have O 0 4.670042017096421e-06
shown O 0 4.108419670956209e-05
that O 0 0.00011288572568446398
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999983310699463
HH B-Disease 1 1.0
) O 0 0.00024447860778309405
is O 0 2.3130054614739493e-05
likely O 0 1.4717212252435274e-05
to O 0 8.00833549874369e-06
be O 0 1.515089206804987e-05
caused O 0 9.065600170288235e-05
by O 0 1.567635808896739e-05
homozygosity O 0 0.0006474422989413142
for O 0 2.6711089958553202e-05
a O 0 0.00010689336340874434
Cys282Tyr O 0 0.002226900774985552
mutation O 0 2.792660779959988e-05
in O 0 1.9674822397064418e-05
the O 0 9.030260116560385e-05
HFE O 0 0.03460364043712616
gene O 0 9.998197492677718e-05
located O 0 0.00032754961284808815
4 O 0 0.00035674794344231486
. O 0 0.000270996184553951

5 O 0 0.0024963656906038523
Mb O 0 0.011000972241163254
telomeric O 0 0.005866091698408127
to O 0 0.0007881994242779911
HLA O 1 0.9999476671218872
- O 0 0.006116919685155153
A O 0 0.0023644270841032267
. O 0 0.00023741877521388233

Population O 0 6.958968879189342e-05
studies O 0 1.4688187548017595e-05
of O 0 3.1126186513574794e-05
this O 0 7.840209946152754e-06
polymorphism O 0 2.7696974939317442e-05
are O 0 3.0343476282723714e-06
facilitated O 0 4.0754344809101894e-05
by O 0 4.814192379853921e-06
the O 0 1.5289189832401462e-05
fact O 0 1.1306649867037777e-05
that O 0 3.459289473539684e-06
the O 0 4.902403088635765e-05
Cys282Tyr O 0 0.004326680209487677
mutation O 0 6.27352055744268e-05
creates O 0 0.00017370142450090498
a O 0 0.00017827010015025735
Rsal O 0 0.006750051863491535
restriction O 0 0.00034263069392181933
site O 0 0.0009069177322089672
. O 0 0.00021220963390078396

We O 0 0.00010436886077513918
have O 0 1.1590905160119291e-05
studied O 0 6.318706437014043e-05
the O 0 3.0317005439428613e-05
codon O 0 8.41478758957237e-05
282 O 0 0.0005284841754473746
( O 0 0.0005416736239567399
Cys O 1 0.9974626302719116
/ O 0 0.004885516595095396
Tyr O 0 0.003998851869255304
) O 0 5.397426866693422e-05
polymorphism O 0 3.261163874412887e-05
in O 0 1.925382821355015e-05
different O 0 4.332218850322533e-06
ethnic O 0 4.870965494774282e-05
groups O 0 8.499489922542125e-05
. O 0 0.0002652199473232031

In O 0 0.00027107782079838216
agreement O 0 9.162224887404591e-05
with O 0 1.11693852886674e-05
previous O 0 5.877341754967347e-05
observations O 0 8.271456317743286e-05
the O 0 0.00017403166566509753
Tyr O 0 0.0021910446230322123
allele O 0 7.638172974111512e-05
appeared O 0 8.384566899621859e-05
to O 0 2.4674760425114073e-05
be O 0 2.2784326574765146e-05
rare O 0 7.02863690094091e-05
or O 0 5.372705345507711e-05
absent O 0 0.0004969180445186794
in O 0 0.00011326072853989899
Asiatic O 0 0.00113207777030766
( O 0 4.676702883443795e-05
Indian O 0 8.007348515093327e-05
, O 0 3.10412906401325e-05
Chinese O 0 0.00016988211427815259
) O 0 4.103180981473997e-05
populations O 0 4.637903475668281e-05
. O 0 7.580051897093654e-05

The O 0 0.00034575056633912027
highest O 0 0.00040853532846085727
allele O 0 2.2584696125704795e-05
frequency O 0 2.2112422811915167e-05
( O 0 1.4871588064124808e-05
7 O 0 5.423197944764979e-05
. O 0 4.192209416942205e-06
5 O 0 1.5683444871683605e-05
% O 0 6.724128525092965e-06
) O 0 8.442501894023735e-06
was O 0 6.483689503511414e-05
found O 0 1.531087218609173e-05
in O 0 3.683576505864039e-05
Swedes O 0 0.0006517369765788317
. O 0 0.0003145956725347787

Saamis O 0 0.01559089869260788
( O 0 0.00016950203280430287
2 O 0 0.00025579199427738786
% O 0 4.166561848251149e-05
) O 0 2.6295327188563533e-05
and O 0 1.9845021597575396e-05
Mordvinians O 0 0.0014067923184484243
( O 0 2.3591552235302515e-05
1 O 0 6.408095214283094e-05
. O 0 4.607814844348468e-06
8 O 0 2.6371219064458273e-05
% O 0 7.839776117180008e-06
) O 0 1.0182507139688823e-05
had O 0 4.5173128455644473e-05
significantly O 0 7.061408541630954e-05
lower O 0 5.34490063728299e-05
frequencies O 0 1.64876564667793e-05
of O 0 5.462322951643728e-05
the O 0 0.00018621476192492992
Tyr O 0 0.0029108605813235044
allele O 0 0.00024313478206750005
. O 0 0.0002580922737251967

Comparisons O 0 0.0003664378891699016
with O 0 4.068604175699875e-05
allele O 0 3.500338789308444e-05
frequencies O 0 2.468382263032254e-05
based O 0 6.220632258191472e-06
on O 0 3.5897122870665044e-05
prevalence O 0 0.00021839776309207082
estimates O 0 2.738578950811643e-05
of O 0 0.00010801185999298468
HH B-Disease 1 0.9999657869338989
showed O 0 0.00048344474635086954
some O 0 2.723751458688639e-05
disagreements O 0 0.00033145584166049957
with O 0 1.3105517609801609e-05
the O 0 7.954941975185648e-05
RFLP O 0 0.000489095167722553
data O 0 2.438436604279559e-05
, O 0 1.2013565537927207e-05
particularly O 0 2.9713688491028734e-05
in O 0 6.87308784108609e-05
Finns O 0 0.003369429614394903
. O 0 0.00035053264582529664

The O 0 0.0007875177543610334
newly O 0 0.002523610135540366
described O 0 0.0008563541923649609
HFE O 1 0.9846423268318176
marker O 0 0.0006364852888509631
provides O 0 1.4857780115562491e-05
a O 0 1.262049136130372e-05
new O 0 4.732432444143342e-06
approach O 0 6.402725830412237e-06
to O 0 9.659032002673484e-06
the O 0 1.680597779341042e-05
screening O 0 3.075473796343431e-05
of O 0 0.00013562575622927397
HH B-Disease 1 0.9999661445617676
as O 0 9.68588501564227e-05
well O 0 8.731843990972266e-06
as O 0 6.331676104309736e-06
studies O 0 3.088625362579478e-06
of O 0 1.822088597691618e-05
the O 0 7.095522596500814e-05
relationship O 0 0.00016061929636634886
between O 0 0.0003604886296670884
the O 0 0.0004473744484130293
HFE O 1 0.999942421913147
Tyr O 0 0.0060706245712935925
allele O 0 7.587602158309892e-05
and O 0 2.7264566597295925e-05
different O 0 5.8048412029165775e-05
disorders O 1 1.0
including O 1 0.9999871253967285
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999864101409912
dominant I-Disease 1 0.9999995231628418
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999982118606567
associated O 0 0.00033481436548754573
with O 0 4.670783528126776e-05
a O 0 0.00010891559941228479
missense O 0 0.0002547835756558925
mutation O 0 2.7824153221445158e-05
encoding O 0 0.00012488107313401997
Gly23 O 0 0.0231458842754364
- O 0 0.0011642039753496647
- O 0 0.00030964339384809136
> O 0 0.0002695971052162349
Val O 0 0.0010663372231647372
in O 0 0.0002438288793200627
neurophysin O 0 0.2645643651485443
II O 1 0.9999998807907104
. O 0 0.0014627311611548066

Autosomal B-Disease 1 0.9999121427536011
dominant I-Disease 1 0.9999982118606567
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.15550263226032257
ADNDI B-Disease 1 0.9999994039535522
) O 0 5.683377821696922e-05
is O 0 2.2371275917976163e-05
an O 0 0.00013801448221784085
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 0 0.08525851368904114
progressive O 1 0.9999997615814209
degeneration O 1 1.0
of O 1 0.9999799728393555
the O 1 0.9971004128456116
magnocellular O 1 0.9998621940612793
neurons O 0 0.0006201630458235741
of O 0 0.00028464902425184846
the O 0 0.0003869670908898115
hypothalamus O 0 0.002064481610432267
leading O 0 0.0002637219149619341
to O 0 3.8945479900576174e-05
decreased O 0 0.00020029209554195404
ability O 0 1.9988498024758883e-05
to O 0 1.592180888110306e-05
produce O 0 2.0202445739414543e-05
the O 0 9.093357948586345e-05
hormone O 0 0.00045125492033548653
arginine O 0 0.0002883006236515939
vasopressin O 0 0.0012355983490124345
( O 0 0.00031967199174687266
AVP O 0 0.08651231974363327
) O 0 0.0003847640473395586
. O 0 0.00032292469404637814

Affected O 0 0.0004192472842987627
individuals O 0 2.447499537083786e-05
are O 0 8.011795216589235e-06
not O 0 2.7461843274068087e-05
symptomatic O 0 0.43430420756340027
at O 0 0.0033605811186134815
birth O 0 0.00031396732083521783
, O 0 1.7464924894738942e-05
but O 0 7.48622915125452e-06
usually O 0 2.7945361580350436e-05
develop O 0 0.0009847944602370262
diabetes B-Disease 1 0.9999980926513672
insipidus I-Disease 1 0.9994537234306335
at O 0 0.027835620567202568
1 O 0 0.0014425093540921807
- O 0 0.0006134297582320869
6 O 0 0.0003344229480717331
yr O 0 0.001911021419800818
of O 0 0.00019561500812415034
age O 0 0.0010141190141439438
. O 0 0.00033285105018876493

The O 0 0.0002533910737838596
genetic O 0 0.00014644455222878605
locus O 0 0.000287156697595492
of O 0 0.00025380236911587417
the O 0 0.0007343086181208491
disease O 1 0.999893307685852
is O 0 7.543738320237026e-05
the O 0 0.000178608184796758
AVP O 1 0.9970080256462097
- O 0 0.002512474311515689
neurophysin O 0 0.17366516590118408
II O 1 0.9999998807907104
( O 0 0.00034440995659679174
NPII O 1 0.9958903193473816
) O 0 3.575894879759289e-05
gene O 0 1.7345731976092793e-05
, O 0 7.185953563748626e-06
and O 0 1.1186217307113111e-05
mutations O 0 3.842022124445066e-05
that O 0 3.849283530144021e-05
cause O 0 0.004912859294563532
ADNDI B-Disease 1 0.9999873638153076
have O 0 1.915785287565086e-05
been O 0 1.5312669347622432e-05
found O 0 2.123641706930357e-06
in O 0 3.344810693306499e-06
both O 0 2.33961714002362e-06
the O 0 1.3347948879527394e-05
signal O 0 0.00010987131827278063
peptide O 0 6.146598025225103e-05
of O 0 7.555342745035887e-05
the O 0 0.0002480604744050652
prepro O 1 0.9835470914840698
- O 0 0.022109298035502434
AVP O 1 0.9987874627113342
- O 0 0.0028326588217169046
NPII O 1 0.973442554473877
precursor O 0 0.0008854724001139402
and O 0 6.624909292440861e-05
within O 0 0.00024890151689760387
NPII O 1 0.9989221096038818
itself O 0 0.001613268512301147
. O 0 0.0004170103056821972

An O 0 0.0006841344875283539
affected O 0 0.0006401024875231087
girl O 0 0.0002926716406363994
who O 0 1.4896399989083875e-05
presented O 0 6.116386066423729e-05
at O 0 0.00016344817413482815
9 O 0 0.00012745242565870285
months O 0 4.130419256398454e-05
of O 0 5.799175414722413e-05
age O 0 0.0002788868732750416
and O 0 3.553581336745992e-05
her O 0 8.822825475363061e-05
similarly O 0 0.0001311447995249182
affected O 0 0.00018438590632285923
younger O 0 0.0004422978963702917
brother O 0 0.0004467139660846442
and O 0 2.075803240586538e-05
father O 0 0.00012233454617671669
were O 0 2.5147835913230665e-05
all O 0 7.96684980741702e-06
found O 0 6.447075065807439e-06
to O 0 7.834813004592434e-06
have O 0 5.377171419240767e-06
a O 0 1.2858339687227271e-05
novel O 0 4.07482439186424e-05
missense O 0 0.00020291053806431592
mutation O 0 4.261096546542831e-05
( O 0 6.622281216550618e-05
G1758 O 0 0.001614052220247686
- O 0 0.0005938071408309042
- O 0 0.00032881239894777536
> O 0 0.000249178585363552
T O 0 0.00036246803938411176
) O 0 4.565747985907365e-06
encoding O 0 4.944452484778594e-06
the O 0 2.501585186109878e-05
amino O 0 4.695194002124481e-05
acid O 0 0.00011204738984815776
substitution O 0 0.00030548666836693883
Gly23 O 0 0.1870536208152771
- O 0 0.002141208853572607
- O 0 0.0005857370560988784
> O 0 0.0003771113697439432
Val O 0 0.0013417023001238704
within O 0 0.0003560322511475533
NPII O 1 0.9904972314834595
. O 0 0.0005446771392598748

The O 0 0.00045792030869051814
mutation O 0 0.0001260975404875353
was O 0 0.00032075325725600123
confirmed O 0 4.114473995286971e-05
by O 0 1.3368931831791997e-05
restriction O 0 4.461171556613408e-05
endonuclease O 0 0.0003087675431743264
analysis O 0 5.930149927735329e-05
. O 0 0.00025385027402080595

A O 0 0.01594487577676773
T1 O 1 0.9998730421066284
- O 0 0.0008789903949946165
weighted O 0 7.233127689687535e-05
magnetic O 0 0.00015769076708238572
resonance O 0 0.00013200397370383143
imaging O 0 0.00019468966638669372
of O 0 0.0003117630840279162
the O 0 0.001369531499221921
fathers O 0 0.4703438878059387
pituitary O 1 0.999998927116394
gland O 1 0.9996989965438843
demonstrates O 0 0.003758990205824375
an O 0 0.0004598599043674767
attenuated O 1 0.9932985901832581
posterior O 1 0.9979637861251831
pituitary O 1 0.9999998807907104
bright O 1 0.9962841868400574
spot O 0 0.013453977182507515
. O 0 0.0006715789204463363

This O 0 0.0001566161954542622
mutation O 0 9.601731289876625e-05
may O 0 4.540211011772044e-05
be O 0 1.2270058505237103e-05
valuable O 0 3.948880475945771e-05
for O 0 9.116066394199152e-06
developing O 0 4.8082558350870386e-05
models O 0 1.2127710760978516e-05
of O 0 0.00018453436496201903
dominantly B-Disease 1 0.9999974966049194
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.00024197362654376775
as O 0 4.757319038617425e-05
the O 0 1.6149158909684047e-05
early O 0 3.22568703268189e-05
age O 0 4.392295522848144e-05
of O 0 8.739008626434952e-05
onset O 1 0.9999985694885254
of O 1 0.9992221593856812
symptoms O 1 0.9999990463256836
suggests O 0 0.0002115195820806548
that O 0 7.145981271605706e-06
this O 0 4.2374085751362145e-06
mutation O 0 8.552477083867416e-06
may O 0 2.65635007963283e-05
be O 0 1.1247983820794616e-05
particularly O 0 3.3629425161052495e-05
deleterious O 0 0.00032886190456338227
to O 0 0.00010161781392525882
the O 0 0.0003583857323974371
magnocellular O 1 0.6682414412498474
neuron O 0 0.0023799685295671225
. O 0 0.0001700355642242357
. O 0 0.00018729869043454528

Frequent O 0 0.0005464244168251753
inactivation O 0 0.0067953746765851974
of O 0 0.004222379066050053
PTEN O 1 0.9999974966049194
/ O 1 0.9954225420951843
MMAC1 O 1 0.9999973773956299
in O 0 0.0008367215050384402
primary O 1 0.9999873638153076
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.02662566304206848

Sporadic B-Disease 1 0.9999984502792358
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.004669114015996456
the O 0 0.0002326420071767643
most O 0 6.209003186086193e-05
common O 0 8.769262058194727e-05
male B-Disease 0 0.0006405797321349382
cancer I-Disease 1 0.8935655355453491
in O 0 6.332054908853024e-05
the O 0 5.931240593781695e-05
Western O 0 0.00010084931273013353
world O 0 3.8854963349876925e-05
, O 0 4.456424449017504e-06
yet O 0 4.7593575800419785e-06
many O 0 1.2324768476901227e-06
of O 0 1.0882697097258642e-05
the O 0 2.100788515235763e-05
major O 0 0.00028579571517184377
genetic O 0 6.227540143299848e-05
events O 0 3.850175198749639e-05
involved O 0 2.9030872610746883e-05
in O 0 2.0121497072977945e-05
the O 0 5.400892041507177e-05
progression O 0 0.0014961574925109744
of O 0 0.0001022089782054536
this O 0 6.335570651572198e-05
often O 0 0.00013784102338831872
fatal O 1 0.9999691247940063
cancer B-Disease 1 0.999985933303833
remain O 0 0.0011271240655332804
to O 0 0.00010089990973938257
be O 0 0.00011850637383759022
elucidated O 0 0.004782304633408785
. O 0 0.0003514064010232687

Numerous O 0 0.0017813246231526136
cytogenetic O 0 0.028260361403226852
and O 0 0.00034791167126968503
allelotype O 0 0.09022849053144455
studies O 0 5.464396963361651e-05
have O 0 1.1238645129196811e-05
reported O 0 1.731291013129521e-05
frequent O 0 2.7980397135252133e-05
loss O 0 0.0003366534074302763
of O 0 0.000401127414079383
heterozygosity O 1 0.992260754108429
on O 0 0.0019226355943828821
chromosomal O 1 0.776616096496582
arm O 0 0.09282579272985458
10q O 0 0.019034886732697487
in O 0 0.0005499775288626552
sporadic B-Disease 1 0.9999992847442627
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6926692724227905

Deletion O 0 0.001145445043221116
mapping O 0 0.00046502327313646674
studies O 0 7.13529807399027e-05
have O 0 1.451264961360721e-05
unambiguously O 0 0.00016076333122327924
identified O 0 1.9762414012802765e-05
a O 0 2.264862268930301e-05
region O 0 6.960641621844843e-05
of O 0 0.000144686913699843
chromosome O 0 0.0005928266327828169
10q23 O 0 0.000514729181304574
to O 0 2.241661786683835e-05
be O 0 8.98151847650297e-06
the O 0 1.1888957487826701e-05
minimal O 0 6.754643254680559e-05
area O 0 0.00012676000187639147
of O 0 0.00027581374160945415
loss O 1 0.7800410389900208
. O 0 0.001180296647362411

A O 0 0.0024210549890995026
new O 0 0.00031180621590465307
tumor B-Disease 1 0.9962820410728455
suppressor O 0 0.00461208913475275
gene O 0 0.0002215240674559027
, O 0 0.00016707423492334783
PTEN O 1 0.9993733763694763
/ O 0 0.03193692862987518
MMAC1 O 1 0.9997720122337341
, O 0 6.932290125405416e-05
was O 0 0.0002129319909727201
isolated O 0 9.86111190286465e-05
recently O 0 3.7800178688485175e-05
at O 0 3.2594569347565994e-05
this O 0 3.984674549428746e-06
region O 0 9.026643965626135e-05
of O 0 0.00016309914644807577
chromosome O 0 0.0006848951452411711
10q23 O 0 0.0008992270450107753
and O 0 2.306986971234437e-05
found O 0 7.440230092470301e-06
to O 0 6.710522029607091e-06
be O 0 6.459088126575807e-06
inactivated O 0 7.143794937292114e-05
by O 0 3.847297193715349e-06
mutation O 0 6.065485649742186e-06
in O 0 2.7140848033013754e-05
three O 0 0.0015331709291785955
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999946355819702
lines O 0 0.005552249029278755
. O 0 0.00044492416782304645

We O 0 0.0002919732069130987
screened O 0 0.0010410253889858723
80 O 0 0.0026137970853596926
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 0.00010387897054897621
microsatellite O 0 0.0006154776783660054
analysis O 0 1.774301563273184e-05
and O 0 1.21434513857821e-05
found O 0 2.9918955988250673e-05
chromosome O 0 0.00017226117779500782
10q23 O 0 0.00050231849309057
to O 0 3.0271043215179816e-05
be O 0 1.0150123671337496e-05
deleted O 0 5.273343049339019e-05
in O 0 2.827023490681313e-05
23 O 0 0.0003078161389566958
cases O 0 0.00011991659994237125
. O 0 0.00018181501945946366

We O 0 0.0001703494490357116
then O 0 2.3716725991107523e-05
proceeded O 0 5.529300688067451e-05
with O 0 2.3671573217143305e-06
sequence O 0 5.541942755371565e-06
analysis O 0 2.834155566233676e-06
of O 0 2.363415842410177e-05
the O 0 0.00010905694216489792
entire O 0 0.001244424725882709
PTEN O 1 0.9994801878929138
/ O 0 0.007430261000990868
MMAC1 O 1 0.9940168857574463
coding O 0 0.0004556830390356481
region O 0 0.00038972587208263576
and O 0 2.327117181266658e-05
tested O 0 3.706851930473931e-05
for O 0 8.937018719734624e-06
homozygous O 0 6.718905206071213e-05
deletion O 0 9.694146865513176e-05
with O 0 1.945456642715726e-05
new O 0 5.7710505643626675e-05
intragenic O 0 0.005549448076635599
markers O 0 0.00045053326175548136
in O 0 5.645322744385339e-05
these O 0 1.4845968507870566e-05
23 O 0 0.00014570230268873274
cases O 0 2.9083328627166338e-05
with O 0 4.4806136429542676e-05
10q23 O 0 0.0038554882630705833
loss O 0 0.003952485043555498
of O 0 0.0030516553670167923
heterozygosity O 1 0.9998431205749512
. O 0 0.0015535480342805386

The O 0 0.00010178064258070663
identification O 0 1.3422470146906562e-05
of O 0 4.567248106468469e-05
the O 0 7.638508395757526e-05
second O 0 0.00018794160860124975
mutational O 0 0.0008830938022583723
event O 0 0.00011653888941509649
in O 0 1.6212547052418813e-05
10 O 0 1.8261558579979464e-05
( O 0 3.6788101169804577e-06
43 O 0 2.1484702301677316e-05
% O 0 4.639336475520395e-05
) O 0 0.00036124655161984265
tumors B-Disease 1 1.0
establishes O 1 0.9433421492576599
PTEN O 1 0.9999988079071045
/ O 1 0.9175772666931152
MMAC1 O 1 0.9996695518493652
as O 0 8.12355283414945e-05
a O 0 2.92235090455506e-05
main O 0 8.869652810972184e-05
inactivation O 0 0.0002824824186973274
target O 0 1.4590920727641787e-05
of O 0 3.981604095315561e-05
10q O 0 0.001071028527803719
loss O 0 0.0013609851012006402
in O 0 0.00026883117971010506
sporadic B-Disease 1 0.9999995231628418
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00238791573792696
. O 0 0.000386822153814137

Risk O 0 0.001310734893195331
reversals O 0 0.0009028164786286652
in O 0 4.955298936692998e-05
predictive O 0 0.00010587467113509774
testing O 0 0.00012319505913183093
for O 0 0.0007783455075696111
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.008612465113401413

The O 0 6.416186079150066e-05
first O 0 3.292020483058877e-05
predictive O 0 3.87983163818717e-05
testing O 0 6.309854506980628e-05
for O 0 0.00027197928284294903
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0003789822803810239
HD B-Disease 0 0.0236120093613863
) O 0 1.2994283679290675e-05
was O 0 1.9580707885324955e-05
based O 0 1.2675870948442025e-06
on O 0 4.845162038691342e-06
analysis O 0 1.792914076759189e-06
of O 0 3.420589928282425e-05
linked O 0 0.000376753305317834
polymorphic O 0 0.00019355244876351207
DNA O 0 0.00013613651390187442
markers O 0 0.00021353135525714606
to O 0 2.1835936422576196e-05
estimate O 0 1.0259549526381306e-05
the O 0 1.3065621715213638e-05
likelihood O 0 3.994196231360547e-05
of O 0 7.780156010994688e-05
inheriting O 0 0.0007360900053754449
the O 0 0.00010739338904386386
mutation O 0 5.021507240599021e-05
for O 0 6.150486296974123e-05
HD B-Disease 0 0.3329077959060669
. O 0 0.0004451271379366517

Limits O 0 0.00020124559523537755
to O 0 1.5084586266311817e-05
accuracy O 0 1.7346292224829085e-05
included O 0 1.9382730897632428e-05
recombination O 0 5.673289342666976e-05
between O 0 9.929977386491373e-05
the O 0 5.256071744952351e-05
DNA O 0 0.00011853701289510354
markers O 0 0.00021751933672931045
and O 0 1.7133908841060475e-05
the O 0 6.081142055336386e-05
mutation O 0 6.543748895637691e-05
, O 0 4.4916767365066335e-05
pedigree O 0 0.0003842605510726571
structure O 0 0.0004198751412332058
, O 0 2.341417348361574e-05
and O 0 9.128209967457224e-06
whether O 0 6.790264251321787e-06
DNA O 0 2.7127471184940077e-05
samples O 0 9.25715812627459e-06
were O 0 1.70156272361055e-05
available O 0 7.647697202628478e-06
from O 0 3.386145181139e-05
family O 0 9.218637569574639e-05
members O 0 9.388384205522016e-05
. O 0 0.00024912942899391055

With O 0 4.47201200586278e-05
direct O 0 1.8933813407784328e-05
tests O 0 7.28866643839865e-06
for O 0 8.156352123478428e-06
the O 0 4.037605322082527e-05
HD B-Disease 0 0.004510434810072184
mutation O 0 3.522406404954381e-05
, O 0 6.600591405003797e-06
we O 0 4.948112746205879e-06
have O 0 1.7053048395609949e-06
assessed O 0 1.0305108844477218e-05
the O 0 4.547830940282438e-06
accuracy O 0 1.0640622349455953e-05
of O 0 1.9077106117038056e-05
results O 0 1.0659595318429638e-05
obtained O 0 3.433810707065277e-05
by O 0 3.566754094208591e-05
linkage O 0 0.0004466513928491622
approaches O 0 7.565465057268739e-05
when O 0 1.791491376934573e-05
requested O 0 1.4288759302871767e-05
to O 0 2.222357943537645e-05
do O 0 9.800459338293876e-06
so O 0 3.1324657356890384e-06
by O 0 4.319718300394015e-06
the O 0 3.208200359949842e-05
test O 0 3.5846147511620075e-05
individuals O 0 5.3177216614130884e-05
. O 0 0.0002957974502351135

For O 0 0.00020887967548333108
six O 0 9.211423457600176e-05
such O 0 1.181097195512848e-05
individuals O 0 1.0419582395115867e-05
, O 0 2.510250124032609e-05
there O 0 3.155031299684197e-05
was O 0 0.0002477432426530868
significant O 0 0.00010266456956742331
disparity O 0 0.0017287377268075943
between O 0 0.0003635940665844828
the O 0 0.00019697849347721785
tests O 0 8.817291382001713e-05
. O 0 0.00013749668141826987

Three O 0 0.0002430606255074963
went O 0 0.00032001108047552407
from O 0 4.4381980842445046e-05
a O 0 6.57736964058131e-05
decreased O 0 0.0007573571638204157
risk O 0 7.535627810284495e-05
to O 0 2.1966223357594572e-05
an O 0 1.3775330444332212e-05
increased O 0 0.00013168012083042413
risk O 0 0.00011406581324990839
, O 0 1.3986760677653365e-05
while O 0 1.0903224392677657e-05
in O 0 1.2186537787783891e-05
another O 0 2.775673237920273e-05
three O 0 1.1134598025819287e-05
the O 0 6.455987750086933e-05
risk O 0 0.0002420075034024194
was O 0 0.001924368436448276
decreased O 0 0.007203362882137299
. O 0 0.0004221358394715935

Knowledge O 0 0.0006834185915067792
of O 0 0.0003189176495652646
the O 0 0.00017402568482793868
potential O 0 0.0001732214295770973
reasons O 0 2.8887019652756862e-05
for O 0 5.3022185966256075e-06
these O 0 1.9874455574608874e-06
changes O 0 5.753905043093255e-06
in O 0 9.784602298168465e-06
results O 0 7.751663360977545e-06
and O 0 7.169374384830007e-06
impact O 0 4.6145476517267525e-05
of O 0 3.069066588068381e-05
these O 0 1.612253618077375e-05
risk O 0 9.575617150403559e-05
reversals O 0 0.0009405534947291017
on O 0 0.0001438000617781654
both O 0 2.579564716143068e-05
patients O 0 2.0797346223844215e-05
and O 0 5.893921752431197e-06
the O 0 2.270476397825405e-05
counseling O 0 5.314344889484346e-05
team O 0 2.6055067792185582e-05
can O 0 3.7732220334874e-06
assist O 0 1.18945481517585e-05
in O 0 8.618354513600934e-06
the O 0 1.0475546332600061e-05
development O 0 1.2009280908387154e-05
of O 0 1.4277658010541927e-05
strategies O 0 1.8524769984651357e-05
for O 0 7.859704055590555e-06
the O 0 4.101221202290617e-05
prevention O 0 0.0004145766724832356
and O 0 1.5921155863907188e-05
, O 0 8.567023542127572e-06
where O 0 1.5252736375259701e-05
necessary O 0 1.646636337682139e-05
, O 0 8.09647735877661e-06
management O 0 2.0674267943832092e-05
of O 0 5.164176764083095e-05
a O 0 0.00012447804328985512
risk O 0 0.00012504217738751322
reversal O 0 0.00014224428741727024
in O 0 2.4184415451600216e-05
any O 0 1.3080593816994224e-05
predictive O 0 4.4957909267395735e-05
testing O 0 4.9907863285625353e-05
program O 0 4.731123772216961e-05
. O 0 2.396186755504459e-05
. O 0 6.505093188025057e-05

A O 0 0.0038867760449647903
novel O 0 0.0007769202347844839
common O 0 0.00026689539663493633
missense O 0 0.0009051527013070881
mutation O 0 0.00015430980420205742
G301C O 0 0.0007786508649587631
in O 0 4.7108282160479575e-05
the O 0 8.560006972402334e-05
N O 0 0.0020649759098887444
- O 0 0.0009489222429692745
acetylgalactosamine O 0 0.002601340878754854
- O 0 0.00031609891448169947
6 O 0 0.00032375019509345293
- O 0 0.000364039558917284
sulfate O 0 0.000564572517760098
sulfatase O 0 0.005276410840451717
gene O 0 0.00018757210636977106
in O 0 0.00023425213294103742
mucopolysaccharidosis B-Disease 1 0.9325741529464722
IVA I-Disease 1 0.9999310970306396
. O 0 0.0010593099286779761

Mucopolysaccharidosis B-Disease 1 0.9999207258224487
IVA I-Disease 1 0.9999995231628418
( O 0 0.00466116750612855
MPS B-Disease 1 0.999974250793457
IVA I-Disease 1 1.0
) O 0 7.600086973980069e-05
is O 0 2.098954064422287e-05
an O 0 2.3873346435721032e-05
autosomal B-Disease 1 0.9999532699584961
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999998807907104
by O 0 9.85319638857618e-05
a O 0 0.000232283171499148
genetic B-Disease 1 0.9998414516448975
defect I-Disease 1 0.9999996423721313
in O 0 0.0009134544525295496
N O 0 0.08369594812393188
- O 0 0.0010630396427586675
acetylgalactosamine O 0 0.002297916216775775
- O 0 0.0002596323611214757
6 O 0 0.00026840477949008346
- O 0 0.00043318321695551276
sulfate O 0 0.001239360892213881
sulfatase O 0 0.16626568138599396
( O 0 0.0006529500242322683
GALNS O 1 0.998674750328064
) O 0 0.00034241063985973597
. O 0 0.0002533468941692263

In O 0 0.00016730651259422302
previous O 0 7.110242586350068e-05
studies O 0 2.9294156774994917e-05
, O 0 1.0680250852601603e-05
we O 0 5.837451681145467e-06
have O 0 2.5925760382961016e-06
found O 0 2.9571847335319035e-06
two O 0 4.850099230679916e-06
common O 0 2.2403815819416195e-05
mutations O 0 6.290791498031467e-05
in O 0 9.301935642724857e-05
Caucasians O 0 0.001477046636864543
and O 0 7.485343667212874e-05
Japanese O 0 0.001120379427447915
, O 0 8.56409824336879e-05
respectively O 0 0.00024041699361987412
. O 0 0.00027443477301858366

To O 0 0.0003959211171604693
characterize O 0 0.0008312349673360586
the O 0 0.0002218813169747591
mutational O 0 0.0021426507737487555
spectrum O 0 0.000262775196461007
in O 0 2.5932735297828913e-05
various O 0 8.535234883311205e-06
ethnic O 0 2.1455338355735876e-05
groups O 0 6.8352701418916695e-06
, O 0 8.804366188996937e-06
mutations O 0 8.541293027519714e-06
in O 0 1.6581412637606263e-05
the O 0 7.04577614669688e-05
GALNS O 1 0.9926084876060486
gene O 0 5.0011960411211476e-05
in O 0 7.092505984473974e-05
Colombian O 0 0.0007969075813889503
MPS B-Disease 1 0.9999266862869263
IVA I-Disease 1 1.0
patients O 0 0.0014481318648904562
were O 0 0.00013011007104068995
investigated O 0 0.0002243986091343686
, O 0 1.750883529894054e-05
and O 0 1.0040677807410248e-05
genetic O 0 4.908394839731045e-05
backgrounds O 0 4.321283267927356e-05
were O 0 5.4907224694034085e-05
extensively O 0 7.608716987306252e-05
analyzed O 0 1.6319238056894392e-05
to O 0 6.28541693004081e-06
identify O 0 1.0001247574109584e-05
racial O 0 4.1792642150539905e-05
origin O 0 8.37888819660293e-06
, O 0 3.479864062683191e-06
based O 0 2.996634975716006e-06
on O 0 3.322040356579237e-05
mitochondrial O 0 5.577514457399957e-05
DNA O 0 0.00011384739627828822
( O 0 5.286887244437821e-05
mtDNA O 0 6.035950354998931e-05
) O 0 6.567755190189928e-05
lineages O 0 0.0006652722950093448
. O 0 0.0003858549753203988

Three O 0 0.00030619610333815217
novel O 0 0.0005864260601811111
missense O 0 0.0007588938460685313
mutations O 0 0.000173907246789895
never O 0 0.00024031363136600703
identified O 0 5.289342880132608e-05
previously O 0 4.523430106928572e-05
in O 0 2.037110971286893e-05
other O 0 4.811699909623712e-06
populations O 0 9.771062650543172e-06
and O 0 8.345147762156557e-06
found O 0 1.0719557394622825e-05
in O 0 1.5590705515933223e-05
16 O 0 3.288960942882113e-05
out O 0 7.258859113790095e-06
of O 0 3.1934818252921104e-05
19 O 0 0.0003363805008120835
Colombian O 0 0.0005543726147152483
MPS B-Disease 1 0.9970006346702576
IVA I-Disease 1 1.0
unrelated O 0 0.00040028299554251134
alleles O 0 3.5376622690819204e-05
account O 0 3.068680234719068e-05
for O 0 4.1291430534329265e-05
84 O 0 0.0014392600860446692
. O 0 0.0004583967966027558

2 O 0 0.0003813009534496814
% O 0 2.8952657885383815e-05
of O 0 4.43627723143436e-05
the O 0 4.4267686462262645e-05
alleles O 0 2.2324305973597802e-05
in O 0 3.0492919904645532e-05
this O 0 2.1656547687598504e-05
study O 0 5.369514474296011e-05
. O 0 9.563671483192593e-05

The O 0 0.000937215518206358
G301C O 0 0.002653483534231782
and O 0 8.817745401756838e-05
S162F O 0 0.001188740716315806
mutations O 0 5.881961988052353e-05
account O 0 2.6840345526579767e-05
for O 0 4.985530176782049e-05
68 O 0 0.0009911592351272702
. O 0 0.0004667328321374953

4 O 0 0.00121779995970428
% O 0 0.00015987656661309302
and O 0 0.00015113846166059375
10 O 0 0.000624559004791081
. O 0 0.0003442842571530491

5 O 0 0.00045633502304553986
% O 0 9.128318197326735e-05
of O 0 0.00019460113253444433
mutations O 0 0.00023982333368621767
, O 0 5.224838241701946e-05
respectively O 0 0.00013488750846590847
, O 0 1.777068609953858e-05
whereas O 0 2.3912489268695936e-05
the O 0 5.3752730309497565e-05
remaining O 0 0.00039617522270418704
F69V O 1 0.9644975066184998
is O 0 2.4084756660158746e-05
limited O 0 1.302070540987188e-05
to O 0 1.529655492049642e-05
a O 0 5.1358394557610154e-05
single O 0 7.263153383973986e-05
allele O 0 0.00012942963803652674
. O 0 0.0001653904328122735

The O 0 0.0006113735144026577
skewed O 0 0.00035620268317870796
prevalence O 0 0.0006248471327126026
of O 0 0.00024009855405893177
G301C O 0 0.001641574315726757
in O 0 6.844831659691408e-05
only O 0 3.416820982238278e-05
Colombian O 0 0.00016147772839758545
patients O 0 3.694979386636987e-05
and O 0 1.4794212802371476e-05
haplotype O 0 0.00012074805272277445
analysis O 0 1.7279260646319017e-05
by O 0 1.668766708462499e-05
restriction O 0 4.00739700125996e-05
fragment O 0 0.00011919690587092191
length O 0 5.484662688104436e-05
polymorphisms O 0 7.481675129383802e-05
in O 0 2.669830428203568e-05
the O 0 0.0001240195269929245
GALNS O 1 0.9754762649536133
gene O 0 6.749949534423649e-05
suggest O 0 3.9936516259331256e-05
that O 0 1.3866459994460456e-05
G301C O 0 0.0005903693963773549
originated O 0 0.0001291505031986162
from O 0 4.075784090673551e-05
a O 0 8.419909136136994e-05
common O 0 0.00012001750292256474
ancestor O 0 0.002021137159317732
. O 0 0.0005254080751910806

Investigation O 0 0.00028716272208839655
of O 0 0.00012016385153401643
the O 0 6.336107617244124e-05
genetic O 0 7.987018034327775e-05
background O 0 5.713183054467663e-05
by O 0 1.2434467862476595e-05
means O 0 1.729254836391192e-05
of O 0 5.231065006228164e-05
mtDNA O 0 3.820352867478505e-05
lineages O 0 6.942320032976568e-05
indicate O 0 2.746111022133846e-05
that O 0 5.3434932851814665e-06
all O 0 5.452491222968092e-06
our O 0 3.7298366805771366e-05
patients O 0 3.086906508542597e-05
are O 0 4.833425919059664e-06
probably O 0 5.810895163449459e-05
of O 0 7.619658572366461e-05
native O 0 0.00016830608365125954
American O 0 0.00041071148007176816
descent O 0 0.004395663738250732

Low O 0 0.0008713630959391594
frequency O 0 0.00010616298823151737
of O 0 0.000169655482750386
BRCA1 O 0 0.0007864063372835517
germline O 0 0.0007806765497662127
mutations O 0 3.6782446841243654e-05
in O 0 2.597865204734262e-05
45 O 0 8.860285743139684e-05
German O 1 0.9988407492637634
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0026929969899356365
. O 0 0.0005725056398659945

In O 0 0.00010983843822032213
this O 0 1.0923871741397306e-05
study O 0 5.117377440910786e-06
we O 0 4.139679731451906e-06
investigated O 0 2.6406802135170437e-05
45 O 0 4.8589587095193565e-05
German O 1 0.9972642660140991
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00013203393609728664
for O 0 3.5452412703307346e-05
germline O 0 0.0011176462285220623
mutations O 0 6.949234375497326e-05
in O 0 4.168437953921966e-05
the O 0 0.00011654110858216882
BRCA1 O 0 0.0009038876742124557
gene O 0 0.00021589423704426736
. O 0 0.00016938506450969726

We O 0 0.00014028682198841125
identified O 0 7.821993494872004e-05
four O 0 4.203654680168256e-05
germline O 0 0.0006847460172139108
mutations O 0 6.966233195271343e-05
in O 0 4.384532439871691e-05
three O 0 0.00011483982962090522
breast B-Disease 1 0.9999513626098633
cancer I-Disease 1 0.9836687445640564
families O 0 9.211707947542891e-06
and O 0 7.744459253444802e-06
in O 0 3.120810288237408e-05
one O 0 0.0002035466895904392
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.0007134546176530421
. O 0 9.432727892999537e-06
among O 0 3.3206617899850244e-06
these O 0 1.7903885236592032e-06
were O 0 1.6189080270123668e-05
one O 0 2.094938281516079e-05
frameshift O 0 0.0005490012117661536
mutation O 0 4.1290444642072544e-05
, O 0 2.959043013106566e-05
one O 0 2.2088312107371166e-05
nonsense O 0 0.00017841362569015473
mutation O 0 2.0543020582408644e-05
, O 0 1.2417345715221018e-05
one O 0 1.0992468560289126e-05
novel O 0 4.745438491227105e-05
splice O 0 0.00034379257704131305
site O 0 0.0002064689324470237
mutation O 0 3.1347994081443176e-05
, O 0 1.488227007939713e-05
and O 0 1.3572958778240718e-05
one O 0 5.9601516113616526e-05
missense O 0 0.0010234944056719542
mutation O 0 0.0002299465413670987
. O 0 0.0003920376766473055

The O 0 0.0008408088469877839
missense O 0 0.0016336068511009216
mutation O 0 0.00011153284140164033
was O 0 0.00032561953412368894
also O 0 2.1797486624564044e-05
found O 0 1.6951311408774927e-05
in O 0 4.563546826830134e-05
2 O 0 0.0005485739093273878
. O 0 0.0002760684001259506

8 O 0 0.0006951787509024143
% O 0 6.779209797969088e-05
of O 0 5.43296046089381e-05
the O 0 4.0591938159195706e-05
general O 0 3.97145668102894e-05
population O 0 8.865822564985137e-06
, O 0 7.2820594141376205e-06
suggesting O 0 1.750449519022368e-05
that O 0 1.7455516854170128e-06
it O 0 3.234941004848224e-06
is O 0 1.4870282939227764e-05
not O 0 3.178860424668528e-05
disease O 1 0.9995231628417969
associated O 0 0.0006956877186894417
. O 0 0.0005617806455120444

The O 0 0.00040199191425926983
average O 0 0.00018259922217112035
age O 0 0.0004151041794102639
of O 0 0.002099111443385482
disease O 1 1.0
onset O 1 0.9999984502792358
in O 0 0.00045513774966821074
those O 0 4.781670213560574e-05
families O 0 6.33772142464295e-05
harbouring O 1 0.7035045623779297
causative O 0 0.0340183824300766
mutations O 0 0.0007475526072084904
was O 0 0.002231544116511941
between O 0 0.0009428885532543063
32 O 0 0.0009271437302231789
. O 0 0.00025428825756534934

3 O 0 0.0023805731907486916
and O 0 0.00034627801505848765
37 O 0 0.001065578660927713
. O 0 0.00036238148459233344

4 O 0 0.0014387436676770449
years O 0 0.0003699948138091713
, O 0 3.260131779825315e-05
whereas O 0 5.1791204896289855e-05
the O 0 7.491063297493383e-05
family O 0 8.666262874612585e-05
harbouring O 0 0.006569450255483389
the O 0 0.00017430167645215988
missense O 0 0.00039629213279113173
mutation O 0 5.2929714001948014e-05
had O 0 6.820802082074806e-05
an O 0 1.0042229405371472e-05
average O 0 1.7085238141589798e-05
age O 0 4.715632530860603e-05
of O 0 0.00018735404592007399
onset O 1 0.9989836812019348
of O 0 0.011631188914179802
51 O 0 0.01602122187614441
. O 0 0.0012805679580196738

2 O 0 0.00564059242606163
years O 0 0.0020648203790187836
. O 0 0.0004964025574736297

These O 0 3.949867459596135e-05
findings O 0 3.808908149949275e-05
show O 0 4.205727600492537e-05
that O 0 1.1961435120610986e-05
BRCA1 O 0 0.00030246892129071057
is O 0 3.1752671930007637e-05
implicated O 0 0.00027480421704240143
in O 0 2.1675805328413844e-05
a O 0 1.0773999747470953e-05
small O 0 3.3000910661939997e-06
fraction O 0 1.4507018022413831e-05
of O 0 0.0002745360543485731
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.00011789840937126428
suggesting O 0 5.691295882570557e-05
the O 0 1.9159626390319318e-05
involvement O 0 8.270960097433999e-05
of O 0 9.153177234111354e-05
another O 0 0.00011649145017145202
susceptibility O 0 0.0012297221692278981
gene O 0 0.00020072264305781573
( O 0 0.00016662926645949483
s O 0 0.001023435965180397
) O 0 0.0006122364429756999

Paternal O 1 0.9651570916175842
transmission O 1 0.9999924898147583
of O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9999985694885254

We O 0 0.00010388233204139397
report O 0 7.671810635656584e-06
a O 0 9.572869203111622e-06
rare O 0 1.5674773749196902e-05
case O 0 1.9485780285322107e-05
of O 0 0.00036839378299191594
paternally O 1 1.0
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 0.0028391918167471886
. O 0 0.0006403794977813959

The O 0 0.0004909497802145779
proband O 0 0.002251711441203952
is O 0 2.0371418941067532e-05
a O 0 1.5214585801004432e-05
23 O 0 9.063180186785758e-05
year O 0 5.149679054738954e-05
old O 0 0.0006276796339079738
, O 0 0.0003239379439037293
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 1 0.9172013401985168
who O 0 0.46646472811698914
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.999584972858429

He O 0 0.0007228798349387944
presented O 0 0.0007501959917135537
with O 0 0.001577240414917469
respiratory O 1 1.0
and O 0 0.03323420509696007
feeding O 0 0.027856318280100822
difficulties O 1 0.99959796667099
at O 1 0.7997943758964539
birth O 0 0.0025459127500653267
. O 0 0.0006000952562317252

His O 0 0.0018196157179772854
two O 0 0.00038018779014237225
sibs O 1 0.9993446469306946
suffer O 1 0.8122219443321228
from O 0 0.0009788386523723602
childhood O 1 0.9999972581863403
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.10213294625282288

Their O 0 0.00023293988488148898
late O 0 0.0013397064758464694
father O 0 0.000297654332825914
had O 0 3.9838607335696e-05
the O 0 2.3135482479119673e-05
adult O 0 1.822703779907897e-05
type O 0 9.880708967102692e-05
of O 0 0.0007219785475172102
DM B-Disease 1 1.0
, O 0 0.00019666303705889732
with O 0 5.493970093084499e-05
onset O 1 0.9998325109481812
around O 0 0.0014464311534538865
30 O 0 0.0007051518186926842
years O 0 0.0008122521103359759
. O 0 0.000446025951532647

Only O 0 0.00012559066817630082
six O 0 5.119975685374811e-05
other O 0 6.444284281315049e-06
cases O 0 1.1152216757182032e-05
of O 0 9.224063251167536e-05
paternal O 0 0.0283021442592144
transmission O 1 0.9997475743293762
of O 1 0.9999980926513672
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.017413252964615822
been O 0 0.00017216034757439047
reported O 0 0.00010619529348332435
recently O 0 0.00019039862672798336
. O 0 0.00011846332927234471

We O 0 9.282157407142222e-05
review O 0 2.1373060008045286e-05
the O 0 4.020683991257101e-05
sex O 0 7.309365173568949e-05
related O 0 0.00011254736455157399
effects O 0 0.0009097079746425152
on O 0 0.000729489023797214
transmission O 0 0.29961097240448
of O 1 0.9995962977409363
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9995512366294861

Decreased O 0 0.014055825769901276
fertility O 0 0.0008778077899478376
of O 0 6.45588879706338e-05
males O 0 1.3402543117990717e-05
with O 0 1.7726306396070868e-05
adult O 0 0.00017168365593533963
onset O 1 0.9999998807907104
DM B-Disease 1 1.0
and O 0 0.0004918491467833519
contraction O 0 0.0010136672062799335
of O 0 7.794458360876888e-05
the O 0 5.532391878659837e-05
repeat O 0 0.0003309118328616023
upon O 0 0.00016462565690744668
male O 0 0.00017442968965042382
transmission O 0 0.00013468418910633773
contribute O 0 4.382128827273846e-05
to O 0 1.6946250980254263e-05
the O 0 2.7036612664232962e-05
almost O 0 3.248660868848674e-05
absent O 0 5.5354419600917026e-05
occurrence O 0 5.1653441914822906e-05
of O 0 8.245405479101464e-05
paternal O 0 0.002641185186803341
transmission O 1 0.9985108971595764
of O 1 0.9999978542327881
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999446868896484

Also O 0 0.00015720463125035167
the O 0 7.676223322050646e-05
fathers O 0 8.677285222802311e-05
of O 0 6.0123169532744214e-05
the O 0 0.00015769980382174253
reported O 0 0.00043664046097546816
congenitally O 1 0.5087645053863525
affected O 0 0.00018011846987064928
children O 0 3.3239670301554725e-05
showed O 0 7.642063428647816e-05
, O 0 1.1529563380463514e-05
on O 0 4.8054913349915296e-05
average O 0 5.380319635150954e-05
, O 0 4.7799469029996544e-05
shorter O 0 0.0007329407380893826
CTG O 1 0.6986860632896423
repeat O 0 0.0009398749098181725
lengths O 0 0.0011222600005567074
and O 0 2.8724012736347504e-05
hence O 0 8.926331793190911e-05
less O 0 0.00012778709060512483
severe O 1 0.9991990923881531
clinical O 1 0.9462482333183289
symptoms O 1 0.9994120597839355
than O 0 0.00011758884647861123
the O 0 0.00010610480239847675
mothers O 0 7.196291699074209e-05
of O 0 8.771051216172054e-05
children O 0 0.0002768581034615636
with O 1 0.5600192546844482
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9999831914901733

We O 0 9.872261580312625e-05
conclude O 0 0.00020148558542132378
that O 0 1.782907929737121e-05
paternal O 0 0.0006880780565552413
transmission O 0 0.23003624379634857
of O 1 0.9999605417251587
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9379162192344666
rare O 0 0.000319450453389436
and O 0 1.940673973876983e-05
preferentially O 0 2.7905387469218113e-05
occurs O 0 6.712045433232561e-06
with O 0 5.458370196720352e-06
onset O 1 0.9988712668418884
of O 1 0.9618781805038452
DM B-Disease 1 1.0
past O 0 0.0012921299785375595
30 O 0 0.0001670353813096881
years O 0 6.836899410700426e-05
in O 0 2.1793455744045787e-05
the O 0 5.5256212363019586e-05
father O 0 0.00028114113956689835
. O 0 6.09669805271551e-05
. O 0 0.00012700536171905696

The O 0 0.002303360030055046
RB1 O 1 0.9936222434043884
gene O 0 0.00026096627698279917
mutation O 0 5.620462980004959e-05
in O 0 6.861692236270756e-05
a O 0 0.00013651428162120283
child O 0 0.0003463846805971116
with O 0 0.00022831109527032822
ectopic B-Disease 1 0.9999372959136963
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.325967401266098

The O 0 0.0011398334754630923
RB1 O 1 0.9979655742645264
gene O 0 0.0001863802899606526
mutation O 0 4.9434569518780336e-05
was O 0 0.00023847370175644755
investigated O 0 0.00012522665201686323
in O 0 3.428172567510046e-05
a O 0 5.8938763686455786e-05
child O 0 0.00019818797591142356
with O 0 0.00017103480058722198
ectopic B-Disease 1 0.9984152317047119
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9998037219047546
using O 0 8.146515756379813e-05
DNA O 0 6.447097985073924e-05
obtained O 0 1.4176402146404143e-05
from O 0 1.990404234675225e-05
both O 0 2.1335610654205084e-05
the O 0 0.0001809088425943628
pineal B-Disease 1 0.9934915900230408
and I-Disease 0 0.00062928581610322
retinal I-Disease 1 0.9999997615814209
tumours I-Disease 1 1.0
of O 1 0.9998685121536255
the O 1 0.9642711877822876
patient O 0 0.007793471682816744
. O 0 0.00037587835686281323

A O 0 0.002540046349167824
nonsense O 0 0.0012638727203011513
mutation O 0 6.93945330567658e-05
in O 0 9.001870785141364e-05
exon O 0 0.0005436901701614261
17 O 0 0.00024237581237684935
( O 0 3.0323310056701303e-05
codon O 0 5.075407898402773e-05
556 O 0 0.0002087940665660426
) O 0 1.5329527741414495e-05
of O 0 9.047361527336761e-05
the O 0 0.00035113151534460485
RB1 O 1 0.9979325532913208
gene O 0 8.575277024647221e-05
was O 0 0.00014583337178919464
found O 0 9.869132554740645e-06
to O 0 6.9599395828845445e-06
be O 0 7.545095286332071e-06
present O 0 2.309091178176459e-05
homozygously O 0 0.001063650008291006
in O 0 4.370534952613525e-05
both O 0 3.0609986424678937e-05
the O 0 0.00013546495756600052
retinal B-Disease 1 0.9975184202194214
and I-Disease 0 0.00045194392441771924
the I-Disease 1 0.7877616286277771
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 0.005448424722999334

The O 0 0.00027639654581435025
same O 0 6.994336581556126e-05
mutation O 0 5.164166941540316e-05
was O 0 0.000199651243747212
present O 0 7.401085167657584e-05
heterozygously O 0 0.0010506840189918876
in O 0 2.695574949029833e-05
the O 0 1.786925167834852e-05
DNA O 0 1.780756974767428e-05
from O 0 1.153297216660576e-05
the O 0 2.2580172299058177e-05
constitutional O 0 7.29575112927705e-05
cells O 0 1.8905971955973655e-05
of O 0 1.9776818589889444e-05
the O 0 4.618377715814859e-05
patient O 0 5.617055649054237e-05
, O 0 9.783360837900545e-06
proving O 0 0.00014301404007710516
it O 0 5.450453045341419e-06
to O 0 9.487182069278788e-06
be O 0 1.2039647117489949e-05
of O 0 0.0001271370711037889
germline O 0 0.0029244297184050083
origin O 0 0.000358282879460603
. O 0 0.0005744017544202507

The O 0 0.00017759486217983067
initial O 0 8.201273158192635e-05
mutation O 0 3.6657082091551274e-05
was O 0 0.00010026764357462525
shown O 0 1.6166322893695906e-05
to O 0 1.1742058632080443e-05
have O 0 4.280792381905485e-06
occurred O 0 6.357182428473607e-05
in O 0 1.3125831173965707e-05
the O 0 5.019247328164056e-05
paternally O 0 0.0013737953267991543
derived O 0 0.0005426955176517367
RB1 O 1 0.965853750705719
allele O 0 0.0005394556792452931
. O 0 0.0003878850839100778

The O 0 0.0003240895748604089
mutation O 0 6.11999275861308e-05
is O 0 1.4703716260555666e-05
in O 0 1.053426240105182e-05
an O 0 7.872599780966993e-06
area O 0 2.7595471692620777e-05
of O 0 1.049569618771784e-05
the O 0 2.0505480279098265e-05
gene O 0 7.845063919376116e-06
that O 0 1.8106503603121382e-06
encodes O 0 7.0068176682980265e-06
the O 0 1.2450570466171484e-05
protein O 0 4.704246748588048e-05
- O 0 5.514303848030977e-05
binding O 0 1.346146655123448e-05
region O 0 6.41432634438388e-05
known O 0 6.897920684423298e-05
as O 0 4.958371937391348e-05
the O 0 8.301302295876667e-05
pocket O 0 0.001123910304158926
region O 0 0.00016341047012247145
and O 0 2.634801421663724e-05
has O 0 2.0842831872869283e-05
been O 0 2.911196497734636e-05
detected O 0 4.1485382098471746e-05
in O 0 8.734642506169621e-06
other O 0 4.081030965608079e-06
cases O 0 1.4607389857701492e-05
of O 0 0.00042638403829187155
retinoblastoma B-Disease 1 0.9992058873176575
. O 0 0.0003105622308794409
. O 0 0.00029212384833954275

Low O 0 0.001220401143655181
levels O 0 0.00017708992527332157
of O 0 0.00012935460836160928
beta O 0 0.0005541761056520045
hexosaminidase O 0 0.0017560841515660286
A O 0 0.00022608360450249165
in O 0 3.8304067857097834e-05
healthy O 0 4.8970847274176776e-05
individuals O 0 3.761516609301907e-06
with O 0 2.2438134692492895e-05
apparent O 1 0.9999675750732422
deficiency O 1 1.0
of O 1 0.9993501305580139
this O 0 0.000669926346745342
enzyme O 0 0.0006143295904621482
. O 0 0.0003901708987541497

Appreciable O 0 0.013480267487466335
beta O 0 0.0028320152778178453
hexosaminidase O 0 0.008765790611505508
A O 0 0.0011056687217205763
( O 0 0.00012536799476947635
hex O 0 0.0006568040116690099
A O 0 0.0002216455468442291
) O 0 1.4210865629138425e-05
activity O 0 1.197983783640666e-05
has O 0 9.408219739270862e-06
been O 0 2.1571049728663638e-05
detected O 0 0.00014098550309427083
in O 0 0.0001057602494256571
cultured O 0 0.008410599082708359
skin O 1 0.973726749420166
fibroblasts O 0 0.2974911034107208
and O 0 0.008661025203764439
melanoma B-Disease 1 1.0
tissue O 1 0.9999958276748657
from O 0 0.004758942872285843
healthy O 0 0.000555585022084415
individuals O 0 9.554571988701355e-06
previously O 0 0.00010763575119199231
reported O 0 5.009750748286024e-05
as O 0 7.195145735749975e-05
having O 0 0.0015191052807494998
deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.4443216323852539
hex I-Disease 0 0.3176887631416321
A I-Disease 0 0.0010604873532429338
activity O 0 7.364321209024638e-05
indistinguishable O 0 8.558022818760946e-05
from O 0 6.067220965633169e-06
that O 0 1.4710775531057152e-06
of O 0 1.238737331732409e-05
patients O 0 6.567630043718964e-05
with O 0 0.000478922767797485
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0014157891273498535
TSD B-Disease 1 0.9999897480010986
) O 0 0.0007336427224799991
. O 0 0.00036491412902250886

Identification O 0 0.0005148560157977045
and O 0 0.00025047193048521876
quantitation O 0 0.004302865359932184
of O 0 0.0010975489858537912
hex O 0 0.005075984634459019
A O 0 0.0009126171353273094
, O 0 3.3547166822245345e-05
amounting O 0 0.0002923793508671224
to O 0 0.00011506552255013958
3 O 0 0.0005322587676346302
. O 0 0.00026957577210851014

5 O 0 0.0011546947062015533
% O 0 0.000437673443229869
- O 0 0.0015261662192642689
6 O 0 0.0010991801973432302
. O 0 0.0003580448974389583

9 O 0 0.0005551346112042665
% O 0 3.9794176700524986e-05
of O 0 7.184594869613647e-05
total O 0 0.00018632574938237667
beta O 0 0.0005100712296552956
hexosaminidase O 0 0.00101422646548599
activity O 0 4.5916687668068334e-05
, O 0 6.319520707620541e-06
has O 0 3.5821353776555043e-06
been O 0 4.5124820644559804e-06
obtained O 0 9.631437933421694e-06
by O 0 2.726435923250392e-05
cellulose O 0 0.0015779546229168773
acetate O 0 0.0013062533689662814
gel O 0 0.0023883748799562454
electrophoresis O 0 0.0011768130352720618
, O 0 0.0001760914601618424
DEAE O 1 0.9991829991340637
- O 0 0.0018789716996252537
cellulose O 0 0.0017364969244226813
ion O 0 0.0009451353689655662
- O 0 0.0006671033333986998
exchange O 0 0.0002517279062885791
chromatography O 0 0.0028565055690705776
, O 0 0.0001025485253194347
radial O 0 0.0015410849591717124
immunodiffusion O 1 0.6551526188850403
, O 0 0.00019015659927390516
and O 0 0.0001699195127002895
radioimmunoassay O 1 0.6866581439971924
. O 0 0.0005917167873121798

Previous O 0 0.0007032636785879731
family O 0 0.00014478462981060147
studies O 0 3.925927376258187e-05
suggested O 0 3.634842505562119e-05
that O 0 2.721731789279147e-06
these O 0 2.0579116153385257e-06
individuals O 0 4.179777988611022e-06
may O 0 4.429150067153387e-05
be O 0 2.4499560822732747e-05
compound O 0 0.00014496450603473932
heterozygotes O 0 0.00019718351541087031
for O 0 1.932651321112644e-05
the O 0 6.485285121016204e-05
common O 0 6.824392039561644e-05
mutant O 0 0.0009294393821619451
TSD B-Disease 1 0.9991681575775146
gene O 0 7.933683809824288e-05
and O 0 9.916313501889817e-06
a O 0 2.1427507817861624e-05
rare O 0 5.357025293051265e-05
( O 0 2.192821557400748e-05
allelic O 0 0.00029518752126023173
) O 0 5.472547127283178e-05
mutant O 0 0.00042561691952869296
gene O 0 0.0002357751945964992
. O 0 0.00024226008099503815

Thus O 0 0.0006312752957455814
, O 0 4.83190015074797e-05
the O 0 4.4154356146464124e-05
postulated O 0 0.00048660964239388704
rate O 0 7.22362965461798e-05
mutant O 0 0.0001627010351512581
gene O 0 2.059186044789385e-05
appears O 0 2.9342192647163756e-05
to O 0 5.328714905772358e-06
code O 0 3.139745331282029e-06
for O 0 3.047263589905924e-06
the O 0 2.1815620129927993e-05
expression O 0 2.0452220269362442e-05
of O 0 6.282956019276753e-05
low O 0 0.00020920457609463483
amounts O 0 6.795403169235215e-05
of O 0 0.0002655787393450737
hex O 0 0.0032892986200749874
A O 0 0.002861260436475277
. O 0 0.0002638222649693489

Heterozygotes O 0 0.0037951692938804626
for O 0 7.772562094032764e-05
the O 0 0.00011642580648185685
rare O 0 0.0002610128140076995
mutant O 0 0.0005078081740066409
may O 0 0.00012127249647164717
be O 0 2.5090299459407106e-05
indistinguishable O 0 0.0001173999480670318
from O 0 4.223053838359192e-05
heterozygotes O 0 0.0003056640853174031
for O 0 4.2941217543557286e-05
the O 0 0.00014613669191021472
common O 0 0.0004959999932907522
TSD B-Disease 1 0.9999457597732544
mutant O 0 0.004008830990642309
. O 0 0.0006670362781733274

However O 0 0.0001700371940387413
, O 0 3.1053808925207704e-05
direct O 0 5.156214683665894e-05
visualization O 0 0.0007950058206915855
and O 0 0.00013258362014312297
quantitation O 0 0.0030742224771529436
of O 0 0.000908371526747942
hex O 0 0.002239909954369068
A O 0 0.0002911451447289437
by O 0 7.648550308658741e-06
the O 0 1.580509342602454e-05
methods O 0 2.9709353839280084e-05
described O 0 0.00014363479567691684
may O 0 0.00015504487964790314
prevent O 0 0.00019094110757578164
false O 0 0.0001973415055545047
- O 0 0.000518468557856977
positive O 0 5.189601506572217e-05
prenatal O 0 0.00041460059583187103
diagnosis O 0 0.0006172099965624511
of O 0 0.001405156683176756
TSD B-Disease 1 0.9999933242797852
in O 0 0.0007279283017851412
fetuses O 0 0.0005130896461196244
having O 0 7.405963697237894e-05
the O 0 3.010562068084255e-05
incomplete O 0 0.00030390871688723564
hex B-Disease 0 0.007632198743522167
A I-Disease 1 0.9558420181274414
deficiency I-Disease 1 0.9999997615814209
of O 0 0.00119570002425462
the O 0 0.000421774631831795
type O 0 0.0003860514552798122
described O 0 0.00015494233230128884
in O 0 3.508536974550225e-05
the O 0 6.760978430975229e-05
four O 0 0.0001203961146529764
healthy O 0 0.0005509539041668177
individuals O 0 0.00016240125114563853

The O 0 0.001824909239076078
tumor B-Disease 1 0.9998292922973633
suppressor O 0 0.01723460853099823
gene O 0 0.0005608861101791263
Smad4 O 1 0.7281420230865479
/ O 0 0.0013966624392196536
Dpc4 O 0 0.00316720106638968
is O 0 2.4907443730626255e-05
required O 0 8.23284517537104e-06
for O 0 3.088826997554861e-05
gastrulation O 0 0.002340456238016486
and O 0 6.634543387917802e-05
later O 0 0.00014830214786343277
for O 0 3.666757038445212e-05
anterior O 0 0.0020971649792045355
development O 0 0.00036055734381079674
of O 0 0.0007254850352182984
the O 0 0.0010442143538966775
mouse O 0 0.0011426148703321815
embryo O 0 0.00040613210876472294
. O 0 0.00012246877304278314

Mutations O 0 0.0007533151074312627
in O 0 0.0001740583684295416
the O 0 0.00042097229743376374
SMAD4 O 1 0.9999986886978149
/ O 1 0.9989851117134094
DPC4 O 1 0.9999994039535522
tumor B-Disease 1 0.9999840259552002
suppressor O 0 0.0040192739106714725
gene O 0 5.6939286878332496e-05
, O 0 9.441467227588873e-06
a O 0 2.2422755137085915e-05
key O 0 8.971517672762275e-05
signal O 0 0.0002075262163998559
transducer O 0 0.00010361029126215726
in O 0 3.0641473131254315e-05
most O 0 3.834821472992189e-05
TGFbeta O 0 0.14010439813137054
- O 0 0.0006253517349250615
related O 0 7.848547829780728e-05
pathways O 0 0.00015743957192171365
, O 0 1.1309530236758292e-05
are O 0 1.4166022310746484e-06
involved O 0 8.378768143302295e-06
in O 0 1.1408332284190692e-05
50 O 0 2.8590071451617405e-05
% O 0 3.067521538469009e-05
of O 0 0.002925141714513302
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.012074261903762817

Homozygous O 0 0.007101711817085743
Smad4 O 1 0.9553974270820618
mutant O 0 0.012843841686844826
mice O 0 0.004616946913301945
die O 0 0.0022391981910914183
before O 0 0.0001293469686061144
day O 0 0.00022377341520041227
7 O 0 0.00047936139162629843
. O 0 0.00013998271606396884

5 O 0 0.001682337955571711
of O 0 0.001213794224895537
embryogenesis O 0 0.013191482983529568
. O 0 0.0011701153125613928

Mutant O 0 0.0017919476376846433
embryos O 0 0.00012558048183564097
have O 0 7.63805383030558e-06
reduced O 0 3.199764614691958e-05
size O 0 3.506920984364115e-05
, O 0 1.2990046343475115e-05
fail O 0 6.565876537933946e-05
to O 0 3.842230944428593e-05
gastrulate O 0 0.002443416975438595
or O 0 6.470341759268194e-05
express O 0 0.00014347134856507182
a O 0 0.0001631219929549843
mesodermal O 0 0.005076191853731871
marker O 0 0.002500088419765234
, O 0 6.863773887744173e-05
and O 0 3.429450953262858e-05
show O 0 0.0005137267289683223
abnormal O 0 0.0047886609099805355
visceral O 1 0.9984158277511597
endoderm O 1 0.9998857975006104
development O 0 0.025216273963451385
. O 0 0.0009335330687463284

Growth B-Disease 1 0.9999972581863403
retardation I-Disease 1 0.9999997615814209
of O 0 0.005373609717935324
the O 0 0.004893572069704533
Smad4 O 1 0.9999895095825195
- O 0 0.00707213394343853
deficient O 0 0.000553331570699811
embryos O 0 1.238944059878122e-05
results O 0 4.481718406168511e-06
from O 0 1.0654300240275916e-05
reduced O 0 0.00012102804612368345
cell O 0 0.000227289623580873
proliferation O 0 0.0008617533603683114
rather O 0 2.1577963707386516e-05
than O 0 1.8764341803034768e-05
increased O 0 0.0002117631520377472
apoptosis O 0 0.0020602529402822256
. O 0 0.0003752786433324218

Aggregation O 0 0.0009461385780014098
of O 0 0.0005990517674945295
mutant O 0 0.0027968280483037233
Smad4 O 1 0.9988310933113098
ES O 1 0.9728645086288452
cells O 0 0.00019790721125900745
with O 0 2.8585356631083414e-05
wild O 0 0.00015117594739422202
- O 0 0.000267322437139228
type O 0 0.0001725735201034695
tetraploid O 0 0.0006897436105646193
morulae O 0 0.006901367101818323
rescues O 0 0.0009743807604536414
the O 0 0.00033815245842561126
gastrulation B-Disease 1 0.9900548458099365
defect I-Disease 1 0.9983194470405579
. O 0 0.0015218374319374561

These O 0 5.374273314373568e-05
results O 0 3.427777119213715e-05
indicate O 0 6.848802149761468e-05
that O 0 1.490563681727508e-05
Smad4 O 0 0.0012366380542516708
is O 0 1.319292096013669e-05
initially O 0 9.048524589161389e-06
required O 0 1.8077722643283778e-06
for O 0 3.414445473026717e-06
the O 0 2.0058312657056376e-05
differentiation O 0 9.686790144769475e-05
of O 0 0.00012847960169892758
the O 0 0.0003476154524832964
visceral O 1 0.9060802459716797
endoderm O 1 0.9594704508781433
and O 0 4.444708247319795e-05
that O 0 1.5767789591336623e-05
the O 0 7.577132782898843e-05
gastrulation B-Disease 0 0.2999531626701355
defect I-Disease 0 0.020033231005072594
in O 0 7.123536488506943e-05
the O 0 0.00011493085912661627
epiblast O 1 0.605500340461731
is O 0 4.866397284786217e-05
secondary O 0 0.0002186242345487699
and O 0 7.313791866181418e-05
non O 0 0.001628325437195599
- O 0 0.01611400581896305
cell O 0 0.0008533339132554829
autonomous O 0 0.0004254639788996428
. O 0 0.0002061174309346825

Rescued O 0 0.01624472253024578
embryos O 0 0.0011518229730427265
show O 0 0.0007522527012042701
severe O 1 0.7023797035217285
anterior O 1 0.9822760224342346
truncations O 1 0.991491973400116
, O 0 0.0002439544623484835
indicating O 0 0.0004139521042816341
a O 0 4.092083327122964e-05
second O 0 5.3095332987140864e-05
important O 0 3.255738556617871e-05
role O 0 7.606939470861107e-05
for O 0 4.347455978859216e-05
Smad4 O 1 0.9921396374702454
in O 0 0.00034069165121763945
anterior O 1 0.9957505464553833
patterning O 1 0.9981563687324524
during O 1 0.9992508292198181
embryogenesis O 1 0.9954374432563782
. O 0 0.0012077252613380551

Prevalence O 0 0.0063994568772614
of O 0 0.0008132318616844714
p16 O 0 0.0021889356430619955
and O 0 0.00021377763187047094
CDK4 O 1 0.9998388290405273
germline O 0 0.004947638139128685
mutations O 0 0.0002358750207349658
in O 0 0.00018018271657638252
48 O 0 0.001649533398449421
melanoma B-Disease 1 0.9999998807907104
- O 1 0.8176028728485107
prone O 0 0.0020724674686789513
families O 0 4.510055805440061e-05
in O 0 0.00012975189019925892
France O 0 0.000889945134986192
. O 0 0.00031001053866930306

The O 0 0.000537259504199028
French O 0 0.0038147419691085815
Familial B-Disease 1 0.9999996423721313
Melanoma I-Disease 1 1.0
Study O 0 0.03724569454789162
Group O 0 0.000498197681736201
. O 0 0.00037114755832590163

Germline O 0 0.01719125173985958
mutations O 0 0.0005006357096135616
in O 0 0.0001319228031206876
the O 0 0.0001314404944423586
p16 O 0 0.0006206017569638789
and O 0 5.5742490076227114e-05
CDK4 O 1 0.9983251690864563
genes O 0 3.4893335396191105e-05
have O 0 4.3011050365748815e-06
been O 0 8.287149285024498e-06
reported O 0 5.842864993610419e-06
in O 0 4.68954567622859e-06
a O 0 2.182290336349979e-05
subset O 0 0.00010016940359491855
of O 0 0.0005548578919842839
melanoma B-Disease 1 0.9999994039535522
pedigrees O 0 0.005211560055613518
, O 0 8.014438935788348e-05
but O 0 1.1840462320833467e-05
their O 0 1.339419850410195e-05
prevalence O 0 0.0003941678733099252
is O 0 3.210391878383234e-05
not O 0 1.115705799747957e-05
well O 0 5.0878908950835466e-05
known O 0 0.0002929432666860521
. O 0 0.0002137582778232172

We O 0 0.00022228046145755798
searched O 0 8.887881267582998e-05
for O 0 1.3660443073604256e-05
such O 0 2.5330064090667292e-05
germline O 0 0.0013703599106520414
mutations O 0 0.00013154582120478153
in O 0 0.00018113634723704308
48 O 0 0.0005852944450452924
French O 0 0.11133024841547012
melanoma B-Disease 1 1.0
- O 1 0.9246455430984497
prone O 0 0.0012088213115930557
families O 0 9.679882168711629e-06
selected O 0 1.0256751920678653e-05
according O 0 2.328323262190679e-06
to O 0 3.768007900362136e-06
two O 0 3.7111690289748367e-06
major O 0 5.144417445990257e-05
criteria O 0 1.2276565939828288e-05
families O 0 5.399766450864263e-06
with O 0 6.071695679565892e-06
at O 0 0.00010598092922009528
least O 0 1.6133686585817486e-05
three O 0 8.682734915055335e-06
affected O 0 1.9543396774679422e-05
members O 0 5.645230430673109e-06
( O 0 1.6603646145085804e-05
n O 0 8.534568041795865e-05
= O 0 0.00012947357026860118
20 O 0 7.010724220890552e-05
) O 0 1.1068312232964672e-05
or O 0 7.770129741402343e-06
families O 0 4.844066552323056e-06
with O 0 5.362985120882513e-06
two O 0 1.443760993424803e-05
affected O 0 3.700134766404517e-05
members O 0 1.1552875548659358e-05
, O 0 7.843477760616224e-06
one O 0 5.852122285432415e-06
of O 0 3.0438650355790742e-05
them O 0 1.5313895346480422e-05
affected O 0 2.662848237378057e-05
before O 0 2.8147080229246058e-05
the O 0 1.0803651093738154e-05
age O 0 4.045931200380437e-05
of O 0 4.7019595513120294e-05
50 O 0 6.200495408847928e-05
( O 0 1.3959416719444562e-05
n O 0 6.54590839985758e-05
= O 0 9.228850103681907e-05
28 O 0 9.271135058952495e-05
) O 0 1.2166378837719094e-05
, O 0 5.494915512826992e-06
and O 0 5.880295248061884e-06
one O 0 5.1132797125319485e-06
additional O 0 3.325044963276014e-05
minor O 0 0.0039563351310789585
criterion O 1 0.9928487539291382
. O 0 0.000980433076620102

Sixteen O 0 0.0023947046138346195
different O 0 0.00011888724111486226
p16 O 0 0.0017491888720542192
germline O 0 0.0020284345373511314
mutations O 0 0.00011493798228912055
were O 0 6.962507904972881e-05
found O 0 1.340852577413898e-05
in O 0 1.5547131624771282e-05
21 O 0 0.00010528530401643366
families O 0 1.0286923497915268e-05
, O 0 1.0182312507822644e-05
while O 0 1.1696973160724156e-05
one O 0 2.8344738893792965e-05
germline O 0 0.0010978218633681536
mutation O 0 6.7378074163571e-05
, O 0 3.438555359025486e-05
Arg24His O 0 0.005435700993984938
, O 0 2.9986938898218796e-05
was O 0 0.00018694823666010052
detected O 0 9.469440556131303e-05
in O 0 2.8509182811831124e-05
the O 0 0.000215681066038087
CDK4 O 1 0.9979428648948669
gene O 0 0.0008257310837507248
. O 0 0.00030504920869134367

The O 0 0.00018099303997587413
frequency O 0 8.758003968978301e-05
of O 0 0.00015607282693963498
p16 O 0 0.000761692295782268
gene O 0 4.2822459363378584e-05
mutation O 0 1.4182636732584797e-05
in O 0 1.2560156392282806e-05
our O 0 7.596263003506465e-06
sample O 0 1.837046170294343e-06
( O 0 5.016524028178537e-06
44 O 0 1.1335801900713705e-05
% O 0 1.165103731182171e-05
) O 0 8.318457730638329e-06
is O 0 3.7292168144631432e-06
among O 0 4.566675670503173e-06
the O 0 1.3516086255549453e-05
highest O 0 0.00013124475663062185
rates O 0 1.7637812561588362e-05
yet O 0 9.929495718097314e-06
reported O 0 1.3647267223859672e-05
and O 0 6.968713023525197e-06
the O 0 4.281029396224767e-05
CDK4 O 1 0.9525008201599121
mutation O 0 2.9925748094683513e-05
is O 0 8.400330443691928e-06
the O 0 1.6795658666524105e-05
second O 0 4.867075040237978e-05
mutation O 0 2.305161797266919e-05
detected O 0 7.3685085226316e-05
in O 0 1.846941449912265e-05
this O 0 1.663538751017768e-05
gene O 0 9.458465501666069e-05
worldwide O 0 0.0002311171847395599
. O 0 0.00035642023431137204

In O 0 0.0002852529287338257
summary O 0 0.0003125818620901555
, O 0 2.499238689779304e-05
our O 0 1.201902068714844e-05
results O 0 9.79046308202669e-06
show O 0 1.9331562725710683e-05
frequent O 0 1.5605952285113744e-05
involvement O 0 4.5396351197268814e-05
of O 0 4.655925295082852e-05
the O 0 6.865509203635156e-05
p16 O 0 0.000451473897555843
gene O 0 5.310590859153308e-05
in O 0 0.00011503315181471407
familial B-Disease 1 0.998802661895752
melanoma I-Disease 1 0.9999998807907104
and O 0 0.00010017074237111956
confirm O 0 3.934986307285726e-05
the O 0 2.4581424440839328e-05
role O 0 3.647189441835508e-05
of O 0 5.882690311409533e-05
the O 0 0.00012778537347912788
CDK4 O 1 0.9993124008178711
gene O 0 7.265494059538469e-05
as O 0 4.970813824911602e-05
a O 0 0.00019142053497489542
melanoma B-Disease 1 0.9999990463256836
- O 0 0.09958583116531372
predisposing O 0 0.005450714845210314
gene O 0 0.00020692712860181928
. O 0 9.885110921459273e-05
. O 0 0.00020465260604396462

Progression O 1 0.89488285779953
of O 0 0.004357371013611555
somatic O 0 0.12477826327085495
CTG O 1 0.9991368651390076
repeat O 0 0.0012039910070598125
length O 0 0.00011141676077386364
heterogeneity O 0 0.00010857506276806816
in O 0 2.2667487428407185e-05
the O 0 4.337773862062022e-05
blood O 0 0.0007114160689525306
cells O 0 0.001054665306583047
of O 1 0.9999531507492065
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 0 0.003949896898120642

The O 0 0.00013806279457639903
genetic O 0 0.00014387219562195241
basis O 0 0.00018750237359199673
of O 1 0.998174786567688
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999719858169556
DM B-Disease 1 1.0
) O 0 0.00019901624182239175
is O 0 1.880679883470293e-05
the O 0 1.8692451703827828e-05
expansion O 0 0.000128718966152519
of O 0 9.358092211186886e-05
an O 0 0.00016196641081478447
unstable O 1 0.9588029384613037
CTG O 1 0.9914289116859436
repeat O 0 0.0005629644729197025
in O 0 3.568176180124283e-05
the O 0 2.098125514748972e-05
34 O 0 5.9610785683616996e-05
UTR O 0 0.0016256488161161542
of O 0 5.865415369044058e-05
the O 0 0.0001337913708994165
DM B-Disease 1 0.9999978542327881
protein O 0 0.0001662142894929275
kinase O 0 0.00011805646499851719
gene O 0 2.344634776818566e-05
on O 0 0.0001022579162963666
chromosome O 0 0.00037079534376971424
19 O 0 0.0007240517879836261
. O 0 0.00020656520791817456

One O 0 0.0001522801030660048
of O 0 9.053661051439121e-05
the O 0 8.609592623542994e-05
principal O 0 0.00011493053170852363
features O 0 1.785742824722547e-05
of O 0 6.88440995872952e-05
the O 0 0.00047549448208883405
DM B-Disease 1 1.0
mutation O 0 0.00013213040074333549
is O 0 1.4906717296980787e-05
an O 0 9.109375241678208e-06
extraordinarily O 0 0.00016383014735765755
high O 0 0.00010328101780032739
level O 0 0.0001612896885490045
of O 0 0.00016324630996678025
somatic O 0 0.001910460414364934
mosaicism O 1 0.9947038292884827
, O 0 0.0001117617212003097
due O 0 0.0001795319258235395
to O 0 2.7411657356424257e-05
an O 0 2.564093483670149e-05
extremely O 0 8.902300032787025e-05
high O 0 0.00011736592568922788
degree O 0 9.3202615971677e-05
of O 0 0.00012901560694444925
somatic O 0 0.0007208418101072311
instability O 0 0.024387400597333908
both O 0 4.1522824176354334e-05
within O 0 3.4861372114392e-05
and O 0 1.6409019735874608e-05
between O 0 0.0002724851365201175
different O 0 6.437212869059294e-05
tissues O 0 0.0015610824339091778
. O 0 0.0003428100317250937

This O 0 0.0003112406702712178
instability O 0 0.004362052772194147
appears O 0 0.00019836268620565534
to O 0 1.4845542864350136e-05
be O 0 1.3126657904649619e-05
biased O 0 2.185214361816179e-05
towards O 0 5.11798461957369e-05
further O 0 4.227235694997944e-05
expansion O 0 0.0001974821207113564
and O 0 1.5398129107779823e-05
continuous O 0 0.00010482088691787794
throughout O 0 3.70698980987072e-05
the O 0 2.6540430553723127e-05
life O 0 2.1695039322366938e-05
of O 0 1.8060583897749893e-05
an O 0 1.136766150011681e-05
individual O 0 9.441980182600673e-06
, O 0 1.20561917356099e-05
features O 0 1.2546150173875503e-05
that O 0 4.1431235331401695e-06
could O 0 5.689505542250117e-06
be O 0 2.619544147819397e-06
associated O 0 3.5605519315140555e-06
with O 0 4.255092790117487e-06
the O 0 5.965423406451009e-05
progressive O 0 0.001320273382589221
nature O 0 0.00022651533072348684
of O 0 0.0011282123159617186
the O 1 0.9926714897155762
disease O 1 1.0
. O 0 0.0011779064079746604

Although O 0 0.00015273323515430093
increasing O 0 8.868612349033356e-05
measured O 0 8.042704575927928e-05
allele O 0 1.68728620337788e-05
size O 0 2.4592400222900324e-05
between O 0 0.00012656977924052626
patients O 0 4.608926974469796e-05
clearly O 0 4.1110652091447264e-05
correlates O 0 5.546443208004348e-05
with O 0 5.8774144235940184e-06
an O 0 8.924549547373317e-06
increased O 0 8.62434899318032e-05
severity O 0 0.002275743754580617
of O 0 0.001328889629803598
symptoms O 1 0.9993152618408203
and O 0 6.51157897664234e-05
an O 0 2.170012885471806e-05
earlier O 0 6.244333781069145e-05
age O 0 0.00012339846580289304
of O 0 0.0001506610424257815
onset O 1 0.9999293088912964
, O 0 4.5395008783089e-05
this O 0 5.138146661920473e-06
correlation O 0 1.8766131688607857e-05
is O 0 7.096025456121424e-06
not O 0 2.174844212277094e-06
precise O 0 1.046509078150848e-05
and O 0 8.126019565679599e-06
measured O 0 4.495242319535464e-05
allele O 0 1.610581784916576e-05
length O 0 4.261591675458476e-05
cannot O 0 1.3086222679703496e-05
be O 0 3.409863893466536e-06
used O 0 4.622163032763638e-06
as O 0 9.363910976389889e-06
an O 0 4.180336418357911e-06
accurate O 0 2.8906972147524357e-05
predictor O 0 0.0005176961421966553
of O 0 0.00017879033111967146
age O 0 0.0009506344795227051
of O 0 0.0026301974430680275
onset O 1 0.9999996423721313
. O 0 0.0041422368958592415

In O 0 0.00019836077990476042
order O 0 3.244283652747981e-05
to O 0 1.7659760487731546e-05
further O 0 4.9876562115969136e-05
characterize O 0 0.0001383412309223786
the O 0 5.5147509556263685e-05
dynamics O 0 0.0005184264737181365
of O 0 0.002644435502588749
DM B-Disease 1 1.0
CTG O 1 0.9999972581863403
repeat O 0 0.005484161898493767
somatic O 0 0.0017844286048784852
instability O 0 0.005450967699289322
, O 0 3.5680877772392705e-05
we O 0 1.0875505722651724e-05
have O 0 3.0447363315033726e-06
studied O 0 3.1746192689752206e-05
repeat O 0 0.00010328651842428371
length O 0 1.9507959223119542e-05
changes O 0 3.7566840092040366e-06
over O 0 1.0984295840898994e-05
time O 0 2.0400386347319e-05
in O 0 6.37171178823337e-05
111 O 1 0.9997864365577698
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.7444789409637451
with O 0 0.00011683152115438133
varying O 0 0.0001930533180711791
clinical O 0 0.0040647839196026325
severity O 1 0.9951825737953186
and O 0 0.0007304416503757238
CTG O 1 0.9989933371543884
repeat O 0 0.0005936169764027
size O 0 4.841619011131115e-05
over O 0 2.339116508665029e-05
time O 0 1.2898180102638435e-05
intervals O 0 1.6806507119326852e-05
of O 0 6.0196947742952034e-05
1 O 0 0.000530384888406843
- O 0 0.0005275775329209864
7 O 0 0.00037268566666170955
years O 0 0.0002978570410050452
. O 0 0.00018074644322041422

We O 0 0.00018103515321854502
have O 0 1.560937744216062e-05
found O 0 1.2606067684828304e-05
a O 0 2.2445217837230302e-05
direct O 0 2.612790012790356e-05
progression O 0 0.0007012278656475246
of O 0 0.00011792369332397357
the O 0 6.498763104900718e-05
size O 0 3.266517887823284e-05
heterogeneity O 0 6.572266283910722e-05
over O 0 3.6108685890212655e-05
time O 0 2.798672539938707e-05
related O 0 4.4914413592778146e-05
to O 0 3.9973092498257756e-05
initial O 0 0.000254141166806221
CTG O 0 0.03392736613750458
repeat O 0 0.0005728861433453858
size O 0 6.914016557857394e-05
and O 0 1.2157865057815798e-05
the O 0 1.760484155965969e-05
time O 0 2.2094442101661116e-05
interval O 0 8.84299079189077e-05
and O 0 2.5584366085240617e-05
always O 0 3.3250576962018386e-05
biased O 0 3.3879568945849314e-05
towards O 0 0.00012534947018139064
further O 0 0.00012533871631603688
expansion O 0 0.001212080824188888
. O 0 0.0003584496153052896

Attempts O 0 0.0006199001800268888
to O 0 4.727975101559423e-05
mathematically O 0 0.0001249747147085145
model O 0 2.1592455595964566e-05
the O 0 4.9500380555400625e-05
dynamics O 0 0.0006085362401790917
have O 0 3.1868708902038634e-05
proved O 0 0.0003309538005851209
only O 0 1.7824897440732457e-05
partially O 0 0.00017529471369925886
successful O 0 4.755050758831203e-05
suggesting O 0 4.289071512175724e-05
that O 0 1.9507569959387183e-06
individual O 0 1.4832206716164364e-06
specific O 0 2.87039279101009e-06
genetic O 0 8.018811058718711e-05
and O 0 5.10986901645083e-05
/ O 0 0.004198914859443903
or O 0 6.25291359028779e-05
environmental O 0 0.00010830847168108448
factors O 0 3.613490116549656e-05
also O 0 1.3674467481905594e-05
play O 0 2.9490141969290562e-05
a O 0 2.6684940166887827e-05
role O 0 0.0001006471793516539
in O 0 0.00011059365351684391
somatic O 0 0.0017862183740362525
mosaicism O 1 0.9982282519340515
. O 0 0.0005633769324049354
. O 0 0.0005526066524907947

Aspartylglucosaminuria B-Disease 1 0.999947190284729
among O 0 0.000798165739979595
Palestinian O 0 0.0009658975759521127
Arabs O 0 0.0024025319144129753
. O 0 0.0007670028717257082

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9386283755302429
AGU B-Disease 1 1.0
) O 0 0.00013736748951487243
is O 0 2.7412756026024e-05
a O 0 5.4954369261395186e-05
rare O 0 0.0005953883519396186
disorder B-Disease 1 1.0
of I-Disease 1 0.9999986886978149
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999682903289795
caused O 1 0.9233493208885193
by O 0 4.6715587814105675e-05
the O 0 0.000135029578814283
deficiency B-Disease 1 0.9999969005584717
of I-Disease 0 0.0007414913852699101
the I-Disease 0 0.0010789569932967424
lysosomal I-Disease 1 0.9999481439590454
enzyme I-Disease 0 0.0005591476219706237
aspartylglucosaminidase I-Disease 1 0.9767533540725708
( O 0 0.0005000178352929652
AGA O 1 0.9732517004013062
) O 0 0.0001857967145042494
. O 0 0.00018437816470395774

AGU B-Disease 1 1.0
is O 0 0.0004958912613801658
inherited O 1 0.9986794590950012
as O 0 0.00014766094682272524
an O 0 9.21661703614518e-05
autosomal O 1 0.9998574256896973
recessive O 1 0.9999929666519165
trait O 1 0.9999558925628662
and O 0 0.0005651260144077241
occurs O 0 0.00011420424561947584
with O 0 1.8426593669573776e-05
a O 0 5.594805406872183e-05
high O 0 0.00012421493011061102
frequency O 0 2.993316957144998e-05
in O 0 1.865806189016439e-05
Finland O 0 7.323312456719577e-05
because O 0 1.298806364502525e-05
of O 0 5.7219287555199116e-05
a O 0 0.00022004524362273514
founder O 0 0.0025502112694084644
effect O 0 0.0007302808226086199
. O 0 0.0004830891266465187

While O 0 0.0004781670868396759
very O 0 0.00010635724902385846
few O 0 0.00011431537859607488
patients O 0 8.529905608156696e-05
with O 0 9.165352821582928e-05
AGU B-Disease 1 1.0
have O 0 3.50455375155434e-05
been O 0 2.7642192435450852e-05
reported O 0 1.9133733076159842e-05
from O 0 1.7799282431951724e-05
non O 0 0.0001250214409083128
- O 0 0.00020802127255592495
Finnish O 0 0.0003853124799206853
origin O 0 1.827302185120061e-05
, O 0 1.538177821203135e-05
we O 0 3.711223689606413e-05
diagnosed O 1 0.9998363256454468
the O 0 0.00033440449624322355
disorder O 1 0.9999998807907104
in O 0 0.0014859407674521208
8 O 0 0.0038405531086027622
patients O 0 7.827574154362082e-05
originating O 0 7.011192792560905e-05
from O 0 4.6964654757175595e-05
3 O 0 0.000112795656605158
unrelated O 0 5.468811286846176e-05
families O 0 5.186629550735233e-06
, O 0 3.866726274281973e-06
all O 0 3.6432013530429685e-06
Palestinian O 0 4.227082172292285e-05
Arabs O 0 9.520478488411754e-05
from O 0 2.816195228660945e-05
the O 0 4.1112376493401825e-05
region O 0 0.00017383693193551153
of O 0 0.00029203668236732483
Jerusalem O 0 0.005439569242298603
. O 0 0.0004938073689118028

The O 0 0.000693312962539494
clinical O 0 0.0029265242628753185
diagnosis O 1 0.997329831123352
of O 1 0.9998362064361572
AGU B-Disease 1 1.0
is O 0 0.0006868260679766536
often O 0 7.726693002041429e-05
difficult O 0 0.00010225995356449857
, O 0 1.574783345859032e-05
in O 0 1.8706594346440397e-05
particular O 0 1.2613199942279607e-05
early O 0 5.5880551371956244e-05
in O 0 9.045555998454802e-06
the O 0 1.1321670172037557e-05
course O 0 2.8694661523331888e-05
of O 0 5.656617940985598e-05
the O 0 0.0006344331777654588
disease O 1 0.9999961853027344
, O 0 3.33871430484578e-05
and O 0 1.0326612937205937e-05
most O 0 1.0632922567310743e-05
of O 0 6.092786497902125e-05
the O 0 0.00016663482529111207
patients O 0 0.00024370058963540941
are O 0 2.2599517251364887e-05
diagnosed O 1 0.9994558691978455
after O 0 0.00016246011364273727
the O 0 4.2286188545404e-05
age O 0 0.00012099734885850921
of O 0 0.00021443949663080275
5 O 0 0.0007818446611054242
years O 0 0.0008868520380929112
. O 0 0.00028036118601448834

However O 0 0.00041155918734148145
, O 0 7.754690159345046e-05
since O 0 0.0001338622096227482
these O 0 3.0206621886463836e-05
patients O 0 0.00013221308472566307
excrete O 0 0.0011681640753522515
early O 0 0.0001577049115439877
large O 0 2.9555345463450067e-05
amounts O 0 2.5641913453000598e-05
of O 0 5.5154239817056805e-05
aspartylglucosamine O 0 0.002520978217944503
in O 0 9.488150681136176e-05
urine O 0 9.440713620278984e-05
, O 0 2.042209052888211e-05
biochemical O 0 9.182570647681132e-05
screening O 0 5.7573142839828506e-05
is O 0 2.0818495613639243e-05
easy O 0 3.189120252500288e-05
by O 0 2.59767439274583e-05
urine O 0 0.00021547019423451275
chromatography O 0 0.012185687199234962
. O 0 0.0003670616424642503
. O 0 0.0004000039189122617

Detection O 0 0.0007498300401493907
of O 0 0.00018387571617495269
heterozygous O 0 8.933085337048396e-05
carriers O 0 6.561983900610358e-05
of O 0 8.687609079061076e-05
the O 0 0.000631017901469022
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999951124191284
telangiectasia I-Disease 1 0.9999966621398926
( O 0 0.0005536106182262301
ATM O 0 0.002212504157796502
) O 0 3.442945671849884e-05
gene O 0 2.0262257748981938e-05
by O 0 1.5556532162008807e-05
G2 O 0 0.07708121836185455
phase O 0 0.002423325087875128
chromosomal O 0 0.01546535361558199
radiosensitivity O 1 0.958186686038971
of O 0 0.006402913946658373
peripheral O 1 0.9999994039535522
blood O 1 0.9998983144760132
lymphocytes O 1 0.9856928586959839
. O 0 0.0010796963470056653

In O 0 0.006016352213919163
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999966621398926
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.001621806062757969
A B-Disease 1 0.999998927116394
- I-Disease 1 0.9999430179595947
T I-Disease 1 0.9999980926513672
) O 0 5.346256148186512e-05
patients O 0 3.2267358619719744e-05
, O 0 1.180254912469536e-05
mutations O 0 2.0407664123922586e-05
in O 0 3.233133611502126e-05
a O 0 4.283312591724098e-05
single O 0 3.004476093337871e-05
gene O 0 2.7362295440980233e-05
, O 0 1.7114409274654463e-05
ATM O 0 0.0003858745039906353
, O 0 5.827572749694809e-06
result O 0 1.2569035789056215e-05
in O 0 2.8153792300145142e-05
an O 0 0.00022900507610756904
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 1 0.999042809009552
embraces O 0 0.0021955801639705896
a O 0 4.510292274062522e-05
variety O 0 2.4474249585182406e-05
of O 0 9.614072041586041e-05
clinical O 0 0.0006439819117076695
features O 0 0.00024440893321298063
and O 0 7.298026321223006e-05
manifests O 0 0.0009804076980799437
extreme O 0 0.0029052705504000187
radiosensitivity O 1 0.9950436353683472
and O 0 4.5577453420264646e-05
a O 0 5.565346873481758e-05
strong O 0 0.00011579450801946223
pre O 0 0.0018491256050765514
- O 0 0.001711255987174809
disposition O 0 0.0025218466762453318
to O 0 0.0010065309470519423
malignancy B-Disease 1 0.9998888969421387
. O 0 0.0013439466711133718

Heterozygotes O 0 0.0014225662453100085
for O 0 3.730050229933113e-05
the O 0 9.66849984251894e-05
ATM O 0 0.0020710397511720657
gene O 0 2.16294083656976e-05
have O 0 2.9672587515960913e-06
no O 0 3.594787131078192e-06
clinical O 0 2.4483400920871645e-05
expression O 0 2.0693003534688614e-05
of O 0 0.0002668923116289079
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999866485595703
T I-Disease 1 0.9999986886978149
but O 0 2.672839218575973e-05
may O 0 0.00011622570309555158
be O 0 6.732618203386664e-05
cancer B-Disease 0 0.42749708890914917
prone O 0 0.0006312957848422229
with O 0 2.357549237785861e-05
a O 0 8.601221634307876e-05
moderate O 0 0.0002011400938499719
increase O 0 6.405438762158155e-05
in O 0 5.735772356274538e-05
in O 0 5.752523065893911e-05
vitro O 0 0.00039929148624651134
radiosensitivity O 0 0.00785116944462061
. O 0 0.000358518969733268

We O 0 0.0004856689483858645
performed O 0 0.00044110757880844176
a O 0 0.00018781729158945382
blind O 0 0.0008845481788739562
chromosomal O 0 0.00045826833229511976
analysis O 0 4.592361074173823e-05
on O 0 0.0005453119520097971
G2 O 1 0.9984176158905029
- O 0 0.0003531591792125255
phase O 0 0.0002752714790403843
lymphocytes O 0 9.202433284372091e-05
from O 0 3.09536699205637e-05
7 O 0 0.00015618432371411473
unrelated O 0 0.00019537046318873763
A B-Disease 1 0.9996881484985352
- I-Disease 1 0.9994589686393738
T I-Disease 1 0.9999986886978149
patients O 0 9.565077198203653e-05
, O 0 1.4268553059082478e-05
13 O 0 0.00011434197949711233
obligate O 0 0.00020538156968541443
A B-Disease 1 0.9999948740005493
- I-Disease 1 0.9998117089271545
T I-Disease 1 0.9999901056289673
heterozygotes O 0 0.0006254107574932277
( O 0 2.812577258737292e-05
parents O 0 3.2790967452456243e-06
of O 0 1.908416743390262e-05
the O 0 5.876007708138786e-05
patients O 0 5.2829363994533196e-05
) O 0 1.4579361959476955e-05
, O 0 9.647240403864998e-06
and O 0 8.334347512573004e-06
14 O 0 6.105034844949841e-05
normal O 0 3.048123289772775e-05
controls O 0 2.0937499357387424e-05
following O 0 7.140688830986619e-05
X O 0 0.001393326441757381
- O 0 0.000239783083088696
irradiation O 0 5.2241903176764026e-05
with O 0 9.489841431786772e-06
1 O 0 0.00018277671188116074
Gy O 0 0.001240642392076552
in O 0 1.0040391316579189e-05
order O 0 3.999738510174211e-06
to O 0 6.720038527419092e-06
evaluate O 0 1.7837242921814322e-05
this O 0 6.99737529430422e-06
cytogenetic O 0 0.0002255175932077691
method O 0 9.949724699254148e-06
as O 0 2.678156306501478e-05
a O 0 1.859308576968033e-05
tool O 0 5.366166806197725e-05
for O 0 2.3960883481777273e-05
detection O 0 0.00021207857935223728
of O 0 0.0005888823652639985
ATM O 1 0.5605455040931702
carriers O 0 0.00123274652287364
. O 0 0.00044564256677404046

Both O 0 0.0013206932926550508
A B-Disease 1 0.9999924898147583
- I-Disease 1 0.9999672174453735
T I-Disease 1 0.9999985694885254
homozygotes O 0 0.0027909029740840197
and O 0 3.82563921448309e-05
heterozygotes O 0 0.0003089875099249184
showed O 0 8.738909673411399e-05
significantly O 0 4.8494694055989385e-05
increased O 0 3.536744770826772e-05
levels O 0 7.790757081238553e-05
of O 0 0.000267274008365348
radiation O 1 0.999268114566803
- O 0 0.02709764800965786
induced O 0 0.019023209810256958
chromatid O 0 0.016305698081851006
damage O 0 0.0010243830038234591
relative O 0 0.00011791707220254466
to O 0 2.0624405806302093e-05
that O 0 5.862792022526264e-06
of O 0 8.506097947247326e-05
normal O 0 0.0004409406683407724
controls O 0 0.00042462683632038534
. O 0 0.0003014251124113798

These O 0 4.0499686292605475e-05
results O 0 2.4053930246736854e-05
show O 0 4.1320534364786e-05
that O 0 6.867042429803405e-06
the O 0 6.506079080281779e-05
G2 O 1 0.9801325798034668
- O 0 0.0005880077369511127
phase O 0 0.0007605201681144536
chromosomal O 0 0.0013707176549360156
radiosensitivity O 0 0.0023624664172530174
assay O 0 4.456753595150076e-05
can O 0 6.48248214929481e-06
be O 0 3.7678712487831945e-06
used O 0 2.707978410398937e-06
for O 0 2.925632998085348e-06
the O 0 1.2854746273660567e-05
detection O 0 5.9652127674780786e-05
of O 0 0.00025494879810139537
A B-Disease 1 0.9999948740005493
- I-Disease 1 0.9998774528503418
T I-Disease 1 0.9999943971633911
heterozygotes O 0 0.00580490892753005
. O 0 0.0007777317077852786

In O 0 0.0004232932406011969
combination O 0 0.00016895485168788582
with O 0 2.7716789190890267e-05
molecular O 0 0.00019895611330866814
genetic O 0 0.0001031526699080132
analyses O 0 4.0564158553024754e-05
, O 0 1.1306736269034445e-05
this O 0 3.1540128020424163e-06
test O 0 1.140704898716649e-05
may O 0 1.5070051631482784e-05
be O 0 4.237347638991196e-06
of O 0 7.591765097458847e-06
value O 0 1.668451659497805e-05
in O 0 1.3203619346313644e-05
studies O 0 1.1019243174814619e-05
of O 0 5.065529694547877e-05
familial B-Disease 0 0.058937229216098785
and I-Disease 0 0.0004373035626485944
sporadic I-Disease 1 0.9994915723800659
cancers I-Disease 1 0.9999940395355225
aimed O 0 0.0006403813604265451
at O 0 0.00011851429007947445
determination O 0 5.901502299821004e-05
of O 0 2.3342896383837797e-05
the O 0 2.6539215468801558e-05
potential O 0 5.279959805193357e-05
involvement O 0 0.00011839274520752952
of O 0 0.00021073974494356662
ATM O 1 0.5362280607223511
mutations O 0 0.0003093332634307444
in O 0 0.0004883299116045237
tumor B-Disease 1 0.9999955892562866
risk O 0 0.0006988741224631667
or O 0 0.00014241909957490861
development O 0 0.0003035238478332758
. O 0 9.093202243093401e-05
. O 0 0.00012956200225744396

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999955892562866
telangiectasia I-Disease 1 0.9999483823776245
: O 0 6.849226338090375e-05
identification O 0 2.097025208058767e-05
and O 0 1.5372392226709053e-05
detection O 0 9.908638458000496e-05
of O 0 0.0004106519918423146
founder O 0 0.22838832437992096
- O 0 0.0006130709080025554
effect O 0 5.47985291632358e-05
mutations O 0 1.5063844330143183e-05
in O 0 1.2613319995580241e-05
the O 0 3.968882083427161e-05
ATM O 0 0.0005847217980772257
gene O 0 1.8460927094565704e-05
in O 0 2.174388282583095e-05
ethnic O 0 6.035041224095039e-05
populations O 0 9.188131662085652e-05
. O 0 7.739627471892163e-05

To O 0 0.00017940578982234
facilitate O 0 0.00011879724479513243
the O 0 3.22445084748324e-05
evaluation O 0 4.1770490497583523e-05
of O 0 0.0002157185081159696
ATM O 0 0.011422064155340195
heterozygotes O 0 0.0011648184154182673
for O 0 6.59731449559331e-05
susceptibility O 0 0.0017865677364170551
to O 0 0.00011124594311695546
other O 0 5.795073229819536e-05
diseases O 1 0.9999986886978149
, O 0 2.2606933271163143e-05
such O 0 1.3371978639042936e-05
as O 1 0.597758412361145
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 4.385556894703768e-05
we O 0 5.377602064982057e-06
have O 0 1.5831711834835005e-06
attempted O 0 3.3190484828082845e-05
to O 0 7.249976079037879e-06
define O 0 3.081345130340196e-05
the O 0 2.706075792957563e-05
most O 0 1.6188632798730396e-05
common O 0 1.7181442672153935e-05
mutations O 0 2.135230170097202e-05
and O 0 9.788465831661597e-06
their O 0 1.0591751561150886e-05
frequencies O 0 4.196861482341774e-05
in O 0 0.00015023612650111318
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999706745147705
telangiectasia I-Disease 1 0.9999953508377075
( O 0 0.0010432979324832559
A B-Disease 1 0.9999796152114868
- I-Disease 1 0.978299617767334
T I-Disease 1 0.999639630317688
) O 0 3.3571297535672784e-05
homozygotes O 0 0.00027549045626074076
from O 0 3.6957899283152074e-05
10 O 0 4.648955655284226e-05
ethnic O 0 4.834232458961196e-05
populations O 0 7.300351717276499e-05
. O 0 0.0001414986327290535

Both O 0 0.000186384393600747
genomic O 0 0.0003387416363693774
mutations O 0 0.00011428660218371078
and O 0 3.259715231251903e-05
their O 0 1.9854844140354544e-05
effects O 0 0.0002548637567088008
on O 0 0.00023864499235060066
cDNA O 0 0.00047076804912649095
were O 0 0.00015480232832487673
characterized O 0 0.0007353930850513279
. O 0 0.0004541513917502016

Protein O 0 0.0030042375437915325
- O 0 0.0005659242742694914
truncation O 0 0.00019866930961143225
testing O 0 3.083964475081302e-05
of O 0 4.3550331611186266e-05
the O 0 3.80869023501873e-05
entire O 0 0.0002177276328438893
ATM O 0 0.0003624995006248355
cDNA O 0 7.59210524847731e-05
detected O 0 5.844767656526528e-05
92 O 0 4.834287392441183e-05
( O 0 1.1539639672264457e-05
66 O 0 8.724795770831406e-05
% O 0 1.8586491933092475e-05
) O 0 1.697214611340314e-05
truncating O 0 0.00019334144599270076
mutations O 0 3.101022230111994e-05
in O 0 2.9715249183936976e-05
140 O 0 6.842274160590023e-05
mutant O 0 0.0001940186193678528
alleles O 0 7.995476335054263e-05
screened O 0 0.0006145486840978265
. O 0 0.00017442854004912078

The O 0 0.0006435803952626884
haplotyping O 0 0.008267229422926903
of O 0 0.0003520564641803503
patients O 0 0.0002039507671725005
with O 0 2.930292976088822e-05
identical O 0 8.33906015031971e-05
mutations O 0 6.869904609629884e-05
indicates O 0 5.535800664802082e-05
that O 0 5.977192813588772e-06
almost O 0 1.1324628758302424e-05
all O 0 2.7724447591026546e-06
of O 0 1.319611692451872e-05
these O 0 7.739681677776389e-06
represent O 0 2.1224195734248497e-05
common O 0 2.8958347684238106e-05
ancestry O 0 4.5763335947413e-05
and O 0 2.375609074078966e-05
that O 0 1.5336956494138576e-05
very O 0 3.342384297866374e-05
few O 0 8.57943159644492e-05
spontaneously O 0 0.0009599009645171463
recurring O 0 0.01634407788515091
ATM O 1 0.995048463344574
mutations O 0 0.001008567400276661
exist O 0 0.0007891286513768137
. O 0 0.0004101856320630759

Assays O 0 0.0004394053830765188
requiring O 0 0.00014867790741845965
minimal O 0 0.00015264644753187895
amounts O 0 3.761136395041831e-05
of O 0 5.928012615186162e-05
genomic O 0 6.950918032089248e-05
DNA O 0 5.518091711564921e-05
were O 0 1.5179976799117867e-05
designed O 0 2.3856389816501178e-05
to O 0 8.1785501606646e-06
allow O 0 7.411152637359919e-06
rapid O 0 0.00011430055019445717
screening O 0 2.0513303752522916e-05
for O 0 1.2702719686785713e-05
common O 0 3.6597775761038065e-05
ethnic O 0 0.0001537173957331106
mutations O 0 0.0004695443494711071
. O 0 0.0004873226280324161

These O 0 8.525604789610952e-05
rapid O 0 0.0006280108937062323
assays O 0 8.799518400337547e-05
detected O 0 0.00010536384070292115
mutations O 0 1.8684806491364725e-05
in O 0 1.3001101251575164e-05
76 O 0 6.435906107071787e-05
% O 0 1.6197187505895272e-05
of O 0 6.152245623525232e-05
Costa O 0 0.0002424458652967587
Rican O 0 0.00023642483574803919
patients O 0 4.080961298313923e-05
( O 0 1.3984734323457815e-05
3 O 0 7.466536771971732e-05
) O 0 9.664966455602553e-06
, O 0 4.031255230074748e-06
50 O 0 9.960622264770791e-06
% O 0 5.730542852688814e-06
of O 0 5.6893481087172404e-05
Norwegian O 0 0.0004976741620339453
patients O 0 6.416124233510345e-05
( O 0 2.718118230404798e-05
1 O 0 8.424744009971619e-05
) O 0 9.485318514634855e-06
, O 0 4.963027549820254e-06
25 O 0 1.3976760783407371e-05
% O 0 9.525130735710263e-06
of O 0 0.00010226532322121784
Polish O 1 0.9855434894561768
patients O 0 0.00042628488154150546
( O 0 8.510625775670633e-05
4 O 0 0.0002245537907583639
) O 0 1.214592884934973e-05
, O 0 4.555948635243112e-06
and O 0 4.281612746126484e-06
14 O 0 3.513481715344824e-05
% O 0 8.20710829430027e-06
of O 0 4.850986442761496e-05
Italian O 0 0.00097137491684407
patients O 0 0.0001472456060582772
( O 0 3.280468445154838e-05
1 O 0 0.00014304542855825275
) O 0 1.4765289051865693e-05
, O 0 5.552919901674613e-06
as O 0 1.0900770575972274e-05
well O 0 7.99101690063253e-06
as O 0 2.652567854966037e-05
in O 0 4.27502382081002e-05
patients O 0 5.582175435847603e-05
of O 0 0.00032147910678759217
Amish O 0 0.0038675128016620874
/ O 0 0.0034524372313171625
Mennonite O 0 0.0010641448898240924
and O 0 5.2991021220805123e-05
Irish O 0 0.0003762045525945723
English O 0 0.0003185445093549788
backgrounds O 0 0.00044224481098353863
. O 0 0.00035098023363389075

Additional O 0 0.00023089606838766485
mutations O 0 0.00010952946468023583
were O 0 5.947615500190295e-05
observed O 0 6.114602001616731e-05
in O 0 3.423412999836728e-05
Japanese O 0 0.00022290101333055645
, O 0 2.6337038434576243e-05
Utah O 0 0.00032707126229070127
Mormon O 0 0.00018842644931282848
, O 0 1.234148112416733e-05
and O 0 1.3047032553004101e-05
African O 0 0.00014029591693542898
American O 0 0.00034671739558689296
patients O 0 0.0005472758202813566
. O 0 0.0005286370869725943

These O 0 4.268668999429792e-05
assays O 0 1.65518831636291e-05
should O 0 7.305814506253228e-06
facilitate O 0 2.087280881823972e-05
screening O 0 2.082798891933635e-05
for O 0 4.6044202463235706e-05
A B-Disease 1 0.9991881251335144
- I-Disease 1 0.9910954236984253
T I-Disease 1 0.9998809099197388
heterozygotes O 0 0.0008022609399631619
in O 0 5.088696343591437e-05
the O 0 5.3047097026137635e-05
populations O 0 2.5286331947427243e-05
studied O 0 0.0001702072040643543
. O 0 5.039611642132513e-05
. O 0 0.00014354304585140198

The O 0 0.0013180224923416972
von B-Disease 1 0.9971715807914734
Hippel I-Disease 1 0.9999790191650391
- I-Disease 1 0.9996825456619263
Lindau I-Disease 1 0.9999978542327881
tumor I-Disease 1 0.9999376535415649
suppressor O 0 0.0014140899293124676
gene O 0 2.2469848772743717e-05
is O 0 4.991079094907036e-06
required O 0 3.4931306345242774e-06
for O 0 2.2104326490079984e-05
cell O 0 0.00012728397268801928
cycle O 0 5.203402179176919e-05
exit O 0 9.547415538690984e-05
upon O 0 0.00014445230772253126
serum O 0 0.0006320459069684148
withdrawal O 0 0.0012520779855549335
. O 0 0.0005487966700457036

The O 0 0.0002673438866622746
inactivation O 0 0.0013406701618805528
of O 0 0.00030665093800053
the O 0 0.00034185286494903266
von B-Disease 1 0.9938371777534485
Hippel I-Disease 1 0.9998677968978882
- I-Disease 1 0.9502073526382446
Lindau I-Disease 1 0.9998340606689453
( I-Disease 0 0.0006178133189678192
VHL I-Disease 1 0.9999524354934692
) I-Disease 0 0.00028987936093471944
tumor I-Disease 1 0.9999040365219116
suppressor O 0 0.04059456288814545
gene O 0 0.0001979541702894494
predisposes O 0 0.0012685836991295218
affected O 0 3.7490004615392536e-05
individuals O 0 3.614443357946584e-06
to O 0 1.7109352484112605e-05
the O 0 0.00013023358769714832
human O 1 0.998884379863739
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.00019556371262297034
is O 0 2.1928341084276326e-05
associated O 0 1.5708053979324177e-05
with O 0 1.8579474271973595e-05
sporadic B-Disease 1 0.9999382495880127
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999924898147583
RCC B-Disease 1 1.0
) O 0 0.0014465040294453502
and O 0 0.0005259402096271515
brain B-Disease 1 0.9999920129776001
hemangioblastomas I-Disease 1 0.9999783039093018
. O 0 0.0017654466209933162

VHL O 1 0.9989150762557983
- O 0 0.003580925054848194
negative O 0 0.00036658745375461876
786 O 0 0.005386741366237402
- O 0 0.0011478262022137642
0 O 0 0.0004234848893247545
RCC B-Disease 1 0.9999959468841553
cells O 0 7.309762440854684e-05
are O 0 8.204893674701452e-06
tumorigenic O 0 0.0012244863901287317
in O 0 0.00012367963790893555
nude O 0 0.00153758330270648
mice O 0 0.0002317230828339234
which O 0 2.1079968064441346e-05
is O 0 2.1330644813133404e-05
suppressed O 0 0.00020728594972752035
by O 0 9.004312232718803e-06
the O 0 3.231937444070354e-05
reintroduction O 0 0.000725557969417423
of O 0 0.0007550098234787583
VHL B-Disease 1 0.999920129776001
. O 0 0.0010659907711669803

Remarkably O 0 0.006037765182554722
, O 0 4.295104736229405e-05
this O 0 9.340829819848295e-06
occurs O 0 1.7937889424501918e-05
without O 0 1.443448581994744e-05
affecting O 0 5.5115600844146684e-05
the O 0 5.986126052448526e-05
growth O 0 0.00011982517025899142
rate O 0 4.693479058914818e-05
and O 0 2.2603893739869818e-05
cell O 0 8.486086881021038e-05
cycle O 0 5.08254743181169e-05
profile O 0 2.701287485251669e-05
of O 0 4.116561831324361e-05
these O 0 2.4995673811645247e-05
cells O 0 5.2080737077631056e-05
in O 0 4.270574572728947e-05
culture O 0 0.0002841706736944616
. O 0 0.00018236816686112434

The O 0 0.0005898704403080046
786 O 0 0.007106155157089233
- O 0 0.0009040255099534988
0 O 0 0.00021014119556639344
cell O 0 0.0002814109611790627
line O 0 0.00018995165009982884
, O 0 1.7135656889877282e-05
like O 0 2.6290761525160633e-05
many O 0 5.66509370401036e-05
cancer B-Disease 1 0.9997181296348572
cells O 0 0.00021108442160766572
, O 0 2.3996948584681377e-05
fails O 0 3.819081757683307e-05
to O 0 1.011997665045783e-05
exit O 0 0.00010319615103071555
the O 0 7.24238998373039e-05
cell O 0 0.00019508432887960225
cycle O 0 8.713064016774297e-05
upon O 0 0.00017032961477525532
serum O 0 0.0008139697602018714
withdrawal O 0 0.0008688464877195656
. O 0 0.0005449903546832502

Here O 0 0.0006108428933657706
, O 0 2.8129155907663517e-05
it O 0 4.886568149231607e-06
is O 0 2.8476588340708986e-06
shown O 0 8.169819921022281e-06
that O 0 2.864387624867959e-06
reintroduction O 0 7.004702638369054e-05
of O 0 3.598953480832279e-05
the O 0 8.343292574863881e-05
wild O 0 0.00019746291218325496
- O 0 0.00032645693863742054
type O 0 0.000164927143487148
VHL B-Disease 1 0.5662475228309631
gene O 0 4.204328070045449e-05
restores O 0 6.630116695305333e-05
the O 0 2.109275919792708e-05
ability O 0 3.1101619242690504e-05
of O 0 0.00022958157933317125
VHL O 1 0.9999994039535522
- O 1 0.9284074902534485
negative O 0 0.0012962456094101071
RCC B-Disease 1 1.0
cancer I-Disease 1 0.9998157620429993
cells O 0 7.858494063839316e-05
to O 0 2.1464284145622514e-05
exit O 0 0.00011778344924096018
the O 0 6.256952474359423e-05
cell O 0 0.00019063222862314433
cycle O 0 0.00011575166718102992
and O 0 2.9522805562010035e-05
enter O 0 0.0003440233995206654
G0 O 1 0.9617303013801575
/ O 0 0.0013855088036507368
quiescence O 0 0.003708683419972658
in O 0 0.0003011234803125262
low O 0 0.0010847134981304407
serum O 0 0.0016895931912586093
. O 0 0.0002498744579497725

Both O 0 0.002060984494164586
VHL O 1 0.9999020099639893
- O 0 0.0022141141816973686
positive O 0 9.864695311989635e-05
and O 0 0.00013693798973690718
VHL O 1 0.9998044371604919
- O 0 0.0018718310166150331
negative O 0 0.00014632240345235914
RCC B-Disease 1 0.9999605417251587
cells O 0 0.00012101166066713631
exit O 0 0.00011104933946626261
the O 0 8.408996654907241e-05
cell O 0 0.0001320884475717321
cycle O 0 7.424143404932693e-05
by O 0 3.319811003166251e-05
contact O 0 0.00014682738401461393
inhibition O 0 0.0006413329974748194
. O 0 0.0005802017403766513

The O 0 0.000730454979930073
cyclin O 0 0.005620625335723162
- O 0 0.0006664167740382254
dependent O 0 7.513225864386186e-05
kinase O 0 0.00017878657672554255
inhibitor O 0 0.00025129097048193216
, O 0 3.3254065783694386e-05
p27 O 0 0.0006249186117202044
, O 0 2.5494444344076328e-05
accumulates O 0 0.0001609022874617949
upon O 0 6.583853246411309e-05
serum O 0 0.0002644730266183615
withdrawal O 0 0.00013376231072470546
, O 0 9.052218047145288e-06
only O 0 4.364656433608616e-06
in O 0 8.063319000939373e-06
the O 0 2.1456302420119755e-05
presence O 0 4.5466498704627156e-05
of O 0 0.0002492142375558615
VHL B-Disease 1 0.9998247027397156
, O 0 5.002999387215823e-05
as O 0 2.4619921532575972e-05
a O 0 1.262867863260908e-05
result O 0 1.119034641305916e-05
of O 0 2.3798173060640693e-05
the O 0 5.181639426155016e-05
stabilization O 0 0.00033409823663532734
of O 0 0.00030359189258888364
the O 0 0.00045629419037140906
protein O 0 0.0006462032906711102
. O 0 0.00029167247703298926

We O 0 0.00013609732559416443
propose O 0 4.144931153859943e-05
that O 0 3.950841801270144e-06
the O 0 2.1033101802458987e-05
loss O 0 0.00019824998162221164
of O 0 0.0002563060843385756
wild O 0 0.0004346100031398237
- O 0 0.00047849584370851517
type O 0 0.0001533980539534241
VHL B-Disease 1 0.7606357336044312
gene O 0 2.7967993446509354e-05
results O 0 6.505550572910579e-06
in O 0 8.075994628597982e-06
a O 0 2.0646582925110124e-05
specific O 0 1.315149256697623e-05
cellular O 0 0.001187964342534542
defect O 0 0.053689971566200256
in O 0 0.00044139192323200405
serum O 0 0.0022395155392587185
- O 0 0.0005396886263042688
dependent O 0 4.151910252403468e-05
growth O 0 3.9506056054960936e-05
control O 0 2.5048961106222123e-05
, O 0 4.688561602961272e-06
which O 0 5.9903118199144956e-06
may O 0 6.346595182549208e-05
initiate O 0 0.0008575822575949132
tumor B-Disease 1 0.9999735355377197
formation O 0 0.3946613073348999
. O 0 0.0009722339455038309

This O 0 0.0001543143589515239
is O 0 4.5904078433522955e-05
corrected O 0 0.00013194505299907178
by O 0 6.550874786626082e-06
the O 0 1.3541412045015022e-05
reintroduction O 0 0.00016366808267775923
of O 0 9.659284842200577e-05
wild O 0 0.0003417902917135507
- O 0 0.0013786578783765435
type O 0 0.00133142014965415
VHL B-Disease 1 0.9999921321868896
, O 0 0.0003575155569706112
implicating O 1 0.9977228045463562
VHL B-Disease 1 0.9999548196792603
as O 0 0.00012514405534602702
the O 0 7.72471830714494e-05
first O 0 0.00026673232787288725
tumor B-Disease 1 0.9987558126449585
suppressor O 0 0.0014325544470921159
involved O 0 7.216855010483414e-05
in O 0 2.7977783247479238e-05
the O 0 2.741628668445628e-05
regulation O 0 4.590101525536738e-05
of O 0 7.626586011610925e-05
cell O 0 0.00023182164295576513
cycle O 0 8.180559234460816e-05
exit O 0 0.00011943492427235469
, O 0 1.4278814887802582e-05
which O 0 6.3080497056944296e-06
is O 0 4.86261797050247e-06
consistent O 0 1.0037671927420888e-05
with O 0 2.4963781015685527e-06
its O 0 1.4059109162189998e-05
gatekeeper O 0 0.0005113324150443077
function O 0 5.033296474721283e-05
in O 0 6.391661008819938e-05
the O 0 0.00034648305154405534
kidney O 1 0.9999996423721313
. O 0 0.00023912191682029516
. O 0 0.00027658240287564695

Piebaldism B-Disease 1 0.9999998807907104
with O 0 0.0316409207880497
deafness B-Disease 1 1.0
: O 0 0.0004645481240004301
molecular O 0 0.00020213657990098
evidence O 0 7.427351374644786e-05
for O 0 2.6186593458987772e-05
an O 0 9.431914804736152e-05
expanded O 1 0.9702305793762207
syndrome O 1 1.0
. O 0 0.0023577080573886633

In O 0 0.0003189061244484037
a O 0 0.0001683269365457818
South O 0 0.0003531975671648979
African O 0 0.00017122259305324405
girl O 0 8.680033351993188e-05
of O 0 4.636054654838517e-05
Xhosa O 0 0.10138415545225143
stock O 0 0.0009715506457723677
with O 0 7.505478424718603e-05
severe O 1 0.9999996423721313
piebaldism B-Disease 1 1.0
and O 1 0.9988755583763123
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9998563528060913
identified O 0 0.0004363474727142602
a O 0 6.506215868284926e-05
novel O 0 6.439060962293297e-05
missense O 0 0.00017951324116438627
substitution O 0 6.458733696490526e-05
at O 0 0.00022040074691176414
a O 0 6.074221892049536e-05
highly O 0 8.832456660456955e-05
conserved O 0 0.0001255486422451213
residue O 0 8.489754691254348e-05
in O 0 1.2132823030697182e-05
the O 0 2.501332164683845e-05
intracellular O 0 5.867608342668973e-05
kinase O 0 6.206185935297981e-05
domain O 0 4.1242157749366015e-05
of O 0 7.18662267900072e-05
the O 0 0.0003032996610272676
KIT O 0 0.014063668437302113
proto O 0 0.03520536050200462
- O 0 0.0022952239960432053
oncogene O 0 0.0035067545250058174
, O 0 0.00010473754809936509
R796G O 0 0.0022253235802054405
. O 0 0.00021449489577207714

Though O 0 0.0008172635571099818
auditory B-Disease 1 0.5131582021713257
anomalies I-Disease 1 0.9564173817634583
have O 0 4.1360592149430886e-05
been O 0 4.088634887011722e-05
observed O 0 2.8767710318788886e-05
in O 0 4.0769078623270616e-05
mice O 0 9.615594171918929e-05
with O 0 1.7233658581972122e-05
dominant O 0 0.0007242778083309531
white O 0 0.00028564510284923017
spotting O 0 0.0011499680113047361
( O 0 0.0001345512137049809
W O 1 0.9317811727523804
) O 0 2.7019188564736396e-05
due O 0 8.168148633558303e-05
to O 0 5.814231190015562e-05
KIT O 1 0.9894346594810486
mutations O 0 0.0005421758978627622
, O 0 0.00021513577667064965
deafness B-Disease 1 1.0
is O 0 0.00023274427803698927
not O 0 2.571263030404225e-05
typical O 0 6.766479054931551e-05
in O 0 8.06404568720609e-05
human O 0 0.0003177195612806827
piebaldism B-Disease 0 0.07021230459213257
. O 0 0.00035776785807684064

Thus O 0 0.0003578241157811135
, O 0 2.3533220883109607e-05
the O 0 3.5060682421317324e-05
occurrence O 0 0.00041287639760412276
of O 1 0.6556096076965332
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.9976773858070374
this O 0 0.00022297241957858205
patient O 0 0.0001898706832434982
extends O 0 8.312908175867051e-05
considerably O 0 6.167707033455372e-05
the O 0 1.7906184439198114e-05
phenotypic O 0 7.488192932214588e-05
range O 0 5.7431065215496346e-05
of O 0 0.00014901456597726792
piebaldism B-Disease 0 0.004341749008744955
due O 0 0.000414932903368026
to O 0 0.0001232022186741233
KIT O 0 0.0022938954643905163
gene O 0 4.3437350541353226e-05
mutation O 0 2.3248589059221558e-05
in O 0 1.908187368826475e-05
humans O 0 2.9853064916096628e-05
and O 0 7.823620762792416e-06
tightens O 0 3.383052535355091e-05
the O 0 9.68805488810176e-06
clinical O 0 4.679718040279113e-05
similarity O 0 0.00014264523633755744
between O 0 0.001361207920126617
piebaldism B-Disease 1 0.723082959651947
and O 0 2.4525133994757198e-05
the O 0 2.0063514966750517e-05
various O 0 1.549232183606364e-05
forms O 0 0.00012638562475331128
of O 1 0.9998354911804199
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.02752852253615856
. O 0 0.0008163964957930148

Cycloheximide O 0 0.019750546663999557
facilitates O 0 0.0005053055356256664
the O 0 5.2790586778428406e-05
identification O 0 3.4772787330439314e-05
of O 0 0.00015420433192048222
aberrant O 0 0.00046294345520436764
transcripts O 0 0.0005296972813084722
resulting O 0 0.00015910899674054235
from O 0 4.534516847343184e-05
a O 0 3.9565398765262216e-05
novel O 0 7.826185901649296e-05
splice O 0 0.0007768468931317329
- O 0 0.0002846546994987875
site O 0 9.606860112398863e-05
mutation O 0 1.3153749932826031e-05
in O 0 2.6782914574141614e-05
COL17A1 O 1 0.7812331914901733
in O 0 3.936866778531112e-05
a O 0 4.5407909055938944e-05
patient O 0 5.79403385927435e-05
with O 0 4.785173587151803e-05
generalized O 1 0.9999674558639526
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 0.042479898780584335

Patients O 0 0.004724104888737202
with O 0 0.0004056055040564388
generalized O 1 0.9999988079071045
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
often O 0 0.0005970192141830921
show O 0 0.0002126653998857364
decreased O 0 0.0004303670721128583
expression O 0 7.519971404690295e-05
of O 0 0.00020775171287823468
type O 1 0.8595932722091675
XVII O 1 1.0
collagen O 1 0.9998900890350342
, O 0 0.00015458873531315476
a O 0 0.00017836701590567827
transmembrane O 0 0.0025645385030657053
hemidesmosomal O 0 0.0025925252120941877
protein O 0 0.00016203051200136542
encoded O 0 9.13754993234761e-05
by O 0 0.0001017521062749438
COL17A1 O 1 0.9879943132400513
. O 0 0.0007053114240989089

This O 0 8.597908890806139e-05
report O 0 1.8570226529845968e-05
documents O 0 3.428018681006506e-05
a O 0 5.447414150694385e-05
novel O 0 0.000136384172947146
splice O 0 0.0013300469145178795
- O 0 0.0003578831674531102
site O 0 0.00011941294360440224
mutation O 0 2.3232254534377716e-05
in O 0 2.6240519218845293e-05
COL17A1 O 1 0.6547399163246155
in O 0 3.323757846374065e-05
a O 0 3.176575410179794e-05
patient O 0 4.7128098231041804e-05
with O 0 3.064871998503804e-05
generalized O 1 0.9999856948852539
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.000338341313181445
and O 0 1.8747097783489153e-05
applies O 0 1.191421142721083e-05
a O 0 1.4350978744914755e-05
new O 0 4.422275651450036e-06
methodology O 0 6.430949724745005e-06
to O 0 1.0539519280428067e-05
define O 0 5.158004933036864e-05
and O 0 2.1681924408767372e-05
characterize O 0 0.0002440605458104983
the O 0 7.523091335315257e-05
resulting O 0 0.0002156814734917134
mRNA O 0 0.00029489528969861567
splice O 0 0.0010443326318636537
variants O 0 0.0003517422592267394
. O 0 0.000250834011239931

Mutational O 0 0.007326897699385881
analysis O 0 0.00010119264334207401
of O 0 0.0005908826715312898
COL17A1 O 1 0.9929759502410889
identified O 0 0.00018824418657459319
a O 0 0.00010723967716330662
maternally O 0 0.0009330626926384866
inherited O 1 0.9908069968223572
G O 1 0.667811393737793
- O 0 0.0015745898708701134
to O 0 0.00012612207501661032
- O 0 0.0007749559008516371
T O 0 0.0013135632034391165
transversion O 0 0.0008610129589214921
at O 0 0.00010612272308208048
the O 0 4.6414694224949926e-05
- O 0 7.123889372451231e-05
1 O 0 4.3364172597648576e-05
position O 0 3.513635601848364e-05
of O 0 7.754490070510656e-05
exon O 0 0.0010260384296998382
32 O 0 0.00048353764577768743
. O 0 0.00023847052943892777

This O 0 0.0002639012527652085
acceptor O 0 0.0002490282349754125
splice O 0 0.00299852411262691
- O 0 0.0012908014468848705
site O 0 0.00025726703461259604
mutation O 0 3.0443468858720735e-05
led O 0 6.80631201248616e-05
to O 0 1.882617834780831e-05
the O 0 3.277926589362323e-05
formation O 0 0.00018859397096093744
of O 0 0.0001850172848207876
aberrant O 0 0.0007201836560852826
transcripts O 0 0.0006158086471259594
present O 0 0.00021849898621439934
at O 0 0.0006289524608291686
extremely O 0 0.00026581407291814685
low O 0 0.0006153926951810718
levels O 0 0.0005524620646610856
. O 0 0.0002259620523545891

Based O 0 0.00013406964717432857
on O 0 0.00013046925596427172
our O 0 2.7310263249091804e-05
recent O 0 1.210788013850106e-05
finding O 0 2.6456560590304434e-05
that O 0 1.1439829904702492e-05
cycloheximide O 0 0.0038016035687178373
stabilized O 0 0.003834641305729747
mutant O 0 0.0008494495996274054
COL17A1 O 1 0.7493916749954224
transcripts O 0 0.0008141711005009711
in O 0 9.587468230165541e-05
keratinocytes O 0 0.0003450238727964461
homozygous O 0 0.00011355335300322622
for O 0 3.086659489781596e-05
a O 0 0.00013846503861714154
frameshift O 0 0.001304210745729506
mutation O 0 7.491392170777544e-05
, O 0 2.1331377865863033e-05
the O 0 3.383394505362958e-05
effects O 0 0.0001229509653057903
of O 0 7.730053039267659e-05
the O 0 0.00015184597577899694
splice O 0 0.0009427741169929504
- O 0 0.0002691774279810488
site O 0 4.7906618419801816e-05
mutation O 0 3.779376811507973e-06
on O 0 1.064220577973174e-05
splicing O 0 2.45848477788968e-05
of O 0 6.129922257969156e-05
COL17A1 O 0 0.05804609879851341
transcripts O 0 0.0002445790742058307
were O 0 2.2217434889171273e-05
determined O 0 1.4302038835012354e-05
using O 0 5.006821538700024e-06
reverse O 0 7.560980156995356e-05
transcriptase O 0 0.00018030851788353175
polymerase O 0 0.00020177726401016116
chain O 0 5.492314448929392e-05
reaction O 0 5.109126959723653e-06
of O 0 1.9745797544601373e-05
total O 0 8.471403998555616e-05
RNA O 0 0.0002316760364919901
from O 0 6.54527175356634e-05
keratinocytes O 0 0.0003172785509377718
incubated O 0 0.0003819995326921344
for O 0 3.617845504777506e-05
2 O 0 0.0005106733879074454
. O 0 0.0002125753671862185

5 O 0 0.0015393442008644342
h O 0 0.0007475533639080822
in O 0 6.0121790738776326e-05
the O 0 4.887875184067525e-05
presence O 0 6.162533099995926e-05
or O 0 2.3551963749923743e-05
absence O 0 0.00019542372319847345
of O 0 0.0002946353342849761
10 O 0 0.000699841883033514
microg O 0 0.016487540677189827
cycloheximide O 0 0.011425667442381382
per O 0 0.00040522596100345254
ml O 0 0.003817811142653227
. O 0 0.0009143244242295623

Using O 0 0.00016338148270733654
this O 0 2.69791253231233e-05
approach O 0 4.583566260407679e-05
, O 0 2.0573801521095447e-05
an O 0 2.3629154384252615e-05
abnormally O 0 0.0008470046450383961
spliced O 0 0.0004439677286427468
transcript O 0 0.0004239174595568329
was O 0 0.00013227536692284048
identified O 0 1.1867887224070728e-05
that O 0 9.94874653770239e-07
contains O 0 4.749803792947205e-06
an O 0 4.573020760290092e-06
extra O 0 2.2871272449265234e-05
264 O 0 8.310212433570996e-05
bases O 0 4.0812959923641756e-05
upstream O 0 0.00019191470346413553
from O 0 4.025709495181218e-05
exon O 0 0.0002515815431252122
32 O 0 6.7039298301097e-05
, O 0 1.5782501577632502e-05
resulting O 0 3.8268943171715364e-05
in O 0 4.8063669964903966e-05
a O 0 0.00012290127051528543
premature O 0 0.0006340169929899275
termination O 0 0.0004813233681488782
codon O 0 0.00045911286724731326
27 O 0 0.0011569143971428275
bp O 0 0.001118586747907102
downstream O 0 0.0006152706919237971
from O 0 9.108649828704074e-05
the O 0 0.00021024519810453057
cryptic O 0 0.00240790331736207
splice O 0 0.0034975851885974407
site O 0 0.0030534835532307625
. O 0 0.0007010414265096188

Three O 0 0.0002481044502928853
other O 0 2.6627161787473597e-05
splice O 0 0.0003371124912519008
variants O 0 8.389292634092271e-05
, O 0 1.1548600923561025e-05
including O 0 6.9328516474342905e-06
one O 0 6.775057045160793e-06
derived O 0 5.853239144926192e-06
from O 0 1.1012804861820769e-05
the O 0 2.0862798919552006e-05
skipping O 0 8.890270692063496e-05
of O 0 6.443975144065917e-05
exon O 0 0.00034174887696281075
32 O 0 6.479498551925644e-05
, O 0 9.841593964665662e-06
were O 0 1.9341392544447444e-05
also O 0 2.9062699468340725e-05
identified O 0 0.00010492118599358946
. O 0 0.00017131440108641982

These O 0 6.68536449666135e-05
results O 0 3.91512548958417e-05
indicate O 0 6.165142985992134e-05
the O 0 4.675650052377023e-05
usefulness O 0 0.00028827477945014834
of O 0 0.00027376029174774885
cycloheximide O 1 0.9721993803977966
treatment O 0 0.00027759233489632607
in O 0 4.676194294006564e-05
evaluating O 0 5.77197533857543e-05
the O 0 4.346925561549142e-05
abnormal O 0 0.00010289664351148531
processing O 0 7.938723865663633e-05
of O 0 0.00010013540304498747
mRNA O 0 0.0001269577769562602
due O 0 0.00016301423602271825
to O 0 6.459282303694636e-05
splice O 0 0.0006072017131373286
- O 0 0.000253987789619714
site O 0 0.00011097163951490074
mutations O 0 3.391357677173801e-05
, O 0 1.2105547284591012e-05
because O 0 1.4327635653899051e-05
( O 0 4.730654472950846e-05
i O 0 0.00015923421597108245
) O 0 3.8955509808147326e-05
aberrant O 0 0.0002603147295303643
splicing O 0 0.00013943649537395686
often O 0 2.2143822206999175e-05
generates O 0 4.2220712202833965e-05
a O 0 5.531104397960007e-05
premature O 0 0.0003615855530370027
termination O 0 0.00023994798539206386
codon O 0 0.0001013347864500247
, O 0 3.549790562829003e-05
( O 0 2.9920782253611833e-05
ii O 1 0.8762605786323547
) O 0 3.939034286304377e-05
transcripts O 0 0.00021158413437660784
with O 0 4.033218283439055e-05
premature O 0 0.0006585263763554394
termination O 0 0.0006679660291410983
codons O 0 0.0005591801600530744
can O 0 3.3501833968330175e-05
occur O 0 4.0006041672313586e-05
at O 0 0.00023263691400643438
low O 0 0.00023845277610234916
or O 0 5.538070763577707e-05
undetectable O 0 0.0017690302338451147
levels O 0 0.00015571263793390244
due O 0 0.0001261259167222306
to O 0 4.832757622352801e-05
nonsense O 0 0.00032328785164281726
- O 0 0.00018114445265382528
mediated O 0 0.00010994416516041383
mRNA O 0 0.00011216251732548699
decay O 0 0.00028473694692365825
, O 0 1.0120005754288286e-05
and O 0 6.8541148721124046e-06
( O 0 3.451104203122668e-05
iii O 0 0.006444266531616449
) O 0 1.3642867997987196e-05
the O 0 1.1352798537700437e-05
levels O 0 2.070149093924556e-05
of O 0 1.0706633474910632e-05
these O 0 3.5586374451668235e-06
transcripts O 0 5.9466343373060226e-05
can O 0 4.562748927128268e-06
be O 0 7.446071776939789e-06
increased O 0 3.067281795665622e-05
by O 0 4.378144149086438e-05
cycloheximide O 0 0.006205304525792599
. O 0 0.00044919532956555486

A O 0 0.0020998790860176086
deletion O 0 0.0015063830651342869
mutation O 0 0.00023452927416656166
in O 0 0.00017659031436778605
COL17A1 O 1 0.7040368914604187
in O 0 4.3607098632492125e-05
five O 0 2.2419719243771397e-05
Austrian O 0 0.00020355405285954475
families O 0 1.5921246813377365e-05
with O 0 3.949031088268384e-05
generalized O 1 0.9999383687973022
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999988079071045
represents O 0 0.0027763363905251026
propagation O 0 0.0009456964326091111
of O 0 0.00034992783912457526
an O 0 0.00020271018729545176
ancestral O 0 0.0066785626113414764
allele O 0 0.0007129873265512288
. O 0 0.00047352243564091623

Patients O 0 0.0019360992591828108
with O 0 0.00033752090530470014
generalized O 1 0.9999985694885254
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.0003554434806574136
a O 0 5.4109601478558034e-05
usually O 0 1.5405648809974082e-05
nonlethal O 0 0.0001856812450569123
form O 0 6.963789201108739e-05
of O 0 0.234595388174057
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999946355819702
, O 0 7.924860256025568e-05
have O 0 1.568550942465663e-05
generalized O 0 0.0004306641931179911
blistering B-Disease 1 0.9920853972434998
, O 1 0.910009503364563
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.7715287208557129
patchy B-Disease 1 0.9999996423721313
alopecia I-Disease 1 1.0
, O 1 0.9937742948532104
and O 1 0.9983382225036621
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 1 0.997389018535614

Skin B-Disease 1 0.9999697208404541
fragility I-Disease 1 0.9998284578323364
in O 0 0.0004898548359051347
most O 0 5.004392733098939e-05
cases O 0 2.537967884563841e-05
is O 0 1.2552744010463357e-05
due O 0 5.239457459538244e-05
to O 0 1.4535338777932338e-05
mutations O 0 9.66284642345272e-06
in O 0 8.45610338728875e-06
the O 0 1.4955943697714247e-05
gene O 0 6.239419235498644e-06
encoding O 0 2.2610382075072266e-05
type O 0 0.0009550096001476049
XVII O 1 1.0
collagen O 1 0.9999936819076538
( O 0 0.003045738907530904
COL17A1 O 1 0.9999774694442749
) O 0 0.000419766700360924
. O 0 0.00023431761655956507

Recently O 0 0.0011074403300881386
, O 0 4.8480909754289314e-05
we O 0 1.3842215594195295e-05
reported O 0 1.7400572687620297e-05
five O 0 1.2271579180378467e-05
Austrian O 0 0.00018083125178236514
families O 0 1.984214577532839e-05
with O 0 5.545401290873997e-05
generalized O 1 0.9999438524246216
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999991655349731
who O 0 0.0004908554838038981
share O 0 8.181713201338425e-05
the O 0 9.264048276236281e-05
same O 0 0.00015300902305170894
COL17A1 O 1 0.999929666519165
mutation O 0 0.0004993395996280015
. O 0 0.00027426399174146354

Affected O 0 0.0005610341904684901
individuals O 0 2.831399251590483e-05
in O 0 4.125773557461798e-05
three O 0 1.2263717508176342e-05
families O 0 4.727343821286922e-06
are O 0 2.2529898160428274e-06
homozygous O 0 1.5788267774041742e-05
for O 0 1.3946536455478054e-05
4003delTC O 0 0.0009684417746029794
, O 0 3.0847320886095986e-05
whereas O 0 2.9434817406581715e-05
those O 0 1.0941074833681341e-05
in O 0 2.9924322006991133e-05
two O 0 1.7926364307641052e-05
others O 0 2.174778092012275e-05
are O 0 1.640158734517172e-05
compound O 0 0.001006171922199428
heterozygotes O 0 0.00699397549033165
. O 0 0.000905680819414556

To O 0 0.00010973939060932025
determine O 0 2.2614996851189062e-05
if O 0 4.144506874581566e-06
the O 0 1.2934726328239776e-05
occurrence O 0 3.6616176657844335e-05
of O 0 8.737959433346987e-05
4003delTC O 0 0.0017997091636061668
in O 0 7.512539013987407e-05
these O 0 1.3126970770827029e-05
unrelated O 0 6.926548667252064e-05
families O 0 2.154128196707461e-05
signifies O 0 0.0002863207191694528
propagation O 0 0.0001248191692866385
of O 0 8.114316733554006e-05
an O 0 5.694264837075025e-05
ancestral O 0 0.0015205655945464969
allele O 0 9.61766709224321e-05
or O 0 8.985944441519678e-05
a O 0 0.0001858217001426965
mutational O 0 0.0039230468682944775
hot O 0 0.0012642460642382503
spot O 0 0.0002707384410314262
, O 0 1.229407007485861e-05
haplotypes O 0 9.118487650994211e-05
were O 0 2.649493944772985e-05
determined O 0 2.2774287572246976e-05
for O 0 1.1753429134842008e-05
polymorphisms O 0 0.00011307316890452057
both O 0 3.0128596335998736e-05
within O 0 0.0001342198229394853
and O 0 0.00021859649859834462
flanking O 1 0.9982221722602844
COL17A1 O 1 0.9999995231628418
. O 0 0.002272580284625292

Five O 0 0.0011611627414822578
intragenic O 0 0.006117076147347689
polymorphisms O 0 0.0003802258288487792
were O 0 5.294995935400948e-05
chosen O 0 4.014377554995008e-05
based O 0 1.1873887160618324e-05
on O 0 9.686974954092875e-05
their O 0 6.383923755493015e-05
informativeness O 0 0.012910368852317333
. O 0 0.0005782422376796603

One O 0 0.00010487757390365005
of O 0 0.0001138146108132787
these O 0 1.6036387023632415e-05
, O 0 1.2655780665227212e-05
not O 0 4.457682734937407e-06
previously O 0 4.52330095868092e-05
reported O 0 2.3745444195810705e-05
, O 0 8.595232429797761e-06
was O 0 0.00027326325653120875
2988 O 0 0.0016587525606155396
A O 0 0.00046247857972048223
or O 0 4.2303170630475506e-05
C O 0 0.0004943758249282837
that O 0 6.124133051343961e-06
introduces O 0 1.7615069737075828e-05
a O 0 1.192583022202598e-05
new O 0 5.987016720609972e-06
restriction O 0 1.9482658899505623e-05
site O 0 0.00010582136746961623
for O 0 5.3503725212067366e-05
Eco0109 O 0 0.003955899737775326
I O 0 0.005303338170051575
. O 0 0.0003786090237554163

All O 0 7.978431676747277e-05
the O 0 6.63445534883067e-05
4003delTC O 0 0.0006229476421140134
alleles O 0 4.136276402277872e-05
showed O 0 5.876837167306803e-05
the O 0 2.4069762730505317e-05
same O 0 1.2472269190766383e-05
haplotype O 0 7.53090062062256e-05
for O 0 1.9885752408299595e-05
these O 0 2.248184864583891e-05
five O 0 8.51981749292463e-05
polymorphic O 0 0.0006137622403912246
markers O 0 0.004822809714823961
. O 0 0.0013087489642202854

Fourteen O 0 0.005130183883011341
microsatellite O 0 0.005171856377273798
polymorphisms O 0 0.0005359878414310515
were O 0 4.936037657898851e-05
selected O 0 1.9046237866859883e-05
based O 0 5.107626293465728e-06
on O 0 4.0095495933201164e-05
their O 0 1.962186797754839e-05
high O 0 0.0004317016573622823
heterozygosity O 0 0.0018230581190437078
and O 0 2.8920949262101203e-05
their O 0 1.6589194274274632e-05
location O 0 0.00011674221605062485
within O 0 9.123880590777844e-05
10q23 O 0 0.002402285113930702
- O 0 0.0013571239542216063
q25 O 0 0.004136752802878618
near O 0 0.0036668640095740557
COL17A1 O 1 0.9942120909690857
. O 0 0.0007597404182888567

Three O 0 0.00017012316675391048
families O 0 3.743895285879262e-05
shared O 0 0.00021621085761580616
microsatellite O 0 0.0034921015612781048
polymorphisms O 0 0.0009797931415960193
covering O 0 0.0009347554878331721
at O 0 0.0006565680960193276
most O 0 6.180612399475649e-05
19 O 0 0.00031838417635299265
cM O 0 0.0007445878582075238
, O 0 2.2120266294223256e-05
whereas O 0 2.2674428691971116e-05
the O 0 2.82614983007079e-05
others O 0 1.946690827026032e-05
shared O 0 4.5864824642194435e-05
smaller O 0 4.013749639852904e-05
regions O 0 3.2026859116740525e-05
consistent O 0 4.526428529061377e-05
with O 0 2.0043989934492856e-05
cross O 0 0.00032654503593221307
- O 0 0.00021281020599417388
over O 0 3.9533340896014124e-05
events O 0 2.8516007660073228e-05
during O 0 8.079047984210774e-05
passage O 0 5.6209773902082816e-05
of O 0 3.126496812910773e-05
this O 0 1.173392138298368e-05
mutation O 0 1.7924381609191187e-05
through O 0 2.2329884814098477e-05
several O 0 7.006459054537117e-05
generations O 0 0.0007040005875751376
. O 0 0.00025652223848737776

These O 0 6.100843893364072e-05
results O 0 6.0352482250891626e-05
indicate O 0 0.00014635981642641127
that O 0 2.6347412131144665e-05
4003delTC O 0 0.0009641011129133403
occurs O 0 4.4557422370417044e-05
on O 0 6.355746154440567e-05
a O 0 4.9497830332256854e-05
single O 0 4.851560152019374e-05
ancestral O 0 0.000553735182620585
allele O 0 0.00014192683738656342
. O 0 7.810917304595932e-05
. O 0 0.00019812770187854767

The O 0 0.0006644327659159899
haptoglobin O 0 0.009480311535298824
- O 0 0.0007213532808236778
gene O 0 4.295670078136027e-05
deletion O 0 7.141778769437224e-05
responsible O 0 0.00011312515562167391
for O 0 0.00014807915431447327
anhaptoglobinemia B-Disease 1 0.7495526075363159
. O 0 0.0006348967435769737

We O 0 0.00012438501289580017
have O 0 1.0507394108572043e-05
found O 0 7.931249456305522e-06
an O 0 6.720122200931655e-06
allelic O 0 0.00012689278810285032
deletion O 0 0.00016947972471825778
of O 0 0.0001883423828985542
the O 0 0.0003128719690721482
haptoglobin O 0 0.003175561549142003
( O 0 8.256491855718195e-05
Hp O 0 0.0002218332956545055
) O 0 1.6273641449515708e-05
gene O 0 1.1318668839521706e-05
from O 0 8.928406714403536e-06
an O 0 6.700163339701248e-06
individual O 0 1.1136243301734794e-05
with O 0 5.474274803418666e-05
anhaptoglobinemia B-Disease 1 0.9991025924682617
. O 0 0.0007018308388069272

The O 0 0.0007374868728220463
Hp O 0 0.0011247000657022
gene O 0 0.00010564120748313144
cluster O 0 9.967373625840992e-05
consists O 0 2.685967592697125e-05
of O 0 4.8454850912094116e-05
coding O 0 9.607235551811755e-05
regions O 0 4.246921889716759e-05
of O 0 5.4324114898918197e-05
the O 0 0.00010974671022268012
alpha O 0 0.0005113023216836154
chain O 0 5.6996330386027694e-05
and O 0 8.933695426094346e-06
beta O 0 6.217831833055243e-05
chain O 0 2.9657609047717415e-05
of O 0 2.75258717010729e-05
the O 0 7.5863441452384e-05
haptoglobin O 0 0.0016955569153651595
gene O 0 8.062601409619674e-05
( O 0 4.1889124986482784e-05
Hp O 0 0.0001425620139343664
) O 0 8.303288268507458e-06
and O 0 3.2352741072827484e-06
of O 0 3.267225110903382e-05
the O 0 9.851356298895553e-05
alpha O 0 0.0005800867802463472
chain O 0 9.316821524407715e-05
and O 0 1.162012449640315e-05
beta O 0 8.806669939076528e-05
chain O 0 5.108816549181938e-05
of O 0 3.3460451959399506e-05
the O 0 9.0853325673379e-05
haptoglobin O 0 0.002430825959891081
- O 0 0.0002705547376535833
related O 0 4.794546475750394e-05
gene O 0 3.989509423263371e-05
( O 0 3.2249456126010045e-05
Hpr O 0 0.0006989577668718994
) O 0 2.207018042099662e-05
, O 0 1.256680661754217e-05
in O 0 2.4973896870505996e-05
tandem O 0 0.0005170087679289281
from O 0 9.261716331820935e-05
the O 0 0.00010473016300238669
5 O 0 0.0005647888756357133
side O 0 0.0007635622168891132
. O 0 0.00044139448436908424

Southern O 0 0.002259468659758568
blot O 0 0.001468241331167519
and O 0 5.5448777857236564e-05
PCR O 0 7.66707889852114e-05
analyses O 0 2.1016101527493447e-05
have O 0 4.131129571760539e-06
indicated O 0 1.2579850590554997e-05
that O 0 1.5853769355089753e-06
the O 0 7.149942121031927e-06
individual O 0 3.1028584999148734e-06
with O 0 1.4215093870006967e-05
anhaptoglobinemia B-Disease 0 0.0037714822683483362
was O 0 0.00024663066142238677
homozygous O 0 1.7213606042787433e-05
for O 0 3.645762944870512e-06
the O 0 1.2383003195282072e-05
gene O 0 1.0243057658954058e-05
deletion O 0 3.375170490471646e-05
and O 0 7.74759791966062e-06
that O 0 2.369553840253502e-06
the O 0 9.614762348064687e-06
gene O 0 7.970908882271033e-06
deletion O 0 4.052224903716706e-05
was O 0 0.00010509591083973646
included O 0 1.868053004727699e-05
at O 0 7.903148798504844e-05
least O 0 1.2989203241886571e-05
from O 0 1.67992475326173e-05
the O 0 7.05415295669809e-05
promoter O 0 0.0021819542162120342
region O 0 0.0003774914366658777
of O 0 0.0002880654647015035
Hp O 0 0.0006829775520600379
to O 0 0.0001672165672061965
Hpr O 0 0.0023567774333059788
alpha O 0 0.0002473922504577786
but O 0 8.221106327255256e-06
not O 0 3.3892445117089665e-06
to O 0 1.695126229606103e-05
Hpr O 0 0.0013945956015959382
beta O 0 0.0004040987987536937
( O 0 0.00014257643488235772
Hpdel O 0 0.007369187660515308
) O 0 0.0002730275737121701
. O 0 0.00023081348626874387

In O 0 0.0003609675040934235
addition O 0 6.408003537217155e-05
, O 0 2.4070428480627015e-05
we O 0 9.190314813167788e-06
found O 0 7.061038559186272e-06
seven O 0 1.4583589290850796e-05
individuals O 0 3.7041183986730175e-06
with O 0 1.7912623661686666e-05
hypohaptoglobinemia B-Disease 0 0.005676290486007929
in O 0 4.224173244438134e-05
three O 0 1.1879641533596441e-05
families O 0 4.849114247917896e-06
, O 0 5.172389592189575e-06
and O 0 5.245096417638706e-06
the O 0 2.5060931875486858e-05
genotypes O 0 0.00011062932026106864
of O 0 0.00010009758989326656
six O 0 4.498724592849612e-05
of O 0 3.788758840528317e-05
the O 0 5.034683636040427e-05
seven O 0 2.7369133022148162e-05
individuals O 0 4.5499914449464995e-06
were O 0 2.8371403459459543e-05
found O 0 1.4586078577849548e-05
to O 0 3.2372245186707005e-05
be O 0 0.00010890043631661683
Hp2 O 1 0.7797170281410217
/ O 0 0.008395691402256489
Hpdel O 1 0.9108012318611145
. O 0 0.0006766897276975214

The O 0 0.0009670744184404612
phenotypes O 0 0.00116942438762635
and O 0 7.87542448961176e-05
genotypes O 0 0.000591103860642761
in O 0 5.947797035332769e-05
one O 0 1.878521652542986e-05
of O 0 3.0154409614624456e-05
these O 0 5.570391294895671e-06
three O 0 6.696164291497553e-06
families O 0 6.284782102738973e-06
showed O 0 3.388949335203506e-05
the O 0 2.604766450531315e-05
father O 0 7.020692282821983e-05
to O 0 1.504397459939355e-05
be O 0 2.2547852495335974e-05
hypohaptoglobinemic B-Disease 0 0.0011467704316601157
( O 0 6.268030847422779e-05
Hp2 O 0 0.004324794746935368
) O 0 2.736156602622941e-05
and O 0 2.218745430582203e-05
Hp2 O 1 0.9469008445739746
/ O 0 0.0040720668621361256
Hpdel O 0 0.08977191895246506
, O 0 2.8595852199941874e-05
the O 0 3.84484046662692e-05
mother O 0 3.609612031141296e-05
to O 0 1.8196455130237155e-05
be O 0 2.839717490132898e-05
Hp2 O 0 0.00194012641441077
- O 0 0.00018057900888379663
1 O 0 0.00011162837472511455
and O 0 4.814835119759664e-05
Hp1 O 0 0.054680533707141876
/ O 0 0.0012439952697604895
Hp2 O 0 0.004589178133755922
, O 0 2.8814109100494534e-05
one O 0 6.232603482203558e-06
of O 0 1.6606591088930145e-05
the O 0 2.9317239750525914e-05
two O 0 1.2159232937847264e-05
children O 0 5.7388783716305625e-06
to O 0 1.0718454177549575e-05
be O 0 2.7395193683332764e-05
hypohaptoglobinemic B-Disease 0 0.0011724707437679172
( O 0 6.374872464220971e-05
Hp2 O 0 0.003012957749888301
) O 0 3.49613546859473e-05
and O 0 3.4393488022033125e-05
Hp2 O 1 0.9364858865737915
/ O 0 0.004985291510820389
Hpdel O 0 0.3378942310810089
, O 0 3.276135612395592e-05
and O 0 6.41172027826542e-06
the O 0 1.8895516404882073e-05
other O 0 5.757698090746999e-06
child O 0 2.0083311028429307e-05
to O 0 1.1799915228039026e-05
be O 0 4.202163472655229e-05
Hp1 O 0 0.003398874308913946
and O 0 6.947995279915631e-05
Hp1 O 1 0.9980630278587341
/ O 0 0.008563538081943989
Hpdel O 0 0.06393492221832275
, O 0 3.3043877920135856e-05
showing O 0 0.00010437094897497445
an O 0 3.268767613917589e-05
anomalous O 0 0.0015103186015039682
inheritance O 0 0.0012242455268278718
of O 0 0.0028163304086774588
Hp O 0 0.007368852850049734
phenotypes O 0 0.0005874259513802826
in O 0 0.00010275858949171379
the O 0 0.00011701391485985368
child O 0 0.00019118194177281111
with O 0 7.955860201036558e-05
Hp1 O 1 0.998563826084137
. O 0 0.0005934088840149343

The O 0 0.0017337010940536857
Hp2 O 1 0.998721182346344
/ O 0 0.023842738941311836
Hpdel O 0 0.12456072121858597
individuals O 0 4.1806353692663833e-05
had O 0 0.0001407115050824359
an O 0 2.943725667137187e-05
extremely O 0 0.00010818491864483804
low O 0 0.00012293820327613503
level O 0 0.00012232322478666902
of O 0 0.00010996942728525028
Hp O 0 0.0002255249273730442
( O 0 2.1503354219021276e-05
mean O 0 4.604797504725866e-05
+ O 0 0.00010119495709659532
/ O 0 0.00017059390665963292
- O 0 0.0001475081080570817
SD O 0 0.0010912216966971755
= O 0 7.211879710666835e-05
0 O 0 2.8678192393272184e-05
. O 0 8.82544100022642e-06
049 O 0 0.00025608649593777955
+ O 0 9.735054482007399e-05
/ O 0 0.00013434172433335334
- O 0 8.600564615335315e-05
0 O 0 3.811425995081663e-05
. O 0 1.4862625903333537e-05
043 O 0 0.0007684800657443702
mg O 0 0.000613108859397471
/ O 0 0.00036986719351261854
ml O 0 0.0002190346276620403
; O 0 1.1848675057990476e-05
n O 0 0.00010390383249614388
= O 0 0.0001458972110413015
6 O 0 0.00011324819206492975
) O 0 6.62351840219344e-06
, O 0 3.6629339774663094e-06
compared O 0 6.301682333287317e-06
with O 0 2.0016811959067127e-06
the O 0 2.892759584938176e-05
level O 0 0.00013921596109867096
( O 0 1.0366743481426965e-05
1 O 0 3.772714626393281e-05
. O 0 4.7238063416443765e-06
64 O 0 3.0221744964364916e-05
+ O 0 8.24374656076543e-05
/ O 0 0.00012367963790893555
- O 0 7.256942626554519e-05
1 O 0 5.1280188927194104e-05
. O 0 1.2392336429911666e-05
07 O 0 0.00028918261523358524
mg O 0 0.0005069830222055316
/ O 0 0.00021386226580943912
ml O 0 0.0001768344664014876
) O 0 9.219565072271507e-06
obtained O 0 1.8549906599218957e-05
from O 0 4.0378436096943915e-05
52 O 0 0.0002564994792919606
healthy O 0 0.00030189158860594034
volunteers O 0 0.00013194934581406415
having O 0 0.0001515876065241173
phenotype O 0 0.00023446780687663704
Hp2 O 0 0.004293631296604872
, O 0 3.083428964600898e-05
whereas O 0 1.90823102457216e-05
the O 0 4.108725624973886e-05
serum O 0 0.00023384112864732742
Hp O 0 0.00012885479372926056
level O 0 6.191384454723448e-05
of O 0 2.911260526161641e-05
an O 0 1.0016023225034587e-05
individual O 0 1.436780712538166e-05
with O 0 4.556472413241863e-05
Hp1 O 1 0.9983466863632202
/ O 0 0.0070488168857991695
Hpdel O 1 0.6342849135398865
was O 0 0.0015488170320168138
0 O 0 0.0002871258184313774
. O 0 0.00020963128190487623

50 O 0 0.0016009132377803326
mg O 0 0.005726862698793411
/ O 0 0.0015064447652548552
ml O 0 0.0008065192960202694
, O 0 2.656841570569668e-05
which O 0 8.068989700404927e-06
was O 0 5.808828063891269e-05
approximately O 0 1.3116959053149913e-05
half O 0 5.4542283578484785e-06
the O 0 4.8117594815266784e-06
level O 0 3.453754834481515e-05
of O 0 5.143642192706466e-05
Hp O 0 0.00026965184952132404
in O 0 6.829203630331904e-05
control O 0 0.000246104464167729
sera O 0 0.0009251097799278796
from O 0 4.3335065129213035e-05
the O 0 8.383150998270139e-05
Hp1 O 0 0.0018535128328949213
phenotype O 0 8.105918095679954e-05
( O 0 1.603137206984684e-05
1 O 0 4.124310362385586e-05
. O 0 3.917353296856163e-06
26 O 0 3.890828520525247e-05
+ O 0 4.983685357728973e-05
/ O 0 6.038656283635646e-05
- O 0 3.934746564482339e-05
0 O 0 1.519611214462202e-05
. O 0 5.505421995621873e-06
33 O 0 6.550691614393145e-05
mg O 0 0.00036868418101221323
/ O 0 0.00032294256379827857
ml O 0 0.00020755629520863295
; O 0 1.358380995952757e-05
n O 0 0.00012339481327217072
= O 0 0.00015602103667333722
9 O 0 0.00013222014240454882
) O 0 9.990094440581743e-06
, O 0 4.40128087575431e-06
showing O 0 3.423909220146015e-05
a O 0 7.228383765323088e-05
gene O 0 0.0001710069045657292
- O 0 0.00040396052645519376
dosage O 0 0.0005633265245705843
effect O 0 0.00033248632098548114
. O 0 0.00023903050168883055

The O 0 0.0002746774407569319
other O 0 2.9871229344280437e-05
allele O 0 5.142191002960317e-05
( O 0 7.890632696216926e-05
Hp2 O 0 0.0017361901700496674
) O 0 1.6221858459175564e-05
of O 0 3.224097235943191e-05
individuals O 0 1.904961754917167e-05
with O 0 8.202719618566334e-05
Hp2 O 1 0.9999632835388184
/ O 1 0.6021108031272888
Hpdel O 1 0.982174277305603
was O 0 0.0003913362743332982
found O 0 5.80323694521212e-06
to O 0 5.965541276964359e-06
have O 0 3.5170171486242907e-06
, O 0 3.102589516856824e-06
in O 0 5.214055363467196e-06
all O 0 7.540779733972158e-06
exons O 0 0.00018384905706625432
, O 0 1.993242221942637e-05
no O 0 1.7444817785872146e-05
mutation O 0 6.696738637401722e-06
, O 0 5.097932898934232e-06
by O 0 9.27859127841657e-06
DNA O 0 8.286646334454417e-05
sequencing O 0 0.0002568961645010859
. O 0 0.00020226073684170842

On O 0 0.00029206424369476736
the O 0 3.9670238038524985e-05
basis O 0 1.9468430764391087e-05
of O 0 2.7563013645703904e-05
the O 0 3.262579411966726e-05
present O 0 5.1855353376595303e-05
study O 0 1.6903351934161037e-05
, O 0 9.175497325486504e-06
the O 0 2.4753717298153788e-05
mechanism O 0 9.832472278503701e-05
of O 0 0.00012616286403499544
anhaptoglobinemia B-Disease 0 0.042896587401628494
and O 0 2.9543396522058174e-05
the O 0 3.903992546838708e-05
mechanism O 0 0.00010145331907551736
of O 0 0.00015109665400814265
anomalous O 0 0.002701548393815756
inheritance O 0 0.0016280874842777848
of O 0 0.002633539494127035
Hp O 0 0.007141977548599243
phenotypes O 0 0.0007555513875558972
were O 0 0.00013705620949622244
well O 0 7.87164899520576e-05
explained O 0 0.0002843828988261521
. O 0 0.00018517946591600776

However O 0 0.0002591515949461609
, O 0 2.7932361263083294e-05
the O 0 2.7902433430426754e-05
mechanism O 0 0.00010794368427013978
of O 0 0.0003208584967069328
hypohaptoglobinemia B-Disease 1 0.9971844553947449
remains O 0 0.02491092123091221
unknown O 0 0.003937656059861183

ATM O 0 0.0675128772854805
mutations O 0 0.0006190652493387461
and O 0 0.0001901265059132129
phenotypes O 0 0.0012500997399911284
in O 0 0.0013497471809387207
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 0.9999957084655762
families O 0 7.936226757010445e-05
in O 0 4.354269185569137e-05
the O 0 2.88872961391462e-05
British O 0 3.1126186513574794e-05
Isles O 0 7.888390246080235e-05
: O 0 6.9585457822540775e-06
expression O 0 1.2995398719795048e-05
of O 0 9.514734119875357e-05
mutant O 0 0.00046140330960042775
ATM O 0 0.0009274653857573867
and O 0 9.290934940509032e-06
the O 0 1.5860236089793034e-05
risk O 0 5.790830255136825e-05
of O 0 0.001498462981544435
leukemia B-Disease 1 1.0
, O 1 0.9999865293502808
lymphoma B-Disease 1 1.0
, O 1 0.9999109506607056
and O 1 0.99986732006073
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.01653304696083069

We O 0 8.599589637015015e-05
report O 0 5.430073997558793e-06
the O 0 1.1755368177546188e-05
spectrum O 0 6.586457311641425e-05
of O 0 7.33660053811036e-05
59 O 0 0.0004587241564877331
ATM O 0 0.0025391853414475918
mutations O 0 0.00010379857121733949
observed O 0 0.00010448477405589074
in O 0 0.00018542080943007022
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999493360519409
telangiectasia I-Disease 1 0.9999966621398926
( O 0 0.0011628750944510102
A B-Disease 1 0.9999985694885254
- I-Disease 1 0.9996740818023682
T I-Disease 1 0.999996542930603
) O 0 6.558611494256184e-05
patients O 0 3.374339939909987e-05
in O 0 3.583876969059929e-05
the O 0 6.55116600682959e-05
British O 0 0.00019699145923368633
Isles O 0 0.001286384416744113
. O 0 0.0003692763566505164

Of O 0 0.0012625543167814612
51 O 0 0.00197775149717927
ATM O 0 0.008947096765041351
mutations O 0 0.00020132120698690414
identified O 0 4.736098344437778e-05
in O 0 3.223061139578931e-05
families O 0 9.08194670046214e-06
native O 0 1.910572791530285e-05
to O 0 1.1714277206920087e-05
the O 0 2.720102020248305e-05
British O 0 6.477590795839205e-05
Isles O 0 0.0002045217261184007
, O 0 1.8489117792341858e-05
11 O 0 0.00010066752292914316
were O 0 5.541240898310207e-05
founder O 0 0.00043803034350275993
mutations O 0 4.752720633405261e-05
, O 0 1.5387147868750617e-05
and O 0 9.316168871009722e-06
2 O 0 6.001124347676523e-05
of O 0 4.06316394219175e-05
these O 0 8.624496331322007e-06
11 O 0 8.226204226957634e-05
conferred O 0 0.0002674417628441006
a O 0 5.142082954989746e-05
milder O 0 6.750714965164661e-05
clinical O 0 5.336588583304547e-05
phenotype O 0 3.1226471037371084e-05
with O 0 8.968644578999374e-06
respect O 0 6.053034667274915e-05
to O 0 0.00014321942580863833
both O 0 0.0010948270792141557
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9999828338623047
cellular O 1 0.9999532699584961
features O 0 0.0021349741145968437
. O 0 0.0005003501428291202

We O 0 0.00011946772428927943
report O 0 1.4500378711090889e-05
, O 0 8.574511412007269e-06
in O 0 1.232213617186062e-05
two O 0 1.4034326341061387e-05
A B-Disease 1 0.9880579710006714
- I-Disease 0 0.09010124206542969
T I-Disease 1 0.9983664155006409
families O 0 1.3383282748691272e-05
, O 0 5.285674433253007e-06
an O 0 7.4435656642890535e-06
ATM O 0 0.0007294125971384346
mutation O 0 3.759261380764656e-05
( O 0 4.0928793168859556e-05
7271T O 0 0.0007867091335356236
- O 0 0.00026458801585249603
- O 0 0.00010984177788486704
> O 0 8.435869676759467e-05
G O 0 0.0002300204214407131
) O 0 8.185565093299374e-06
that O 0 2.2783603981224587e-06
may O 0 7.65127879276406e-06
be O 0 4.126396561332513e-06
associated O 0 3.432794983382337e-06
with O 0 1.4841347137917182e-06
an O 0 9.170476005238015e-06
increased O 0 9.854353265836835e-05
risk O 0 0.00018280235235579312
of O 0 0.006904426496475935
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999767541885376
in O 0 8.302449714392424e-05
both O 0 4.14163623645436e-05
homozygotes O 0 0.0010776318376883864
and O 0 5.6383501942036673e-05
heterozygotes O 0 0.0007794811972416937
( O 0 9.124576899921522e-05
relative O 0 0.00021756683418061584
risk O 0 0.00016067047545220703
12 O 0 0.00012397128739394248
. O 0 1.414288635714911e-05
7 O 0 9.882886661216617e-05
; O 0 7.299748176592402e-06
P O 0 0.0007553296163678169
= O 0 0.00015070330118760467
. O 0 3.234490941395052e-05
0025 O 0 0.0015136293368414044
) O 0 1.0769500477181282e-05
, O 0 4.022921075375052e-06
although O 0 3.3487208384030964e-06
there O 0 5.290324224915821e-06
is O 0 5.755035090260208e-06
a O 0 1.716830774967093e-05
less O 0 0.00010997592471539974
severe O 1 0.9996206760406494
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.999992847442627
T I-Disease 1 0.9999945163726807
phenotype O 0 6.197432958288118e-05
in O 0 9.489497642789502e-06
terms O 0 9.912531822919846e-06
of O 0 1.793558112694882e-05
the O 0 3.335989822517149e-05
degree O 0 0.0004672966315411031
of O 1 0.808967113494873
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.9996010661125183

This O 0 0.00014074317004997283
mutation O 0 6.069034134270623e-05
( O 0 6.550591206178069e-05
7271T O 0 0.0017574881203472614
- O 0 0.000534931430593133
- O 0 0.00021766891586594284
> O 0 0.00022387270291801542
G O 0 0.0003436169645283371
) O 0 8.438758413831238e-06
also O 0 3.36132688971702e-06
allows O 0 7.0329406298697e-07
expression O 0 6.526256129291141e-06
of O 0 2.2005639038980007e-05
full O 0 8.504574361722916e-05
- O 0 0.00018317121430300176
length O 0 5.6143988331314176e-05
ATM O 0 0.0004164994752500206
protein O 0 3.052335523534566e-05
at O 0 5.638802031171508e-05
a O 0 1.2861527466156986e-05
level O 0 5.186529233469628e-05
comparable O 0 3.6850171454716474e-05
with O 0 8.136627002386376e-06
that O 0 5.7581319197197445e-06
in O 0 6.23482555965893e-05
unaffected O 0 0.0005916531081311405
individuals O 0 7.965842087287456e-05
. O 0 0.0003638790512923151

In O 0 0.0002069131296593696
addition O 0 4.365182758192532e-05
, O 0 1.2957358194398694e-05
we O 0 4.093582447239896e-06
have O 0 1.6774133655417245e-06
studied O 0 4.890892523690127e-05
18 O 0 0.0002959331322927028
A B-Disease 1 0.9999674558639526
- I-Disease 1 0.9998915195465088
T I-Disease 1 0.9999994039535522
patients O 0 6.572918937308714e-05
, O 0 1.327158861386124e-05
in O 0 1.4145854038360994e-05
15 O 0 2.7893122023670003e-05
families O 0 4.942670784657821e-06
, O 0 5.284691724227741e-06
who O 0 2.5825675038504414e-05
developed O 1 0.8993138670921326
leukemia B-Disease 1 1.0
, O 1 0.9996362924575806
lymphoma B-Disease 1 1.0
, O 1 0.9986635446548462
preleukemic O 1 1.0
T O 1 0.9999998807907104
- O 1 0.9986011385917664
cell O 0 0.034647539258003235
proliferation O 1 0.9992815852165222
, O 0 6.263382238103077e-05
or O 1 0.9980841875076294
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9608560800552368
mostly O 0 0.0005981377325952053
in O 0 0.000405176542699337
childhood O 1 0.971111536026001
. O 0 0.0006666355766355991

A O 0 0.0030036887619644403
wide O 0 0.0005433047190308571
variety O 0 7.462529902113602e-05
of O 0 0.0003750071919057518
ATM O 0 0.19731934368610382
mutation O 0 0.00015073057147674263
types O 0 7.444390212185681e-05
, O 0 3.52046154148411e-05
including O 0 3.408249540370889e-05
missense O 0 0.0008690336253494024
mutations O 0 0.00016114763275254518
and O 0 7.928495324449614e-05
in O 0 0.00031525263329967856
- O 0 0.0013084647944197059
frame O 0 0.00043022268800996244
deletions O 0 0.00016386513016186655
, O 0 2.202386167482473e-05
were O 0 3.5145203582942486e-05
seen O 0 0.00011704584176186472
in O 0 4.79469308629632e-05
these O 0 5.6724558817222714e-05
patients O 0 0.00046645215479657054
. O 0 0.00042893114732578397

We O 0 0.00021368369925767183
also O 0 1.8658896806300618e-05
show O 0 1.8280097719980404e-05
that O 0 2.1123223632457666e-06
25 O 0 1.8644403098733164e-05
% O 0 4.710558187071001e-06
of O 0 3.828161061392166e-05
all O 0 6.655061588389799e-05
A B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999645948410034
T I-Disease 1 0.999998927116394
patients O 0 0.0001467358524678275
carried O 0 0.00010667862079571933
in O 0 9.989429963752627e-05
- O 0 0.00041023563244380057
frame O 0 0.0002709362597670406
deletions O 0 0.00012528733350336552
or O 0 4.5447424781741574e-05
missense O 0 0.00027335344930179417
mutations O 0 4.096483098692261e-05
, O 0 8.785326826910023e-06
many O 0 4.369921043689828e-06
of O 0 2.1773801563540474e-05
which O 0 1.9473853171803057e-05
were O 0 1.8134383935830556e-05
also O 0 7.095376076904358e-06
associated O 0 1.1256837751716375e-05
with O 0 3.8768203012296e-06
expression O 0 3.963473500334658e-05
of O 0 0.00020500767277553678
mutant O 0 0.001634717918932438
ATM O 0 0.025317389518022537
protein O 0 0.000690857064910233
. O 0 0.0003030936059076339

The O 0 0.0007359784794971347
DMPK O 1 0.9991950392723083
gene O 0 0.0002125753671862185
of O 0 0.000954181479755789
severely O 1 0.9999998807907104
affected O 1 0.9999996423721313
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999828338623047
is O 0 0.0011330766137689352
hypermethylated O 1 0.9871728420257568
proximal O 1 0.822274923324585
to O 0 0.00015423331933561713
the O 0 0.00013980569201521575
largely O 0 0.0003099065215792507
expanded O 0 0.0009212576551362872
CTG O 0 0.40477919578552246
repeat O 0 0.0028308345936238766
. O 0 0.0005939017282798886

Using O 0 0.0003075462591368705
methylation O 0 0.0008434304036200047
- O 0 0.0009856128599494696
sensitive O 0 0.0002123484737239778
restriction O 0 6.110462709330022e-05
enzymes O 0 3.3945576433325186e-05
, O 0 1.342920495517319e-05
we O 0 8.79242543305736e-06
characterized O 0 2.943613799288869e-05
the O 0 2.7089781724498607e-05
methylation O 0 5.879426680621691e-05
pattern O 0 0.00010711896902648732
on O 0 9.041470184456557e-05
the O 0 5.53319368918892e-05
5 O 0 7.764266047161072e-05
side O 0 5.476311343954876e-05
of O 0 0.00011829174763988703
the O 0 0.0002763628144748509
CTG O 1 0.7887405753135681
repeat O 0 0.00022135116159915924
in O 0 3.593720248318277e-05
the O 0 7.413545245071873e-05
DMPK O 0 0.022048622369766235
gene O 0 3.1263509299606085e-05
of O 0 3.987508898717351e-05
normal O 0 4.878180334344506e-05
individuals O 0 4.2512069740041625e-06
and O 0 8.79011167853605e-06
of O 0 0.00028882993501611054
patients O 1 0.6135741472244263
affected O 1 0.835436999797821
with O 1 0.9980681538581848
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 0.000833544007036835
showing O 0 0.0003923771728295833
expansions O 0 0.0005518821417354047
of O 0 0.00015554213314317167
the O 0 0.00020110981131438166
repetitive O 0 0.002191005041822791
sequence O 0 0.0005225089262239635
. O 0 0.0005128211923874915

The O 0 0.00030006427550688386
gene O 0 6.13178126513958e-05
segment O 0 7.123060640878975e-05
analyzed O 0 1.9625575077952817e-05
corresponds O 0 2.1483430828084238e-05
to O 0 1.432598310202593e-05
the O 0 5.293597496347502e-05
genomic O 0 0.00018230661225970834
SacI O 0 0.00832262821495533
- O 0 0.0005020925891585648
HindIII O 0 0.0009849778143689036
fragment O 0 7.972727325977758e-05
carrying O 0 5.6930595746962354e-05
exons O 0 0.00030426093144342303
11 O 0 0.0005731679266318679
- O 0 0.0006865929462946951
15 O 0 0.0002988711348734796
. O 0 0.0001700612046988681

There O 0 0.00017659318109508604
is O 0 3.6625358916353434e-05
constitutive O 0 0.00040135113522410393
methylation O 0 0.00013765924086328596
in O 0 0.00010101245425175875
intron O 0 0.0023797170724719763
12 O 0 0.00020005616534035653
at O 0 0.0001254198868991807
restriction O 0 3.0151019018376246e-05
sites O 0 2.50708544626832e-05
of O 0 9.383488213643432e-05
SacII O 0 0.006321501452475786
and O 0 0.00011235348938498646
HhaI O 0 0.0043347482569515705
, O 0 3.809503687079996e-05
localized O 0 0.0001008836625260301
1 O 0 0.00014878953516017646
, O 0 1.4403134628082626e-05
159 O 0 6.739349919371307e-05
- O 0 8.289238758152351e-05
1 O 0 7.819353777449578e-05
, O 0 8.988046829472296e-06
232 O 0 6.177024624776095e-05
bp O 0 0.00016307485930155963
upstream O 0 0.00010640206892276183
of O 0 2.8555767130455934e-05
the O 0 0.0001376224827254191
CTG O 1 0.7693878412246704
repeat O 0 0.000347943656379357
, O 0 1.4949569958844222e-05
whereas O 0 1.4935973922547419e-05
most O 0 8.000975867616944e-06
, O 0 5.549764864554163e-06
if O 0 2.4612263587187044e-06
not O 0 1.200855763272557e-06
all O 0 1.5492220200030715e-06
, O 0 1.760531063155213e-06
of O 0 7.180041393439751e-06
the O 0 1.51746071423986e-05
other O 0 4.91417858938803e-06
sites O 0 2.5205148631357588e-05
of O 0 0.00011857327626785263
SacII O 0 0.24603021144866943
, O 0 0.00010264263983117417
HhaI O 0 0.007702717557549477
, O 0 3.8028905692044646e-05
and O 0 2.1177451344556175e-05
HpaII O 0 0.002382820937782526
in O 0 3.8728372601326555e-05
this O 0 1.1671389074763283e-05
region O 0 9.704394324216992e-05
are O 0 5.1074116527161095e-06
unmethylated O 0 0.00036221175105310977
, O 0 1.72502168425126e-05
in O 0 2.680409852473531e-05
normal O 0 5.375929322326556e-05
individuals O 0 7.997535249160137e-06
and O 0 1.626625635253731e-05
most O 0 2.8418035071808845e-05
of O 0 0.00018519163131713867
the O 0 0.0009616145980544388
patients O 0 0.0015685084508731961
. O 0 0.0008245029603131115

In O 0 0.0001758086000336334
a O 0 7.428484968841076e-05
number O 0 2.8503693101811223e-05
of O 0 0.00017067656153813004
young O 0 0.001063769101165235
and O 0 0.00013620039680972695
severely O 1 0.9997397065162659
affected O 0 0.0004145157872699201
patients O 0 8.123376028379425e-05
, O 0 1.1624223589024041e-05
however O 0 9.136353583016898e-06
, O 0 3.4393256100884173e-06
complete O 0 2.1956671844236553e-05
methylation O 0 2.4070817744359374e-05
of O 0 6.174633017508313e-05
these O 0 1.196369430545019e-05
restriction O 0 2.145869621017482e-05
sites O 0 2.8765489332727157e-05
was O 0 8.737326425034553e-05
found O 0 6.2878752942197025e-06
in O 0 1.4975795238569845e-05
the O 0 5.07473960169591e-05
mutated O 0 0.0002608533250167966
allele O 0 8.289064862765372e-05
. O 0 0.00014749124238733202

In O 0 0.00020174587552901357
most O 0 3.0083523597568274e-05
of O 0 6.6974556830246e-05
these O 0 2.5536737666698173e-05
patients O 0 3.669275974971242e-05
, O 0 7.315044967981521e-06
the O 0 1.3654255781148095e-05
onset O 1 0.934293270111084
of O 0 0.0017083234852179885
the O 1 0.9999406337738037
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9985690116882324

Preliminary O 0 0.0002809669531416148
in O 0 0.00020301366748753935
vivo O 0 0.0011424446711316705
footprinting O 0 0.002596925711259246
data O 0 3.265359191573225e-05
gave O 0 2.8620490411412902e-05
evidence O 0 2.999571916006971e-05
for O 0 2.1547630240092985e-05
protein O 0 0.00011989157064817846
- O 0 0.00017753576685208827
DNA O 0 3.123823626083322e-05
contact O 0 1.2604036783159245e-05
in O 0 1.2215930837555788e-05
normal O 0 2.349263559153769e-05
genes O 0 1.526200503576547e-05
at O 0 7.728866330580786e-05
an O 0 3.041410309378989e-05
Sp1 O 0 0.00211277580820024
consensus O 0 0.00020833966846112162
binding O 0 5.8820631238631904e-05
site O 0 0.00017263837798964232
upstream O 0 0.0002567003248259425
of O 0 8.189932850655168e-05
the O 0 0.0002728399995248765
CTG O 0 0.24482053518295288
repeat O 0 0.0002635160635691136
and O 0 1.4102778550295625e-05
for O 0 6.378579200827517e-06
a O 0 1.6792007954791188e-05
significant O 0 3.174062294419855e-05
reduction O 0 4.974825424142182e-05
of O 0 3.486944842734374e-05
this O 0 8.092772077361587e-06
interaction O 0 4.402565900818445e-05
in O 0 3.5960027162218466e-05
cells O 0 1.78839127329411e-05
with O 0 6.729479082423495e-06
a O 0 8.873264596331865e-05
hypermethylated O 1 0.809226393699646
DMPK O 1 0.9998568296432495
gene O 0 0.0001878158509498462
. O 0 8.376038749702275e-05
. O 0 0.00015534530393779278

The O 0 0.004409792833030224
hemochromatosis B-Disease 1 1.0
gene O 0 0.00037369425990618765
product O 0 0.00018615953740663826
complexes O 0 0.000376966199837625
with O 0 2.0946627046214417e-05
the O 0 9.283910185331479e-05
transferrin O 0 0.0013076880713924766
receptor O 0 0.00011443754192441702
and O 0 1.177426292997552e-05
lowers O 0 4.931896910420619e-05
its O 0 5.536274784390116e-06
affinity O 0 2.1883464796701446e-05
for O 0 2.5820898372330703e-05
ligand O 0 0.0004195915244054049
binding O 0 0.00030269508715718985
. O 0 0.00026725418865680695

We O 0 0.0003456174163147807
recently O 0 0.00017531744379084557
reported O 0 1.8983531845151447e-05
the O 0 1.8193937648902647e-05
positional O 0 0.00021695013856515288
cloning O 0 7.111522427294403e-05
of O 0 5.059692921349779e-05
a O 0 3.41400082106702e-05
candidate O 0 4.4446827814681455e-05
gene O 0 6.230528379091993e-05
for O 0 0.00024047978513408452
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 0.004093993455171585

The O 0 0.00022565505059901625
gene O 0 6.764692079741508e-05
product O 0 2.1968025976093486e-05
, O 0 6.9380707827804144e-06
a O 0 1.2495938790380023e-05
member O 0 1.4890803868183866e-05
of O 0 3.0369930755114183e-05
the O 0 0.00012974646233487874
major O 0 0.00421718368306756
histocompatibility O 1 0.9999998807907104
complex O 1 0.999729335308075
class O 0 0.002212016610428691
I O 0 0.18419726192951202
- O 0 0.00027185119688510895
like O 0 2.0889754523523152e-05
family O 0 1.4992656360846013e-05
, O 0 6.625679361604853e-06
was O 0 5.0277649279451e-05
found O 0 7.172855475801043e-06
to O 0 8.83903521753382e-06
have O 0 6.652448519162135e-06
a O 0 2.6951867766911164e-05
mutation O 0 3.4797267289832234e-05
, O 0 5.278771641314961e-05
Cys O 0 0.06879999488592148
- O 0 0.0007140518864616752
282 O 0 0.0007627102313563228
- O 0 0.000753430649638176
- O 0 0.0003936952562071383
> O 0 0.0003332136257085949
Tyr O 0 0.0010560539085417986
( O 0 3.9094735257094726e-05
C282Y O 0 0.00048071405035443604
) O 0 1.0624378774082288e-05
, O 0 3.031958385690814e-06
in O 0 4.404118953971192e-06
85 O 0 2.905859764723573e-05
% O 0 2.1762882170150988e-05
of O 0 0.0001712866360321641
patient O 0 0.0010680686682462692
chromosomes O 0 0.0006514057167805731
. O 0 0.00025401130551472306

This O 0 0.00025708830798976123
mutation O 0 0.00011636766430456191
eliminates O 0 0.00018642401846591383
the O 0 5.246507134870626e-05
ability O 0 4.952351810061373e-05
of O 0 0.00018753885524347425
HFE O 1 0.9518699645996094
to O 0 0.00012191390851512551
associate O 0 0.00012233605957590044
with O 0 3.0076582334004343e-05
beta2 O 1 0.626293420791626
- O 0 0.002316549653187394
microglobulin O 0 0.008045222610235214
( O 0 0.0001336487039225176
beta2m O 0 0.0023291693069040775
) O 0 4.48974096798338e-05
and O 0 2.8796361220884137e-05
prevents O 0 0.0003203773812856525
cell O 0 0.004779157694429159
- O 0 0.002967060310766101
surface O 0 0.001069302554242313
expression O 0 0.0003756927908398211
. O 0 0.00026703407638706267

A O 0 0.0016018914757296443
second O 0 0.00024511743686161935
mutation O 0 2.73947498499183e-05
that O 0 3.6895260109304218e-06
has O 0 7.848722816561349e-06
no O 0 9.224058885592967e-06
effect O 0 3.4730404877336696e-05
on O 0 0.00010491508146515116
beta2m O 0 0.012989487498998642
association O 0 9.968258382286876e-05
, O 0 5.6973072787513956e-05
H63D O 1 0.9942500591278076
, O 0 2.2760477804695256e-05
was O 0 0.0001402311900164932
found O 0 8.800512659945525e-06
in O 0 8.828285899653565e-06
eight O 0 1.476624674978666e-05
out O 0 5.426874849945307e-06
of O 0 4.043115404783748e-05
nine O 0 0.00019644545682240278
patients O 0 4.8610163503326476e-05
heterozygous O 0 1.9295737729407847e-05
for O 0 1.7450858649681322e-05
the O 0 0.00011584176536416635
C282Y O 0 0.002432442968711257
mutant O 0 0.0011208823416382074
. O 0 0.0003125940856989473

In O 0 0.00019231843180023134
this O 0 3.4928561944980174e-05
report O 0 2.0452063836273737e-05
, O 0 6.354827291943366e-06
we O 0 6.504669272544561e-06
demonstrate O 0 6.719097291352227e-05
in O 0 5.8852041547652334e-05
cultured O 0 0.000467736303107813
293 O 0 0.001176559249870479
cells O 0 0.0006165454396978021
overexpressing O 0 0.004965146537870169
wild O 0 0.0003515076241455972
- O 0 0.0002634441771078855
type O 0 0.00010784245387185365
or O 0 7.32405242160894e-05
mutant O 0 0.0006775834481231868
HFE O 0 0.0139342425391078
proteins O 0 3.5873305023415014e-05
that O 0 7.2970751716638915e-06
both O 0 5.17014041179209e-06
the O 0 2.763022894214373e-05
wild O 0 0.00011614561663009226
- O 0 0.00019164186960551888
type O 0 0.00013604438572656363
and O 0 9.905936167342588e-05
H63D O 1 0.9999799728393555
HFE O 1 0.9966439008712769
proteins O 0 6.881056469865143e-05
form O 0 5.268346285447478e-05
stable O 0 0.000340825819876045
complexes O 0 0.00013115517504047602
with O 0 1.128413623519009e-05
the O 0 6.607268733205274e-05
transferrin O 0 0.0016668678727000952
receptor O 0 0.00039276713505387306
( O 0 0.00011401327355997637
TfR O 0 0.008892947807908058
) O 0 0.0001485860557295382
. O 0 0.00012839141709264368

The O 0 0.0010985698318108916
C282Y O 0 0.00500542763620615
mutation O 0 0.0002193343243561685
nearly O 0 0.00029401687788777053
completely O 0 0.0002697997260838747
prevents O 0 6.238322384888306e-05
the O 0 3.3675958547974005e-05
association O 0 2.4294029572047293e-05
of O 0 6.527954974444583e-05
the O 0 0.00014308020763564855
mutant O 0 0.0010755786206573248
HFE O 1 0.875613272190094
protein O 0 0.0002170571096939966
with O 0 4.97711225762032e-05
the O 0 0.00033252121647819877
TfR O 1 0.9704627394676208
. O 0 0.0008168797357939184

Studies O 0 0.0006449324428103864
on O 0 0.0009895081166177988
cell O 0 0.001202537096105516
- O 0 0.0005143848829902709
associated O 0 4.6041128371143714e-05
transferrin O 0 0.0003344876749906689
at O 0 0.0001230684865731746
37 O 0 4.1142149711959064e-05
degrees O 0 4.511776569415815e-05
C O 0 0.0002191277890233323
suggest O 0 1.539774712000508e-05
that O 0 3.658570221887203e-06
the O 0 4.201434421702288e-05
overexpressed O 0 0.0018592099659144878
wild O 0 0.00021394016221165657
- O 0 0.00027981933089904487
type O 0 0.00014541596465278417
HFE O 0 0.02605481445789337
protein O 0 7.178020314313471e-05
decreases O 0 5.43193455087021e-05
the O 0 1.8211572751170024e-05
affinity O 0 3.005092185048852e-05
of O 0 7.150923920562491e-05
the O 0 0.00027998079895041883
TfR O 0 0.012982686050236225
for O 0 0.0003244899562560022
transferrin O 0 0.011578962206840515
. O 0 0.0006911444943398237

The O 0 0.0023901339154690504
overexpressed O 0 0.29325172305107117
H63D O 1 0.9989616870880127
protein O 0 0.00016546570986974984
does O 0 8.11961308500031e-06
not O 0 2.9639638796652434e-06
have O 0 1.6579706425545737e-06
this O 0 1.866334855549212e-06
effect O 0 1.6532336303498596e-05
, O 0 3.6731937598233344e-06
providing O 0 8.56275983096566e-06
the O 0 1.4987682334322017e-05
first O 0 1.6696549209882505e-05
direct O 0 1.3992445019539446e-05
evidence O 0 1.7572217984707095e-05
for O 0 1.1008750334440265e-05
a O 0 4.765445919474587e-05
functional O 0 0.00014434187323786318
consequence O 0 0.00046687101712450385
of O 0 0.0004511095175985247
the O 0 0.001706878305412829
H63D O 1 0.9999850988388062
mutation O 0 0.0006083695334382355
. O 0 0.000523700553458184

Addition O 0 0.00022655508655589074
of O 0 0.0006649800925515592
soluble O 0 0.09325962513685226
wild O 0 0.0009723877883516252
- O 0 0.0014816665789112449
type O 0 0.0009019854478538036
HFE O 1 0.9999958276748657
/ O 1 0.6429863572120667
beta2m O 1 0.5171281695365906
heterodimers O 0 0.007648779544979334
to O 0 0.000282153720036149
cultured O 0 0.0005943524301983416
cells O 0 4.359778540674597e-05
also O 0 1.015310590446461e-05
decreased O 0 8.071779302554205e-05
the O 0 1.548360705783125e-05
apparent O 0 0.00011710546095855534
affinity O 0 3.6572932003764436e-05
of O 0 9.889512875815853e-05
the O 0 0.0001359031884931028
TfR O 0 0.001815498573705554
for O 0 2.516511085559614e-05
its O 0 2.5185134290950373e-05
ligand O 0 0.00014611035294365138
under O 0 0.0003092805272899568
steady O 0 0.0015237152110785246
- O 0 0.00017047228175215423
state O 0 6.9820571297896095e-06
conditions O 0 2.7328396754455753e-05
, O 0 9.826457244344056e-06
both O 0 8.860404705046676e-06
in O 0 4.385946158436127e-05
293 O 0 0.0005049937753938138
cells O 0 0.00011982471187366173
and O 0 3.8853075238876045e-05
in O 0 0.0002982372243423015
HeLa O 1 0.6338610649108887
cells O 0 0.0006175548769533634
. O 0 0.00018639523477759212

Furthermore O 0 0.0005979436682537198
, O 0 5.821038575959392e-05
at O 0 0.00015955323760863394
4 O 0 0.00013536553888116032
degrees O 0 0.00012556913134176284
C O 0 0.0003594813751988113
, O 0 1.306385274801869e-05
the O 0 2.1351730538299307e-05
added O 0 9.950393723556772e-05
soluble O 0 0.00026870204601436853
complex O 0 0.0003351992345415056
of O 0 0.0006113837007433176
HFE O 1 0.9999995231628418
/ O 1 0.5595134496688843
beta2m O 0 0.014054082334041595
inhibited O 0 0.0004040483327116817
binding O 0 2.8185624614707194e-05
of O 0 0.00013681869313586503
transferrin O 0 0.0035113163758069277
to O 0 0.0004107721906621009
HeLa O 1 0.93088698387146
cell O 0 0.0011121846036985517
TfR O 0 0.002826194278895855
in O 0 7.721617294009775e-05
a O 0 0.00014553511573467404
concentration O 0 0.010225102305412292
- O 0 0.001152988406829536
dependent O 0 0.00011691755935316905
manner O 0 0.0001997843646677211
. O 0 0.00019427076040301472

Scatchard O 0 0.0019410204840824008
plots O 0 0.00022284385340753943
of O 0 5.7331471907673404e-05
these O 0 8.179267751984298e-06
data O 0 1.5052929484227207e-05
indicate O 0 2.1581132386927493e-05
that O 0 3.906269284925656e-06
the O 0 2.7443780709290877e-05
added O 0 5.8723999245557934e-05
heterodimer O 0 0.00038365478394553065
substantially O 0 0.00011727799574146047
reduced O 0 3.117418964393437e-05
the O 0 1.305111527472036e-05
affinity O 0 5.681659604306333e-05
of O 0 0.0002264250797452405
TfR O 0 0.05820048972964287
for O 0 0.0002478141395840794
transferrin O 0 0.008303031325340271
. O 0 0.000429934065323323

These O 0 6.940492312423885e-05
results O 0 5.0618447858141735e-05
establish O 0 0.00012690911535173655
a O 0 8.340826025232673e-05
molecular O 0 0.00023807566321920604
link O 0 0.0009581178892403841
between O 0 0.002270596334710717
HFE O 1 0.9991998076438904
and O 0 5.9869937103940174e-05
a O 0 7.085908146109432e-05
key O 0 0.0002121206489391625
protein O 0 6.663380190730095e-05
involved O 0 7.05372222000733e-05
in O 0 0.0001329214865108952
iron O 1 0.9998383522033691
transport O 0 0.000501768197864294
, O 0 3.384027149877511e-05
the O 0 7.873832510085776e-05
TfR O 0 0.07602205872535706
, O 0 3.4433855034876615e-05
and O 0 1.5575502402498387e-05
raise O 0 5.4636879212921485e-05
the O 0 3.701412060763687e-05
possibility O 0 7.368635124294087e-05
that O 0 8.793499546300154e-06
alterations O 0 0.0001643938012421131
in O 0 2.9524129786295816e-05
this O 0 1.1697720765369013e-05
regulatory O 0 8.423843974014744e-05
mechanism O 0 0.00014633595128543675
may O 0 7.239152182592079e-05
play O 0 4.840377005166374e-05
a O 0 2.2239688405534253e-05
role O 0 6.128682434791699e-05
in O 0 1.9747869373532012e-05
the O 0 8.517575042787939e-05
pathogenesis O 1 0.999997615814209
of O 1 0.9998918771743774
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.999976396560669
. O 0 0.002607094356790185

Genomic O 0 0.0004142250691074878
organization O 0 8.726342639420182e-05
of O 0 0.00015112994879018515
the O 0 0.0004048687987960875
UBE3A O 1 0.9998977184295654
/ O 0 0.016750648617744446
E6 O 1 0.9993452429771423
- O 0 0.0029716116841882467
AP O 0 0.0006547633674927056
gene O 0 3.436123370192945e-05
and O 0 1.7265820133616216e-05
related O 0 0.00019013629935216159
pseudogenes O 0 0.002861743327230215
. O 0 0.0005344054661691189

The O 0 0.0006501066382043064
UBE3A O 0 0.020077930763363838
gene O 0 8.895342762116343e-05
encodes O 0 5.6390494137303904e-05
the O 0 7.281683065230027e-05
E6 O 0 0.07543788850307465
- O 0 0.0008084035362116992
AP O 0 0.00052775809308514
ubiquitin O 0 0.0004520475340541452
- O 0 0.0001537173957331106
protein O 0 2.5082834326894954e-05
ligase O 0 6.215852044988424e-05
and O 0 7.520226063206792e-06
has O 0 6.5346948758815415e-06
recently O 0 1.1055652976210695e-05
been O 0 2.670919684533146e-06
shown O 0 2.5862148049782263e-06
to O 0 3.685302772282739e-06
be O 0 8.389282811549492e-06
mutated O 0 0.00017168709018733352
in O 0 0.004104620311409235
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999715089797974
who O 0 0.0007483466761186719
lack O 0 0.005655954591929913
15q11 O 0 0.26144862174987793
- O 0 0.0015208502300083637
q13 O 0 0.0008143802406266332
deletions O 0 0.00016468155081383884
or O 0 9.156024316325784e-05
chromosome O 0 0.000948248547501862
15 O 0 0.0009549082024022937
paternal O 0 0.010189750231802464
uniparental B-Disease 1 0.9999896287918091
disomy I-Disease 1 0.9997981190681458
. O 0 0.0022380000445991755

Previous O 0 0.0021659547928720713
UBE3A O 0 0.02492128685116768
cDNA O 0 0.0003081711183767766
analysis O 0 1.7696731447358616e-05
has O 0 1.052554671332473e-05
shown O 0 9.282070095650852e-06
a O 0 1.1914984497707337e-05
coding O 0 8.605405309936032e-05
region O 0 0.0001556308416184038
of O 0 0.00010981864033965394
approximately O 0 0.0004689036577474326
2 O 0 0.0009147095843218267
. O 0 0.00029232833185233176

6 O 0 0.0025163765531033278
kb O 0 0.0030888181645423174
and O 0 5.4881791584193707e-05
a O 0 8.454618364339694e-05
3 O 0 0.00038869254058226943
- O 0 0.0005498385871760547
untranslated O 0 0.0019263055874034762
region O 0 0.00042813067557290196
( O 0 6.149570981506258e-05
UTR O 0 0.0031834200490266085
) O 0 1.8293509128852747e-05
of O 0 7.411920523736626e-05
< O 0 0.0008472565095871687
50 O 0 0.0001298410352319479
bp O 0 0.00024346416466869414
, O 0 1.4701052350574173e-05
whereas O 0 1.644431358727161e-05
Northern O 0 2.0167835828033276e-05
analysis O 0 4.808644916920457e-06
has O 0 5.496608082466992e-06
indicated O 0 1.7920552636496723e-05
mRNA O 0 2.4551742171752267e-05
sizes O 0 8.458127922494896e-06
of O 0 3.4273165510967374e-05
5 O 0 0.00020762438361998647
- O 0 0.0004158317169640213
8 O 0 0.0003684236144181341
kb O 0 0.0027576470747590065
. O 0 0.0003270721936132759

We O 0 6.089567978051491e-05
have O 0 5.506019988388289e-06
analyzed O 0 1.04203172668349e-05
additional O 0 7.1141921580419876e-06
cDNA O 0 0.00014203772298060358
clones O 0 0.00013294556993059814
and O 0 5.862445505044889e-06
provide O 0 4.92689559905557e-06
evidence O 0 1.1239792911510449e-05
for O 0 5.825022071803687e-06
an O 0 7.654461114725564e-06
additional O 0 2.863198460545391e-05
0 O 0 0.0003072247782256454
. O 0 0.00020174242672510445

5 O 0 0.0017032616306096315
kb O 0 0.0034218861255794764
of O 0 0.0008416625787504017
5 O 0 0.001164511195383966
- O 0 0.0011409682920202613
UTR O 0 0.005300589837133884
and O 0 3.7912599509581923e-05
> O 0 0.00012415606761351228
2 O 0 0.00010744592873379588
kb O 0 0.0005205490160733461
of O 0 0.00019406674255151302
3 O 0 0.0012951177777722478
- O 0 0.0026360657066106796
UTR O 0 0.034058570861816406
. O 0 0.0002938915858976543

We O 0 0.0001636924280319363
have O 0 1.1086662198067643e-05
established O 0 3.385166564839892e-05
the O 0 1.6832218534545973e-05
genomic O 0 4.0686194552108645e-05
organization O 0 3.3480180718470365e-05
of O 0 0.00019105273531749845
UBE3A O 0 0.05987532436847687
and O 0 2.6514553610468283e-05
the O 0 2.0839353965129703e-05
sequence O 0 2.4136215870385058e-05
of O 0 0.00017169311468023807
intron O 0 0.04665271192789078
- O 0 0.004397636279463768
exon O 0 0.0017808988923206925
borders O 0 0.00022090859420131892
. O 0 0.00019394446280784905

We O 0 0.00012387252354528755
have O 0 1.4670212294731755e-05
also O 0 5.887590759812156e-06
mapped O 0 2.1972487957100384e-05
two O 0 6.995253443164984e-06
highly O 0 8.35372120491229e-05
homologous O 0 8.922255074139684e-05
processed O 0 0.00010111296433024108
pseudogenes O 0 0.0003988673270214349
, O 0 7.336649287026376e-05
UBE3AP1 O 1 0.8629708886146545
and O 0 8.665138011565432e-05
UBE3AP2 O 1 0.6605944633483887
, O 0 1.7815551473177038e-05
to O 0 8.727148269827012e-06
chromosomes O 0 1.897589572763536e-05
2 O 0 5.287779640639201e-05
and O 0 7.703040864726063e-06
21 O 0 8.813853492029011e-05
, O 0 1.0641352673701476e-05
respectively O 0 4.010451812064275e-05
, O 0 6.033454610587796e-06
and O 0 4.15551767218858e-06
determined O 0 3.677630957099609e-05
their O 0 2.1986134015605785e-05
genomic O 0 0.00017943793500307947
organization O 0 0.00025196632486768067
. O 0 0.00029410686693154275

These O 0 6.402617873391137e-05
results O 0 3.143115100101568e-05
will O 0 1.0842337360372767e-05
form O 0 3.936557732231449e-06
the O 0 8.496741429553367e-06
basis O 0 6.811128514527809e-06
for O 0 6.145135102997301e-06
studies O 0 1.2334950952208601e-05
of O 0 9.225487883668393e-05
mutation O 0 8.380833605770022e-05
and O 0 7.841096521588042e-05
imprinting O 0 0.001615696121007204
of O 0 0.006107476074248552
UBE3A O 1 0.999984622001648
. O 0 0.001981228357180953

Mutation O 0 0.0005027482402510941
spectrum O 0 0.0008221844909712672
and O 0 0.00014622617163695395
genotype O 0 0.0008919545798562467
- O 0 0.000748156220652163
phenotype O 0 6.816587847424671e-05
analyses O 0 5.2335548389237374e-05
in O 0 0.0001434207515558228
Cowden B-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999998807907104
and O 0 0.0011410312727093697
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0002813999599311501
two O 0 0.00022640197130385786
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 0.9999998807907104
with O 1 0.8787859082221985
germline O 1 0.9999990463256836
PTEN O 1 0.9999998807907104
mutation O 0 0.002698073396459222
. O 0 0.0009816825622692704

The O 0 0.006655945908278227
tumour B-Disease 1 1.0
suppressor O 1 0.9986644983291626
gene O 0 0.001933334395289421
PTEN O 1 0.6973516941070557
, O 0 3.35021541104652e-05
which O 0 8.73732460604515e-06
maps O 0 5.279531978885643e-05
to O 0 0.00011325121886329725
10q23 O 0 0.003972775302827358
. O 0 0.00039829962770454586

3 O 0 0.0005845463019795716
and O 0 3.9687001844868064e-05
encodes O 0 3.768011447391473e-05
a O 0 3.5327775549376383e-05
403 O 0 4.8575089749647304e-05
amino O 0 1.732291821099352e-05
acid O 0 3.3568994695087895e-05
dual O 0 0.00010848358215298504
specificity O 0 0.00016247917665168643
phosphatase O 0 0.002162042073905468
( O 0 0.00012701009109150618
protein O 0 0.00013838874292559922
tyrosine O 0 0.00027914438396692276
phosphatase O 0 0.0008158746641129255
; O 0 3.863924939651042e-05
PTPase O 0 0.0019144897814840078
) O 0 2.803440838761162e-05
, O 0 1.3948783816886134e-05
was O 0 0.00010717414261307567
shown O 0 2.6262998289894313e-05
recently O 0 4.0861246816348284e-05
to O 0 8.016083484108094e-06
play O 0 2.500998198229354e-05
a O 0 1.7015057892422192e-05
broad O 0 4.148363950662315e-05
role O 0 0.00013260776177048683
in O 0 0.00018714943144004792
human O 0 0.0010872103739529848
malignancy B-Disease 1 0.9999935626983643
. O 0 0.0007691518985666335

Somatic O 0 0.07648730278015137
PTEN O 1 0.9987316727638245
deletions O 0 0.0013923527440056205
and O 0 7.442786591127515e-05
mutations O 0 6.236752960830927e-05
were O 0 4.041071952087805e-05
observed O 0 3.412262594792992e-05
in O 0 3.2823776564328e-05
sporadic B-Disease 0 0.001043393393047154
breast I-Disease 1 0.9999597072601318
, I-Disease 0 0.0005890530301257968
brain I-Disease 1 0.9999994039535522
, I-Disease 0 0.003113501239567995
prostate I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9999947547912598
lines O 0 0.0003893289540428668
and O 0 1.104530383599922e-05
in O 0 1.5169933249126188e-05
several O 0 1.7460248272982426e-05
primary O 0 0.0016674591461196542
tumours B-Disease 1 1.0
such O 0 0.0002485348959453404
as O 1 0.9996283054351807
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9999607801437378

In O 0 0.0003899340226780623
addition O 0 0.00017335625307168812
, O 0 0.00014599936548620462
PTEN O 0 0.36160412430763245
was O 0 0.00034856770071201026
identified O 0 1.8154732970288023e-05
as O 0 5.6182261687354185e-06
the O 0 7.685783202759922e-06
susceptibility O 0 7.49909013393335e-05
gene O 0 1.1317503776808735e-05
for O 0 1.1815724974439945e-05
two O 0 8.9869303337764e-05
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0032943100668489933
CD B-Disease 1 0.975779116153717
; O 0 0.0001140832100645639
MIM O 1 0.990723192691803
158350 O 0 0.002039613900706172
) O 0 4.990086381440051e-05
and O 0 5.710819095838815e-05
Bannayan B-Disease 1 0.6169953346252441
- I-Disease 0 0.004754062741994858
Zonana I-Disease 1 0.945737898349762
( I-Disease 0 0.00021467845363076776
BZS I-Disease 1 0.5758923292160034
) I-Disease 0 7.382652984233573e-05
or I-Disease 0 6.035184924257919e-05
Ruvalcaba I-Disease 0 0.01122465543448925
- I-Disease 0 0.001520276186056435
Riley I-Disease 0 0.0019814239349216223
- I-Disease 0 0.008867628872394562
Smith I-Disease 0 0.08037519454956055
syndrome I-Disease 1 1.0
( O 0 0.005240902304649353
MIM O 1 0.9999959468841553
153480 O 1 0.955141007900238
) O 0 0.0004407583037391305
. O 0 0.0003175339079461992

Constitutive O 0 0.0058216676115989685
DNA O 0 0.0006558545283041894
from O 0 0.0002154298999812454
37 O 0 0.00046617124462500215
CD B-Disease 0 0.0009430726640857756
families O 0 2.169520485040266e-05
and O 0 1.6920284906518646e-05
seven O 0 7.806791109032929e-05
BZS B-Disease 1 0.5300533771514893
families O 0 2.961306927318219e-05
was O 0 0.00022355784312821925
screened O 0 0.0001400863257003948
for O 0 9.322768164565787e-05
germline O 0 0.025490744039416313
PTEN O 1 0.9995638728141785
mutations O 0 0.001319648465141654
. O 0 0.0004172199114691466

PTEN O 1 0.6876351237297058
mutations O 0 0.0002668254019226879
were O 0 5.64478432352189e-05
identified O 0 2.3786647943779826e-05
in O 0 2.0853887690464035e-05
30 O 0 4.206798621453345e-05
of O 0 6.138497701613232e-05
37 O 0 0.00010446804662933573
( O 0 1.9220584363210946e-05
81 O 0 0.00011882693797815591
% O 0 2.8301335987634957e-05
) O 0 3.211341390851885e-05
CD B-Disease 0 0.00048675903235562146
families O 0 1.6261014025076292e-05
, O 0 1.3154452972230501e-05
including O 0 2.302323264302686e-05
missense O 0 0.00040080701000988483
and O 0 6.968531670281664e-05
nonsense O 0 0.001457742415368557
point O 0 0.0006697188946418464
mutations O 0 0.00010917992767645046
, O 0 3.43078572768718e-05
deletions O 0 0.00014448507863562554
, O 0 2.65802245849045e-05
insertions O 0 0.00019664729188662022
, O 0 3.2086991268442944e-05
a O 0 5.702199268853292e-05
deletion O 0 0.0005089396145194769
/ O 0 0.0010530941653996706
insertion O 0 0.0004968019784428179
and O 0 0.00013962489902041852
splice O 0 0.0017477957298979163
site O 0 0.0015515072736889124
mutations O 0 0.0005773662705905735
. O 0 0.0002796153421513736

These O 0 0.00024218411999754608
mutations O 0 0.0001888617262011394
were O 0 0.00010822588228620589
scattered O 0 9.527953079668805e-05
over O 0 3.946309152524918e-05
the O 0 4.9066118663176894e-05
entire O 0 0.0001284676109207794
length O 0 7.573117181891575e-05
of O 0 0.0001914689055411145
PTEN O 1 0.9185674786567688
, O 0 3.1716899684397504e-05
with O 0 7.567723514512181e-06
the O 0 2.3936927391332574e-05
exception O 0 1.8746401110547595e-05
of O 0 4.169288513367064e-05
the O 0 4.5960405259393156e-05
first O 0 8.08667900855653e-05
, O 0 1.7877910067909397e-05
fourth O 0 0.00015655811876058578
and O 0 4.0280603570863605e-05
last O 0 0.00025513654691167176
exons O 0 0.0010663002030923963
. O 0 0.0003916757123079151

A O 0 0.003952845931053162
hot O 0 0.0013825214700773358
spot O 0 0.00035876926267519593
for O 0 8.368518319912255e-05
PTEN O 0 0.010279962792992592
mutation O 0 7.208119495771825e-05
in O 0 5.4841340897837654e-05
CD B-Disease 0 0.0009249679860658944
was O 0 0.0002699721371755004
identified O 0 2.1779762391815893e-05
in O 0 1.4465892490989063e-05
exon O 0 0.00015282881213352084
5 O 0 2.2148997231852263e-05
that O 0 2.8301258225837955e-06
contains O 0 9.297015822085086e-06
the O 0 3.309057865408249e-05
PTPase O 0 0.002642169129103422
core O 0 0.0009054529946297407
motif O 0 0.00011783061927417293
, O 0 6.3593502090952825e-06
with O 0 3.634858785517281e-06
13 O 0 5.4853950132383034e-05
of O 0 5.6137836509151384e-05
30 O 0 9.214736201101914e-05
( O 0 1.4207125786924735e-05
43 O 0 4.348741640569642e-05
% O 0 2.2529304260388017e-05
) O 0 3.347315578139387e-05
CD B-Disease 0 0.000788555946201086
mutations O 0 7.035987073322758e-05
identified O 0 4.382588667795062e-05
in O 0 5.599342694040388e-05
this O 0 4.848743265029043e-05
exon O 0 0.001735843252390623
. O 0 0.0003234497271478176

Seven O 0 0.00032376503804698586
of O 0 0.00026715072453953326
30 O 0 0.00020221367594785988
( O 0 2.9821592761436477e-05
23 O 0 0.00010556970664765686
% O 0 2.2952028302825056e-05
) O 0 1.0017016393248923e-05
were O 0 1.818632154027e-05
within O 0 2.4530889277230017e-05
the O 0 5.7785182434599847e-05
core O 0 0.0006812236970290542
motif O 0 0.0002139281277777627
, O 0 7.794377779646311e-06
the O 0 1.2065416740369983e-05
majority O 0 5.9538156165217515e-06
( O 0 5.911969310545828e-06
five O 0 8.559411980968434e-06
of O 0 2.4784423658275045e-05
seven O 0 3.521089820424095e-05
) O 0 9.080682502826676e-06
of O 0 2.266699266328942e-05
which O 0 1.5270697986125015e-05
were O 0 9.569163375999779e-05
missense O 0 0.00045442310511134565
mutations O 0 0.0002282708592247218
, O 0 5.583581150858663e-05
possibly O 0 0.00019675343355629593
pointing O 0 0.00010227644088445231
to O 0 1.678212902334053e-05
the O 0 2.386421874689404e-05
functional O 0 6.547482189489529e-05
significance O 0 0.00020878628129139543
of O 0 0.00018920996808446944
this O 0 7.754660327918828e-05
region O 0 0.0006680755177512765
. O 0 0.00035302876494824886

Germline O 1 0.9237323999404907
PTEN O 1 0.9890241622924805
mutations O 0 0.0004668716574087739
were O 0 0.00013062907964922488
identified O 0 4.2183160985587165e-05
in O 0 1.1071859262301587e-05
four O 0 6.9649263423343655e-06
of O 0 2.839040280377958e-05
seven O 0 8.45557005959563e-05
( O 0 4.328558861743659e-05
57 O 0 0.00015553263074252754
% O 0 7.315354741876945e-05
) O 0 0.00013925062376074493
BZS B-Disease 0 0.4653330147266388
families O 0 0.0001947193668456748
studied O 0 0.0014203591272234917
. O 0 0.0005709668039344251

Interestingly O 0 0.0019005383364856243
, O 0 6.415336247300729e-05
none O 0 5.083574797026813e-05
of O 0 3.996886152890511e-05
these O 0 1.514784435130423e-05
mutations O 0 7.096795161487535e-05
was O 0 0.00029170745983719826
observed O 0 3.9124981412896886e-05
in O 0 2.5209548766724765e-05
the O 0 0.00016629340825602412
PTPase O 1 0.9157683253288269
core O 0 0.023454148322343826
motif O 0 0.0025064977817237377
. O 0 0.0004243047733325511

It O 0 0.0001029979539453052
is O 0 2.8049329557688907e-05
also O 0 7.666479177714791e-06
worthy O 0 7.891226414358243e-05
of O 0 5.661215982399881e-05
note O 0 4.074520984431729e-05
that O 0 7.192034900072031e-06
a O 0 2.4039642084972e-05
single O 0 2.8979673516005278e-05
nonsense O 0 0.00023053465702105314
point O 0 0.0002398363867541775
mutation O 0 4.607959999702871e-05
, O 0 3.505877612042241e-05
R233X O 0 0.00039295738679356873
, O 0 1.5089766748133115e-05
was O 0 0.00011039579112548381
observed O 0 2.953488910861779e-05
in O 0 1.297721883020131e-05
the O 0 4.479613562580198e-05
germline O 0 0.00043031355016864836
DNA O 0 6.940976163605228e-05
from O 0 2.8813945391448215e-05
two O 0 1.884629818960093e-05
unrelated O 0 0.0001467122056055814
CD B-Disease 0 0.0011259719030931592
families O 0 3.9782531530363485e-05
and O 0 4.753110624733381e-05
one O 0 0.00015186132804956287
BZS B-Disease 1 0.999541163444519
family O 0 0.0008425591513514519
. O 0 0.00036326475674286485

Genotype O 0 0.0056534260511398315
- O 0 0.0012684338726103306
phenotype O 0 6.334610225167125e-05
studies O 0 1.2076940038241446e-05
were O 0 1.5195068954199087e-05
not O 0 3.2142327199835563e-06
performed O 0 2.47548014158383e-05
on O 0 2.109666274918709e-05
this O 0 5.784936092823045e-06
small O 0 1.4012981409905478e-05
group O 0 1.9443066776148044e-05
of O 0 0.00025717238895595074
BZS B-Disease 1 0.999897837638855
families O 0 0.00030141303432174027
. O 0 0.0004103252140339464

However O 0 0.0005779686034657061
, O 0 0.00010983843822032213
genotype O 0 0.00048505826271139085
- O 0 0.00043443040340207517
phenotype O 0 5.6460230553057045e-05
analysis O 0 1.561442513775546e-05
inthe O 0 0.0007840440957807004
group O 0 3.566411032807082e-05
of O 0 0.0001754510449245572
CD B-Disease 0 0.0034857620485126972
families O 0 2.6388024707557634e-05
revealed O 0 8.780181087786332e-05
two O 0 8.936831363826059e-06
possible O 0 2.32651800615713e-05
associations O 0 1.3483707334671635e-05
worthy O 0 0.00019531922589521855
of O 0 0.00011639141303021461
follow O 0 7.369169179582968e-05
- O 0 0.00014631780504714698
up O 0 2.252343801956158e-05
in O 0 9.83491372608114e-06
independent O 0 1.115101531468099e-05
analyses O 0 6.599610787816346e-05
. O 0 0.00010632590419845656

The O 0 0.00023574460647068918
first O 0 0.00011697410809574649
was O 0 0.0002542509464547038
an O 0 1.6708941984688863e-05
association O 0 3.6114299291512e-05
noted O 0 2.0677107386291027e-05
in O 0 5.951278126303805e-06
the O 0 1.3884350664739031e-05
group O 0 7.77808509155875e-06
of O 0 5.7144472521031275e-05
CD B-Disease 0 0.004359254147857428
families O 0 5.691203841706738e-05
with O 0 0.0006489225197583437
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0026942214462906122

A O 0 0.0007271853392012417
correlation O 0 0.00011727173114195466
was O 0 0.00019147600687574595
observed O 0 2.3349241018877365e-05
between O 0 3.89695524063427e-05
the O 0 3.183599255862646e-05
presence O 0 8.54161917231977e-05
/ O 0 0.000270471180556342
absence O 0 0.00016778577992226928
of O 0 0.0002452796616125852
a O 0 0.0004706577165052295
PTEN O 1 0.9835826754570007
mutation O 0 3.694380211527459e-05
and O 0 7.550652753707254e-06
the O 0 1.343865915259812e-05
type O 0 5.6986220442922786e-05
of O 0 0.00041279615834355354
breast O 1 0.9989808201789856
involvement O 0 0.4165008068084717
( O 0 0.0004920716746710241
unaffected O 0 0.004300965927541256
versus O 0 0.11381280422210693
benign O 1 0.9999494552612305
versus O 1 0.999902606010437
malignant O 1 1.0
) O 0 0.0016963124508038163
. O 0 0.0006742174737155437

Specifically O 0 0.00023184287420008332
and O 0 3.601133721531369e-05
more O 0 9.3688413471682e-06
directly O 0 2.7804895580629818e-05
, O 0 6.63149512547534e-06
an O 0 6.079720606066985e-06
association O 0 2.5512053980492055e-05
was O 0 0.0001531672605779022
also O 0 8.814876309770625e-06
observed O 0 1.1505661859700922e-05
between O 0 1.8897806512541138e-05
the O 0 1.5644309314666316e-05
presence O 0 2.3213340682559647e-05
of O 0 5.4149142670212314e-05
a O 0 0.00021865380404051393
PTEN O 1 0.9999527931213379
mutation O 0 0.0007076173787936568
and O 0 0.02575785480439663
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.08460037410259247

Secondly O 0 0.0035083997063338757
, O 0 5.155054896022193e-05
there O 0 2.630079325172119e-05
appeared O 0 6.961186591070145e-05
to O 0 1.2413532203936484e-05
be O 0 9.392468200530857e-06
an O 0 1.4181406186253298e-05
interdependent O 0 0.0007683318108320236
association O 0 6.859325367258862e-05
between O 0 0.0005813880125060678
mutations O 0 0.00018848593754228204
upstream O 0 0.00032380022457800806
and O 0 9.692056664789561e-06
within O 0 1.3035615666012745e-05
the O 0 4.934597745887004e-05
PTPase O 0 0.4589625298976898
core O 0 0.0022081281058490276
motif O 0 0.0002842441026587039
, O 0 1.4669429219793528e-05
the O 0 2.707609201024752e-05
core O 0 0.0003920782473869622
motif O 0 0.0001431136333849281
containing O 0 2.7195492293685675e-05
the O 0 1.564134072395973e-05
majority O 0 6.949360795260873e-06
of O 0 8.332923607667908e-05
missense O 0 0.0009058180148713291
mutations O 0 0.0001058104753610678
, O 0 1.8863776858779602e-05
and O 0 8.75500791153172e-06
the O 0 1.985554445127491e-05
involvement O 0 9.195959864882752e-05
of O 0 5.9739566495409235e-05
all O 0 4.68784746772144e-05
major O 1 0.7892143726348877
organ O 1 0.9999992847442627
systems O 1 0.9849717020988464
( O 0 0.00013965363905299455
central O 0 0.0009586054948158562
nervous O 0 0.3984190821647644
system O 0 0.0008972411160357296
, O 0 0.0003305549034848809
thyroid O 1 1.0
, O 1 0.9996933937072754
breast O 1 1.0
, O 1 0.9996370077133179
skin O 1 1.0
and O 1 0.9999905824661255
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9892198443412781
. O 0 0.0012988107046112418

However O 0 0.00029858178459107876
, O 0 2.571478944446426e-05
these O 0 4.577628715196624e-06
observations O 0 2.0467616195674054e-05
would O 0 7.620300948474323e-06
need O 0 9.302283615397755e-06
to O 0 9.093108928937e-06
be O 0 5.6678759392525535e-06
confirmed O 0 4.144847025600029e-06
by O 0 2.651006298037828e-06
studying O 0 1.2496057024691254e-05
a O 0 1.2847331163357012e-05
larger O 0 1.3326987755135633e-05
number O 0 1.4028652913111728e-05
of O 0 0.00016721368592698127
CD B-Disease 0 0.005177206825464964
families O 0 0.0001799351448426023
. O 0 0.00027139284065924585

Molecular O 1 0.9958958625793457
defects O 1 0.9999810457229614
leading O 0 0.0012352607445791364
to O 0 4.0798637201078236e-05
human O 0 4.1553321352694184e-05
complement B-Disease 0 0.0005756773753091693
component I-Disease 1 0.9999992847442627
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0007970135193318129
an O 0 6.142391794128343e-05
African O 0 0.00036696999450214207
- O 0 0.0003547013329807669
American O 0 7.583624392282218e-05
family O 0 7.767508213873953e-05
. O 0 0.00012133842392358929

Complement B-Disease 0 0.007865851745009422
component I-Disease 1 0.9999979734420776
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.6141824126243591
C6D B-Disease 1 0.999995231628418
) O 0 0.00017192347149830312
was O 0 0.0006499202572740614
diagnosed O 0 0.01098302099853754
in O 0 4.2298568587284535e-05
a O 0 7.060694770189002e-05
16 O 0 0.00016023627540562302
- O 0 0.00011921304394491017
year O 0 3.9856160583440214e-05
- O 0 5.43644891877193e-05
old O 0 7.342002936638892e-05
African O 0 5.588257408817299e-05
- O 0 6.747786392224953e-05
American O 0 2.099758967233356e-05
male O 0 7.713145896559581e-05
with O 0 0.0002243504859507084
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.010094855912029743

The O 0 0.0014498233795166016
patients O 0 0.0005084571894258261
father O 0 0.0005941548151895404
and O 0 3.113022830802947e-05
two O 0 3.690978337544948e-05
brothers O 0 0.0005397689528763294
also O 0 5.09770106873475e-05
had O 0 0.00025821165763773024
C6D B-Disease 1 0.9997907280921936
, O 0 2.754759043455124e-05
but O 0 4.709183940576622e-06
gave O 0 1.3531639524444472e-05
no O 0 1.0046616807812825e-05
history O 0 0.0001051632862072438
of O 0 0.0009687998099252582
meningitis B-Disease 1 1.0
or O 0 0.003679568413645029
other O 0 0.000715496251359582
neisserial B-Disease 1 0.9999997615814209
infection I-Disease 1 0.9999754428863525
. O 0 0.000731742475181818

By O 0 0.000200369642698206
using O 0 7.07754006725736e-05
exon O 0 0.0007547904388047755
- O 0 0.00016162685642484576
specific O 0 8.434333722107112e-06
polymerase O 0 0.0001967161224456504
chain O 0 8.757661998970434e-05
reaction O 0 1.5562065527774394e-05
( O 0 2.978100565087516e-05
PCR O 0 8.642097964184359e-05
) O 0 3.324854696984403e-05
/ O 0 0.0001540782250231132
single O 0 5.4618591093458235e-05
- O 0 0.00020444219990167767
strand O 0 6.995116564212367e-05
conformation O 0 1.7026093701133505e-05
polymorphism O 0 1.0286511496815365e-05
as O 0 1.0752895832411014e-05
a O 0 7.392883617285406e-06
screening O 0 8.36182152852416e-06
step O 0 2.625836532388348e-05
and O 0 3.4328470519540133e-06
nucleotide O 0 5.77892615183373e-06
sequencing O 0 8.10772689874284e-06
of O 0 1.4901288523105904e-05
target O 0 1.725331094348803e-05
exons O 0 0.0001052286897902377
, O 0 8.320672350237146e-06
we O 0 5.73051011087955e-06
determined O 0 6.971132734179264e-06
that O 0 1.827895971473481e-06
the O 0 1.7088985259761102e-05
proband O 0 0.0010946632828563452
was O 0 0.0002415503840893507
a O 0 5.0801292672986165e-05
compound O 0 0.00018110043311025947
heterozygote O 0 0.000508840661495924
for O 0 8.884466660674661e-05
two O 0 0.00024677999317646027
C6 O 1 0.9999847412109375
gene O 0 0.0006483243778347969
mutations O 0 0.0005796722252853215
. O 0 0.00046979484613984823

The O 0 0.00046856096014380455
first O 0 0.00017203300376422703
, O 0 2.95677764370339e-05
1195delC O 0 0.0004929087008349597
located O 0 0.00019704538863152266
in O 0 3.461361848167144e-05
exon O 0 0.0003049323277082294
7 O 0 0.00015241853543557227
, O 0 9.72574889601674e-06
is O 0 5.8545560932543594e-06
a O 0 1.2200725905131549e-05
novel O 0 3.0474839149974287e-05
mutation O 0 7.235374596348265e-06
, O 0 2.698959633562481e-06
while O 0 4.397131306177471e-06
the O 0 1.5971509128576145e-05
second O 0 6.039450818207115e-05
, O 0 1.3984334145789035e-05
1936delG O 0 0.00025539888883940876
in O 0 3.968616874772124e-05
exon O 0 0.0002797414781525731
12 O 0 5.96756799495779e-05
, O 0 1.2498345313360915e-05
has O 0 5.975630756438477e-06
been O 0 1.3274057891976554e-05
described O 0 1.8363372873864137e-05
before O 0 2.5850858946796507e-05
to O 0 3.8132769986987114e-05
cause O 0 0.0005941264680586755
C6D B-Disease 1 0.9997753500938416
in O 0 9.982316987589002e-05
an O 0 3.308269151602872e-05
unrelated O 0 0.0003182191285304725
African O 0 0.0007279171259142458
- O 0 0.0006923076580278575
American O 0 8.143976447172463e-05
individual O 0 3.216520417481661e-05
. O 0 0.00020831603615079075

Both O 0 0.0003533986455295235
mutations O 0 0.0001900895149447024
result O 0 0.00022088650439400226
in O 0 0.00026822698418982327
premature O 0 0.0011182597372680902
termination O 0 0.001701101427897811
codons O 0 0.0020319316536188126
and O 0 0.0005745971575379372
C6 O 1 0.9996663331985474
null O 0 0.002033325145021081
alleles O 0 0.0006471190718002617
. O 0 0.0006409357883967459

Allele O 0 0.000846913899295032
- O 0 0.00035245725302957
specific O 0 8.475488357362337e-06
PCR O 0 5.237100049271248e-05
indicated O 0 3.2562355045229197e-05
that O 0 3.824681698461063e-06
the O 0 1.866204729594756e-05
probands O 0 0.0007942682132124901
two O 0 2.4456654500681907e-05
brothers O 0 0.0002586194023024291
also O 0 3.3269479899900034e-05
inherited O 0 0.22873564064502716
the O 0 0.00020446887356229126
1195delC O 0 0.0023061761166900396
mutation O 0 4.705170795205049e-05
from O 0 2.772720472421497e-05
their O 0 1.3206339644966647e-05
heterozygous O 0 4.006759263575077e-05
mother O 0 5.938094909652136e-05
and O 0 6.954227046662709e-06
the O 0 3.162242501275614e-05
1936delG O 0 0.0005925639416091144
mutation O 0 2.3693484763498418e-05
from O 0 3.223848034394905e-05
their O 0 4.1168128518620506e-05
homozygous O 0 0.0004936835612170398
father O 0 0.0009555562282912433
. O 0 0.00011306648229947314
. O 0 0.0002359175414312631

PAX6 O 1 0.9926880598068237
mutations O 0 0.0022542024962604046
reviewed O 0 0.0025346362963318825
. O 0 0.000589420844335109

Mutations O 0 0.0011952297063544393
in O 0 0.0005107761244289577
PAX6 O 0 0.39827612042427063
are O 0 1.674544000707101e-05
responsible O 0 3.8117206713650376e-05
for O 0 2.986747131217271e-05
human O 0 0.0002479639369994402
aniridia B-Disease 1 0.9999991655349731
and O 0 4.315629121265374e-05
have O 0 6.095797289162874e-06
also O 0 4.729206466436153e-06
been O 0 7.108956197043881e-06
found O 0 3.093415671173716e-06
in O 0 9.853389201452956e-06
patients O 0 2.7400314138503745e-05
with O 0 4.710540815722197e-05
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 0.05805091932415962
with O 1 0.9999896287918091
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9999959468841553
with O 1 0.9999433755874634
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 0.13615672290325165
and O 0 0.0002249088283861056
with O 0 0.0008856968488544226
isolated B-Disease 1 0.9999988079071045
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.9217517971992493

No O 0 0.00036334473406895995
locus O 0 0.0002615581324789673
other O 0 1.591371801623609e-05
than O 0 2.066204797301907e-05
chromosome O 0 0.0002454195637255907
11p13 O 0 0.0005106087191961706
has O 0 3.3594100386835635e-05
been O 0 5.5751632316969335e-05
implicated O 0 0.0004248281184118241
in O 0 0.0001973725447896868
aniridia B-Disease 1 0.9999983310699463
, O 0 0.0001380131725454703
and O 0 7.943858508951962e-05
PAX6 O 1 0.9199407696723938
is O 0 4.334275581641123e-05
clearly O 0 4.955077019985765e-05
the O 0 2.77807757811388e-05
major O 0 0.00014755652227904648
, O 0 1.1198396350664552e-05
if O 0 3.1862336982158013e-06
not O 0 1.7098579974117456e-06
only O 0 4.980134235665901e-06
, O 0 1.1025582352885976e-05
gene O 0 4.239993359078653e-05
responsible O 0 0.00021444768935907632
. O 0 0.0002956167154479772

Twenty O 0 0.0020343572832643986
- O 0 0.0003296073991805315
eight O 0 3.2824558729771525e-05
percent O 0 2.5114763047895394e-05
of O 0 3.710275632329285e-05
identified O 0 7.195997022790834e-05
PAX6 O 0 0.005928156431764364
mutations O 0 6.136085721664131e-05
are O 0 1.615430119272787e-05
C O 0 0.0021885919850319624
- O 0 0.0006573459249921143
T O 0 0.0004210683982819319
changes O 0 1.3774831131740939e-05
at O 0 0.00015007863112259656
CpG O 0 0.0005183543544262648
dinucleotides O 0 0.0009609675034880638
, O 0 1.6698364561307244e-05
20 O 0 2.1808880774187855e-05
% O 0 5.538614004763076e-06
are O 0 2.57539522863226e-06
splicing O 0 6.0300935729173943e-05
errors O 0 0.00019710588094312698
, O 0 2.008350202231668e-05
and O 0 6.9554735091514885e-06
more O 0 3.747888513316866e-06
than O 0 7.014165021246299e-06
30 O 0 3.0347408028319478e-05
% O 0 1.1756108506233431e-05
are O 0 7.647879101568833e-06
deletion O 0 0.00024330776068381965
or O 0 0.00019891456759069115
insertion O 0 0.0007921654614619911
events O 0 0.0010034282458946109
. O 0 0.0007368641090579331

There O 0 0.00038990352186374366
is O 0 3.6516266845865175e-05
a O 0 6.394282536348328e-05
noticeably O 0 0.0007857172749936581
elevated O 0 0.003259293967857957
level O 0 0.00017829050193540752
of O 0 7.209438626887277e-05
mutation O 0 1.5875370081630535e-05
in O 0 1.652172977628652e-05
the O 0 2.0527882952592336e-05
paired O 0 3.7198944482952356e-05
domain O 0 4.483511656871997e-05
compared O 0 3.273059337516315e-05
with O 0 6.544779807882151e-06
the O 0 3.0075319955358282e-05
rest O 0 6.678768841084093e-05
of O 0 6.539238529512659e-05
the O 0 0.00021826183365192264
gene O 0 0.00021167735394556075
. O 0 0.0002036895602941513

Increased O 0 0.0007861336343921721
mutation O 0 6.729581946274266e-05
in O 0 3.269989610998891e-05
the O 0 5.3894083976047114e-05
homeodomain O 0 0.0007203345885500312
is O 0 1.3827807379129808e-05
accounted O 0 2.2652533516520634e-05
for O 0 8.035814971663058e-06
by O 0 1.076826811186038e-05
the O 0 0.00011561709106899798
hypermutable O 0 0.0075691561214625835
CpG O 0 0.002039124723523855
dinucleotide O 0 0.0023208437487483025
in O 0 0.0002817717904690653
codon O 0 0.00033315899781882763
240 O 0 0.0004741557058878243
. O 0 0.00022345533943735063

Very O 0 0.0003135500883217901
nearly O 0 0.00017164141172543168
all O 0 2.7358617444406264e-05
mutations O 0 0.00010563455725787207
appear O 0 0.00016689368931110948
to O 0 9.433371451450512e-05
cause O 0 0.000547775998711586
loss O 0 0.0004956682096235454
of O 0 0.00019116973271593451
function O 0 9.138046880252659e-05
of O 0 0.00010071245924336836
the O 0 9.68602325883694e-05
mutant O 0 0.00019374352996237576
allele O 0 2.9469645596691407e-05
, O 0 5.941320523561444e-06
and O 0 2.1237065084278584e-06
more O 0 1.5923077398838359e-06
than O 0 2.124075081155752e-06
80 O 0 1.4691353499074467e-05
% O 0 7.076671863615047e-06
of O 0 6.0862239479320124e-05
exonic O 0 0.0033634763676673174
substitutions O 0 0.00025524114607833326
result O 0 0.00014275326975621283
in O 0 0.00025967368856072426
nonsense O 0 0.002138496143743396
codons O 0 0.0016398137668147683
. O 0 0.0009125536307692528

In O 0 0.00019750057253986597
a O 0 7.909865234978497e-05
gene O 0 2.083800245600287e-05
with O 0 4.7784910748305265e-06
such O 0 1.425578011549078e-05
extraordinarily O 0 0.00057979766279459
high O 0 0.0001705460890661925
sequence O 0 1.7050339010893367e-05
conservation O 0 1.7380107237841003e-05
throughout O 0 8.423819963354617e-06
evolution O 0 2.4512415620847605e-05
, O 0 6.136761385278078e-06
there O 0 8.639057341497391e-06
are O 0 4.0117570279107895e-06
presumed O 0 0.0005618277937173843
undiscovered O 1 0.9652202129364014
missense O 0 0.0008453782647848129
mutations O 0 0.00010255654342472553
, O 0 2.4369675884372555e-05
these O 0 4.602307399181882e-06
are O 0 4.770932264364092e-06
hypothesized O 0 0.00010240399569738656
to O 0 2.266003139084205e-05
exist O 0 5.356672409106977e-05
in O 0 3.929777449229732e-05
as O 0 0.00010281523282174021
- O 0 0.0004222859861329198
yet O 0 8.428352157352492e-05
unidentified O 0 0.0001958241919055581
phenotypes O 0 0.00022013988927938044
. O 0 0.00010419643513159826
. O 0 0.00030683164368383586

Genetic O 0 0.0014166340697556734
heterogeneity O 0 0.0008574781822972
and O 0 8.549002086510882e-05
penetrance O 0 0.0005614113761112094
analysis O 0 2.1283542082528584e-05
of O 0 0.00010100994404638186
the O 0 0.00015387430903501809
BRCA1 O 0 0.000350471178535372
and O 0 3.957935768994503e-05
BRCA2 O 0 0.0005023760022595525
genes O 0 0.00013803975889459252
in O 0 0.0003616527537815273
breast B-Disease 1 0.9999887943267822
cancer I-Disease 1 0.9999651908874512
families O 0 0.00022587933926843107
. O 0 0.0003175169404130429

The O 1 0.9022383689880371
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999724626541138
Consortium O 0 0.004393944051116705
. O 0 0.00034811574732884765

The O 0 0.00011032549082301557
contribution O 0 0.00015280752268154174
of O 0 0.00017399282660335302
BRCA1 O 0 0.0007248015608638525
and O 0 4.362490290077403e-05
BRCA2 O 0 0.001933237654156983
to O 0 0.0029335159342736006
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9983349442481995
assessed O 0 0.00020071497419849038
by O 0 2.0222762032062747e-05
linkage O 0 0.00015373379574157298
and O 0 1.0034132174041588e-05
mutation O 0 4.923448159388499e-06
analysis O 0 3.1088891319086542e-06
in O 0 1.0276578905177303e-05
237 O 0 6.706281419610605e-05
families O 0 1.0294873391103465e-05
, O 0 3.1356637464341475e-06
each O 0 7.864269377932942e-07
with O 0 3.3063786304410314e-06
at O 0 6.37922712485306e-05
least O 0 1.1362569239281584e-05
four O 0 8.367070222448092e-06
cases O 0 1.1501834705995861e-05
of O 0 0.0008391119772568345
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999876022338867
, O 0 1.981274181162007e-05
collected O 0 1.468883147026645e-05
by O 0 1.3134020264260471e-05
the O 0 0.0007343677571043372
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999904632568359
Consortium O 0 0.003987995442003012
. O 0 0.000483509007608518

Families O 0 0.0001424874208169058
were O 0 6.919266161276028e-05
included O 0 4.5079272240400314e-05
without O 0 2.850467171811033e-05
regard O 0 5.7348919654032215e-05
to O 0 2.8820759325753897e-05
the O 0 4.3866948544746265e-05
occurrence O 0 0.00019832220277749002
of O 0 0.006857724394649267
ovarian B-Disease 1 1.0
or I-Disease 1 0.9717289805412292
other I-Disease 0 0.005836520344018936
cancers I-Disease 1 0.9999991655349731
. O 0 0.0021573908161371946

Overall O 0 0.004268816206604242
, O 0 0.0007155106286518276
disease O 1 0.9999932050704956
was O 0 0.03403029590845108
linked O 0 0.0005379717913456261
to O 0 3.615961759351194e-05
BRCA1 O 0 0.00015424066805280745
in O 0 9.528420378046576e-06
an O 0 6.6032421273121145e-06
estimated O 0 2.2504822482005693e-05
52 O 0 2.286385824845638e-05
% O 0 5.895242793485522e-06
of O 0 2.9946442737127654e-05
families O 0 1.4836316950095352e-05
, O 0 1.6932246580836363e-05
to O 0 3.215732431272045e-05
BRCA2 O 0 0.00027278688503429294
in O 0 2.6109168175025843e-05
32 O 0 3.493808981147595e-05
% O 0 1.0479532647877932e-05
of O 0 3.9611419197171926e-05
families O 0 1.7663145627011545e-05
, O 0 1.3807316463498864e-05
and O 0 6.06830917604384e-06
to O 0 1.0001103873946704e-05
neither O 0 2.706524719542358e-05
gene O 0 6.000443590892246e-06
in O 0 8.174324648280162e-06
16 O 0 3.443103196332231e-05
% O 0 8.363240340258926e-06
( O 0 6.698438028251985e-06
95 O 0 3.706360439537093e-05
% O 0 1.2694098586507607e-05
confidence O 0 0.00023765860532876104
interval O 0 0.00023036764468997717
[ O 0 0.0007729122298769653
CI O 0 0.4319559633731842
] O 0 0.0004165133577771485
6 O 0 0.00015155783330556005
% O 0 2.9590710255433805e-05
- O 0 7.574792834930122e-05
28 O 0 5.4924610594753176e-05
% O 0 1.0187305633735377e-05
) O 0 9.563897947373334e-06
, O 0 8.861554306349717e-06
suggesting O 0 4.198318492854014e-05
other O 0 2.986231447721366e-05
predisposition O 1 0.6236516237258911
genes O 0 0.0006538808811455965
. O 0 0.0004977486678399146

The O 0 0.000220367539441213
majority O 0 5.134830644237809e-05
( O 0 4.1679846617626026e-05
81 O 0 0.00010507486877031624
% O 0 1.7066364307538606e-05
) O 0 8.183246791304555e-06
of O 0 4.619972241926007e-05
the O 0 0.0011308877728879452
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.716185114579275e-05
were O 0 4.694683229899965e-05
due O 0 0.000167216727277264
to O 0 6.298781227087602e-05
BRCA1 O 0 0.0003295436326880008
, O 0 1.0128116628038697e-05
with O 0 6.214773748070002e-06
most O 0 1.436420643585734e-05
others O 0 1.319317289016908e-05
( O 0 1.14689200927387e-05
14 O 0 4.383323903311975e-05
% O 0 2.3926975700305775e-05
) O 0 2.65759153990075e-05
due O 0 0.0002516110544092953
to O 0 0.00030784253613092005
BRCA2 O 0 0.005386746022850275
. O 0 0.0005639201262965798

Conversely O 0 0.0010396259604021907
, O 0 1.7236106941709295e-05
the O 0 9.339761163573712e-06
majority O 0 4.4858707042294554e-06
of O 0 2.5499501134618185e-05
families O 0 1.1339759112161119e-05
with O 0 1.4599871065001935e-05
male B-Disease 0 0.00021599348110612482
and I-Disease 0 0.0001333279360551387
female I-Disease 1 0.6814969778060913
breast I-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999940395355225
were O 0 0.000209053439903073
due O 0 0.0004094497417099774
to O 0 6.75573101034388e-05
BRCA2 O 0 0.0003751298354472965
( O 0 5.961271745036356e-05
76 O 0 0.0003613202425185591
% O 0 8.524027362000197e-05
) O 0 0.00014137184189166874
. O 0 0.00020677743304986507

The O 0 0.0003576433809939772
largest O 0 0.0005387127748690546
proportion O 0 4.7641467972425744e-05
( O 0 1.6578787835896946e-05
67 O 0 5.399337169365026e-05
% O 0 1.0180837307416368e-05
) O 0 4.199451723252423e-06
of O 0 1.5494981198571622e-05
families O 0 9.87035582511453e-06
due O 0 0.00010799372830661014
to O 0 2.1908272174187005e-05
other O 0 1.1238109436817467e-05
genes O 0 2.4766088245087303e-05
was O 0 0.00013777136337012053
found O 0 8.159370736393612e-06
in O 0 7.840822945581749e-06
families O 0 3.5888203910872107e-06
with O 0 3.0254739158408483e-06
four O 0 1.1041691323043779e-05
or O 0 1.0737297998275608e-05
five O 0 1.653754043218214e-05
cases O 0 1.183327185572125e-05
of O 0 0.0004920740029774606
female O 1 0.9995539784431458
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
only O 0 0.0004310681251809001
. O 0 0.0003525578649714589

These O 0 4.470958810998127e-05
estimates O 0 2.8596970878425054e-05
were O 0 2.0623461750801653e-05
not O 0 8.687737135915086e-06
substantially O 0 7.833279960323125e-05
affected O 0 1.7516049410915002e-05
either O 0 7.007606200204464e-06
by O 0 5.232670446275733e-06
changing O 0 1.7596430552657694e-05
the O 0 1.9736422473215498e-05
assumed O 0 0.0002101143472827971
penetrance O 0 0.0006249483558349311
model O 0 2.2207053916645236e-05
for O 0 2.0205643522785977e-05
BRCA1 O 0 0.0003080977185163647
or O 0 4.684942541643977e-05
by O 0 2.351007060497068e-05
including O 0 4.164429265074432e-05
or O 0 8.725302905077115e-05
excluding O 0 0.0006148439133539796
BRCA1 O 0 0.0026152099017053843
mutation O 0 0.00012632101424969733
data O 0 0.0002076703094644472
. O 0 0.0003378568508196622

Among O 0 0.0002361788065172732
those O 0 2.9975160941830836e-05
families O 0 3.036839552805759e-05
with O 0 8.339959458680823e-05
disease O 1 0.9999992847442627
due O 0 0.2130201905965805
to O 0 0.0002716328017413616
BRCA1 O 0 0.0002691489935386926
that O 0 8.341495231434237e-06
were O 0 1.5485984476981685e-05
tested O 0 1.059261012414936e-05
by O 0 2.878661007343908e-06
one O 0 3.0050575787754497e-06
of O 0 1.0325992661819328e-05
the O 0 1.776827957655769e-05
standard O 0 1.4643234862887766e-05
screening O 0 1.10389319161186e-05
methods O 0 9.791921002033632e-06
, O 0 8.965668712335173e-06
mutations O 0 1.6680378394084983e-05
were O 0 2.3221731680678204e-05
detected O 0 6.259847577894107e-05
in O 0 1.4244339581637178e-05
the O 0 1.560172859171871e-05
coding O 0 2.2932599677005783e-05
sequence O 0 1.303457156609511e-05
or O 0 1.0626748917275108e-05
splice O 0 6.870886863907799e-05
sites O 0 2.628239235491492e-05
in O 0 7.402358733088477e-06
an O 0 5.967532615613891e-06
estimated O 0 2.514774132578168e-05
63 O 0 5.0594757340149954e-05
% O 0 1.1463256669230759e-05
( O 0 1.5644847735529765e-05
95 O 0 5.227987639955245e-05
% O 0 6.67881322442554e-05
CI O 0 0.02811116725206375
51 O 0 0.0004151869216002524
% O 0 0.00010517070768401027
- O 0 0.0003902735479641706
77 O 0 0.00019895308651030064
% O 0 8.60768705024384e-05
) O 0 0.00010474254668224603
. O 0 0.00019791907106991857

The O 0 0.00027056169346906245
estimated O 0 0.0001704316382529214
sensitivity O 0 0.0001409489195793867
was O 0 0.00016148526628967375
identical O 0 1.3175367712392472e-05
for O 0 7.224879936984507e-06
direct O 0 1.7373511582263745e-05
sequencing O 0 5.474478530231863e-05
and O 0 2.3219496142701246e-05
other O 0 1.8412578356219456e-05
techniques O 0 0.00020831065194215626
. O 0 0.00023560640693176538

The O 0 0.0007899171323515475
penetrance O 0 0.004602074157446623
of O 0 0.001116124796681106
BRCA2 O 0 0.0024610322434455156
was O 0 0.0006157130119390786
estimated O 0 6.603879592148587e-05
by O 0 1.0521432159293909e-05
maximizing O 0 7.968030695337802e-05
the O 0 4.306876508053392e-05
LOD O 0 0.007017847150564194
score O 0 0.00013683096040040255
in O 0 8.241712203016505e-05
BRCA2 O 0 0.0008808944839984179
- O 0 0.0002235433494206518
mutation O 0 7.709228157182224e-06
families O 0 4.954713858751347e-06
, O 0 3.4013803542620735e-06
over O 0 1.4218700925994199e-05
all O 0 1.494024763815105e-05
possible O 0 7.034363807179034e-05
penetrance O 0 0.0019089800771325827
functions O 0 0.0003247434215154499
. O 0 0.0006035310216248035

The O 0 0.00013801488967146724
estimated O 0 8.670544775668532e-05
cumulative O 0 0.00030187430093064904
risk O 0 0.00014365301467478275
of O 0 0.00031585313263349235
breast B-Disease 1 0.9999071359634399
cancer I-Disease 1 0.9866674542427063
reached O 0 0.000413179601309821
28 O 0 7.961186929605901e-05
% O 0 5.065356617706129e-06
( O 0 4.716167950391537e-06
95 O 0 2.3973021598067135e-05
% O 0 3.159370317007415e-05
CI O 0 0.031511735171079636
9 O 0 0.0002612411044538021
% O 0 3.9773614844307303e-05
- O 0 7.273854862432927e-05
44 O 0 3.1741954444441944e-05
% O 0 1.1200640074093826e-05
) O 0 8.825474651530385e-06
by O 0 6.9497182266786695e-06
age O 0 8.216521382564679e-05
50 O 0 4.4732107198797166e-05
years O 0 3.8311671232804656e-05
and O 0 1.0855549589905422e-05
84 O 0 6.667740672128275e-05
% O 0 1.4555966117768548e-05
( O 0 1.0661405212886166e-05
95 O 0 8.016700303414837e-05
% O 0 3.874735921272077e-05
CI O 0 0.01643172837793827
43 O 0 0.00011457478831289336
% O 0 2.8396172638167627e-05
- O 0 5.857366704731248e-05
95 O 0 2.1965573978377506e-05
% O 0 7.978300345712341e-06
) O 0 5.195491212361958e-06
by O 0 1.0346080671297386e-05
age O 0 0.00012543125194497406
70 O 0 0.00020463134569581598
years O 0 0.000423836667323485
. O 0 0.00015006001922301948

The O 0 0.0006531292456202209
corresponding O 1 0.9992172718048096
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.99982088804245
were O 0 0.0005659374292008579
0 O 0 0.0003606041136663407
. O 0 0.00023101364786271006

4 O 0 0.0006511431420221925
% O 0 6.686906999675557e-05
( O 0 3.665246913442388e-05
95 O 0 9.920361480908468e-05
% O 0 4.9247537390328944e-05
CI O 0 0.006693338975310326
0 O 0 7.210772309917957e-05
% O 0 3.3207732485607266e-05
- O 0 9.05246997717768e-05
1 O 0 4.750418520416133e-05
% O 0 8.256738510681316e-06
) O 0 4.600876764015993e-06
by O 0 3.5662476420839084e-06
age O 0 7.217129314085469e-05
50 O 0 4.465274469112046e-05
years O 0 3.0487803087453358e-05
and O 0 8.173684364010114e-06
27 O 0 6.481284799519926e-05
% O 0 1.0326493793400005e-05
( O 0 8.856468411977403e-06
95 O 0 3.7327474274206907e-05
% O 0 3.428130003158003e-05
CI O 0 0.007664779666811228
0 O 0 0.00010681409912649542
% O 0 5.21068723173812e-05
- O 0 0.00012927272473461926
47 O 0 5.1202492613811046e-05
% O 0 1.742310450936202e-05
) O 0 1.743226130201947e-05
by O 0 1.6925641830312088e-05
age O 0 0.00021813368948642164
70 O 0 0.0003984587674494833
years O 0 0.0008244801429100335
. O 0 0.0004035707679577172

The O 0 0.0002287015231559053
lifetime O 0 0.00048100779531523585
risk O 0 0.00035637777182273567
of O 0 0.024080561473965645
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999890327453613
appears O 0 7.898001786088571e-05
similar O 0 2.718027417358826e-06
to O 0 7.589738288515946e-06
the O 0 3.158641266054474e-05
risk O 0 6.297700019786134e-05
in O 0 6.000631765346043e-05
BRCA1 O 0 0.0006486782222054899
carriers O 0 7.159125379985198e-05
, O 0 8.087401511147618e-06
but O 0 2.8206518436491024e-06
there O 0 8.714540854271036e-06
was O 0 6.384545122273266e-05
some O 0 5.165665697859367e-06
suggestion O 0 3.8037611375330016e-05
of O 0 3.372782884980552e-05
a O 0 8.262809569714591e-05
lower O 0 0.00018757247016765177
risk O 0 8.494361100019887e-05
in O 0 7.444050424965099e-05
BRCA2 O 0 0.0004972280003130436
carriers O 0 6.50305810268037e-05
< O 0 0.00046287814620882273
50 O 0 7.214101788122207e-05
years O 0 7.908395491540432e-05
of O 0 0.00019609213632065803
age O 0 0.0020809774287045
. O 0 0.0007685422897338867

Eye B-Disease 1 0.9999634027481079
movement I-Disease 0 0.018930789083242416
abnormalities I-Disease 1 0.9907568097114563
correlate O 0 0.0002484746801201254
with O 0 5.7893175835488364e-05
genotype O 0 0.00047914261813275516
in O 0 0.0004848539247177541
autosomal O 1 0.9999518394470215
dominant O 1 0.9999998807907104
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 0.002026541391387582

We O 0 0.0004825453506782651
compared O 0 0.0005381727823987603
horizontal O 0 0.004639709368348122
eye O 0 0.3149256706237793
movements O 0 0.0006296313367784023
( O 0 0.00027420776314102113
visually O 0 0.0007672756328247488
guided O 0 0.0012988026719540358
saccades O 0 0.027432383969426155
, O 0 0.00018481150618754327
antisaccades O 0 0.00300301774404943
, O 0 4.905722744297236e-05
and O 0 2.7975862394669093e-05
smooth O 0 0.00041788641829043627
pursuit O 0 0.0005657980218529701
) O 0 2.168432365579065e-05
in O 0 2.7809352104668505e-05
control O 0 6.005440081935376e-05
subjects O 0 9.490720549365506e-05
( O 0 2.4805138309602626e-05
n O 0 0.00010329085489502177
= O 0 0.00013617365038953722
14 O 0 9.95242444332689e-05
) O 0 1.686428913671989e-05
and O 0 8.081842679530382e-06
patients O 0 1.7722519260132685e-05
with O 0 8.308166798087768e-06
three O 0 1.290711406909395e-05
forms O 0 2.8375407055136748e-05
of O 0 0.0055026160553097725
autosomal O 1 0.9999755620956421
dominant O 1 0.9999994039535522
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999810457229614
I I-Disease 1 0.9999924898147583
spinocerebellar B-Disease 1 0.9999784231185913
ataxias I-Disease 0 0.1065080314874649
1 I-Disease 0 0.0004560341185424477
and I-Disease 0 2.3598662664880976e-05
2 I-Disease 0 0.00011201908637303859
( O 0 3.811836722888984e-05
SCA1 B-Disease 0 0.005884966813027859
, O 0 1.4076938896323554e-05
n O 0 5.8483801694819704e-05
= O 0 8.248575613833964e-05
11 O 0 8.05932650109753e-05
; O 0 1.7080985344364308e-05
SCA2 B-Disease 0 0.00390270771458745
, O 0 2.2642403564532287e-05
n O 0 6.445056351367384e-05
= O 0 7.39377792342566e-05
10 O 0 3.657056004158221e-05
) O 0 1.5636747775715776e-05
and O 0 5.0630369514692575e-05
SCA3 B-Disease 1 0.9999998807907104
/ O 0 0.004276122897863388
Machado B-Disease 0 0.004230310209095478
- I-Disease 0 0.001630087848752737
Joseph I-Disease 1 0.9911975264549255
disease I-Disease 1 0.9999814033508301
( O 0 0.000416166236391291
MJD B-Disease 1 0.9999998807907104
) O 0 6.78040596540086e-05
( O 0 2.745817619143054e-05
n O 0 0.00012626696843653917
= O 0 0.0003305697173345834
16 O 0 0.00028817422571592033
) O 0 0.00010384411143604666
. O 0 0.00012965418864041567

In O 0 0.0015724404947832227
SCA1 B-Disease 1 0.9887017011642456
, O 0 7.922782242530957e-05
saccade O 0 0.0004346048226580024
amplitude O 0 0.0002890332543756813
was O 0 0.00040718147647567093
significantly O 0 0.00011182122398167849
increased O 0 6.191360444063321e-05
, O 0 1.7272672266699374e-05
resulting O 0 8.692632400197908e-05
in O 0 0.0001840981567511335
hypermetria B-Disease 0 0.021121937781572342
. O 0 0.0006377440877258778

The O 0 0.0010111824376508594
smooth O 0 0.0016849954845383763
pursuit O 0 0.0017693048575893044
gain O 0 0.0015339113306254148
was O 0 0.004838906694203615
decreased O 0 0.005389927886426449
. O 0 0.00034551366115920246

In O 0 0.0016651626210659742
SCA2 B-Disease 1 0.9987194538116455
, O 0 0.00012558659364003688
saccade O 0 0.001010228181257844
velocity O 0 0.000510270067024976
was O 0 0.0011365246027708054
markedly O 0 0.003796058241277933
decreased O 0 0.003729520831257105
. O 0 0.00042079517152160406

The O 0 0.0003636410110630095
percentage O 0 0.00031764048617333174
of O 0 0.0001803780032787472
errors O 0 0.0007756933337077498
in O 0 0.0003296300128567964
antisaccades O 0 0.31278350949287415
was O 0 0.0007321686716750264
greatly O 0 0.0001716833357932046
increased O 0 3.0190494726411998e-05
and O 0 8.99001861398574e-06
was O 0 7.087765698088333e-05
significantly O 0 3.234749965486117e-05
correlated O 0 2.033197961281985e-05
with O 0 8.516567504557315e-06
age O 0 0.0007542892126366496
at O 1 0.9997788071632385
disease O 1 1.0
onset O 1 0.9999997615814209
. O 0 0.004216672852635384

In O 0 0.0004383220511954278
addition O 0 9.058514115167782e-05
, O 0 2.486922858224716e-05
a O 0 1.5683444871683605e-05
correlation O 0 4.58845570392441e-05
between O 0 0.00019974113092757761
smooth O 0 0.0006161315250210464
pursuit O 0 0.000540505163371563
gain O 0 0.00025396913406439126
and O 0 1.2773250091413502e-05
the O 0 2.3603817680850625e-05
number O 0 2.050207694992423e-05
of O 0 0.00015612327842973173
trinucleotide O 1 0.9978779554367065
repeats O 0 0.0016758585115894675
was O 0 0.0014680596068501472
found O 0 0.00013896157906856388
. O 0 0.0001766524655977264

In O 0 0.004870961420238018
SCA3 B-Disease 1 1.0
, O 0 0.0007587639847770333
gaze B-Disease 0 0.07242964208126068
- I-Disease 0 0.0032559989485889673
evoked I-Disease 0 0.0035393366124480963
nystagmus I-Disease 0 0.004830051213502884
was O 0 0.0009739250526763499
often O 0 2.474583379807882e-05
present O 0 4.069993519806303e-05
as O 0 7.63775096856989e-05
was O 0 0.0006345441215671599
saccade O 0 0.002001696266233921
hypometria O 0 0.005698769818991423
and O 0 9.009239147417247e-05
smooth O 0 0.0008041705586947501
pursuit O 0 0.0013208341551944613
gain O 0 0.0018706386908888817
was O 0 0.005025530233979225
markedly O 0 0.004698071163147688
decreased O 0 0.004469107370823622
. O 0 0.0006033452809788287

Three O 0 0.00022086669923737645
major O 0 0.00042558767017908394
criteria O 0 8.360112406080589e-05
, O 0 2.8568023481057025e-05
saccade O 0 0.0002907919988501817
amplitude O 0 0.00027437094831839204
, O 0 4.1706567571964115e-05
saccade O 0 0.0005558928241953254
velocity O 0 0.0001250964414793998
, O 0 2.7127265639137477e-05
and O 0 2.0635265173041262e-05
presence O 0 7.366498903138563e-05
of O 0 0.0006317776278592646
gaze B-Disease 1 0.7667869925498962
- I-Disease 0 0.00532021326944232
evoked I-Disease 0 0.0031788263004273176
nystagmus I-Disease 0 0.0015421770513057709
, O 0 2.9689557777601294e-05
permitted O 0 2.144063364539761e-05
the O 0 1.8216471289633773e-05
correct O 0 2.5647736038081348e-05
assignment O 0 3.332066262373701e-05
of O 0 4.060913124703802e-05
90 O 0 5.255951327853836e-05
% O 0 1.688533666310832e-05
of O 0 5.945057637291029e-05
the O 0 0.00022159422223921865
SCA1 B-Disease 1 0.9391555786132812
, O 0 1.3995353583595715e-05
90 O 0 1.39805206345045e-05
% O 0 6.032833425706485e-06
of O 0 2.88512837869348e-05
the O 0 0.0001660432171775028
SCA2 B-Disease 1 0.9985190033912659
, O 0 1.801359212549869e-05
and O 0 4.280506345821777e-06
93 O 0 3.87912878068164e-05
% O 0 1.0747266060207039e-05
of O 0 6.429501809179783e-05
the O 0 0.0001472958829253912
patients O 0 0.00015868069021962583
with O 0 0.00010044420196209103
SCA3 B-Disease 1 1.0
to O 0 7.633055793121457e-05
their O 0 2.0473433323786594e-05
genetically O 0 4.484195960685611e-05
confirmed O 0 4.8076504754135385e-05
patient O 0 4.590714524965733e-05
group O 0 9.871401744021568e-06
and O 0 1.285811868001474e-05
, O 0 1.1093992725363933e-05
therefore O 0 2.3522405172116123e-05
, O 0 1.0101136467710603e-05
may O 0 4.589663876686245e-05
help O 0 6.109297828515992e-05
orient O 0 0.0040869442746043205
diagnoses O 0 0.0009593158611096442
of O 0 0.004778082948178053
SCA1 B-Disease 1 1.0
, O 0 0.00024002301506698132
SCA2 B-Disease 1 0.9999518394470215
, O 0 4.2715520976344123e-05
and O 0 5.025281643611379e-05
SCA3 B-Disease 1 1.0
at O 0 0.0004087994166184217
early O 0 6.13228403381072e-05
clinical O 0 3.475935591268353e-05
stages O 0 0.00022117182379588485
of O 0 0.0004906637477688491
the O 1 0.8592658638954163
diseases O 1 1.0
. O 0 0.000303485372569412
. O 0 0.0003664431278593838

Genetic O 0 0.0003441959561314434
basis O 0 7.311310764634982e-05
and O 0 3.3978740248130634e-05
molecular O 0 0.00016961876826826483
mechanism O 0 0.001394227729178965
for O 0 0.07238569855690002
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9999921321868896

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 1 0.9951106905937195
more O 0 0.00011359851487213746
than O 0 4.153003101237118e-05
300 O 0 5.830427471664734e-05
, O 0 2.1230149286566302e-05
000 O 0 0.0002470521430950612
sudden O 0 0.0005221140454523265
deaths O 0 7.11948232492432e-05
each O 0 8.29858527140459e-06
year O 0 5.809138383483514e-05
in O 0 2.77137787634274e-05
the O 0 0.00012097600847482681
USA O 0 0.0006967872031964362
alone O 0 0.00028199859661981463
. O 0 0.00019372212409507483

In O 0 0.00039295663009397686
approximately O 0 0.00040141656063497066
5 O 0 0.0003762013220693916
- O 0 0.00013848088565282524
12 O 0 3.058579386561178e-05
% O 0 6.3709253481647465e-06
of O 0 2.1026924514444545e-05
these O 0 7.404045845760265e-06
cases O 0 1.8497232304071076e-05
, O 0 1.1427780918893404e-05
there O 0 8.068804163485765e-06
are O 0 2.491193527021096e-06
no O 0 3.935676795663312e-05
demonstrable O 1 0.9998158812522888
cardiac O 1 1.0
or O 1 0.8850464820861816
non O 1 0.9999991655349731
- O 1 0.9999996423721313
cardiac O 1 0.9999998807907104
causes O 0 0.0013341149315238
to O 0 3.582749195629731e-05
account O 0 8.104232620098628e-06
for O 0 4.58468002761947e-06
the O 0 1.7216429114341736e-05
episode O 0 7.727820775471628e-05
, O 0 7.075187113514403e-06
which O 0 3.0327912554639624e-06
is O 0 2.6196314593107672e-06
therefore O 0 5.939790753473062e-06
classified O 0 8.534926018910483e-05
as O 0 0.0005635381094180048
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 1.0
IVF B-Disease 1 1.0
) O 0 0.0016196203650906682
. O 0 0.00047254125820472836

A O 0 0.0009672190644778311
distinct O 0 0.00010623905109241605
group O 0 7.650127372471616e-05
of O 0 0.0006935197743587196
IVF B-Disease 1 1.0
patients O 0 0.0005044787540100515
has O 0 2.1968400687910616e-05
been O 0 1.2978060112800449e-05
found O 0 3.5711211694433587e-06
to O 0 4.494443601288367e-06
present O 0 2.5750961867743172e-05
with O 0 2.3483762561227195e-05
a O 0 0.00016976601909846067
characteristic O 0 0.006142960395663977
electrocardiographic O 1 0.999987006187439
pattern O 0 0.07500337064266205
. O 0 0.0006583575741387904

Because O 0 0.00012679917563218623
of O 0 8.504962170263752e-05
the O 0 6.259871588554233e-05
small O 0 1.3441325791063718e-05
size O 0 1.2640003660635557e-05
of O 0 1.6562005839659832e-05
most O 0 2.2291544155450538e-05
pedigrees O 0 0.00013974531611893326
and O 0 1.4127169379207771e-05
the O 0 5.713553400710225e-05
high O 0 0.0007190897013060749
incidence O 0 0.001703002955764532
of O 0 0.0004180663381703198
sudden B-Disease 1 0.9684175252914429
death I-Disease 0 0.0009687860147096217
, O 0 1.4301834198704455e-05
however O 0 8.86459747562185e-06
, O 0 3.124100203422131e-06
molecular O 0 2.5117707991739735e-05
genetic O 0 3.154775549774058e-05
studies O 0 2.4115188352880068e-05
of O 0 0.0002057145320577547
IVF B-Disease 1 0.9999629259109497
have O 0 2.2120308130979538e-05
not O 0 9.120639333559666e-06
yet O 0 1.876321402960457e-05
been O 0 4.279396671336144e-05
done O 0 9.418900299351662e-05
. O 0 0.00014746059605386108

Because O 0 0.10706711560487747
IVF B-Disease 1 1.0
causes O 1 0.9999996423721313
cardiac O 1 1.0
rhythm O 1 1.0
disturbance O 1 0.9999997615814209
, O 0 6.619654595851898e-05
we O 0 1.8452972653904e-05
investigated O 0 8.233683183789253e-05
whether O 0 3.0705883546033874e-05
malfunction O 0 0.0029908984433859587
of O 0 0.00015859067207202315
ion O 0 0.0004119049699511379
channels O 0 0.00018878538685385138
could O 0 5.937584865023382e-05
cause O 0 8.522548159817234e-05
the O 0 5.7505381846567616e-05
disorder O 1 0.9996545314788818
by O 0 3.3169944799738005e-05
studying O 0 0.0001150927200797014
mutations O 0 3.040589581360109e-05
in O 0 2.9147635359549895e-05
the O 0 5.4774129239376634e-05
cardiac O 0 0.0148807717487216
sodium O 0 0.0004732090746983886
channel O 0 0.0008107951725833118
gene O 0 0.0003168356488458812
SCN5A O 0 0.29352426528930664
. O 0 0.000304508168483153

We O 0 0.00021211011335253716
have O 0 1.6946543837548234e-05
now O 0 1.888793303805869e-05
identified O 0 1.4597058907384053e-05
a O 0 2.1078581994515844e-05
missense O 0 0.00019833656551782042
mutation O 0 2.320149724255316e-05
, O 0 2.4323959223693237e-05
a O 0 5.1947306928923354e-05
splice O 0 0.0015019157435745
- O 0 0.0010115359909832478
donor O 0 4.6186862164177e-05
mutation O 0 2.187778773077298e-05
, O 0 8.739724762563128e-06
and O 0 8.265586984634865e-06
a O 0 4.0153423469746485e-05
frameshift O 0 0.0004167512524873018
mutation O 0 2.0932689949404448e-05
in O 0 1.728852657834068e-05
the O 0 3.0492048608721234e-05
coding O 0 8.833340689307079e-05
region O 0 0.00015586802328471094
of O 0 0.00026945245917886496
SCN5A O 1 0.9991881251335144
in O 0 0.00023085114662535489
three O 0 0.00015446011093445122
IVF B-Disease 1 0.9057213068008423
families O 0 0.000229806246352382
. O 0 0.0003408336197026074

We O 0 9.826099267229438e-05
show O 0 3.8120622775750235e-05
that O 0 2.9034388262516586e-06
sodium O 0 8.496303053107113e-06
channels O 0 1.0995613592967857e-05
with O 0 2.8594038212759187e-06
the O 0 3.31892806570977e-05
missense O 0 0.0003096658329013735
mutation O 0 2.5579804059816524e-05
recover O 0 0.0001847012317739427
from O 0 3.615879177232273e-05
inactivation O 0 0.0008633885299786925
more O 0 2.458419112372212e-05
rapidly O 0 0.0001293820096179843
than O 0 3.2682326036592713e-06
normal O 0 6.349950581352459e-06
and O 0 1.9291130683996016e-06
that O 0 2.2705778519593878e-06
the O 0 4.231951243127696e-05
frameshift O 0 0.0005167239578440785
mutation O 0 4.29871870437637e-05
causes O 0 4.678281766246073e-05
the O 0 2.875443533412181e-05
sodium O 0 3.1623992981621996e-05
channel O 0 4.649949187296443e-05
to O 0 1.292666365770856e-05
be O 0 1.667837568675168e-05
non O 0 0.00019871306722052395
- O 0 0.00040591650758869946
functional O 0 0.00035468814894557
. O 0 0.0002824155963025987

Our O 0 0.00016539469652343541
results O 0 2.3886850613052957e-05
indicate O 0 3.649544669315219e-05
that O 0 4.805729076906573e-06
mutations O 0 2.9560982511611655e-05
in O 0 9.72071138676256e-05
cardiac O 0 0.19941501319408417
ion O 0 0.001011151005513966
- O 0 0.0003903289616573602
channel O 0 5.101047281641513e-05
genes O 0 6.803468295402126e-06
contribute O 0 5.925126060901675e-06
to O 0 6.470666448876727e-06
the O 0 1.7620361177250743e-05
risk O 0 3.794522854150273e-05
of O 0 0.00011480193643365055
developing O 0 0.0013321817386895418
IVF B-Disease 1 0.9995719790458679
. O 0 0.00015200822963379323
. O 0 0.0001457865146221593

Molecular O 0 0.0010586415883153677
heterogeneity O 0 0.0018569451058283448
in O 0 0.0007852702983655035
mucopolysaccharidosis B-Disease 1 0.9910323023796082
IVA I-Disease 1 0.9995831847190857
in O 0 0.00010353374091209844
Australia O 0 3.517263394314796e-05
and O 0 8.54563586472068e-06
Northern O 0 1.7182803276227787e-05
Ireland O 0 3.4762342693284154e-05
: O 0 9.917116585711483e-06
nine O 0 4.803342744708061e-05
novel O 0 3.783181091421284e-05
mutations O 0 2.8704678697977215e-05
including O 0 3.5824345104629174e-05
T312S O 0 0.0013569662114605308
, O 0 2.665525971679017e-05
a O 0 2.8079301046091132e-05
common O 0 2.5366201953147538e-05
allele O 0 2.9037322747171856e-05
that O 0 9.448772289033514e-06
confers O 0 0.0002575637772679329
a O 0 0.00015484158939216286
mild O 0 0.0024232862051576376
phenotype O 0 0.001281888340599835
. O 0 0.0005012269830331206

Mucopolysaccharidosis B-Disease 1 0.9998733997344971
IVA I-Disease 1 0.9999995231628418
( O 0 0.004073804244399071
MPS B-Disease 1 0.9999831914901733
IVA I-Disease 1 1.0
) O 0 6.321213732007891e-05
is O 0 1.4240386917663272e-05
an O 0 2.463918281137012e-05
autosomal B-Disease 1 0.999975323677063
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999998807907104
by O 0 0.0001786700013326481
a O 0 0.0003636623441707343
genetic B-Disease 1 0.9998295307159424
defect I-Disease 1 0.9999978542327881
in O 0 0.0007149727898649871
N O 0 0.01395872887223959
- O 0 0.00074658019002527
acetylgalactosamine O 0 0.0026932070031762123
- O 0 0.00026692438405007124
6 O 0 0.00028316027601249516
- O 0 0.00045187908108346164
sulfate O 0 0.0021353818010538816
sulfatase O 0 0.1001383513212204
( O 0 0.0005371604347601533
GALNS O 1 0.9988075494766235
) O 0 0.00031016868888400495
. O 0 0.00027123113977722824

Previous O 0 0.0005787342670373619
studies O 0 8.872266334947199e-05
of O 0 0.00023027913994155824
patients O 0 0.00018109283701051027
from O 0 0.0001387513184454292
a O 0 9.707874414743856e-05
British O 0 0.00014105596346780658
- O 0 0.00013948517153039575
Irish O 0 5.7794655731413513e-05
population O 0 6.062859938538168e-06
showed O 0 2.0587795006576926e-05
that O 0 1.4426051393456873e-06
the O 0 1.4570382518286351e-05
I113F O 0 0.0002934542717412114
mutation O 0 1.075751060852781e-05
is O 0 4.991346031602006e-06
the O 0 7.0288629103743006e-06
most O 0 6.858475444460055e-06
common O 0 1.2807159691874404e-05
single O 0 2.2686497686663643e-05
mutation O 0 2.1665555323124863e-05
among O 0 0.00011659492156468332
MPS B-Disease 1 0.9999990463256836
IVA I-Disease 1 1.0
patients O 0 0.4069921374320984
and O 0 0.00013091466098558158
produces O 0 0.0001136770733864978
a O 0 0.00022921236813999712
severe O 1 0.9997637867927551
clinical O 1 0.694283664226532
phenotype O 0 0.0030978950671851635
. O 0 0.0010266995523124933

We O 0 0.0002133331581717357
studied O 0 0.00023151615459937602
mutations O 0 5.671482358593494e-05
in O 0 3.4612294257385656e-05
the O 0 8.60184445627965e-05
GALNS O 0 0.027267497032880783
gene O 0 3.0770141165703535e-05
from O 0 2.934798612841405e-05
23 O 0 0.00010134029434993863
additional O 0 5.497172605828382e-05
MPS B-Disease 1 0.9989973902702332
IVA I-Disease 1 1.0
patients O 0 0.0005641798488795757
( O 0 6.709314038744196e-05
15 O 0 7.694112719036639e-05
from O 0 2.955154013761785e-05
Australia O 0 1.3898285942559596e-05
, O 0 5.576929197559366e-06
8 O 0 1.9801031157840043e-05
from O 0 1.573435110913124e-05
Northern O 0 3.1885883799986914e-05
Ireland O 0 2.8003250918118283e-05
) O 0 5.266594143904513e-06
, O 0 2.016840198848513e-06
with O 0 1.4377951629285235e-06
various O 0 1.196933226310648e-05
clinical O 0 0.005089540965855122
phenotypes O 0 0.05284349247813225
( O 0 0.0006443865713663399
severe O 1 0.9997758269309998
, O 0 5.5489344958914444e-05
16 O 0 0.0001242707367055118
cases O 0 1.963463546417188e-05
; O 0 8.785385034570936e-06
intermediate O 0 0.00014771630230825394
, O 0 2.8476115403464064e-05
4 O 0 8.477222581859678e-05
cases O 0 2.394400507910177e-05
; O 0 1.3174023479223251e-05
mild O 0 0.00017167595797218382
, O 0 3.381491478648968e-05
3 O 0 0.00011896026990143582
cases O 0 7.242624997161329e-05
) O 0 7.117642962839454e-05
. O 0 0.00015489976794924587

We O 0 0.0002717861207202077
found O 0 3.867972918669693e-05
two O 0 1.3856308214599267e-05
common O 0 2.2112591977929696e-05
mutations O 0 2.8193257094244473e-05
that O 0 4.2721867430373095e-06
together O 0 8.938689461501781e-06
accounted O 0 2.3487662474508397e-05
for O 0 4.673085186368553e-06
32 O 0 1.7862486856756732e-05
% O 0 9.411872269993182e-06
of O 0 3.216606273781508e-05
the O 0 6.508897058665752e-05
44 O 0 0.00015668205742258579
unrelated O 0 0.00015852840442676097
alleles O 0 5.76235142943915e-05
in O 0 8.139635610859841e-05
these O 0 6.421235593734309e-05
patients O 0 0.0004286858602426946
. O 0 0.00036727587576024234

One O 0 0.00021856316016055644
is O 0 3.8069400034146383e-05
the O 0 6.677552300971001e-05
T312S O 0 0.0008037014049477875
mutation O 0 2.7974474505754188e-05
, O 0 1.0788391591631807e-05
a O 0 2.5711307898745872e-05
novel O 0 7.52917694626376e-05
mutation O 0 1.696597973932512e-05
found O 0 1.5785000869072974e-05
exclusively O 0 8.438299846602604e-05
in O 0 0.00011717872985173017
milder O 0 0.0009854747913777828
patients O 0 0.0006884525646455586
. O 0 0.0005495744990184903

The O 0 0.00012422572763171047
other O 0 1.4944722352083772e-05
is O 0 7.403608378808713e-06
the O 0 1.4551024833053816e-05
previously O 0 4.9031699745683e-05
described O 0 9.340769611299038e-05
I113F O 0 0.0005646403296850622
that O 0 2.2553207600140013e-05
produces O 0 6.0237602156121284e-05
a O 0 0.00022745462774764746
severe O 1 0.9703390002250671
phenotype O 0 0.0025480915792286396
. O 0 0.0010615803766995668

The O 0 0.0010439337929710746
I113F O 0 0.0024268897250294685
and O 0 5.943277574260719e-05
T312S O 0 0.0007375146960839629
mutations O 0 3.7825422623427585e-05
accounted O 0 5.686836448148824e-05
for O 0 2.3731725377729163e-05
8 O 0 9.002781007438898e-05
( O 0 1.531228917883709e-05
18 O 0 4.410431574797258e-05
% O 0 1.6819061784190126e-05
) O 0 1.0225810910924338e-05
and O 0 1.0052885045297444e-05
6 O 0 0.00010369983647251502
( O 0 2.0042287360411137e-05
14 O 0 6.801309791626409e-05
% O 0 1.331733164988691e-05
) O 0 8.720443474885542e-06
of O 0 5.7997385738417506e-05
44 O 0 0.00019645200518425554
unrelated O 0 0.00026862008962780237
alleles O 0 0.00016283575678244233
, O 0 0.0001447418617317453
respectively O 0 0.0007302280864678323
. O 0 0.00039623171323910356

The O 0 0.0006136096199043095
relatively O 0 0.0002524513693060726
high O 0 0.0006134678260423243
residual O 0 0.007204134948551655
GALNS O 1 0.9998095631599426
activity O 0 0.0002832874597515911
seen O 0 0.00015370213077403605
when O 0 1.4881717106618453e-05
the O 0 1.952636921487283e-05
T312S O 0 0.00023604754824191332
mutant O 0 6.706959538860247e-05
cDNA O 0 0.00014944230497349054
is O 0 2.116160248988308e-05
overexpressed O 0 0.0002664400381036103
in O 0 2.7079346182290465e-05
mutant O 0 0.00015582746709696949
cells O 0 1.5498188076890074e-05
provides O 0 2.7467119707580423e-06
an O 0 2.9505420116038295e-06
explanation O 0 6.751153705408797e-06
for O 0 6.473888333857758e-06
the O 0 3.808940891758539e-05
mild O 0 0.0004009675176348537
phenotype O 0 0.0001876404567155987
in O 0 0.00011219376028748229
patients O 0 5.60682310606353e-05
with O 0 1.5830284610274248e-05
this O 0 3.7568599509540945e-05
mutation O 0 0.00011200476728845388
. O 0 0.00019410911772865802

The O 0 0.0002823378308676183
distribution O 0 6.1029506468912587e-05
and O 0 1.9446182704996318e-05
relative O 0 8.049088501138613e-05
frequencies O 0 3.641687726485543e-05
of O 0 6.0039168602088466e-05
the O 0 0.00011776547762565315
I113F O 0 0.001518619479611516
and O 0 5.36993466084823e-05
T312S O 0 0.0010211451444774866
mutations O 0 4.3123338400619105e-05
in O 0 2.0046991267008707e-05
Australia O 0 1.6221052646869794e-05
corresponded O 0 4.590272146742791e-05
to O 0 1.6519132259418257e-05
those O 0 1.1682480362651404e-05
observed O 0 4.066059773322195e-05
in O 0 3.8934933400014415e-05
Northern O 0 8.725369843887165e-05
Ireland O 0 3.299428499303758e-05
and O 0 6.723711976519553e-06
are O 0 1.548214754620858e-06
unique O 0 5.8105692914978135e-06
to O 0 1.1063014426326845e-05
these O 0 3.2164309686777415e-06
two O 0 4.394184088596376e-06
populations O 0 5.848105047334684e-06
, O 0 4.150566837779479e-06
suggesting O 0 1.52898755914066e-05
that O 0 2.4023145215323893e-06
both O 0 5.8519881349639036e-06
mutations O 0 2.096555363095831e-05
were O 0 3.9384256524499506e-05
probably O 0 5.351510480977595e-05
introduced O 0 1.1267383342783432e-05
to O 0 5.706764568458311e-06
Australia O 0 8.041502951527946e-06
by O 0 6.92922958478448e-06
Irish O 0 9.146023512585089e-05
migrants O 0 3.1323790608439595e-05
during O 0 0.00015729430015198886
the O 0 6.90933593432419e-05
19th O 0 0.0009032466914504766
century O 0 0.0014532591449096799
. O 0 0.0003782569256145507

Haplotype O 0 0.0012636140454560518
analysis O 0 4.902201544609852e-05
using O 0 4.258370245224796e-05
6 O 0 0.00029891618760302663
RFLPs O 0 0.0008361365180462599
provides O 0 5.043761575507233e-06
additional O 0 3.862509856844554e-06
data O 0 6.602102530450793e-06
that O 0 2.9349441774684237e-06
the O 0 2.9972759875818156e-05
I113F O 0 0.0005819227662868798
mutation O 0 2.953787407022901e-05
originated O 0 0.00011883622937602922
from O 0 6.981688784435391e-05
a O 0 7.374595588771626e-05
common O 0 0.00017135227972175926
ancestor O 0 0.0025487474631518126
. O 0 0.0007381579489447176

The O 0 0.0003478785220067948
other O 0 3.982097769039683e-05
9 O 0 0.0002758394693955779
novel O 0 6.454208778450266e-05
mutations O 0 4.733442983706482e-05
identified O 0 4.166498183622025e-05
in O 0 1.7506330550531857e-05
these O 0 1.0013825885835104e-05
23 O 0 0.0002065856970148161
patients O 0 3.4516175219323486e-05
were O 0 2.146733459085226e-05
each O 0 3.487784624667256e-06
limited O 0 1.5304478438338265e-05
to O 0 3.7488003727048635e-05
a O 0 0.00014996377285569906
single O 0 0.00015519250882789493
family O 0 0.0002382564271101728
. O 0 0.00021536831627599895

These O 0 5.946254532318562e-05
data O 0 4.1075814806390554e-05
provide O 0 1.5311092283809558e-05
further O 0 1.9350081856828183e-05
evidence O 0 2.7909594791708514e-05
for O 0 1.4138610822556075e-05
extensive O 0 0.00029539724346250296
allelic O 0 0.0013988028513267636
heterogeneity O 0 0.0018695377511903644
in O 0 0.0008933281060308218
MPS B-Disease 1 0.9986869692802429
IVA I-Disease 1 0.9999997615814209
in O 0 0.0003922604664694518
British O 0 0.00037185027031227946
- O 0 0.0009206578251905739
Irish O 0 0.00032478556386195123
patients O 0 3.723581903614104e-05
and O 0 9.910858352668583e-06
provide O 0 1.20734284791979e-05
evidence O 0 2.2056254238123074e-05
for O 0 9.598930773790926e-06
their O 0 1.688230986474082e-05
transmission O 0 9.067069186130539e-05
to O 0 2.135175236617215e-05
Australia O 0 1.1226797141716816e-05
by O 0 8.61807529872749e-06
British O 0 5.9919395425822586e-05
- O 0 0.00022629558225162327
Irish O 0 0.0002132373774657026
migrants O 0 7.42652264307253e-05
. O 0 4.483007069211453e-05
. O 0 0.00010739440767792985

Identification O 0 0.00011693116539390758
of O 0 0.00024692589067853987
constitutional O 0 0.002524597104638815
WT1 O 1 0.9999772310256958
mutations O 0 0.00020743501954711974
, O 0 2.82588316622423e-05
in O 0 2.885315552703105e-05
patients O 0 5.2110648539382964e-05
with O 0 5.5898512073326856e-05
isolated O 1 0.9999560117721558
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.0006711712921969593
and O 0 2.3320510081248358e-05
analysis O 0 1.0458266842761077e-05
of O 0 7.817272853571922e-05
genotype O 0 0.0009794076904654503
/ O 0 0.0022597170900553465
phenotype O 0 0.00011169439676450565
correlations O 0 9.216010948875919e-05
by O 0 8.16467945696786e-06
use O 0 6.4891187321336474e-06
of O 0 4.938081110594794e-05
a O 0 9.280565427616239e-05
computerized O 0 0.00039196613943204284
mutation O 0 7.912165892776102e-05
database O 0 0.000157403846969828
. O 0 0.0001558585063321516

Constitutional O 0 0.001132978475652635
mutations O 0 0.00013280923303682357
of O 0 0.00013001050683669746
the O 0 0.00026467026327736676
WT1 O 0 0.043457239866256714
gene O 0 3.023668068635743e-05
, O 0 7.953822205308825e-06
encoding O 0 3.676792766782455e-05
a O 0 0.00014825462130829692
zinc O 1 0.9058501124382019
- O 0 0.0007002805941738188
finger O 0 0.00032537130755372345
transcription O 0 0.00019310008792672306
factor O 0 0.00010552592721069232
involved O 0 9.527280781185254e-05
in O 0 0.0002016599173657596
renal O 1 1.0
and O 0 0.32869261503219604
gonadal O 1 1.0
development O 0 0.029208563268184662
, O 0 2.11147762456676e-05
are O 0 2.989920858453843e-06
found O 0 5.0141802603320684e-06
in O 0 9.36656397243496e-06
most O 0 1.4324043149827048e-05
patients O 0 2.96931521006627e-05
with O 0 5.053896165918559e-05
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.23684975504875183
DDS B-Disease 1 1.0
) O 0 0.00010082757944473997
, O 0 1.891836291179061e-05
or O 0 0.00018823753634933382
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999921321868896
DMS B-Disease 1 1.0
) O 0 0.00011860868107760325
associated O 0 4.0329414332518354e-05
with O 0 3.6183351767249405e-05
pseudohermaphroditism B-Disease 1 0.9999998807907104
and O 0 0.00031802375451661646
/ O 1 0.9972749352455139
or O 0 0.15553997457027435
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 0.016521155834197998
WT B-Disease 1 0.9999995231628418
) O 0 0.0005685848882421851
. O 0 0.00044089026050642133

Most O 0 0.0004824492207262665
mutations O 0 0.0005822870298288763
in O 0 0.0009004604071378708
DDS B-Disease 1 1.0
patients O 0 0.003349856473505497
lie O 0 0.00351968826726079
in O 0 0.00032420764910057187
exon O 0 0.0010101040825247765
8 O 0 0.0003375463420525193
or O 0 8.19219058030285e-05
exon O 0 0.000538423249963671
9 O 0 0.00026162422727793455
, O 0 3.7883615732425824e-05
encoding O 0 0.00016357135609723628
zinc O 0 0.02131367288529873
finger O 0 0.003937368281185627
2 O 0 0.0015735406195744872
or O 0 0.00040239241207018495
zinc O 1 0.5988565683364868
finger O 0 0.0013165390118956566
3 O 0 0.0001765426859492436
, O 0 2.324832348676864e-05
respectively O 0 5.1646202336996794e-05
, O 0 1.0303871022188105e-05
with O 0 6.040288553776918e-06
a O 0 8.156940020853654e-05
hot O 0 0.0005931684863753617
spot O 0 0.00023986402084119618
( O 0 4.11964429076761e-05
R394W O 0 0.0006993551505729556
) O 0 4.2260668124072254e-05
in O 0 0.00010627380106598139
exon O 0 0.0018191454000771046
9 O 0 0.0015627526445314288
. O 0 0.00036989766522310674

We O 0 5.8061585150426254e-05
analyzed O 0 3.6332236049929634e-05
a O 0 8.442928447038867e-06
series O 0 9.824695553106721e-06
of O 0 4.9878941354108974e-05
24 O 0 0.00025726802414283156
patients O 0 5.752643846790306e-05
, O 0 1.1812491720775142e-05
10 O 0 2.4758439394645393e-05
with O 0 1.5789997632964514e-05
isolated B-Disease 0 0.0028803192544728518
DMS I-Disease 1 0.9999997615814209
( O 0 0.0004839479806832969
IDMS B-Disease 1 0.9991395473480225
) O 0 4.946026820107363e-05
, O 0 1.1073105270043015e-05
10 O 0 2.314673656655941e-05
with O 0 2.8024356652167626e-05
DDS B-Disease 1 0.9999988079071045
, O 0 3.499857848510146e-05
and O 0 1.6118538042064756e-05
4 O 0 0.00021321073290891945
with O 0 0.00011178944259881973
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 1 0.9578824043273926
/ O 1 0.9999959468841553
or O 1 0.9676955342292786
WT B-Disease 1 1.0
. O 0 0.002191428327932954

We O 0 0.00022169460135046393
report O 0 0.00011418879148550332
WT1 O 0 0.003463983302935958
heterozygous O 0 6.140792538644746e-05
mutations O 0 5.326450627762824e-05
in O 0 6.058273356757127e-05
16 O 0 0.00031307453173212707
patients O 0 5.885995415155776e-05
, O 0 2.107828186126426e-05
4 O 0 9.273726755054668e-05
of O 0 0.00010705587192205712
whom O 0 0.00020978804968763143
presented O 0 0.0006506763165816665
with O 0 0.000697766721714288
IDMS B-Disease 1 0.9999988079071045
. O 0 0.003241943893954158

One O 0 0.0003615893656387925
male O 0 0.00023526811855845153
and O 0 3.9528586057713255e-05
two O 0 6.699289224343374e-05
female O 0 0.002247247379273176
IDMS B-Disease 1 0.9999998807907104
patients O 0 0.004877349827438593
with O 0 0.0006691747112199664
WT1 O 1 0.9999998807907104
mutations O 0 0.031358566135168076
underwent O 1 0.9999879598617554
normal O 0 0.014012097381055355
puberty O 1 0.5258644819259644
. O 0 0.0006306574214249849

Two O 0 0.0004788343794643879
mutations O 0 0.00031918962486088276
associated O 0 0.0002353848103666678
with O 0 0.00014024428674019873
IDMS B-Disease 1 0.9998636245727539
are O 0 1.4425485460378695e-05
different O 0 2.4126625248754863e-06
from O 0 2.624099397507962e-05
those O 0 2.6379746486782096e-05
described O 0 0.0002768844715319574
in O 0 0.0008992446237243712
DDS B-Disease 1 1.0
patients O 0 0.05056705325841904
. O 0 0.0010932725854218006

No O 0 0.0021798706147819757
WT1 O 1 0.9685133695602417
mutations O 0 0.0002528610930312425
were O 0 8.270399848697707e-05
detected O 0 9.773384954314679e-05
in O 0 1.1217722203582525e-05
the O 0 1.938099376275204e-05
six O 0 4.4160420657135546e-05
other O 0 3.9803286199457943e-05
IDMS B-Disease 1 0.9999997615814209
patients O 0 0.0005056881345808506
, O 0 3.663419556687586e-05
suggesting O 0 6.972121627768502e-05
genetic O 0 5.209504524827935e-05
heterogeneity O 0 0.0002533039078116417
of O 0 0.0005809072172269225
this O 0 0.0012581257615238428
disease O 1 0.9999998807907104
. O 0 0.0006288919248618186

We O 0 0.0003906979109160602
analyzed O 0 0.00047131406608968973
genotype O 0 0.0008787274127826095
/ O 0 0.0015342882834374905
phenotype O 0 0.00017119193216785789
correlations O 0 0.0002213918778579682
, O 0 2.1052526790299453e-05
on O 0 2.7313963073538616e-05
the O 0 8.386378794966731e-06
basis O 0 6.359859526128275e-06
of O 0 1.7998514522332698e-05
the O 0 1.9824989067274146e-05
constitution O 0 1.7744167053024285e-05
of O 0 3.131017001578584e-05
a O 0 9.864515595836565e-05
WT1 O 0 0.008586687035858631
mutation O 0 1.809587593015749e-05
database O 0 9.09869595488999e-06
of O 0 7.214892684714869e-05
84 O 0 0.003046781988814473
germ O 1 0.9999997615814209
- O 0 0.010342399589717388
line O 0 0.0003503572370391339
mutations O 0 4.7367895604111254e-05
, O 0 7.361730240518227e-06
to O 0 8.497713679389562e-06
compare O 0 1.8612992789712735e-05
the O 0 3.16609293804504e-05
distribution O 0 2.2450034521170892e-05
and O 0 2.079516343655996e-05
type O 0 9.036350820679218e-05
of O 0 0.00015853716467972845
mutations O 0 8.274328865809366e-05
, O 0 1.1560502571228426e-05
according O 0 3.321928716104594e-06
to O 0 1.2307819815760013e-05
the O 0 3.831262074527331e-05
different O 0 3.303130506537855e-05
symptoms O 1 0.560348629951477
. O 0 0.0009013325325213373

This O 0 0.00015577187878079712
demonstrated O 0 0.0003131530247628689
( O 0 6.497796857729554e-05
1 O 0 0.00013115729962009937
) O 0 1.3322463018994313e-05
the O 0 1.7153299268102273e-05
association O 0 1.7941410987987183e-05
between O 0 6.85320483171381e-05
mutations O 0 2.9635355531354435e-05
in O 0 5.1767452532658353e-05
exons O 0 0.000226254400331527
8 O 0 0.00011774908489314839
and O 0 2.2728507246938534e-05
9 O 0 0.00013591472816187888
and O 0 2.802494418574497e-05
DMS B-Disease 1 0.9766929745674133
; O 0 1.3051750102022197e-05
( O 0 1.842719029809814e-05
2 O 0 8.324823284056038e-05
) O 0 1.5795840226928703e-05
among O 0 1.717670966172591e-05
patients O 0 2.8022966944263317e-05
with O 0 4.7552413889206946e-05
DMS B-Disease 1 0.999993085861206
, O 0 4.5013584895059466e-05
a O 0 2.4747272618697025e-05
higher O 0 1.713851816020906e-05
frequency O 0 1.2344493370619603e-05
of O 0 3.5580203984864056e-05
exon O 0 0.0003274303744547069
8 O 0 0.0001051609797286801
mutations O 0 2.435903479636181e-05
among O 0 2.368151217524428e-05
46 O 0 0.00013460498303174973
, O 0 6.459220458054915e-05
XY O 1 0.8170015811920166
patients O 0 0.00010385342466179281
with O 0 2.8119229682488367e-05
female O 0 7.869967521401122e-05
phenotype O 0 4.37897106166929e-05
than O 0 1.084519135474693e-05
among O 0 1.9726601749425754e-05
46 O 0 7.575096242362633e-05
, O 0 3.759326136787422e-05
XY O 1 0.9918647408485413
patients O 0 0.00011600492871366441
with O 0 2.8900190955027938e-05
sexual O 0 0.00028883517370559275
ambiguity O 0 0.0033051150385290384
or O 0 0.00038973736809566617
male O 0 0.0004145215207245201
phenotype O 0 0.00011446329153841361
; O 0 1.5680827345931903e-05
and O 0 1.5092184185050428e-05
( O 0 3.0240458727348596e-05
3 O 0 7.747801282675937e-05
) O 0 6.694478543067817e-06
statistically O 0 8.337647159351036e-06
significant O 0 2.093592229357455e-05
evidence O 0 2.5732746507856064e-05
that O 0 6.205896170285996e-06
mutations O 0 1.702161353023257e-05
in O 0 3.3318312489427626e-05
exons O 0 0.000250487239100039
8 O 0 0.00014855561312288046
and O 0 1.4742130588274449e-05
9 O 0 6.145830411696807e-05
preferentially O 0 3.309256862848997e-05
affect O 0 2.0148419935139827e-05
amino O 0 1.1164560419274494e-05
acids O 0 3.2561117677687434e-06
with O 0 2.0047723410243634e-06
different O 0 3.2597001791145885e-06
functions O 0 3.889982326654717e-05
. O 0 5.1570110372267663e-05
. O 0 0.00012993589916732162

The O 0 0.0013905313098803163
185delAG O 0 0.01112720649689436
BRCA1 O 0 0.0022172746248543262
mutation O 0 0.00012437600526027381
originated O 0 0.00014605338219553232
before O 0 4.788176738657057e-05
the O 0 1.8331142200622708e-05
dispersion O 0 6.870624929433689e-05
of O 0 7.817280129529536e-05
Jews O 0 0.0002743411168921739
in O 0 5.682033224729821e-05
the O 0 3.7088677345309407e-05
diaspora O 0 7.457392348442227e-05
and O 0 1.2701387277047615e-05
is O 0 7.99655208538752e-06
not O 0 5.908412731514545e-06
limited O 0 2.1345214918255806e-05
to O 0 9.076785499928519e-05
Ashkenazim O 0 0.01768694818019867
. O 0 0.0007820621831342578

The O 0 0.0010938247432932258
185delAG O 0 0.004358235280960798
mutation O 0 0.00018202766659669578
in O 0 0.00013081333599984646
BRCA1 O 0 0.00040387007175013423
is O 0 2.393756585661322e-05
detected O 0 5.419811714091338e-05
in O 0 9.213746125169564e-06
Ashkenazi O 0 3.332399865030311e-05
Jews O 0 4.287459887564182e-05
both O 0 1.1003355211869348e-05
in O 0 7.351754902629182e-05
familial B-Disease 1 0.9999982118606567
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0005215361015871167
in O 0 4.3778272811323404e-05
the O 0 2.9099199309712276e-05
general O 0 4.775153865921311e-05
population O 0 3.638619091361761e-05
. O 0 0.0001047355544869788

All O 0 0.00025834288680925965
tested O 0 0.0002683886559680104
Ashkenazi O 0 0.00029061100212857127
mutation O 0 3.4359563869656995e-05
carriers O 0 2.987436528201215e-05
share O 0 1.3859558748663403e-05
the O 0 2.4219683837145567e-05
same O 0 2.0549290638882667e-05
allelic O 0 0.0002518515393603593
pattern O 0 0.0003099449095316231
at O 0 0.00041106241405941546
the O 0 0.00020663790928665549
BRCA1 O 0 0.001764059066772461
locus O 0 0.0019279454136267304
. O 0 0.0004844339855480939

Our O 0 0.0002712981658987701
previous O 0 7.093547174008563e-05
study O 0 2.6782097847899422e-05
showed O 0 4.6481043682433665e-05
that O 0 3.628327021942823e-06
this O 0 6.757131359336199e-06
Ashkenazi O 0 0.00012668351700995117
mutation O 0 3.197254045517184e-05
also O 0 1.8218001059722155e-05
occurs O 0 1.4864809600112494e-05
in O 0 2.0729328753077425e-05
Iraqi O 0 7.928004197310656e-05
Jews O 0 0.0001491664006607607
with O 0 2.043578751909081e-05
a O 0 5.6850738474167883e-05
similar O 0 5.1679700845852494e-05
allelic O 0 0.002188486745581031
pattern O 0 0.0030073693487793207
. O 0 0.0010069588897749782

We O 0 0.00011319776967866346
extended O 0 5.1809282012982294e-05
our O 0 1.1310834452160634e-05
analysis O 0 2.148260591638973e-06
to O 0 7.272648872458376e-06
other O 0 8.320283086504787e-06
non O 0 0.00013872618728782982
- O 0 0.00015459315909538418
Ashkenazi O 0 8.689415699336678e-05
subsets O 0 5.6541812227806076e-05
354 O 0 0.00012120624887757003
of O 0 6.642274092882872e-05
Moroccan O 0 0.00025769323110580444
origin O 0 3.4705637517618015e-05
, O 0 2.9894827093812637e-05
200 O 0 9.079753363039345e-05
Yemenites O 0 0.0017302138730883598
and O 0 3.682322858367115e-05
150 O 0 0.00010202862904407084
Iranian O 0 0.0003137516032438725
Jews O 0 0.0009411805658601224
. O 0 0.0005686081130988896

Heteroduplex O 0 0.007413856219500303
analysis O 0 3.711103636305779e-05
complemented O 0 0.00012776831863448024
by O 0 9.602290447219275e-06
direct O 0 1.796894684957806e-05
DNA O 0 5.78034196223598e-05
sequencing O 0 5.9275946114212275e-05
of O 0 0.0001733546087052673
abnormally O 0 0.0010435131844133139
migrating O 0 0.00013661010598298162
bands O 0 0.00019368279026821256
were O 0 0.00011370483844075352
employed O 0 0.000388193380786106
. O 0 0.00036137140705250204

Four O 0 0.00016254486399702728
of O 0 0.00017961906269192696
Moroccan O 0 0.0002914711949415505
origin O 0 2.697755553526804e-05
( O 0 1.589579005667474e-05
1 O 0 4.892548531643115e-05
. O 0 6.258637768041808e-06
1 O 0 3.683250179165043e-05
% O 0 1.2274669643375091e-05
) O 0 1.2088612493244e-05
and O 0 7.35406774765579e-06
none O 0 3.214757816749625e-05
of O 0 7.161699613789096e-05
the O 0 0.0001891369029181078
Yemenites O 0 0.004929143935441971
or O 0 9.811193740461022e-05
Iranians O 0 0.0002725482627283782
was O 0 0.00017569480405654758
a O 0 3.0345148843480274e-05
carrier O 0 4.987594365957193e-05
of O 0 4.923283995594829e-05
the O 0 0.0001380471367156133
185delAG O 0 0.005614933557808399
mutation O 0 0.00024058137205429375
. O 0 0.00026143150171265006

BRCA1 O 0 0.011722068302333355
allelic O 0 0.0027969011571258307
patterns O 0 0.00022803198953624815
were O 0 4.957596320309676e-05
determined O 0 2.2295178496278822e-05
for O 0 7.534770247730194e-06
four O 0 7.685329364903737e-06
of O 0 2.101642166962847e-05
these O 0 4.965901098330505e-06
individuals O 0 5.22681557413307e-06
and O 0 1.2611227248271462e-05
for O 0 1.414339931216091e-05
12 O 0 6.187417602632195e-05
additional O 0 2.7830523322336376e-05
non O 0 0.0002272298006573692
- O 0 0.00015614782751072198
Ashkenazi O 0 8.41258151922375e-05
185delAG O 0 0.0002350511058466509
mutation O 0 1.8907936464529485e-05
carriers O 0 2.636749741213862e-05
who O 0 3.072562685701996e-05
had O 0 0.0020826426334679127
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.15808165073394775

Six O 0 0.0012575460132211447
non O 0 0.00179862673394382
- O 0 0.0005059605464339256
Ashkenazi O 0 0.00013396232679951936
individuals O 0 1.0043676411441993e-05
shared O 0 3.040952105948236e-05
the O 0 2.927884997916408e-05
common O 0 4.963750689057633e-05
Ashkenazi O 0 0.0002767904952634126
haplotype O 0 0.0005568324704654515
, O 0 2.906170266214758e-05
four O 0 3.153178477077745e-05
had O 0 4.771548992721364e-05
a O 0 3.185706736985594e-05
closely O 0 5.2116014558123425e-05
related O 0 7.916279719211161e-05
pattern O 0 0.00026563851861283183
, O 0 3.656825720099732e-05
and O 0 1.8829034161171876e-05
the O 0 4.834983701584861e-05
rest O 0 0.00012684911780525
( O 0 2.5494005967630073e-05
n O 0 0.00010424036008771509
= O 0 0.0001356319698970765
6 O 0 0.00016940235218498856
) O 0 1.8550932509242557e-05
displayed O 0 0.00017167710757348686
a O 0 9.464564936934039e-05
distinct O 0 0.00018102549074683338
BRCA1 O 0 0.002748046535998583
allelic O 0 0.005037439987063408
pattern O 0 0.004225524142384529
. O 0 0.001171217067167163

We O 0 0.00016764458268880844
conclude O 0 0.00015298713697120547
that O 0 9.822934771364089e-06
the O 0 6.160863995319232e-05
185delAG O 0 0.0023277003783732653
BRCA1 O 0 0.0009986161021515727
mutation O 0 3.8453574234154075e-05
occurs O 0 1.832299676607363e-05
in O 0 1.2453514500521123e-05
some O 0 1.0772571840789169e-05
non O 0 0.00013219770335126668
- O 0 0.0001475376629969105
Ashkenazi O 0 7.136876956792548e-05
populations O 0 7.309166448976612e-06
at O 0 4.197657835902646e-05
rates O 0 7.333113899221644e-06
comparable O 0 2.3641056031920016e-05
with O 0 4.37779635831248e-06
that O 0 1.113872895075474e-05
of O 0 0.00024258971097879112
Ashkenazim O 1 0.5874585509300232
. O 0 0.0010141790844500065

The O 0 0.00016347700147889555
majority O 0 3.266698695369996e-05
of O 0 0.00010204401041846722
Jewish O 0 0.00020238073193468153
185delAG O 0 0.0018692822195589542
mutation O 0 7.383462798316032e-05
carriers O 0 4.815524516743608e-05
have O 0 6.573892733285902e-06
a O 0 2.4559913072152995e-05
common O 0 3.426287366892211e-05
allelic O 0 0.0005106014432385564
pattern O 0 0.00040887465002015233
, O 0 2.431987741147168e-05
supporting O 0 3.4940356272272766e-05
the O 0 6.945524364709854e-05
founder O 0 0.0007574961637146771
effect O 0 7.16296344762668e-05
notion O 0 4.9525973736308515e-05
, O 0 5.396209417085629e-06
but O 0 2.4945693439804018e-06
dating O 0 3.410170756978914e-05
the O 0 7.94580137153389e-06
mutations O 0 7.3500573307683226e-06
origin O 0 4.0194317989517e-06
to O 0 1.2062792848155368e-05
an O 0 1.0826156540133525e-05
earlier O 0 3.813735020230524e-05
date O 0 7.462401845259592e-05
than O 0 1.117105784942396e-05
currently O 0 2.094998308166396e-05
estimated O 0 0.00011505926522659138
. O 0 0.00013035298616159707

However O 0 0.0002494983491487801
, O 0 2.903532913478557e-05
the O 0 2.1387802917161025e-05
different O 0 5.768694791186135e-06
allelic O 0 0.00026407590485177934
pattern O 0 0.0002732804568950087
at O 0 0.00037343212170526385
the O 0 0.00010285838652634993
BRCA1 O 0 0.0002866495924536139
locus O 0 9.732686157803982e-05
even O 0 1.0608147931634448e-05
in O 0 8.60191630636109e-06
some O 0 4.0643185457156505e-06
Jewish O 0 4.154143971391022e-05
mutation O 0 3.079109956161119e-05
carriers O 0 5.767298353021033e-05
, O 0 1.3057088835921604e-05
might O 0 7.4646991379268e-06
suggest O 0 9.084546036319807e-06
that O 0 1.9856306607834995e-06
the O 0 2.0648200006689876e-05
mutation O 0 3.0456130843958817e-05
arose O 0 0.00016519014025107026
independently O 0 4.155950591666624e-05
. O 0 2.721897544688545e-05
. O 0 0.00011425979755586013

Crystal O 0 0.39170730113983154
structure O 0 0.0009443791932426393
of O 0 0.0005630216328427196
the O 0 0.2012787014245987
hemochromatosis B-Disease 1 1.0
protein O 1 0.9287015199661255
HFE O 1 0.9999110698699951
and O 0 4.0672621253179386e-05
characterization O 0 7.228094182210043e-05
of O 0 6.82762183714658e-05
its O 0 2.6672600142774172e-05
interaction O 0 6.128519453341141e-05
with O 0 5.1913531933678314e-05
transferrin O 0 0.003969118464738131
receptor O 0 0.0007867961539886892
. O 0 0.00026269402587786317

HFE O 1 0.9786567091941833
is O 0 0.00024272433074656874
an O 0 8.549197809770703e-05
MHC O 0 0.42977645993232727
- O 0 0.001104487106204033
related O 0 4.937845733365975e-05
protein O 0 2.0397994376253337e-05
that O 0 2.7924179448746145e-06
is O 0 5.245131433184724e-06
mutated O 0 1.04575092336745e-05
in O 0 7.194277714006603e-06
the O 0 8.127652108669281e-05
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9999988079071045

HFE O 0 0.1857101172208786
binds O 0 0.0007410607649944723
to O 0 0.000163622826221399
transferrin O 0 0.0020989698823541403
receptor O 0 0.00032792676938697696
( O 0 0.00014810060383751988
TfR O 0 0.0029466375708580017
) O 0 2.7641455744742416e-05
and O 0 1.3522997505788226e-05
reduces O 0 4.2378349462524056e-05
its O 0 2.500506889191456e-05
affinity O 0 0.00011333872680552304
for O 0 0.00015220245404634625
iron O 1 0.9999659061431885
- O 0 0.0033652288839221
loaded O 0 0.0003508990630507469
transferrin O 0 0.001680611982010305
, O 0 0.0001536327035864815
implicating O 1 0.822306752204895
HFE O 1 0.9999979734420776
in O 0 0.38497549295425415
iron O 1 1.0
metabolism O 1 0.9958590865135193
. O 0 0.0010509168496355414

The O 0 0.0018253730377182364
2 O 0 0.004092310089617968
. O 0 0.0008845212287269533

6 O 0 0.007552850525826216
A O 0 0.004022845067083836
crystal O 0 0.3453579843044281
structure O 0 0.0018084635958075523
of O 0 0.0009340486139990389
HFE O 1 0.9999020099639893
reveals O 0 0.00026317633455619216
the O 0 2.1529865989577956e-05
locations O 0 1.5880335922702216e-05
of O 0 0.0004833615676034242
hemochromatosis B-Disease 1 1.0
mutations O 0 0.004819316789507866
and O 0 0.00017204384494107217
a O 0 0.0004148787120357156
patch O 1 0.9927873015403748
of O 0 0.0006388223846442997
histidines O 1 0.821357250213623
that O 0 9.624072845326737e-06
could O 0 1.3565802873927169e-05
be O 0 3.596069518607692e-06
involved O 0 1.2326237992965616e-05
in O 0 6.367144669638947e-05
pH O 0 0.002838194603100419
- O 0 0.0011374186724424362
dependent O 0 0.0001349392405245453
interactions O 0 0.00014722932246513665
. O 0 0.00012202892685309052

We O 0 0.00017995161761064082
also O 0 4.228642865200527e-05
demonstrate O 0 0.0001602451375219971
that O 0 6.367569585563615e-05
soluble O 0 0.004021114204078913
TfR O 1 0.9914615154266357
and O 0 0.00033057128894142807
HFE O 1 0.9989494681358337
bind O 0 0.0004397968004923314
tightly O 0 0.00031515402952209115
at O 0 8.197942224796861e-05
the O 0 1.9186065401299857e-05
basic O 0 6.23175801592879e-05
pH O 0 0.00029808402177877724
of O 0 0.00017729825049173087
the O 0 0.0003393201914150268
cell O 0 0.0004899140913039446
surface O 0 0.00026637600967660546
, O 0 2.2300901036942378e-05
but O 0 4.433584308571881e-06
not O 0 3.1543374916509492e-06
at O 0 4.4912827434018254e-05
the O 0 4.958882345817983e-05
acidic O 0 0.000306508009089157
pH O 0 0.001029631239362061
of O 0 0.0007709261844865978
intracellular O 0 0.07370307296514511
vesicles O 0 0.28127607703208923
. O 0 0.00081555952783674

TfR O 1 0.9704562425613403
HFE O 0 0.22051112353801727
stoichiometry O 0 0.0014467514120042324
( O 0 0.00017843098612502217
2 O 0 0.00029200135031715035
1 O 0 0.00024104128533508629
) O 0 1.4109074982115999e-05
differs O 0 2.6306237487006e-05
from O 0 6.290725286817178e-05
TfR O 0 0.002611001720651984
transferrin O 0 0.0007172118057496846
stoichiometry O 0 0.00016809918452054262
( O 0 3.211616785847582e-05
2 O 0 9.042384044732898e-05
2 O 0 0.00012366619193926454
) O 0 1.1952312888752203e-05
, O 0 5.038588824390899e-06
implying O 0 3.879121140926145e-05
a O 0 9.044176294992212e-06
different O 0 1.1191339126526145e-06
mode O 0 4.7803434426896274e-05
of O 0 5.064302604296245e-05
binding O 0 4.699243072536774e-05
for O 0 0.00010365612979512662
HFE O 1 0.9986997842788696
and O 0 0.00014726414519827813
transferrin O 0 0.002503665629774332
to O 0 0.0001851031993282959
TfR O 0 0.018669981509447098
, O 0 3.395237581571564e-05
consistent O 0 3.6388548323884606e-05
with O 0 1.0949603165499866e-05
our O 0 6.569540710188448e-05
demonstration O 0 0.0004712797235697508
that O 0 3.8081856473581865e-05
HFE O 1 0.9536612033843994
, O 0 9.629836131352931e-05
transferrin O 0 0.0017717183800414205
, O 0 6.239250797079876e-05
and O 0 4.858337706536986e-05
TfR O 0 0.010777070187032223
form O 0 0.00016777410928625613
a O 0 0.0004438424948602915
ternary O 0 0.021028338000178337
complex O 1 0.9724803566932678
. O 0 0.0010861988412216306

Identification O 0 0.0001775068521965295
of O 0 0.00021183544595260173
three O 0 0.00010329361248295754
novel O 0 0.00016146601410582662
mutations O 0 3.0744973628316075e-05
and O 0 1.2389416951918975e-05
a O 0 3.565414226613939e-05
high O 0 8.869863813742995e-05
frequency O 0 2.5923292923835106e-05
of O 0 5.239422171143815e-05
the O 0 8.092217467492446e-05
Arg778Leu O 0 0.0023006529081612825
mutation O 0 3.4190929000033066e-05
in O 0 4.793065818375908e-05
Korean O 1 0.5497201085090637
patients O 0 0.00014011062739882618
with O 0 0.0001490603171987459
Wilson B-Disease 1 0.999991774559021
disease I-Disease 1 0.9999998807907104
. O 0 0.0013167927972972393

Four O 0 0.0006429284112527966
mutations O 0 0.0010077626211568713
- O 0 0.0014512244379147887
- O 0 0.0005389638245105743
R778L O 0 0.0011219099396839738
, O 0 3.9408674638252705e-05
A874V O 0 0.0005543832085095346
, O 0 4.685389649239369e-05
L1083F O 0 0.000599479244556278
, O 0 2.315265555807855e-05
and O 0 3.342776108183898e-05
2304delC O 0 0.002296515041962266
- O 0 0.0005918197566643357
- O 0 0.00017202382150571793
in O 0 2.6978483219863847e-05
the O 0 8.992356742965057e-05
copper O 0 0.004873630125075579
- O 0 0.00018219818593934178
transporting O 0 8.358302875421941e-05
enzyme O 0 2.3383046936942264e-05
, O 0 2.4240433049271815e-05
P O 0 0.001171208219602704
- O 0 0.0002493656356818974
type O 0 0.0001124889895436354
ATPase O 0 0.00042743602534756064
( O 0 8.524441363988444e-05
ATP7B O 0 0.04232332482933998
) O 0 1.3452316125039943e-05
, O 0 4.012109002360376e-06
were O 0 8.246768629760481e-06
identified O 0 1.326277015323285e-05
in O 0 2.907972339016851e-05
Korean O 1 0.9849315881729126
Patients O 0 0.00027641525957733393
with O 0 0.0002171504747821018
Wilson B-Disease 1 0.9999953508377075
disease I-Disease 1 1.0
. O 0 0.001159875886514783

Arg778Leu O 0 0.2538641691207886
, O 0 4.7896475734887645e-05
the O 0 3.1231385946739465e-05
most O 0 1.1296443517494481e-05
frequently O 0 1.562963552714791e-05
reported O 0 1.3616469914268237e-05
mutation O 0 4.554306542559061e-06
of O 0 2.0592646251316182e-05
this O 0 1.739529579936061e-05
enzyme O 0 3.116462175967172e-05
, O 0 1.8976057617692277e-05
was O 0 0.00010330051009077579
found O 0 6.269032382988371e-06
in O 0 7.494122201023856e-06
six O 0 1.3679019502887968e-05
of O 0 4.859357068198733e-05
eight O 0 0.00011589391942834482
unrelated O 0 0.00028559964266605675
patients O 0 4.45180521637667e-05
studied O 0 9.049863729160279e-05
, O 0 9.140553629549686e-06
an O 0 4.565743438433856e-06
allele O 0 1.1598735000006855e-05
frequency O 0 3.227286651963368e-05
of O 0 0.0002488184254616499
37 O 0 0.0008683035848662257
. O 0 0.0004016186576336622

5 O 0 0.0006299479864537716
% O 0 0.00011831159645225853
, O 0 2.376841803197749e-05
which O 0 9.675442015577573e-06
is O 0 8.551334758521989e-06
considerably O 0 5.1708444516407326e-05
higher O 0 1.9622018953668885e-05
than O 0 5.676596174453152e-06
those O 0 5.976907686999766e-06
in O 0 2.1237397959339432e-05
other O 0 2.0969611796317622e-05
Asian O 0 0.00035030298749916255
populations O 0 7.105151598807424e-05
. O 0 0.00010805707279359922

The O 0 0.00028767134062945843
novel O 0 0.0001542558311484754
single O 0 3.987988020526245e-05
nucleotide O 0 5.4299824114423245e-05
deletion O 0 0.0001361453323625028
, O 0 4.4239241105969995e-05
2304delC O 0 0.0007961105438880622
, O 0 2.6767798772198148e-05
was O 0 0.0001775572745827958
found O 0 1.4891428691043984e-05
in O 0 2.9217992050689645e-05
one O 0 7.363289478234947e-05
patient O 0 0.00031589253921993077
. O 0 0.00027037886320613325

Since O 0 0.0005898749805055559
a O 0 6.912447133800015e-05
mutation O 0 2.2009080566931516e-05
at O 0 0.00012346766015980393
cDNA O 0 0.00015539284504484385
nucleotide O 0 0.000144718520459719
2302 O 0 0.0022417851723730564
( O 0 4.8097095714183524e-05
2302insC O 0 0.00043878756696358323
) O 0 2.174185101466719e-05
had O 0 4.1847557440632954e-05
been O 0 2.2787105990573764e-05
previously O 0 3.333801942062564e-05
described O 0 3.165156886097975e-05
, O 0 4.128231012145989e-06
this O 0 2.4996652427944355e-06
region O 0 1.8294609617441893e-05
of O 0 2.931751987489406e-05
the O 0 8.83195098140277e-05
ATP7B O 1 0.9999865293502808
gene O 0 7.162048132158816e-05
may O 0 3.404003655305132e-05
be O 0 1.1180170076841023e-05
susceptible O 0 3.842143269139342e-05
to O 0 3.286182982265018e-05
gene O 0 0.00023281820176634938
rearrangements O 1 0.9990861415863037
causing O 1 0.9999986886978149
Wilson B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999997615814209
. O 0 0.0009746964788064361

Disruption O 0 0.005884693469852209
of O 0 0.0005142514710314572
splicing O 0 0.0003887736820615828
regulated O 0 6.635941826971248e-05
by O 0 6.980725174798863e-06
a O 0 5.777514888904989e-05
CUG O 1 0.9867072105407715
- O 0 0.0004252669168636203
binding O 0 5.517775935004465e-05
protein O 0 0.00025705224834382534
in O 0 0.0025551768485456705
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.023516643792390823

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999406337738037
DM B-Disease 1 1.0
) O 0 0.001097168424166739
is O 0 0.00010257080430164933
caused O 0 0.00032948169973678887
by O 0 3.24658649333287e-05
a O 0 0.00011061369878007099
CTG O 0 0.022938622161746025
expansion O 0 0.00018663692753762007
in O 0 1.8249946151627228e-05
the O 0 1.5953133697621524e-05
3 O 0 7.108390855137259e-05
untranslated O 0 0.0011570609640330076
region O 0 0.00013067419058643281
of O 0 0.00014570758503396064
the O 0 0.0009148037061095238
DM B-Disease 1 1.0
gene O 0 0.0014451672323048115
. O 0 0.00042577480780892074

One O 0 0.00014616847329307348
model O 0 8.135980897350237e-05
of O 0 0.0007167410221882164
DM B-Disease 1 1.0
pathogenesis O 1 0.9999995231628418
suggests O 0 0.00034628791036084294
that O 0 1.528789107396733e-05
RNAs O 0 0.00014577344700228423
from O 0 1.9788212739513256e-05
the O 0 1.605775105417706e-05
expanded O 0 2.9772005291306414e-05
allele O 0 8.115153832477517e-06
create O 0 1.5927822460071184e-05
a O 0 2.247936208732426e-05
gain O 0 0.00020951798069290817
- O 0 0.00018174272554460913
of O 0 8.404939580941573e-05
- O 0 0.00012732562026940286
function O 0 1.987665018532425e-05
mutation O 0 6.115087217040127e-06
by O 0 3.2494856441189768e-06
the O 0 1.2566051736939698e-05
inappropriate O 0 4.966586857335642e-05
binding O 0 1.4484125131275505e-05
of O 0 5.6196702644228935e-05
proteins O 0 4.10327484132722e-05
to O 0 4.270460703992285e-05
the O 0 0.0002667038352228701
CUG O 1 0.9971123933792114
repeats O 0 0.0012978961458429694
. O 0 0.0003461694286670536

Data O 0 0.0001919681380968541
presented O 0 0.0001386341464240104
here O 0 5.447175135486759e-05
indicate O 0 1.7464910342823714e-05
that O 0 2.9078807983751176e-06
the O 0 1.977031206479296e-05
conserved O 0 0.00015990840620361269
heterogeneous O 0 0.0013763528550043702
nuclear O 0 0.08813063055276871
ribonucleoprotein O 1 0.8650999069213867
, O 0 0.00011003467807313427
CUG O 0 0.27372172474861145
- O 0 0.0003489237860776484
binding O 0 2.6550329494057223e-05
protein O 0 6.479702278738841e-05
( O 0 6.816977838752791e-05
CUG O 1 0.8145380616188049
- O 0 0.0008933231001719832
BP O 0 0.0012484911130741239
) O 0 1.73599964909954e-05
, O 0 6.552361810463481e-06
may O 0 2.7259315174887888e-05
mediate O 0 0.0001998201769310981
the O 0 0.00017177108384203166
trans O 0 0.0014142864383757114
- O 0 0.000521976500749588
dominant O 0 0.00010899478365899995
effect O 0 3.1578249036101624e-05
of O 0 4.2094634409295395e-05
the O 0 8.369397255592048e-05
RNA O 0 0.000981451477855444
. O 0 0.00021594672580249608

CUG O 1 0.9999126195907593
- O 0 0.00875070970505476
BP O 0 0.0023993474896997213
was O 0 0.0001506414992036298
found O 0 6.019994998496259e-06
to O 0 5.598479219770525e-06
bind O 0 1.2142941159254406e-05
to O 0 1.090376463253051e-05
the O 0 9.608866821508855e-05
human O 0 0.0003683512913994491
cardiac O 1 0.999998927116394
troponin O 1 0.9999983310699463
T O 1 0.9996391534805298
( O 0 0.00012692934251390398
cTNT O 0 0.00136371364351362
) O 0 2.6494182748137973e-05
pre O 0 0.00044166381121613085
- O 0 0.0003444342873990536
messenger O 0 0.00012065745977452025
RNA O 0 9.988516103476286e-05
and O 0 9.538557605992537e-06
regulate O 0 3.187037873431109e-05
its O 0 1.7118001778726466e-05
alternative O 0 3.634471431723796e-05
splicing O 0 0.0002314472949365154
. O 0 0.0002308341790921986

Splicing O 0 0.0008925534784793854
of O 0 0.0006619475316256285
cTNT O 1 0.8809506893157959
was O 0 0.013310804963111877
disrupted O 0 0.02514651045203209
in O 0 0.0007425470394082367
DM B-Disease 1 1.0
striated O 1 0.9999723434448242
muscle O 1 0.9913133978843689
and O 0 0.0001940176880452782
in O 0 0.00012618076289072633
normal O 0 0.000147435421240516
cells O 0 3.4926895750686526e-05
expressing O 0 7.40799805498682e-05
transcripts O 0 0.0003887781349476427
that O 0 3.896004272974096e-05
contain O 0 0.0004262239090166986
CUG O 1 0.9603732824325562
repeats O 0 0.002369317226111889
. O 0 0.0005030811880715191

Altered O 0 0.0009795083897188306
expression O 0 0.00011111246567452326
of O 0 0.00021805983851663768
genes O 0 0.00015611240814905614
regulated O 0 0.0002060054539470002
posttranscriptionally O 0 0.0020583143923431635
by O 0 9.273646719520912e-05
CUG O 1 0.9997914433479309
- O 0 0.0020784640219062567
BP O 0 0.0006605069502256811
therefore O 0 2.2208832888281904e-05
may O 0 1.9355804397491738e-05
contribute O 0 3.810572161455639e-05
to O 0 0.00037286439328454435
DM B-Disease 1 1.0
pathogenesis O 1 0.9999992847442627
. O 0 0.0006444878526963294
. O 0 0.0003860746219288558

Identification O 0 0.00018578644085209817
of O 0 0.00028259475948289037
a O 0 0.0002593864337541163
novel O 0 0.0002793352759908885
nonsense O 0 0.0005500456318259239
mutation O 0 4.75400775030721e-05
and O 0 1.836673436628189e-05
a O 0 4.641407576855272e-05
missense O 0 0.00018453154189046472
substitution O 0 7.743162132101133e-05
in O 0 4.7599234676454216e-05
the O 0 0.00012903368042316288
vasopressin O 0 0.0009169146069325507
- O 0 0.0008383491658605635
neurophysin O 0 0.0035905339755117893
II O 1 0.999995231628418
gene O 0 3.462041786406189e-05
in O 0 1.3735884749621619e-05
two O 0 4.839422217628453e-06
Spanish O 0 4.380031896289438e-05
kindreds O 0 0.0003685655537992716
with O 0 7.402257324429229e-05
familial B-Disease 1 0.9999997615814209
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.01965213008224964

Familial B-Disease 1 0.9999996423721313
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9733790755271912
FNDI B-Disease 1 1.0
) O 0 3.771941192098893e-05
is O 0 7.3101564339594916e-06
an O 0 1.7625670807319693e-05
autosomal B-Disease 1 0.9999973773956299
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 1.0
by O 1 0.592150092124939
deficiency O 1 1.0
in O 0 0.001985881244763732
the O 0 0.0011251936666667461
antidiuretic O 0 0.028329087421298027
hormone O 0 0.0016907000681385398
arginine O 0 0.0006083811167627573
vasopressin O 0 0.0010754270479083061
( O 0 0.000126972547150217
AVP O 0 0.0018003860022872686
) O 0 5.687351858796319e-06
encoded O 0 4.737358722195495e-06
by O 0 3.787216883210931e-06
the O 0 4.3988511606585234e-05
AVP O 0 0.08547040075063705
- O 0 0.0010462321806699038
neurophysin O 0 0.007822699844837189
II O 1 0.9999998807907104
( O 0 0.0004747422644868493
AVP O 1 0.9917078614234924
- O 0 0.0009850909700617194
NPII O 0 0.08231998234987259
) O 0 3.696466956171207e-05
gene O 0 3.18220590997953e-05
on O 0 0.0002094892115565017
chromosome O 0 0.0012433341471478343
20p13 O 0 0.004968842025846243
. O 0 0.00038872851291671395

In O 0 0.0001270661741727963
this O 0 1.3745818250754382e-05
study O 0 1.753563992679119e-05
, O 0 4.308536063035717e-06
we O 0 4.0632294258102775e-06
analyzed O 0 9.725619747769088e-06
two O 0 2.2239212285057874e-06
families O 0 5.402717761171516e-06
with O 0 2.0811330614378676e-05
FNDI B-Disease 1 0.9999994039535522
using O 0 5.160878208698705e-05
direct O 0 8.867597352946177e-05
automated O 0 0.00033848616294562817
fluorescent O 0 0.0001017529793898575
, O 0 2.343454434594605e-05
solid O 0 0.00015981541946530342
phase O 0 0.0005273059359751642
, O 0 3.7849888030905277e-05
single O 0 2.7342213797965087e-05
- O 0 4.807503864867613e-05
stranded O 0 2.3466345737688243e-05
DNA O 0 4.70456052426016e-06
sequencing O 0 5.110311121825362e-06
of O 0 3.951826147385873e-05
PCR O 0 0.0005208401125855744
- O 0 0.001135301310569048
amplified O 0 0.0026034205220639706
AVP O 0 0.10790527611970901
- O 0 0.0032346162479370832
NPII O 0 0.19322194159030914
DNA O 0 0.00073431950295344
. O 0 0.00042257754830643535

In O 0 0.00028932190616615117
one O 0 4.819806054001674e-05
of O 0 8.52521407068707e-05
the O 0 7.472726429114118e-05
families O 0 2.5085035304073244e-05
, O 0 2.388732900726609e-05
affected O 0 2.6806783353094943e-05
individuals O 0 4.868859377893386e-06
presented O 0 0.00010892744467128068
a O 0 7.644812285434455e-05
novel O 0 0.00011706571240210906
nonsense O 0 0.0003003318852279335
mutation O 0 2.574129030108452e-05
in O 0 2.6100180548382923e-05
exon O 0 0.0001433165743947029
3 O 0 3.773858770728111e-05
of O 0 2.8372702217893675e-05
the O 0 3.3943437301786616e-05
gene O 0 1.4095181541051716e-05
, O 0 2.725004151216126e-06
consisting O 0 7.693144652876072e-06
in O 0 1.39392759592738e-05
a O 0 4.13081215810962e-05
G O 0 0.0005253829876892269
to O 0 8.203157631214708e-05
T O 0 0.0012462455779314041
transition O 0 0.00029001812799833715
at O 0 0.00024703703820705414
nucleotide O 0 0.0001487462577642873
2101 O 0 0.002164040692150593
, O 0 1.9344655811437406e-05
which O 0 7.0020078055677e-06
produces O 0 8.623879693914205e-06
a O 0 1.817538395698648e-05
stop O 0 4.187062950222753e-05
signal O 0 0.00019651681941468269
in O 0 3.709001975948922e-05
codon O 0 4.85641612613108e-05
82 O 0 0.00026666646590456367
( O 0 0.00015315061318688095
Glu O 0 0.011025882326066494
) O 0 0.0001076494954759255
of O 0 0.0006427495391108096
NPII O 1 0.9998971223831177
. O 0 0.0013407084625214338

The O 0 0.0010296283289790154
premature O 0 0.0014402952510863543
termination O 0 0.0006222922238521278
eliminates O 0 0.0002453093766234815
part O 0 8.705008076503873e-05
of O 0 0.00010857443703571334
the O 0 0.00015919626457616687
C O 0 0.0021410188637673855
- O 0 0.000306756206555292
terminal O 0 0.0002255053404951468
domain O 0 5.4041276598582044e-05
of O 0 0.00012724599218927324
NPII O 1 0.9969868063926697
, O 0 2.255716572108213e-05
including O 0 1.1265009561611805e-05
a O 0 5.5915839766385034e-05
cysteine O 0 5.5650496506132185e-05
residue O 0 0.00019333149248268455
in O 0 3.121884583379142e-05
position O 0 6.0820006183348596e-05
85 O 0 4.0849088691174984e-05
, O 0 7.194682893896243e-06
which O 0 4.43267072114395e-06
could O 0 1.0211192602582742e-05
be O 0 4.465111487661488e-06
involved O 0 8.942799468059093e-06
in O 0 1.6357631466235034e-05
the O 0 2.996307193825487e-05
correct O 0 8.250078099081293e-05
folding O 0 0.0007939806091599166
of O 0 0.0003309651219751686
the O 0 0.0009850402129814029
prohormone O 1 0.9983716607093811
. O 0 0.0009807093301787972

In O 0 0.00029511857428587973
the O 0 0.0001522109960205853
second O 0 0.000229106837650761
family O 0 5.3905288950772956e-05
, O 0 1.0560112968960311e-05
a O 0 2.9810844353050925e-05
G279A O 0 0.0003527887165546417
substitution O 0 5.069279359304346e-05
at O 0 0.00011185086623299867
position O 0 7.533845928264782e-05
- O 0 4.991190871805884e-05
1 O 0 1.9368171706446446e-05
of O 0 1.1659018127829768e-05
the O 0 1.789346606528852e-05
signal O 0 0.00023273075930774212
peptide O 0 0.0002325424284208566
was O 0 0.0002178748691221699
observed O 0 2.3483516997657716e-05
in O 0 1.681418507359922e-05
all O 0 9.851040886132978e-06
affected O 0 6.12910371273756e-05
individuals O 0 3.6471370549406856e-05
. O 0 0.0002762176445685327

This O 0 0.00017534619837533683
missense O 0 0.00046479926095344126
mutation O 0 4.412918497109786e-05
, O 0 1.5677134797442704e-05
which O 0 1.8659982742974535e-05
replaces O 0 0.0005965744494460523
Ala O 0 0.0028491627890616655
with O 0 0.00011997036199318245
Thr O 1 0.9984930753707886
, O 0 5.654968481394462e-05
is O 0 1.956984488060698e-05
frequent O 0 7.112614548532292e-05
among O 0 0.0005006216233596206
FNDI B-Disease 1 1.0
patients O 0 0.0007553807809017599
and O 0 3.515271600917913e-05
is O 0 2.6154151782975532e-05
thought O 0 3.283745900262147e-05
to O 0 1.3026568012719508e-05
reduce O 0 3.740290776477195e-05
the O 0 2.978089287353214e-05
efficiency O 0 5.569700806518085e-05
of O 0 8.893154154065996e-05
cleavage O 0 0.0008274812716990709
by O 0 0.00012259051436558366
signal O 0 0.0018414484802633524
peptidases O 0 0.0051598139107227325
. O 0 0.00019317523401696235
. O 0 0.00028460341854952276

Genetic O 0 0.00059705221792683
heterogeneity O 0 0.0012583823408931494
of O 0 0.0035112497862428427
Saethre B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.00014732945419382304
due O 0 0.0005959671689197421
to O 0 0.00014960227417759597
TWIST O 0 0.018195245414972305
and O 0 0.00023222228628583252
FGFR O 1 0.9999854564666748
mutations O 0 0.0011988715268671513
. O 0 0.0004039412597194314

Thirty O 0 0.009788946248590946
- O 0 0.0015289416769519448
two O 0 4.5562595914816484e-05
unrelated O 0 0.00021455707610584795
patients O 0 2.4836097509250976e-05
with O 0 1.2073911420884542e-05
features O 0 4.3898922740481794e-05
of O 0 0.0008211698150262237
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.989735291223042e-05
a O 0 7.630311301909387e-05
common O 0 0.00015196243475656956
autosomal B-Disease 1 0.9997820258140564
dominant I-Disease 1 0.999998927116394
condition I-Disease 1 0.9999994039535522
of O 1 0.9999996423721313
craniosynostosis B-Disease 1 1.0
and O 1 0.9999995231628418
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999997615814209
, O 0 0.00014714314602315426
were O 0 4.0363349398830906e-05
screened O 0 5.578386480920017e-05
for O 0 1.0692164323700126e-05
mutations O 0 2.8596452466445044e-05
in O 0 9.240827057510614e-05
TWIST O 0 0.0030481202993541956
, O 0 0.00013707412290386856
FGFR2 O 1 0.9994840621948242
, O 0 0.0001557285140734166
and O 0 0.00019441102631390095
FGFR3 O 1 0.9999642372131348
. O 0 0.0008540399721823633

Nine O 0 0.0010023926151916385
novel O 0 0.0002970796776935458
and O 0 4.831209298572503e-05
three O 0 8.884780254447833e-05
recurrent O 0 0.24511341750621796
TWIST O 0 0.14640477299690247
mutations O 0 0.00029270819504745305
were O 0 9.560726903146133e-05
found O 0 3.4788208722602576e-05
in O 0 5.508459798875265e-05
12 O 0 0.00021840193949174136
families O 0 7.013486174400896e-05
. O 0 0.00019126069673802704

Seven O 0 0.00044953712495043874
families O 0 5.705027433577925e-05
were O 0 3.4670636523514986e-05
found O 0 1.0498119081603363e-05
to O 0 1.2725430678983685e-05
have O 0 1.3760521142103244e-05
the O 0 7.745643961243331e-05
FGFR3 O 1 0.9990973472595215
P250R O 0 0.0018406828166916966
mutation O 0 4.302705201553181e-05
, O 0 2.0776609744643793e-05
and O 0 8.88124941411661e-06
one O 0 9.121683433477301e-06
individual O 0 9.026924089994282e-06
was O 0 0.00014925604045856744
found O 0 7.690547136007808e-06
to O 0 9.10945345822256e-06
have O 0 8.99092719919281e-06
an O 0 2.3498325390391983e-05
FGFR2 O 1 0.9968217611312866
VV269 O 0 0.0047053005546331406
- O 0 0.0006160137709230185
270 O 0 0.00021512449893634766
deletion O 0 0.0010055940365418792
. O 0 0.00046033531543798745

To O 0 0.00024762091925367713
date O 0 0.00024331935856025666
, O 0 1.4990483578003477e-05
our O 0 1.2649626114580315e-05
detection O 0 3.076503344345838e-05
rate O 0 2.174782275687903e-05
for O 0 1.0843826203199569e-05
TWIST O 0 0.00044947757851332426
or O 0 5.5477397836511955e-05
FGFR O 1 0.9553439617156982
mutations O 0 4.6332435886142775e-05
is O 0 1.0058965017378796e-05
68 O 0 2.5660847313702106e-05
% O 0 9.99493568087928e-06
in O 0 3.008653766300995e-05
our O 0 0.00012593629071488976
Saethre B-Disease 1 0.9999904632568359
- I-Disease 1 0.9999779462814331
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.004763032775372267
, O 0 3.7310037441784516e-05
including O 0 2.140710421372205e-05
our O 0 6.053329343558289e-05
five O 0 5.772454460384324e-05
patients O 0 5.516944656847045e-05
elsewhere O 0 5.101908391225152e-05
reported O 0 5.341237556422129e-05
with O 0 3.5778186429524794e-05
TWIST O 0 0.007212528493255377
mutations O 0 0.0009733601473271847
. O 0 0.0009113646228797734

More O 0 8.059441461227834e-05
than O 0 2.111125286319293e-05
35 O 0 4.28689963882789e-05
different O 0 4.6036066123633645e-06
TWIST O 0 0.00033543771132826805
mutations O 0 4.486428952077404e-05
are O 0 6.6578622863744386e-06
now O 0 2.097805372613948e-05
known O 0 2.4379878595937043e-05
in O 0 1.5468493074877188e-05
the O 0 4.1756429709494114e-05
literature O 0 0.00017056787328328937
. O 0 0.00022626796271651983

The O 0 0.00044271702063269913
most O 0 4.6428242058027536e-05
common O 0 3.6294906749390066e-05
phenotypic O 0 0.0001493582531111315
features O 0 7.947805715957657e-05
, O 0 1.0215400834567845e-05
present O 0 2.0747422240674496e-05
in O 0 1.4398163330042735e-05
more O 0 4.518821242527338e-06
than O 0 4.022077064291807e-06
a O 0 1.3655662769451737e-05
third O 0 4.011415148852393e-05
of O 0 4.125395935261622e-05
our O 0 5.363209857023321e-05
patients O 0 3.7469202652573586e-05
with O 0 2.0688346921815537e-05
TWIST O 0 0.01030686404556036
mutations O 0 9.812813368625939e-05
, O 0 1.985414382943418e-05
are O 0 9.288436558563262e-06
coronal B-Disease 0 0.01658531464636326
synostosis I-Disease 1 0.9952736496925354
, O 0 0.00016271825006697327
brachycephaly B-Disease 1 0.8942750096321106
, O 0 0.00016831312677823007
low B-Disease 0 0.021256864070892334
frontal I-Disease 1 0.9999995231628418
hairline I-Disease 1 1.0
, O 1 0.5719127655029297
facial B-Disease 1 0.9999998807907104
asymmetry I-Disease 1 0.9999998807907104
, O 1 0.5498690605163574
ptosis B-Disease 1 0.9999995231628418
, O 0 0.0006178080220706761
hypertelorism B-Disease 1 0.9997970461845398
, O 0 0.00019425686332397163
broad B-Disease 0 0.020555203780531883
great I-Disease 1 0.9999963045120239
toes I-Disease 1 0.9999560117721558
, O 0 0.00010586861026240513
and O 0 0.00014088336320128292
clinodactyly B-Disease 1 0.9940903782844543
. O 0 0.0007118108333088458

Significant O 0 0.002957671880722046
intra O 1 0.5946353673934937
- O 0 0.001550300046801567
and O 0 4.139977681916207e-05
interfamilial O 0 0.0010323446476832032
phenotypic O 0 0.0003989334509242326
variability O 0 0.0002592728997115046
is O 0 1.4129756891634315e-05
present O 0 1.6063817383837886e-05
for O 0 1.6325246178894304e-05
either O 0 0.0001004465957521461
TWIST O 0 0.0028107985854148865
mutations O 0 0.00027023814618587494
or O 0 0.00039357668720185757
FGFR O 1 0.999981164932251
mutations O 0 0.0018181628547608852
. O 0 0.0006642250227741897

The O 0 0.0004150333988945931
overlap O 0 0.00025777280097827315
in O 0 0.00010271870269207284
clinical O 0 0.00016518776828888804
features O 0 5.575790783041157e-05
and O 0 2.2817506760475226e-05
the O 0 3.190151255694218e-05
presence O 0 3.422303052502684e-05
, O 0 6.0176644183229655e-06
in O 0 5.0121052481699735e-06
the O 0 8.493273526255507e-06
same O 0 4.824602456210414e-06
genes O 0 8.246784091170412e-06
, O 0 2.952422391899745e-06
of O 0 1.100134068110492e-05
mutations O 0 8.247036021202803e-06
for O 0 6.868385298730573e-06
more O 0 5.318205694493372e-06
than O 0 1.022964443109231e-05
one O 0 2.401402707619127e-05
craniosynostotic B-Disease 0 0.004255898296833038
condition I-Disease 0 0.0005437556537799537
- O 0 0.0002162432501791045
such O 0 1.0936068065348081e-05
as O 0 0.00011426339187892154
Saethre B-Disease 1 0.9925490617752075
- I-Disease 0 0.0018952632090076804
Chotzen I-Disease 0 0.01821172423660755
, I-Disease 0 5.4854474001331255e-05
Crouzon I-Disease 0 0.008804906159639359
, I-Disease 0 7.990583981154487e-05
and I-Disease 0 0.00020439150102902204
Pfeiffer I-Disease 1 0.9999997615814209
syndromes I-Disease 1 0.9999996423721313
- O 0 0.010547737590968609
support O 0 5.5784079449949786e-05
the O 0 6.256815686356276e-05
hypothesis O 0 4.750948937726207e-05
that O 0 8.378536222153343e-06
TWIST O 0 0.00029279859154485166
and O 0 1.7434074834454805e-05
FGFRs O 0 0.0012540568131953478
are O 0 6.1872456171840895e-06
components O 0 2.4497596314176917e-05
of O 0 4.173799970885739e-05
the O 0 5.769785275333561e-05
same O 0 1.9911864001187496e-05
molecular O 0 6.371117342496291e-05
pathway O 0 0.00010959821520373225
involved O 0 2.066729030048009e-05
in O 0 1.030343810271006e-05
the O 0 2.1735131667810492e-05
modulation O 0 0.00019802064343821257
of O 0 0.0035631186328828335
craniofacial O 1 1.0
and O 1 0.9974391460418701
limb O 1 1.0
development O 1 0.865918755531311
in O 0 0.0007741004810668528
humans O 0 0.0004430448461789638
. O 0 4.998850999982096e-05
. O 0 7.631140761077404e-05

Mutation O 0 6.891661178087816e-05
analysis O 0 1.754812001308892e-05
of O 0 0.00044910755241289735
UBE3A O 1 0.9999998807907104
in O 1 0.9999973773956299
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999983310699463
. O 0 0.006454086396843195

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9998263716697693
AS B-Disease 1 1.0
) O 0 0.0001003080906230025
is O 0 3.142671630484983e-05
caused O 0 0.00022069238184485584
by O 0 5.2667386626126245e-05
chromosome O 0 0.0010109604336321354
15q11 O 0 0.0050500668585300446
- O 0 0.001189910457469523
q13 O 0 0.0008478048257529736
deletions O 0 0.00010364782792748883
of O 0 0.0001031666251947172
maternal O 0 0.00034229407901875675
origin O 0 3.259242657804862e-05
, O 0 2.687084997887723e-05
by O 0 3.5536286304704845e-05
paternal O 0 0.0020337735768407583
uniparental B-Disease 1 0.9999866485595703
disomy I-Disease 1 0.9999828338623047
( O 0 0.0037400207947939634
UPD B-Disease 1 0.9999990463256836
) O 0 8.882636757334694e-05
15 O 0 6.524681521113962e-05
, O 0 9.974177373806015e-06
by O 0 2.7477979529066943e-05
imprinting O 0 0.039039961993694305
defects O 1 0.9999749660491943
, O 0 7.400676258839667e-05
and O 0 1.8270773580297828e-05
by O 0 1.5406281818286516e-05
mutations O 0 2.871902506740298e-05
in O 0 6.482422031695023e-05
the O 0 0.00034440093440935016
UBE3A O 1 0.9997215867042542
gene O 0 0.0003264634869992733
. O 0 0.00017310651310253888

UBE3A O 0 0.0984727293252945
encodes O 0 0.0007228228496387601
a O 0 0.0002667740627657622
ubiquitin O 0 0.0009962820913642645
- O 0 0.0004218442481942475
protein O 0 4.473193621379323e-05
ligase O 0 0.00013915756426285952
and O 0 2.9929657102911733e-05
shows O 0 0.0002484502620063722
brain O 1 0.7831149101257324
- O 0 0.0008050189935602248
specific O 0 4.844477734877728e-05
imprinting O 0 0.0018006799509748816
. O 0 0.0004479311464820057

Here O 0 0.0006780485855415463
we O 0 5.701742702513002e-05
describe O 0 0.0002787260746117681
UBE3A O 0 0.1514965146780014
coding O 0 0.001532522146590054
- O 0 0.0011029110755771399
region O 0 0.0001841255434555933
mutations O 0 3.842234946205281e-05
detected O 0 7.824306521797553e-05
by O 0 1.365992193314014e-05
SSCP O 0 0.002381630940362811
analysis O 0 8.099813385342713e-06
in O 0 3.208696216461249e-05
13 O 0 0.0003000413707923144
AS B-Disease 1 0.9915798902511597
individuals O 0 1.747170608723536e-05
or O 0 6.232708983588964e-05
families O 0 9.903971658786759e-05
. O 0 0.00028788065537810326

Two O 0 0.00022417301079258323
identical O 0 0.00010373128316132352
de O 0 0.001253172056749463
novo O 0 0.0009761332185007632
5 O 0 0.0006054178229533136
- O 0 0.0004144237609580159
bp O 0 0.0002753172011580318
duplications O 0 0.0006358377868309617
in O 0 8.681878534844145e-05
exon O 0 0.0007963083335198462
16 O 0 0.00024402864801231772
were O 0 0.00010539600043557584
found O 0 0.00013408179802354425
. O 0 0.0002659096207935363

Among O 0 0.0001569706801092252
the O 0 2.8756465326296166e-05
other O 0 6.602070698136231e-06
11 O 0 3.6411322071217e-05
unique O 0 1.818913187889848e-05
mutations O 0 2.2982254449743778e-05
, O 0 1.0369422852818388e-05
8 O 0 6.407631008187309e-05
were O 0 2.659756864886731e-05
small O 0 1.8686803741729818e-05
deletions O 0 7.595797796966508e-05
or O 0 3.9062124415067956e-05
insertions O 0 0.00043320300756022334
predicted O 0 0.00037922998308204114
to O 0 0.0001341394818155095
cause O 0 0.0007186307921074331
frameshifts O 0 0.005075421184301376
, O 0 5.3650208428734913e-05
1 O 0 0.00019222419359721243
was O 0 0.00014281290350481868
a O 0 2.3869793949415907e-05
mutation O 0 9.225950634572655e-06
to O 0 1.315748886554502e-05
a O 0 3.800341801252216e-05
stop O 0 6.835478416178375e-05
codon O 0 5.423203037935309e-05
, O 0 1.8579330571810715e-05
1 O 0 0.00011468135198811069
was O 0 0.00020098710956517607
a O 0 4.001741035608575e-05
missense O 0 0.00014704553177580237
mutation O 0 2.170785046473611e-05
, O 0 9.917514034896158e-06
and O 0 1.0460132216394413e-05
1 O 0 0.00016211952606681734
was O 0 0.00031183738610707223
predicted O 0 0.00010328101780032739
to O 0 2.0747145754285157e-05
cause O 0 7.508155249524862e-05
insertion O 0 0.00012551332474686205
of O 0 0.0002234189014416188
an O 0 0.00011372326844139025
isoleucine O 0 0.0016595125198364258
in O 0 9.090835374081507e-05
the O 0 9.863631566986442e-05
hect O 0 0.0012985087232664227
domain O 0 0.00010407915397081524
of O 0 0.00013713752559851855
the O 0 0.00022938683105167001
UBE3A O 1 0.9813656806945801
protein O 0 9.434406092623249e-05
, O 0 6.592979389097309e-06
which O 0 3.8897751437616535e-06
functions O 0 1.4421523701457772e-05
in O 0 7.40681862225756e-05
E2 O 0 0.0091049550101161
binding O 0 9.02922693057917e-05
and O 0 0.00010041136556537822
ubiquitin O 0 0.0007825266802683473
transfer O 0 0.0008703367202542722
. O 0 0.0006057756254449487

Eight O 0 0.0003231957380194217
of O 0 0.00011239699233556166
the O 0 6.963503983570263e-05
cases O 0 4.1191848140442744e-05
were O 0 7.899418415036052e-05
familial O 0 0.0017357936594635248
, O 0 8.764547237660736e-05
and O 0 3.792638017330319e-05
five O 0 4.9428628699388355e-05
were O 0 0.00012237361806910485
sporadic O 0 0.001058610389009118
. O 0 0.00035066233249381185

In O 0 0.0005709982360713184
two O 0 0.00010978104546666145
familial O 0 0.005485475063323975
cases O 0 0.0002783752279356122
and O 0 6.302194378804415e-05
one O 0 4.079023710801266e-05
sporadic O 0 0.00018798033124767244
case O 0 0.00012411490024533123
, O 0 4.256608008290641e-05
mosaicism O 0 0.0105206947773695
for O 0 0.0002288446412421763
UBE3A O 1 0.9999358654022217
mutations O 0 0.0001853559515438974
was O 0 0.000509044446516782
detected O 0 0.00010357076826039702
in O 0 1.61099942488363e-05
the O 0 1.73069020092953e-05
mother O 0 2.4196597223635763e-05
of O 0 3.420880238991231e-05
three O 0 6.761339318472892e-05
AS B-Disease 1 0.9999324083328247
sons O 0 0.001920692971907556
, O 0 2.1606751033687033e-05
in O 0 1.842371239035856e-05
the O 0 6.080811363062821e-05
maternal O 0 0.0004400593170430511
grandfather O 0 0.0008484201971441507
of O 0 0.00016929626872297376
two O 0 5.125691677676514e-05
AS B-Disease 1 0.9993153810501099
first O 0 0.0001535806804895401
cousins O 0 0.00013905078230891377
, O 0 1.4293829735834152e-05
and O 0 7.238465968839591e-06
in O 0 1.5899717254796997e-05
the O 0 3.20136641676072e-05
mother O 0 3.5530592867871746e-05
of O 0 6.680304068140686e-05
an O 0 0.00012478894495870918
AS B-Disease 1 0.9999995231628418
daughter O 0 0.03214353695511818
. O 0 0.0006292046164162457

The O 0 0.00019052244897466153
frequencies O 0 4.1104885895038024e-05
with O 0 1.1713941603375133e-05
which O 0 1.2541304386104457e-05
we O 0 1.1710479157045484e-05
detected O 0 6.400235724868253e-05
mutations O 0 1.6179850717890076e-05
were O 0 2.0783742002095096e-05
5 O 0 4.600267857313156e-05
( O 0 1.1733272913261317e-05
14 O 0 3.7849487853236496e-05
% O 0 9.515470992482733e-06
) O 0 7.563726285297889e-06
of O 0 2.584637149993796e-05
35 O 0 6.37065531918779e-05
in O 0 3.722268229466863e-05
sporadic O 0 0.0001062621595337987
cases O 0 1.8834511138265952e-05
and O 0 1.5115374480956234e-05
8 O 0 7.500699575757608e-05
( O 0 9.661519470682833e-06
80 O 0 1.947192140505649e-05
% O 0 5.890915417694487e-06
) O 0 3.1411830150318565e-06
of O 0 2.7343361580278724e-05
10 O 0 7.785202615195885e-05
in O 0 7.639980321982875e-05
familial O 0 0.003307747421786189
cases O 0 0.0006098888698033988
. O 0 0.0002631507522892207
. O 0 0.000253433856414631

The O 0 0.005518770776689053
hemochromatosis B-Disease 1 1.0
845 O 1 0.9957980513572693
G O 1 0.9619099497795105
- O 0 0.0027819538954645395
- O 0 0.00037306189187802374
> O 0 9.052608220372349e-05
A O 0 0.00013059670163784176
and O 0 1.0988747817464173e-05
187 O 0 6.400718120858073e-05
C O 0 0.0005194182740524411
- O 0 0.00025547193945385516
- O 0 0.0001588070736033842
> O 0 0.00014439996448345482
G O 0 0.0004047175752930343
mutations O 0 2.2149059077491984e-05
: O 0 1.252911170013249e-05
prevalence O 0 0.0002141446602763608
in O 0 6.327835581032559e-05
non O 0 0.0005557598196901381
- O 0 0.0013792015379294753
Caucasian O 0 0.0006165879894979298
populations O 0 5.237050208961591e-05
. O 0 7.670187915209681e-05

Hemochromatosis B-Disease 1 0.9999997615814209
, O 0 0.0005045469733886421
the O 0 0.1905193328857422
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999998807907104
, O 0 0.00030090479413047433
leads O 0 0.00038943547406233847
, O 0 3.296635259175673e-05
if O 0 4.5864610001444817e-05
untreated O 1 0.999994158744812
, O 0 9.746655996423215e-05
to O 0 0.00041627875179983675
progressive O 1 0.9999980926513672
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 0 0.2686701714992523
premature B-Disease 1 0.9993877410888672
death I-Disease 1 0.9971230626106262
. O 0 0.0008227198268286884

The O 0 0.0067373174242675304
hemochromatosis B-Disease 1 1.0
gene O 0 0.004770001862198114
, O 0 0.00038315841811709106
HFE O 1 0.9994931221008301
, O 0 0.00010862933413591236
recently O 0 0.00012561077892314643
has O 0 1.3373789442994166e-05
been O 0 1.0636868864821736e-05
identified O 0 8.267163138953038e-06
, O 0 4.2429360291862395e-06
and O 0 3.6253522921469994e-06
characterization O 0 3.799740443355404e-05
of O 0 5.6049095292109996e-05
this O 0 2.2021258700988255e-05
gene O 0 2.4742481400608085e-05
has O 0 7.79715810494963e-06
shown O 0 6.757930350431707e-06
that O 0 1.1558610140127712e-06
it O 0 9.456329053136869e-07
contains O 0 1.6677662415531813e-06
two O 0 2.142462335541495e-06
mutations O 0 6.537045010190923e-06
that O 0 4.096933480468579e-06
result O 0 1.3200572539062705e-05
in O 0 4.036970130982809e-05
amino O 0 3.835143434116617e-05
acid O 0 8.706138032721356e-05
substitutions O 0 0.0002080996346194297
- O 0 0.0002639055310282856
cDNA O 0 8.833096217131242e-05
nucleotides O 0 5.337774200597778e-05
845 O 0 0.0005325069068931043
G O 0 0.0009620553464628756
- O 0 0.000311201874865219
- O 0 0.00014414821635000408
> O 0 6.213304004631937e-05
A O 0 0.00010671555355656892
( O 0 2.1521938833757304e-05
C282Y O 0 0.00017801225476432592
) O 0 5.146969670022372e-06
and O 0 5.105259333504364e-06
187 O 0 3.5282791941426694e-05
C O 0 0.0003983877249993384
- O 0 0.0003128889366053045
- O 0 0.00017575662059243768
> O 0 0.000179788883542642
G O 0 0.0008351571159437299
( O 0 0.00016252488421741873
H63D O 1 0.9135045409202576
) O 0 0.0002156109840143472
. O 0 0.00016947682888712734

Although O 0 0.005147804971784353
hemochromatosis B-Disease 1 1.0
is O 0 0.00042385849519632757
common O 0 9.055525879375637e-05
in O 0 0.00015195751620922238
Caucasians O 0 0.0012858998961746693
, O 0 3.6274079320719466e-05
affecting O 0 0.0001222946448251605
> O 0 0.00020913754997309297
= O 0 0.0001915556495077908
1 O 0 0.0002000371168833226
/ O 0 0.0001455664896639064
300 O 0 2.544771268730983e-05
individuals O 0 3.41093050337804e-06
of O 0 3.1089697586139664e-05
northern O 0 4.044071465614252e-05
European O 0 1.5972042092471384e-05
origin O 0 9.605092600395437e-06
, O 0 6.378329999279231e-06
it O 0 2.0294799014664022e-06
has O 0 2.7901310204470064e-06
not O 0 1.4431115005208994e-06
been O 0 5.259822955849813e-06
recognized O 0 7.732702215434983e-06
in O 0 1.6086030882433988e-05
other O 0 1.368192897643894e-05
populations O 0 4.4465017708716914e-05
. O 0 0.00010230307816527784

The O 0 0.0002173261163989082
present O 0 9.09412992768921e-05
study O 0 2.6083238481078297e-05
used O 0 3.4248332667630166e-05
PCR O 0 9.056682756636292e-05
and O 0 2.315556957910303e-05
restriction O 0 6.73332397127524e-05
- O 0 0.0001116045459639281
enzyme O 0 1.4754113180970307e-05
digestion O 0 3.5887263948097825e-05
to O 0 5.457402039610315e-06
analyze O 0 1.0393797310825903e-05
the O 0 6.750895863660844e-06
frequency O 0 9.542241969029419e-06
of O 0 3.357091190991923e-05
the O 0 0.00010647708404576406
845 O 0 0.0017820859793573618
G O 0 0.0019777552224695683
- O 0 0.0004437951429281384
- O 0 9.25332133192569e-05
> O 0 3.412636579014361e-05
A O 0 5.857869837200269e-05
and O 0 7.618237304996001e-06
187 O 0 6.126560765551403e-05
C O 0 0.00040949039976112545
- O 0 0.00022268795873969793
- O 0 0.0001210459231515415
> O 0 0.0001132456018240191
G O 0 0.00045662419870495796
mutations O 0 6.863341695861891e-05
in O 0 0.00013574244803749025
HLA O 0 0.06072342023253441
- O 0 0.0003847919579129666
typed O 0 5.129652709001675e-05
samples O 0 1.111551137000788e-05
from O 0 2.9723580155405216e-05
non O 0 0.00031034203129820526
- O 0 0.0004302202141843736
Caucasian O 0 0.0004690699279308319
populations O 0 1.0625715731293894e-05
, O 0 5.8529540183371864e-06
comprising O 0 2.28397566388594e-05
Australian O 0 7.761748565826565e-05
Aboriginal O 0 0.00016168049478437752
, O 0 2.7813275664811954e-05
Chinese O 0 0.00016498283366672695
, O 0 3.85451057809405e-05
and O 0 4.802371404366568e-05
Pacific O 0 0.001381519134156406
Islanders O 0 0.0012306642020121217
. O 0 0.00030699055059812963

Results O 0 0.00018651488062459975
showed O 0 0.0001636346714803949
that O 0 1.628087557037361e-05
the O 0 5.191551099414937e-05
845 O 0 0.0019797193817794323
G O 0 0.004788451828062534
- O 0 0.0008785391109995544
- O 0 0.0002595343685243279
> O 0 7.021288183750585e-05
A O 0 9.367485472466797e-05
mutation O 0 6.695084721286548e-06
was O 0 4.0120274206856266e-05
present O 0 1.0725529136834666e-05
in O 0 1.0315007784811314e-05
these O 0 3.981327608926222e-06
populations O 0 4.579733285936527e-06
( O 0 2.4761527583905263e-06
allele O 0 1.3507711855709204e-06
frequency O 0 4.902045930066379e-06
0 O 0 1.07346777440398e-05
. O 0 2.1576397557510063e-06
32 O 0 8.145904757839162e-06
% O 0 6.507356374640949e-06
) O 0 9.360767762700561e-06
, O 0 9.522878826828673e-06
and O 0 1.039695052895695e-05
, O 0 1.3177982509660069e-05
furthermore O 0 3.325178113300353e-05
, O 0 1.0688504517020192e-05
it O 0 7.605918199260486e-06
was O 0 0.00010924585512839258
always O 0 1.951497506524902e-05
seen O 0 1.821452497097198e-05
in O 0 8.782420081843156e-06
conjunction O 0 3.975237996201031e-05
with O 0 5.398786015575752e-05
HLA O 1 0.9999927282333374
haplotypes O 0 0.002876492915675044
common O 0 0.00019203350530005991
in O 0 0.0001555732887936756
Caucasians O 0 0.0013204279821366072
, O 0 3.078146983170882e-05
suggesting O 0 5.059789327788167e-05
that O 0 2.205387681897264e-05
845 O 0 0.001559078460559249
G O 0 0.006870622746646404
- O 0 0.0012951368698850274
- O 0 0.00028609478613361716
> O 0 9.670029976405203e-05
A O 0 0.00015876149700488895
may O 0 2.2273525246419013e-05
have O 0 2.637598299770616e-06
been O 0 6.415696134354221e-06
introduced O 0 5.464130936161382e-06
into O 0 6.1760506468999665e-06
these O 0 1.6324388525390532e-06
populations O 0 7.556083801318891e-06
by O 0 1.9249844626756385e-05
Caucasian O 0 0.0012992393458262086
admixture O 0 0.004045638721436262
. O 0 0.0016726021422073245

187 O 0 0.001970215467736125
C O 0 0.0035265686456114054
- O 0 0.0008833836764097214
- O 0 0.00021687691332772374
> O 0 0.00012264720862731338
G O 0 0.00031931165722198784
was O 0 0.00011938048555748537
present O 0 1.9950184650951996e-05
at O 0 5.7671553804539144e-05
an O 0 8.119860467559192e-06
allele O 0 6.314231086435029e-06
frequency O 0 2.53605903708376e-05
of O 0 0.00014346203533932567
2 O 0 0.0011103441938757896
. O 0 0.00027963935281150043

68 O 0 0.0005978163098916411
% O 0 7.717716653132811e-05
in O 0 3.8825255614938214e-05
the O 0 2.671198126336094e-05
two O 0 6.799401035095798e-06
populations O 0 7.483808985853102e-06
analyzed O 0 3.2732656109146774e-05
( O 0 1.848855390562676e-05
Australian O 0 6.206848047440872e-05
Aboriginal O 0 0.00015534707927145064
and O 0 5.4102118156151846e-05
Chinese O 0 0.0006712211761623621
) O 0 0.00014418037608265877
. O 0 0.00020326042431406677

In O 0 0.0002992883091792464
the O 0 9.393022628501058e-05
Australian O 0 0.00012866596807725728
Aboriginal O 0 7.58311798563227e-05
samples O 0 1.4536766684614122e-05
, O 0 8.319631888298318e-06
187 O 0 4.150049790041521e-05
C O 0 0.0003399065462872386
- O 0 0.00022627509315498173
- O 0 0.0001060595823219046
> O 0 8.952408825280145e-05
G O 0 0.00022000937315169722
was O 0 5.902752309339121e-05
found O 0 3.16005775857775e-06
to O 0 4.496505880524637e-06
be O 0 5.158025487617124e-06
associated O 0 1.1905625797226094e-05
with O 0 3.136845043627545e-05
HLA O 1 0.9999973773956299
haplotypes O 0 0.0037947981618344784
common O 0 0.0002027030277531594
in O 0 0.0001677616237429902
Caucasians O 0 0.002070770598948002
, O 0 3.849970016744919e-05
suggesting O 0 4.8728474212111905e-05
that O 0 2.865926035156008e-06
it O 0 4.746896593132988e-06
was O 0 8.137772238114849e-05
introduced O 0 1.902949770737905e-05
by O 0 4.967407676303992e-06
recent O 0 4.1695071558933705e-05
admixture O 0 0.0007770219817757607
. O 0 0.0005275228759273887

In O 0 0.00022981854272074997
the O 0 6.35241303825751e-05
Chinese O 0 8.085807348834351e-05
samples O 0 6.754219157301122e-06
analyzed O 0 1.3183637747715693e-05
, O 0 4.8681863518140744e-06
187 O 0 2.2701169655192643e-05
C O 0 0.00029165076557546854
- O 0 0.00019151218293700367
- O 0 0.00013776835112366825
> O 0 0.00010397292498964816
G O 0 0.00032445593387819827
was O 0 0.00018039347196463495
present O 0 4.036819882458076e-05
in O 0 2.791691258607898e-05
association O 0 3.0488587071886286e-05
with O 0 8.636397978989407e-06
a O 0 3.3395168429706246e-05
wide O 0 0.00017128467152360827
variety O 0 5.918099486734718e-05
of O 0 0.0007232481148093939
HLA O 1 0.9999979734420776
haplotypes O 0 0.0015063830651342869
, O 0 4.802774856216274e-05
showing O 0 7.630384061485529e-05
this O 0 7.302060112124309e-06
mutation O 0 9.04388252820354e-06
to O 0 7.547520908701699e-06
be O 0 9.338416930404492e-06
widespread O 0 6.061393651179969e-05
and O 0 1.9545372197171673e-05
likely O 0 4.038698898511939e-05
to O 0 2.6082143449457362e-05
predate O 0 0.00042904276051558554
the O 0 4.8776684707263485e-05
more O 0 1.0657877282937989e-05
genetically O 0 3.4177632187493145e-05
restricted O 0 2.012854201893788e-05
845 O 0 0.0009362506680190563
G O 0 0.0028513448778539896
- O 0 0.0010779091389849782
- O 0 0.0002919765538536012
> O 0 0.0001874158624559641
A O 0 0.00026282452745363116
mutation O 0 9.135703294305131e-05
. O 0 0.00014420485240407288

Genotype O 0 0.006963956169784069
- O 0 0.0022997274063527584
phenotype O 0 0.00023881749075371772
correlations O 0 0.0008534404914826155
in O 0 0.0006969544920139015
attenuated B-Disease 1 0.9989259839057922
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999997615814209
. O 0 0.005737352184951305

Germ O 1 0.9999992847442627
- O 0 0.006703143008053303
line O 0 0.00037240187521092594
mutations O 0 4.8141464503714815e-05
of O 0 8.299617184093222e-05
the O 0 0.00035256711998954415
tumor B-Disease 1 0.9999914169311523
suppressor O 0 0.01849767006933689
APC O 0 0.0016644397983327508
are O 0 1.1202540918020532e-05
implicated O 0 0.00042417942313477397
in O 0 0.0002376459160586819
attenuated B-Disease 1 0.9987800717353821
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9850754737854004
AAPC B-Disease 1 1.0
) O 0 6.231264706002548e-05
, O 0 7.145040854084073e-06
a O 0 9.900522854877636e-06
variant O 0 6.787360325688496e-05
of O 0 0.0006460610893554986
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999924898147583
FAP B-Disease 1 0.9999985694885254
) O 0 0.0006712154136039317
. O 0 0.0002627010107971728

AAPC B-Disease 1 0.9999905824661255
is O 0 0.000110375571239274
recognized O 0 3.406160249141976e-05
by O 0 5.480852451000828e-06
the O 0 1.5795072613400407e-05
occurrence O 0 4.761884702020325e-05
of O 0 0.00016617498476989567
< O 0 0.11700659990310669
100 O 0 0.0015405613230541348
colonic B-Disease 1 0.9998918771743774
adenomas I-Disease 1 0.9136998653411865
and O 0 2.4259394194814377e-05
a O 0 2.990680150105618e-05
later O 0 9.434271487407386e-05
onset O 1 0.9999299049377441
of O 1 0.9999916553497314
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0013699436094611883
age O 0 0.0009676577756181359
> O 0 0.000517547654453665
40 O 0 0.00025577808264642954
years O 0 0.00027917977422475815
) O 0 9.425296593690291e-05
. O 0 0.00014139032282400876

The O 0 0.00032595935044810176
aim O 0 0.00015509162039961666
of O 0 4.20487740484532e-05
this O 0 1.077313663699897e-05
study O 0 8.72125838213833e-06
was O 0 4.3307143641868606e-05
to O 0 1.0306583135388792e-05
assess O 0 9.265469998354092e-05
genotype O 0 0.00023256195709109306
- O 0 0.0005097382818348706
phenotype O 0 0.00010688765905797482
correlations O 0 0.0004302680026739836
in O 0 0.0008450562017969787
AAPC B-Disease 1 0.9999992847442627
families O 0 0.0005235926946625113
. O 0 0.00035442030639387667

By O 0 0.00024488757480867207
protein O 0 0.00030070202774368227
- O 0 0.00017532445781398565
truncation O 0 0.00015864695888012648
test O 0 2.1520872905966826e-05
( O 0 2.7885354938916862e-05
PTT O 0 0.00029510873719118536
) O 0 5.688941655535018e-06
assay O 0 1.2668750059674494e-05
, O 0 4.172346507402835e-06
the O 0 8.72997861733893e-06
entire O 0 6.736335490131751e-05
coding O 0 7.81980124884285e-05
region O 0 7.744639879092574e-05
of O 0 6.092147305025719e-05
the O 0 0.0002184973272960633
APC B-Disease 0 0.0028812249656766653
gene O 0 8.911031909519807e-05
was O 0 0.00016052606224548072
screened O 0 9.187000978272408e-05
in O 0 1.4761445527256e-05
affected O 0 1.8735801859293133e-05
individuals O 0 7.872577953094151e-06
from O 0 0.00014481667312793434
11 O 0 0.08971599489450455
AAPC B-Disease 1 1.0
kindreds O 0 0.00506910216063261
, O 0 4.5797874918207526e-05
and O 0 9.278989637095947e-06
their O 0 8.090255505521782e-06
phenotypic O 0 0.00019441083713900298
differences O 0 0.00038283292087726295
were O 0 0.0003619135241024196
examined O 0 0.00110424414742738
. O 0 0.00037096047890372574

Five O 0 0.0010310758370906115
novel O 0 0.0015767241129651666
germ O 1 0.9999639987945557
- O 0 0.003194415243342519
line O 0 0.0008060390828177333
APC B-Disease 0 0.001365572796203196
mutations O 0 0.00011380787327652797
were O 0 7.635937072336674e-05
identified O 0 7.178595114964992e-05
in O 0 9.796722588362172e-05
seven O 0 0.0003566447412595153
kindreds O 0 0.0047826385125517845
. O 0 0.0006332678021863103

Mutations O 0 0.000556168903131038
were O 0 0.00012552649423014373
located O 0 9.026076440932229e-05
in O 0 9.446898729947861e-06
three O 0 3.969415502069751e-06
different O 0 1.1888479320987244e-06
regions O 0 1.0319593457097653e-05
of O 0 3.3133241231553257e-05
the O 0 8.40139837237075e-05
APC B-Disease 0 0.0006360159604810178
gene O 0 2.243229391751811e-05
( O 0 7.477916824427666e-06
1 O 0 4.56588932138402e-05
) O 0 4.510055987339001e-06
at O 0 1.8928722056443803e-05
the O 0 9.67446521826787e-06
5 O 0 2.7009398763766512e-05
end O 0 0.00011758437176467851
spanning O 0 0.0005266760708764195
exons O 0 0.00021220419148448855
4 O 0 9.040996519615874e-05
and O 0 1.2912727470393293e-05
5 O 0 4.690776040661149e-05
, O 0 9.801562555367127e-06
( O 0 6.084906090109143e-06
2 O 0 3.4043412597384304e-05
) O 0 6.173023848532466e-06
within O 0 1.4758447832718957e-05
exon O 0 0.00018282607197761536
9 O 0 0.00010053878941107541
, O 0 1.0168184417125303e-05
and O 0 7.716554137005005e-06
( O 0 1.3915248928242363e-05
3 O 0 5.9073237935081124e-05
) O 0 1.1687940968840849e-05
at O 0 5.4245221690507606e-05
the O 0 2.6652309315977618e-05
3 O 0 0.00010106785339303315
distal O 0 0.0012798125389963388
end O 0 0.000706366787198931
of O 0 0.00019370827067177743
the O 0 0.00023560911358799785
gene O 0 0.0002639986341819167
. O 0 0.0001833571441238746

Variability O 0 0.0016949782148003578
in O 0 6.489399675047025e-05
the O 0 3.890056541422382e-05
number O 0 6.036445847712457e-05
of O 1 0.6399424076080322
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9992262125015259
most O 0 5.140563007444143e-05
apparent O 0 0.0001318576541962102
in O 0 1.2619431799976155e-05
individuals O 0 3.0228291052480927e-06
with O 0 8.544649972463958e-06
mutations O 0 3.046676101803314e-05
in O 0 6.436765397666022e-05
region O 0 0.00028724654112011194
1 O 0 0.0003828016051556915
, O 0 3.336327426950447e-05
and O 0 7.06613645888865e-05
upper O 1 0.9999263286590576
- O 1 0.9999939203262329
gastrointestinal O 1 0.9999995231628418
manifestations O 1 0.9999499320983887
were O 0 0.001129816402681172
more O 0 8.866886491887271e-05
severe O 0 0.2556364834308624
in O 0 0.00016238438547588885
them O 0 9.913722169585526e-05
. O 0 0.00023743823112454265

In O 0 0.0001669201155891642
individuals O 0 1.3319261597644072e-05
with O 0 1.2894982319267001e-05
mutations O 0 5.875368879060261e-05
in O 0 4.7089280997170135e-05
either O 0 6.157868483569473e-05
region O 0 0.00026416880427859724
2 O 0 0.00015327362052630633
or O 0 1.685708593868185e-05
region O 0 6.91567111061886e-05
3 O 0 4.5993554522283375e-05
, O 0 3.942636340070749e-06
the O 0 8.897238330973778e-06
average O 0 1.1159739187860396e-05
number O 0 6.589773420273559e-06
of O 0 0.00011639750300673768
adenomas B-Disease 1 0.9822101593017578
tended O 0 0.00019647915905807167
to O 0 3.267975989729166e-05
be O 0 2.059928374364972e-05
lower O 0 3.80947494704742e-05
than O 0 5.566163963521831e-06
those O 0 4.044841716677183e-06
in O 0 8.76415469974745e-06
individuals O 0 3.7943352708680322e-06
with O 0 9.967426194634754e-06
mutations O 0 3.948993617086671e-05
in O 0 5.828681605635211e-05
region O 0 0.0001437435857951641
1 O 0 8.328935655299574e-05
, O 0 1.4347256183100399e-05
although O 0 8.48271793074673e-06
age O 0 7.886344974394888e-05
at O 0 0.0003686982090584934
diagnosis O 0 0.001667221775278449
was O 0 0.0014669527299702168
similar O 0 0.00011304341751383618
. O 0 0.0003900764277204871

In O 0 0.0008617574931122363
all O 0 0.0007744520553387702
AAPC B-Disease 1 0.9999996423721313
kindreds O 0 0.005543451756238937
, O 0 6.256588676478714e-05
a O 0 3.743777415365912e-05
predominance O 0 0.001109524630010128
of O 0 0.0009900465374812484
right O 1 0.9969283938407898
- O 1 0.9999998807907104
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.999998927116394
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 0.34376221895217896
was O 0 0.015011291950941086
observed O 0 0.0005573114030994475
. O 0 0.00021988963999319822

No O 0 0.008022747933864594
desmoid B-Disease 1 0.999998927116394
tumors I-Disease 1 1.0
were O 0 0.00033475086092948914
found O 0 5.399923611548729e-05
in O 0 7.760674634482712e-05
these O 0 6.045997724868357e-05
kindreds O 0 0.0035739424638450146
. O 0 0.0005397478817030787

Our O 0 0.00020847420091740787
data O 0 4.8560777941020206e-05
suggest O 0 3.523366467561573e-05
that O 0 7.526115950895473e-06
, O 0 1.546315434097778e-05
in O 0 0.00010456910240463912
AAPC B-Disease 1 0.9999978542327881
families O 0 3.4679993405006826e-05
, O 0 5.8869391068583354e-06
the O 0 1.1592828741413541e-05
location O 0 3.424013630137779e-05
of O 0 4.649523543776013e-05
the O 0 0.00019514537416398525
APC B-Disease 1 0.6572305560112
mutation O 0 0.0001059069691109471
may O 0 0.0002861646353267133
partially O 0 0.000616051722317934
predict O 0 0.00012054660328431055
specific O 0 1.0670019037206657e-05
phenotypic O 0 0.0006409919587895274
expression O 0 0.0005959071568213403
. O 0 0.0005848031723871827

This O 0 9.323470294475555e-05
should O 0 1.9713137589860708e-05
help O 0 1.119019725592807e-05
in O 0 5.0164280764875e-06
the O 0 8.277293090941384e-06
design O 0 1.5199358131212648e-05
of O 0 3.651174120022915e-05
tailored O 0 8.276814332930371e-05
clinical O 0 0.0005798194906674325
- O 0 0.0010749169159680605
management O 0 0.00011951933993259445
protocols O 0 0.00012666356633417308
in O 0 2.5850093152257614e-05
this O 0 8.045307367865462e-06
subset O 0 5.705903095076792e-05
of O 0 0.0003075831918977201
FAP B-Disease 1 0.9999638795852661
patients O 0 0.0013790300581604242
. O 0 0.00014130958879832178
. O 0 0.00018556691065896302

Wilms B-Disease 1 0.9999953508377075
' I-Disease 0 0.19448614120483398
tumor I-Disease 1 0.9924259185791016
1 O 0 0.0008906356524676085
and O 0 8.06185562396422e-05
Dax O 1 0.9994910955429077
- O 0 0.00028562985244207084
1 O 0 0.0001071691294782795
modulate O 0 0.0001239678676938638
the O 0 5.138161577633582e-05
orphan O 0 0.000563376466743648
nuclear O 0 0.0007222166168503463
receptor O 0 0.0004101394733879715
SF O 0 0.2514786422252655
- O 0 0.0001830632972996682
1 O 0 6.293317710515112e-05
in O 0 2.4433111320831813e-05
sex O 0 7.124841067707166e-05
- O 0 7.596898649353534e-05
specific O 0 1.4414786164707039e-05
gene O 0 6.743991252733395e-05
expression O 0 0.00020354357548058033
. O 0 0.00037202468956820667

Products O 0 0.0002926791494246572
of O 0 0.00040484065539203584
steroidogenic O 0 0.008625230751931667
factor O 0 0.00034719068207778037
1 O 0 0.00031724796281196177
( O 0 0.00010320470755686983
SF O 0 0.3216261565685272
- O 0 0.00012339164095465094
1 O 0 8.006233838386834e-05
) O 0 1.3751232472714037e-05
and O 0 3.0793333280598745e-05
Wilms B-Disease 1 0.9999901056289673
tumor I-Disease 1 0.9998101592063904
1 O 0 0.0015585055807605386
( O 0 0.00015267934941221029
WT1 O 0 0.008880420587956905
) O 0 1.982364665309433e-05
genes O 0 6.368721187755e-06
are O 0 1.3182506108933012e-06
essential O 0 1.7523403585073538e-05
for O 0 1.4497986740025226e-05
mammalian O 0 0.00020095109357498586
gonadogenesis O 0 0.002552403835579753
prior O 0 0.00023009411233942956
to O 0 8.706121298018843e-05
sexual O 0 0.00036444186116568744
differentiation O 0 0.00688738701865077
. O 0 0.0013344091130420566

In O 0 0.0004921434447169304
males O 0 0.0001273435918847099
, O 0 0.0001463048392906785
SF O 1 0.9993459582328796
- O 0 0.00040563257061876357
1 O 0 0.00011344426457071677
participates O 0 4.6751061745453626e-05
in O 0 1.7402147932443768e-05
sexual O 0 4.288130367058329e-05
development O 0 3.687130083562806e-05
by O 0 7.580825695185922e-06
regulating O 0 4.792819163412787e-05
expression O 0 1.5134385648707394e-05
of O 0 6.360965926432982e-05
the O 0 0.00021075340919196606
polypeptide O 0 0.11440412700176239
hormone O 0 0.004332744050770998
Mullerian O 1 0.9994572997093201
inhibiting O 0 0.0055017550475895405
substance O 0 0.03157031536102295
( O 0 0.0008465225109830499
MIS O 1 0.9998013377189636
) O 0 0.00022120578796602786
. O 0 0.00013807254435960203

Here O 0 0.0004547318385448307
, O 0 2.9809196348651312e-05
we O 0 1.2047089512634557e-05
show O 0 4.846954107051715e-05
that O 0 3.559054675861262e-05
WT1 O 1 0.8434471487998962
- O 0 0.004409361630678177
KTS O 1 0.9341003894805908
isoforms O 0 0.00010663965804269537
associate O 0 0.00013805029448121786
and O 0 3.2454103347845376e-05
synergize O 0 0.0024907852057367563
with O 0 0.0001806020736694336
SF O 1 0.9999446868896484
- O 0 0.0010454710572957993
1 O 0 0.0002080744452541694
to O 0 7.814454875187948e-05
promote O 0 0.0006156889139674604
MIS O 1 0.991399884223938
expression O 0 0.0005474732606671751
. O 0 0.0003045679768547416

In O 0 0.0005510305636562407
contrast O 0 0.00048733054427430034
, O 0 0.0002736976312007755
WT1 O 1 0.9927306771278381
missense O 0 0.0013760606525465846
mutations O 0 0.00015276498743332922
, O 0 2.6012588932644576e-05
associated O 0 1.8868598999688402e-05
with O 0 1.5938474462018348e-05
male B-Disease 0 0.0004925498506054282
pseudohermaphroditism I-Disease 1 0.9999997615814209
in O 0 0.0014373932499438524
Denys B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.00011809833813458681
fail O 0 0.00013562344247475266
to O 0 3.298446608823724e-05
synergize O 0 0.0033988128416240215
with O 0 0.000239694636547938
SF O 1 0.9999997615814209
- O 0 0.007076887879520655
1 O 0 0.0011402054224163294
. O 0 0.00020515473443083465

Additionally O 0 0.00038833514554426074
, O 0 3.830235073110089e-05
the O 0 5.489434624905698e-05
X O 0 0.0032700703013688326
- O 0 0.0012788724852725863
linked O 0 0.0003326740406919271
, O 0 1.75197419594042e-05
candidate O 0 6.0208367358427495e-05
dosage O 0 0.00026589364279061556
- O 0 0.0003008446074090898
sensitive O 0 0.00027528146165423095
sex O 0 0.00012499520380515605
- O 0 0.00012136041914345697
reversal O 0 0.0001190957918879576
gene O 0 2.6989471734850667e-05
, O 0 2.1496136469068006e-05
Dax O 1 0.9821834564208984
- O 0 0.00033073301892727613
1 O 0 0.00010376689169788733
, O 0 2.209317790402565e-05
antagonizes O 0 0.00035480569931678474
synergy O 0 0.0009893685346469283
between O 0 0.0026035804767161608
SF O 1 0.9999949932098389
- O 0 0.0012072700774297118
1 O 0 0.0002770931168925017
and O 0 5.1086022722302005e-05
WT1 O 0 0.009429958648979664
, O 0 1.5580404578940943e-05
most O 0 6.952754574740538e-06
likely O 0 1.0372192264185287e-05
through O 0 3.6526571420836262e-06
a O 0 6.945147106307559e-06
direct O 0 1.1424031981732696e-05
interaction O 0 4.9540896725375205e-05
with O 0 8.664395136293024e-05
SF O 1 0.9999934434890747
- O 0 0.003802741877734661
1 O 0 0.0009012543596327305
. O 0 0.00027242847136221826

We O 0 0.0002639440062921494
propose O 0 0.00016027415404096246
that O 0 3.4861939639085904e-05
WT1 O 0 0.014529385603964329
and O 0 0.0001767552603268996
Dax O 1 0.9999547004699707
- O 0 0.0009692803141660988
1 O 0 0.00024172250414267182
functionally O 0 0.00016009516548365355
oppose O 0 2.059653343167156e-05
each O 0 2.3593661353515927e-06
other O 0 6.292698344623204e-06
in O 0 5.539925041375682e-05
testis O 0 0.0018248134292662144
development O 0 0.00012887557386420667
by O 0 4.786528734257445e-05
modulating O 0 0.0022255436051636934
SF O 1 0.99997878074646
- O 0 0.001118571381084621
1 O 0 0.0004481224750634283
- O 0 0.00043720897519961
mediated O 0 0.0005262929480522871
transactivation O 0 0.0033118731807917356
. O 0 0.00010312031372450292
. O 0 0.0001875209854915738

A O 0 0.0018896842375397682
mouse O 0 0.00015233733574859798
model O 0 3.354851287440397e-05
for O 0 7.808727968949825e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999996423721313
- O 1 0.9999932050704956
centre O 1 0.8824785351753235
mutations O 0 0.000695149356033653
. O 0 0.0005287317908369005

Imprinting O 0 0.005392794031649828
in O 0 0.0003934551787097007
the O 0 0.0003912599931936711
15q11 O 0 0.005433608312159777
- O 0 0.0008462737314403057
q13 O 0 0.0007412674021907151
region O 0 0.00010552502499194816
involves O 0 3.091016333200969e-05
an O 0 2.1043053493485786e-05
imprinting O 0 0.0010389434173703194
centre O 0 0.0021582043264061213
( O 0 0.00017629876674618572
IC O 0 0.0057715498842298985
) O 0 3.480383747955784e-05
, O 0 4.479620656638872e-06
mapping O 0 1.9561035514925607e-05
in O 0 1.4314619875221979e-05
part O 0 3.2019528589444235e-05
to O 0 2.8800344807677902e-05
the O 0 5.7282995840068907e-05
promoter O 0 0.0010557732312008739
and O 0 2.4552891773055308e-05
first O 0 9.002832666737959e-05
exon O 0 0.0006995777948759496
of O 0 0.0007658864487893879
SNRPN O 1 0.9999880790710449
. O 0 0.0007042945362627506

Deletion O 0 0.0022644749842584133
of O 0 0.0008582296431995928
this O 0 0.0002251613768748939
IC O 0 0.08016081154346466
abolishes O 0 0.0019290450727567077
local O 0 0.00011721818009391427
paternally O 0 0.0005215254495851696
derived O 0 3.493382246233523e-05
gene O 0 1.187719408335397e-05
expression O 0 8.187853381969035e-06
and O 0 4.353179065219592e-06
results O 0 7.233394171635155e-06
in O 0 9.972972475225106e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999945163726807
PWS B-Disease 1 1.0
) O 0 0.0031147166155278683
. O 0 0.0005152637022547424

We O 0 0.00013725120516028255
have O 0 9.73855821939651e-06
created O 0 3.007749910466373e-05
two O 0 7.3292899287480395e-06
deletion O 0 0.00011990814527962357
mutations O 0 7.01025637681596e-05
in O 0 9.590465924702585e-05
mice O 0 0.00020099901303183287
to O 0 5.2062561735510826e-05
understand O 0 0.0004580373060889542
PWS B-Disease 1 1.0
and O 0 6.101286271587014e-05
the O 0 5.293759022606537e-05
mechanism O 0 9.604982187738642e-05
of O 0 0.00010697393008740619
this O 0 9.411860082764179e-05
IC O 1 0.5908918380737305
. O 0 0.0008499215473420918

Mice O 0 0.041197918355464935
harbouring O 0 0.13420291244983673
an O 0 0.00035952182952314615
intragenic O 0 0.018340444192290306
deletion O 0 0.0013854349963366985
in O 0 0.0005890748579986393
Snrpn O 0 0.4039718508720398
are O 0 4.35799483966548e-05
phenotypically O 0 0.0009729753364808857
normal O 0 6.231003499124199e-05
, O 0 1.4555591405951418e-05
suggesting O 0 2.7197465897188522e-05
that O 0 4.729499778477475e-06
mutations O 0 2.140902324754279e-05
of O 0 0.00015394974616356194
SNRPN O 1 0.9995914101600647
are O 0 7.920237294456456e-06
not O 0 5.227294423093554e-06
sufficient O 0 6.817836401751265e-05
to O 0 0.00018300012743566185
induce O 1 0.6003440022468567
PWS B-Disease 1 1.0
. O 0 0.003131465520709753

Mice O 0 0.0010593043407425284
with O 0 1.823395723477006e-05
a O 0 3.9244856452569366e-05
larger O 0 3.59592741006054e-05
deletion O 0 0.00016431983385700732
involving O 0 0.00024240101629402488
both O 0 0.00010489988198969513
Snrpn O 0 0.0835704430937767
and O 0 5.437242361949757e-05
the O 0 0.0002280469925608486
putative O 1 0.9928190112113953
PWS O 1 1.0
- O 1 0.9799599647521973
IC O 0 0.4897884428501129
lack O 0 0.0003241730446461588
expression O 0 4.746778358821757e-05
of O 0 6.204351666383445e-05
the O 0 0.00013433456479106098
imprinted O 0 0.0007320134318433702
genes O 0 0.00014881619426887482
Zfp127 O 0 0.006794274784624577
( O 0 0.00015372660709545016
mouse O 0 0.00025443959748372436
homologue O 0 0.0005238867597654462
of O 0 0.0002084002480842173
ZNF127 O 1 0.9996627569198608
) O 0 0.00016722404689062387
, O 0 0.00011364088277332485
Ndn O 0 0.006876124069094658
and O 0 0.00011199236905667931
Ipw O 0 0.006115348543971777
, O 0 7.792317774146795e-05
and O 0 2.486820812919177e-05
manifest O 0 0.0005247513763606548
several O 0 8.588247874286026e-05
phenotypes O 0 0.0008491832995787263
common O 0 0.0005598341813310981
to O 1 0.5610008239746094
PWS B-Disease 1 1.0
infants O 1 0.9999722242355347
. O 0 0.0012903682654723525

These O 0 6.949360249564052e-05
data O 0 5.032024273532443e-05
demonstrate O 0 7.377001747954637e-05
that O 0 5.640021299768705e-06
both O 0 4.741919838124886e-06
the O 0 1.70600505953189e-05
position O 0 3.821197969955392e-05
of O 0 4.680101847043261e-05
the O 0 0.0001032979489536956
IC O 0 0.00822081696242094
and O 0 2.839284024958033e-05
its O 0 2.0547997337416746e-05
role O 0 4.1658910049591213e-05
in O 0 8.30317640065914e-06
the O 0 6.980912075960077e-06
coordinate O 0 1.4975338672229555e-05
expression O 0 1.2289006008359138e-05
of O 0 5.0792135880328715e-05
genes O 0 4.527119381236844e-05
is O 0 3.2782329071778804e-05
conserved O 0 0.00021090052905492485
between O 0 0.0003249258443247527
mouse O 0 0.00015920370060484856
and O 0 2.19998892134754e-05
human O 0 2.4524571927031502e-05
, O 0 8.064942448982038e-06
and O 0 4.6695704440935515e-06
indicate O 0 2.469557148288004e-05
that O 0 9.429273632122204e-06
the O 0 5.539074481930584e-05
mouse O 0 5.750965647166595e-05
is O 0 4.527042619884014e-06
a O 0 4.754988822242012e-06
suitable O 0 1.7342490536975674e-05
model O 0 9.730601050250698e-06
system O 0 1.4434953300224151e-05
in O 0 7.617743449372938e-06
which O 0 3.6497774544841377e-06
to O 0 5.96041172684636e-06
investigate O 0 1.6581285308348015e-05
the O 0 2.656258766364772e-05
molecular O 0 7.54024222260341e-05
mechanisms O 0 7.447855750797316e-05
of O 0 0.00014030742750037462
imprinting O 0 0.00041477629565633833
in O 0 6.244107498787344e-05
this O 0 9.984702955989633e-06
region O 0 4.400051329866983e-05
of O 0 3.322382326587103e-05
the O 0 8.278802852146327e-05
genome O 0 0.00016937375767156482
. O 0 5.856227653566748e-05
. O 0 0.00013418258458841592

Mutations O 0 0.00028625139384530485
of O 0 0.0001570661988807842
the O 0 0.00023573786893393844
ATM O 0 0.002874312223866582
gene O 0 8.223528857342899e-05
detected O 0 0.00011151262879138812
in O 0 5.0392274715704843e-05
Japanese O 0 0.02533763460814953
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
patients O 0 0.0006346009322442114
: O 0 2.6088337108376436e-05
possible O 0 3.2502102840226144e-05
preponderance O 0 0.0005679381429217756
of O 0 5.459026579046622e-05
the O 0 6.325820868369192e-05
two O 0 3.7511821574298665e-05
founder O 0 0.0010406837100163102
mutations O 0 0.0001629576727282256
4612del165 O 0 0.002049073576927185
and O 0 0.00015568546950817108
7883del5 O 0 0.0045998962596058846
. O 0 0.000461279705632478

The O 0 0.0006109849782660604
ATM O 0 0.004318951163440943
( O 0 0.00034681789111346006
A O 1 0.999500036239624
- O 1 0.7392199039459229
T O 1 0.9989733695983887
, O 0 3.059895243495703e-05
mutated O 0 2.6927100407192484e-05
) O 0 1.0765003025881015e-05
gene O 0 2.4085766199277714e-05
on O 0 0.00011302811617497355
human O 0 0.00028580226353369653
chromosome O 0 0.0020518191158771515
11q22 O 0 0.007350222207605839
. O 0 0.0006465974729508162

3 O 0 0.000862910645082593
has O 0 8.30051867524162e-05
recently O 0 6.821569695603102e-05
been O 0 1.1115966117358766e-05
identified O 0 5.77922901356942e-06
as O 0 3.2422856293123914e-06
the O 0 4.285890099708922e-06
gene O 0 3.4181857699877582e-06
responsible O 0 7.392234692815691e-06
for O 0 5.0957164603460114e-06
the O 0 6.21527069597505e-05
human O 0 0.0007092396845109761
recessive B-Disease 1 0.9999996423721313
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.4147006869316101
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9997982382774353
T I-Disease 1 0.9999899864196777
) O 0 0.0001913544547278434
. O 0 0.00018048913625534624

In O 0 0.00014890178863424808
order O 0 2.651642353157513e-05
to O 0 1.5294337572413497e-05
define O 0 3.566142186173238e-05
the O 0 2.640453567437362e-05
types O 0 7.738261774647981e-05
of O 0 0.48315733671188354
disease O 1 1.0
- O 1 0.9962741136550903
causing O 0 0.002366074360907078
ATM O 0 0.0021990907844156027
mutations O 0 2.9212251320132054e-05
in O 0 4.048489427077584e-05
Japanese O 0 0.0007995981140993536
A B-Disease 1 0.9999843835830688
- I-Disease 1 0.9999269247055054
T I-Disease 1 0.9999995231628418
patients O 0 8.430080924881622e-05
as O 0 2.989402855746448e-05
well O 0 1.5379842807305977e-05
as O 0 1.021438765747007e-05
to O 0 7.5255347837810405e-06
look O 0 1.3908735127188265e-05
for O 0 6.615861366299214e-06
possible O 0 5.998697815812193e-05
mutational O 0 0.0018515287665650249
hotspots O 0 0.0017516728257760406
, O 0 3.5421115171629936e-05
reverse O 0 0.0001724282919894904
- O 0 0.00019812073151115328
transcribed O 0 0.00012353186320979148
RNA O 0 5.822088132845238e-05
derived O 0 1.188554506370565e-05
from O 0 1.638373578316532e-05
ten O 0 8.381808584090322e-05
patients O 0 4.0677812648937106e-05
belonging O 0 7.058243500068784e-05
to O 0 4.593166886479594e-05
eight O 0 7.975981861818582e-05
unrelated O 0 0.0001961033558472991
Japanese O 0 0.0013897145399823785
A B-Disease 1 0.9999716281890869
- I-Disease 1 0.9331302046775818
T I-Disease 1 0.9988657236099243
families O 0 1.3222798770584632e-05
was O 0 8.964419976109639e-05
analyzed O 0 2.696115006983746e-05
for O 0 7.799909326422494e-06
mutations O 0 2.2670623366138898e-05
by O 0 1.1611173249548301e-05
the O 0 3.351461418787949e-05
restriction O 0 5.352301741368137e-05
endonuclease O 0 0.00029922608518972993
fingerprinting O 0 0.00029408495174720883
method O 0 0.00022930985142011195
. O 0 0.00022481621999759227

As O 0 0.000293875636998564
has O 0 3.6600427847588435e-05
been O 0 2.750448402366601e-05
reported O 0 1.1532311873452272e-05
by O 0 4.462284778128378e-06
others O 0 1.3353576832741965e-05
, O 0 1.0684355402190704e-05
mutations O 0 1.3809871234116144e-05
that O 0 9.588894499756861e-06
lead O 0 0.00011577176337596029
to O 0 0.0001132155884988606
exon O 0 0.0017147763865068555
skipping O 0 0.0008035742794163525
or O 0 0.00011650489614112303
premature O 0 0.0006522577023133636
protein O 0 0.00013723001757171005
truncation O 0 0.0005591695080511272
were O 0 8.149732457241043e-05
also O 0 2.850921191566158e-05
predominant O 0 0.00016011302068363875
in O 0 6.223069794941694e-05
our O 0 0.00010455484880367294
mutants O 0 0.001009067171253264
. O 0 0.00022901703778188676

Six O 0 0.00015451743092853576
different O 0 8.585311661590822e-06
mutations O 0 2.247584779979661e-05
were O 0 2.3884367692517117e-05
identified O 0 1.871901440608781e-05
on O 0 2.0501745893852785e-05
12 O 0 2.2740474378224462e-05
of O 0 2.853001751645934e-05
the O 0 7.957899651955813e-05
16 O 0 0.00018776071374304593
alleles O 0 9.269349538953975e-05
examined O 0 0.00035543570993468165
. O 0 0.0001491712173447013

Four O 0 0.0002710675180424005
were O 0 0.00011625641491264105
deletions O 0 0.00023013407189864665
involving O 0 0.00017141245189122856
a O 0 8.222604083130136e-05
loss O 0 0.0004152149776928127
of O 0 0.00023761464399285614
a O 0 0.00018720814841799438
single O 0 8.420849189860746e-05
exon O 0 0.0007034251466393471
exon O 0 0.0007919284398667514
7 O 0 0.00027802673866972327
, O 0 3.501707760733552e-05
exon O 0 0.0003269808366894722
16 O 0 0.00019959166820626706
, O 0 4.763874312629923e-05
exon O 0 0.0005267348606139421
33 O 0 0.0003566590603441
or O 0 0.0001764857879607007
exon O 0 0.0021650996059179306
35 O 0 0.0009706375421956182
. O 0 0.00048186874482780695

The O 0 0.00046812876826152205
others O 0 8.371376316063106e-05
were O 0 7.607512088725343e-05
minute O 0 0.00012086173956049606
deletions O 0 0.00021680766076315194
, O 0 4.671563146985136e-05
4649delA O 0 0.00039162609027698636
in O 0 6.701244274154305e-05
exon O 0 0.0005672905826941133
33 O 0 0.00019591925956774503
and O 0 5.5958193115657195e-05
7883del5 O 0 0.0009062038152478635
in O 0 0.0001186045992653817
exon O 0 0.0010469183325767517
55 O 0 0.0004665557644329965
. O 0 0.00021463360462803394

The O 0 0.0009161618654616177
mutations O 0 0.0008268821984529495
4612del165 O 0 0.002236035419628024
and O 0 9.688877617008984e-05
7883del5 O 0 0.0012854738160967827
were O 0 8.639313455205411e-05
found O 0 1.6185205822694115e-05
in O 0 1.4541369637299795e-05
more O 0 4.384974545246223e-06
than O 0 7.179986823757645e-06
two O 0 6.398587174771819e-06
unrelated O 0 3.804094740189612e-05
families O 0 8.355698810191825e-06
; O 0 4.08259620598983e-06
44 O 0 2.673606650205329e-05
% O 0 1.7087975720642135e-05
( O 0 2.0289910025894642e-05
7 O 0 7.594407361466438e-05
of O 0 4.5864737330703065e-05
16 O 0 0.00011105018347734585
) O 0 7.576330517622409e-06
of O 0 1.667827928031329e-05
the O 0 2.778973248496186e-05
mutant O 0 7.820546306902543e-05
alleles O 0 1.5464953321497887e-05
had O 0 2.0114628568990156e-05
one O 0 4.908646587864496e-06
of O 0 2.17883844015887e-05
the O 0 7.801894389558583e-05
two O 0 4.829914541915059e-05
mutations O 0 0.00015763410192448646
. O 0 0.0003516356518957764

The O 0 0.0010946491966024041
4612del165 O 0 0.004489236976951361
mutations O 0 0.00010407766967546195
in O 0 2.753120134002529e-05
three O 0 7.153890692279674e-06
different O 0 1.2717500794678926e-06
families O 0 2.8850204216723796e-06
were O 0 1.920456998050213e-05
all O 0 7.331987490033498e-06
ascribed O 0 0.00012096307909814641
to O 0 2.2307387553155422e-05
the O 0 7.899365300545469e-05
same O 0 8.671206160215661e-05
T O 0 0.00538325821980834
- O 0 0.0005781333311460912
- O 0 0.00020611763466149569
> O 0 9.822015272220597e-05
A O 0 9.891192166833207e-05
substitution O 0 2.9804703444824554e-05
at O 0 9.071706153918058e-05
the O 0 4.153894406044856e-05
splice O 0 0.0003031063242815435
donor O 0 6.36397599009797e-05
site O 0 0.00013087572006043047
in O 0 9.35373900574632e-05
intron O 0 0.005249306093901396
33 O 0 0.0014851521700620651
. O 0 0.00030509461066685617

Microsatellite O 0 0.017612267285585403
genotyping O 0 0.003918161150068045
around O 0 0.00043906812788918614
the O 0 0.0001211850976687856
ATM O 0 0.0009412514045834541
locus O 0 0.00012624937517102808
also O 0 1.451004936825484e-05
indicated O 0 1.7549291442264803e-05
that O 0 2.9564628221123712e-06
a O 0 8.276692824438214e-06
common O 0 1.0025292795035057e-05
haplotype O 0 0.00012314373452682048
was O 0 0.0002764392120297998
shared O 0 2.8481656045187265e-05
by O 0 4.199952400085749e-06
the O 0 1.4826316146354657e-05
mutant O 0 6.979571480769664e-05
alleles O 0 1.2194012924737763e-05
in O 0 2.1434130758279935e-05
both O 0 3.393800216144882e-05
mutations O 0 0.00020396029867697507
. O 0 0.0003525726788211614

This O 0 9.881048026727512e-05
suggests O 0 5.965463424217887e-05
that O 0 4.521010851021856e-06
these O 0 3.968098553741584e-06
two O 0 1.806644104362931e-05
founder O 0 0.000687833409756422
mutations O 0 7.39439856261015e-05
may O 0 8.034671191126108e-05
be O 0 1.92609331861604e-05
predominant O 0 6.145595398265868e-05
among O 0 3.0275316021288745e-05
Japanese O 0 0.00041124902782030404
ATM O 0 0.0018091307720169425
mutant O 0 0.0005461936816573143
alleles O 0 0.00020743759523611516
. O 0 0.00027190125547349453

W474C O 0 0.015487142838537693
amino O 0 0.0007888587424531579
acid O 0 0.00043881393503397703
substitution O 0 0.00020834662427660078
affects O 0 0.00017725718498695642
early O 0 5.7402696256758645e-05
processing O 0 2.9313690902199596e-05
of O 0 3.2476393243996426e-05
the O 0 3.474756522336975e-05
alpha O 0 6.836873217253014e-05
- O 0 2.1663985535269603e-05
subunit O 0 5.424815299193142e-06
of O 0 1.8885591998696327e-05
beta O 0 0.0002313753793714568
- O 0 0.00013991196465212852
hexosaminidase O 0 0.0006697418866679072
A O 0 8.115864329738542e-05
and O 0 9.130282705882564e-06
is O 0 7.572516551590525e-06
associated O 0 1.6246845916612074e-05
with O 0 2.0550427507259883e-05
subacute O 1 0.9999929666519165
G B-Disease 1 0.9999821186065674
( I-Disease 0 0.003424044232815504
M2 I-Disease 1 0.9999891519546509
) I-Disease 0 0.00029441461083479226
gangliosidosis I-Disease 0 0.009275192394852638
. O 0 0.00042829601443372667

Mutations O 0 0.0005419243243522942
in O 0 0.0001619600661797449
the O 0 0.00020965308067388833
HEXA O 0 0.030786138027906418
gene O 0 3.272416506661102e-05
, O 0 4.4957555473956745e-06
encoding O 0 4.706512754637515e-06
the O 0 1.5895258911768906e-05
alpha O 0 7.452211139025167e-05
- O 0 1.9516539396136068e-05
subunit O 0 4.090191850991687e-06
of O 0 2.539306842663791e-05
beta O 0 0.00019433464331086725
- O 0 0.00022603249817620963
hexosaminidase O 0 0.000760011316742748
A O 0 0.00021380883117672056
( O 0 2.9661850931006484e-05
Hex O 0 0.0005062586860731244
A O 0 0.0002824134426191449
) O 0 1.793226329027675e-05
, O 0 3.6931558042851975e-06
that O 0 2.642666686369921e-06
abolish O 0 0.0001371645921608433
Hex O 0 0.00043464763439260423
A O 0 7.636527152499184e-05
enzyme O 0 1.5068772881932091e-05
activity O 0 8.185498154489323e-05
cause O 1 0.597511887550354
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
( O 0 0.0003153319703415036
TSD B-Disease 1 0.999943733215332
) O 0 0.00011328524851705879
, O 0 2.3979813704499975e-05
the O 0 7.577378710266203e-05
fatal O 1 0.9476203322410583
infantile B-Disease 1 0.9705900549888611
form I-Disease 0 0.00039505193126387894
of I-Disease 0 0.259200781583786
G I-Disease 1 0.9997190833091736
( I-Disease 0 0.0005402337992563844
M2 I-Disease 1 0.9996988773345947
) I-Disease 0 5.9157584473723546e-05
gangliosidosis I-Disease 0 0.0011443272233009338
, I-Disease 0 4.9293670599581674e-05
Type I-Disease 0 0.0002988025080412626
1 I-Disease 0 0.0012382540153339505
. O 0 0.0004804867785423994

Less O 0 0.0030224882066249847
severe O 1 0.9994839429855347
, O 0 0.00031251003383658826
subacute O 1 0.9999916553497314
( O 0 0.0014383995439857244
juvenile O 1 0.9999703168869019
- O 0 0.3786168396472931
onset O 1 0.9999926090240479
) O 0 0.00012808131577912718
and O 0 0.00010842751362361014
chronic O 1 1.0
( O 0 0.0017595330718904734
adult O 0 0.00041214891825802624
- O 0 0.0012817870592698455
onset O 1 0.998167872428894
) O 0 4.2269133700756356e-05
variants O 0 2.4703109374968335e-05
are O 0 4.5486376620829105e-06
characterized O 0 3.237854252802208e-05
by O 0 1.2019088899251074e-05
a O 0 3.170208219671622e-05
broad O 0 0.0001067470948328264
spectrum O 0 0.0003371681086719036
of O 0 0.0003692497266456485
clinical O 0 0.1945662647485733
manifestations O 1 0.9888494610786438
and O 0 0.00011299266043351963
are O 0 8.567603799747303e-06
associated O 0 1.0425346772535704e-05
with O 0 1.068324490915984e-05
residual O 0 0.0031128725968301296
levels O 0 0.0006534062558785081
of O 0 0.00037946179509162903
Hex O 0 0.002773413434624672
A O 0 0.0005458772648125887
enzyme O 0 7.082503725541756e-05
activity O 0 0.00015229899145197123
. O 0 9.222075459547341e-05

We O 0 0.00025974703021347523
identified O 0 0.00012445573520381004
a O 0 0.0001657407556194812
1422 O 0 0.18605849146842957
G O 0 0.009317453019320965
- O 0 0.0014756006421521306
- O 0 0.0002523651928640902
> O 0 0.00011040463868994266
C O 0 0.0002700702170841396
( O 0 2.410966953902971e-05
amino O 0 2.696148476388771e-05
acid O 0 6.894599937368184e-05
W474C O 0 0.0004115303745493293
) O 0 1.1904466191481333e-05
substitution O 0 1.3111105545249302e-05
in O 0 1.5844876543269493e-05
the O 0 1.2539654562715441e-05
first O 0 2.8869395464425907e-05
position O 0 4.998784061172046e-05
of O 0 9.294664050685242e-05
exon O 0 0.0006409381749108434
13 O 0 0.0003295385977253318
of O 0 0.0003856200200971216
HEXA O 1 0.7866045236587524
of O 0 0.00043363356962800026
a O 0 0.0003175541933160275
non O 0 0.0009557391749694943
- O 0 0.0006821754504926503
Jewish O 0 0.00017543148715049028
proband O 0 0.004473181441426277
who O 0 4.958560748491436e-05
manifested O 0 0.00039721064968034625
a O 0 0.00010854918218683451
subacute O 0 0.36634862422943115
variant O 0 0.0003050468803849071
of O 0 0.0011370372958481312
G B-Disease 1 0.9980523586273193
( I-Disease 0 0.0006954331765882671
M2 I-Disease 1 0.9999063014984131
) I-Disease 0 0.00021439287229441106
gangliosidosis I-Disease 0 0.006734353490173817
. O 0 0.0003687069984152913

On O 0 0.0003880612784996629
the O 0 0.00010428569657960907
second O 0 0.0003278520598541945
maternally O 0 0.0015532996039837599
inherited O 1 0.569843053817749
allele O 0 8.499417890561745e-05
, O 0 1.5048351997393183e-05
we O 0 7.3223527579102665e-06
identified O 0 1.4942213965696283e-05
the O 0 5.317133036442101e-05
common O 0 0.0009515800047665834
infantile O 1 1.0
disease O 1 1.0
- O 1 0.9999271631240845
causing O 0 0.13817545771598816
4 O 0 0.0009790732292458415
- O 0 0.00035881769144907594
bp O 0 0.0001155244026449509
insertion O 0 6.623115041293204e-05
, O 0 3.495161945465952e-05
+ O 0 0.00037635702756233513
TATC O 1 0.9932479858398438
1278 O 0 0.11812072992324829
, O 0 7.174954225774854e-05
in O 0 9.557070734445006e-05
exon O 0 0.0012802398996427655
11 O 0 0.0009316905634477735
. O 0 0.00026725645875558257

Pulse O 0 0.014933078549802303
- O 0 0.0009680215734988451
chase O 0 9.232845332007855e-05
analysis O 0 5.256884378468385e-06
using O 0 1.8474418538971804e-05
proband O 0 0.002541461493819952
fibroblasts O 0 0.000374679162632674
revealed O 0 0.0001154198034782894
that O 0 6.4963760451064445e-06
the O 0 3.510364331305027e-05
W474C O 0 0.0005773784359917045
- O 0 0.00010170807945542037
containing O 0 3.669759098556824e-05
alpha O 0 0.0001438051403965801
- O 0 4.535852713161148e-05
subunit O 0 1.757364225341007e-05
precursor O 0 0.00018184237706009299
was O 0 0.00017860630759969354
normally O 0 3.229589856346138e-05
synthesized O 0 0.00010270959319313988
, O 0 1.0644824214978144e-05
but O 0 5.232421244727448e-06
not O 0 5.667038294632221e-06
phosphorylated O 0 9.645588579587638e-05
or O 0 3.1374675018014386e-05
secreted O 0 5.784886525361799e-05
, O 0 1.3063116966804955e-05
and O 0 8.089098628261127e-06
the O 0 8.569047349737957e-05
mature O 0 0.0005410778685472906
lysosomal O 0 0.007152886595577002
alpha O 0 0.0006271614693105221
- O 0 0.00011248383816564456
subunit O 0 3.8611324271187186e-05
was O 0 0.00013213367492426187
not O 0 1.6397974832216278e-05
detected O 0 0.0002644372289068997
. O 0 0.00011367685510776937

When O 0 0.0002477325906511396
the O 0 9.618033072911203e-05
W474C O 0 0.0009398749098181725
- O 0 0.000151867134263739
containing O 0 4.3501309846760705e-05
alpha O 0 0.00016303008305840194
- O 0 8.176284609362483e-05
subunit O 0 3.09127863147296e-05
was O 0 0.0001800189056666568
transiently O 0 0.000621336861513555
co O 0 0.00020962307462468743
- O 0 4.948612695443444e-05
expressed O 0 8.599799912190065e-06
with O 0 3.489325081318384e-06
the O 0 2.391087036812678e-05
beta O 0 0.0001218790202983655
- O 0 5.854647315572947e-05
subunit O 0 5.817111741635017e-06
to O 0 8.319386324728839e-06
produce O 0 1.6774352843640372e-05
Hex O 0 0.0004031745484098792
A O 0 0.00022787963098380715
( O 0 3.332711276016198e-05
alphabeta O 0 0.0007961231167428195
) O 0 3.0716779292561114e-05
in O 0 0.00010815718997037038
COS O 1 0.9940012097358704
- O 0 0.0010680798441171646
7 O 0 0.0002683461643755436
cells O 0 3.1800307624507695e-05
, O 0 5.569381755776703e-06
the O 0 2.1679939891328104e-05
mature O 0 7.739073771517724e-05
alpha O 0 0.00010074790770886466
- O 0 3.080620081163943e-05
subunit O 0 1.1438051842560526e-05
was O 0 5.888190935365856e-05
present O 0 1.5412468201247975e-05
, O 0 4.4094731492805295e-06
but O 0 3.107436668869923e-06
its O 0 3.1452475468540797e-06
level O 0 7.278003613464534e-05
was O 0 9.508112270850688e-05
much O 0 1.6128104107338004e-05
lower O 0 1.7863816538010724e-05
than O 0 3.1111312637222e-06
that O 0 1.4799595646763919e-06
from O 0 1.2068131582054775e-05
normal O 0 4.344223998486996e-05
alpha O 0 0.00014886715507600456
- O 0 4.991372043150477e-05
subunit O 0 1.886323661892675e-05
transfections O 0 0.00021118084259796888
, O 0 4.3130048652528785e-06
although O 0 3.1744900752528338e-06
higher O 0 1.4715977158630267e-05
than O 0 4.547548996924888e-06
in O 0 1.0746006410045084e-05
those O 0 1.8683025700738654e-05
cells O 0 2.6319612516090274e-05
transfected O 0 0.0002716374583542347
with O 0 6.351500815071631e-06
an O 0 9.02503052202519e-06
alpha O 0 0.00013837371079716831
- O 0 5.4212025133892894e-05
subunit O 0 2.41585530602606e-05
associated O 0 1.8600321709527634e-05
with O 0 5.534449883271009e-05
infantile O 1 0.9999186992645264
TSD B-Disease 1 0.9999994039535522
. O 0 0.0033769283909350634

Furthermore O 0 0.0006787306629121304
, O 0 5.558272096095607e-05
the O 0 5.052363849245012e-05
precursor O 0 0.0003951255639549345
level O 0 0.00015275886107701808
of O 0 5.7432269386481494e-05
the O 0 7.504704990424216e-05
W474C O 0 0.0008351221331395209
alpha O 0 0.00021655685850419104
- O 0 5.245256397756748e-05
subunit O 0 1.381506081088446e-05
was O 0 4.252108919899911e-05
found O 0 2.47509024120518e-06
to O 0 9.889632565318607e-06
accumulate O 0 5.736396269639954e-05
in O 0 1.127703671954805e-05
comparison O 0 1.1050065950257704e-05
to O 0 9.621227945899591e-06
the O 0 2.7736752599594183e-05
normal O 0 4.2320196371292695e-05
alpha O 0 0.00010797075810842216
- O 0 5.314324516803026e-05
subunit O 0 2.510614285711199e-05
precursor O 0 0.0003834549570456147
levels O 0 0.0003375991072971374
. O 0 0.0001179689061245881

We O 0 0.0002501893904991448
conclude O 0 0.0003400660352781415
that O 0 2.1561423636740074e-05
the O 0 8.123669249471277e-05
1422 O 1 0.6385722160339355
G O 0 0.01548400241881609
- O 0 0.0018190555274486542
- O 0 0.00042629416566342115
> O 0 0.00016536065959371626
C O 0 0.0002815483312588185
mutation O 0 9.217262231686618e-06
is O 0 4.180400082987035e-06
the O 0 1.0423358617117628e-05
cause O 0 5.0706672482192516e-05
of O 0 0.0001543064136058092
Hex B-Disease 0 0.2283325344324112
A I-Disease 1 0.998893678188324
enzyme I-Disease 1 0.9999336004257202
deficiency I-Disease 1 1.0
in O 0 0.0007880056509748101
the O 0 0.0005085308803245425
proband O 0 0.08528970927000046
. O 0 0.0002894019416999072

The O 0 0.0007927544065751135
resulting O 0 0.0006320640095509589
W474C O 0 0.0014862945536151528
substitution O 0 0.0002585284528322518
clearly O 0 0.00017602814477868378
interferes O 0 0.00010157693031942472
with O 0 9.03527961781947e-06
alpha O 0 0.00011520790576469153
- O 0 3.979288521804847e-05
subunit O 0 1.154487927124137e-05
processing O 0 2.1558669686783105e-05
, O 0 4.456024726096075e-06
but O 0 2.1779742382932454e-06
because O 0 4.068130238010781e-06
the O 0 1.8219945559394546e-05
base O 0 4.72709143650718e-05
substitution O 0 6.824691809015349e-05
falls O 0 0.00045952771324664354
at O 0 6.573683640453964e-05
the O 0 1.5366822481155396e-05
first O 0 1.625875120225828e-05
position O 0 2.117215990438126e-05
of O 0 5.719364344258793e-05
exon O 0 0.0004124385886825621
13 O 0 0.0001435301819583401
, O 0 1.923545823956374e-05
aberrant O 0 0.0001245839666808024
splicing O 0 0.0001217612370965071
may O 0 7.314461254281923e-05
also O 0 1.0793703040690161e-05
contribute O 0 4.6096742153167725e-05
to O 0 7.8044984547887e-05
Hex B-Disease 0 0.007108640857040882
A I-Disease 1 0.7186939120292664
deficiency I-Disease 1 0.9999984502792358
in O 0 0.00038622450665570796
this O 0 0.000128685831441544
proband O 0 0.01284817699342966
. O 0 0.00014723354252055287
. O 0 0.0002073482028208673

Two O 0 0.00010472296708030626
frequent O 0 0.00014446854765992612
missense O 0 0.0013870905386283994
mutations O 0 0.0008300762274302542
in O 0 0.014912707731127739
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.09331939369440079

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.006040535401552916
an O 1 0.5607646107673645
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9997938275337219
early O 1 0.9999997615814209
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9998142123222351

A O 0 0.0011618277058005333
century O 0 0.0004883726360276341
after O 0 5.118804256198928e-05
its O 0 7.592358997499105e-06
recognition O 0 4.146315040998161e-05
as O 0 9.31946124183014e-05
a O 0 0.0003670791629701853
syndrome O 1 0.9999997615814209
by O 0 0.000115477159852162
Vaughan O 0 0.002299020765349269
Pendred O 1 0.9825464487075806
, O 0 3.0450322810793296e-05
the O 0 9.847552428254858e-05
disease O 1 0.9999901056289673
gene O 0 9.81483535724692e-05
( O 0 0.00012227364641148597
PDS O 1 0.9967362284660339
) O 0 5.108544064569287e-05
was O 0 0.00021082856983412057
mapped O 0 0.00017960707191377878
to O 0 0.00011525779700605199
chromosome O 0 0.0017285163048654795
7q22 O 0 0.012550437822937965
- O 0 0.004822400398552418
q31 O 0 0.005937204230576754
. O 0 0.0003706437419168651

1 O 0 0.0016510920831933618
and O 0 0.00011180597357451916
, O 0 3.2224586902884766e-05
recently O 0 7.425389776472002e-05
, O 0 5.322061952028889e-06
found O 0 3.1184117688098922e-06
to O 0 5.877447620150633e-06
encode O 0 3.544984065229073e-05
a O 0 0.000126035520224832
putative O 0 0.0016926617827266455
sulfate O 0 0.011707059107720852
transporter O 1 0.7362816333770752
. O 0 0.001381370471790433

We O 0 0.00015739513037260622
performed O 0 0.00010888693941524252
mutation O 0 1.0384009328845423e-05
analysis O 0 3.852507688861806e-06
of O 0 3.1277581001631916e-05
the O 0 0.0001764864573488012
PDS B-Disease 1 0.9990187883377075
gene O 0 0.00014597066910937428
in O 0 8.774247544351965e-05
patients O 0 7.941896910779178e-05
from O 0 8.775753667578101e-05
14 O 0 0.00036216064472682774
Pendred B-Disease 0 0.002531708450987935
families O 0 2.018478699028492e-05
originating O 0 2.5180906959576532e-05
from O 0 2.1700958313886076e-05
seven O 0 1.9814611732726917e-05
countries O 0 3.6832366276939865e-06
and O 0 5.781615982414223e-06
identified O 0 3.323691271361895e-05
all O 0 2.7061119908466935e-05
mutations O 0 0.00016524213424418122
. O 0 0.0003250603040214628

The O 0 0.000507872726302594
mutations O 0 0.00016125278489198536
include O 0 6.680756632704288e-05
three O 0 4.750309744849801e-05
single O 0 4.507269477471709e-05
base O 0 0.00010472616122569889
deletions O 0 0.00014743668725714087
, O 0 1.6515319657628424e-05
one O 0 1.2853042790084146e-05
splice O 0 0.0003495550772640854
site O 0 0.00035670920624397695
mutation O 0 4.345234265201725e-05
and O 0 3.639247370301746e-05
10 O 0 0.00028794410172849894
missense O 0 0.0016125161200761795
mutations O 0 0.0008013983606360853
. O 0 0.0006583976792171597

One O 0 0.0002907848102040589
missense O 0 0.0007252776995301247
mutation O 0 7.237101817736402e-05
( O 0 8.515254012309015e-05
L236P O 0 0.0008649236988276243
) O 0 2.3742864868836477e-05
was O 0 8.10499768704176e-05
found O 0 1.0007200216932688e-05
in O 0 1.3102181583235506e-05
a O 0 1.878600232885219e-05
homozygous O 0 3.476976780802943e-05
state O 0 1.5992587577784434e-05
in O 0 3.0000896003912203e-05
two O 0 2.6117286324733868e-05
consanguineous O 0 0.0007923824596218765
families O 0 2.503923860786017e-05
and O 0 2.0065392163814977e-05
in O 0 2.0116547602810897e-05
a O 0 3.442551678745076e-05
heterozygous O 0 1.3192820006224792e-05
state O 0 7.646434823982418e-06
in O 0 9.905944352794904e-06
five O 0 1.546222483739257e-05
additional O 0 3.979364555561915e-05
non O 0 0.0009553131530992687
- O 0 0.0015056931879371405
consanguineous O 0 0.004815386608242989
families O 0 0.00019086411339230835
. O 0 0.00019880195031873882

Another O 0 0.0015876875258982182
missense O 0 0.003233598778024316
mutation O 0 0.0002780466165859252
( O 0 0.0001787668006727472
T416P O 0 0.0015133547130972147
) O 0 5.292143760016188e-05
was O 0 0.00015910719230305403
found O 0 1.0713935807871167e-05
in O 0 1.7108535757870413e-05
a O 0 2.3484346456825733e-05
homozygous O 0 3.710795863298699e-05
state O 0 1.7935137293534353e-05
in O 0 2.2494328732136637e-05
one O 0 2.354924799874425e-05
family O 0 2.1002315406803973e-05
and O 0 8.441028512606863e-06
in O 0 2.7410875190980732e-05
a O 0 3.909350562025793e-05
heterozygous O 0 1.2653849807975348e-05
state O 0 1.0247502359561622e-05
in O 0 1.0016902706411202e-05
four O 0 2.1311125237843953e-05
families O 0 3.259665390942246e-05
. O 0 0.00013306135952007025

Pendred B-Disease 1 0.9976323843002319
patients O 0 0.0006581803900189698
in O 0 0.00023272009275387973
three O 0 0.00013463078357744962
non O 0 0.0008360444917343557
- O 0 0.0006211432046256959
consanguineous O 0 0.0004042555810883641
families O 0 6.731327630404849e-06
were O 0 1.4183569874148816e-05
shown O 0 1.242976122739492e-05
to O 0 1.2567669728014152e-05
be O 0 1.4762557839276269e-05
compound O 0 0.00010399809980299324
heterozygotes O 0 0.00030552828684449196
for O 0 8.929269097279757e-05
L236P O 0 0.0029646423645317554
and O 0 0.00019092945149168372
T416P O 0 0.005617345683276653
. O 0 0.0004537125932984054

In O 0 0.00021270696015562862
total O 0 0.00012307471479289234
, O 0 2.7802563636214472e-05
one O 0 1.3576985111285467e-05
or O 0 9.80813547357684e-06
both O 0 8.072051969065797e-06
of O 0 3.925294367945753e-05
these O 0 1.5205447198241018e-05
mutations O 0 4.046980393468402e-05
were O 0 3.7393885577330366e-05
found O 0 1.6571548258070834e-05
in O 0 8.696641089045443e-06
nine O 0 2.464576391503215e-05
of O 0 3.802448554779403e-05
the O 0 3.72903305105865e-05
14 O 0 0.00010513300367165357
families O 0 2.1811418264405802e-05
analyzed O 0 0.0001334698754362762
. O 0 0.0001243245496880263

The O 0 0.0001385487848892808
identification O 0 3.663555617094971e-05
of O 0 0.00010377520811744034
two O 0 5.258959936327301e-05
frequent O 0 0.00017646154446993023
PDS B-Disease 1 0.999530553817749
mutations O 0 5.424279152066447e-05
will O 0 9.489082003710791e-06
facilitate O 0 1.7900054444908164e-05
the O 0 1.7359798221150413e-05
molecular O 0 0.00010155649215448648
diagnosis O 0 0.23707126080989838
of O 1 0.9999768733978271
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9945344924926758

Insertional O 0 0.022754300385713577
mutation O 0 0.00017096209921874106
by O 0 5.6129967560991645e-05
transposable O 0 0.0016402510227635503
element O 0 0.0006076636491343379
, O 0 0.00011853701289510354
L1 O 0 0.00885351188480854
, O 0 2.3087035515345633e-05
in O 0 1.8429263946018182e-05
the O 0 6.0749633121304214e-05
DMD B-Disease 1 0.9999855756759644
gene O 0 3.906108031515032e-05
results O 0 1.5783585695317015e-05
in O 0 5.96271020185668e-05
X B-Disease 1 0.9707569479942322
- I-Disease 1 0.9983398914337158
linked I-Disease 1 0.9994361996650696
dilated I-Disease 1 0.9999713897705078
cardiomyopathy I-Disease 1 1.0
. O 0 0.006460332777351141

X B-Disease 1 0.9994446635246277
- I-Disease 1 0.99969482421875
linked I-Disease 1 0.999550998210907
dilated I-Disease 1 0.9999970197677612
cardiomyopathy I-Disease 1 1.0
( O 1 0.9221052527427673
XLDCM B-Disease 1 0.9999997615814209
) O 0 3.85159655706957e-05
is O 0 1.1790646567533258e-05
a O 0 1.142466499004513e-05
clinical O 0 4.128914588363841e-05
phenotype O 0 4.120740413782187e-05
of O 0 0.00019231365877203643
dystrophinopathy B-Disease 1 0.9985482096672058
which O 0 5.656369830830954e-05
is O 0 2.073547693726141e-05
characterized O 0 5.690287071047351e-05
by O 0 3.142318018944934e-05
preferential O 0 0.0014317468740046024
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.9997208714485168
without O 0 0.00022645984427072108
any O 0 6.958650919841602e-05
overt O 0 0.001803157851099968
clinical O 1 0.9075242877006531
signs O 1 0.9999361038208008
of O 1 0.9999994039535522
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9999501705169678

To O 0 0.0001159708626801148
date O 0 0.00011434416228439659
, O 0 7.72331259213388e-06
several O 0 5.826728283864213e-06
mutations O 0 2.435445821902249e-05
in O 0 5.7142508012475446e-05
the O 1 0.8711315393447876
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9998311996459961
, O 0 0.009272361174225807
DMD O 1 1.0
, O 0 5.5672473536105826e-05
have O 0 5.976508873573039e-06
been O 0 1.182783398689935e-05
identified O 0 1.7103791833505966e-05
in O 0 2.9120852559572086e-05
patients O 0 5.590880391537212e-05
with O 0 6.00923303863965e-05
XLDCM B-Disease 1 0.9999997615814209
, O 0 5.232257171883248e-05
but O 0 6.844989457022166e-06
a O 0 1.0702508916438092e-05
pathogenic O 0 1.0462396858201828e-05
correlation O 0 7.706787982897367e-06
of O 0 1.5988942323019728e-05
these O 0 1.0317123269487638e-05
cardiospecific O 0 0.00644694734364748
mutations O 0 0.00015328824520111084
in O 0 0.00023028507712297142
DMD O 1 0.9999985694885254
with O 0 9.930620581144467e-05
the O 0 0.0005376554909162223
XLDCM B-Disease 1 0.9999555349349976
phenotype O 0 0.00022467758390121162
has O 0 3.080258466070518e-05
remained O 0 0.0002697387826628983
to O 0 3.5395383747527376e-05
be O 0 0.00010427933011669666
elucidated O 0 0.0065750423818826675
. O 0 0.0005558038246817887

We O 0 0.0002089868939947337
report O 0 2.6579262339510024e-05
here O 0 1.4760037629457656e-05
the O 0 7.21466267350479e-06
identification O 0 4.207281108392635e-06
of O 0 2.787830999295693e-05
a O 0 4.972093665855937e-05
unique O 0 7.479500345652923e-05
de O 0 0.0008629505755379796
novo O 0 0.0008115966920740902
L1 O 0 0.0035562498960644007
insertion O 0 0.00024033925728872418
in O 0 6.936258432688192e-05
the O 0 0.00013770110672339797
muscle O 0 0.0006918733706697822
exon O 0 0.0013056861935183406
1 O 0 0.0009207429829984903
in O 0 0.0003222210507374257
DMD O 1 0.9999938011169434
in O 0 0.000258622138062492
three O 0 0.00021448201732710004
XLDCM B-Disease 1 0.9999040365219116
patients O 0 0.0001773843396222219
from O 0 6.612058496102691e-05
two O 0 4.32392189395614e-05
unrelated O 0 0.0003456776903476566
Japanese O 0 0.0013052374124526978
families O 0 0.00011260060273343697
. O 0 0.00020101603877265006

The O 0 0.0004784347547683865
insertion O 0 0.000828857475426048
was O 0 0.000748992373701185
a O 0 8.590344077674672e-05
5 O 0 0.00015738207730464637
- O 0 5.235471689957194e-05
truncated O 0 4.7817156882956624e-05
form O 0 1.1974355402344372e-05
of O 0 6.641431536991149e-05
human O 0 7.049916166579351e-05
L1 O 0 0.005495178978890181
inversely O 0 0.00045421806862577796
integrated O 0 0.00011170398647664115
in O 0 2.0271419998607598e-05
the O 0 2.769848106254358e-05
5 O 0 9.071290696738288e-05
- O 0 0.00014431709132622927
untranslated O 0 0.0006525685894303024
region O 0 0.00010332770034437999
in O 0 2.5372493837494403e-05
the O 0 4.7760189772816375e-05
muscle O 0 0.00024007981119211763
exon O 0 0.00034336678800173104
1 O 0 0.00013836630387231708
, O 0 7.261178325279616e-06
which O 0 2.583897412478109e-06
affected O 0 5.492761829373194e-06
the O 0 1.2004196833004244e-05
transcription O 0 9.02487154235132e-05
or O 0 1.8597645976115018e-05
the O 0 2.8830547307734378e-05
stability O 0 0.0002525702875573188
of O 0 0.00010740178549895063
the O 0 0.0001927494740812108
muscle O 0 0.000683582155033946
form O 0 6.074325574445538e-05
of O 0 0.0003117018786724657
dystrophin O 0 0.002889215247705579
transcripts O 0 0.0004920064238831401
but O 0 6.69589599056053e-06
not O 0 1.2282293937460054e-06
that O 0 9.323974836661364e-07
of O 0 2.237165972474031e-05
the O 0 0.0004801088653039187
brain O 1 0.9999969005584717
or O 0 0.005602027289569378
Purkinje O 1 0.9999852180480957
cell O 0 0.0033605683129280806
form O 0 7.944010576466098e-05
, O 0 2.6408966732560657e-05
probably O 0 4.133042966714129e-05
due O 0 3.905475023202598e-05
to O 0 1.2702199455816299e-05
its O 0 7.780518899380695e-06
unique O 0 1.2183005310362205e-05
site O 0 9.988583042286336e-05
of O 0 0.00011200327571714297
integration O 0 0.0008019040105864406
. O 0 0.0003916413406841457

We O 0 0.00023593910736963153
speculate O 0 8.905289723770693e-05
that O 0 3.635854000094696e-06
this O 0 2.70354530584882e-06
insertion O 0 3.1056861189426854e-05
of O 0 4.7857396566541865e-05
an O 0 4.091138907824643e-05
L1 O 0 0.00376400095410645
sequence O 0 8.583015733165666e-05
in O 0 0.0001487703702878207
DMD O 1 0.9999948740005493
is O 0 2.259533721371554e-05
responsible O 0 1.2133228665334173e-05
for O 0 2.843045649569831e-06
some O 0 2.577247641966096e-06
of O 0 1.0505990758247208e-05
the O 0 1.5983590856194496e-05
population O 0 3.940899659937713e-06
of O 0 3.5218217817600816e-05
Japanese O 0 0.0011457562213763595
patients O 0 0.00013725983444601297
with O 0 7.863553037168458e-05
XLDCM B-Disease 1 0.9999978542327881
. O 0 0.00022546705440618098
. O 0 0.000235887840972282

Severe O 1 0.9998024106025696
early O 1 0.8810225129127502
- O 1 0.999984860420227
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999860525131226
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999995231628418
red O 1 0.9999996423721313
hair O 1 0.9997147917747498
pigmentation O 1 0.9999376535415649
caused O 1 0.999976396560669
by O 0 0.001012561027891934
POMC O 1 0.9999971389770508
mutations O 0 0.001009188825264573
in O 0 0.0005427250289358199
humans O 0 0.001237883698195219
. O 0 0.000423381949076429

Sequential O 0 0.0007899055490270257
cleavage O 0 0.0011343376245349646
of O 0 0.00025450438261032104
the O 0 0.00021750708401668817
precursor O 0 0.0010926389368250966
protein O 0 0.00013915705494582653
pre O 0 0.001023874618113041
- O 0 0.0005851552123203874
pro O 0 0.0014566935133188963
- O 0 0.00045514749945141375
opiomelanocortin O 0 0.0018094064434990287
( O 0 0.00017740868497639894
POMC O 0 0.00749534135684371
) O 0 2.727075661823619e-05
generates O 0 3.1113013392314315e-05
the O 0 5.363439777283929e-05
melanocortin O 0 0.0042555443942546844
peptides O 0 0.00040827252087183297
adrenocorticotrophin O 0 0.006351975724101067
( O 0 0.00026376391178928316
ACTH O 0 0.0034907914232462645
) O 0 7.237101817736402e-05
, O 0 6.814819789724424e-05
melanocyte O 0 0.05384381115436554
- O 0 0.005585245322436094
stimulating O 0 0.0027387100271880627
hormones O 0 0.0006236970075406134
( O 0 8.74132601893507e-05
MSH O 0 0.011013840325176716
) O 0 2.2318259652820416e-05
alpha O 0 8.394159522140399e-05
, O 0 5.570752364292275e-06
beta O 0 4.536021879175678e-05
and O 0 1.1854043805215042e-05
gamma O 0 5.953710206085816e-05
as O 0 1.3030321497353725e-05
well O 0 7.055296464386629e-06
as O 0 1.0365744856244419e-05
the O 0 2.0842155208811164e-05
opioid O 0 0.0004681640421040356
- O 0 0.00036345075932331383
receptor O 0 0.00011571348295547068
ligand O 0 0.0005607657949440181
beta O 0 0.0013559043873101473
- O 0 0.0013873931020498276
endorphin O 0 0.0036807989235967398
. O 0 0.0001703234447631985

While O 0 0.00023663323372602463
a O 0 5.3340860176831484e-05
few O 0 1.8773685951600783e-05
cases O 0 1.2031016012770124e-05
of O 0 0.0002629739174153656
isolated O 1 0.9999542236328125
ACTH B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
have O 0 5.8563280617818236e-05
been O 0 4.6687080612173304e-05
reported O 0 5.000757300877012e-05
( O 0 7.736963016213849e-05
OMIM O 0 0.29209238290786743
201400 O 0 0.0020282333716750145
) O 0 2.1660722268279642e-05
, O 0 1.4539263247570489e-05
an O 0 6.023852256475948e-05
inherited O 1 1.0
POMC O 1 1.0
defect O 1 0.9999977350234985
has O 0 9.197116742143407e-05
not O 0 1.108644028136041e-05
been O 0 1.7353970179101452e-05
described O 0 4.608447852660902e-05
so O 0 1.8627873942023143e-05
far O 0 7.067336264299229e-05
. O 0 9.14415722945705e-05

Recent O 0 0.0005515865050256252
studies O 0 0.00010170642781304196
in O 0 7.877498137531802e-05
animal O 0 6.441536243073642e-05
models O 0 2.1426671082735993e-05
elucidated O 0 0.0005493597709573805
a O 0 5.169172800378874e-05
central O 0 7.290993380593136e-05
role O 0 4.490794526645914e-05
of O 0 0.00015807707677595317
alpha O 0 0.0031559814233332872
- O 0 0.0018502884777262807
MSH O 0 0.05897407978773117
in O 0 2.066405795630999e-05
the O 0 1.9786741177085787e-05
regulation O 0 3.3864871511468664e-05
of O 0 4.733465539175086e-05
food O 0 3.441895023570396e-05
intake O 0 2.7889876946574077e-05
by O 0 2.534582790758577e-06
activation O 0 2.2316111426334828e-05
of O 0 0.00010145157284568995
the O 0 0.0005155990947969258
brain O 0 0.12314043939113617
melanocortin O 0 0.23288802802562714
- O 0 0.00060157390544191
4 O 0 0.00014561839634552598
- O 0 0.0001645691372686997
receptor O 0 6.414571544155478e-05
( O 0 5.525674350792542e-05
MC4 O 0 0.009989812038838863
- O 0 0.00027270629652775824
R O 0 0.00023608583433087915
; O 0 8.326363968080841e-06
refs O 0 0.00014905819261912256
3 O 0 0.00010032751015387475
- O 0 8.174904360203072e-05
5 O 0 3.0231978598749265e-05
) O 0 4.409094799484592e-06
and O 0 1.6108804175019031e-06
the O 0 1.2749274901580065e-05
linkage O 0 0.0001668064942350611
of O 0 0.00018528719374444336
human O 0 0.0008977767429314554
obesity B-Disease 1 0.999998927116394
to O 0 0.00010919378109974787
chromosome O 0 0.00016755939577706158
2 O 0 9.717728971736506e-05
in O 0 2.0799685444217175e-05
close O 0 5.170721124159172e-05
proximity O 0 4.459325282368809e-05
to O 0 2.1834477593074553e-05
the O 0 8.661106403451413e-05
POMC O 0 0.03168128430843353
locus O 0 0.00032108218874782324
, O 0 1.2847503057855647e-05
led O 0 2.0694167687906884e-05
to O 0 5.944370059296489e-06
the O 0 1.1063182682846673e-05
proposal O 0 1.022460128297098e-05
of O 0 1.731191878207028e-05
an O 0 1.9267859897809103e-05
association O 0 5.6015109294094145e-05
of O 0 0.0004840600595343858
POMC O 1 0.999998927116394
with O 0 0.0005983351147733629
human O 1 0.8891932368278503
obesity B-Disease 1 1.0
. O 0 0.0009649943094700575

The O 0 0.00015358200471382588
dual O 0 0.00013268124894239008
role O 0 0.00019378142314963043
of O 0 0.0007473303121514618
alpha O 0 0.007873651571571827
- O 0 0.005885441321879625
MSH O 1 0.9953275918960571
in O 0 0.00011561300198081881
regulating O 0 0.0005212771357037127
food O 0 0.00013014209980610758
intake O 0 0.00021662622748408467
and O 0 4.603296110872179e-05
influencing O 0 0.0011480646207928658
hair O 0 0.0013659402029588819
pigmentation O 0 0.0034551257267594337
predicts O 0 0.00017728963575791568
that O 0 4.777316007675836e-06
the O 0 1.5229421478579752e-05
phenotype O 0 4.9977163143921643e-05
associated O 0 2.303267683601007e-05
with O 0 1.5948373402352445e-05
a O 0 0.00018674996681511402
defect O 1 0.9791975021362305
in O 0 0.0004660366103053093
POMC O 1 0.9999548196792603
function O 0 0.00014196975098457187
would O 0 5.3564170229947194e-05
include O 0 0.00015328999143093824
obesity B-Disease 1 1.0
, O 0 0.00015952008834574372
alteration O 0 0.2885207533836365
in O 0 0.0028971927240490913
pigmentation O 1 0.9999932050704956
and O 1 0.9989370703697205
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.051883965730667114

The O 0 0.00029460329096764326
observation O 0 0.0004859436012338847
of O 0 0.00036055289092473686
these O 0 7.678691326873377e-05
symptoms O 0 0.01806548424065113
in O 0 0.00015967559011187404
two O 0 5.027141742175445e-05
probands O 0 0.002522881841287017
prompted O 0 0.00013274946832098067
us O 0 2.187345307902433e-05
to O 0 8.093558790278621e-06
search O 0 1.5198083929135464e-05
for O 0 9.475817023485433e-06
mutations O 0 4.960736623615958e-05
within O 0 7.600463868584484e-05
their O 0 0.00018248679407406598
POMC O 1 0.9984377026557922
genes O 0 0.0006004247115924954
. O 0 0.0004027950344607234

Patient O 0 0.0010544343385845423
1 O 0 0.0005227428046055138
was O 0 0.00028329098131507635
found O 0 8.637105565867387e-06
to O 0 6.719872089888668e-06
be O 0 6.703614417347126e-06
a O 0 1.9148810679325834e-05
compound O 0 6.763041892554611e-05
heterozygote O 0 9.914998372551054e-05
for O 0 1.6787844288046472e-05
two O 0 1.312481708737323e-05
mutations O 0 2.165138539567124e-05
in O 0 5.6450535339536145e-05
exon O 0 0.0005256794975139201
3 O 0 0.00020341164781711996
( O 0 6.959792517591268e-05
G7013T O 0 0.0006474232068285346
, O 0 2.7635762307909317e-05
C7133delta O 0 0.0009052252862602472
) O 0 9.715201485960279e-06
which O 0 2.8620938792300876e-06
interfere O 0 1.2737972610921133e-05
with O 0 2.8446459054976003e-06
appropriate O 0 1.5180729860730935e-05
synthesis O 0 9.857238183030859e-05
of O 0 0.0006403062725439668
ACTH O 0 0.027433160692453384
and O 0 0.00023609866912011057
alpha O 0 0.002411352703347802
- O 0 0.0039492445066571236
MSH O 1 0.8746949434280396
. O 0 0.00041579807293601334

Patient O 0 0.0016640027752146125
2 O 0 0.0007426306256093085
was O 0 0.000378123892005533
homozygous O 0 5.646076533594169e-05
for O 0 1.4418209502764512e-05
a O 0 2.57408701145323e-05
mutation O 0 2.0304505596868694e-05
in O 0 4.928888301947154e-05
exon O 0 0.00034814776154235005
2 O 0 0.000190718041267246
( O 0 4.407400410855189e-05
C3804A O 0 0.0005085371667519212
) O 0 2.5047742383321747e-05
which O 0 3.245818516006693e-05
abolishes O 0 0.0022914623841643333
POMC O 1 0.9955554604530334
translation O 0 0.0012356196530163288
. O 0 0.0005625410121865571

These O 0 7.532494782935828e-05
findings O 0 2.7280408176011406e-05
represent O 0 1.891818283183966e-05
the O 0 2.8307895263424143e-05
first O 0 2.9572231142083183e-05
examples O 0 3.0278983103926294e-05
of O 0 5.22458904015366e-05
a O 0 0.00047083807294256985
genetic B-Disease 1 0.9999953508377075
defect I-Disease 1 0.9999996423721313
within O 0 0.00022969915880821645
the O 0 0.00022258286480791867
POMC O 1 0.998675525188446
gene O 0 4.086744229425676e-05
and O 0 5.617229817289626e-06
define O 0 3.788737012655474e-05
a O 0 6.389625195879489e-05
new O 0 0.00022834833362139761
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 1 0.9995187520980835
in O 0 0.0010444704676046968
early O 1 0.9786498546600342
- O 1 0.9999711513519287
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.999953031539917
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999990463256836
red O 1 0.9999991655349731
hair O 1 0.9973394274711609
pigmentation O 1 0.997348427772522
. O 0 0.0004668160108849406
. O 0 0.0004517933411989361

A O 0 0.0016750514041632414
European O 0 0.00010134773037862033
multicenter O 0 0.00087857706239447
study O 0 6.573508289875463e-05
of O 0 0.0006520359311252832
phenylalanine B-Disease 1 0.9999990463256836
hydroxylase I-Disease 1 0.9999986886978149
deficiency I-Disease 1 1.0
: O 0 0.00019896998128388077
classification O 0 9.995298751164228e-05
of O 0 9.153893915936351e-05
105 O 0 0.00025314069353044033
mutations O 0 3.7535512092290446e-05
and O 0 1.180826893687481e-05
a O 0 1.2877016160928179e-05
general O 0 2.7244241209700704e-05
system O 0 2.524712726881262e-05
for O 0 1.0823141565197147e-05
genotype O 0 0.00015027166227810085
- O 0 0.00012587686069309711
based O 0 8.55998405313585e-06
prediction O 0 0.00012474943650886416
of O 0 0.0003459186991676688
metabolic O 1 0.9999258518218994
phenotype O 0 0.004894621670246124
. O 0 0.0013728910125792027

Phenylketonuria B-Disease 1 0.9999485015869141
( O 0 0.007723707240074873
PKU B-Disease 1 0.9999881982803345
) O 0 0.0003479412116575986
and O 0 7.88397592259571e-05
mild B-Disease 1 0.9849851131439209
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9985211491584778
MHP B-Disease 1 1.0
) O 0 6.693491013720632e-05
are O 0 1.3694944755116012e-05
allelic B-Disease 1 0.7485323548316956
disorders I-Disease 1 1.0
caused O 1 0.9999837875366211
by O 0 6.41921506030485e-05
mutations O 0 2.8537093385239132e-05
in O 0 1.3795023733109701e-05
the O 0 2.439036688883789e-05
gene O 0 1.3421497897070367e-05
encoding O 0 3.6685200029751286e-05
phenylalanine O 0 0.0007789651281200349
hydroxylase O 0 0.005471468903124332
( O 0 0.0022935299202799797
PAH O 1 1.0
) O 0 0.0006367674795910716
. O 0 0.0003785217122640461

Previous O 0 0.00026693279505707324
studies O 0 5.1687191444216296e-05
have O 0 5.01331942359684e-06
suggested O 0 1.2136978511989582e-05
that O 0 1.6739519423936144e-06
the O 0 5.155080089025432e-06
highly O 0 4.281290966900997e-05
variable O 0 4.329888542997651e-05
metabolic O 1 0.9854009747505188
phenotypes O 0 0.07279524952173233
of O 1 0.9999974966049194
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.999396562576294
with O 1 0.9791375398635864
PAH O 1 1.0
genotypes O 1 0.9981586337089539
. O 0 0.0012603133218362927

We O 0 0.00025348461349494755
identified O 0 5.6591325119370595e-05
both O 0 2.7373334887670353e-05
causative O 0 0.0009840581333264709
mutations O 0 0.00016034264990594238
in O 0 0.00023394703748635948
686 O 0 0.008990737609565258
patients O 0 0.00018225204257760197
from O 0 6.631862197536975e-05
seven O 0 0.00012721907114610076
European O 0 0.00011690339306369424
centers O 0 0.0003944996278733015
. O 0 0.00023088284069672227

On O 0 0.00020932671031914651
the O 0 2.0578570911311544e-05
basis O 0 1.6887495803530328e-05
of O 0 4.118563811061904e-05
the O 0 3.6551453376887366e-05
phenotypic O 0 0.00018336798530071974
characteristics O 0 0.00015666444960515946
of O 0 0.00035140241379849613
297 O 0 0.004565487150102854
functionally O 1 0.535161554813385
hemizygous O 1 0.9881828427314758
patients O 0 0.0001507957058493048
, O 0 1.7405516700819135e-05
105 O 0 5.0803082558559254e-05
of O 0 4.1250499634770676e-05
the O 0 3.468730574240908e-05
mutations O 0 2.0457233404158615e-05
were O 0 1.8658078261069022e-05
assigned O 0 2.0374294763314538e-05
to O 0 1.0456800737301819e-05
one O 0 6.4935884438455105e-06
of O 0 2.19105277210474e-05
four O 0 2.894807403208688e-05
arbitrary O 0 6.835178646724671e-05
phenotype O 0 0.0002564410388004035
categories O 0 0.0006022265879437327
. O 0 0.0003305826394353062

We O 0 0.00021354478667490184
proposed O 0 6.703814142383635e-05
and O 0 2.4743896574364044e-05
tested O 0 3.264381302869879e-05
a O 0 1.3373522051551845e-05
simple O 0 6.738860975019634e-06
model O 0 5.30215311300708e-06
for O 0 6.534377007483272e-06
correlation O 0 6.322732951957732e-05
between O 0 0.0002186679921578616
genotype O 0 0.00022884811914991587
and O 0 7.628732419107109e-05
phenotypic O 0 0.000580949941650033
outcome O 0 0.001128992298617959
. O 0 0.0007237090030685067

The O 0 0.00042126557673327625
observed O 0 0.0001954820763785392
phenotype O 0 0.00013264507288113236
matched O 0 9.296721691498533e-05
the O 0 4.644887303584255e-05
predicted O 0 0.00012027414049953222
phenotype O 0 3.1262046832125634e-05
in O 0 1.2384420188027434e-05
79 O 0 8.323742804350331e-05
% O 0 1.8722870663623326e-05
of O 0 4.380641985335387e-05
the O 0 8.077907841652632e-05
cases O 0 2.057431083812844e-05
, O 0 1.4546279999194667e-05
and O 0 5.830429927300429e-06
in O 0 1.1499718311824836e-05
only O 0 9.24462074181065e-06
5 O 0 3.23894782923162e-05
of O 0 3.840091812890023e-05
184 O 0 0.00022742251167073846
patients O 0 7.773296238156036e-05
was O 0 0.00032464470132254064
the O 0 5.167777999304235e-05
observed O 0 3.453046520007774e-05
phenotype O 0 2.15581549127819e-05
more O 0 4.562653430184582e-06
than O 0 4.7750063458806835e-06
one O 0 7.2406483013764955e-06
category O 0 1.402233920089202e-05
away O 0 1.743763277772814e-05
from O 0 1.6481271813972853e-05
that O 0 1.0918622137978673e-05
expected O 0 0.00022376616834662855
. O 0 0.00018973568512592465

Among O 0 0.00031675471109338105
the O 0 8.92162715899758e-05
seven O 0 0.0001017672402667813
contributing O 0 0.00017603168089408427
centers O 0 7.888917025411502e-05
, O 0 9.633394256525207e-06
the O 0 1.8057933630188927e-05
proportion O 0 3.7932924897177145e-05
of O 0 5.6368877267232165e-05
patients O 0 5.648597652907483e-05
for O 0 2.0279579985071905e-05
whom O 0 7.165976421674713e-05
the O 0 4.109791188966483e-05
observed O 0 3.709875818458386e-05
phenotype O 0 2.7894930099137127e-05
did O 0 1.7305417713942006e-05
not O 0 3.452217470112373e-06
match O 0 2.384397157584317e-05
the O 0 2.625033084768802e-05
predicted O 0 9.445063915336505e-05
phenotype O 0 2.65394937741803e-05
was O 0 9.300569945480675e-05
4 O 0 6.10795323154889e-05
% O 0 1.7974534785025753e-05
- O 0 6.481730088125914e-05
23 O 0 4.6080393076408654e-05
% O 0 1.144563611887861e-05
( O 0 3.220286816940643e-05
P O 0 0.0012757908552885056
< O 0 0.0006877698469907045
. O 0 3.501720857457258e-05
0001 O 0 0.0019042522180825472
) O 0 1.693465128482785e-05
, O 0 8.176974915841129e-06
suggesting O 0 2.6849125788430683e-05
that O 0 4.669507688959129e-06
differences O 0 4.2643641791073605e-05
in O 0 1.8173632270190865e-05
methods O 0 7.897241630416829e-06
used O 0 1.2112730473745614e-05
for O 0 1.320158025919227e-05
mutation O 0 3.629860657383688e-05
detection O 0 0.00016886323282960802
or O 0 7.164561975514516e-05
phenotype O 0 8.173196692951024e-05
classification O 0 0.000142545293783769
may O 0 9.33739502215758e-05
account O 0 1.4891003047523554e-05
for O 0 4.62090247310698e-06
a O 0 1.6423718989244662e-05
considerable O 0 7.181922410381958e-05
proportion O 0 5.973842417006381e-05
of O 0 0.0001639898691792041
genotype O 0 0.0015304667176678777
- O 0 0.006462782621383667
phenotype O 0 0.00042156141716986895
inconsistencies O 0 0.0022730790078639984
. O 0 0.0006996917654760182

Our O 0 0.00015821641136426479
data O 0 2.4145514544215985e-05
indicate O 0 3.604717130656354e-05
that O 0 1.3949090316600632e-05
the O 0 0.00032161097624339163
PAH O 1 1.0
- O 0 0.0018690188881009817
mutation O 0 1.5104841622815002e-05
genotype O 0 2.8246113288332708e-05
is O 0 4.3149757402716205e-06
the O 0 4.938854090141831e-06
main O 0 4.170954707660712e-05
determinant O 0 0.0002296034654136747
of O 0 0.0002894206845667213
metabolic O 1 0.9998705387115479
phenotype O 0 0.00025347809423692524
in O 0 0.00011035369243472815
most O 0 0.00011619523138506338
patients O 0 0.011481101624667645
with O 1 0.9987702965736389
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9966092109680176

In O 0 0.00022177069331519306
the O 0 5.314364898367785e-05
present O 0 4.870083284913562e-05
study O 0 1.2555018656712491e-05
, O 0 3.338080659887055e-06
the O 0 7.556487162219128e-06
classification O 0 5.97979269514326e-05
of O 0 0.0003547611995600164
105 O 1 0.868876576423645
PAH O 1 1.0
mutations O 0 0.0005346610560081899
may O 0 7.633405039086938e-05
allow O 0 7.360466952377465e-06
the O 0 1.4297374946181662e-05
prediction O 0 2.9158392862882465e-05
of O 0 1.7589702110853978e-05
the O 0 3.5594992368714884e-05
biochemical O 0 0.00021370244212448597
phenotype O 0 0.00010106650006491691
in O 0 7.460465712938458e-05
> O 0 0.0001795632269931957
10 O 0 4.9591944843996316e-05
, O 0 8.995001735456754e-06
000 O 0 7.515798642998561e-05
genotypes O 0 0.00010242616554023698
, O 0 9.190271157422103e-06
which O 0 6.2090275605442e-06
may O 0 1.9041715859202668e-05
be O 0 4.671235728892498e-06
useful O 0 3.4873091863119043e-06
for O 0 3.5003670291189337e-06
the O 0 2.9666063710465096e-05
management O 0 0.00011542673746589571
of O 0 0.0006288010627031326
hyperphenylalaninemia B-Disease 1 1.0
in O 0 0.002075203927233815
newborns O 0 0.004421712830662727
. O 0 0.000474616012070328

Somatic O 0 0.0039612650871276855
instability O 0 0.00860261358320713
of O 0 0.0008603330934420228
the O 0 0.0011037540389224887
CTG O 1 0.9997510313987732
repeat O 0 0.0010153391631320119
in O 0 0.00016620066890027374
mice O 0 0.0001723834138829261
transgenic O 0 0.00011365237151039764
for O 0 2.5307293981313705e-05
the O 0 0.0032202121801674366
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9961100220680237
is O 0 0.00011553685908438638
age O 0 0.00018293959146831185
dependent O 0 3.697756983456202e-05
but O 0 3.840559656964615e-06
not O 0 2.293310672030202e-06
correlated O 0 9.965486242435873e-06
to O 0 7.285643732757308e-06
the O 0 1.5840312698855996e-05
relative O 0 6.412772927433252e-05
intertissue O 0 0.0012699340004473925
transcription O 0 0.000595462101045996
levels O 0 0.0006322115659713745
and O 0 0.00016140261141117662
proliferative O 1 0.9999434947967529
capacities O 0 0.36555612087249756
. O 0 0.0010992796160280704

A O 0 0.0049538821913301945
( O 0 0.0007231605122797191
CTG O 0 0.22210073471069336
) O 0 7.91224156273529e-05
nexpansion O 0 0.0006827676552347839
in O 0 2.7186417355551384e-05
the O 0 3.1953732104739174e-05
3 O 0 0.00013206414587330073
- O 0 0.00013837871665600687
untranslated O 0 0.0014399182982742786
region O 0 0.0002614147961139679
( O 0 3.5801363992504776e-05
UTR O 0 0.001999704400077462
) O 0 8.634964615339413e-06
of O 0 2.1795491193188354e-05
the O 0 0.00012317651999183
DM O 1 0.9999964237213135
protein O 0 0.00021579298481810838
kinase O 0 0.00014847969578113407
gene O 0 6.001376095809974e-05
( O 0 5.2544884965755045e-05
DMPK O 0 0.007682738360017538
) O 0 1.4817368537478615e-05
is O 0 7.976588676683605e-06
responsible O 0 3.9111702790251e-05
for O 0 0.00011660470045171678
causing O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999958276748657
DM B-Disease 1 1.0
) O 0 0.0016791054513305426
. O 0 0.0005900834803469479

Major O 0 0.3718976676464081
instability O 1 0.6992943286895752
, O 0 4.9985028454102576e-05
with O 0 7.353899491135962e-06
very O 0 1.5719248040113598e-05
large O 0 2.8464466595323756e-05
expansions O 0 0.00025271097547374666
between O 0 0.00014387040573637933
generations O 0 0.00010034914157586172
and O 0 1.8963990441989154e-05
high O 0 0.00011939915566472337
levels O 0 6.953159027034417e-05
of O 0 7.72904313635081e-05
somatic O 0 0.0008376294281333685
mosaicism O 1 0.9797018766403198
, O 0 5.2653627790277824e-05
is O 0 2.3940625396789983e-05
observed O 0 6.035225305822678e-05
in O 0 8.833914034767076e-05
patients O 0 0.00023280644381884485
. O 0 0.00039652810664847493

There O 0 0.0003070815873797983
is O 0 4.260133209754713e-05
a O 0 3.2275824196403846e-05
good O 0 2.3553109713247977e-05
correlation O 0 2.8411152015905827e-05
between O 0 8.568737393943593e-05
repeat O 0 0.00018426112364977598
size O 0 3.592438588384539e-05
( O 0 8.421007805736735e-06
at O 0 3.3044980227714404e-05
least O 0 5.474264980875887e-06
in O 0 2.254542414448224e-05
leucocytes O 0 0.0006470302469097078
) O 0 1.4335029845824465e-05
, O 0 1.0453301001689397e-05
clinical O 0 7.459768676199019e-05
severity O 0 0.0007474336889572442
and O 0 8.468011947115883e-05
age O 0 0.0009087658836506307
of O 0 0.0035231185611337423
onset O 1 0.9999998807907104
. O 0 0.0033979055006057024

The O 0 0.0021205656230449677
trinucleotide O 1 0.9994339346885681
repeat O 0 0.0039612241089344025
instability O 0 0.2895921468734741
mechanisms O 0 0.000605850771535188
involved O 0 0.00015684829850215465
in O 0 0.00033369302400387824
DM B-Disease 1 1.0
and O 0 0.00010304727038601413
other O 0 4.931012517772615e-05
human O 1 0.7039479613304138
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 0.00013336124538909644
unknown O 0 0.000955376832280308
. O 0 0.0003423188754823059

We O 0 0.0003228831337764859
studied O 0 0.0005463675479404628
somatic O 0 0.0010257087415084243
instability O 0 0.0027989086229354143
by O 0 8.965633605839685e-05
measuring O 0 0.00231920275837183
the O 0 0.0005124918534420431
CTG O 1 0.8419303894042969
repeat O 0 0.0005433606565929949
length O 0 8.423040708294138e-05
at O 0 6.134774594102055e-05
several O 0 6.604394457099261e-06
ages O 0 3.964549978263676e-05
in O 0 1.5150386388995685e-05
various O 0 2.448732266202569e-05
tissues O 0 0.00023778984905220568
of O 0 0.000534638820681721
transgenic O 0 0.0031748611945658922
mice O 0 0.000146655977005139
carrying O 0 3.01820309687173e-05
a O 0 5.62649111088831e-05
( O 0 8.942571002990007e-05
CTG O 0 0.31221941113471985
) O 0 6.886196206323802e-05
55expansion O 0 0.0012168961111456156
surrounded O 0 0.00039451243355870247
by O 0 1.8732800526777282e-05
45 O 0 4.903188528260216e-05
kb O 0 0.0005419583758339286
of O 0 0.00016441357729490846
the O 0 0.0003824670275207609
human O 0 0.0007910059648565948
DM B-Disease 1 1.0
region O 0 0.0016846883809193969
, O 0 4.234110747347586e-05
using O 0 2.4127610231516883e-05
small O 0 9.07426729099825e-05
- O 0 0.0005940842092968524
pool O 0 0.0006998544558882713
PCR O 0 0.00043857304262928665
. O 0 0.00022224400890991092

These O 0 0.00018571030523162335
mice O 0 0.00014747859677299857
have O 0 5.431803401734214e-06
been O 0 9.947580110747367e-06
shown O 0 1.2730442904285155e-05
to O 0 1.622622221475467e-05
reproduce O 0 3.482551983324811e-05
the O 0 2.5731127607286908e-05
intergenerational O 0 0.00041178171522915363
and O 0 5.178251740289852e-05
somatic O 0 0.0005254140705801547
instability O 0 0.003908380400389433
of O 0 0.0006241262890398502
the O 0 0.0003086618962697685
55 O 0 0.000851588265504688
CTG O 1 0.8991186618804932
repeat O 0 0.000537497631739825
suggesting O 0 0.00011049025488318875
that O 0 7.304880455194507e-06
surrounding O 0 0.00010985487460857257
sequences O 0 2.178431168431416e-05
and O 0 1.5416540918522514e-05
the O 0 4.5174852857599035e-05
chromatin O 0 0.0003004908503498882
environment O 0 5.368931306293234e-05
are O 0 3.961300080845831e-06
involved O 0 4.6037173888180405e-05
in O 0 0.00018440982967149466
instability O 1 0.9986913800239563
mechanisms O 0 0.03129489719867706
. O 0 0.000605634821113199

As O 0 0.0004718463169410825
observed O 0 0.00011950646148761734
in O 0 2.2687772798235528e-05
some O 0 6.7363225753069855e-06
of O 0 4.277781044947915e-05
the O 0 0.00012603455979842693
tissues O 0 0.0006666699191555381
of O 1 0.6238265633583069
DM B-Disease 1 1.0
patients O 1 0.7057664394378662
, O 0 6.926647620275617e-05
there O 0 2.4753244360908866e-05
is O 0 1.4270348401623778e-05
a O 0 1.8789425666909665e-05
tendency O 0 5.105164382257499e-05
for O 0 2.544907147239428e-05
repeat O 0 0.00039851159090176225
length O 0 0.00011775064922403544
and O 0 3.332587584736757e-05
somatic O 0 0.00027756401686929166
mosaicism O 0 0.00563446618616581
to O 0 5.0316979468334466e-05
increase O 0 1.7355378076899797e-05
with O 0 4.187734248262132e-06
the O 0 4.761203672387637e-05
age O 0 0.00014706318324897438
of O 0 0.0001672888029133901
the O 0 0.0003750579780898988
mouse O 0 0.000575337850023061
. O 0 0.00013542830129154027

Furthermore O 0 0.0011782723013311625
, O 0 6.200376810738817e-05
we O 0 1.5483754395972937e-05
observed O 0 1.1505608199513517e-05
no O 0 4.918529612041311e-06
correlation O 0 9.265363587473985e-06
between O 0 5.6620043324073777e-05
the O 0 6.252317689359188e-05
somatic O 0 0.0002787653938867152
mutation O 0 6.245238910196349e-05
rate O 0 0.00010123028187081218
and O 0 0.00010049335105577484
tissue O 1 0.9609891772270203
proliferation O 1 0.999958872795105
capacity O 0 0.0443916879594326
. O 0 0.00025645544519647956

The O 0 0.0006335179787129164
somatic O 0 0.0013113117311149836
mutation O 0 0.000170721163158305
rates O 0 4.38202841905877e-05
in O 0 1.4192012713465374e-05
different O 0 2.99295629702101e-06
tissues O 0 4.581429675454274e-05
were O 0 1.7041757018887438e-05
also O 0 8.000602065294515e-06
not O 0 2.3408290417137323e-06
correlated O 0 1.2109658200643025e-05
to O 0 5.923295702814357e-06
the O 0 1.529888868390117e-05
relative O 0 0.00011727720993803814
inter O 0 0.20900370180606842
- O 0 0.0024658297188580036
tissue O 0 9.572778799338266e-05
difference O 0 4.1237715777242556e-05
in O 0 1.1200724657101091e-05
transcriptional O 0 7.436514715664089e-05
levels O 0 3.1636725907446817e-05
of O 0 1.1090373845945578e-05
the O 0 2.1731029846705496e-05
three O 0 1.6537383999093436e-05
genes O 0 3.4811240766430274e-05
( O 0 9.186624811263755e-05
DMAHP O 1 0.79547119140625
, O 0 0.0001418639294570312
DMPK O 1 0.5818262100219727
and O 0 5.2104682254139334e-05
59 O 0 0.00025701033882796764
) O 0 3.398759145056829e-05
surrounding O 0 0.00022765400353819132
the O 0 0.00011587955668801442
repeat O 0 0.0007986564887687564
. O 0 0.00011275231372565031
. O 0 0.00020066616707481444

A O 0 0.0018218400655314326
novel O 0 0.00041959231020882726
missense O 0 0.0008176967385224998
mutation O 0 5.895269714528695e-05
in O 0 3.914154876838438e-05
patients O 0 7.861431367928162e-05
from O 0 6.90267188474536e-05
a O 0 0.00020266961655579507
retinoblastoma B-Disease 1 0.8566904067993164
pedigree O 0 0.0009381875861436129
showing O 0 0.0003613254230003804
only O 0 4.944838292431086e-05
mild O 0 0.0001362675684504211
expression O 0 5.6536635383963585e-05
of O 0 0.00024339060473721474
the O 0 0.00220153178088367
tumor B-Disease 1 0.9999986886978149
phenotype O 0 0.000842446053866297
. O 0 0.000363929575541988

We O 0 0.00033781639649532735
have O 0 1.78908903762931e-05
used O 0 2.031800613622181e-05
single O 0 4.3558600737014785e-05
strand O 0 6.244988617254421e-05
conformation O 0 1.7295435100095347e-05
polymorphism O 0 1.0075842510559596e-05
analysis O 0 3.3531659937580116e-06
to O 0 5.137636890140129e-06
study O 0 4.56403722637333e-06
the O 0 9.175550076179206e-06
27 O 0 7.454144360963255e-05
exons O 0 5.316250826581381e-05
of O 0 4.8842317482922226e-05
the O 0 0.00014826988626737148
RB1 O 1 0.9896149635314941
gene O 0 3.0237488317652605e-05
in O 0 1.631485065445304e-05
individuals O 0 3.87390127798426e-06
from O 0 2.077371573250275e-05
a O 0 3.597333488869481e-05
family O 0 3.8754678826080635e-05
showing O 0 0.00013391887478064746
mild O 0 0.0002462035045027733
expression O 0 8.78317077877e-05
of O 0 0.00023413759481627494
the O 0 0.0012285934062674642
retinoblastoma B-Disease 1 0.9998564720153809
phenotype O 0 0.002869256306439638
. O 0 0.0007035217131488025

In O 0 0.0002769813872873783
this O 0 3.90947716368828e-05
family O 0 4.7680096031399444e-05
affected O 0 4.499076021602377e-05
individuals O 0 1.392727699567331e-05
developed O 0 0.0011201532324776053
unilateral B-Disease 0 0.050889480859041214
tumors I-Disease 1 1.0
and O 0 0.0001660902489675209
, O 0 2.4018425392569043e-05
as O 0 1.0160341844311915e-05
a O 0 9.54074948822381e-06
result O 0 1.2570570106618106e-05
of O 0 5.293435606290586e-05
linkage O 0 0.0005878712399862707
analysis O 0 2.4919087081798352e-05
, O 0 2.6547646484686993e-05
unaffected O 0 0.00024228527036029845
mutation O 0 2.9271814128151163e-05
carriers O 0 3.759426545002498e-05
were O 0 3.926942008547485e-05
also O 0 1.665303898334969e-05
identified O 0 2.346050678170286e-05
within O 0 4.108967914362438e-05
the O 0 0.0001448359980713576
pedigree O 0 0.0014680903404951096
. O 0 0.00032440366339869797

A O 0 0.0019579227082431316
single O 0 0.00019149683066643775
band O 0 0.0002136781986337155
shift O 0 9.40642348723486e-05
using O 0 3.941520844819024e-05
SSCP O 0 0.13254058361053467
was O 0 0.00022869955864734948
identified O 0 2.8261931220185943e-05
in O 0 2.595485420897603e-05
exon O 0 0.0002011964825214818
21 O 0 0.00011021550017176196
which O 0 1.431063446943881e-05
resulted O 0 6.611604476347566e-05
in O 0 3.484838089207187e-05
a O 0 5.710448749596253e-05
missense O 0 0.0003044269105885178
mutation O 0 4.3558975448831916e-05
converting O 0 0.00029642388108186424
a O 0 0.0003498729201965034
cys O 0 0.2241041511297226
- O 0 0.0016701482236385345
- O 0 0.00041449995478615165
> O 0 0.00018653231381904334
arg O 0 0.0001656393287703395
at O 0 8.158761193044484e-05
nucleotide O 0 2.3983793653314933e-05
position O 0 7.116136112017557e-05
28 O 0 0.00013897166354581714
in O 0 4.805578282685019e-05
the O 0 0.0001852211426012218
exon O 0 0.0025155365001410246
. O 0 0.0003348111640661955

The O 0 0.00041701627196744084
mutation O 0 0.00016882621275726706
destroyed O 0 0.0013787164352834225
an O 0 6.716304051224142e-05
NdeI O 0 0.004030149895697832
restriction O 0 0.00010582157119642943
enzyme O 0 8.782501390669495e-05
site O 0 0.0007262079161591828
. O 0 0.00020150384807493538

Analysis O 0 6.742782716173679e-05
of O 0 0.00010768532956717536
all O 0 3.937621659133583e-05
family O 0 3.441947410465218e-05
members O 0 8.717250238987617e-06
demonstrated O 0 3.491776806185953e-05
that O 0 3.856392595480429e-06
the O 0 1.764979424478952e-05
missense O 0 0.00032346113584935665
mutation O 0 7.954290049383417e-05
co O 0 0.0003286139981355518
- O 0 0.0002464453864376992
segregated O 0 0.00013151587336324155
with O 0 2.571150253061205e-05
patients O 0 0.0020434646867215633
with O 0 0.10216685384511948
tumors B-Disease 1 1.0
or O 0 0.001712392084300518
who O 0 7.91315469541587e-05
, O 0 9.099042472371366e-06
as O 0 1.0426182598166633e-05
a O 0 1.3545274669013452e-05
result O 0 1.4816661860095337e-05
of O 0 5.2500854508252814e-05
linkage O 0 0.0004446182865649462
analysis O 0 1.8325512428418733e-05
had O 0 6.811734056100249e-05
been O 0 2.6160565539612435e-05
predicted O 0 5.5792585044400766e-05
to O 0 1.3555250006902497e-05
carry O 0 1.5661851648474112e-05
the O 0 0.0001293006062041968
predisposing O 0 0.0033583170734345913
mutation O 0 0.00029645723407156765
. O 0 0.00028535767341963947

These O 0 8.199591684387997e-05
observations O 0 8.106907625915483e-05
point O 0 0.00015989894745871425
to O 0 2.077831231872551e-05
another O 0 2.6700012313085608e-05
region O 0 5.603220415650867e-05
of O 0 0.0001107745774788782
the O 0 0.00033334584441035986
RB1 O 1 0.9983982443809509
gene O 0 5.757363760494627e-05
where O 0 3.945003481931053e-05
mutations O 0 1.0147820830752607e-05
only O 0 3.5399800708546536e-06
modify O 0 6.755713911843486e-06
the O 0 9.510126801615115e-06
function O 0 1.1150675163662527e-05
of O 0 2.710497756197583e-05
the O 0 4.6123124775476754e-05
gene O 0 2.648415284056682e-05
and O 0 8.461968718620483e-06
raise O 0 3.168412877130322e-05
important O 0 1.6474639778607525e-05
questions O 0 9.763200978341047e-06
for O 0 6.531673079734901e-06
genetic O 0 3.3404787245672196e-05
counseling O 0 5.952484207227826e-05
in O 0 4.306876508053392e-05
families O 0 9.24477990338346e-06
with O 0 8.695819815329742e-06
these O 0 2.273030622745864e-05
distinctive O 0 0.00035493893665261567
phenotypes O 0 0.0016903660725802183
. O 0 0.0002960852289106697
. O 0 0.00041120019159279764

Maternal B-Disease 0 0.40655747056007385
disomy I-Disease 1 0.999861478805542
and O 0 0.0940578505396843
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.3488563001155853
with O 0 0.00025728813488967717
gamete O 0 0.005467603914439678
complementation O 0 0.028697805479168892
in O 0 0.00015560178144369274
a O 0 7.524540706072003e-05
case O 0 2.985460014315322e-05
of O 0 6.679304351564497e-05
familial O 0 0.0026865387335419655
translocation O 0 0.00627521937713027
( O 0 0.00013748959463555366
3 O 0 0.00019537884509190917
; O 0 1.08151143649593e-05
15 O 0 6.311714969342574e-05
) O 0 2.175906229240354e-05
( O 0 2.3266777134267613e-05
p25 O 0 0.0007199482060968876
; O 0 3.0453866202151403e-05
q11 O 0 0.0007132720202207565
. O 0 2.7509233404998668e-05
2 O 0 0.000272686273092404
) O 0 7.231886411318555e-05
. O 0 0.000211297461646609

Maternal B-Disease 1 0.9753336906433105
uniparental I-Disease 1 0.9999808073043823
disomy I-Disease 1 0.9999377727508545
( I-Disease 0 0.005152441561222076
UPD I-Disease 1 0.9999852180480957
) I-Disease 0 7.330466905841604e-05
for I-Disease 0 2.6266407076036558e-05
chromosome I-Disease 0 0.0001700242137303576
15 I-Disease 0 7.233348151203245e-05
is O 0 5.3918215598969255e-06
responsible O 0 7.738552994851489e-06
for O 0 2.3870684344728943e-06
an O 0 4.052316853631055e-06
estimated O 0 2.239099922007881e-05
30 O 0 1.3875455806555692e-05
% O 0 2.4930852760007838e-06
of O 0 8.521556992491242e-06
cases O 0 2.9711452953051776e-05
of O 0 0.002904117340222001
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999948740005493
PWS B-Disease 1 1.0
) O 0 0.0019552125595510006
. O 0 0.0005654087290167809

We O 0 0.00022421660833060741
report O 0 1.757144673319999e-05
on O 0 1.9890758267138153e-05
an O 0 6.021704848535592e-06
unusual O 0 1.2839602277381346e-05
case O 0 2.469787978043314e-05
of O 0 8.163967140717432e-05
maternal B-Disease 0 0.002804005052894354
disomy I-Disease 1 0.9945582151412964
15 I-Disease 0 0.0007067493279464543
in O 0 0.00032360118348151445
PWS B-Disease 1 1.0
that O 0 2.430132735753432e-05
is O 0 7.215845926111797e-06
most O 0 4.985266514268005e-06
consistent O 0 1.5076419913384598e-05
with O 0 5.285221050144173e-06
adjacent O 0 0.000240784022025764
- O 0 0.00016462849453091621
1 O 0 9.313988994108513e-05
segregation O 0 0.00016150667215697467
of O 0 2.9925005947006866e-05
a O 0 6.28137422609143e-05
paternal O 0 0.00022484040528070182
t O 0 0.00024366899742744863
( O 0 2.9643184461747296e-05
3 O 0 7.65393051551655e-05
; O 0 1.1510239346534945e-05
15 O 0 6.768215826014057e-05
) O 0 1.873026485554874e-05
( O 0 2.5298464606748894e-05
p25 O 0 0.000583078945055604
; O 0 2.0056630091858096e-05
q11 O 0 0.0004749232903122902
. O 0 1.4759207260794938e-05
2 O 0 4.49381914222613e-05
) O 0 7.462101166311186e-06
with O 0 7.218943210318685e-06
simultaneous O 0 0.00011048025044146925
maternal O 0 0.0018404725706204772
meiotic O 1 0.6124471426010132
nondisjunction O 1 0.9768750667572021
for O 0 0.0006030095391906798
chromosome O 0 0.003168171038851142
15 O 0 0.0014179013669490814
. O 0 0.0003587545361369848

The O 0 0.0007163702393881977
patient O 0 0.0003824772429652512
( O 0 0.00011725138028850779
J O 0 0.0038494181353598833
. O 0 3.7296515074558556e-05
B O 0 0.00028474998543970287
. O 0 8.225138117268216e-06
) O 0 4.273661943443585e-06
, O 0 5.123628852743423e-06
a O 0 2.184539334848523e-05
17 O 0 0.00015394622460007668
- O 0 0.00017375542665831745
year O 0 6.408982153516263e-05
- O 0 0.0002091487403959036
old O 0 0.00014256582653615624
white O 0 8.98336511454545e-05
male O 0 8.458158117718995e-05
with O 0 0.00010263069270877168
PWS B-Disease 1 1.0
, O 0 9.374036017106846e-05
was O 0 0.00021042990556452423
found O 0 4.609537427313626e-06
to O 0 7.364089469774626e-06
have O 0 4.368745976535138e-06
47 O 0 5.1081544370390475e-05
chromosomes O 0 2.7395297365728766e-05
with O 0 8.450887435174081e-06
a O 0 7.697635010117665e-05
supernumerary O 0 0.009712162427604198
, O 0 0.00011243838525842875
paternal O 0 0.0014038593508303165
der O 1 0.9962959885597229
( O 0 7.65715740271844e-05
15 O 0 5.627800419460982e-05
) O 0 5.919320301472908e-06
consisting O 0 1.319234161201166e-05
of O 0 6.632102304138243e-05
the O 0 0.00016995874466374516
short O 0 0.0002637153666000813
arm O 0 0.00038952328031882644
and O 0 3.7931262340862304e-05
the O 0 0.00024282527738250792
proximal O 1 0.9999514818191528
long O 0 0.0186788197606802
arm O 0 0.0007123971008695662
of O 0 0.00034850058727897704
chromosome O 0 0.0012006795732304454
15 O 0 0.00040966158849187195
, O 0 3.180264320690185e-05
and O 0 5.826103006256744e-05
distal O 1 0.9999955892562866
chromosome O 1 0.9999890327453613
arm O 1 0.999971866607666
3p O 1 0.9999879598617554
. O 0 0.002362199127674103

The O 0 0.0010691842762753367
t O 0 0.0007677258108742535
( O 0 9.86133745755069e-05
3 O 0 0.00011460604582680389
; O 0 6.47613615001319e-06
15 O 0 4.389741661725566e-05
) O 0 1.3616508113045711e-05
was O 0 7.174256461439654e-05
present O 0 2.8393113097990863e-05
in O 0 1.925428477989044e-05
the O 0 2.812845559674315e-05
balanced O 0 2.442600452923216e-05
state O 0 9.953880180546548e-06
in O 0 1.3109218343743123e-05
the O 0 5.981110371067189e-05
patients O 0 0.00011985338642261922
father O 0 0.00037073137355037034
and O 0 4.05190403398592e-05
a O 0 0.00022672407794743776
sister O 0 0.0013317328412085772
. O 0 0.00035344884963706136

Fluorescent O 0 0.0011419793590903282
in O 0 0.00011738338798750192
situ O 0 0.0006730009336024523
hybridization O 0 2.0948964447597973e-05
analysis O 0 5.320529453456402e-06
demonstrated O 0 4.275350147509016e-05
that O 0 6.916203346918337e-06
the O 0 6.416154792532325e-05
PWS B-Disease 1 1.0
critical O 0 0.0008134483941830695
region O 0 0.0003938561421819031
resided O 0 0.0005172636010684073
on O 0 5.9872225392609835e-05
the O 0 2.7981306629953906e-05
derivative O 0 0.00014349639241117984
chromosome O 0 0.00020432857854757458
3 O 0 0.00010237353126285598
and O 0 9.281529855797999e-06
that O 0 3.800789045271813e-06
there O 0 8.469444765069056e-06
was O 0 7.67724122852087e-05
no O 0 8.277466804429423e-06
deletion O 0 6.611125718336552e-05
of O 0 0.0001618655805941671
the O 0 0.0009168744436465204
PWS B-Disease 1 1.0
region O 0 0.0010387770598754287
on O 0 0.00013416542788036168
the O 0 6.063694672775455e-05
normal O 0 6.628959818044677e-05
pair O 0 5.7403023674851283e-05
of O 0 0.0001071217266144231
15s O 0 0.0018359734676778316
present O 0 0.00038965867133811116
in O 0 0.0008606365299783647
J O 1 0.9985666871070862
. O 0 0.0011508052702993155

B O 0 0.31019484996795654
. O 0 0.002088165143504739

Methylation O 0 0.00023495947243645787
analysis O 0 4.602031549438834e-05
at O 0 0.00032090404420159757
exon O 0 0.0003965833457186818
alpha O 0 0.00011418769281590357
of O 0 4.681940845330246e-05
the O 0 8.016394713195041e-05
small O 0 8.32550649647601e-05
nuclear O 0 0.001542695565149188
ribonucleoprotein O 0 0.012558607384562492
- O 0 0.00034131569555029273
associated O 0 3.303369885543361e-05
polypeptide O 0 0.0003615636960603297
N O 0 0.0010237493552267551
( O 0 7.181232649600133e-05
SNRPN O 1 0.6658709049224854
) O 0 2.6670513761928305e-05
gene O 0 1.9730417989194393e-05
showed O 0 3.15507932100445e-05
a O 0 2.1477264454006217e-05
pattern O 0 7.245125016197562e-05
characteristic O 0 6.696274067508057e-05
of O 0 0.00011185363837284967
only O 0 3.068463774980046e-05
the O 0 7.029735570540652e-05
maternal O 0 0.0005393868195824325
chromosome O 0 0.00036149387597106397
15 O 0 0.0002735176822170615
in O 0 0.00023554128711111844
J O 1 0.7879767417907715
. O 0 0.0006051380769349635

B O 0 0.43650805950164795
. O 0 0.0017565866000950336

Maternal B-Disease 0 0.019154561683535576
disomy I-Disease 0 0.04121116176247597
was O 0 0.000665274215862155
confirmed O 0 4.4146610889583826e-05
by O 0 1.0629100870573893e-05
polymerase O 0 0.00017857906641438603
chain O 0 8.251557301264256e-05
reaction O 0 1.568320658407174e-05
analysis O 0 9.89002910500858e-06
of O 0 6.93557012709789e-05
microsatellite O 0 0.0008908809395506978
repeats O 0 0.0002653150586411357
at O 0 0.00020835654868278652
the O 0 8.354453893844038e-05
gamma O 0 0.000308824994135648
- O 0 0.00023477022477891296
aminobutyric O 0 0.0008260702597908676
acid O 0 5.256507938611321e-05
receptor O 0 0.0001337126741418615
beta3 O 0 0.0013711719075217843
subunit O 0 0.00012873849482275546
( O 0 0.00018202350474894047
GABRB3 O 0 0.015582936815917492
) O 0 0.00011454267223598436
locus O 0 0.0007526266854256392
. O 0 0.00030242506181821227

A O 0 0.0038907621055841446
niece O 0 0.0023723170161247253
( O 0 8.383247768506408e-05
B O 0 0.0003685999836307019
. O 0 1.5453852029168047e-05
B O 0 0.0001577394868945703
. O 0 5.2895575208822265e-06
) O 0 1.5328209883591626e-06
with O 0 1.7166239558719099e-06
45 O 0 2.1639927581418306e-05
chromosomes O 0 1.877372051239945e-05
and O 0 7.179877229646081e-06
the O 0 1.953322316694539e-05
derivative O 0 7.893740985309705e-05
3 O 0 6.422460137400776e-05
but O 0 8.542400792066474e-06
without O 0 9.29211364564253e-06
the O 0 5.0207891035825014e-05
der O 0 0.1761854737997055
( O 0 4.349778464529663e-05
15 O 0 5.664110358338803e-05
) O 0 1.656157837715e-05
demonstrated O 0 6.70896188239567e-05
a O 0 3.3739092032192275e-05
phenotype O 0 4.9023936298908666e-05
consistent O 0 4.266052565071732e-05
with O 0 7.178412033681525e-06
that O 0 6.093012871133396e-06
reported O 0 1.9969958884757943e-05
for O 0 1.534658258606214e-05
haploinsufficiency O 0 0.0014266592916101217
of O 0 0.0005205026245675981
distal O 1 0.9975638389587402
3 O 0 0.4975317716598511
p O 0 0.01050796452909708
. O 0 0.0006208901759237051

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999991655349731
associated O 0 0.0013688248582184315
with O 0 0.00021235132589936256
unbalanced O 0 0.004496112931519747
segregation O 0 0.0433233305811882
of O 0 0.0015188581310212612
non O 1 0.897348165512085
- O 0 0.45173510909080505
Robertsonian O 1 0.859006404876709
translocations O 0 0.0003770040930248797
has O 0 2.7833391868625768e-05
been O 0 1.9010056348633952e-05
reported O 0 1.438468461856246e-05
previously O 0 2.35883126151748e-05
but O 0 5.0870444283646066e-06
has O 0 4.974143848812673e-06
not O 0 1.8140515294362558e-06
, O 0 2.403694224994979e-06
to O 0 4.582516339723952e-06
our O 0 1.4331763850350399e-05
knowledge O 0 6.390491034835577e-05
, O 0 1.3130063052813057e-05
been O 0 2.077954195556231e-05
observed O 0 1.954082472366281e-05
in O 0 1.522895854577655e-05
a O 0 5.029040403314866e-05
case O 0 0.0001303677709074691
of O 0 0.001489237998612225
PWS B-Disease 1 1.0
. O 0 0.003348416183143854

Furthermore O 0 0.0012363253626972437
, O 0 5.7377201301278546e-05
our O 0 3.0607185180997476e-05
findings O 0 9.743816008267459e-06
are O 0 1.6572417962379404e-06
best O 0 1.0159556950384285e-05
interpreted O 0 2.3526890799985267e-05
as O 0 2.6695784981711768e-05
true O 0 9.707263234304264e-05
gamete O 0 0.0006817613611929119
complementation O 0 0.003292323788627982
resulting O 0 0.00046926227514632046
in O 0 0.0007327250204980373
maternal B-Disease 1 0.9984610080718994
UPD I-Disease 1 1.0
15 I-Disease 0 0.11436069011688232
and O 0 0.0026758043095469475
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9127412438392639
- I-Disease 1 0.9969179630279541
Jampel I-Disease 1 0.9999980926513672
syndrome I-Disease 1 1.0
type I-Disease 0 0.0020866135600954294
2 I-Disease 0 0.006880990229547024
and O 0 0.0002450027095619589
Stuve B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999691247940063
Wiedemann I-Disease 1 0.9999955892562866
syndrome I-Disease 1 0.9999998807907104
: O 0 6.506600766442716e-05
a O 0 7.085259130690247e-05
case O 0 6.710069283144549e-05
for O 0 2.5676954464870505e-05
" O 0 0.0002579537976998836
lumping O 0 0.0015661712968721986
" O 0 0.0008485657745040953
. O 0 0.0002717257593758404

Recent O 0 0.00048767973203212023
studies O 0 6.322974513750523e-05
demonstrated O 0 0.00016083940863609314
the O 0 3.509410089463927e-05
existence O 0 7.796941645210609e-05
of O 0 5.0942220696015283e-05
a O 0 0.00010195880167884752
genetically O 0 7.340427691815421e-05
distinct O 0 1.3370500710152555e-05
, O 0 9.366063750348985e-06
usually O 0 7.064466899464605e-06
lethal O 0 1.2568508282129187e-05
form O 0 1.0814927918545436e-05
of O 0 5.502401108969934e-05
the O 0 0.00016091945872176439
Schwartz B-Disease 0 0.1302843540906906
- I-Disease 1 0.9941902160644531
Jampel I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
( O 0 0.002535591134801507
SJS B-Disease 1 0.999998927116394
) O 0 9.617354953661561e-05
of O 0 0.000543358619324863
myotonia B-Disease 1 1.0
and O 1 0.8415789604187012
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 0.00167998974211514
which O 0 8.625434566056356e-05
we O 0 7.388152880594134e-05
called O 0 0.000398933858377859
SJS B-Disease 1 0.9998888969421387
type I-Disease 0 0.0009122811025008559
2 I-Disease 0 0.0013372428948059678
. O 0 0.00033479207195341587

This O 0 0.0007768571958877146
disorder O 1 0.9999997615814209
is O 0 0.0002908896130975336
reminiscent O 0 0.0032423383090645075
of O 0 0.0005200166488066316
another O 0 0.00021172764536459
rare O 0 0.0002903788990806788
condition O 0 0.000583434768486768
, O 0 1.9168561266269535e-05
the O 0 0.00015442636504303664
Stuve B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999992847442627
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.01994919218122959
SWS B-Disease 1 0.9999070167541504
) O 0 5.1514081860659644e-05
, O 0 6.0365455283317715e-06
which O 0 4.2068877519341186e-06
comprises O 0 4.5769706048304215e-05
campomelia B-Disease 0 0.0045323907397687435
at O 0 0.0006987279048189521
birth O 0 0.0007580412784591317
with O 0 0.0008505311561748385
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.999927282333374
contractures B-Disease 1 1.0
, O 0 0.0007250813650898635
and O 0 0.00016065913951024413
early B-Disease 0 0.0015404254663735628
death I-Disease 0 0.011798861436545849
. O 0 0.0002477527013979852

To O 0 7.23563862266019e-05
test O 0 1.5023687410575803e-05
for O 0 7.502052994823316e-06
possible O 0 4.1058192437049e-05
nosologic O 0 0.002319568069651723
identity O 0 7.589679444208741e-05
between O 0 0.0010876152664422989
these O 0 0.00020738301100209355
disorders O 1 1.0
, O 0 0.00013231548655312508
we O 0 2.3106771550374106e-05
reviewed O 0 2.3506328943767585e-05
the O 0 1.404793238179991e-05
literature O 0 1.642534880375024e-05
and O 0 5.003222213417757e-06
obtained O 0 1.3726337783737108e-05
a O 0 2.636452882143203e-05
follow O 0 1.766120840329677e-05
- O 0 4.519941649050452e-05
up O 0 7.958951755426824e-06
of O 0 8.276030712295324e-06
the O 0 1.2169117326266132e-05
only O 0 5.9631520343828015e-06
two O 0 7.698208719375543e-06
surviving O 0 0.0006086456123739481
patients O 0 5.1094353693770245e-05
, O 0 1.0699029189709108e-05
one O 0 1.5794697901583277e-05
with O 0 4.0071790863294154e-05
SJS B-Disease 1 0.9997822642326355
type I-Disease 0 0.00024428986944258213
2 I-Disease 0 0.0003815851523540914
at O 0 0.00023044123372528702
age O 0 0.00011318362521706149
10 O 0 4.476154936128296e-05
years O 0 4.518476271186955e-05
and O 0 1.218350553244818e-05
another O 0 4.894143785350025e-05
with O 0 5.7203025789931417e-05
SWS B-Disease 1 0.9495477676391602
at O 0 0.0011233772384002805
age O 0 0.000634174095466733
7 O 0 0.0009827155154198408
years O 0 0.0008044055430218577
. O 0 0.0004519426147453487

Patients O 0 0.0016894323052838445
reported O 0 0.00022243904822971672
as O 0 7.411700789816678e-05
having O 0 0.00013344774197321385
either O 0 0.00032349934917874634
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.0027293229941278696
SWS B-Disease 1 0.9950767159461975
presented O 0 0.00011423540854593739
a O 0 3.145859227515757e-05
combination O 0 2.1677871700376272e-05
of O 0 4.639566395781003e-05
a O 0 0.00010420250328024849
severe O 1 0.9992823004722595
, O 0 8.595974213676527e-05
prenatal O 1 0.9998639822006226
- O 1 0.9999998807907104
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999992847442627
with O 1 0.9999992847442627
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 1 0.9999587535858154
feeding O 1 0.9988007545471191
difficulties O 1 0.9998722076416016
, O 0 0.00013067096006125212
tendency O 0 0.000441497570136562
to O 0 0.000590419105719775
hyperthermia B-Disease 1 0.9999823570251465
, O 0 0.0001442652428522706
and O 0 4.499754140852019e-05
frequent O 0 9.539899474475533e-05
death O 0 0.0012635082239285111
in O 0 0.00010655599908204749
infancy O 0 0.0008838724461384118
) O 0 9.01476050785277e-06
with O 0 2.851822046068264e-06
a O 0 2.4396229491685517e-05
distinct O 0 9.658990165917203e-05
campomelic B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999984502792358
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.63069748878479

The O 0 0.00021711380395572633
similarity O 0 0.00026791414711624384
of O 0 0.00020987326570320874
the O 0 0.00011537215323187411
clinical O 0 0.0003033413377124816
and O 0 4.9960435717366636e-05
radiographic O 0 0.001037423498928547
findings O 0 7.318201824091375e-05
is O 0 2.3942795451148413e-05
so O 0 9.309419510827865e-06
extensive O 0 7.689528138143942e-05
that O 0 1.839432297856547e-05
these O 0 4.378786979941651e-05
disorders O 1 0.9999992847442627
appear O 0 0.001010956009849906
to O 0 0.00010941276559606194
be O 0 4.1936284105759114e-05
a O 0 4.532744424068369e-05
single O 0 4.842389898840338e-05
entity O 0 0.00024961281451396644
. O 0 0.00036765611730515957

The O 0 0.0005943377036601305
follow O 0 0.0002648727095220238
- O 0 0.0003187720139976591
up O 0 6.003756425343454e-05
observation O 0 8.666064240969718e-05
of O 0 3.912009560735896e-05
an O 0 1.260545559489401e-05
identical O 0 1.8798100427375175e-05
and O 0 6.741438483004458e-06
unique O 0 1.8991826436831616e-05
pattern O 0 0.00033031360362656415
of O 1 0.572114884853363
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.0033600544556975365
the O 0 0.0002102432044921443
two O 0 4.083786916453391e-05
patients O 0 3.257981370552443e-05
( O 0 2.3617305487277918e-05
one O 0 2.620848135848064e-05
with O 0 4.013359284726903e-05
SJS B-Disease 1 0.9999079704284668
type I-Disease 0 0.0004076109908055514
2 I-Disease 0 0.00033457219251431525
, O 0 1.6111007425934076e-05
one O 0 1.0887782991630957e-05
with O 0 3.466918133199215e-05
SWS B-Disease 1 0.9887815117835999
) O 0 8.318418986164033e-05
surviving O 0 0.0008326353854499757
beyond O 0 0.0004479851631913334
infancy O 0 0.0006095726857893169
adds O 0 3.1537769245915115e-05
to O 0 1.5149534192460123e-05
the O 0 1.7055868738680147e-05
evidence O 0 2.5274881409131922e-05
in O 0 1.8090682715410367e-05
favor O 0 2.3108314053388312e-05
of O 0 0.00016113118908833712
identity O 0 0.0003725524293258786
. O 0 0.0004573296755552292

The O 0 0.0006675205659121275
hypothesis O 0 0.00045914005022495985
that O 0 7.528573769377545e-05
SWS B-Disease 0 0.12321116775274277
and O 0 0.0002706630912143737
SJS B-Disease 1 0.9997404217720032
type I-Disease 0 0.00020427520212251693
2 I-Disease 0 0.00012410660565365106
are O 0 3.7044435430289013e-06
the O 0 1.1329598237352911e-05
same O 0 5.3488165576709434e-05
disorder O 1 0.9999899864196777
should O 0 8.301025081891567e-05
be O 0 2.896773730753921e-05
testable O 0 5.5304823035839945e-05
by O 0 7.004305189184379e-06
molecular O 0 4.23790370405186e-05
methods O 0 5.8140591136179864e-05
. O 0 8.695451106177643e-05
. O 0 0.0001869683910626918

A O 0 0.0014731795527040958
mouse O 0 0.00010246621241094545
model O 0 1.1402982636354864e-05
of O 0 9.632958972360939e-05
severe O 1 0.9999998807907104
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9997739195823669
defects O 1 0.9999998807907104
in O 0 0.4784102737903595
hemostasis O 1 0.9999998807907104
and O 1 0.9978929162025452
thrombosis B-Disease 1 1.0
. O 0 0.212178573012352

von B-Disease 1 0.9969642758369446
Willebrand I-Disease 1 0.9999994039535522
factor I-Disease 0 0.008814324624836445
( I-Disease 0 0.0014777585165575147
vWf I-Disease 1 0.9999572038650513
) I-Disease 1 0.9984215497970581
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9982720613479614
humans O 0 0.004087330307811499
. O 0 0.0003040048759430647

We O 0 0.00021590203687082976
generated O 0 0.00016116394544951618
a O 0 8.104124572128057e-05
mouse O 0 6.240779475774616e-05
model O 0 9.952040272764862e-06
for O 0 8.884095223038457e-06
this O 0 2.6488698495086282e-05
disease O 0 0.0032428426202386618
by O 0 1.3549227332987357e-05
using O 0 2.39656164922053e-05
gene O 0 6.819709233241156e-05
targeting O 0 0.0001889328850666061
. O 0 0.00018605556397233158

vWf B-Disease 1 0.9988011121749878
- I-Disease 1 0.9980091452598572
deficient I-Disease 1 0.9974572062492371
mice O 0 0.00048275283188559115
appeared O 0 0.00017341875354759395
normal O 0 5.587532723438926e-05
at O 0 9.870134090306237e-05
birth O 0 6.787075835745782e-05
; O 0 4.9657073759590276e-06
they O 0 3.8061464238126064e-06
were O 0 3.098131492151879e-05
viable O 0 0.0003209992137271911
and O 0 0.000121888100693468
fertile O 0 0.004282565787434578
. O 0 0.0006857644766569138

Neither O 0 0.004572804551571608
vWf O 0 0.019671708345413208
nor O 0 0.0024472668301314116
vWf O 0 0.021451817825436592
propolypeptide O 0 0.04686766490340233
( O 0 0.00046737215598113835
von B-Disease 0 0.17451174557209015
Willebrand I-Disease 1 0.9999916553497314
antigen O 0 0.007579561322927475
II O 1 1.0
) O 0 0.00012473885726649314
were O 0 5.854842675034888e-05
detectable O 0 0.0004165470600128174
in O 0 3.717989966389723e-05
plasma O 0 0.0002552438236307353
, O 0 2.2407062715501525e-05
platelets O 0 0.00025561838992871344
, O 0 2.6506968424655497e-05
or O 0 3.033207576663699e-05
endothelial O 0 0.00164589355699718
cells O 0 6.785444566048682e-05
of O 0 8.127342880470678e-05
the O 0 0.00016179954400286078
homozygous O 0 0.0005577008705586195
mutant O 0 0.0018307100981473923
mice O 0 0.0013347624335438013
. O 0 0.0002754269225988537

The O 0 0.0010091555304825306
mutant O 0 0.060250941663980484
mice O 0 0.05713792145252228
exhibited O 1 0.5337532758712769
defects O 1 0.9997805953025818
in O 0 0.0003095285501331091
hemostasis O 1 0.9527407884597778
with O 0 7.145784911699593e-05
a O 0 0.00025612922036089003
highly O 0 0.1862456202507019
prolonged O 1 0.9999995231628418
bleeding O 1 1.0
time O 0 0.0019708736799657345
and O 0 0.0002563473826739937
spontaneous O 0 0.07494930922985077
bleeding O 1 0.9999871253967285
events O 0 0.0002585792390163988
in O 0 5.833458635606803e-05
approximately O 0 5.276028605294414e-05
10 O 0 3.682111855596304e-05
% O 0 3.151537384837866e-05
of O 0 0.00047564684064127505
neonates O 0 0.013778687454760075
. O 0 0.0011562984436750412

As O 0 0.0003229034482501447
in O 0 6.785496225347742e-05
the O 0 0.00011087422899436206
human O 0 0.0004269656492397189
disease O 1 0.9996867179870605
, O 0 2.0714032871183008e-05
the O 0 3.057620779145509e-05
factor O 0 0.00013352578389458358
VIII O 1 0.9995864033699036
level O 0 0.0008102058782242239
in O 0 4.659216574509628e-05
these O 0 1.5139106835704297e-05
mice O 0 8.936773519963026e-05
was O 0 6.950255192350596e-05
reduced O 0 3.0283314117696136e-05
strongly O 0 6.630963525822153e-06
as O 0 8.74722081789514e-06
a O 0 1.2606633390532807e-05
result O 0 1.1011669812432956e-05
of O 0 3.7168338167248294e-05
the O 0 6.157415919005871e-05
lack O 0 0.00011541309504536912
of O 0 0.00019268332107458264
protection O 0 0.0005229194066487253
provided O 0 0.00023080228129401803
by O 0 0.00026459459331817925
vWf O 0 0.01190419215708971
. O 0 0.0007848058012314141

Defective O 1 0.9999973773956299
thrombosis B-Disease 1 0.9999997615814209
in O 0 0.004213162697851658
mutant O 0 0.02409498207271099
mice O 0 0.0009817469399422407
was O 0 0.0003071196551900357
also O 0 2.2814285330241546e-05
evident O 0 8.686863293405622e-05
in O 0 9.905907063512132e-06
an O 0 6.3066481743589975e-06
in O 0 3.26531553582754e-05
vivo O 0 0.0002627681824378669
model O 0 8.42487279442139e-05
of O 0 0.0028784682508558035
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.30475524067878723

In O 0 0.0001728413044475019
this O 0 1.552031608298421e-05
model O 0 1.9035014702240005e-05
, O 0 8.030160643102136e-06
the O 0 3.993857171735726e-05
exteriorized O 0 0.004232948180288076
mesentery O 0 0.0037144364323467016
was O 0 0.0009067773353308439
superfused O 0 0.0025014253333210945
with O 0 0.00011312429705867544
ferric O 1 0.9999738931655884
chloride O 0 0.42529019713401794
and O 0 0.00016572671302128583
the O 0 0.00015691469889134169
accumulation O 0 0.2555740773677826
of O 0 0.001468774862587452
fluorescently O 1 0.9552609920501709
labeled O 0 0.0017942734993994236
platelets O 0 0.0022841794416308403
was O 0 0.001049814629368484
observed O 0 0.00014400423970073462
by O 0 6.0279606259427965e-05
intravital O 0 0.005030196160078049
microscopy O 0 0.0011139612179249525
. O 0 0.0006826153839938343

We O 0 0.00025656743673607707
conclude O 0 0.00020418933127075434
that O 0 8.44938858790556e-06
these O 0 9.695727385405917e-06
mice O 0 9.501559543423355e-05
very O 0 1.7710592146613635e-05
closely O 0 6.8457200541161e-05
mimic O 0 0.00379574834369123
severe O 1 0.9998693466186523
human O 1 0.9926736950874329
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.0002755839959718287
will O 0 2.1931748051429167e-05
be O 0 6.876145107526099e-06
very O 0 3.0288429115898907e-06
useful O 0 5.275985131447669e-06
for O 0 5.075327408121666e-06
investigating O 0 3.783556167036295e-05
the O 0 2.597055208752863e-05
role O 0 8.770498970989138e-05
of O 0 0.00015180920308921486
vWf O 0 0.0025369205977767706
in O 0 0.00011231386451981962
normal O 0 0.00016264097939711064
physiology O 0 0.0005629851366393268
and O 0 6.211503205122426e-05
in O 0 0.00037584538222290576
disease O 1 0.9999947547912598
models O 0 0.00019238702952861786
. O 0 0.00010044928058050573
. O 0 0.000259729684330523

Oral O 1 0.9920931458473206
contraceptives O 0 0.07783212512731552
and O 0 7.849311805330217e-05
the O 0 0.00010420141188660637
risk O 0 0.00040593600715510547
of O 1 0.9781672954559326
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.999565064907074

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999923706054688
Study O 0 0.0019344487227499485
Group O 0 0.00027441931888461113
. O 0 0.00022016593720763922

BACKGROUND O 0 0.0034468143712729216
Women O 0 0.0002380062360316515
with O 0 4.436332164914347e-05
mutations O 0 7.055915921228006e-05
in O 0 4.571910176309757e-05
either O 0 4.1860690544126555e-05
the O 0 8.772740693530068e-05
BRCA1 O 0 0.00024201419728342444
or O 0 2.38119755522348e-05
the O 0 7.728674972895533e-05
BRCA2 O 0 0.0003077970468439162
gene O 0 1.4119656043476425e-05
have O 0 3.056312152693863e-06
a O 0 9.012061127577908e-06
high O 0 7.174214988481253e-05
lifetime O 0 0.00011695201101247221
risk O 0 0.0005554468953050673
of O 1 0.9992638230323792
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.21300160884857178

Oral O 1 0.9998088479042053
contraceptives O 1 0.9999504089355469
protect O 1 0.9805471301078796
against O 1 0.9999997615814209
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0011769554112106562
general O 0 0.00015838092076592147
, O 0 1.3381725693761837e-05
but O 0 1.779377043931163e-06
it O 0 2.0943334675394e-06
is O 0 2.380253135925159e-06
not O 0 1.8762428908303264e-06
known O 0 1.180895560537465e-05
whether O 0 7.210735930129886e-06
they O 0 4.150059794483241e-06
also O 0 7.721854672126938e-06
protect O 0 3.469213334028609e-05
against O 0 6.615590245928615e-05
hereditary B-Disease 1 0.9999939203262329
forms I-Disease 1 0.9996923208236694
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.994772732257843

METHODS O 0 0.0006119378376752138
We O 0 0.00011058649397455156
enrolled O 0 0.0002814109611790627
207 O 0 0.0002717035240493715
women O 0 3.120833935099654e-05
with O 0 0.0001641466369619593
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0061072190292179585
161 O 0 0.00040034513222053647
of O 0 0.00016568547289352864
their O 0 5.771953510702588e-05
sisters O 0 0.0003443695604801178
as O 0 3.3052358048735186e-05
controls O 0 2.5775285394047387e-05
in O 0 2.878063423850108e-05
a O 0 4.8893205530475825e-05
case O 0 0.0001129025113186799
- O 0 0.0004811885592062026
control O 0 0.00019734959641937166
study O 0 8.351339056389406e-05
. O 0 0.00015776537475176156

All O 0 0.00019125815015286207
the O 0 0.000225861047510989
patients O 0 0.00012381286069285125
carried O 0 4.65326702396851e-05
a O 0 3.731010656338185e-05
pathogenic O 0 7.632131018908694e-05
mutation O 0 2.1774259948870167e-05
in O 0 2.675001451279968e-05
either O 0 4.104934123461135e-05
BRCA1 O 0 0.0002882544358726591
( O 0 2.6325435101171024e-05
179 O 0 9.269720612792298e-05
women O 0 2.18430177483242e-05
) O 0 1.3566863344749436e-05
or O 0 3.577552706701681e-05
BRCA2 O 0 0.0007129043806344271
( O 0 0.0001483267406001687
28 O 0 0.0007663986762054265
women O 0 9.443199814995751e-05
) O 0 8.178585267160088e-05
. O 0 0.00011174649262102321

The O 0 0.000752242689486593
control O 0 0.00040877022547647357
women O 0 3.991378252976574e-05
were O 0 1.964680996024981e-05
enrolled O 0 6.911379023222253e-05
regardless O 0 1.8097895008395426e-05
of O 0 2.898558886954561e-05
whether O 0 1.973102189367637e-05
or O 0 1.3247296919871587e-05
not O 0 7.185946287791012e-06
they O 0 5.961412625765661e-06
had O 0 4.8682541091693565e-05
either O 0 5.8516387070994824e-05
mutation O 0 0.0001111789169954136
. O 0 0.00021083661704324186

Lifetime O 0 0.001963874325156212
histories O 0 0.0006858314736746252
of O 0 0.0012726207496598363
oral O 1 0.9983327984809875
- O 0 0.16235321760177612
contraceptive O 0 0.0002850775490514934
use O 0 9.26349912333535e-06
were O 0 1.1101422387582716e-05
obtained O 0 1.3052085705567151e-05
by O 0 7.4847444011538755e-06
interview O 0 3.23719359585084e-05
or O 0 5.389842044678517e-06
by O 0 5.988387329125544e-06
written O 0 6.140647201391403e-06
questionnaire O 0 1.9648457964649424e-05
and O 0 6.2498888837581035e-06
were O 0 2.8523762011900544e-05
compared O 0 7.560921949334443e-05
between O 0 0.0009119152673520148
patients O 0 0.00024199578911066055
and O 0 5.8059868024429306e-05
control O 0 0.00048722856445237994
women O 0 3.824960731435567e-05
, O 0 1.496483037044527e-05
after O 0 4.667034590966068e-05
adjustment O 0 0.00015578436432406306
for O 0 2.3301015971810557e-05
year O 0 7.853413262637332e-05
of O 0 0.0001540739758638665
birth O 0 0.000545573013368994
and O 0 0.00022558080672752112
parity O 0 0.013093286193907261
. O 0 0.00039772744639776647

RESULTS O 0 0.0003171632706653327
The O 0 7.255067612277344e-05
adjusted O 0 0.00011916644143639132
odds O 0 0.00020813079026993364
ratio O 0 0.00016108725685626268
for O 0 0.0008044775458984077
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.0004336140991654247
with O 0 2.781969669740647e-05
any O 0 3.070275124628097e-05
past O 0 4.49171093350742e-05
use O 0 9.198645784636028e-06
of O 0 0.00016670854529365897
oral O 0 0.24320203065872192
contraceptives O 1 0.7192476391792297
was O 0 0.003739235457032919
0 O 0 0.0006031387601979077
. O 0 0.00024021166609600186

5 O 0 0.0007030894630588591
( O 0 7.4602103268262e-05
95 O 0 9.809856419451535e-05
percent O 0 6.015023245709017e-05
confidence O 0 9.582787606632337e-05
interval O 0 5.131858779350296e-05
, O 0 8.593896382080857e-06
0 O 0 1.0503466910449788e-05
. O 0 2.8390113584464416e-06
3 O 0 1.4091002412897069e-05
to O 0 8.553178304282483e-06
0 O 0 3.294818816357292e-05
. O 0 1.4800209100940265e-05
8 O 0 0.00016888529353309423
) O 0 7.005884981481358e-05
. O 0 0.00011129231279483065

The O 0 0.0010122426319867373
risk O 0 0.000515940017066896
decreased O 0 0.0005265295621939003
with O 0 2.173480243072845e-05
increasing O 0 6.023599416948855e-05
duration O 0 7.640635885763913e-05
of O 0 4.38732240581885e-05
use O 0 1.807750595617108e-05
( O 0 2.8955058951396495e-05
P O 0 0.0004503194650169462
for O 0 1.6709578630980104e-05
trend O 0 6.307941657723859e-05
, O 0 7.09597179593402e-06
< O 0 0.00013471425336319953
0 O 0 2.5224311684723943e-05
. O 0 8.979479389381595e-06
001 O 0 0.00039008568273857236
) O 0 8.40305528981844e-06
; O 0 1.8129688896806329e-06
use O 0 2.653257297424716e-06
for O 0 9.860402315098327e-06
six O 0 3.9461774576921016e-05
or O 0 1.5599258404108696e-05
more O 0 7.45028410165105e-06
years O 0 5.0484337407397106e-05
was O 0 9.497456630924717e-05
associated O 0 8.089561561064329e-06
with O 0 2.9606217140099034e-06
a O 0 3.2630054192850366e-05
60 O 0 0.00010341661254642531
percent O 0 0.00011758929758798331
reduction O 0 0.00040068745147436857
in O 0 0.0003163536312058568
risk O 0 0.0010390477254986763
. O 0 0.0004428940883371979

Oral O 1 0.9892565011978149
- O 0 0.03823487088084221
contraceptive O 0 0.000748138059861958
use O 0 7.261906284838915e-05
protected O 0 0.016470668837428093
against O 1 0.9999333620071411
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 5.5791737395338714e-05
for O 0 2.107261389028281e-05
carriers O 0 2.1188321625231765e-05
of O 0 2.9672715754713863e-05
the O 0 6.104942440288141e-05
BRCA1 O 0 0.0001888653205242008
mutation O 0 2.010375465033576e-05
( O 0 2.2893356799613684e-05
odds O 0 0.0001278255949728191
ratio O 0 3.964145798818208e-05
, O 0 4.591601737047313e-06
0 O 0 6.971465609240113e-06
. O 0 2.2295380404102616e-06
5 O 0 7.324755188165e-06
; O 0 1.4911814787410549e-06
95 O 0 1.5438856280525215e-05
percent O 0 2.1517731511266902e-05
confidence O 0 4.842173075303435e-05
interval O 0 3.0022934879525565e-05
, O 0 5.21709444001317e-06
0 O 0 5.3258495427144226e-06
. O 0 1.5185735264822142e-06
3 O 0 6.037092134647537e-06
to O 0 5.072196472610813e-06
0 O 0 1.1987722245976329e-05
. O 0 5.147730917087756e-06
9 O 0 4.355016790213995e-05
) O 0 5.003012120141648e-06
and O 0 2.456475385770318e-06
for O 0 5.42412180948304e-06
carriers O 0 1.6736881661927328e-05
of O 0 3.163147630402818e-05
the O 0 8.419941150350496e-05
BRCA2 O 0 0.0003707819269038737
mutation O 0 2.204004158556927e-05
( O 0 1.763098407536745e-05
odds O 0 0.00010715851385612041
ratio O 0 2.5259745598305017e-05
, O 0 3.960185949836159e-06
0 O 0 6.758278232155135e-06
. O 0 2.936027840405586e-06
4 O 0 2.415532617305871e-05
; O 0 2.332336862309603e-06
95 O 0 2.3436197807313874e-05
percent O 0 2.467511330905836e-05
confidence O 0 9.218892955686897e-05
interval O 0 3.771322371903807e-05
, O 0 6.006071544106817e-06
0 O 0 8.290042387670837e-06
. O 0 2.998207264681696e-06
2 O 0 1.4425182598643005e-05
to O 0 6.615969141421374e-06
1 O 0 5.2044491894776e-05
. O 0 1.2245241123309825e-05
1 O 0 0.0001422486238880083
) O 0 4.5825396227883175e-05
. O 0 0.00010852414561668411

CONCLUSIONS O 0 0.0047816806472837925
Oral O 1 0.9597480893135071
- O 0 0.02641451172530651
contraceptive O 0 0.00040864324546419084
use O 0 1.240711753780488e-05
may O 0 2.311259049747605e-05
reduce O 0 1.4093246136326343e-05
the O 0 1.7980157281272113e-05
risk O 0 0.00010049613047158346
of O 1 0.8941025733947754
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.0013361608143895864
women O 0 3.1411615054821596e-05
with O 0 1.186061399494065e-05
pathogenic O 0 8.933230128604919e-05
mutations O 0 3.951735561713576e-05
in O 0 4.4978922232985497e-05
the O 0 0.00014616931730415672
BRCA1 O 0 0.0012343087000772357
or O 0 0.0004008397227153182
BRCA2 O 0 0.00739801162853837
gene O 0 0.0024096325505524874

A O 0 0.0033670670818537474
Japanese O 0 0.0013879976468160748
family O 0 0.00013727085024584085
with O 0 9.182964276988059e-05
adrenoleukodystrophy B-Disease 1 1.0
with O 0 0.00017114133515860885
a O 0 0.0001801263861125335
codon O 0 0.00013534720346797258
291 O 0 0.00014124599692877382
deletion O 0 0.00010875703446799889
: O 0 1.834432805480901e-05
a O 0 3.184203160344623e-05
clinical O 0 0.00012240851356182247
, O 0 6.842547736596316e-05
biochemical O 0 0.002842883812263608
, O 0 0.00021214612934272736
pathological O 1 0.9998787641525269
, O 0 0.00012728761066682637
and O 0 7.300706784008071e-05
genetic O 0 0.000816978223156184
report O 0 0.00014954608923289925
. O 0 0.00018700172950048

We O 0 9.061002492671832e-05
report O 0 7.762404493405484e-06
a O 0 7.345215635723434e-06
Japanese O 0 6.875178951304406e-05
family O 0 3.0452298233285546e-05
with O 0 6.804806616855785e-05
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999561309814453
ALD B-Disease 1 1.0
) O 0 9.692407911643386e-05
with O 0 2.1792997358716093e-05
a O 0 3.660811125882901e-05
three O 0 1.566476385050919e-05
base O 0 8.79507206263952e-05
pair O 0 6.527643563458696e-05
deletion O 0 0.00019499043992254883
( O 0 0.0001887328107841313
delGAG O 0 0.0031522600911557674
291 O 0 0.0004527355486061424
) O 0 5.323535515344702e-05
in O 0 8.156325930031016e-05
the O 0 0.0005764397792518139
ALD B-Disease 1 1.0
gene O 0 0.00199707574211061
. O 0 0.0008616466075181961

A O 0 0.0011255055433139205
variety O 0 8.258814341388643e-05
of O 0 9.233867604052648e-05
phenotypes O 0 0.00030766826239414513
were O 0 5.364463140722364e-05
observed O 0 7.423690112773329e-05
within O 0 3.375312371645123e-05
this O 0 2.1223731891950592e-05
family O 0 0.00013609952293336391
. O 0 0.00020583244622685015

While O 0 0.00023640725703444332
the O 0 0.00019024364883080125
proband O 0 0.006366155110299587
( O 0 0.00012557569425553083
patient O 0 8.379659266211092e-05
1 O 0 0.00022125241230241954
) O 0 2.8924727303092368e-05
was O 0 0.00013508445408660918
classified O 0 7.905409438535571e-05
as O 0 3.140260014333762e-05
having O 0 8.751326822675765e-05
a O 0 3.655647378764115e-05
rare O 0 8.009594603208825e-05
intermediate O 0 0.0003420223365537822
type O 0 0.00017145328456535935
of O 0 0.00036372736212797463
adult O 0 0.0007987144053913653
cerebral O 1 0.9999524354934692
and O 0 0.0013045574305579066
cerebello O 1 1.0
- O 1 0.9999971389770508
brain O 1 0.9999302625656128
stem O 0 0.0011898844968527555
forms O 0 5.9233389038126916e-05
, O 0 1.9214372514397837e-05
his O 0 0.000158226364874281
younger O 0 0.0007358479779213667
brother O 0 0.0006743553094565868
( O 0 3.802832361543551e-05
patient O 0 7.187102892203256e-05
2 O 0 0.00016425545618403703
) O 0 1.61742191266967e-05
and O 0 2.850874989235308e-05
nephew O 0 0.00203158357180655
( O 0 8.935111691243947e-05
patient O 0 8.138990961015224e-05
3 O 0 0.0001324043405475095
) O 0 2.155258334823884e-05
had O 0 0.00010863906936720014
a O 0 0.00042490242049098015
childhood O 1 0.9999914169311523
ALD B-Disease 1 1.0
type O 1 0.9997783303260803
. O 0 0.0022193538025021553

Another O 0 0.0017829072894528508
nephew O 0 0.011436330154538155
( O 0 0.0003058786387555301
patient O 0 0.00013991942978464067
4 O 0 0.00016364450857508928
) O 0 1.145908117905492e-05
of O 0 5.712572601623833e-05
patient O 0 0.00012437008263077587
1 O 0 0.0002572140656411648
was O 0 0.0002902579726651311
classified O 0 9.691862942418084e-05
as O 0 2.5445406208746135e-05
having O 0 4.318655555834994e-05
an O 0 2.9986536901560612e-05
adolescent O 0 0.0018189636757597327
form O 0 0.0005722350324504077
. O 0 0.0009025838226079941

The O 0 0.0008111824281513691
tau O 0 0.0018980776658281684
level O 0 0.0003826592583209276
in O 0 5.4550968343392015e-05
the O 0 0.0001171720286947675
cerebrospinal O 0 0.08358270674943924
fluid O 0 0.0095622343942523
( O 0 0.0010893361177295446
CSF O 1 0.9999130964279175
) O 0 6.82917088852264e-05
in O 0 3.859089338220656e-05
patient O 0 3.878647476085462e-05
1 O 0 0.00010048089461633936
was O 0 0.00011490981705719605
as O 0 1.0443059181852732e-05
high O 0 2.2096022803452797e-05
as O 0 5.334887646313291e-06
that O 0 1.452736000828736e-06
of O 0 1.833295937103685e-05
patients O 0 9.084448538487777e-05
with O 0 0.000904829881619662
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 0.0013624400598928332
AD B-Disease 0 0.006492512300610542
) O 0 0.00011793798330472782
. O 0 8.214955596486107e-05

His O 0 0.006831798702478409
brain O 1 0.9976600408554077
magnetic O 0 0.0014206302585080266
resonance O 0 0.0007347583305090666
image O 0 0.0003818451950792223
( O 0 9.391285857418552e-05
MRI O 0 0.0031392902601510286
) O 0 6.516517169075087e-05
showed O 0 0.0002658148587215692
abnormalities B-Disease 0 0.04503300040960312
in I-Disease 0 0.0001803752384148538
the I-Disease 0 0.00041383987991139293
bilateral I-Disease 1 0.9999598264694214
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9998599290847778
and O 1 0.8640453815460205
brain O 1 0.9999997615814209
stem O 1 0.995144784450531
, O 0 3.185965397278778e-05
but O 0 6.024588856234914e-06
not O 0 3.922743871953571e-06
in O 0 1.8336579159949906e-05
the O 0 0.0001867232349468395
cerebral O 1 0.9997153878211975
white O 0 0.0008924135472625494
matter O 0 0.0003061729948967695
, O 0 1.8419530533719808e-05
where O 0 2.010622847592458e-05
marked O 0 0.00011112455104012042
reductions O 0 9.829379268921912e-05
of O 0 8.424374391324818e-05
the O 0 0.0005309251137077808
cerebral O 1 0.9999793767929077
blood O 1 0.5537130236625671
flow O 0 0.0026377008762210608
and O 0 0.0001595815410837531
oxygen O 0 0.00043671909952536225
metabolism O 0 0.00018561205070000142
were O 0 4.7325538616860285e-05
clearly O 0 6.651952571701258e-05
demonstrated O 0 0.0001569292217027396
by O 0 4.0941129554994404e-05
positron O 0 0.000777625769842416
emission O 0 0.00019468372920528054
tomography O 0 0.0002306179521838203
( O 0 0.0002176635171053931
PET O 0 0.0014820341020822525
) O 0 0.0001768149231793359
. O 0 0.0002763211668934673

In O 0 0.00047427977551706135
patients O 0 0.00022752575750928372
2 O 0 0.000435595226008445
and O 0 4.666011227527633e-05
3 O 0 0.00011481342517072335
, O 0 1.321541094512213e-05
the O 0 2.2231677576201037e-05
autopsy O 0 8.759165939409286e-05
findings O 0 4.9847029004013166e-05
showed O 0 0.0003189778362866491
massive O 0 0.1187095195055008
demyelination B-Disease 1 0.9999998807907104
of I-Disease 0 0.4710289239883423
the I-Disease 1 0.8256917595863342
cerebral I-Disease 1 0.9999964237213135
white I-Disease 0 0.0008895187056623399
matter I-Disease 0 0.00010416940494906157
with O 0 9.138297173194587e-06
sparing O 0 9.651108121033758e-05
of O 0 0.0001261927973246202
the O 0 0.0019648803863674402
U O 1 1.0
- O 1 0.9824934005737305
fibers O 0 0.0011179359862580895
, O 0 2.5339508283650503e-05
compatible O 0 3.139927866868675e-05
with O 0 3.143346475553699e-06
the O 0 2.2299242118606344e-05
findings O 0 4.0419276047032326e-05
of O 0 0.0006644763634540141
childhood O 1 0.9999995231628418
ALD B-Disease 1 1.0
. O 0 0.016593612730503082

Oleic O 0 0.04513617604970932
and O 0 0.001340421149507165
erucic O 1 0.8976673483848572
acids O 0 0.000859211606439203
( O 0 0.00037123056245036423
Lorenzos O 0 0.008062249980866909
Oil O 0 0.0003690095618367195
) O 0 1.0514330824662466e-05
were O 0 1.5369345419458114e-05
administered O 0 2.702733218029607e-05
to O 0 2.456886250001844e-05
patients O 0 3.0092362067080103e-05
1 O 0 0.00013911485439166427
and O 0 2.2975547835812904e-05
4 O 0 8.575751417083666e-05
, O 0 6.900786502228584e-06
but O 0 2.3462016542907804e-06
sufficient O 0 3.4028485970338807e-05
effectiveness O 0 6.304778798948973e-05
was O 0 0.00016124632384162396
not O 0 1.904605596791953e-05
obtained O 0 6.771062908228487e-05
. O 0 0.00012784301361534745

The O 0 0.0003616174217313528
findings O 0 5.637597860186361e-05
in O 0 2.2010466636857018e-05
this O 0 8.569613783038221e-06
family O 0 1.6825350030558184e-05
suggest O 0 1.5988684026524425e-05
that O 0 4.581463144859299e-06
delGAG291 O 0 0.00024280349316541106
is O 0 6.964979547774419e-06
part O 0 1.8854820154956542e-05
of O 0 3.403179289307445e-05
the O 0 0.00011015310155926272
cause O 0 0.00034111287095583975
of O 0 0.0006103093037381768
Japanese O 1 0.9990993738174438
ALD B-Disease 1 1.0
with O 0 0.00019849909585900605
phenotypic O 0 0.0019968561828136444
variations O 0 0.0014970209449529648
. O 0 0.0006563453353010118

Moreover O 0 0.0013853966956958175
, O 0 4.257964246789925e-05
although O 0 1.017506201606011e-05
the O 0 2.1994204871589318e-05
scale O 0 7.420717884087935e-05
of O 0 3.855959221255034e-05
the O 0 2.5138580895145424e-05
study O 0 1.0735731848399155e-05
is O 0 4.789906597579829e-06
limited O 0 5.108055120217614e-06
, O 0 4.308461939217523e-06
there O 0 5.229906946624396e-06
is O 0 5.502272415469633e-06
a O 0 1.7767637473298237e-05
possibility O 0 6.64946564938873e-05
that O 0 3.0691484425915405e-05
PET O 0 0.0007644970319233835
can O 0 1.6530129869352095e-05
detect O 0 0.000384732848033309
an O 0 0.0001355607237201184
insidious B-Disease 1 0.9988425970077515
lesion I-Disease 1 0.9989803433418274
which O 0 5.538947880268097e-05
is O 0 3.139211912639439e-05
undetectable O 0 0.0003865394101012498
by O 0 7.340964657487348e-06
computed O 0 5.182781023904681e-05
tomogram O 0 0.001943068578839302
( O 0 0.00010951401054626331
CT O 0 0.003197341226041317
) O 0 3.431610457482748e-05
or O 0 2.7878866603714414e-05
MRI O 0 0.0006982430350035429
analysis O 0 1.7267400835407898e-05
, O 0 1.0565572665655054e-05
and O 0 4.4817570596933365e-06
that O 0 3.2214993552770466e-06
the O 0 2.3290263925446197e-05
higher O 0 2.5483142962912098e-05
level O 0 8.186473860405385e-05
of O 0 6.78512078593485e-05
tau O 0 0.00040185305988416076
reflects O 0 2.0490973838604987e-05
the O 0 1.004985642794054e-05
process O 0 1.0988056601490825e-05
of O 0 0.00019504081865306944
neuronal B-Disease 1 0.9996708631515503
degeneration I-Disease 1 1.0
in O 1 0.9999949932098389
ALD B-Disease 1 1.0
. O 0 0.031012041494250298

Lorenzos O 0 0.33091500401496887
Oil O 0 0.0014595496468245983
should O 0 2.3202450393000618e-05
be O 0 3.955961801693775e-06
given O 0 5.685318228643155e-06
in O 0 1.037658512359485e-05
the O 0 2.3150005290517583e-05
early O 0 0.00011579418060136959
stage O 0 0.0006282107788138092
. O 0 7.215340883703902e-05
. O 0 0.00012365159636829048

Nonsense O 0 0.004718011245131493
mutation O 0 0.00010048013064078987
in O 0 7.21814067219384e-05
exon O 0 0.0003538639284670353
4 O 0 0.00015247480769176036
of O 0 8.802607044344768e-05
human O 0 0.00010029375698650256
complement O 0 0.00033898037509061396
C9 O 1 0.977489173412323
gene O 0 8.263715426437557e-05
is O 0 1.403630813001655e-05
the O 0 2.3282578695216216e-05
major O 0 0.00016736316320020705
cause O 0 0.00014932606427464634
of O 0 0.00040128568070940673
Japanese O 1 0.9911244511604309
complement B-Disease 1 0.978950023651123
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.009135909378528595

Deficiency B-Disease 1 0.9999996423721313
of I-Disease 0 0.0014366528484970331
the I-Disease 0 0.0005367486737668514
ninth I-Disease 0 0.001455985358916223
component I-Disease 0 0.00015516379789914936
of I-Disease 0 0.00010704148007789627
human I-Disease 0 6.982960621826351e-05
complement I-Disease 0 0.00019003552733920515
( O 0 0.00013956472685094923
C9 O 1 0.9971837401390076
) O 0 2.24085379159078e-05
is O 0 5.76628599446849e-06
the O 0 1.054137828759849e-05
most O 0 1.5437297406606376e-05
common O 0 0.0001010611085803248
complement B-Disease 1 0.9999973773956299
deficiency I-Disease 1 1.0
in O 0 0.004495933651924133
Japan O 0 0.0012916623381897807
but O 0 8.820727998681832e-06
is O 0 6.9866391640971415e-06
rare O 0 1.8159131286665797e-05
in O 0 2.0870898879365996e-05
other O 0 1.91000071936287e-05
countries O 0 4.660950435209088e-05
. O 0 0.00015583103231620044

We O 0 0.0001052985608112067
studied O 0 5.659294401993975e-05
the O 0 1.4162808838591445e-05
molecular O 0 2.0786241293535568e-05
basis O 0 4.347439607954584e-05
of O 0 0.0010023171780630946
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0006555719883181155
four O 0 0.00019820063607767224
Japanese O 0 0.17599312961101532
C9 B-Disease 1 1.0
- I-Disease 1 0.9998522996902466
deficient I-Disease 1 0.9987574815750122
patients O 0 0.000246346287894994
who O 0 0.00010292246588505805
had O 0 0.0012075243284925818
suffered O 1 0.9999998807907104
from O 1 0.9999648332595825
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.017940431833267212

Direct O 0 0.0006328662857413292
sequencing O 0 0.0004698172560892999
of O 0 0.0006955534918233752
amplified O 0 0.003770790994167328
C9 O 0 0.01878882199525833
cDNA O 0 0.00034766370663419366
and O 0 2.876118196581956e-05
DNA O 0 4.759778312291019e-05
revealed O 0 0.00011057921074097976
a O 0 4.24994359491393e-05
nonsense O 0 0.0002757374895736575
substitution O 0 0.00012350782344583422
( O 0 0.00018434933735989034
CGA O 0 0.0032508978620171547
- O 0 0.0006699372315779328
- O 0 0.00031958631007000804
> O 0 0.0002242602058686316
TGA O 0 0.0009594794828444719
) O 0 1.9089682609774172e-05
at O 0 4.636501398636028e-05
codon O 0 2.003090048674494e-05
95 O 0 3.77950600523036e-05
in O 0 3.184218439855613e-05
exon O 0 0.0002038599777733907
4 O 0 6.956175639061257e-05
in O 0 2.5824541808106005e-05
the O 0 7.444546645274386e-05
four O 0 0.00027514767134562135
C9 B-Disease 1 0.9999637603759766
- I-Disease 0 0.3008180558681488
deficient I-Disease 0 0.011643770150840282
individuals O 0 0.00010223304707324132
. O 0 0.00032501661917194724

An O 0 0.0001851604029070586
allele O 0 0.00010974932956742123
- O 0 9.023752500070259e-05
specific O 0 5.339245035429485e-06
polymerase O 0 0.00021074597316328436
chain O 0 8.701829210622236e-05
reaction O 0 2.3511323888669722e-05
system O 0 6.693286559311673e-05
designed O 0 7.001143967499956e-05
to O 0 3.8488611608045176e-05
detect O 0 0.0001359743473585695
exclusively O 0 5.9719175624195486e-05
only O 0 1.0241172276437283e-05
one O 0 5.99199165662867e-06
of O 0 2.7006359232473187e-05
the O 0 7.075562461977825e-05
normal O 0 7.315271068364382e-05
and O 0 1.6034016880439594e-05
mutant O 0 5.191274613025598e-05
alleles O 0 1.0334149010304827e-05
indicated O 0 2.5795574401854537e-05
that O 0 2.1634541553794406e-06
all O 0 3.6774454201804474e-06
the O 0 1.351094488200033e-05
four O 0 1.6375770428567193e-05
patients O 0 1.7833603124017827e-05
were O 0 1.5015007193142083e-05
homozygous O 0 1.4491669389826711e-05
for O 0 7.062823442538502e-06
the O 0 2.4947428755695e-05
mutation O 0 1.635784974496346e-05
in O 0 2.5013274353113957e-05
exon O 0 0.00021068126079626381
4 O 0 5.9319703723303974e-05
and O 0 5.372261057345895e-06
that O 0 2.1792850475321757e-06
the O 0 1.2671033800870646e-05
parents O 0 3.3949900171137415e-06
of O 0 3.37563396897167e-05
patient O 0 8.361881918972358e-05
2 O 0 0.00020059464441146702
were O 0 9.902195597533137e-05
heterozygous O 0 0.00016256686649285257
. O 0 0.00016381358727812767

The O 0 0.0004985909909009933
common O 0 0.00010657663369784132
mutation O 0 3.97186195186805e-05
at O 0 0.00012718752259388566
codon O 0 5.210627205087803e-05
95 O 0 6.304712587734684e-05
in O 0 4.264413291821256e-05
exon O 0 0.000316527730319649
4 O 0 0.00011326764069963247
might O 0 1.8203898434876464e-05
be O 0 3.9457772800233215e-06
responsible O 0 1.183687254524557e-05
for O 0 1.1999390153505374e-05
most O 0 9.527881047688425e-05
Japanese O 1 0.9961181879043579
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.0011161386501044035
. O 0 0.0005813126335851848

BRCA1 O 0 0.0008182633318938315
required O 0 3.1832041713641956e-05
for O 0 3.7819580029463395e-05
transcription O 0 0.0025018774904310703
- O 0 0.001272020977921784
coupled O 0 0.0005618604482151568
repair O 0 0.0031732514034956694
of O 0 0.0006564085488207638
oxidative O 0 0.13472136855125427
DNA O 0 0.006652534939348698
damage O 1 0.9788545370101929
. O 0 0.0008350607822649181

The O 0 0.001222583232447505
breast B-Disease 1 0.9999990463256836
and I-Disease 1 0.9997205138206482
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999967813491821
gene O 0 0.0010349330259487033
BRCA1 O 0 0.0012754433555528522
encodes O 0 0.00023509007587563246
a O 0 0.00025176562485285103
zinc O 0 0.008060665801167488
finger O 0 0.0010055920574814081
protein O 0 0.000103173908428289
of O 0 0.00015248236013576388
unknown O 0 0.0005188605282455683
function O 0 0.00033304528915323317
. O 0 0.00041331545799039304

Association O 0 0.00031764930463396013
of O 0 0.00015768656157888472
the O 0 0.00013060617493465543
BRCA1 O 0 0.0004112482420168817
protein O 0 2.2443977286457084e-05
with O 0 5.503941338247387e-06
the O 0 3.415273749851622e-05
DNA O 0 0.0001827272353693843
repair O 0 0.0034921281039714813
protein O 0 0.00030937869451008737
Rad51 O 0 0.001643864787183702
and O 0 2.014665187743958e-05
changes O 0 5.218577371124411e-06
in O 0 6.92810635882779e-06
the O 0 8.341185093740933e-06
phosphorylation O 0 1.0879593901336193e-05
and O 0 1.0987334462697618e-05
cellular O 0 5.647994112223387e-05
localization O 0 0.00018689603894017637
of O 0 5.2646195399574935e-05
the O 0 4.293970050639473e-05
protein O 0 4.242970680934377e-05
after O 0 5.423746188171208e-05
exposure O 0 0.00011330793495289981
to O 0 4.131182504352182e-05
DNA O 0 0.00016655937361065298
- O 0 0.0002000336826313287
damaging O 0 9.888267959468067e-05
agents O 0 1.0245958947052713e-05
are O 0 1.5404765463244985e-06
consistent O 0 8.892929145076778e-06
with O 0 2.557589368734625e-06
a O 0 1.522362890682416e-05
role O 0 7.677914982195944e-05
for O 0 6.097959339967929e-05
BRCA1 O 0 0.001286719343625009
in O 0 0.00027732120361179113
DNA O 0 0.0011715941363945603
repair O 0 0.26227256655693054
. O 0 0.0007106672856025398

Here O 0 0.00044945572153665125
, O 0 2.33613136515487e-05
it O 0 2.8404060685716104e-06
is O 0 4.678011919168057e-06
shown O 0 1.9428813175181858e-05
that O 0 2.0206105546094477e-05
mouse O 0 0.0002909695031121373
embryonic O 0 0.0016089380951598287
stem O 0 0.005209651775658131
cells O 0 0.00019767708727158606
deficient B-Disease 0 0.0008748956024646759
in I-Disease 0 4.3697102228179574e-05
BRCA1 I-Disease 0 0.00025482900673523545
are O 0 8.806792720861267e-06
defective O 0 0.00018921175797004253
in O 0 2.0993364159949124e-05
the O 0 2.4685776224941947e-05
ability O 0 1.2338256055954844e-05
to O 0 6.269612185860751e-06
carry O 0 6.511049832624849e-06
out O 0 1.1374266250641085e-05
transcription O 0 0.0002886425063479692
- O 0 0.00034922955092042685
coupled O 0 0.0001990120654227212
repair O 0 0.001146324910223484
of O 0 0.00028612231835722923
oxidative O 0 0.010976786725223064
DNA O 0 0.0011401604861021042
damage O 0 0.19093972444534302
, O 0 2.9864278985769488e-05
and O 0 1.2211527973704506e-05
are O 0 9.610123925085645e-06
hypersensitive O 0 0.0022210502065718174
to O 0 0.00039811021997593343
ionizing O 1 0.9987346529960632
radiation O 1 0.5779073238372803
and O 0 0.00012419609993230551
hydrogen O 0 0.00041685812175273895
peroxide O 0 0.0009262131643481553
. O 0 0.00039233642746694386

These O 0 7.609217573190108e-05
results O 0 3.910961459041573e-05
suggest O 0 6.0301972553133965e-05
that O 0 2.545542702137027e-05
BRCA1 O 0 0.0003394554369151592
participates O 0 0.0001058730558725074
, O 0 2.4229526388808154e-05
directly O 0 3.5678087442647666e-05
or O 0 1.3790366210741922e-05
indirectly O 0 9.446783224120736e-05
, O 0 1.2203867299831472e-05
in O 0 2.883032721001655e-05
transcription O 0 0.0010351724922657013
- O 0 0.0007687261095270514
coupled O 0 0.0003169459232594818
repair O 0 0.0013585335109382868
of O 0 0.0004260431742295623
oxidative O 0 0.13651756942272186
DNA O 0 0.003085580887272954
damage O 1 0.8355848789215088
. O 0 0.0002793845778796822
. O 0 0.00024292415764648467

Truncation O 0 0.0033850569743663073
mutations O 0 0.00022534283925779164
in O 0 7.259268750203773e-05
the O 0 8.165204781107605e-05
transactivation O 0 0.0016695355297997594
region O 0 0.0002382525708526373
of O 0 0.00022675757645629346
PAX6 O 1 0.9970695972442627
result O 0 0.00017141245189122856
in O 0 0.00015729820006527007
dominant O 0 0.0011890449095517397
- O 0 0.00041819564648903906
negative O 0 0.00011912146146642044
mutants O 0 0.0008594065438956022
. O 0 0.0001958828215720132

PAX6 O 0 0.04112813249230385
is O 0 8.837426867103204e-05
a O 0 3.046234451176133e-05
transcription O 0 0.00016794631665106863
factor O 0 3.516277502058074e-05
with O 0 4.994859864382306e-06
two O 0 1.3250266420072876e-05
DNA O 0 8.382408850593492e-05
- O 0 9.049406071426347e-05
binding O 0 1.0308981472917367e-05
domains O 0 0.0001454032026231289
( O 0 6.642888183705509e-05
paired O 0 0.00012630199489649385
box O 0 0.0002465342404320836
and O 0 2.741840398812201e-05
homeobox O 0 0.0010775970295071602
) O 0 2.6343266654293984e-05
and O 0 1.8523711332818493e-05
a O 0 9.419079287908971e-05
proline O 0 0.000688420026563108
- O 0 0.0006558738532476127
serine O 0 0.00035037679481320083
- O 0 0.0003768079332076013
threonine O 0 0.00022958748741075397
( O 0 0.00012090185919078067
PST O 0 0.0677681714296341
) O 0 0.00014915913925506175
- O 0 0.0005079127149656415
rich O 0 0.00014207782805897295
transactivation O 0 0.0020888668950647116
domain O 0 0.000814637984149158
. O 0 0.00036226853262633085

PAX6 O 1 0.999976634979248
regulates O 0 0.011925535276532173
eye O 0 0.033069830387830734
development O 0 0.000318261852953583
in O 0 0.00010783525067381561
animals O 0 3.7103960494278e-05
ranging O 0 0.0001711507939035073
from O 0 0.00012972841795999557
jellyfish O 0 7.472726429114118e-05
to O 0 3.8601643609581515e-05
Drosophila O 0 0.0001735822152113542
to O 0 9.520523599348962e-05
humans O 0 0.0004889894044026732
. O 0 0.00019725837046280503

Heterozygous O 0 0.0005169535288587213
mutations O 0 0.00012575964501593262
in O 0 5.793039599666372e-05
the O 0 0.00014173331146594137
human O 0 0.00022658683883491904
PAX6 O 1 0.795102059841156
gene O 0 8.518200775142759e-05
result O 0 2.3658603822696023e-05
in O 0 1.0897465472226031e-05
various O 0 9.433393643121235e-06
phenotypes O 0 0.00014090836339164525
, O 0 3.0022934879525565e-05
including O 0 0.00010151349852094427
aniridia B-Disease 1 1.0
, O 0 0.0007197370287030935
Peters B-Disease 1 0.9999996423721313
anomaly I-Disease 1 1.0
, O 0 0.0008279362809844315
autosomal B-Disease 1 0.9998577833175659
dominant I-Disease 1 0.9999991655349731
keratitis I-Disease 1 1.0
, O 0 0.0032026737462729216
and O 0 0.0008538255351595581
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9995204210281372

It O 0 0.00011474327038740739
is O 0 2.6090800020028837e-05
believed O 0 5.005614730180241e-05
that O 0 2.8696538265648996e-06
the O 0 1.2626919669855852e-05
mutated O 0 3.0146589779178612e-05
allele O 0 1.5069979781401344e-05
of O 0 0.00014904994168318808
PAX6 O 0 0.10477276146411896
produces O 0 4.975603587809019e-05
an O 0 1.9980569049948826e-05
inactive O 0 0.00030799637897871435
protein O 0 7.60057955631055e-05
and O 0 2.7441896236268803e-05
aniridia B-Disease 1 0.9999939203262329
is O 0 6.71186062390916e-05
caused O 0 0.0003370016347616911
due O 0 0.00026270427042618394
to O 0 0.00015253268065862358
genetic O 0 0.0013037805911153555
haploinsufficiency O 1 0.9728325009346008
. O 0 0.0008099117549136281

However O 0 0.00036957679549232125
, O 0 3.378700421308167e-05
several O 0 1.1529662515386008e-05
truncation O 0 0.00031832620152272284
mutations O 0 8.349691779585555e-05
have O 0 1.8430038835504092e-05
been O 0 3.0260853236541152e-05
found O 0 7.167945568653522e-06
to O 0 7.669206752325408e-06
occur O 0 1.2261028132343199e-05
in O 0 2.176433554268442e-05
the O 0 5.243550913291983e-05
C O 0 0.0012143654748797417
- O 0 0.0003306106955278665
terminal O 0 0.0003740181855391711
half O 0 4.0820203139446676e-05
of O 0 0.00015152778360061347
PAX6 O 1 0.886670708656311
in O 0 0.00016752279771026224
patients O 0 0.0001065246106008999
with O 0 7.821829058229923e-05
Aniridia B-Disease 1 0.9999997615814209
resulting O 0 0.00046310233301483095
in O 0 6.964885687921196e-05
mutant O 0 8.246584911830723e-05
proteins O 0 6.489700353995431e-06
that O 0 1.3810166592520545e-06
retain O 0 2.3028329451335594e-05
the O 0 2.2893618734087795e-05
DNA O 0 0.0001266774779651314
- O 0 0.00014730179100297391
binding O 0 2.036225123447366e-05
domains O 0 6.767705781385303e-05
but O 0 9.504097761237063e-06
have O 0 6.934174507478019e-06
lost O 0 9.577453602105379e-05
most O 0 7.222909971460467e-06
of O 0 3.826011379715055e-05
the O 0 0.00012664968380704522
transactivation O 0 0.0074265203438699245
domain O 0 0.0014738012105226517
. O 0 0.0005027582519687712

It O 0 8.654444536659867e-05
is O 0 1.6503576262039132e-05
not O 0 2.0864788439212134e-06
clear O 0 1.4579612980014645e-05
whether O 0 7.628953881066991e-06
such O 0 1.303683347941842e-05
mutants O 0 0.0006314365891739726
really O 0 0.00011890163295902312
behave O 0 6.469613435911015e-05
as O 0 4.1415256418986246e-05
loss O 0 0.0003254283801652491
- O 0 0.00022520966012962162
of O 0 7.269499474205077e-05
- O 0 0.00022988163982518017
function O 0 4.643873398890719e-05
mutants O 0 0.00012008539488306269
as O 0 3.3686043025227264e-05
predicted O 0 0.00020438797946553677
by O 0 6.133827264420688e-05
haploinsufficiency O 0 0.007209194358438253
. O 0 0.0005291346460580826

Contrary O 0 0.0003058083530049771
to O 0 3.417652260395698e-05
this O 0 9.778388630365953e-06
theory O 0 4.223496580380015e-05
, O 0 6.130116616986925e-06
our O 0 6.0559254961845e-06
data O 0 7.011102297838079e-06
showed O 0 2.1279685824993066e-05
that O 0 3.2716502573748585e-06
these O 0 3.929288595827529e-06
mutants O 0 8.437639917246997e-05
are O 0 7.273161827470176e-06
dominant O 0 0.00032861027284525335
- O 0 0.00021276621555443853
negative O 0 3.956645377911627e-05
in O 0 4.2612020479282364e-05
transient O 0 0.0002652401744853705
transfection O 0 0.00035797321470454335
assays O 0 2.6051888198708184e-05
when O 0 9.48114029597491e-06
they O 0 2.4966636829049094e-06
are O 0 2.4590256089140894e-06
coexpressed O 0 0.00041139250970445573
with O 0 3.838106931652874e-05
wild O 0 0.00046888174256309867
- O 0 0.0017710895044729114
type O 0 0.0013086242834106088
PAX6 O 1 0.9986233711242676
. O 0 0.0008673369884490967

We O 0 8.24767048470676e-05
found O 0 7.106699285941431e-06
that O 0 2.1032244603702566e-06
the O 0 1.6608664736850187e-05
dominant O 0 0.00026444802642799914
- O 0 8.781110955169424e-05
negative O 0 1.0492292858543806e-05
effects O 0 4.859292312175967e-05
result O 0 1.4336151252791751e-05
from O 0 1.094618892238941e-05
the O 0 1.647915087232832e-05
enhanced O 0 6.74648690619506e-05
DNA O 0 2.736918395385146e-05
binding O 0 5.56009990759776e-06
ability O 0 1.3876143384550232e-05
of O 0 5.077988316770643e-05
these O 0 3.5776072763837874e-05
mutants O 0 0.0008977498509921134
. O 0 0.00025355396792292595

Kinetic O 0 0.0016922380309551954
studies O 0 9.527426300337538e-05
of O 0 0.00013812955876346678
binding O 0 7.837567682145163e-05
and O 0 4.953649840899743e-05
dissociation O 0 0.000158288239617832
revealed O 0 0.000119163712952286
that O 0 2.190476607211167e-06
various O 0 7.217600796138868e-06
truncation O 0 0.00033585820347070694
mutants O 0 0.00027287195553071797
have O 0 1.6396772480220534e-05
3 O 0 0.00015166858793236315
- O 0 0.00017719365132506937
5 O 0 9.4731425633654e-05
- O 0 8.340157364727929e-05
fold O 0 3.251869202358648e-05
higher O 0 1.168419657915365e-05
affinity O 0 7.114592335710768e-06
to O 0 5.805240562040126e-06
various O 0 1.3292778930917848e-05
DNA O 0 0.00010226785525446758
- O 0 6.380693230312318e-05
binding O 0 6.018927251716377e-06
sites O 0 1.747617352521047e-05
when O 0 1.022499145619804e-05
compared O 0 1.3419346942100674e-05
with O 0 7.711140824540053e-06
the O 0 8.271267870441079e-05
wild O 0 0.0004050015704706311
- O 0 0.0008510244661010802
type O 0 0.0009520229650661349
PAX6 O 1 0.9941458702087402
. O 0 0.00087371637346223

These O 0 6.55497788102366e-05
results O 0 2.808214230753947e-05
provide O 0 1.8480091966921464e-05
a O 0 2.638203659444116e-05
new O 0 1.2451817383407615e-05
insight O 0 3.86868450732436e-05
into O 0 1.007221271720482e-05
the O 0 1.1212395293114241e-05
role O 0 3.956509681302123e-05
of O 0 8.873028127709404e-05
mutant O 0 0.001718794577755034
PAX6 O 1 0.9995548129081726
in O 0 0.0007628909079357982
causing O 1 0.6919791102409363
aniridia B-Disease 1 0.999998927116394
. O 0 0.00026949637685902417
. O 0 0.0002827912103384733

Reversal O 0 0.05186619237065315
of O 1 0.9950799942016602
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9707415699958801
excellent O 0 0.007497587241232395
neuropsychologic O 1 0.7861973643302917
outcome O 0 0.0003472039243206382
in O 0 6.408499029930681e-05
very B-Disease 0 4.789355079992674e-05
- I-Disease 0 0.00020722013141494244
long I-Disease 0 0.00019550927390810102
- I-Disease 0 0.0002753234875854105
chain I-Disease 0 0.00012821488780900836
acyl I-Disease 0 0.00012144687934778631
- I-Disease 0 0.0002715199370868504
coenzyme I-Disease 0 0.00010341700544813648
A I-Disease 0 0.005781340412795544
dehydrogenase I-Disease 0 0.1692851036787033
deficiency I-Disease 1 0.9999997615814209
. O 0 0.0026756462175399065

Very B-Disease 0 0.0011420197552070022
- I-Disease 0 0.001546933432109654
long I-Disease 0 0.0005337853799574077
- I-Disease 0 0.00031822125311009586
chain I-Disease 0 7.197789091151208e-05
acyl I-Disease 0 6.176900205900893e-05
- I-Disease 0 7.150760211516172e-05
coenzyme I-Disease 0 1.1150759746669792e-05
A I-Disease 0 0.00011686875222949311
dehydrogenase I-Disease 0 0.0001517733180662617
( I-Disease 0 0.00022316089598461986
VLCAD I-Disease 1 0.9999988079071045
) I-Disease 0 0.0008904794231057167
deficiency I-Disease 1 0.9999984502792358
is O 0 8.292384882224724e-05
a O 0 0.00012845805031247437
disorder O 1 0.9999982118606567
of O 1 0.997525155544281
fatty O 1 0.9995710253715515
acid O 0 0.0007521556108258665
beta O 0 0.00037899220478720963
oxidation O 0 8.852034079609439e-05
that O 0 1.88873218576191e-05
reportedly O 0 9.380062692798674e-05
has O 0 1.1446028111095075e-05
high O 0 7.105327676981688e-05
rates O 0 2.3281736503122374e-05
of O 0 6.363684224197641e-05
morbidity O 0 0.0019793144892901182
and O 0 0.00026775148580782115
mortality O 0 0.0054968055337667465
. O 0 0.000533109181560576

We O 0 0.00012071764649590477
describe O 0 2.8739905246766284e-05
the O 0 1.4557840586348902e-05
outcome O 0 2.3388063709717244e-05
of O 0 3.501486935419962e-05
a O 0 6.11365758231841e-05
5 O 0 0.00021462072618305683
- O 0 0.00021187665697652847
year O 0 7.317615381907672e-05
- O 0 0.0001643677824176848
old O 0 0.0001673191145528108
girl O 0 0.00016117531049530953
with O 0 0.0001463755761506036
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 0.0021169662941247225
was O 0 0.0009515052661299706
first O 0 5.6255568779306486e-05
seen O 0 6.223895616130903e-05
at O 0 2.8181433663121425e-05
5 O 0 2.329466224182397e-05
months O 0 1.7687332729110494e-05
of O 0 2.166588637919631e-05
age O 0 0.00022407811775337905
with O 0 0.0002520114940125495
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 0 0.15258587896823883
and O 0 0.003046072321012616
hypotonia B-Disease 1 0.9999819993972778
. O 0 0.0032251474913209677

Biochemical O 0 0.012260915711522102
studies O 0 0.0006826784228906035
indicated O 1 0.9981693029403687
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9999903440475464
by O 0 0.0001951985905179754
a O 0 0.00023050121671985835
stable O 0 0.0010722066508606076
yet O 0 0.00014040379028301686
inactive O 0 0.0006161882192827761
enzyme O 0 0.0003740699030458927
. O 0 0.0002916621742770076

Molecular O 0 0.0005092237843200564
genetic O 0 0.00010208565799985081
analysis O 0 1.9702200006577186e-05
of O 0 0.00018319494847673923
her O 0 0.00028753752121701837
VLCAD O 1 0.9999725818634033
gene O 0 0.00035300961462780833
revealed O 0 0.0005065067671239376
a O 0 0.00012410484487190843
T1372C O 0 0.001249374938197434
( O 0 0.00014319895126391202
F458L O 0 0.001315223053097725
) O 0 8.23966838652268e-05
missense O 0 0.00043456832645460963
mutation O 0 7.484836532967165e-05
and O 0 4.762965181726031e-05
a O 0 0.00031215124181471765
1668 O 1 0.9999431371688843
ACAG O 1 0.9999983310699463
1669 O 1 0.9800963997840881
splice O 0 0.0033488094341009855
site O 0 0.001263284357264638
mutation O 0 0.00026566258748061955
. O 0 0.00019268185133114457

After O 0 0.000668943568598479
initial O 0 0.00018168955284636468
treatment O 0 0.0005971278878860176
with O 0 0.00018317243666388094
intravenous O 1 0.999826967716217
glucose O 1 0.9763336777687073
and O 0 0.0005574867827817798
carnitine O 1 0.9846230149269104
, O 0 3.7147146940696985e-05
the O 0 3.113254206255078e-05
patient O 0 5.289822365739383e-05
has O 0 1.5442683434230275e-05
thrived O 0 0.00024711695732548833
on O 0 3.9856997318565845e-05
a O 0 5.2224568207748234e-05
low O 0 0.00029251904925331473
- O 0 0.0004246204043738544
fat O 0 0.00015685157268308103
diet O 0 4.251995051163249e-05
supplemented O 0 3.789084075833671e-05
with O 0 1.1921985787921585e-05
medium O 0 0.0002741379721555859
- O 0 0.0004953843308612704
chain O 0 0.0002013697667280212
triglyceride O 0 0.00034538653562776744
oil O 0 0.00035583850694820285
and O 0 6.30602880846709e-05
carnitine O 0 0.0027513715904206038
and O 0 8.949916082201526e-05
avoidance O 0 0.002680353354662657
of O 0 0.0028994872700423002
fasting O 0 0.003760491032153368
. O 0 0.000604877423029393

Her O 0 0.008993210271000862
ventricular O 1 0.9999990463256836
hypertrophy O 1 0.9999904632568359
resolved O 0 0.12591411173343658
significantly O 0 0.00026623360463418067
over O 0 4.306884511606768e-05
1 O 0 0.00011757900210795924
year O 0 4.477191760088317e-05
, O 0 1.5180643458734266e-05
and O 0 2.8921169359819032e-05
cognitively O 0 0.0028205090202391148
, O 0 3.7227368011372164e-05
she O 0 2.4973136532935314e-05
is O 0 9.54034931055503e-06
in O 0 1.2285022421565372e-05
the O 0 4.58542890555691e-05
superior O 0 0.0002562005538493395
range O 0 0.00013364155893214047
for O 0 8.433988114120439e-05
age O 0 0.00147011480294168
. O 0 0.0005455026985146105

Clinical O 0 0.0005919587565585971
recognition O 0 0.0010519700590521097
of O 1 0.9999980926513672
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.0010769243817776442
important O 0 9.158557077171281e-05
because O 0 4.547423031908693e-06
it O 0 9.730339343150263e-07
is O 0 1.1793105159085826e-06
one O 0 1.4002276884639286e-06
of O 0 8.92909611138748e-06
the O 0 2.5665523935458623e-05
few O 0 0.00010314253449905664
directly O 0 0.0005199398146942258
treatable O 1 1.0
causes O 1 0.9995131492614746
of O 1 0.9999946355819702
cardiomyopathy B-Disease 1 1.0
in O 1 0.9997177720069885
children O 0 0.0016054201405495405
. O 0 0.00017746993398759514
. O 0 0.0002597608545329422

Cloning O 0 0.0008160138968378305
of O 0 0.00011898545199073851
a O 0 6.212184234755114e-05
novel O 0 5.192442404222675e-05
member O 0 2.7978903744951822e-05
of O 0 4.907379116048105e-05
the O 0 6.687200220767409e-05
low O 0 0.0003273033071309328
- O 0 0.0001919739879667759
density O 0 7.278670091181993e-05
lipoprotein O 0 0.0013096318580210209
receptor O 0 0.0006954517448320985
family O 0 0.0003436176339164376
. O 0 0.00020960990514140576

A O 0 0.0005304865771904588
gene O 0 1.3543994100473356e-05
encoding O 0 9.970088285626844e-06
a O 0 2.519493682484608e-05
novel O 0 6.341185508063063e-05
transmembrane O 0 0.0004926761612296104
protein O 0 8.9089255197905e-05
was O 0 0.00014330701378639787
identified O 0 1.184311622637324e-05
by O 0 1.9491949387884233e-06
DNA O 0 4.7490157157881185e-06
sequence O 0 2.952675913547864e-06
analysis O 0 1.4474546787823783e-06
within O 0 3.296665454399772e-06
the O 0 3.057914727833122e-05
insulin B-Disease 0 0.0005146551411598921
- I-Disease 0 0.0028489623218774796
dependent I-Disease 0 0.0005629344377666712
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 0.2923615574836731
IDDM B-Disease 1 0.9999964237213135
) O 0 0.00010993630712619051
locus O 0 0.0005673221312463284
IDDM4 O 1 0.9276418685913086
on O 0 0.0005318225594237447
chromosome O 0 0.00162295694462955
11q13 O 0 0.003935525193810463
. O 0 0.00041598439565859735

Based O 0 0.00013063731603324413
on O 0 0.000151059080963023
its O 0 3.919148730346933e-05
chromosomal O 0 0.0006027919589541852
position O 0 0.00021001981804147363
, O 0 1.5230148164846469e-05
this O 0 8.842433089739643e-06
gene O 0 9.37735239858739e-06
is O 0 4.508490292209899e-06
a O 0 6.396232492988929e-06
candidate O 0 8.353691555385012e-06
for O 0 8.796090696705505e-06
conferring O 0 0.00047434825683012605
susceptibility O 1 0.8590746521949768
to O 0 0.07777697592973709
diabetes B-Disease 1 1.0
. O 0 0.0029926663264632225

The O 0 0.00071092473808676
gene O 0 0.00015620516205672175
, O 0 3.632329753600061e-05
termed O 0 0.00035592637141235173
low O 0 0.00041600578697398305
- O 0 0.00019494710431899875
density O 0 5.472823977470398e-05
lipoprotein O 0 0.00033289488055743277
receptor O 0 0.00011859126971103251
related O 0 9.886269981507212e-05
protein O 0 9.85734150162898e-05
5 O 0 0.00011735036969184875
( O 0 5.587990744970739e-05
LRP5 O 0 0.00509401923045516
) O 0 1.4594997992389835e-05
, O 0 6.132800535851857e-06
encodes O 0 8.579622772231232e-06
a O 0 1.4575997738575097e-05
protein O 0 2.391734960838221e-05
of O 0 0.00012451318616513163
1615 O 0 0.003626110265031457
amino O 0 6.966538785491139e-05
acids O 0 1.6762343875598162e-05
that O 0 4.342461124906549e-06
contains O 0 1.4222173376765568e-05
conserved O 0 8.287428499897942e-05
modules O 0 6.485514313681051e-05
which O 0 5.488981059897924e-06
are O 0 1.6252715795417316e-06
characteristic O 0 1.3462017705023754e-05
of O 0 6.750541797373444e-05
the O 0 0.00010678231774363667
low O 0 0.00039085213211365044
- O 0 0.00020518347446341068
density O 0 5.8172539866063744e-05
lipoprotein O 0 0.0011204744223505259
( O 0 0.0002317769976798445
LDL O 0 0.007055441848933697
) O 0 9.999207395594567e-05
receptor O 0 0.0003233044990338385
family O 0 0.00028423406183719635
. O 0 0.00022518972400575876

These O 0 7.719636050751433e-05
modules O 0 0.00038489027065224946
include O 0 5.132642399985343e-05
a O 0 8.223410986829549e-05
putative O 0 0.0002868165902327746
signal O 0 0.00034214562037959695
peptide O 0 8.802087540971115e-05
for O 0 1.720946966088377e-05
protein O 0 3.782931889872998e-05
export O 0 5.514324948308058e-05
, O 0 7.776728125463706e-06
four O 0 2.28514527407242e-05
epidermal O 0 0.0008648735238239169
growth O 0 0.0001853338471846655
factor O 0 8.968541078502312e-05
( O 0 6.389235204551369e-05
EGF O 0 0.0025893973652273417
) O 0 1.4305640434031375e-05
repeats O 0 2.829545337590389e-05
with O 0 8.543387593817897e-06
associated O 0 4.0688446460990235e-05
spacer O 0 0.00047164372517727315
domains O 0 0.00040077074663713574
, O 0 5.698377208318561e-05
three O 0 7.896888564573601e-05
LDL O 0 0.20649375021457672
- O 0 0.0012536674039438367
receptor O 0 0.00012966012582182884
( O 0 6.270099402172491e-05
LDLR O 0 0.005751749034970999
) O 0 1.7038944861269556e-05
repeats O 0 6.550954276463017e-05
, O 0 7.671781531826127e-06
a O 0 1.7756015949998982e-05
single O 0 2.7513326131156646e-05
transmembrane O 0 0.0008178876014426351
spanning O 0 0.003666857024654746
domain O 0 0.00049871631199494
, O 0 4.3996402382617816e-05
and O 0 2.605849840620067e-05
a O 0 9.141166810877621e-05
cytoplasmic O 0 0.0004336157871875912
domain O 0 0.0009703795076347888
. O 0 0.0002784079115372151

The O 0 0.0001104456969187595
encoded O 0 5.800336293759756e-05
protein O 0 3.836460382444784e-05
has O 0 5.7068518799496815e-06
a O 0 5.832265287608607e-06
unique O 0 6.97020232109935e-06
organization O 0 6.410485184460413e-06
of O 0 6.054894038243219e-05
EGF O 1 0.9991612434387207
and O 0 0.00013947932166047394
LDLR O 1 0.999922513961792
repeats O 0 0.0002766470133792609
; O 0 9.64562059380114e-06
therefore O 0 3.519827077980153e-05
, O 0 2.72317229246255e-05
LRP5 O 1 0.8368827700614929
likely O 0 3.612680302467197e-05
represents O 0 1.503673138358863e-05
a O 0 1.1670164894894697e-05
new O 0 4.368404461274622e-06
category O 0 1.0228765859210398e-05
of O 0 2.643492007337045e-05
the O 0 0.00027239133487455547
LDLR O 1 0.9999810457229614
family O 0 0.000472394865937531
. O 0 0.00027260181377641857

Both O 0 0.00037765843444503844
human O 0 0.0003637214540503919
and O 0 0.00023087140289135277
mouse O 0 0.0011416042689234018
LRP5 O 1 0.9999638795852661
cDNAs O 0 0.02052578516304493
have O 0 1.5061445083119906e-05
been O 0 1.879659430414904e-05
isolated O 0 1.9272729332442395e-05
and O 0 1.4885231394146103e-06
the O 0 5.904892532271333e-06
encoded O 0 1.397457435814431e-05
mature O 0 2.910477815021295e-05
proteins O 0 3.1251670407073107e-06
are O 0 1.0173654345635441e-06
95 O 0 1.591377986187581e-05
% O 0 1.1459889719844796e-05
identical O 0 2.694277100090403e-05
, O 0 1.393508955516154e-05
indicating O 0 8.081374107860029e-05
a O 0 4.547438948065974e-05
high O 0 0.0001392709236824885
degree O 0 0.0001531558664282784
of O 0 0.0003650397411547601
evolutionary O 0 0.0006947966176085174
conservation O 0 0.0002042880660155788
. O 0 4.0190127037931234e-05
. O 0 8.84428882272914e-05

The O 0 0.0007931461441330612
APC B-Disease 0 0.0032215288374572992
variants O 0 0.0002464964345563203
I1307K O 0 0.0008092699572443962
and O 0 3.007704253832344e-05
E1317Q O 0 0.00035521603422239423
are O 0 7.84596886660438e-06
associated O 0 9.14358242880553e-05
with O 1 0.9959601759910583
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.4874766170978546
but O 0 3.038290742551908e-05
not O 0 5.921635420236271e-06
always O 0 1.1279295904387254e-05
with O 0 3.7870292999286903e-06
a O 0 3.507034489302896e-05
family O 0 7.797276339260861e-05
history O 0 0.0006547958473674953
. O 0 0.00028585700783878565

Classical O 0 0.4594727158546448
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998506307601929
FAP B-Disease 1 0.9999029636383057
) O 0 4.756860653287731e-05
is O 0 1.023014192469418e-05
a O 0 1.794866875570733e-05
high O 0 0.0005717710591852665
- O 0 0.010781749151647091
penetrance O 1 0.9880573749542236
autosomal B-Disease 1 0.9999717473983765
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
that O 0 9.168430551653728e-05
predisposes O 0 0.003726683324202895
to O 0 5.970892743789591e-05
hundreds O 0 6.220393697731197e-05
or O 0 2.7321257221046835e-05
thousands O 0 0.00025441095931455493
of O 1 0.9997846484184265
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999996423721313
carcinoma I-Disease 1 1.0
and O 0 0.0010260238777846098
that O 0 1.5491657904931344e-05
results O 0 1.0635914804879576e-05
from O 0 2.747981488937512e-05
truncating O 0 0.0002992181107401848
mutations O 0 3.520515383570455e-05
in O 0 5.640071685775183e-05
the O 0 0.00019265284936409444
APC B-Disease 0 0.00504729337990284
gene O 0 0.0003564095532055944
. O 0 0.00020502606639638543

A O 0 0.0015665426617488265
variant O 0 0.0006538170855492353
of O 0 0.0007301132427528501
FAP B-Disease 1 0.9987905621528625
is O 0 0.00041120860259979963
attenuated B-Disease 1 0.6912171244621277
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
coli I-Disease 1 0.9999803304672241
, O 0 6.302115798462182e-05
which O 0 1.4479431229119655e-05
results O 0 2.1708201529690996e-05
from O 0 0.00015326017455663532
germ O 1 0.9999816417694092
- O 0 0.001270428067073226
line O 0 0.00016880076145753264
mutations O 0 1.0027836651715916e-05
in O 0 8.713277566130273e-06
the O 0 1.6526615581824444e-05
5 O 0 3.1308678444474936e-05
and O 0 6.02222189627355e-06
3 O 0 3.672923776321113e-05
regions O 0 1.6627875083941035e-05
of O 0 5.6848461099434644e-05
the O 0 0.00025643393746577203
APC B-Disease 0 0.006820258684456348
gene O 0 0.0003303857520222664
. O 0 0.00023699695884715766

Attenuated B-Disease 1 0.9999884366989136
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.12484905123710632
have O 0 6.12910371273756e-05
" O 0 0.00019527175754774362
multiple O 0 0.0003490794915705919
" O 1 0.999977707862854
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0008984095766209066
typically O 0 4.5515211240854114e-05
fewer O 0 2.1456240574480034e-05
than O 0 1.2895166946691461e-05
100 O 0 3.959264722652733e-05
) O 0 1.3307542758411728e-05
without O 0 1.6267111277556978e-05
the O 0 7.323591853491962e-05
florid O 0 0.002182263880968094
phenotype O 0 0.00016987450362648815
of O 0 0.0005323957302607596
classical O 0 0.05242158845067024
FAP B-Disease 1 0.9998767375946045
. O 0 0.0008813301683403552

Another O 0 0.00033423936110921204
group O 0 6.123184721218422e-05
of O 0 0.00020084901188965887
patients O 0 0.00025267578894272447
with O 0 9.924959158524871e-05
multiple O 0 0.027411004528403282
adenomas B-Disease 1 0.9999996423721313
has O 0 0.00010334199032513425
no O 0 2.530603887862526e-05
mutations O 0 1.7094120266847312e-05
in O 0 2.814192521327641e-05
the O 0 0.00010136242781300098
APC B-Disease 0 0.0014959536492824554
gene O 0 4.0808445191942155e-05
, O 0 1.0409491551399697e-05
and O 0 6.8821805143670645e-06
their O 0 9.732448233989999e-06
phenotype O 0 5.381992377806455e-05
probably O 0 7.51176557969302e-05
results O 0 8.089098628261127e-06
from O 0 1.7147476683021523e-05
variation O 0 3.054997432627715e-05
at O 0 0.0001457386970287189
a O 0 5.587532723438926e-05
locus O 0 0.0001347707730019465
, O 0 2.3580081688123755e-05
or O 0 2.6911748136626557e-05
loci O 0 0.00014932379417587072
, O 0 3.497552825137973e-05
elsewhere O 0 3.730163734871894e-05
in O 0 3.7228968722047284e-05
the O 0 9.127151861321181e-05
genome O 0 0.00046812964137643576
. O 0 0.00027899540145881474

Recently O 0 0.0012811596971005201
, O 0 4.586670911521651e-05
however O 0 2.7619056709227152e-05
, O 0 8.463397534796968e-06
a O 0 1.472027270210674e-05
missense O 0 0.00014937820378690958
variant O 0 0.00012607252574525774
of O 0 0.00048164514009840786
APC B-Disease 1 0.6266876459121704
( O 0 0.00020036716887261719
I1307K O 0 0.001306939055211842
) O 0 3.4522105124779046e-05
was O 0 7.177855877671391e-05
described O 0 2.1361180188250728e-05
that O 0 1.6499514003953664e-06
confers O 0 2.202541691076476e-05
an O 0 7.290175290108891e-06
increased O 0 9.274265903513879e-05
risk O 0 0.0008302969508804381
of O 1 0.999984860420227
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.006289875600486994
including O 0 0.0002004755224334076
multiple O 0 0.014906966127455235
adenomas B-Disease 1 0.9999991655349731
, O 0 0.0003205591347068548
in O 0 0.0005236611468717456
Ashkenazim O 1 0.9939110279083252
. O 0 0.0009289112058468163

We O 0 0.00014299018948804587
have O 0 6.656535333604552e-06
studied O 0 4.153866757405922e-05
a O 0 8.291252015624195e-06
set O 0 6.496759851870593e-06
of O 0 1.0210296750301495e-05
164 O 0 8.25690949568525e-05
patients O 0 4.230679769534618e-05
with O 0 2.8998443667660467e-05
multiple O 1 0.9999964237213135
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999970197677612
/ I-Disease 1 0.9999998807907104
or I-Disease 1 0.9990158081054688
carcinoma I-Disease 1 1.0
and O 0 0.0014918617671355605
analyzed O 0 0.0004916173638775945
codons O 0 0.0008468585438095033
1263 O 0 0.026202674955129623
- O 0 0.0028456347063183784
1377 O 0 0.00660353247076273
( O 0 0.0001903209340525791
exon O 0 0.0006010946817696095
15G O 0 0.0004173873458057642
) O 0 5.851229616382625e-06
of O 0 1.3171928003430367e-05
the O 0 3.420528082642704e-05
APC B-Disease 0 0.0007116112974472344
gene O 0 5.7363467931281775e-05
for O 0 0.00010449374531162903
germ O 1 0.9999966621398926
- O 0 0.003182354848831892
line O 0 0.0005340820644050837
variants O 0 0.00017484415729995817
. O 0 0.0002445539284963161

Three O 0 0.0002923322608694434
patients O 0 9.581636550137773e-05
with O 0 1.5181974958977662e-05
the O 0 7.248166366480291e-05
I1307K O 0 0.000953358190599829
allele O 0 4.9550581024959683e-05
were O 0 3.154225123580545e-05
detected O 0 0.0001027082180371508
, O 0 6.007182946632383e-06
each O 0 2.6663485641620355e-06
of O 0 8.955209341365844e-05
Ashkenazi O 0 0.001166063011623919
descent O 0 0.0025310979690402746
. O 0 0.0008655511192046106

Four O 0 0.0005875127972103655
patients O 0 0.0006420010467991233
had O 0 0.0006623438093811274
a O 0 0.0009691922459751368
germ O 1 0.9999969005584717
- O 0 0.0025346579495817423
line O 0 0.0006474512629210949
E1317Q O 0 0.0007859983015805483
missense O 0 0.0002573480305727571
variant O 0 0.000114309492346365
of O 0 0.0001964990224223584
APC O 0 0.002065358217805624
that O 0 1.0506471880944446e-05
was O 0 0.00010948956332867965
not O 0 3.3108462957898155e-06
present O 0 8.9160766947316e-06
in O 0 2.4497971025994048e-05
controls O 0 4.0575265302322805e-05
; O 0 2.898959564845427e-06
one O 0 4.349286882643355e-06
of O 0 1.7849000869318843e-05
these O 0 7.368332717305748e-06
individuals O 0 9.83671452559065e-06
had O 0 6.73918257234618e-05
an O 0 1.1154833373439033e-05
unusually O 0 6.289693556027487e-05
large O 0 3.2403379009338096e-05
number O 0 1.2470341971493326e-05
of O 0 0.00014072975318413228
metaplastic B-Disease 1 0.971146821975708
polyps I-Disease 0 0.006387748755514622
of I-Disease 0 0.0005157000268809497
the I-Disease 0 0.0008604446775279939
colorectum I-Disease 1 0.9229824542999268
. O 0 0.0008390923612751067

There O 0 0.0002577155828475952
is O 0 2.6785904992721044e-05
increasing O 0 2.4821749320835806e-05
evidence O 0 1.94934709725203e-05
that O 0 4.617527793016052e-06
there O 0 2.009848140005488e-05
exist O 0 0.00010553780884947628
germ O 1 0.9979816675186157
- O 0 0.000385620747692883
line O 0 6.829106132499874e-05
variants O 0 7.826314686099067e-06
of O 0 1.8101020032190718e-05
the O 0 8.194978727260605e-05
APC B-Disease 0 0.0009374473011121154
gene O 0 2.817001222865656e-05
that O 0 5.335986770660384e-06
predispose O 0 7.026419189060107e-05
to O 0 7.526324225182179e-06
the O 0 9.291448805015534e-06
development O 0 1.8778375306283124e-05
of O 0 0.00011133094812976196
multiple O 1 0.9999862909317017
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.020764680579304695
but O 0 3.057154026464559e-05
without O 0 2.256914922327269e-05
the O 0 5.671482358593494e-05
florid O 0 0.0019924365915358067
phenotype O 0 0.00011078186798840761
of O 0 0.0002170328953070566
classical O 0 0.023116404190659523
FAP B-Disease 1 0.9996141195297241
, O 0 2.434904672554694e-05
and O 0 4.189351784589235e-06
possibly O 0 2.152631350327283e-05
with O 0 2.904770781242405e-06
importance O 0 0.0035663158632814884
for O 1 0.9997430443763733
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9270101189613342
in O 0 5.126845644554123e-05
the O 0 2.1058109268778935e-05
general O 0 3.1059498724061996e-05
population O 0 2.1288780772010796e-05
. O 0 3.560816548997536e-05
. O 0 0.0001191932606161572

Genomic O 0 0.0003664414107333869
structure O 0 0.0002838165091816336
of O 0 0.00013899762416258454
the O 0 0.0011771818390116096
human O 1 0.9999797344207764
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999996423721313
CLD B-Disease 1 1.0
) O 0 0.0008851357852108777
gene O 0 0.00043079355964437127
. O 0 0.00018852276843972504

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999996423721313
CLD B-Disease 1 1.0
) O 0 0.0002594292163848877
is O 0 4.885177258984186e-05
caused O 0 9.022943413583562e-05
by O 0 1.0849650607269723e-05
mutations O 0 1.7423919416614808e-05
in O 0 2.5394183467142284e-05
a O 0 2.85796559182927e-05
gene O 0 1.3691849744645879e-05
which O 0 9.690781553217676e-06
encodes O 0 5.7838547945721075e-05
an O 0 0.00010919450869550928
intestinal O 1 0.9999995231628418
anion O 1 0.9848549962043762
transporter O 1 0.9987377524375916
. O 0 0.001388084259815514

We O 0 0.0001849811087595299
report O 0 2.2421900212066248e-05
here O 0 1.3610355381388217e-05
the O 0 8.439354132860899e-06
complete O 0 4.4781743781641126e-05
genomic O 0 5.7878489315044135e-05
organization O 0 1.3395565474638715e-05
of O 0 4.3491065298439935e-05
the O 0 0.0001250126224476844
human O 0 0.0002102273574564606
CLD B-Disease 1 0.9968774318695068
gene O 0 7.258444384206086e-05
which O 0 2.3982580387382768e-05
spans O 0 0.0003345594450365752
approximately O 0 0.00015301427629310638
39kb O 0 0.0016840589232742786
, O 0 2.3899930965853855e-05
and O 0 1.4809796084591653e-05
comprises O 0 0.00016001518815755844
21 O 0 0.0008689136011525989
exons O 0 0.0018993628909811378
. O 0 0.000448934588348493

All O 0 0.0006136624724604189
exon O 0 0.004466255195438862
/ O 0 0.0013342058518901467
intron O 0 0.00212461338378489
boundaries O 0 4.45518089691177e-05
conform O 0 4.327745773480274e-05
to O 0 3.263124017394148e-05
the O 0 0.0002135684189852327
GT O 0 0.008689147420227528
/ O 0 0.017863070592284203
AG O 1 0.9991102814674377
rule O 0 0.001963926712051034
. O 0 0.00042631960241124034

An O 0 0.00010203116107732058
analysis O 0 2.0551095076370984e-05
of O 0 8.987461478682235e-05
the O 0 0.00018588389502838254
putative O 0 0.001155629986897111
promoter O 0 0.002417094772681594
region O 0 0.00012030052312184125
sequence O 0 1.6402134860982187e-05
shows O 0 2.3441025405190885e-05
a O 0 5.310009146342054e-05
putative O 0 0.0010057645849883556
TATA O 1 0.9908539056777954
box O 0 0.00073815236100927
and O 0 2.4230543203884736e-05
predicts O 0 5.353894448489882e-05
multiple O 0 2.4854389266693033e-05
transcription O 0 0.00044381688348948956
factor O 0 0.00026732985861599445
binding O 0 0.00010353660036344081
sites O 0 0.00017882137035485357
. O 0 0.00015018886188045144

The O 0 0.0005099506815895438
genomic O 0 0.00033765059197321534
structure O 0 0.0004169781459495425
was O 0 0.00020518465316854417
determined O 0 2.2698528482578695e-05
using O 0 1.074723604688188e-05
DNA O 0 2.3036280254018493e-05
from O 0 1.6125581169035286e-05
several O 0 6.3277284425566904e-06
sources O 0 1.1101951713499147e-05
including O 0 8.620475455245469e-06
multiple O 0 4.468017505132593e-05
large O 0 0.00032351911067962646
- O 0 0.0008038097294047475
insert O 0 0.0002168486244045198
libaries O 0 0.0004963651299476624
and O 0 5.473215878737392e-06
genomic O 0 1.7161841242341325e-05
DNA O 0 5.901142503716983e-05
from O 0 0.00012549094390124083
Finnish O 1 0.9411839842796326
CLD B-Disease 1 0.9999996423721313
patients O 0 0.0015451809158548713
and O 0 0.0001795214629964903
controls O 0 0.0008091654744930565
. O 0 0.00032398736220784485

Exon O 0 0.014620216563344002
- O 0 0.0005204440676607192
specific O 0 1.441826498194132e-05
primers O 0 0.00012036442058160901
developed O 0 5.453853736980818e-05
in O 0 7.405952601402532e-06
this O 0 1.7067951603166875e-06
study O 0 2.010901880566962e-06
will O 0 2.056491211988032e-06
facilitate O 0 1.0523339369683526e-05
mutation O 0 4.533860646915855e-06
screening O 0 9.961192517948803e-06
studies O 0 6.132034286565613e-06
of O 0 4.2007533920696005e-05
patients O 0 0.0001032966683851555
with O 0 5.77655628148932e-05
the O 0 0.29854047298431396
disease O 1 1.0
. O 0 0.0014068217715248466

Genomic O 0 0.00023093281197361648
sequencing O 0 0.00013064379163552076
of O 0 0.00021361811377573758
a O 0 0.0004954802570864558
BAC O 1 0.9982908368110657
clone O 0 0.015705205500125885
H O 1 0.9999898672103882
_ O 0 0.00019916337623726577
RG364P16 O 0 0.0005022553377784789
revealed O 0 6.832467624917626e-05
the O 0 1.4035156709724106e-05
presence O 0 1.9615730707300827e-05
of O 0 3.4386470360914245e-05
another O 0 4.466705286176875e-05
, O 0 1.3915978342993185e-05
highly O 0 3.903271135641262e-05
homologous O 0 6.902658788021654e-05
gene O 0 3.194468081346713e-05
3 O 0 7.908802945166826e-05
of O 0 6.689943256787956e-05
the O 0 0.00019521775539033115
CLD B-Disease 1 0.993844747543335
gene O 0 9.286115528084338e-05
, O 0 6.7430078161123674e-06
with O 0 2.710849230425083e-06
a O 0 1.542908648843877e-05
similar O 0 7.729664503131062e-06
genomic O 0 6.942200707271695e-05
structure O 0 0.00024705377290956676
, O 0 1.2355176295386627e-05
recently O 0 1.8778124285745434e-05
identified O 0 6.5718363657651935e-06
as O 0 1.3022270650253631e-05
the O 0 0.00014596593973692507
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.010318408720195293
( O 0 0.0010015822481364012
PDS B-Disease 1 0.9999610185623169
) O 0 0.0001137787985499017
. O 0 7.555429328931496e-05
. O 0 0.00015832054486963898

The O 0 0.001029235078021884
APCI1307K O 1 0.9998286962509155
allele O 0 0.0004638257378246635
and O 0 0.0001932013692567125
cancer B-Disease 1 0.9996414184570312
risk O 0 0.0002194207045249641
in O 0 4.6027602365938947e-05
a O 0 2.8615633709705435e-05
community O 0 1.2805205187760293e-05
- O 0 1.888975384645164e-05
based O 0 1.2035798135912046e-06
study O 0 2.550747012719512e-06
of O 0 1.8918433852377348e-05
Ashkenazi O 0 0.00029555163928307593
Jews O 0 0.0012928735231980681
. O 0 0.00043479789746925235

Mutations O 0 0.0009979426395148039
in O 0 0.0004238985129632056
APC O 0 0.004503521136939526
are O 0 2.593516001070384e-05
classically O 0 0.000499288784340024
associated O 0 7.113761239452288e-05
with O 0 0.00011033306509489194
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.999996542930603
FAP B-Disease 1 0.9999983310699463
) O 0 5.013535337639041e-05
, O 0 7.565775376860984e-06
a O 0 2.2977344997343607e-05
highly O 0 0.010000607930123806
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 1.0
by O 1 0.9993109703063965
multiple O 1 1.0
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 0 0.003164973808452487
, O 0 5.071585837868042e-05
without O 0 3.675390689750202e-05
surgical O 0 0.004803824238479137
intervention O 0 0.0004048340779263526
, O 0 2.0860750737483613e-05
the O 0 3.359192123753019e-05
development O 0 0.0003535873838700354
of O 1 0.9999470710754395
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999345541000366
CRC B-Disease 1 0.9999300241470337
) O 0 0.0003340329567436129
. O 0 0.00025449853274039924

APC B-Disease 0 0.015358682721853256
is O 0 0.00023880500521045178
a O 0 0.0007684137672185898
tumour O 1 1.0
- O 1 0.8671960830688477
suppressor O 0 0.0024292829912155867
gene O 0 4.1567553125787526e-05
, O 0 9.85147289611632e-06
and O 0 1.7310501789324917e-05
somatic O 0 0.0004888640251010656
loss O 1 0.9813976287841797
occurs O 0 0.0012795913498848677
in O 0 0.002076328732073307
tumours B-Disease 1 1.0
. O 0 0.00317757879383862

The O 0 0.002438283758237958
germline O 0 0.05695370212197304
T O 1 0.5202998518943787
- O 0 0.0010348373325541615
to O 0 6.490723171737045e-05
- O 0 0.0003012538654729724
A O 0 0.00025373752578161657
transversion O 0 0.0006872355006635189
responsible O 0 3.2975629437714815e-05
for O 0 7.755227670713793e-06
the O 0 9.445864998269826e-05
APC O 0 0.0013753622770309448
I1307K O 0 0.0005437636864371598
allele O 0 2.6254683689330705e-05
converts O 0 2.3258258806890808e-05
the O 0 3.865915277856402e-05
wild O 0 2.914796641562134e-05
- O 0 2.4130831661750562e-05
type O 0 4.1927810343622696e-06
sequence O 0 3.980519068136346e-06
to O 0 1.4870679478917737e-05
a O 0 0.000137729337438941
homopolymer O 1 0.998513400554657
tract O 1 0.9999758005142212
( O 0 0.0007562857936136425
A8 O 1 0.9958196878433228
) O 0 5.42688176210504e-05
that O 0 1.7707687220536172e-05
is O 0 5.9724017773987725e-05
genetically O 0 0.00032927008578553796
unstable O 0 0.003178892657160759
and O 0 8.898566011339426e-05
prone O 0 0.004317942075431347
to O 0 0.00022721011191606522
somatic O 0 0.0022264004219323397
mutation O 0 0.0005792676820419729
. O 0 0.0007241497514769435

The O 0 0.0008547470206394792
I1307K O 0 0.003190843388438225
allele O 0 0.00013488854165188968
was O 0 0.00038231778307817876
found O 0 3.143882713629864e-05
in O 0 6.90300075802952e-05
6 O 0 0.000800558365881443
. O 0 0.0002472830528859049

1 O 0 0.0006610012496821582
% O 0 7.974065374583006e-05
of O 0 0.0002161212032660842
unselected O 0 0.17345060408115387
Ashkenazi O 0 0.000547948875464499
Jews O 0 0.0004844910290557891
and O 0 5.044964200351387e-05
higher O 0 0.00013513804879039526
proportions O 0 0.00028684534481726587
of O 0 0.00015430920757353306
Ashkenazim O 0 0.007662277203053236
with O 0 5.9278434491716325e-05
family O 0 0.00010473455768078566
or O 0 4.6634402679046616e-05
personal O 0 0.00028207869036123157
histories O 0 0.001060936483554542
of O 1 0.6481566429138184
CRC B-Disease 1 0.9999500513076782
( O 0 0.0008350273128598928
ref O 0 0.014374841004610062
. O 0 7.14156121830456e-05
2 O 0 0.00036589265801012516
) O 0 8.267829252872616e-05
. O 0 0.00011588331835810095

To O 0 0.0001419772015651688
evaluate O 0 7.290006033144891e-05
the O 0 2.4913953893701546e-05
role O 0 4.905254900222644e-05
of O 0 0.00010887593816732988
I1307K O 0 0.0024086746852844954
in O 0 0.00020233691611792892
cancer B-Disease 1 0.8872100114822388
, O 0 3.0973424145486206e-05
we O 0 3.751475378521718e-05
genotyped O 0 0.0018127233488485217
5 O 0 0.0002269955148221925
, O 0 5.99902996327728e-05
081 O 0 0.002795048989355564
Ashkenazi O 0 0.00045552404480986297
volunteers O 0 0.0001981830719159916
in O 0 4.2637300794012845e-05
a O 0 6.392404611688107e-05
community O 0 4.87368852191139e-05
survey O 0 9.40172394621186e-05
. O 0 0.0001888818951556459

Risk O 0 0.001383401919156313
of O 0 0.0013519960921257734
developing O 1 0.9998879432678223
colorectal B-Disease 1 1.0
, I-Disease 0 0.07370681315660477
breast I-Disease 1 0.999868631362915
and I-Disease 0 7.522990927100182e-05
other I-Disease 0 3.898970317095518e-05
cancers I-Disease 1 0.9857258796691895
were O 0 0.00010838721209438518
compared O 0 0.0001430124102625996
between O 0 0.0008189950603991747
genotyped O 0 0.2204877734184265
I1307K O 0 0.002853806596249342
carriers O 0 0.00012151257396908477
and O 0 3.0343122489284724e-05
non O 0 0.0003332467167638242
- O 0 0.00035532371839508414
carriers O 0 4.391876791487448e-05
and O 0 6.1022005866107065e-06
their O 0 7.610307875438593e-06
first O 0 8.965034794528037e-05
- O 0 0.0001861666387412697
degree O 0 0.00017854415636975318
relatives O 0 0.0002634103293530643
. O 0 0.0001251421490451321

Sperm O 0 0.0001703052403172478
DNA O 0 5.576216062763706e-05
analysis O 0 1.0916123756032903e-05
in O 0 2.2528636691276915e-05
a O 0 0.0001838266325648874
Friedreich B-Disease 1 0.9997379183769226
ataxia I-Disease 1 0.99998939037323
premutation O 1 0.9999865293502808
carrier O 0 0.0035395289305597544
suggests O 0 0.00033754619653336704
both O 0 4.849751712754369e-05
meiotic O 0 0.0022326961625367403
and O 0 7.649449253221974e-05
mitotic O 0 0.0007657696842215955
expansion O 0 0.0006373552605509758
in O 0 9.952215623343363e-05
the O 0 0.00017342767387162894
FRDA B-Disease 1 0.9992151260375977
gene O 0 0.00030597197473980486
. O 0 0.00018461108265910298

Friedreich B-Disease 1 0.9999977350234985
ataxia I-Disease 1 0.9999990463256836
is O 0 0.0020452234894037247
usually O 0 0.00014761873171664774
caused O 0 0.0003605347010307014
by O 0 1.313231678068405e-05
an O 0 1.3183663213567343e-05
expansion O 0 0.00024532273528166115
of O 0 0.00014956931408960372
a O 0 0.0003406608011573553
GAA O 0 0.012658649124205112
trinucleotide O 0 0.05881465598940849
repeat O 0 0.0005325751844793558
in O 0 0.00010472336725797504
intron O 0 0.0007869176333770156
1 O 0 0.00011678862938424572
of O 0 5.841184611199424e-05
the O 0 0.00017330105765722692
FRDA B-Disease 1 0.9998173117637634
gene O 0 0.0003352606145199388
. O 0 0.00023404676176141948

Occasionally O 0 0.0007100116927176714
, O 0 4.841106056119315e-05
a O 0 3.69233384844847e-05
fully O 0 8.991781942313537e-05
expanded O 0 6.37598495814018e-05
allele O 0 1.646115015319083e-05
has O 0 1.012446591630578e-05
been O 0 1.2061505003657658e-05
found O 0 5.008454536437057e-06
to O 0 1.6737680198275484e-05
arise O 0 6.257322820601985e-05
from O 0 3.797363751800731e-05
a O 0 5.971433347440325e-05
premutation O 0 0.0014167501358315349
of O 0 0.000233892205869779
100 O 0 0.0003914897970389575
or O 0 0.000122335011838004
less O 0 0.00027254229644313455
triplet O 0 0.002723037963733077
repeats O 0 0.0025701222475618124
. O 0 0.0008662516484037042

We O 0 0.00024153957201633602
have O 0 1.5164264368650038e-05
examined O 0 3.7734593206550926e-05
the O 0 1.724949288472999e-05
sperm O 0 1.7684567865217105e-05
DNA O 0 2.0646131815738045e-05
of O 0 7.362651376752183e-05
a O 0 0.00033084338065236807
premutation O 0 0.0165106151252985
carrier O 0 0.0021994567941874266
. O 0 0.00037280749529600143

This O 0 0.0002803047827910632
mans O 0 0.0011685191420838237
leucocyte O 0 0.003097220789641142
DNA O 0 0.0001797972508938983
showed O 0 0.00013363633479457349
one O 0 2.064888940367382e-05
normal O 0 3.352183921379037e-05
allele O 0 1.5319736121455207e-05
and O 0 9.031575245899148e-06
one O 0 1.009146035357844e-05
allele O 0 9.658488124841824e-06
of O 0 6.023909372743219e-05
approximately O 0 0.00020868440333288163
100 O 0 0.00036801642272621393
repeats O 0 0.0009360633557662368
. O 0 0.00023245866759680212

His O 0 0.0015778826782479882
sperm O 0 0.00018746196292340755
showed O 0 6.418683187803254e-05
an O 0 9.349420906801242e-06
expanded O 0 7.672820356674492e-05
allele O 0 2.025186586251948e-05
in O 0 3.26316112477798e-05
a O 0 9.051209781318903e-05
tight O 0 0.0002869361487682909
range O 0 9.068271901924163e-05
centering O 0 0.00022234722564462572
on O 0 7.964725227793679e-05
a O 0 1.9111816072836518e-05
size O 0 1.2540323950815946e-05
of O 0 2.767226214928087e-05
approximately O 0 0.0001934341707965359
320 O 0 0.0006879782886244357
trinucleotide O 0 0.09361493587493896
repeats O 0 0.0015001262072473764
. O 0 0.00040432921377941966

His O 0 0.0033790201414376497
affected O 0 0.0012152900453656912
son O 0 0.003866777988150716
has O 0 9.672548185335472e-05
repeat O 0 0.00026684984914027154
sizes O 0 4.849862671107985e-05
of O 0 0.00015482993330806494
1040 O 0 0.001972498372197151
and O 0 0.00021166283113416284
540 O 0 0.0030901299323886633
. O 0 0.0004529347934294492

These O 0 6.661430234089494e-05
data O 0 4.365986387711018e-05
suggest O 0 5.134967796038836e-05
that O 0 9.707069693831727e-06
expansion O 0 0.00017723387281876057
occurs O 0 2.094147384923417e-05
in O 0 1.2325132956902962e-05
two O 0 4.4282937778916676e-06
stages O 0 9.845834574662149e-05
, O 0 8.348984010808636e-06
the O 0 1.5385916412924416e-05
first O 0 3.729964737431146e-05
during O 0 0.00020261183090042323
meiosis O 0 0.0005028690211474895
followed O 0 8.343785157194361e-05
by O 0 1.4565270248567685e-05
a O 0 4.553574763122015e-05
second O 0 0.0001830734108807519
mitotic O 0 0.0012092026881873608
expansion O 0 0.0036533840466290712
. O 0 0.0006677006022073328

We O 0 0.00010727015614975244
also O 0 1.312788481300231e-05
show O 0 1.8180997358285822e-05
that O 0 1.436430125068e-06
in O 0 2.714124093472492e-06
all O 0 4.591842298395932e-06
informative O 0 5.8383891882840544e-05
carrier O 0 9.594601579010487e-05
father O 0 0.00010995801130775362
to O 0 3.7307047023205087e-05
affected O 0 0.0001512536546215415
child O 0 0.00013321737060323358
transmissions O 0 0.00014130232739262283
, O 0 9.264161235478241e-06
with O 0 3.3572168831597082e-06
the O 0 2.4847848180797882e-05
notable O 0 4.6337827370734885e-05
exception O 0 4.676158641814254e-05
of O 0 9.441866859560832e-05
the O 0 0.00023839187633711845
premutation O 0 0.03249124065041542
carrier O 0 0.0002231472753919661
, O 0 1.5869223716435954e-05
the O 0 2.502014467609115e-05
expansion O 0 0.00016412237891927361
size O 0 8.958060789154842e-05
decreases O 0 0.0002237071021227166
. O 0 4.747448110720143e-05
. O 0 0.0001083672686945647

The O 0 0.000799000496044755
R496H O 0 0.0023276007268577814
mutation O 0 4.1129278542939574e-05
of O 0 0.0001933407038450241
arylsulfatase O 1 0.8322368860244751
A O 0 0.0011568391928449273
does O 0 3.5037115594604984e-05
not O 0 5.068762038717978e-05
cause O 1 0.8724809885025024
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 0.003279983764514327

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.1307113617658615
arylsulfatase I-Disease 1 0.9999727010726929
A I-Disease 0 0.24411414563655853
( O 0 0.00034835742553696036
ARSA O 1 0.9823295474052429
) O 0 8.653083204990253e-05
enzyme O 0 8.629424701211974e-05
activity O 0 0.0003910078958142549
causes O 1 0.5751364231109619
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.6586435437202454
MLD B-Disease 1 1.0
) O 0 0.0011987962061539292
. O 0 0.00045319306082092226

A O 0 0.0005762502551078796
number O 0 2.9737702789134346e-05
of O 0 0.00015336879005189985
ARSA O 1 0.9985982775688171
gene O 0 0.00016577426868025213
mutations O 0 7.647882011951879e-05
responsible O 0 0.00013003703497815877
for O 0 0.0001923301606439054
MLD B-Disease 1 1.0
have O 0 0.0001260513672605157
been O 0 0.00011404242104617879
identified O 0 7.493192242691293e-05
. O 0 0.0001319041766691953

Recently O 0 0.0012260694056749344
, O 0 3.92047586501576e-05
the O 0 5.009583765058778e-05
R496H O 0 0.0006390604539774358
mutation O 0 4.22576122218743e-05
of O 0 0.00022627053840551525
ARSA O 1 0.9960495829582214
was O 0 0.0004622375126928091
proposed O 0 2.456839501974173e-05
to O 0 1.0082014341605827e-05
be O 0 6.349690011120401e-06
a O 0 1.918917587317992e-05
cause O 0 0.0001517177588539198
of O 0 0.001359719317406416
MLD B-Disease 1 1.0
( O 0 0.0006985951331444085
Draghia O 0 0.02919825166463852
et O 0 0.0012527244398370385
al O 0 0.0005948627949692309
. O 0 1.9193970729247667e-05
, O 0 1.3680337360710837e-05
1997 O 0 0.00011872262984979898
) O 0 5.331563443178311e-05
. O 0 9.651162690715864e-05

We O 0 0.0002120395511155948
have O 0 2.1761428797617555e-05
investigated O 0 7.968683348735794e-05
the O 0 5.899477037019096e-05
R496H O 0 0.000563401379622519
mutation O 0 1.4042358998267446e-05
and O 0 6.955141998332692e-06
found O 0 5.026705366617534e-06
this O 0 3.924031261703931e-06
mutation O 0 7.665404154977296e-06
at O 0 3.946960350731388e-05
a O 0 1.585830068506766e-05
relatively O 0 1.727965718600899e-05
high O 0 2.9627472031279467e-05
frequency O 0 5.966047410765896e-06
in O 0 6.752093668183079e-06
an O 0 4.660076683649095e-06
African O 0 3.253678005421534e-05
American O 0 1.1454339073679876e-05
population O 0 5.515827069757506e-06
( O 0 7.588637799926801e-06
f O 0 4.2804207623703405e-05
= O 0 5.330932981451042e-05
0 O 0 2.5360686777275987e-05
. O 0 9.219644198310561e-06
09 O 0 0.00016779603902250528
, O 0 1.6784850231488235e-05
n O 0 7.724386523477733e-05
= O 0 0.00018354218627791852
61 O 0 0.0002483287826180458
subjects O 0 0.0004482986987568438
) O 0 0.00020643624884542078
. O 0 0.0002841073146555573

The O 0 0.0019922952633351088
ARSA O 1 0.962879478931427
enzyme O 0 0.0002445128629915416
activity O 0 0.00011173083476023749
in O 0 2.7013315047952347e-05
subjects O 0 6.843879236839712e-05
with O 0 1.1853535397676751e-05
and O 0 1.3531781405617949e-05
without O 0 1.5345442079706118e-05
the O 0 5.97747894062195e-05
R496H O 0 0.000527747964952141
mutation O 0 2.0975512597942725e-05
was O 0 6.818902329541743e-05
determined O 0 2.7705691536539234e-05
and O 0 7.632264896528795e-06
found O 0 5.2922209761163685e-06
to O 0 2.7106683774036355e-05
be O 0 4.186991282040253e-05
normal O 0 0.0001702356239547953
. O 0 0.00014250766253098845

It O 0 0.00012248441635165364
is O 0 3.7548397813225165e-05
therefore O 0 1.379420700686751e-05
concluded O 0 4.223077849019319e-05
that O 0 2.6815496312337928e-06
the O 0 2.0610857973224483e-05
R496H O 0 0.00037025101482868195
mutation O 0 2.689450775505975e-05
of O 0 0.00015685487596783787
ARSA O 1 0.9992772936820984
does O 0 2.4448214389849454e-05
not O 0 8.642946340842173e-06
negatively O 0 4.066975088790059e-05
influence O 0 6.5026426455006e-05
the O 0 4.191805419395678e-05
activity O 0 8.015745697775856e-05
of O 0 0.00021290054428391159
ARSA O 1 0.9861699342727661
and O 0 5.976156171527691e-05
is O 0 2.8088998078601435e-05
not O 0 8.60312138684094e-06
a O 0 6.967614172026515e-05
cause O 0 0.0011365716345608234
of O 0 0.07690013200044632
MLD B-Disease 1 1.0

Down O 0 0.011699514463543892
- O 0 0.0006348774186335504
regulation O 0 3.420090797590092e-05
of O 0 6.0628557548625395e-05
transmembrane O 0 0.0032464019022881985
carbonic O 1 0.5723259449005127
anhydrases O 1 0.9999037981033325
in O 1 0.918908953666687
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999985694885254
lines O 0 0.0016760100843384862
by O 0 6.788616155972704e-05
wild O 0 0.00014662690227851272
- O 0 0.0003206276160199195
type O 0 0.00028347523766569793
von B-Disease 1 0.9887403845787048
Hippel I-Disease 1 0.9999171495437622
- I-Disease 1 0.945174515247345
Lindau I-Disease 1 0.9978583455085754
transgenes O 0 0.01947609893977642
. O 0 0.000853396428283304

To O 0 0.0002037579397438094
discover O 0 0.00011349273700034246
genes O 0 3.0044100640225224e-05
involved O 0 4.495456596487202e-05
in O 0 6.777412636438385e-05
von B-Disease 0 0.1996227353811264
Hippel I-Disease 1 0.9994220733642578
- I-Disease 1 0.7787977457046509
Lindau I-Disease 1 0.9998701810836792
( O 0 0.0003196926845703274
VHL B-Disease 1 0.9934539794921875
) O 0 0.00014823453966528177
- O 0 0.0004290096985641867
mediated O 0 0.00041923727258108556
carcinogenesis O 1 0.5444571375846863
, O 0 4.707172774942592e-05
we O 0 3.842905425699428e-05
used O 0 0.0007377894362434745
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999998807907104
lines O 1 0.8197422623634338
stably O 0 0.2973632216453552
transfected O 0 0.0027132811956107616
with O 0 4.506943150772713e-05
wild O 0 0.00039079549605958164
- O 0 0.001561668235808611
type O 0 0.0014876632485538721
VHL O 1 0.9999891519546509
- O 0 0.0038164041470736265
expressing O 0 0.0007788994116708636
transgenes O 0 0.007114196661859751
. O 0 0.0007171133765950799

Large O 0 0.0014360155910253525
- O 0 0.0007228245958685875
scale O 0 0.0004579028463922441
RNA O 0 0.00026980668189935386
differential O 0 0.0001575900532770902
display O 0 0.00010986890265485272
technology O 0 0.00011116990935988724
applied O 0 1.7562519133207388e-05
to O 0 1.647448334551882e-05
these O 0 1.728507959342096e-05
cell O 0 0.0001293975510634482
lines O 0 5.169498035684228e-05
identified O 0 2.506217424524948e-05
several O 0 1.08242975329631e-05
differentially O 0 0.00016165518900379539
expressed O 0 3.293424015282653e-05
genes O 0 1.0398894119134638e-05
, O 0 6.8532458499248605e-06
including O 0 6.191336524352664e-06
an O 0 2.7489775675348938e-05
alpha O 0 0.0006886080955155194
carbonic O 0 0.004265546333044767
anhydrase O 0 0.009913057088851929
gene O 0 0.0002756912144832313
, O 0 0.00011391960288165137
termed O 0 0.002564001362770796
CA12 O 1 0.9992068409919739
. O 0 0.0009123976342380047

The O 0 0.00028892746195197105
deduced O 0 0.0002351656585233286
protein O 0 2.863343252101913e-05
sequence O 0 1.9678649550769478e-05
was O 0 8.466025610687211e-05
classified O 0 4.048335176776163e-05
as O 0 2.265065450046677e-05
a O 0 3.6890010960632935e-05
one O 0 5.364933895180002e-05
- O 0 0.0005493490025401115
pass O 0 0.00039431918412446976
transmembrane O 0 0.004239776637405157
CA O 0 0.0025710612535476685
possessing O 0 0.0003195269382558763
an O 0 8.868375152815133e-05
apparently O 0 0.0002518515393603593
intact O 0 0.00039890114567242563
catalytic O 0 0.0001706527837086469
domain O 0 0.00021124571503605694
in O 0 6.99975571478717e-05
the O 0 0.00016947650874499232
extracellular O 0 0.00446650106459856
CA O 1 0.946397066116333
module O 0 0.010194768197834492
. O 0 0.0005220867460593581

Reintroduced O 0 0.006567222066223621
wild O 0 0.001055880798958242
- O 0 0.001214766874909401
type O 0 0.0005497809615917504
VHL B-Disease 1 0.9931064248085022
strongly O 0 0.00015287630958482623
inhibited O 0 0.00018586122314445674
the O 0 3.112238846370019e-05
overexpression O 0 7.39298848202452e-05
of O 0 5.953585423412733e-05
the O 0 8.501557749696076e-05
CA12 O 1 0.6976600885391235
gene O 0 1.9474096916383132e-05
in O 0 8.169055945472792e-06
the O 0 1.9766599507420324e-05
parental O 0 0.0006641155341640115
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.991647481918335
. O 0 0.0010441840859130025

Similar O 0 0.0001334263797616586
results O 0 3.4433331165928394e-05
were O 0 3.4435892303008586e-05
obtained O 0 5.337341644917615e-05
with O 0 6.426914478652179e-05
CA9 O 1 0.9454478621482849
, O 0 5.497649544849992e-05
encoding O 0 5.983478331472725e-05
another O 0 0.00020624247554223984
transmembrane O 0 0.004810622427612543
CA O 0 0.0013240596745163202
with O 0 2.1398816897999495e-05
an O 0 6.198035407578573e-05
intact O 0 0.0014009904116392136
catalytic O 0 0.0010641615372151136
domain O 0 0.0017852578312158585
. O 0 0.0005367345293052495

Although O 0 0.00013083640078548342
both O 0 2.3119822799344547e-05
domains O 0 0.00018200126942247152
of O 0 0.00019748794147744775
the O 0 0.0005138227716088295
VHL B-Disease 1 0.9995996356010437
protein O 0 0.00011057277879444882
contribute O 0 6.904159090481699e-05
to O 0 3.522690894897096e-05
regulation O 0 9.11792230908759e-05
of O 0 0.00022743378940504044
CA12 O 1 0.9994813799858093
expression O 0 0.00013051889254711568
, O 0 2.384153958701063e-05
the O 0 4.9983551434706897e-05
elongin O 0 0.0012016365071758628
binding O 0 4.319277286413126e-05
domain O 0 0.0002150217624148354
alone O 0 0.00012803713616449386
could O 0 4.155031274422072e-05
effectively O 0 0.00024290029250551015
regulate O 0 0.0006084321066737175
CA9 O 1 0.990212619304657
expression O 0 0.0013735067332163453
. O 0 0.0004422152996994555

We O 0 0.0006129172979854047
mapped O 0 0.0018645321251824498
CA12 O 1 0.8938130736351013
and O 0 0.0004695996467489749
CA9 O 1 0.9793184995651245
loci O 0 0.0013634786009788513
to O 0 0.0003785436856560409
chromosome O 0 0.002271972829475999
bands O 0 0.0016177278012037277
15q22 O 0 0.006836822256445885
and O 0 0.00040380883729085326
17q21 O 0 0.010199856013059616
. O 0 0.000686831830535084

2 O 0 0.0020581851713359356
respectively O 0 0.0006716819480061531
, O 0 7.993356848601252e-05
regions O 0 0.0001334645348833874
prone O 0 0.0006120821344666183
to O 0 4.9806640163296834e-05
amplification O 0 0.0003420435532461852
in O 0 8.668518421472982e-05
some O 0 8.179888391168788e-05
human O 0 0.0009014252573251724
cancers B-Disease 1 0.9997839331626892
. O 0 0.0007099592476151884

Additional O 0 0.00020819093333557248
experiments O 0 0.0001956642372533679
are O 0 5.277755917632021e-06
needed O 0 1.6875259461812675e-05
to O 0 5.689212684956146e-06
define O 0 2.236944237665739e-05
the O 0 1.8586775695439428e-05
role O 0 5.626404890790582e-05
of O 0 0.00028743938310071826
CA O 1 0.9966321587562561
IX O 1 0.9999927282333374
and O 0 0.00027320883236825466
CA O 0 0.01865067146718502
XII O 1 0.9999005794525146
enzymes O 0 5.892291301279329e-05
in O 0 2.5457855372224003e-05
the O 0 2.5948320399038494e-05
regulation O 0 1.869878360594157e-05
of O 0 4.050756251672283e-05
pH O 0 0.000238165826885961
in O 0 3.2316231227014214e-05
the O 0 5.0950187869602814e-05
extracellular O 0 0.00040533492574468255
microenvironment O 0 0.0006334927165880799
and O 0 8.333878213306889e-06
its O 0 1.2263366443221457e-05
potential O 0 7.247336907312274e-05
impact O 0 0.00020593807857949287
on O 0 0.00039982935413718224
cancer B-Disease 1 0.9999655485153198
cell O 0 0.005004107486456633
growth O 0 0.0010344283655285835
. O 0 0.0002170935331378132

A O 0 0.000590562354773283
gene O 0 2.8138974812463857e-05
encoding O 0 1.688624070084188e-05
a O 0 5.4188967624213547e-05
transmembrane O 0 0.0004752353415824473
protein O 0 3.861751247313805e-05
is O 0 7.45281295166933e-06
mutated O 0 1.9645873180706985e-05
in O 0 9.404380762134679e-06
patients O 0 2.7249334380030632e-05
with O 0 0.00033275969326496124
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.0695221796631813
. O 0 0.000973530753981322

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999700784683228
WFS B-Disease 1 1.0
; O 0 0.0006193431909196079
OMIM O 1 0.9999839067459106
222300 O 0 0.008235832676291466
) O 0 3.394929808564484e-05
is O 0 7.817504410922993e-06
an O 0 2.4090362785500474e-05
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.9999469518661499
by O 0 0.0010967578273266554
young O 0 0.004908947739750147
- O 0 0.006234321743249893
onset O 1 0.9999957084655762
non O 1 0.9981862902641296
- O 1 0.998325765132904
immune O 1 0.9913705587387085
insulin B-Disease 0 0.36262765526771545
- I-Disease 1 0.9960929751396179
dependent I-Disease 0 0.03674505650997162
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999986886978149
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9957098960876465

Linkage O 0 0.0039444961585104465
to O 0 0.0002614147961139679
markers O 0 0.001317635178565979
on O 0 0.00082060118438676
chromosome O 0 0.002309865551069379
4p O 1 0.9625769853591919
was O 0 0.0009024518076330423
confirmed O 0 9.354398935101926e-05
in O 0 3.0132849133224227e-05
five O 0 3.397816180950031e-05
families O 0 4.368118607089855e-05
. O 0 0.00018672217265702784

On O 0 0.00018780653772410005
the O 0 2.8137579647591338e-05
basis O 0 2.784549542411696e-05
of O 0 0.00014447075955104083
meiotic O 1 0.9994483590126038
recombinants O 1 0.9999994039535522
and O 0 0.45372286438941956
disease O 1 1.0
- O 0 0.36973732709884644
associated O 0 6.0687561926897615e-05
haplotypes O 0 0.00013721456343773752
, O 0 2.479213071637787e-05
the O 0 6.462997407652438e-05
WFS B-Disease 1 0.9974181652069092
gene O 0 4.490237552090548e-05
was O 0 0.00022051572159398347
localized O 0 0.00013556628255173564
to O 0 3.0370511012733914e-05
a O 0 0.0002043030399363488
BAC O 1 0.6473525762557983
/ O 0 0.0012558881426230073
P1 O 0 0.01048933807760477
contig O 0 0.0014231312088668346
of O 0 9.090306411962956e-05
less O 0 3.615148307289928e-05
than O 0 2.5512879801681265e-05
250 O 0 0.00012933388643432409
kb O 0 0.0034565809182822704
. O 0 0.0003595509915612638

Mutations O 0 0.00034982938086614013
in O 0 8.978038385976106e-05
a O 0 7.265798922162503e-05
novel O 0 0.00016838086594361812
gene O 0 7.75953521952033e-05
( O 0 9.177885658573359e-05
WFS1 O 0 0.005408823490142822
) O 0 1.7801965441321954e-05
encoding O 0 1.60499730554875e-05
a O 0 5.226572466199286e-05
putative O 0 0.00045111513463780284
transmembrane O 0 0.0011563117150217295
protein O 0 9.421388676855713e-05
were O 0 3.432271478231996e-05
found O 0 6.688460871373536e-06
in O 0 9.275813681597356e-06
all O 0 6.614145604544319e-06
affected O 0 2.433748886687681e-05
individuals O 0 7.6030532909499016e-06
in O 0 4.8571062507107854e-05
six O 0 0.00014133060176391155
WFS B-Disease 1 0.9992283582687378
families O 0 2.687620508368127e-05
, O 0 7.009103228483582e-06
and O 0 3.5118359846819658e-06
these O 0 4.313379122322658e-06
mutations O 0 1.6614274500170723e-05
were O 0 2.6611371140461415e-05
associated O 0 2.0403771486599e-05
with O 0 2.2651885956292972e-05
the O 0 0.10330921411514282
disease O 1 1.0
phenotype O 0 0.004482148680835962
. O 0 0.0006557921878993511

WFS1 O 1 0.9985287189483643
appears O 0 0.0006390339112840593
to O 0 2.2948483092477545e-05
function O 0 2.9772374546155334e-05
in O 0 3.37464916810859e-05
survival O 0 0.00023665057960897684
of O 0 0.00020677507563959807
islet O 0 0.0060846637934446335
beta O 0 0.0025659145321696997
- O 0 0.0018080546287819743
cells O 0 0.0001269735221285373
and O 0 5.434562262962572e-05
neurons O 0 0.00023816991597414017
. O 0 8.67043636390008e-05
. O 0 0.0002538001863285899

Stable O 0 0.005021850112825632
interaction O 0 0.00020658608991652727
between O 0 0.00015519872249569744
the O 0 5.117769615026191e-05
products O 0 2.25755666178884e-05
of O 0 4.7364956117235124e-05
the O 0 8.37694969959557e-05
BRCA1 O 0 0.000640255631878972
and O 0 7.070544961607084e-05
BRCA2 O 0 0.0064253718592226505
tumor B-Disease 1 0.9996788501739502
suppressor O 0 0.003104659030213952
genes O 0 6.249695434235036e-05
in O 0 5.888246960239485e-05
mitotic O 0 0.0004927535774186254
and O 0 0.00020546284213196486
meiotic O 1 0.9794936776161194
cells O 0 0.003390432568266988
. O 0 0.000604716595262289

BRCA1 O 0 0.010714642703533173
and O 0 0.0002973004011437297
BRCA2 O 0 0.0003915334527846426
account O 0 1.5518555301241577e-05
for O 0 8.402382263739128e-06
most O 0 6.851056696177693e-06
cases O 0 7.178343821578892e-06
of O 0 4.3529569666134194e-05
familial O 0 0.026447352021932602
, O 0 0.00010949468560284004
early O 0 0.0021258057095110416
onset O 1 1.0
breast B-Disease 1 0.999997615814209
and I-Disease 0 0.0013716270914301276
/ I-Disease 1 0.9999991655349731
or I-Disease 1 0.9999969005584717
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.0001485765678808093
encode O 0 6.547131488332525e-05
products O 0 1.984895789064467e-05
that O 0 3.831099547824124e-06
each O 0 2.766175157375983e-06
interact O 0 2.2537577024195343e-05
with O 0 2.996469811478164e-05
hRAD51 O 0 0.004461932461708784
. O 0 0.0006044423207640648

Results O 0 0.00023446354316547513
presented O 0 0.00032663438469171524
here O 0 8.011642057681456e-05
show O 0 4.6022953029023483e-05
that O 0 1.2063253961969167e-05
BRCA1 O 0 0.0003184364177286625
and O 0 5.137034168001264e-05
BRCA2 O 0 0.0006536958389915526
coexist O 0 0.0002034537319559604
in O 0 3.670816295198165e-05
a O 0 5.31050463905558e-05
biochemical O 0 0.0005675452412106097
complex O 0 0.0066697304137051105
and O 0 0.000159220231580548
colocalize O 0 0.45595335960388184
in O 0 0.00024328642757609487
subnuclear O 0 0.2601185739040375
foci O 0 0.004895522724837065
in O 0 0.000238732376601547
somatic O 0 0.0005124991876073182
cells O 0 0.00012811344640795141
and O 0 1.3508843949239235e-05
on O 0 2.2038424503989518e-05
the O 0 1.728746974549722e-05
axial O 0 3.1612747989129275e-05
elements O 0 4.46066987933591e-05
of O 0 0.00034895073622465134
developing O 0 0.0017542509594932199
synaptonemal O 1 0.9584330916404724
complexes O 0 0.008849252946674824
. O 0 0.0005726169911213219

Like O 0 0.002138406503945589
BRCA1 O 0 0.005782255437225103
and O 0 0.0006096023134887218
RAD51 O 1 0.998904824256897
, O 0 0.00034031897666864097
BRCA2 O 0 0.0011760678607970476
relocates O 0 0.00053930509602651
to O 0 0.00011279415775788948
PCNA O 0 0.005731730256229639
+ O 0 0.0001620590774109587
replication O 0 6.593509897356853e-05
sites O 0 1.4795553397561889e-05
following O 0 3.2284195185638964e-05
exposure O 0 0.00013546923582907766
of O 0 0.00020972584025003016
S O 0 0.0048463111743330956
phase O 0 0.0029585075099021196
cells O 0 0.0001499896461609751
to O 0 0.0001216233940795064
hydroxyurea O 0 0.0033397243823856115
or O 0 0.00042500309064053
UV O 1 0.9795031547546387
irradiation O 0 0.002382215578109026
. O 0 0.0005293621798045933

Thus O 0 0.0010343731846660376
, O 0 0.00016810462693683803
BRCA1 O 0 0.0007852871785871685
and O 0 5.739597327192314e-05
BRCA2 O 0 0.000355051044607535
participate O 0 4.2365179979242384e-05
, O 0 1.1229710253246594e-05
together O 0 1.959572546184063e-05
, O 0 6.155921710160328e-06
in O 0 1.5562436601612717e-05
a O 0 4.951874871039763e-05
pathway O 0 0.00022279798577073961
( O 0 6.566164665855467e-05
s O 0 0.00015576565056107938
) O 0 1.0409183232695796e-05
associated O 0 7.885651939432137e-06
with O 0 5.716983650927432e-06
the O 0 5.433338810689747e-05
activation O 0 0.00025618370273150504
of O 0 0.0006231771549209952
double O 0 0.0013661704724654555
- O 0 0.0015442285221070051
strand O 0 0.00022903365606907755
break O 0 0.0003296425857115537
repair O 0 0.0013396606082096696
and O 0 0.00011158624693052843
/ O 0 0.0006091551040299237
or O 0 0.00012207607505843043
homologous O 0 0.0006228615529835224
recombination O 0 0.0009826350724324584
. O 0 0.0006603420479223132

Dysfunction O 1 0.9999619722366333
of O 0 0.0013672208879143
this O 0 0.0001085698968381621
pathway O 0 0.0010342227760702372
may O 0 6.122449121903628e-05
be O 0 9.452845915802754e-06
a O 0 1.3106193364365026e-05
general O 0 4.5603799662785605e-05
phenomenon O 0 7.848173845559359e-05
in O 0 1.067902849172242e-05
the O 0 7.48231013858458e-06
majority O 0 2.4442863377771573e-06
of O 0 8.266178156191017e-06
cases O 0 1.6487341781612486e-05
of O 0 0.000709764426574111
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9997498393058777
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.019505014643073082
. O 0 0.0003727009170688689

A O 0 0.002494719112291932
novel O 0 0.0005326619721017778
Arg362Ser O 0 0.0021248511038720608
mutation O 0 1.8190052287536673e-05
in O 0 2.4686669348739088e-05
the O 0 4.137602081755176e-05
sterol O 0 0.0003745563153643161
27 O 0 0.00039812427712604403
- O 0 0.0003441872831899673
hydroxylase O 0 0.00030403301934711635
gene O 0 8.027763396967202e-05
( O 0 7.742187881376594e-05
CYP27 O 0 0.011892440728843212
) O 0 2.5937111786333844e-05
: O 0 8.007891665329225e-06
its O 0 1.0907579962804448e-05
effects O 0 8.826495468383655e-05
on O 0 0.00010936227772617713
pre O 0 0.00037299023824743927
- O 0 0.00017752224812284112
mRNA O 0 4.1115556086879224e-05
splicing O 0 4.130359957343899e-05
and O 0 1.3147027857485227e-05
enzyme O 0 5.542081271414645e-05
activity O 0 0.00022463922505266964
. O 0 0.00017415349429938942

A O 0 0.002374083735048771
novel O 0 0.0003555947041604668
C O 0 0.0005004610866308212
to O 0 3.8428319385275245e-05
A O 0 0.00014701217878609896
mutation O 0 9.812392818275839e-06
in O 0 1.0553870197327342e-05
the O 0 2.4872975700418465e-05
sterol O 0 0.00020970884361304343
27 O 0 0.0004263157316017896
- O 0 0.00037908577360212803
hydroxylase O 0 0.0002871211327146739
gene O 0 5.6457429309375584e-05
( O 0 4.618553793989122e-05
CYP27 O 0 0.011741113848984241
) O 0 3.05788817058783e-05
was O 0 7.071718573570251e-05
identified O 0 1.1670810636132956e-05
by O 0 4.787623765878379e-06
sequencing O 0 7.009848195593804e-05
amplified O 0 0.00046434623072855175
CYP27 O 0 0.13903968036174774
gene O 0 5.835316187585704e-05
products O 0 2.2746200556866825e-05
from O 0 2.9302425900823437e-05
a O 0 3.115089566563256e-05
patient O 0 6.33948075119406e-05
with O 0 5.4506985179614276e-05
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 0.0061396947130560875
CTX B-Disease 1 0.999991774559021
) O 0 0.0005820738733746111
. O 0 0.00039440151886083186

The O 0 0.0002898312814068049
mutation O 0 8.55218167998828e-05
changed O 0 0.0001065663673216477
the O 0 7.395929424092174e-05
adrenodoxin O 0 0.0015486017800867558
cofactor O 0 0.00045690606930293143
binding O 0 8.904201968107373e-05
residue O 0 0.0004217421228531748
362Arg O 0 0.0009944281773641706
to O 0 0.00010628636664478108
362Ser O 0 0.003123669419437647
( O 0 0.0002740177733357996
CGT O 1 0.98868328332901
362Arg O 0 0.005192199721932411
to O 0 0.00032752277911640704
AGT O 1 0.999996542930603
362Ser O 0 0.009363073855638504
) O 0 6.0736772866221145e-05
, O 0 1.069596783054294e-05
and O 0 9.817372301768046e-06
was O 0 0.00021276134066283703
responsible O 0 0.00010897077299887314
for O 0 0.00012549106031656265
deficiency O 1 1.0
in O 0 0.0005518905236385763
the O 0 0.00035958626540377736
sterol O 0 0.000956149073317647
27 O 0 0.000774524814914912
- O 0 0.0004885356174781919
hydroxylase O 0 0.00030303755193017423
activity O 0 4.7148772864602506e-05
, O 0 5.641984898829833e-06
as O 0 6.546515578520484e-06
confirmed O 0 5.886046892555896e-06
by O 0 2.2139815882837866e-06
expression O 0 6.135462172096595e-06
of O 0 2.0939876776537858e-05
mutant O 0 0.00011480040848255157
cDNA O 0 0.00012910076475236565
into O 0 0.00010787804058054462
COS O 0 0.1468069702386856
- O 0 0.0006766142323613167
1 O 0 0.0005171849625185132
cells O 0 0.00019467482343316078
. O 0 8.235081622842699e-05

Quantitative O 0 0.00020491446775849909
analysis O 0 1.989373777178116e-05
showed O 0 5.5603024520678446e-05
that O 0 4.6926770664867945e-06
the O 0 1.4820111573499162e-05
expression O 0 3.064638440264389e-05
of O 0 0.0001746482157614082
CYP27 O 1 0.9115001559257507
gene O 0 4.9883456085808575e-05
mRNA O 0 4.964106119587086e-05
in O 0 2.090464113280177e-05
the O 0 1.9495146261760965e-05
patient O 0 2.6382916985312477e-05
represented O 0 5.96118661633227e-05
52 O 0 0.00041562545811757445
. O 0 0.00023340765619650483

5 O 0 0.0008970777271315455
% O 0 0.000104232007288374
of O 0 0.0002579719584900886
the O 0 0.00029978377278894186
normal O 0 0.00043294933857396245
level O 0 0.0019547087140381336
. O 0 0.00042461513658054173

As O 0 0.00034041370963677764
the O 0 9.677557682152838e-05
mutation O 0 3.740312240552157e-05
occurred O 0 0.00011209239164600149
at O 0 6.261160160647705e-05
the O 0 1.2254576176928822e-05
penultimate O 0 0.00033185104257427156
nucleotide O 0 5.158171916264109e-05
of O 0 0.00011037725926144049
exon O 0 0.00047692848602309823
6 O 0 0.00021147685765754431
( O 0 3.595858652261086e-05
- O 0 6.329839379759505e-05
2 O 0 4.1079889342654496e-05
position O 0 4.627697853720747e-05
of O 0 5.366028563003056e-05
exon O 0 0.0005586313782259822
6 O 0 0.00040668531437404454
- O 0 0.0003977486921939999
intron O 0 0.0006486300262622535
6 O 0 0.00014688522787764668
splice O 0 0.00019373191753402352
site O 0 4.63371179648675e-05
) O 0 2.873175162676489e-06
of O 0 7.681885108468123e-06
the O 0 2.7530912120710127e-05
gene O 0 1.385498671879759e-05
, O 0 5.722503829019843e-06
we O 0 4.113297563890228e-06
hypothesized O 0 3.315160211059265e-05
that O 0 3.6474566513788886e-06
the O 0 2.0350680642877705e-05
mutation O 0 1.8034184904536232e-05
may O 0 5.536577373277396e-05
partially O 0 0.00019205347052775323
affect O 0 2.390528425166849e-05
the O 0 2.181951276725158e-05
normal O 0 3.221810402465053e-05
splicing O 0 4.636983430827968e-05
efficiency O 0 7.470190757885575e-05
in O 0 3.917986396118067e-05
exon O 0 0.0004892232245765626
6 O 0 0.00025099239428527653
and O 0 2.983934427902568e-05
cause O 0 0.00011239464220125228
alternative O 0 2.9049786462564953e-05
splicing O 0 6.972015398787335e-05
elsewhere O 0 4.2351606680313125e-05
, O 0 5.500216047948925e-06
which O 0 3.632807420217432e-06
resulted O 0 4.24765057687182e-05
in O 0 3.5025292163481936e-05
decreased O 0 0.0002681543701328337
transcript O 0 0.00021889850904699415
in O 0 5.951610000920482e-05
the O 0 0.0001330248051090166
patient O 0 0.00047456510947085917
. O 0 0.0003054796834476292

Transfection O 0 0.006045221351087093
of O 0 0.0010651868069544435
constructed O 1 0.841940701007843
minigenes O 0 0.21338756382465363
, O 0 4.39315008406993e-05
with O 0 1.2248289749550167e-05
or O 0 3.0122910175123252e-05
without O 0 4.574500781018287e-05
the O 0 7.922056829556823e-05
mutation O 0 3.6778867070097476e-05
, O 0 2.425333696010057e-05
into O 0 0.0001155324571300298
COS O 1 0.9972395896911621
- O 0 0.00037414408870972693
1 O 0 0.00011884178820764646
cells O 0 9.794086508918554e-06
confirmed O 0 4.906255071546184e-06
that O 0 1.2937523479195079e-06
the O 0 8.294456165458541e-06
mutant O 0 0.00012276340567041188
minigene O 0 0.0014380196807906032
was O 0 0.00016017637972254306
responsible O 0 2.7989528462057933e-05
for O 0 1.234284536621999e-05
a O 0 3.648285201052204e-05
mRNA O 0 5.9490335843292996e-05
species O 0 2.3781881282047834e-06
alternatively O 0 3.3808817534008995e-05
spliced O 0 0.00017156157991848886
at O 0 0.0002063852734863758
an O 0 5.750231139245443e-05
activated O 0 0.0020693789701908827
cryptic O 0 0.0011777550680562854
5 O 0 0.00026045029517263174
splice O 0 0.0006986363441683352
site O 0 0.0003489413938950747
88 O 0 0.00019226416770834476
bp O 0 0.00029947637813165784
upstream O 0 0.00017712591215968132
from O 0 1.3505314200301655e-05
the O 0 1.977817555598449e-05
3 O 0 5.1975752285216004e-05
end O 0 0.00015179067850112915
of O 0 0.00017666796338744462
exon O 0 0.0024904722813516855
6 O 0 0.0017038616351783276
. O 0 0.0005356156034395099

Our O 0 0.0001923268719110638
data O 0 3.3447882742621005e-05
suggest O 0 1.6829761079861782e-05
that O 0 2.6354434794484405e-06
the O 0 1.3723850315727759e-05
C O 0 0.00016119683277793229
to O 0 2.5174449547193944e-05
A O 0 0.00015169577091000974
mutation O 0 1.2798321222362574e-05
at O 0 5.08794910274446e-05
the O 0 2.012176628340967e-05
penultimate O 0 0.00035370874684304
nucleotide O 0 4.945828550262377e-05
of O 0 0.00010305159230483696
exon O 0 0.00037746495218016207
6 O 0 0.0001301968441111967
of O 0 4.87468350911513e-05
the O 0 0.00011644047481240705
CYP27 O 1 0.999434769153595
gene O 0 3.502395702525973e-05
not O 0 5.3095200200914405e-06
only O 0 9.640019925427623e-06
causes O 0 0.00015144573990255594
the O 0 0.00024004775332286954
deficiency B-Disease 1 0.999997615814209
in I-Disease 0 0.00030162575421854854
the I-Disease 0 0.0002646344364620745
sterol I-Disease 0 0.0009724692790769041
27 I-Disease 0 0.0011930555338039994
- I-Disease 0 0.0006880383007228374
hydroxylase I-Disease 0 0.00042651555850170553
activity I-Disease 0 6.567103264387697e-05
, O 0 1.2042311027471442e-05
but O 0 5.460161446535494e-06
also O 0 9.40319660003297e-06
partially O 0 0.00010477591422386467
leads O 0 3.1475487048737705e-05
to O 0 1.7472073523094878e-05
alternative O 0 1.885158235381823e-05
pre O 0 0.00022117604385130107
- O 0 0.00011102118878625333
mRNA O 0 2.1803287381771952e-05
splicing O 0 1.5475474356207997e-05
of O 0 2.1024579837103374e-05
the O 0 0.00011662850010907277
gene O 0 0.0002018701925408095
. O 0 0.00023778465401846915

To O 0 0.00042192544788122177
our O 0 0.00018290190200787038
knowledge O 0 0.00015650827845092863
, O 0 1.9492803403409198e-05
this O 0 4.736405571748037e-06
is O 0 3.971467776864301e-06
the O 0 4.1279554352513514e-06
first O 0 1.2614811566891149e-05
report O 0 5.168484221940162e-06
regarding O 0 2.1223750081844628e-05
effects O 0 0.00015494793478865176
on O 0 0.00013312442752067
pre O 0 0.0005538101540878415
- O 0 0.00011588718189159408
mRNA O 0 2.5860845198621973e-05
splicing O 0 1.0178700904361904e-05
of O 0 1.2774760762113146e-05
a O 0 1.5926561900414526e-05
mutation O 0 7.278365956153721e-06
at O 0 6.922578904777765e-05
the O 0 3.8993901398498565e-05
- O 0 9.366422455059364e-05
2 O 0 4.205106233712286e-05
position O 0 2.5296583771705627e-05
of O 0 3.663352981675416e-05
a O 0 8.293824066640809e-05
5 O 0 0.0001974587794393301
splice O 0 0.0009928178042173386
site O 0 0.0012250246945768595
. O 0 0.0003749296593014151

ATM O 0 0.026857124641537666
germline O 0 0.004928994458168745
mutations O 0 0.00023071648320183158
in O 0 0.00019609046285040677
classical O 1 0.9973018169403076
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 0.0005688987439498305
in O 0 5.7956258388003334e-05
the O 0 4.802609691978432e-05
Dutch O 0 0.00037024321500211954
population O 0 4.048894697916694e-05
. O 0 0.00013975835463497788

Germline O 0 0.01024985034018755
mutations O 0 0.00025722142891027033
in O 0 8.249039092333987e-05
the O 0 8.057981904130429e-05
ATM O 0 0.000748547085095197
gene O 0 1.1975726010859944e-05
are O 0 8.598681233706884e-07
responsible O 0 4.606171842169715e-06
for O 0 3.818296590907266e-06
the O 0 0.0003153403813485056
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9963753819465637
A B-Disease 1 1.0
- I-Disease 1 0.9999661445617676
T I-Disease 1 0.9999970197677612
) O 0 0.00010615013161441311
. O 0 0.00013765542826149613

In O 0 0.0003569746622815728
our O 0 8.464782877126709e-05
study O 0 1.7821193978306837e-05
, O 0 6.52134076517541e-06
we O 0 2.533753786337911e-06
have O 0 9.442829878025805e-07
determined O 0 7.0092769419716205e-06
the O 0 1.558990334160626e-05
ATM O 0 0.00038225780008360744
mutation O 0 1.375578449369641e-05
spectrum O 0 5.4343181545846164e-05
in O 0 2.8997974368394352e-05
19 O 0 0.00014801252109464258
classical O 0 0.0005005715065635741
A B-Disease 1 0.9999982118606567
- I-Disease 1 0.9999945163726807
T I-Disease 1 0.9999998807907104
patients O 0 6.120774924056605e-05
, O 0 7.770463525957894e-06
including O 0 3.968915734731127e-06
some O 0 6.16928082308732e-06
immigrant O 0 1.8159704268327914e-05
populations O 0 4.1145372051687445e-06
, O 0 2.44876605393074e-06
as O 0 4.7454750529141165e-06
well O 0 4.172091848886339e-06
as O 0 1.5795780200278386e-05
12 O 0 3.506780558382161e-05
of O 0 4.420685218065046e-05
Dutch O 0 0.00029846481629647315
ethnic O 0 0.0001081516093108803
origin O 0 0.00011427232675487176
. O 0 0.000256276543950662

Both O 0 7.622964767506346e-05
the O 0 7.895269664004445e-05
protein O 0 4.8626952775521204e-05
truncation O 0 0.00026282729231752455
test O 0 7.065880345180631e-05
( O 0 6.456991104641929e-05
PTT O 0 0.0005591038498096168
) O 0 1.3739251699007582e-05
and O 0 6.7520677475840785e-06
the O 0 1.8888473277911544e-05
restriction O 0 6.0023659898433834e-05
endonuclease O 0 0.00030602270271629095
fingerprinting O 0 0.0003271529858466238
( O 0 0.00017598502745386213
REF O 0 0.007473988924175501
) O 0 9.60500165092526e-06
method O 0 2.9578786779893562e-06
were O 0 8.808741768007167e-06
used O 0 1.0211835615336895e-05
and O 0 1.0103303793584928e-05
compared O 0 3.131004996248521e-05
for O 0 1.0953039236483164e-05
their O 0 1.1719907888618764e-05
detection O 0 8.608984353486449e-05
efficiency O 0 6.317615770967677e-05
, O 0 7.103257303242572e-06
identifying O 0 2.2982801965554245e-05
76 O 0 7.720284338574857e-05
% O 0 1.0969702998409048e-05
and O 0 1.2117352525820024e-05
60 O 0 3.360035043442622e-05
% O 0 8.721915946807712e-06
of O 0 3.880485746776685e-05
the O 0 8.898888336261734e-05
mutations O 0 7.1790607762523e-05
, O 0 3.9485115848947316e-05
respectively O 0 0.0004143669211771339
. O 0 0.0002865623973775655

Most O 0 0.0002768652339000255
patients O 0 0.00010079565981868654
were O 0 4.885582529823296e-05
found O 0 1.4622679373132996e-05
to O 0 2.9397788239293732e-05
be O 0 6.495608977274969e-05
compound O 0 0.0005977519904263318
heterozygote O 0 0.004569940734654665
. O 0 0.0007491586729884148

Seventeen O 0 0.002405015518888831
mutations O 0 0.00019247840100433677
were O 0 5.90222334722057e-05
distinct O 0 1.895440618682187e-05
, O 0 8.727098247618414e-06
of O 0 2.281232809764333e-05
which O 0 1.3559477338276338e-05
10 O 0 2.0644476535380818e-05
were O 0 1.7707889128359966e-05
not O 0 5.994260845909594e-06
reported O 0 4.886700844508596e-05
previously O 0 0.00018978092703036964
. O 0 0.0002309374394826591

Mutations O 0 0.0009362311102449894
are O 0 4.331416494096629e-05
small O 0 6.115144060458988e-05
deletions O 0 0.0003910755622200668
or O 0 0.00011515452933963388
point O 0 0.0008756804163567722
mutations O 0 0.00022549263667315245
frequently O 0 0.00012075115228071809
affecting O 0 0.0003836110990960151
splice O 0 0.0015838344115763903
sites O 0 0.0009611534769646823
. O 0 0.0005869234446436167

Moreover O 0 0.0022570418659597635
, O 0 0.00022356743284035474
a O 0 0.00026812904980033636
16 O 0 0.0010639040265232325
. O 0 0.0003606814716476947

7 O 0 0.0026227054186165333
- O 0 0.000616788980551064
kb O 0 0.00036689580883830786
genomic O 0 4.711205474450253e-05
deletion O 0 7.272842049133033e-05
of O 0 5.863905607839115e-05
the O 0 5.454785059555434e-05
3 O 0 6.51323061902076e-05
end O 0 6.933281838428229e-05
of O 0 1.948775206983555e-05
the O 0 2.5806721168919466e-05
gene O 0 1.7141999705927446e-05
, O 0 5.694554147339659e-06
most O 0 4.723648544313619e-06
likely O 0 9.941530151991174e-06
a O 0 4.18523495682166e-06
result O 0 5.293775757309049e-06
of O 0 1.676496322033927e-05
recombination O 0 4.707208790932782e-05
between O 0 0.0001661464775679633
two O 0 3.990506593254395e-05
LINE O 0 0.0023643551394343376
elements O 0 0.00015450593491550535
, O 0 5.359712667996064e-05
was O 0 0.0006750519969500601
identified O 0 0.00025044739595614374
. O 0 0.00018404217553324997

The O 0 0.0004573407641146332
most O 0 9.03518739505671e-05
frequently O 0 5.17905100423377e-05
found O 0 1.620737020857632e-05
mutation O 0 1.5234738384606317e-05
, O 0 1.0227614438917954e-05
identified O 0 1.3914320334151853e-05
in O 0 2.3533983039669693e-05
three O 0 2.1821424525114708e-05
unrelated O 0 9.771903569344431e-05
Turkish O 0 0.00046422830200754106
A B-Disease 1 0.999987006187439
- I-Disease 1 0.9993854761123657
T I-Disease 1 0.9999488592147827
individuals O 0 2.1156300135771744e-05
, O 0 1.7338817997369915e-05
was O 0 0.00014939969696570188
previously O 0 4.164722849964164e-05
described O 0 1.5140146388148423e-05
to O 0 7.074809673213167e-06
be O 0 5.973442966933362e-06
a O 0 1.0592267244646791e-05
Turkish O 0 0.00018486403860151768
A B-Disease 1 0.9997779726982117
- I-Disease 1 0.9995637536048889
T I-Disease 1 0.9999990463256836
founder O 0 0.006170980166643858
mutation O 0 0.00016362126916646957
. O 0 0.00024377125373575836

The O 0 0.00019565770344343036
presence O 0 0.00012270607112441212
of O 0 0.00014592477236874402
a O 0 0.0002965236781165004
founder O 0 0.001562392571941018
mutation O 0 4.8642537876730785e-05
among O 0 2.9660435757250525e-05
relatively O 0 1.6270818377961405e-05
small O 0 3.6683522921521217e-06
ethnic O 0 8.502179298375268e-06
population O 0 3.925543296645628e-06
groups O 0 2.178688646381488e-06
in O 0 1.4964459296606947e-05
Western O 0 8.836069901008159e-05
Europe O 0 7.675191591260955e-05
could O 0 1.258724387298571e-05
indicate O 0 1.823397360567469e-05
a O 0 2.137430419679731e-05
high O 0 8.717452874407172e-05
carrier O 0 4.0939416066976264e-05
frequency O 0 1.9553985111997463e-05
in O 0 2.305583984707482e-05
such O 0 1.681683170318138e-05
communities O 0 6.467116327257827e-05
. O 0 0.00021635399025399238

In O 0 0.0004299278953112662
patients O 0 9.773171041160822e-05
of O 0 0.00015679759962949902
Dutch O 0 0.0004809386155102402
ethnic O 0 5.289096225169487e-05
origin O 0 2.0619290808099322e-05
, O 0 1.3850178220309317e-05
however O 0 1.1252544027229305e-05
, O 0 1.0967735761369113e-05
no O 0 1.639827314647846e-05
significant O 0 0.00011383935634512454
founder O 0 0.0010495185852050781
effect O 0 0.00010846289660548791
could O 0 4.596881990437396e-05
be O 0 1.4636742889706511e-05
identified O 0 5.030910688219592e-05
. O 0 7.904398808022961e-05

The O 0 0.00027873352519236505
observed O 0 8.813912427285686e-05
genetic O 0 0.0001288452185690403
heterogeneity O 0 0.00020339747425168753
including O 0 3.251959424233064e-05
the O 0 6.818538531661034e-05
relative O 0 0.00014149080379866064
high O 0 0.00010165871208300814
percentage O 0 4.325529880588874e-05
of O 0 7.128089055186138e-05
splice O 0 0.0013139710063114762
- O 0 0.0005760942585766315
site O 0 0.00019458180759102106
mutations O 0 5.245966895017773e-05
had O 0 6.405426393030211e-05
no O 0 3.584895239328034e-05
reflection O 0 0.00015258330677170306
on O 0 0.00022697693202644587
the O 0 0.0002379485813435167
phenotype O 0 0.0004184849967714399
. O 0 0.0002162234450224787

All O 0 0.00027529720682650805
patients O 0 0.00022279054974205792
manifested O 0 0.0012512957910075784
classical O 0 0.0045412201434373856
A B-Disease 1 0.999996542930603
- I-Disease 1 0.9973337650299072
T I-Disease 1 0.9997259974479675
and O 0 1.9917371901101433e-05
increased O 0 9.888645581668243e-05
cellular O 0 0.0003218950005248189
radioresistant O 0 0.0036607924848794937
DNA O 0 0.0004073418094776571
synthesis O 0 0.0007472000434063375
. O 0 0.0005125358002260327

Determination O 0 0.0008196235285140574
of O 0 0.00017753441352397203
the O 0 8.8541790319141e-05
genomic O 0 8.419074583798647e-05
structure O 0 8.757310570217669e-05
of O 0 6.46449625492096e-05
the O 0 0.0001366682117804885
COL4A4 O 1 0.9995317459106445
gene O 0 2.2926655219634995e-05
and O 0 5.6983244576258585e-06
of O 0 3.454607940511778e-05
novel O 0 0.0002070735936285928
mutations O 0 0.0006031104130670428
causing O 1 0.999970555305481
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999613761901855

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.8844954371452332
a O 0 0.0036746766418218613
progressive O 1 0.999996542930603
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999808073043823
by O 0 0.05384194850921631
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 1 0.9999948740005493
abnormalities I-Disease 1 0.9999929666519165
and O 0 0.00011339894990669563
associated O 0 8.812097075860947e-05
with O 0 2.9148357498343103e-05
mutations O 0 7.34372588340193e-05
in O 0 5.141543806530535e-05
either O 0 5.4418997024185956e-05
the O 0 0.00013106614642310888
COL4A3 O 1 0.999363362789154
or O 0 5.134585444466211e-05
the O 0 0.00011181162699358538
COL4A4 O 1 0.9273914694786072
gene O 0 2.952503018605057e-05
, O 0 5.152661742613418e-06
which O 0 2.073391669910052e-06
encode O 0 1.005253943731077e-05
the O 0 3.999170075985603e-05
alpha3 O 0 0.0011302425991743803
and O 0 5.4465104767587036e-05
alpha4 O 0 0.4151639938354492
type O 1 0.9856780171394348
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9434429407119751
, O 0 0.00014957973326090723
respectively O 0 0.0006208857521414757
. O 0 0.00036661780904978514

To O 0 0.00032586956513114274
date O 0 0.00022850472305435687
, O 0 1.4691871911054477e-05
mutation O 0 4.60389674117323e-06
screening O 0 1.055076063494198e-05
in O 0 1.1486806215543766e-05
the O 0 1.3817300896334928e-05
two O 0 6.6785942181013525e-06
genes O 0 1.3031140952080023e-05
has O 0 1.2483907994464971e-05
been O 0 2.2532374714501202e-05
hampered O 0 0.00015596006414853036
by O 0 4.2309397940698545e-06
the O 0 1.0737277989392169e-05
lack O 0 4.387561057228595e-05
of O 0 7.145007839426398e-05
genomic O 0 0.0001754124095896259
structure O 0 0.001156540703959763
information O 0 0.00023587771283928305
. O 0 0.00021899412968195975

We O 0 0.00023424568644259125
report O 0 2.438069168420043e-05
here O 0 1.6668436728650704e-05
the O 0 7.152485977712786e-06
complete O 0 3.266066050855443e-05
characterization O 0 4.8291549319401383e-05
of O 0 5.869511733180843e-05
the O 0 6.269381992751732e-05
48 O 0 6.896841659909114e-05
exons O 0 8.879823872121051e-05
of O 0 7.644411380169913e-05
the O 0 0.00012781060650013387
COL4A4 O 1 0.9989416003227234
gene O 0 8.354485180461779e-05
, O 0 1.169302504422376e-05
a O 0 1.7212292732438073e-05
comprehensive O 0 8.680356404511258e-05
gene O 0 2.6597772375680506e-05
screen O 0 7.066567923175171e-05
, O 0 1.1509854630276095e-05
and O 0 3.319794132039533e-06
the O 0 9.400309863849543e-06
subsequent O 0 3.259478762629442e-05
detection O 0 3.373432991793379e-05
of O 0 3.735813879757188e-05
10 O 0 5.0001377530861646e-05
novel O 0 2.2718626496498473e-05
mutations O 0 8.698523743078113e-06
in O 0 1.1685779099934734e-05
eight O 0 8.605044422438368e-05
patients O 0 0.014764729887247086
diagnosed O 1 1.0
with O 1 0.8187547326087952
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999889135360718

Furthermore O 0 0.0008952696225605905
, O 0 4.99056295666378e-05
we O 0 2.1328243747120723e-05
identified O 0 1.50778578245081e-05
a O 0 1.1277402336418163e-05
glycine O 0 3.0186172807589173e-05
to O 0 3.059183291043155e-05
alanine O 0 7.564657425973564e-05
substitution O 0 8.441479440080002e-05
in O 0 0.00012436557153705508
the O 0 0.00021497358102351427
collagenous O 0 0.008052692748606205
domain O 0 0.00015196330787148327
that O 0 2.5470046239206567e-05
is O 0 2.223305455117952e-05
apparently O 0 4.165489735896699e-05
silent O 0 0.00021670122805517167
in O 0 1.766648347256705e-05
the O 0 2.1917843696428463e-05
heterozygous O 0 2.1691605070373043e-05
carriers O 0 2.3949029127834365e-05
, O 0 1.1271359653619584e-05
in O 0 6.09407652518712e-05
11 O 0 0.0006741464603692293
. O 0 0.00033052742946892977

5 O 0 0.000404401303967461
% O 0 3.895376357831992e-05
of O 0 8.94570184755139e-05
all O 0 5.708520984626375e-05
control O 0 0.00020761170890182257
individuals O 0 2.4450640921713784e-05
, O 0 4.060002902406268e-05
and O 0 1.6879235772648826e-05
in O 0 2.9396245736279525e-05
one O 0 1.6430753021268174e-05
control O 0 3.026619197044056e-05
individual O 0 4.335773610364413e-06
homozygous O 0 1.8176058802055195e-05
for O 0 8.760570381127764e-06
this O 0 8.850558515405282e-06
glycine O 0 0.00012605087249539793
substitution O 0 0.00024021510034799576
. O 0 0.00035445799585431814

There O 0 0.0005424716509878635
has O 0 7.409757381537929e-05
been O 0 2.474824032105971e-05
no O 0 1.096579035220202e-05
previous O 0 1.3046424101048615e-05
finding O 0 2.8939848562004045e-05
of O 0 5.2749819587916136e-05
a O 0 4.143943078815937e-05
glycine O 0 8.297527529066429e-05
substitution O 0 3.940408714697696e-05
that O 0 1.0692857358662877e-05
is O 0 6.339549145195633e-06
not O 0 3.3467349567217752e-06
associated O 0 7.581664249300957e-06
with O 0 5.8015652939502615e-06
any O 0 3.768712485907599e-05
obvious O 0 0.00040553667349740863
phenotype O 0 0.00019646418513730168
in O 0 0.00013212311023380607
homozygous O 0 0.00039730643038637936
individuals O 0 0.00011797317711170763
. O 0 0.0005086340825073421

Founder O 0 0.20730797946453094
BRCA1 O 0 0.002483505057170987
and O 0 0.00012555810099001974
BRCA2 O 0 0.000598197104409337
mutations O 0 5.7132263464154676e-05
in O 0 3.434917744016275e-05
French O 0 0.0001927450648508966
Canadian O 0 0.0008213967084884644
breast B-Disease 1 0.9999955892562866
and I-Disease 1 0.9996477365493774
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.009550937451422215
. O 0 0.0008994056261144578

We O 0 0.00020537999807856977
have O 0 1.4748570720257703e-05
identified O 0 1.7836155166151002e-05
four O 0 1.0158432814932894e-05
mutations O 0 7.810925126250368e-06
in O 0 6.295591447269544e-06
each O 0 1.0538034302953747e-06
of O 0 4.0386603359365836e-05
the O 0 0.0005559058045037091
breast B-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9999984502792358
- O 0 0.13045845925807953
susceptibility O 0 0.0006268913275562227
genes O 0 6.195777677930892e-05
, O 0 2.8976690373383462e-05
BRCA1 O 0 0.00018897088011726737
and O 0 2.3372209398075938e-05
BRCA2 O 0 0.00012841542775277048
, O 0 6.159627446322702e-06
in O 0 7.618949439347489e-06
French O 0 7.489798736060038e-05
Canadian O 0 0.0005201376043260098
breast B-Disease 1 0.9999980926513672
cancer I-Disease 1 0.9999997615814209
and O 0 0.3713112771511078
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0006266219425015152
from O 0 0.0003704031987581402
Quebec O 0 0.002814054721966386
. O 0 0.0005776057369075716

To O 0 0.0008001007372513413
identify O 0 0.0011266452493146062
founder O 0 0.009130390360951424
effects O 0 0.0011487385490909219
, O 0 3.967682278016582e-05
we O 0 9.664615390647668e-06
examined O 0 3.126643059658818e-05
independently O 0 5.873682312085293e-06
ascertained O 0 7.155808998504654e-05
French O 0 0.0001000918637146242
Canadian O 0 0.00014324660878628492
cancer B-Disease 0 0.0009317589574493468
families O 0 8.686925866641104e-06
for O 0 8.96903748071054e-06
the O 0 2.613719698274508e-05
distribution O 0 2.241967558802571e-05
of O 0 4.864457878284156e-05
these O 0 2.262798443553038e-05
eight O 0 0.00016359878645744175
mutations O 0 0.000368832319509238
. O 0 0.0003356843953952193

Mutations O 0 0.00044597021769732237
were O 0 0.00010578486399026588
found O 0 2.297519677085802e-05
in O 0 2.5686507797217928e-05
41 O 0 5.2641829825006425e-05
of O 0 8.002418326213956e-05
97 O 0 0.0004222940478939563
families O 0 6.64483304717578e-05
. O 0 0.00016992796736303717

Six O 0 0.0001787811197573319
of O 0 0.0001275936228921637
eight O 0 0.0001424629590474069
mutations O 0 5.636500645778142e-05
were O 0 4.26008045906201e-05
observed O 0 8.322822395712137e-05
at O 0 0.00020193065574858338
least O 0 7.26678263163194e-05
twice O 0 0.00032132628257386386
. O 0 0.00018838727555703372

The O 0 0.001486221794039011
BRCA1 O 0 0.002626262605190277
C4446T O 0 0.0015947844367474318
mutation O 0 4.377292498247698e-05
was O 0 0.00010955861216643825
the O 0 2.6975962100550532e-05
most O 0 1.351379160041688e-05
common O 0 2.0402021618792787e-05
mutation O 0 2.707092608034145e-05
found O 0 1.3076353752694558e-05
, O 0 5.4030324463383295e-06
followed O 0 1.895643254101742e-05
by O 0 1.376246382278623e-05
the O 0 0.00010745280451374128
BRCA2 O 0 0.0014913261402398348
8765delAG O 0 0.004053560085594654
mutation O 0 0.00033104815520346165
. O 0 0.0002531467180233449

Together O 0 0.0004606355505529791
, O 0 4.4851494749309495e-05
these O 0 9.053970643435605e-06
mutations O 0 2.769747698039282e-05
were O 0 4.137254654779099e-05
found O 0 1.4712469237565529e-05
in O 0 2.1283949536154978e-05
28 O 0 0.00010049757111119106
of O 0 5.341272844816558e-05
41 O 0 6.827048491686583e-05
families O 0 1.0048763215309009e-05
identified O 0 2.0272889742045663e-05
to O 0 2.5637536964495666e-05
have O 0 1.4072387784835882e-05
a O 0 5.339077688404359e-05
mutation O 0 0.00011100382107542828
. O 0 0.000233731436310336

The O 0 0.0003967565135098994
odds O 0 0.0004663080908358097
of O 0 7.903840742073953e-05
detection O 0 0.00010280533751938492
of O 0 4.7551140596624464e-05
any O 0 1.0508576451684348e-05
of O 0 4.5689121179748327e-05
the O 0 6.011004006722942e-05
four O 0 6.51981754344888e-05
BRCA1 O 0 0.00041367695666849613
mutations O 0 0.00010207163722952828
was O 0 0.0008324644295498729
18 O 0 0.0007641007541678846
. O 0 0.00027486163889989257

7x O 0 0.031003504991531372
greater O 0 0.00046138704055920243
if O 0 3.2548945455346256e-05
one O 0 9.394699191034306e-06
or O 0 5.258594228507718e-06
more O 0 2.078190163956606e-06
cases O 0 2.015203244809527e-05
of O 1 0.943753719329834
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.0006342841079458594
also O 0 2.605429654067848e-05
present O 0 3.096338332397863e-05
in O 0 3.341345291119069e-05
the O 0 0.00012549081293400377
family O 0 0.00020042313553858548
. O 0 0.00018044939497485757

The O 0 0.00048772135050967336
odds O 0 0.0007271458744071424
of O 0 0.00011685113713610917
detection O 0 0.00012912786041852087
of O 0 7.362594624282792e-05
any O 0 3.232622111681849e-05
of O 0 8.106853783829138e-05
the O 0 4.824906136491336e-05
four O 0 5.145359318703413e-05
BRCA2 O 0 0.0005099773989059031
mutations O 0 0.00011823896784335375
was O 0 0.000969118787907064
5 O 0 0.0004743019235320389
. O 0 0.00019148860883433372

3x O 0 0.00873567070811987
greater O 0 0.0004037578182760626
if O 0 2.070516347885132e-05
there O 0 1.2250742656760849e-05
were O 0 1.211386188515462e-05
at O 0 4.1201117710443214e-05
least O 0 6.881268291181186e-06
five O 0 1.0296718755853362e-05
cases O 0 1.3128210412105545e-05
of O 0 0.0004609921888913959
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999995231628418
in O 0 0.00028711510822176933
the O 0 0.0003671738086268306
family O 0 0.00019458867609500885
. O 0 0.00016086484538391232

Interestingly O 0 0.0009989328682422638
, O 0 2.7977064746664837e-05
the O 0 3.067948637180962e-05
presence O 0 4.2925006709992886e-05
of O 0 0.0001599541719770059
a O 0 0.0016719779232516885
breast B-Disease 1 0.9999909400939941
cancer I-Disease 1 0.9997976422309875
case O 0 0.00018732616445049644
< O 0 0.0008137281984090805
36 O 0 5.8891793742077425e-05
years O 0 3.52599163306877e-05
of O 0 3.75863783119712e-05
age O 0 0.00016677152598276734
was O 0 0.00019657531811390072
strongly O 0 1.9430683096288703e-05
predictive O 0 2.187866448366549e-05
of O 0 5.5376800446538255e-05
the O 0 6.479467992903665e-05
presence O 0 4.350865492597222e-05
of O 0 5.021104880142957e-05
any O 0 2.6067868020618334e-05
of O 0 8.33936283015646e-05
the O 0 9.537934238323942e-05
eight O 0 0.00015680522483307868
mutations O 0 0.0001220707199536264
screened O 0 0.0008247536025010049
. O 0 0.0002483063144609332

Carriers O 0 0.00023486917780246586
of O 0 9.551295806886628e-05
the O 0 8.7690947111696e-05
same O 0 2.88184528471902e-05
mutation O 0 1.5758558220113628e-05
, O 0 6.234904503799044e-06
from O 0 9.38841185416095e-06
different O 0 1.4698183576911106e-06
families O 0 6.449461125157541e-06
, O 0 1.0657877282937989e-05
shared O 0 2.4166063667507842e-05
similar O 0 1.6765730833867565e-05
haplotypes O 0 0.00022039716714061797
, O 0 2.352814954065252e-05
indicating O 0 5.948942634859122e-05
that O 0 4.3581844693108e-06
the O 0 1.2004311429336667e-05
mutant O 0 5.449752643471584e-05
alleles O 0 1.2619118933798745e-05
were O 0 2.425127604510635e-05
likely O 0 3.2161278795683756e-05
to O 0 1.0124582331627607e-05
be O 0 7.74756153987255e-06
identical O 0 1.2039302418997977e-05
by O 0 7.752972123853397e-06
descent O 0 8.154871466103941e-05
for O 0 2.456183392496314e-05
a O 0 9.889720240607858e-05
mutation O 0 3.624012242653407e-05
in O 0 4.543182149063796e-05
the O 0 0.0001415496226400137
founder O 0 0.0015480697620660067
population O 0 0.00011415035260142758
. O 0 0.00017227069474756718

The O 0 0.00010847488738363609
identification O 0 3.1291991035686806e-05
of O 0 0.0001868238759925589
common O 0 0.00024123025650624186
BRCA1 O 0 0.0033266558311879635
and O 0 0.0001547167485114187
BRCA2 O 0 0.0009031740482896566
mutations O 0 4.744487887364812e-05
will O 0 1.321107629337348e-05
facilitate O 0 4.470600470085628e-05
carrier O 0 5.6004100770223886e-05
detection O 0 1.735307705530431e-05
in O 0 7.94880270404974e-06
French O 0 5.1517719839466736e-05
Canadian O 0 0.0002107256732415408
breast B-Disease 1 0.9999896287918091
cancer I-Disease 1 0.9999992847442627
and O 0 0.24562150239944458
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.0034759039990603924
. O 0 0.0004428189422469586

Are O 0 0.00016304347082041204
Dp71 O 0 0.20381344854831696
and O 0 0.00019242483540438116
Dp140 O 0 0.4476169943809509
brain O 1 0.7084670066833496
dystrophin O 0 0.0014110356569290161
isoforms O 0 7.063051452860236e-05
related O 0 6.720263627357781e-05
to O 0 0.00011425925185903907
cognitive B-Disease 1 0.9998863935470581
impairment I-Disease 1 1.0
in O 1 1.0
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999915361404419

Molecular O 0 0.0010706521570682526
study O 0 8.01517307991162e-05
and O 0 2.277191924804356e-05
neuropsychological O 0 0.00019300657731946558
analysis O 0 9.81916946329875e-06
were O 0 1.971411438717041e-05
performed O 0 3.67471766367089e-05
concurrently O 0 2.752873297140468e-05
on O 0 5.404622424975969e-05
49 O 0 0.00020693030091933906
patients O 0 0.0006809374317526817
with O 1 0.9548829197883606
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DMD B-Disease 1 1.0
) O 0 0.00013945762475486845
in O 0 1.9985467588412575e-05
order O 0 5.277071977616288e-06
to O 0 6.497620688605821e-06
find O 0 9.617008799978066e-06
a O 0 1.4359193301061168e-05
molecular O 0 2.6910029191640206e-05
explanation O 0 1.4197252312442288e-05
for O 0 1.1940315744141117e-05
the O 0 9.262157982448116e-05
cognitive B-Disease 0 0.17164942622184753
impairment I-Disease 1 0.9999419450759888
observed O 0 0.0012291494058445096
in O 0 0.00047191555495373905
most O 0 0.002640243386849761
DMD B-Disease 1 1.0
patients O 0 0.3657280206680298
. O 0 0.0008390088332816958

Complete O 0 0.0003699891676660627
analysis O 0 2.3563512513646856e-05
of O 0 7.76456217863597e-05
the O 0 0.00012133020209148526
dystrophin O 0 0.001311745261773467
gene O 0 7.062574150040746e-05
was O 0 0.0001713561941869557
performed O 0 4.782901669386774e-05
to O 0 1.2908960343338549e-05
define O 0 3.0344050173880532e-05
the O 0 5.090972990728915e-05
localization O 0 0.0006907573551870883
of O 0 0.00021446484606713057
deletions O 0 0.0004774934786837548
and O 0 6.656673940597102e-05
duplications O 0 0.0006770496838726103
in O 0 5.22842128702905e-05
relation O 0 8.275102300103754e-05
to O 0 2.5335812097182497e-05
the O 0 7.699169509578496e-05
different O 0 7.434330473188311e-05
DMD B-Disease 1 1.0
promoters O 1 0.9975072741508484
. O 0 0.0010681032435968518

Qualitative O 0 0.0002830223529599607
analysis O 0 2.8992224542889744e-05
of O 0 8.990718924906105e-05
the O 0 0.00015418537077493966
Dp71 O 0 0.023739106953144073
transcript O 0 0.0003327476151753217
and O 0 1.001739929051837e-05
testing O 0 5.932584372203564e-06
for O 0 2.7929770567425294e-06
the O 0 7.830227332306094e-06
specific O 0 3.610040948842652e-06
first O 0 7.509172428399324e-05
exon O 0 0.0002983052399940789
of O 0 0.00011301453923806548
Dp140 O 0 0.0009680911898612976
were O 0 6.28359048278071e-05
also O 0 3.032574022654444e-05
carried O 0 9.904104081215337e-05
out O 0 5.2383533329702914e-05
. O 0 0.00016852092812769115

Neuropsychological O 0 0.002662774408236146
analysis O 0 5.7295943406643346e-05
assessed O 0 0.0001101236921385862
verbal O 0 0.00029223973979242146
and O 0 0.0001405995135428384
visuospatial O 0 0.22445973753929138
intelligence O 0 0.00035824396763928235
, O 0 6.181083153933287e-05
verbal O 0 0.00048331322614103556
memory O 1 0.9997716546058655
, O 0 0.00017835614562500268
and O 0 7.17234070179984e-05
reading O 0 0.0013643034035339952
skills O 0 0.0038822575006633997
. O 0 0.0009620970231480896

Comparison O 0 0.0004040140483994037
of O 0 0.00039230816764757037
molecular O 0 0.000607506197411567
and O 0 5.517365570995025e-05
psychometric O 0 0.0007597473450005054
findings O 0 5.883173071197234e-05
demonstrated O 0 0.0002978246775455773
that O 0 2.561815381341148e-05
deletions O 0 0.0001593768538441509
and O 0 3.9309430576395243e-05
duplications O 0 0.0006407604087144136
that O 0 1.609094033483416e-05
were O 0 4.111978705623187e-05
localized O 0 0.00015189580153673887
in O 0 3.187354013789445e-05
the O 0 5.844913175678812e-05
distal O 0 0.0012224557576701045
part O 0 0.0001328333019046113
of O 0 0.00015789463941473514
the O 0 0.00016009225510060787
gene O 0 5.0355385610600933e-05
seemed O 0 8.44912210595794e-05
to O 0 1.0771965207823087e-05
be O 0 8.803702257864643e-06
preferentially O 0 2.5382949388585985e-05
associated O 0 2.8811415177187882e-05
with O 0 5.3117910283617675e-05
cognitive B-Disease 1 0.9988288283348083
impairment I-Disease 1 0.9999998807907104
. O 1 0.8884661793708801

Two O 0 0.0003577446623239666
altered O 0 0.0010399265447631478
Dp71 O 0 0.0038458597846329212
transcripts O 0 0.00037997905747033656
and O 0 3.095473221037537e-05
two O 0 1.2403119399095885e-05
deleted O 0 9.745967690832913e-05
Dp140 O 0 0.00020838894124608487
DNA O 0 2.367701927141752e-05
sequences O 0 1.1122509022243321e-05
were O 0 1.2152081581007224e-05
found O 0 4.512370196607662e-06
in O 0 1.3618794582725968e-05
four O 0 2.073654468404129e-05
patients O 0 0.0001240685087395832
with O 0 0.0006156736635603011
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9999575614929199

These O 0 8.738676115171984e-05
findings O 0 7.049660780467093e-05
suggest O 0 4.396636722958647e-05
that O 0 5.036576112615876e-06
some O 0 5.728876203647815e-06
sequences O 0 1.3876460798201151e-05
located O 0 9.333282650914043e-05
in O 0 1.6425285139121115e-05
the O 0 3.546076186466962e-05
distal O 0 0.0005600783624686301
part O 0 0.00010760022996691987
of O 0 0.00011127172183478251
the O 0 7.552777969976887e-05
gene O 0 2.4958850190159865e-05
and O 0 8.326569513883442e-06
, O 0 8.318465916090645e-06
in O 0 1.0057439794763923e-05
particular O 0 1.1743715731427073e-05
, O 0 1.2155418517068028e-05
some O 0 1.3926705833000597e-05
DMD B-Disease 1 0.9998918771743774
isoforms O 0 4.231688944855705e-05
expressed O 0 4.312210148782469e-05
in O 0 2.6746265575638972e-05
the O 0 0.00014941138215363026
brain O 1 0.8384393453598022
may O 0 7.222472049761564e-05
be O 0 7.165703664213652e-06
related O 0 1.5181134585873224e-05
to O 0 1.3413180568022653e-05
the O 0 7.753595855319872e-05
cognitive B-Disease 1 0.5412430763244629
impairment I-Disease 1 0.9999966621398926
associated O 1 0.7289014458656311
with O 0 0.21103064715862274
DMD B-Disease 1 1.0
. O 0 0.0020687230862677097
. O 0 0.00048547828919254243

I1307K O 0 0.044344983994960785
APC O 0 0.013731202110648155
and O 0 0.0002596449921838939
hMLH1 O 0 0.0026743512134999037
mutations O 0 0.00011249563976889476
in O 0 5.261147452984005e-05
a O 0 6.110998947406188e-05
non O 0 0.00018684007227420807
- O 0 0.00013129744911566377
Jewish O 0 2.5159399228869006e-05
family O 0 9.550773938826751e-06
with O 0 1.3527408555091824e-05
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9947975873947144

We O 0 0.00013776861305814236
describe O 0 8.042168337851763e-05
a O 0 2.9709071895922534e-05
French O 0 0.00012158697791164741
Canadian O 0 0.00018418842228129506
hereditary B-Disease 1 0.9999973773956299
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999973773956299
HNPCC B-Disease 1 1.0
) O 0 0.00026031944435089827
kindred O 0 0.0010653341887518764
which O 0 3.1575960747431964e-05
carries O 0 7.409128011204302e-05
a O 0 5.8872028603218496e-05
novel O 0 0.00012956224964000285
truncating O 0 0.0007806125795468688
mutation O 0 8.299735782202333e-05
in O 0 0.0002661406761035323
hMLH1 O 0 0.006823030300438404
. O 0 0.0006767732556909323

Interestingly O 0 0.0024683692026883364
, O 0 9.922310709953308e-05
the O 0 0.0001445440575480461
I1307K O 0 0.0021935792174190283
APC O 0 0.0013551905285567045
polymorphism O 0 0.00017394506721757352
, O 0 1.9673620045068674e-05
associated O 0 7.664687473152298e-06
with O 0 3.7607703688991023e-06
an O 0 1.0886049494729377e-05
increased O 0 0.00011321213241899386
risk O 0 0.001238557044416666
of O 1 0.999988317489624
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0002994067326653749
is O 0 2.434695852571167e-05
also O 0 5.386656084738206e-06
present O 0 1.3306388609635178e-05
in O 0 2.278475949424319e-05
this O 0 1.8451846699463204e-05
family O 0 8.431800961261615e-05
. O 0 0.00012218017945997417

The O 0 0.0007621424738317728
I1307K O 0 0.0022279806435108185
polymorphism O 0 0.00010170380846830085
has O 0 2.434342968626879e-05
previously O 0 2.035871693806257e-05
only O 0 5.807422439829679e-06
been O 0 1.2179428267700132e-05
identified O 0 9.772068551683333e-06
in O 0 7.037139766907785e-06
individuals O 0 5.812469680677168e-06
of O 0 0.00012361173867248
self O 0 0.0016200884710997343
- O 0 0.0013636278454214334
reported O 0 8.719778998056427e-05
Ashkenazi O 0 0.00013916670286562294
Jewish O 0 0.0003130832046736032
origins O 0 0.0013630662579089403
. O 0 0.00045585373300127685

In O 0 0.00024164414207916707
addition O 0 5.706898809876293e-05
, O 0 1.7124955775216222e-05
in O 0 1.3603009392681997e-05
this O 0 1.5080415323609486e-05
family O 0 2.2142681700643152e-05
, O 0 9.065885933523532e-06
there O 0 1.0884689800150227e-05
appears O 0 2.393290924374014e-05
to O 0 5.475899342854973e-06
be O 0 8.853833605826367e-06
no O 0 1.2698818864009809e-05
relationship O 0 5.177896309760399e-05
between O 0 0.00013501491048373282
the O 0 7.145253039197996e-05
I1307K O 0 0.000462359341327101
polymorphism O 0 4.603361594490707e-05
and O 0 7.305423878278816e-06
the O 0 2.529766788939014e-05
presence O 0 4.038101906189695e-05
or O 0 3.728656520252116e-05
absence O 0 0.0006578508182428777
of O 0 0.3605411946773529
cancer B-Disease 1 0.9999996423721313
. O 0 0.0004409667453728616
. O 0 0.00033867964521050453

Identification O 0 0.00017223718168679625
of O 0 0.00022179947700351477
a O 0 8.924774010665715e-05
novel O 0 8.766352402744815e-05
mutation O 0 1.7419699361198582e-05
of O 0 4.5058342948323116e-05
the O 0 0.0001964864641195163
CPO O 0 0.005445820279419422
gene O 0 4.674794399761595e-05
in O 0 3.040406954823993e-05
a O 0 6.090329043217935e-05
Japanese O 0 0.0011481468100100756
hereditary B-Disease 1 0.9999938011169434
coproporphyria I-Disease 1 0.999997615814209
family O 0 0.0035697442945092916
. O 0 0.0004956275224685669

Hereditary B-Disease 1 0.9999996423721313
coproporphyria I-Disease 1 0.9999988079071045
( O 1 0.7360907793045044
HCP B-Disease 1 0.9999995231628418
) O 0 0.0001103711620089598
is O 0 2.6297029762645252e-05
an O 0 4.657679528463632e-05
autosomal B-Disease 1 0.9999946355819702
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 1 0.9943694472312927
by O 0 0.00011574747622944415
a O 0 0.0010925246169790626
deficiency B-Disease 1 1.0
of I-Disease 1 0.9932830333709717
coproporphyrinogen I-Disease 1 0.9999951124191284
oxidase I-Disease 0 0.000566263566724956
( O 0 0.00017655902775004506
CPO O 0 0.007220222614705563
) O 0 3.488401853246614e-05
caused O 0 0.00011595338582992554
by O 0 9.216189937433228e-06
a O 0 2.5701403501443565e-05
mutation O 0 1.4978151739342138e-05
in O 0 3.08271155518014e-05
the O 0 0.00014758057659491897
CPO O 0 0.04844256117939949
gene O 0 0.0002834965998772532
. O 0 0.0002783547970466316

Only O 0 0.00015123591583687812
11 O 0 0.00015675618487875909
mutations O 0 2.1567779185716063e-05
of O 0 3.738539817277342e-05
the O 0 5.782812513643876e-05
gene O 0 2.371055234107189e-05
have O 0 5.272916496323887e-06
been O 0 1.8673370504984632e-05
reported O 0 3.511592876748182e-05
in O 0 0.00016680841508787125
HCP B-Disease 1 0.9999994039535522
patients O 0 0.0030261429492384195
. O 0 0.0007046355167403817

We O 0 0.000211342194234021
report O 0 4.4283984607318416e-05
another O 0 3.60605408786796e-05
mutation O 0 2.32301936193835e-05
in O 0 2.4960898372228257e-05
a O 0 0.00011519846884766594
Japanese O 0 0.0008578062988817692
family O 0 0.0004100116202607751
. O 0 0.00031006490462459624

Polymerase O 0 0.009868256747722626
chain O 0 0.0015438373666256666
reaction O 0 0.0003407270705793053
- O 0 0.0008269775426015258
single O 0 9.31670656427741e-05
strand O 0 8.263085328508168e-05
conformational O 0 2.3777192836860195e-05
polymorphism O 0 3.5525918065104634e-05
and O 0 8.033470294321887e-06
direct O 0 9.024910468724556e-06
sequence O 0 1.3288889931573067e-05
analyses O 0 1.58271304826485e-05
demonstrated O 0 7.435919542331249e-05
a O 0 5.368413985706866e-05
C O 0 0.00033870694460347295
to O 0 6.654109893133864e-05
T O 0 0.0003789143229369074
substitution O 0 1.5028001143946312e-05
in O 0 2.0088826204300858e-05
exon O 0 0.00013298841076903045
1 O 0 5.766924368799664e-05
of O 0 4.451423228601925e-05
the O 0 9.674327884567901e-05
CPO O 0 0.0017382907681167126
gene O 0 3.022379314643331e-05
at O 0 8.3345606981311e-05
nucleotide O 0 2.833381950040348e-05
position O 0 4.519390131463297e-05
85 O 0 5.775251338491216e-05
, O 0 5.509234597411705e-06
which O 0 5.81563062951318e-06
lies O 0 0.00010116369230672717
in O 0 2.0364406736916862e-05
the O 0 3.5754041164182127e-05
putative O 0 0.00021934352116659284
presequence O 0 0.0007867649546824396
for O 0 2.496335218893364e-05
targeting O 0 5.814064570586197e-05
to O 0 0.00013693381333723664
mitochondria O 0 0.000821287278085947
. O 0 0.0002591844240669161

This O 0 0.00012073986727045849
mutation O 0 5.423399852588773e-05
changes O 0 2.3144993974710815e-05
the O 0 2.8202159228385426e-05
codon O 0 1.996971150219906e-05
for O 0 9.693007996247616e-06
glutamine O 0 3.393735096324235e-05
to O 0 1.9427887309575453e-05
a O 0 2.0919997041346505e-05
termination O 0 9.747343574417755e-05
codon O 0 8.835320477373898e-05
at O 0 0.0003571507113520056
amino O 0 9.68206295510754e-05
acid O 0 0.00018112269754055887
position O 0 0.0006865196628496051
29 O 0 0.001759165432304144
. O 0 0.0003670555306598544

MaeI O 0 0.00939363706856966
restriction O 0 0.00021164971985854208
analysis O 0 1.9836657884297892e-05
showed O 0 6.780502735637128e-05
two O 0 8.923639143176842e-06
other O 0 7.717216249147896e-06
carriers O 0 2.711904380703345e-05
in O 0 2.6645448087947443e-05
the O 0 8.300407353090122e-05
family O 0 0.0002470127947162837
. O 0 0.00015799509128555655

The O 0 0.002079874509945512
C O 1 0.7309221625328064
- O 0 0.009892495349049568
T O 0 0.002148436149582267
mutation O 0 2.1151821783860214e-05
is O 0 5.966098797216546e-06
located O 0 3.681753878481686e-05
within O 0 8.39325184642803e-06
a O 0 1.1143829397042282e-05
recently O 0 2.1799565729452297e-05
proposed O 0 1.913497362693306e-05
putative O 0 9.300533565692604e-05
alternative O 0 1.2083922229066957e-05
translation O 0 4.5375796617008746e-05
initiation O 0 0.00022156273189466447
codon O 0 0.00011233999248361215
( O 0 0.00013272011710796505
TIC O 0 0.013690082356333733
- O 0 0.00018706238188315183
1 O 0 7.907913095550612e-05
) O 0 5.115118710818933e-06
, O 0 3.2497523534402717e-06
supporting O 0 2.0879358999081887e-05
that O 0 2.1408002794487402e-05
TIC O 0 0.19860531389713287
- O 0 0.00023549098114017397
1 O 0 6.930452946107835e-05
is O 0 7.510320756409783e-06
the O 0 2.218425834144e-05
real O 0 0.0004039559280499816
TIC O 1 0.9158858060836792
rather O 0 0.00011060537508456036
than O 0 0.00013290042988955975
TIC O 1 0.9675050973892212
- O 0 0.000892041192855686
2 O 0 0.00034321079147048295
. O 0 7.291285874089226e-05
. O 0 8.494960638927296e-05

Human B-Disease 0 0.00018088366778101772
complement I-Disease 0 0.0003038588329218328
factor I-Disease 1 0.9762858152389526
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.9969417452812195
with O 1 0.9999967813491821
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999966621398926

This O 0 7.615496724611148e-05
study O 0 2.4031023713178e-05
reports O 0 9.806405614654068e-06
on O 0 3.8780708564445376e-05
six O 0 2.569858406786807e-05
cases O 0 2.1699301214539446e-05
of O 0 0.0005174805992282927
deficiency B-Disease 1 1.0
in I-Disease 0 0.00014480356185231358
the I-Disease 0 3.6274494050303474e-05
human I-Disease 0 7.4130612119915895e-06
complement I-Disease 0 1.2033196071570273e-05
regulatory I-Disease 0 2.8618716896744445e-05
protein I-Disease 0 5.626066922559403e-05
Factor I-Disease 0 0.00022095745953265578
H I-Disease 1 0.9996163845062256
( O 0 0.0001435360754840076
FH O 0 0.001914336928166449
) O 0 8.555837666790467e-06
in O 0 4.921950221614679e-06
the O 0 6.1036785155010875e-06
context O 0 1.742069434840232e-05
of O 0 9.559569298289716e-05
an O 0 0.02392302267253399
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999949932098389

Five O 0 0.00020062907424289733
of O 0 9.881425648927689e-05
the O 0 4.063074811710976e-05
cases O 0 1.716410042718053e-05
were O 0 2.7311043595545925e-05
observed O 0 2.0692845282610506e-05
in O 0 1.3390073036134709e-05
children O 0 9.663325727160554e-06
presenting O 0 7.172108598751947e-05
with O 0 0.0009360994445160031
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 0.37313607335090637
. O 0 0.0006607077666558325

Two O 0 6.986657535890117e-05
of O 0 0.00010927981202257797
the O 0 0.00012126023648306727
children O 0 0.00010010465484810993
exhibited O 0 0.0016875577857717872
a O 0 0.0010612934129312634
homozygous O 1 0.9813752174377441
deficiency O 1 1.0
characterized O 0 0.020642315968871117
by O 0 6.96049610269256e-05
the O 0 6.36593031231314e-05
absence O 0 0.00012483631144277751
of O 0 6.71134257572703e-05
the O 0 7.078194903442636e-05
150 O 0 0.00010181150719290599
- O 0 0.00019289730698801577
kD O 0 0.000501162139698863
form O 0 1.7062571714632213e-05
of O 0 0.00012841873103752732
Factor O 0 0.0008526251767762005
H O 1 0.9999775886535645
and O 0 3.344061042298563e-05
the O 0 2.5016614017658867e-05
presence O 0 4.060076753376052e-05
, O 0 6.5991566771117505e-06
upon O 0 4.862973582930863e-05
immunoblotting O 0 0.0005681011825799942
, O 0 1.005415015242761e-05
of O 0 2.5842624381766655e-05
the O 0 7.255634409375489e-05
42 O 0 0.00026317007723264396
- O 0 0.0004691779031418264
kD O 0 0.0037288584280759096
Factor O 0 0.0005187861388549209
H O 1 0.5267465710639954
- O 0 0.0002887333102989942
like O 0 1.5542593246209435e-05
protein O 0 2.0515964934020303e-05
1 O 0 0.00010632965859258547
( O 0 3.966384247178212e-05
FHL O 0 0.0029017350170761347
- O 0 0.00010152086179004982
1 O 0 4.823861308977939e-05
) O 0 6.09118842476164e-06
and O 0 3.0599342153436737e-06
other O 0 9.40149311645655e-06
FH O 0 0.016215261071920395
- O 0 0.00031763294828124344
related O 0 8.695334690855816e-05
protein O 0 9.821097046369687e-05
( O 0 0.00013067357940599322
FHR O 1 0.9264631867408752
) O 0 0.00022522748622577637
bands O 0 0.0010225388687103987
. O 0 0.00038868439150974154

Southern O 0 0.0013948120176792145
blot O 0 0.0006590490811504424
and O 0 3.498513615340926e-05
PCR O 0 3.570429180399515e-05
analysis O 0 3.3350102057738695e-06
of O 0 2.1189331164350733e-05
DNA O 0 3.931786704924889e-05
of O 0 5.63079011044465e-05
one O 0 3.531702532200143e-05
patient O 0 7.66353405197151e-05
with O 0 5.995518222334795e-05
homozygous O 0 0.03034953959286213
deficiency O 1 1.0
ruled O 0 0.0011912868358194828
out O 0 2.2175776393851265e-05
the O 0 1.5345718566095456e-05
presence O 0 1.1828443348349538e-05
of O 0 2.221997783635743e-05
a O 0 1.893858097901102e-05
large O 0 2.2652599000139162e-05
deletion O 0 3.779599865083583e-05
of O 0 9.934543049894273e-05
the O 0 0.0001972103927982971
FH O 0 0.4467218220233917
gene O 0 3.741100590559654e-05
as O 0 1.8708056813920848e-05
the O 0 4.5477419917006046e-05
underlying O 0 0.1805775761604309
defect O 1 0.9910166263580322
for O 0 0.0004918620688840747
the O 1 0.9777008891105652
deficiency O 1 1.0
. O 0 0.0076630306430161

The O 0 0.00019586062990128994
other O 0 1.5610477930749767e-05
four O 0 1.9638979210867546e-05
children O 0 1.3718643458560109e-05
presented O 0 7.913034642115235e-05
with O 0 8.603821333963424e-05
heterozygous O 0 0.006504765711724758
deficiency O 1 1.0
and O 0 0.0007665067678317428
exhibited O 1 0.8245643973350525
a O 0 0.0005370152648538351
normal O 0 0.00029639279819093645
immunoblotting O 0 0.0020376599859446287
pattern O 0 0.0001283089368371293
of O 0 0.00010590757301542908
proteins O 0 4.188896491541527e-05
of O 0 0.00014551014464814216
the O 0 0.000515976338647306
FH O 1 0.9994415640830994
family O 0 0.0006101132603362203
. O 0 0.00025040344917215407

Factor B-Disease 1 0.999554455280304
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 3.782931889872998e-05
the O 0 3.101936454186216e-05
only O 0 5.009267988498323e-05
complement B-Disease 1 0.9999834299087524
deficiency I-Disease 1 1.0
associated O 1 0.9530543684959412
with O 0 0.06069702282547951
HUS B-Disease 1 1.0
. O 0 0.019412217661738396

These O 0 8.511202031513676e-05
observations O 0 9.101113391807303e-05
suggest O 0 4.757382339448668e-05
a O 0 3.4626031265361235e-05
role O 0 0.0001052192528732121
for O 0 6.082946129026823e-05
FH O 1 0.951395571231842
and O 0 0.00017808152188081294
/ O 0 0.0019438769668340683
or O 0 0.0003092548286076635
FH O 0 0.16524335741996765
receptors O 0 0.00015670267748646438
in O 0 4.92062208650168e-05
the O 0 0.0001791070244507864
pathogenesis O 1 0.9999587535858154
of O 1 0.9265738725662231
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 0.1205054223537445
. O 0 0.0009914051042869687

Further O 0 0.000165022152941674
evidence O 0 4.356587305665016e-05
for O 0 1.1500200344016775e-05
a O 0 3.13063501380384e-05
major O 0 0.00011467436706880108
ancient O 0 0.0014083907008171082
mutation O 0 0.02776692993938923
underlying O 1 1.0
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9997009038925171
linkage O 1 0.9995262622833252
disequilibrium O 1 0.997077226638794
studies O 0 9.764060814632103e-05
in O 0 5.55833539692685e-05
the O 0 5.074923683423549e-05
Japanese O 0 0.00047396362060680985
population O 0 5.3510255384026095e-05
. O 0 0.00013981355004943907

The O 1 0.9975641965866089
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9993619322776794
DM B-Disease 1 1.0
) O 0 0.0002721997443586588
mutation O 0 2.8643644327530637e-05
is O 0 1.3752754057350103e-05
an O 0 1.729122959659435e-05
unstable O 0 0.003098475281149149
( O 0 0.00012382952263578773
CTG O 0 0.454122394323349
) O 0 3.440595537540503e-05
n O 0 8.719795732758939e-05
repeat O 0 0.00014553942310158163
, O 0 1.123174479289446e-05
present O 0 1.921242983371485e-05
at O 0 8.01753340056166e-05
a O 0 1.6645735740894452e-05
copy O 0 2.0608949853340164e-05
number O 0 1.364867239317391e-05
of O 0 4.83131043438334e-05
5 O 0 0.00023533856438007206
- O 0 0.00013360587763600051
37 O 0 3.553659189492464e-05
repeats O 0 3.175533493049443e-05
on O 0 3.364973235875368e-05
normal O 0 2.5489485778962262e-05
chromosomes O 0 1.9715618691407144e-05
but O 0 5.498632162925787e-06
amplified O 0 3.288590960437432e-05
to O 0 1.4170428585202899e-05
50 O 0 5.5583463108632714e-05
- O 0 6.562345515703782e-05
3000 O 0 9.005820174934343e-05
copies O 0 5.080071059637703e-05
on O 0 0.00037636529305018485
DM B-Disease 1 0.9999985694885254
chromosomes O 0 0.0015319321537390351
. O 0 0.0005554198287427425

Previous O 0 0.0002583742025308311
findings O 0 7.779502630000934e-05
in O 0 5.5826225434429944e-05
Caucasian O 0 0.00024623190984129906
populations O 0 1.4824026948190294e-05
of O 0 6.099936945247464e-05
a O 0 0.0006189655978232622
DM B-Disease 1 1.0
founder O 1 0.9954046010971069
chromosome O 0 0.0005445370334200561
raise O 0 0.0001061215007212013
a O 0 1.650785816309508e-05
question O 0 1.2762936421495397e-05
about O 0 4.848300250159809e-06
the O 0 7.857785931264516e-06
molecular O 0 1.6826008504722267e-05
events O 0 2.4212615244323388e-05
involved O 0 3.592281063902192e-05
in O 0 3.533144626999274e-05
the O 0 6.982874037930742e-05
expansion O 0 0.0009808616014197469
mutation O 0 0.00014398666098713875
. O 0 0.00014468582230620086

To O 0 0.00016185168351512402
investigate O 0 0.00013830987154506147
whether O 0 3.549313623807393e-05
a O 0 4.826769509236328e-05
founder O 0 0.0003657369234133512
chromosome O 0 4.496991459745914e-05
for O 0 8.477735718770418e-06
the O 0 0.00014700123574584723
DM B-Disease 1 1.0
mutation O 0 4.751166488858871e-05
exists O 0 3.5610915801953524e-05
in O 0 6.909551757416921e-06
the O 0 1.0411169569124468e-05
Japanese O 0 8.036771032493562e-05
population O 0 4.506375262280926e-06
, O 0 6.00387238591793e-06
we O 0 9.820274499361403e-06
genotyped O 0 0.00033556981361471117
families O 0 6.4185846895270515e-06
using O 0 7.240641025418881e-06
polymorphic O 0 0.00011504390568006784
markers O 0 0.0003804920124821365
near O 0 0.0008518235990777612
the O 0 9.034894173964858e-05
( O 0 0.0001108018186641857
CTG O 0 0.012350191362202168
) O 0 2.9596836611744948e-05
n O 0 0.00011309538240311667
repeat O 0 0.0005447646835818887
region O 0 0.00044666623580269516
and O 0 0.00010966889385599643
constructed O 0 0.009448189288377762
haplotypes O 0 0.003785892389714718
. O 0 0.0007556064520031214

Six O 0 0.00017639932048041373
different O 0 1.3029451110924128e-05
haplotypes O 0 0.00030907560721971095
were O 0 7.646577432751656e-05
found O 0 2.6117137167602777e-05
and O 0 8.015661296667531e-05
DM B-Disease 1 0.9999998807907104
alleles O 0 0.00022095411259215325
were O 0 0.00019516621250659227
always O 0 0.00014093052595853806
haplotype O 0 0.0007670770864933729
A O 0 0.0027359528467059135
. O 0 0.0005705837975256145

To O 0 0.00025934362201951444
find O 0 6.645687244599685e-05
an O 0 1.293422064918559e-05
origin O 0 1.798237099137623e-05
of O 0 5.982856237096712e-05
the O 0 0.00017059537640307099
( O 0 0.0002570000651758164
CTG O 0 0.03307951241731644
) O 0 4.985358827980235e-05
n O 0 0.00013176677748560905
repeat O 0 0.0002754437446128577
mutation O 0 3.0356497518368997e-05
and O 0 8.340699423570186e-06
to O 0 1.3411772670224309e-05
investigate O 0 2.928879257524386e-05
the O 0 2.4003746148082428e-05
mechanism O 0 3.8289970689220354e-05
of O 0 3.0390154279302806e-05
the O 0 4.8945454182103276e-05
expansion O 0 0.0002702677738852799
mutation O 0 1.301854535995517e-05
in O 0 8.863312359608244e-06
the O 0 1.371027155983029e-05
Japanese O 0 6.303636473603547e-05
population O 0 1.4635157867814996e-06
we O 0 2.022798071266152e-06
have O 0 6.208940135365992e-07
studied O 0 1.4062809896131512e-05
90 O 0 2.332137773919385e-05
Japanese O 0 0.0004237067769281566
DM B-Disease 1 0.9999951124191284
families O 0 2.121509169228375e-05
comprising O 0 4.025709495181218e-05
190 O 0 8.288898970931768e-05
affected O 0 3.9144761103671044e-05
and O 0 2.620175655465573e-05
130 O 0 0.0002647886285558343
unaffected O 0 0.0007628814782947302
members O 0 0.00013412541011348367
. O 0 0.0002707559906411916

The O 0 0.0001471743016736582
results O 0 2.840616798494011e-05
suggest O 0 2.047450834652409e-05
that O 0 3.1596418921253644e-06
a O 0 1.6283545846818015e-05
few O 0 2.1132727852091193e-05
common O 0 1.5619920304743573e-05
ancestral O 0 0.0005200200830586255
mutations O 0 7.079086208250374e-05
in O 0 3.8787216908531263e-05
both O 0 2.9715985874645412e-05
Caucasian O 0 0.0006354342331178486
and O 0 4.3065232603112236e-05
Japanese O 0 0.0003801149141509086
populations O 0 1.0781111996038817e-05
have O 0 2.462599923092057e-06
originated O 0 1.1101422387582716e-05
by O 0 3.3474625524831936e-06
expansion O 0 6.95717753842473e-05
of O 0 3.903401375282556e-05
an O 0 3.673442188301124e-05
ancestral O 0 0.0006093537085689604
n O 0 0.0004165522404946387
= O 0 0.00018538828589953482
5 O 0 6.814773951191455e-05
repeat O 0 8.519378752680495e-05
to O 0 3.3739703212631866e-05
n O 0 0.00011399795766919851
= O 0 0.00013560934166889638
19 O 0 0.0002763372322078794
- O 0 0.0003275384078733623
37 O 0 0.00015412246284540743
copies O 0 0.0002102708676829934
. O 0 0.00020936221699230373

These O 0 3.096996806561947e-05
data O 0 3.3359930966980755e-05
support O 0 2.1213310901657678e-05
multistep O 0 0.00015299793449230492
models O 0 3.057416688534431e-05
of O 0 0.00019145375699736178
triplet O 0 0.0014455269556492567
repeat O 0 0.0005088101024739444
expansion O 0 0.0002326903777429834
that O 0 5.010972472518915e-06
have O 0 1.505942805124505e-06
been O 0 3.273479251220124e-06
proposed O 0 2.997075171151664e-06
for O 0 6.590049906662898e-06
both O 0 5.566854451899417e-05
DM B-Disease 1 1.0
and O 0 0.0016621232498437166
Friedreichs B-Disease 1 0.9999970197677612
ataxia I-Disease 1 0.9999862909317017
. O 0 0.0007134828483685851
. O 0 0.00036564646870829165

The O 0 0.00016069039702415466
molecular O 0 7.803531480021775e-05
basis O 0 0.00013692806533072144
of O 1 0.993229866027832
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.0011749486438930035
the O 0 0.00017337690223939717
western O 0 0.00019952889124397188
Cape O 0 0.0005535943782888353
, O 0 3.111378464382142e-05
South O 0 0.00047261090367101133
Africa O 0 0.00031750454218126833
. O 0 0.0001419990003341809

Deficiency B-Disease 1 0.9999992847442627
of I-Disease 0 0.0018250325229018927
the I-Disease 0 0.0004436525923665613
sixth I-Disease 0 0.0008097682730294764
component I-Disease 0 0.0001864846417447552
of I-Disease 0 9.394931112183258e-05
human I-Disease 0 9.475763363298029e-05
complement I-Disease 0 0.0002511843922547996
( O 0 0.00028700780239887536
C6 O 1 0.9999425411224365
) O 0 4.5908105676062405e-05
has O 0 1.2401132153172512e-05
been O 0 1.141939173976425e-05
reported O 0 8.578927918279078e-06
in O 0 5.075240096630296e-06
a O 0 6.908681825734675e-06
number O 0 4.3362038013583515e-06
of O 0 2.1123740225448273e-05
families O 0 6.838693025201792e-06
from O 0 2.4249866328318603e-05
the O 0 3.499684316921048e-05
western O 0 6.35569158475846e-05
Cape O 0 0.00035764218773692846
, O 0 2.691410918487236e-05
South O 0 0.0002466167788952589
Africa O 0 0.0004277878033462912
. O 0 0.00017152966756839305

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.0006158121977932751
endemic O 0 0.0004589758755173534
in O 0 2.9751769034191966e-05
the O 0 2.7884716473636217e-05
Cape O 0 0.0001613607455510646
and O 0 3.6219691992300795e-06
almost O 0 4.796132543560816e-06
all O 0 1.9509652702254243e-06
pedigrees O 0 3.5416724131209776e-05
of O 0 0.00010665551963029429
total O 1 0.9997616410255432
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.8767757415771484
C6Q0 O 1 0.9999974966049194
) O 0 3.4643566323211417e-05
have O 0 5.4022752919991035e-06
been O 0 1.245865769305965e-05
ascertained O 0 0.0001042914591380395
because O 0 1.806061845854856e-05
of O 0 0.000532938982360065
recurrent O 1 1.0
disease O 1 1.0
. O 0 0.00818863045424223

We O 0 0.00010695638775359839
have O 0 1.3541864063881803e-05
sequenced O 0 4.1315059206681326e-05
the O 0 1.0684020708140451e-05
expressed O 0 1.829940447350964e-05
exons O 0 0.00010185461724177003
of O 0 8.801340300124139e-05
the O 0 0.00032214951352216303
C6 O 1 0.999816358089447
gene O 0 5.5819517001509666e-05
from O 0 1.2822874850826338e-05
selected O 0 1.4787469808652531e-05
cases O 0 7.171514425863279e-06
and O 0 3.3724784316291334e-06
have O 0 2.748381120909471e-06
found O 0 5.125935331307119e-06
three O 0 1.2438654266588856e-05
molecular O 0 0.00042949127964675426
defects O 1 0.9989269375801086
leading O 0 0.001068592187948525
to O 0 0.0001301394950132817
total O 0 0.013150768354535103
deficiency O 1 1.0
879delG O 1 0.9865037202835083
, O 0 2.4307146304636262e-05
which O 0 6.185493930388475e-06
is O 0 8.242491276178043e-06
the O 0 3.0431741834036075e-05
common O 0 9.676303307060152e-05
defect O 0 0.060786616057157516
in O 0 0.00018267585255671293
the O 0 0.00024644940276630223
Cape O 0 0.001978460466489196
and O 0 7.463782094419003e-05
hitherto O 0 0.0017852926393970847
unreported O 0 0.0007276931428350508
, O 0 4.528319914243184e-05
and O 0 3.352720887050964e-05
1195delC O 0 0.0014344148803502321
and O 0 7.26387370377779e-05
1936delG O 0 0.0010887219104915857
, O 0 1.5485837138839997e-05
which O 0 4.120458470424637e-06
have O 0 2.352773435632116e-06
been O 0 6.587215921172174e-06
previously O 0 1.8299439034308307e-05
reported O 0 1.3893396499042865e-05
in O 0 2.513191611797083e-05
African O 0 0.0002715036098379642
- O 0 0.0006682481616735458
Americans O 0 0.00012556338333524764
. O 0 0.00013851521362084895

We O 0 0.00015854260709602386
also O 0 1.551120112708304e-05
show O 0 2.3054739358485676e-05
that O 0 2.1970374746160815e-06
the O 0 1.2932273421029095e-05
879delG O 0 0.000540397479198873
and O 0 6.329108873615041e-05
1195delC O 1 0.6073351502418518
defects O 1 0.9943224191665649
are O 0 1.144221914728405e-05
associated O 0 3.777535312110558e-05
with O 0 4.85942218801938e-05
characteristic O 1 0.9997585415840149
C6 O 1 1.0
/ O 1 0.9999998807907104
C7 O 1 0.9999998807907104
region O 0 0.001847504056058824
DNA O 0 0.00017007092537824064
marker O 0 0.0004545030533336103
haplotypes O 0 0.00026416959008201957
, O 0 2.031957592407707e-05
although O 0 1.3847272384737153e-05
small O 0 3.779185499297455e-05
variations O 0 8.832422463456169e-05
were O 0 0.00018324126722291112
observed O 0 0.0003568197425920516
. O 0 0.0002969502820633352

The O 0 0.0016017915913835168
1936delG O 1 0.6705647110939026
defect O 1 0.9478522539138794
was O 0 0.001394471270032227
observed O 0 4.488807826419361e-05
only O 0 1.062468254531268e-05
once O 0 4.659336627810262e-05
in O 0 1.0302475857315585e-05
the O 0 1.5693709428887814e-05
Cape O 0 0.00024148961529135704
, O 0 6.365751687553711e-06
but O 0 2.1432920220831875e-06
its O 0 5.976542979624355e-06
associated O 0 2.762717122095637e-05
haplotype O 0 0.00020222949387971312
could O 0 7.522044325014576e-05
be O 0 4.998364602215588e-05
deduced O 0 0.0004212141502648592
. O 0 0.00023898587096482515

The O 0 0.00015314301708713174
data O 0 2.5923292923835106e-05
from O 0 1.448379407520406e-05
the O 0 2.966649117297493e-05
haplotypes O 0 0.00015082491154316813
indicate O 0 4.2665771616157144e-05
that O 0 2.570164269855013e-06
these O 0 2.097103788401e-06
three O 0 1.3927556210546754e-05
molecular O 0 0.00029972975607961416
defects O 0 0.2763356566429138
account O 0 6.011840741848573e-05
for O 0 3.943927731597796e-05
the O 0 0.00024729676079005003
defects O 0 0.1257040798664093
in O 0 4.6011453378014266e-05
all O 0 1.1791905308200512e-05
the O 0 4.311807424528524e-05
38 O 0 0.00012924389739055187
unrelated O 0 0.00040427138446830213
C6Q0 O 1 0.9987702965736389
individuals O 0 3.541270416462794e-05
we O 0 2.912704621849116e-05
have O 0 8.656029422127176e-06
studied O 0 7.648224709555507e-05
from O 0 4.949272988596931e-05
the O 0 0.0001564354752190411
Cape O 0 0.0023243145551532507
. O 0 0.00024539310834370553

We O 0 0.00016675911319907755
have O 0 8.629713192931376e-06
also O 0 8.685840839461889e-06
observed O 0 1.9373823306523263e-05
the O 0 5.380134825827554e-05
879delG O 0 0.002424586797133088
defect O 0 0.0020106500014662743
in O 0 0.00013251195196062326
two O 0 0.00012170134868938476
Dutch O 1 0.9996486902236938
C6 B-Disease 1 1.0
- I-Disease 1 0.9999984502792358
deficient I-Disease 1 0.9999988079071045
kindreds O 0 0.002342791296541691
, O 0 2.817710628733039e-05
but O 0 1.0570430276857223e-05
the O 0 5.7890083553502336e-05
879delG O 0 0.0038448914419859648
defect O 0 0.005715123377740383
in O 0 0.00010705106979003176
the O 0 0.00014238228322938085
Cape O 0 0.0011799570638686419
probably O 0 0.00015007519687060267
did O 0 2.2828997316537425e-05
not O 0 3.42846965395438e-06
come O 0 9.23729021451436e-06
from O 0 1.63958320626989e-05
The O 0 8.936432277550921e-05
Netherlands O 0 0.0004638330719899386
. O 0 6.806156306993216e-05
. O 0 0.0001373517734464258

Complement B-Disease 1 0.9999982118606567
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.0004083951353095472
seven O 0 0.00016397720901295543
further O 0 0.00021746270067524165
molecular O 0 0.004167178180068731
defects O 1 0.9978532195091248
and O 0 8.06167081464082e-05
their O 0 8.227514626923949e-05
associated O 0 0.0004221696872264147
marker O 0 0.004595516249537468
haplotypes O 0 0.0061911651864647865
. O 0 0.0010177381336688995

Seven O 0 0.00035936455242335796
further O 0 0.00015472470840904862
molecular O 0 0.00020721204055007547
bases O 0 0.0004579650703817606
of O 1 0.9975447058677673
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0017919084057211876
described O 0 0.002156563801690936
. O 0 0.00041443874943070114

All O 0 9.45311039686203e-05
these O 0 2.4369397578993812e-05
new O 0 6.031991870258935e-05
molecular O 0 0.0012808620231226087
defects O 1 0.9283846616744995
involve O 0 0.0005214389530010521
single O 0 0.00026327595696784556
- O 0 0.00047761775203980505
nucleotide O 0 7.203061977634206e-05
events O 0 5.900579708395526e-05
, O 0 1.7956441297428682e-05
deletions O 0 9.273257455788553e-05
and O 0 1.9146491467836313e-05
substitutions O 0 6.568557000719011e-05
, O 0 1.75439035956515e-05
some O 0 4.901265128864907e-06
of O 0 3.5054963518632576e-05
which O 0 3.296484283055179e-05
alter O 0 9.836205572355539e-05
splice O 0 0.00023119895195122808
sites O 0 7.769797230139375e-05
, O 0 2.5832769097178243e-05
and O 0 2.8518972612801008e-05
others O 0 0.00010567303252173588
codons O 0 0.0007333369576372206
. O 0 0.0005024454439990222

They O 0 3.428669515415095e-05
are O 0 2.9249074486870086e-06
distributed O 0 5.608167612081161e-06
along O 0 1.5088241525518242e-05
the O 0 7.472548168152571e-05
C7 O 1 0.9997155070304871
gene O 0 5.5952114053070545e-05
, O 0 8.721159247215837e-06
but O 0 2.6033537778857863e-06
predominantly O 0 6.34921752862283e-06
towards O 0 7.268710032803938e-05
the O 0 5.278575190459378e-05
3 O 0 0.00023714704730082303
end O 0 0.0009921228047460318
. O 0 0.00024487447808496654

All O 0 0.00011981957504758611
were O 0 0.00012299352965783328
found O 0 4.082708619534969e-05
in O 0 7.134780753403902e-05
compound O 0 0.00040534030995331705
heterozygous O 0 0.00015162865747697651
individuals O 0 5.57305829715915e-05
. O 0 0.00027112310635857284

The O 0 0.012921785935759544
C6 O 1 1.0
/ O 1 0.9999357461929321
C7 O 1 0.9999934434890747
marker O 0 0.0038962438702583313
haplotypes O 0 0.0014884865377098322
associated O 0 0.0001502475788583979
with O 0 8.927072485676035e-05
most O 0 0.002820616355165839
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999982118606567
are O 0 6.217286136234179e-05
tabulated O 0 0.0007513127638958395
. O 0 6.79939694236964e-05
. O 0 0.0001207045279443264

A O 0 0.002602491993457079
genome O 0 0.0005429813754744828
- O 0 0.00017135980306193233
wide O 0 4.042802902404219e-05
search O 0 1.2380759471852798e-05
for O 0 1.0962403393932618e-05
chromosomal O 0 0.001219833386130631
loci O 0 0.0017172994557768106
linked O 1 0.9523965716362
to O 0 0.0010137887438759208
mental O 1 1.0
health O 1 0.8241602778434753
wellness O 0 0.002374138217419386
in O 0 4.5979606511536986e-05
relatives O 0 5.634985427604988e-05
at O 0 0.00010750300862127915
high O 0 0.0002587874187156558
risk O 0 0.0001122650210163556
for O 0 0.0004581132670864463
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9998762607574463
the O 0 0.003200284671038389
Old O 0 0.0034973358269780874
Order O 0 0.00015753130719531327
Amish O 0 0.0004712347872555256
. O 0 0.000155255853314884

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 0.9999927282333374
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 0.000304578134091571
is O 0 1.936396256496664e-05
characterized O 0 2.9554134016507305e-05
by O 0 4.524910764303058e-06
episodes O 0 8.259350579464808e-05
of O 0 0.0006480383453890681
mania B-Disease 1 0.9999996423721313
and O 0 0.0005989820929244161
/ O 1 0.9896467328071594
or O 0 0.0006108201923780143
hypomania B-Disease 1 0.9999974966049194
interspersed O 0 0.004857730586081743
with O 0 8.604666800238192e-05
periods O 0 0.0021154528949409723
of O 0 0.07589144259691238
depression B-Disease 1 1.0
. O 0 0.0031959188636392355

Compelling O 0 0.0006249382277019322
evidence O 0 0.00010796097194543108
supports O 0 3.483409091131762e-05
a O 0 2.9054441256448627e-05
significant O 0 4.8935835366137326e-05
genetic O 0 6.720840610796586e-05
component O 0 0.00012868068006355315
in O 0 3.873498280881904e-05
the O 0 8.40934953885153e-05
susceptibility O 0 0.0006245812401175499
to O 0 0.0004326380440033972
develop O 1 0.7794228792190552
BPAD B-Disease 1 1.0
. O 0 0.0019036517478525639

To O 0 0.00019471155246719718
date O 0 0.00022099561465438455
, O 0 3.443109744694084e-05
however O 0 2.6802259526448324e-05
, O 0 1.6482717910548672e-05
linkage O 0 0.00021737375936936587
studies O 0 2.1991418179823086e-05
have O 0 9.334454261988867e-06
attempted O 0 6.558110908372328e-05
only O 0 9.724024494062178e-06
to O 0 1.3015913282288238e-05
identify O 0 7.131420716177672e-05
chromosomal O 0 0.0015119101153686643
loci O 0 0.0005026758299209177
that O 0 4.3736206862377e-05
cause O 0 0.0002777173067443073
or O 0 2.5330522475996986e-05
increase O 0 2.7856491215061396e-05
the O 0 5.8813224313780665e-05
risk O 0 0.00011222084140172228
of O 0 0.00038819489418528974
developing O 0 0.02470051310956478
BPAD B-Disease 1 1.0
. O 0 0.0010853238636627793

To O 0 0.0001276581024285406
determine O 0 4.008081305073574e-05
whether O 0 2.399790901108645e-05
there O 0 1.5440504284924828e-05
could O 0 1.3774279068456963e-05
be O 0 8.74154193297727e-06
protective O 0 5.2629733545472845e-05
alleles O 0 9.247689376934431e-06
that O 0 6.888668394822162e-06
prevent O 0 6.228335405467078e-05
or O 0 1.0074287274619564e-05
reduce O 0 3.297352304798551e-05
the O 0 2.7310263249091804e-05
risk O 0 6.255126936594024e-05
of O 0 0.00012370642798487097
developing O 0 0.0023619383573532104
BPAD B-Disease 1 1.0
, O 0 1.4826981896476354e-05
similar O 0 1.5614322137480485e-06
to O 0 3.7503127714444418e-06
what O 0 3.4636800592124928e-06
is O 0 2.9582677143480396e-06
observed O 0 7.195519629021874e-06
in O 0 1.1170577636221424e-05
other O 0 5.185708141652867e-05
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 0.07872631400823593
we O 0 0.00013585419219452888
used O 0 0.0003684654366225004
mental O 1 1.0
health O 1 0.999351441860199
wellness O 1 0.7863097786903381
( O 0 5.348031118046492e-05
absence O 0 0.0001503387320553884
of O 0 0.00016477280587423593
any O 0 0.00046391753130592406
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.000959761964622885
as O 0 0.0001240105484612286
the O 0 5.172392775421031e-05
phenotype O 0 3.887902130372822e-05
in O 0 2.294708428962622e-05
our O 0 4.954439282300882e-05
genome O 0 0.0001695149694569409
- O 0 0.0002527671167626977
wide O 0 0.00012507247447501868
linkage O 0 0.00028944798395968974
scan O 0 9.020611469168216e-05
of O 0 0.00011231793905608356
several O 0 5.122339280205779e-05
large O 0 0.00024342240067198873
multigeneration O 0 0.007276135962456465
Old O 0 0.0009996973676607013
Order O 0 0.00015294455806724727
Amish O 0 0.00042858251254074275
pedigrees O 0 0.0004933058517053723
exhibiting O 0 0.0004682827857322991
an O 0 9.73519345279783e-05
extremely O 0 0.0004972781171090901
high O 0 0.001961395377293229
incidence O 1 0.8018472194671631
of O 1 0.5316874980926514
BPAD B-Disease 1 1.0
. O 0 0.0018806798616424203

We O 0 0.000333054835209623
have O 0 1.7810081772040576e-05
found O 0 1.5427525795530528e-05
strong O 0 1.592039734532591e-05
evidence O 0 2.2669995814794675e-05
for O 0 1.270291340915719e-05
a O 0 4.570358578348532e-05
locus O 0 0.00021067865600343794
on O 0 0.00018058691057376564
chromosome O 0 0.0007974138716235757
4p O 0 0.12556354701519012
at O 0 0.0008907366427592933
D4S2949 O 0 0.001066114753484726
( O 0 4.460193304112181e-05
maximum O 0 0.00021828470926266164
GENEHUNTER O 0 0.2868591248989105
- O 0 0.0005552536458708346
PLUS O 0 0.0003572981513570994
nonparametric O 0 0.00019821822934318334
linkage O 0 0.00026175123639404774
score O 0 6.890957592986524e-05
= O 0 8.684942440595478e-05
4 O 0 6.296012725215405e-05
. O 0 1.043920565280132e-05
05 O 0 0.00030007114401087165
, O 0 1.9035558580071665e-05
P O 0 0.00037653930485248566
= O 0 8.094486111076549e-05
5 O 0 3.911502062692307e-05
. O 0 4.757710485137068e-06
22 O 0 1.9584220353863202e-05
x O 0 3.341925184940919e-05
10 O 0 3.2525669666938484e-05
( O 0 1.8957969587063417e-05
- O 0 6.285005656536669e-05
4 O 0 5.2763854910153896e-05
) O 0 8.626125236332882e-06
; O 0 1.0218489478575066e-05
SIBPAL O 0 0.003840500023216009
Pempirical O 0 0.0015275205951184034
value O 0 7.273189112311229e-05
< O 0 0.0002268706593895331
3 O 0 4.583872214425355e-05
x O 0 2.9772261768812314e-05
10 O 0 2.610408773762174e-05
( O 0 1.540513403597288e-05
- O 0 5.2528848755173385e-05
5 O 0 2.6781766791827977e-05
) O 0 8.483057172270492e-06
) O 0 4.90969523525564e-06
and O 0 7.043531695671845e-06
suggestive O 0 0.00015522299509029835
evidence O 0 4.233400250086561e-05
for O 0 1.2794756912626326e-05
a O 0 4.7825462388573214e-05
locus O 0 0.00026174349477514625
on O 0 0.0003572031273506582
chromosome O 0 0.001476044300943613
4q O 0 0.002633529482409358
at O 0 0.0005690307589247823
D4S397 O 0 0.001304739504121244
( O 0 6.256236520130187e-05
maximum O 0 0.00028751720674335957
GENEHUNTER O 1 0.6208128333091736
- O 0 0.0006843259325250983
PLUS O 0 0.00034897486330009997
nonparametric O 0 0.0001943670940818265
linkage O 0 0.0002469786850269884
score O 0 6.438016862375662e-05
= O 0 7.840304169803858e-05
3 O 0 3.8411832065321505e-05
. O 0 5.73730221731239e-06
29 O 0 5.880340904695913e-05
, O 0 6.161754299682798e-06
P O 0 0.00019965220417361706
= O 0 3.9720929635223e-05
2 O 0 3.27232301060576e-05
. O 0 3.252480610171915e-06
57 O 0 1.6922689610510133e-05
x O 0 2.713875255722087e-05
10 O 0 2.8487225790740922e-05
( O 0 1.3709565791941714e-05
- O 0 4.425223596626893e-05
3 O 0 3.099354944424704e-05
) O 0 8.071906449913513e-06
; O 0 7.241904768306995e-06
SIBPAL O 0 0.003397821681573987
Pempirical O 0 0.0013188531156629324
value O 0 6.816282257204875e-05
< O 0 0.00021525561169255525
1 O 0 8.967018948169425e-05
x O 0 6.158719770610332e-05
10 O 0 4.3131767597515136e-05
( O 0 2.0666304408223368e-05
- O 0 5.4738626204198226e-05
3 O 0 2.4657259928062558e-05
) O 0 4.520851689449046e-06
) O 0 2.5077119971683715e-06
that O 0 1.1773068990805768e-06
are O 0 3.113366346951807e-06
linked O 0 0.000170347819221206
to O 0 0.00039903688593767583
mental O 1 1.0
health O 1 0.9996165037155151
wellness O 1 0.9938074946403503
. O 0 0.0008520436240360141

These O 0 7.231196650536731e-05
findings O 0 3.735874634003267e-05
are O 0 5.95709298067959e-06
consistent O 0 2.8269478207221255e-05
with O 0 4.158545834798133e-06
the O 0 2.0631881852750666e-05
hypothesis O 0 1.7041757018887438e-05
that O 0 1.7141455828095786e-06
certain O 0 5.393369519879343e-06
alleles O 0 2.9079279556754045e-05
could O 0 6.595352169824764e-05
prevent O 0 0.0001383474445901811
or O 0 1.8834691218216904e-05
modify O 0 3.898866270901635e-05
the O 0 3.292607652838342e-05
clinical O 0 0.00015082994650583714
manifestations O 0 0.020416099578142166
of O 1 0.9792523980140686
BPAD B-Disease 1 1.0
and O 0 0.00013464335643220693
perhaps O 0 9.342774137621745e-05
other O 0 1.9071376300416887e-05
related O 1 0.9980239868164062
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.9999216794967651

Segregation O 1 0.9999876022338867
distortion O 1 0.9999995231628418
in O 1 0.9999972581863403
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9801831245422363

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999887943267822
DM B-Disease 1 1.0
) O 0 0.0001518479984952137
is O 0 2.180763112846762e-05
an O 0 3.246199412387796e-05
autosomal B-Disease 1 0.9997585415840149
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
which O 0 0.00021748138533439487
, O 0 2.0399607819854282e-05
in O 0 1.6904576114029624e-05
the O 0 3.610348721849732e-05
typical O 0 0.00010085277608595788
pedigree O 0 0.00016051197599153966
, O 0 1.2516452443378512e-05
shows O 0 2.197246612922754e-05
a O 0 4.451771383173764e-05
three O 0 5.5361339036608115e-05
generation O 0 0.0008628293289802969
anticipation O 0 0.0022291108034551144
cascade O 0 0.012125297449529171
. O 0 0.0006801739800721407

This O 0 3.261418896727264e-05
results O 0 3.7562509533017874e-05
in O 0 0.00029113711207173765
infertility B-Disease 1 1.0
and O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 0.9999994039535522
) O 0 3.3798922231653705e-05
with O 0 4.784465090779122e-06
the O 0 4.0657261706655845e-05
disappearance O 0 0.00033792079193517566
of O 0 0.0010477075120434165
DM B-Disease 1 1.0
in O 0 0.000666225329041481
that O 0 9.203732042806223e-05
pedigree O 0 0.0009066684287972748
. O 0 0.00015563025954179466

The O 0 0.00021619971084874123
concept O 0 0.00016064918600022793
of O 0 0.00037416658597067
segregation O 1 0.9885987043380737
distortion O 1 0.9531241059303284
, O 0 4.869136319030076e-05
where O 0 3.656103945104405e-05
there O 0 1.2812804015993606e-05
is O 0 1.0395661774964537e-05
preferential O 0 4.0728700696490705e-05
transmission O 0 7.698384433751926e-05
of O 0 3.341443880344741e-05
the O 0 5.425029303296469e-05
larger O 0 3.090624159085564e-05
allele O 0 1.1579349120438565e-05
at O 0 8.755975431995466e-05
the O 0 0.00016777122800704092
DM B-Disease 1 0.9999988079071045
locus O 0 0.000551957287825644
, O 0 2.054948708973825e-05
has O 0 6.621169177378761e-06
been O 0 1.3346205378184095e-05
put O 0 1.6852487533469684e-05
forward O 0 2.2357200577971525e-05
to O 0 1.7608517737244256e-05
explain O 0 8.755574526730925e-05
partially O 0 0.00016102168592624366
the O 0 3.276826100773178e-05
maintenance O 0 0.0004017458122689277
of O 0 0.0007143339607864618
DM B-Disease 1 1.0
in O 0 0.00023037687060423195
the O 0 0.00012113957927795127
population O 0 3.5226676118327305e-05
. O 0 8.98728976608254e-05

In O 0 0.0002912953495979309
a O 0 9.677262278273702e-05
survey O 0 7.649412873433903e-05
of O 0 0.0003248357097618282
DM B-Disease 1 0.9999997615814209
in O 0 0.0002850193704944104
Northern O 0 0.0001896098256111145
Ireland O 0 0.00010172048496315256
, O 0 1.1676777830871288e-05
59 O 0 0.00010960950021399185
pedigrees O 0 0.0002738495822995901
were O 0 0.0001754724798956886
ascertained O 0 0.0022279126569628716
. O 0 0.0005026044091209769

Sibships O 0 0.014066357165575027
where O 0 0.00010032540740212426
the O 0 1.6705022062524222e-05
status O 0 1.5124892343010288e-05
of O 0 1.824717764975503e-05
all O 0 1.2414479897415731e-05
the O 0 2.2930456907488406e-05
members O 0 1.27786352095427e-05
had O 0 3.219522113795392e-05
been O 0 1.725248876027763e-05
identified O 0 9.290633897762746e-06
were O 0 9.548979505780153e-06
examined O 0 1.6094256352516823e-05
to O 0 5.774926648882683e-06
determine O 0 1.6394222257076763e-05
the O 0 3.446398477535695e-05
transmission O 0 6.759417738066986e-05
of O 0 5.716125087928958e-05
the O 0 0.0002940187987405807
DM B-Disease 1 1.0
expansion O 0 0.004311538301408291
from O 0 0.00017412990564480424
affected O 0 0.00010111103620147333
parents O 0 1.6749350834288634e-05
to O 0 2.2153601094032638e-05
their O 0 9.058842988451943e-05
offspring O 0 0.0008153749513439834
. O 0 0.0003795576631091535

Where O 0 0.0003287130384705961
the O 0 0.00012546330981422216
transmitting O 0 0.0033168112859129906
parent O 0 0.00019711039203684777
was O 0 0.0008190138032659888
male O 0 0.00014165307220537215
, O 0 6.480938463937491e-05
58 O 0 0.000517004809807986
. O 0 0.0003877129638567567

3 O 0 0.00045360231888480484
% O 0 5.3765441407449543e-05
of O 0 7.051058491924778e-05
the O 0 0.00010263362491969019
offspring O 0 0.00015482446178793907
were O 0 6.786551239201799e-05
affected O 0 4.427562453201972e-05
, O 0 8.698175406607334e-06
and O 0 5.86208716413239e-06
in O 0 1.274132591788657e-05
the O 0 1.6905187294469215e-05
case O 0 1.144376892625587e-05
of O 0 2.201344796048943e-05
a O 0 4.29166539106518e-05
female O 0 7.83806899562478e-05
transmitting O 0 0.0017244844930246472
parent O 0 0.00010136706259800121
, O 0 3.941333488910459e-05
68 O 0 0.0004397968004923314
. O 0 0.00025684869615361094

7 O 0 0.0013143803225830197
% O 0 0.00018500298028811812
were O 0 0.0002010127791436389
affected O 0 0.0006892100209370255
. O 0 0.00042145512998104095

Studies O 0 0.00027347568538971245
on O 0 0.0004061115614604205
meiotic O 0 0.006163600366562605
drive O 0 0.0007803805056028068
in O 0 0.00025628312141634524
DM B-Disease 1 0.9999998807907104
have O 0 2.2004338461556472e-05
shown O 0 2.8665972422459163e-05
increased O 0 4.024484951514751e-05
transmission O 0 4.4551939936354756e-05
of O 0 1.5422820069943555e-05
the O 0 1.4752594324818347e-05
larger O 0 1.625520053494256e-05
allele O 0 7.580999408673961e-06
at O 0 6.633734301431105e-05
the O 0 7.385588833130896e-05
DM B-Disease 1 0.9999784231185913
locus O 0 0.00038091439637355506
in O 0 0.00011961830023210496
non O 0 0.0011895382776856422
- O 0 0.014787040650844574
DM O 1 0.9999998807907104
heterozygotes O 0 0.0025514145381748676
for O 0 0.0002832304744515568
CTGn O 1 0.9355329871177673
. O 0 0.0006514029228128493

This O 0 9.07065041246824e-05
study O 0 2.3867996787885204e-05
provides O 0 1.1612623893597629e-05
further O 0 2.2297646864899434e-05
evidence O 0 2.105847124767024e-05
that O 0 9.86610302788904e-06
the O 0 0.00011316594464005902
DM B-Disease 1 0.9999998807907104
expansion O 0 0.0023283474147319794
tends O 0 0.00014381486107595265
to O 0 2.6998945031664334e-05
be O 0 3.699824446812272e-05
transmitted O 0 0.00026233287644572556
preferentially O 0 0.00015668131527490914
. O 0 9.909885557135567e-05

Diagnosis O 1 0.9998409748077393
of O 1 0.9997417330741882
hemochromatosis B-Disease 1 1.0
. O 1 0.9788262844085693

If O 0 0.004382407758384943
untreated O 1 1.0
, O 1 0.999552309513092
hemochromatosis B-Disease 1 1.0
can O 1 0.9998574256896973
cause O 1 1.0
serious O 1 1.0
illness O 1 1.0
and O 0 0.00022642551630269736
early B-Disease 0 0.0011003053514286876
death I-Disease 0 0.0006714342162013054
, O 0 1.0385258065070957e-05
but O 0 6.487757673312444e-06
the O 0 4.932847514282912e-05
disease O 1 0.9996058344841003
is O 0 3.2853993616299704e-05
still O 0 5.652719846693799e-05
substantially O 0 0.00025786057813093066
under O 0 0.0005457149818539619
- O 1 0.8762736320495605
diagnosed O 1 0.9999617338180542
. O 0 0.001037608366459608

The O 0 0.0006162548088468611
cornerstone O 0 0.1170501857995987
of O 0 0.00022850101231597364
screening O 0 0.00013606772699858993
and O 0 2.6085375793627463e-05
case O 0 3.1162810046225786e-05
detection O 0 3.4147724363720044e-05
is O 0 6.289290922723012e-06
the O 0 1.0713732990552671e-05
measurement O 0 3.503678453853354e-05
of O 0 0.00010675707744667307
serum O 0 0.0007385006174445152
transferrin O 0 0.0018544781487435102
saturation O 0 0.000587047659792006
and O 0 5.758253610110842e-05
the O 0 0.0001559404336148873
serum O 0 0.0016469870461151004
ferritin O 0 0.007960398681461811
level O 0 0.0022358724381774664
. O 0 0.00035800872137770057

Once O 0 0.0015515743289142847
the O 0 0.00014657517021987587
diagnosis O 0 0.0011391931911930442
is O 0 6.749536987626925e-05
suspected O 0 0.0002797163906507194
, O 0 2.853208570741117e-05
physicians O 0 4.672084469348192e-05
must O 0 3.464184919721447e-05
use O 0 4.751460801344365e-05
serum O 0 0.0018266974948346615
ferritin O 0 0.311267226934433
levels O 0 0.0028191013261675835
and O 0 0.0003696271451190114
hepatic O 1 0.9999984502792358
iron O 1 1.0
stores O 0 0.0010878717293962836
on O 0 0.0019079335033893585
liver O 1 0.9991586208343506
biopsy O 0 0.0031532025896012783
specimens O 0 0.00019756893743760884
to O 0 3.49337569787167e-05
assess O 0 0.0001281700242543593
patients O 0 2.3807617253623903e-05
for O 0 8.29633790999651e-06
the O 0 4.8771755245979875e-05
presence O 0 0.00016711727948859334
of O 0 0.007025809492915869
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
. O 0 0.0034908426459878683

Liver O 1 0.9999985694885254
biopsy O 1 0.5019491314888
is O 0 8.249103120760992e-05
also O 0 8.79484105098527e-06
used O 0 7.0544292611884885e-06
to O 0 7.174729944381397e-06
establish O 0 2.1312182070687413e-05
the O 0 1.4808031664870214e-05
presence O 0 1.641642302274704e-05
or O 0 1.1476578947622329e-05
absence O 0 0.00013047820539213717
of O 0 0.0009033331880345941
cirrhosis B-Disease 1 1.0
, O 0 0.0002161698357667774
which O 0 1.9102139049209654e-05
can O 0 6.853232662251685e-06
affect O 0 4.670079579227604e-05
prognosis O 1 0.7809658050537109
and O 0 0.00014298976748250425
management O 0 0.002461884869262576
. O 0 0.0005598365678451955

A O 0 0.0015925074694678187
DNA O 0 0.0002553818339947611
- O 0 6.776650116080418e-05
based O 0 2.012123786698794e-06
test O 0 1.811220158742799e-06
for O 0 2.536952706577722e-06
the O 0 2.8157657652627677e-05
HFE O 0 0.03342931345105171
gene O 0 2.0532212147372775e-05
is O 0 7.225851277326001e-06
commercially O 0 1.0981698324030731e-05
available O 0 1.3241347005532589e-06
, O 0 8.825464874462341e-07
but O 0 4.5172387785896717e-07
its O 0 1.023700292535068e-06
place O 0 8.862619324645493e-06
in O 0 4.4290031837590504e-06
the O 0 1.99962014448829e-05
diagnosis O 0 0.0008505506557412446
of O 0 0.05127834156155586
hemochromatosis B-Disease 1 1.0
is O 0 0.001988637261092663
still O 0 0.00013894330186303705
being O 0 7.810969691490754e-05
evaluated O 0 0.00017068078159354627
. O 0 0.0001345455675618723

Currently O 0 0.0003962473710998893
, O 0 2.1684489183826372e-05
the O 0 1.970524317584932e-05
most O 0 6.813038453401532e-06
useful O 0 1.1317826647427864e-05
role O 0 3.100631874985993e-05
for O 0 5.392700586526189e-06
this O 0 3.15160104946699e-06
test O 0 5.795604465674842e-06
is O 0 2.947600250990945e-06
in O 0 3.910552095476305e-06
the O 0 1.4654607184638735e-05
detection O 0 0.00010306554759154096
of O 0 0.0003707889700308442
hemochromatosis B-Disease 1 1.0
in O 0 0.0004015497397631407
the O 0 0.00011741316120605916
family O 0 3.2060594094218686e-05
members O 0 4.347939011495328e-06
of O 0 4.084605097887106e-05
patients O 0 6.275159830693156e-05
with O 0 2.0476205463637598e-05
a O 0 0.00015991466352716088
proven O 0 0.0014403706882148981
case O 0 6.172306893859059e-05
of O 0 0.00012029145727865398
the O 0 0.0010719839483499527
disease O 1 0.9999978542327881
. O 0 0.0005891604814678431

It O 0 4.802554758498445e-05
is O 0 1.4836373338766862e-05
crucial O 0 0.00014520618424285203
to O 0 0.0002894352946896106
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999973773956299
because O 0 0.21901600062847137
phlebotomy O 1 0.9999964237213135
therapy O 1 0.9994137287139893
can O 0 0.0001727892376948148
avert O 1 0.9999967813491821
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 0.0026728902012109756
can O 0 3.779585313168354e-05
even O 0 3.6453846405493096e-05
lead O 0 5.863597834832035e-05
to O 0 3.485077468212694e-05
normal O 0 0.00012091072858311236
life O 0 0.00024700502399355173
expectancy O 0 0.0007567576831206679
. O 0 9.581325866747648e-05
. O 0 0.00019228340534027666

Prevalence O 0 0.004389578476548195
of O 0 0.0005635977140627801
the O 0 0.0005177149432711303
I1307K O 0 0.005878833122551441
APC B-Disease 0 0.0019349396461620927
gene O 0 5.191037053009495e-05
variant O 0 4.260422065271996e-05
in O 0 1.635395165067166e-05
Israeli O 0 2.14719202631386e-05
Jews O 0 4.31979242421221e-05
of O 0 2.4952283638413064e-05
differing O 0 9.08022320800228e-06
ethnic O 0 2.7806037905975245e-05
origin O 0 2.7271536964690313e-05
and O 0 4.3878917495021597e-05
risk O 0 0.0013026553206145763
for O 1 0.9167128205299377
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9850864410400391

BACKGROUND O 0 0.008162022568285465
& O 0 0.004068632144480944
AIMS O 0 0.0011616400443017483
Israeli O 0 9.235451580025256e-05
Jews O 0 0.00022992791491560638
of O 0 0.00012247134873177856
European O 0 0.00015380566765088588
birth O 0 0.00047625432489439845
, O 0 3.799073601840064e-05
i O 0 5.5024847824824974e-05
. O 0 7.567925422335975e-06
e O 0 2.16142743738601e-05
. O 0 5.614942892862018e-06
, O 0 6.626159574807389e-06
Ashkenazim O 0 0.00032593728974461555
, O 0 8.99744645721512e-06
have O 0 4.206033281661803e-06
the O 0 3.72052236343734e-05
highest O 1 0.9999873638153076
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9996789693832397
of O 0 0.00039800588274374604
any O 0 3.670053047244437e-05
Israeli O 0 8.248740778071806e-05
ethnic O 0 0.00010417099838377908
group O 0 0.0001236676034750417
. O 0 0.00016843932098709047

The O 0 0.0008127738838084042
I1307K O 0 0.0054234704002738
APC B-Disease 0 0.004748867824673653
gene O 0 0.00018758677470032126
variant O 0 0.00031271029729396105
was O 0 0.0004738294519484043
found O 0 3.1660809327149764e-05
in O 0 8.076813537627459e-05
6 O 0 0.0008398880017921329
. O 0 0.0002489442122168839

1 O 0 0.0004523622337728739
% O 0 3.9689388358965516e-05
of O 0 6.616637983825058e-05
American O 0 7.027457468211651e-05
Jews O 0 0.00015563426131848246
, O 0 1.2602401511685457e-05
28 O 0 4.354647171567194e-05
% O 0 7.81878043198958e-06
of O 0 4.8672696721041575e-05
their O 0 0.0003064682532567531
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9993581175804138
, O 0 7.679892587475479e-05
but O 0 8.278335371869616e-06
not O 0 5.019137006456731e-06
in O 0 2.643285370140802e-05
non O 0 0.000363261962775141
- O 0 0.0009629668784327805
Jews O 0 0.0008488237508572638
. O 0 0.0003951873513869941

We O 0 0.0002296737366123125
assessed O 0 0.0001725633192108944
the O 0 6.515280256280676e-05
I1307K O 0 0.0007377645815722644
prevalence O 0 0.00022025789075996727
in O 0 1.0976494195347186e-05
Israeli O 0 1.4530473890772555e-05
Jews O 0 2.5455865397816524e-05
of O 0 1.556169445393607e-05
differing O 0 6.940604635019554e-06
ethnic O 0 1.5665033060940914e-05
origin O 0 1.4355688108480535e-05
and O 0 2.8330847271718085e-05
risk O 0 0.004576548933982849
for O 1 0.9890730977058411
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9364054203033447

METHODS O 0 0.0004811348335351795
DNA O 0 0.00016753302770666778
samples O 0 3.0362518373294733e-05
from O 0 2.8655258574872278e-05
500 O 0 6.038713763700798e-05
unrelated O 0 3.839835335384123e-05
Jews O 0 7.840991747798398e-05
of O 0 7.611357432324439e-05
European O 0 8.531850471626967e-05
or O 0 8.198684372473508e-05
non O 0 0.0003598043695092201
- O 0 0.0001258457632502541
European O 0 1.0578589353826828e-05
origin O 0 7.203608220152091e-06
, O 0 6.833236511738505e-06
with O 0 5.845094619871816e-06
or O 0 2.2354173779604025e-05
without O 0 4.18094641645439e-05
a O 0 8.276127482531592e-05
personal O 0 0.00048196938587352633
and O 0 0.00018404463480692357
/ O 0 0.0038530861493200064
or O 0 8.880180394044146e-05
family O 0 9.161394700640813e-05
history O 0 0.0002038932143477723
of O 0 0.000599979714024812
neoplasia B-Disease 1 0.9998335838317871
, O 0 9.139798203250393e-05
were O 0 5.1768787670880556e-05
examined O 0 9.527662768959999e-05
for O 0 1.8518871002015658e-05
the O 0 8.835725020617247e-05
I1307K O 0 0.0008763610967434943
variant O 0 7.962660311022773e-05
by O 0 1.0495435162738431e-05
the O 0 2.8161201043985784e-05
allele O 0 4.096721750102006e-05
- O 0 0.00013398491137195379
specific O 0 1.2914107173855882e-05
oligonucleotide O 0 0.0004903177614323795
( O 0 0.00031879666494205594
ASO O 1 0.9861792325973511
) O 0 0.00010730484063969925
method O 0 0.00012016569235129282
. O 0 0.0002520412963349372

RESULTS O 0 0.0005840993253514171
In O 0 0.00010372594260843471
persons O 0 4.122190875932574e-05
at O 0 0.00015433452790603042
average O 0 5.389614307205193e-05
risk O 0 0.00018124173220712692
for O 0 0.00150104274507612
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0006444841856136918
I1307K O 0 0.0030531524680554867
was O 0 0.0004020725900772959
found O 0 1.9070703274337575e-05
in O 0 4.667323446483351e-05
5 O 0 0.0003238443750888109
. O 0 0.00019457272719591856

0 O 0 0.00020725390641018748
% O 0 6.123190541984513e-05
of O 0 0.00010186724830418825
120 O 0 0.00010278543777531013
European O 0 4.243609873810783e-05
and O 0 4.023452856927179e-05
1 O 0 0.0007228467147797346
. O 0 0.00016290142957586795

6 O 0 0.000983605394139886
% O 0 7.623801502631977e-05
of O 0 0.00013028562534600496
188 O 0 0.0003609225677791983
non O 0 0.0004129663575440645
- O 0 0.0001516757911304012
European O 0 1.9669756511575542e-05
Jews O 0 0.00011541265121195465
( O 0 4.5818793296348304e-05
P O 0 0.0008797469781711698
= O 0 0.00013265505549497902
0 O 0 5.5844011512817815e-05
. O 0 1.9057866666116752e-05
08 O 0 0.0007579061784781516
) O 0 0.00012326028081588447
. O 0 0.0001555335329612717

It O 0 0.00020408033742569387
occurred O 0 0.0007472706492990255
in O 0 0.00011912180343642831
15 O 0 0.00031061048503033817
. O 0 0.0001483810628997162

4 O 0 0.0004894049488939345
% O 0 4.5313528971746564e-05
of O 0 0.0001053923842846416
52 O 0 0.0001889521663542837
Ashkenazi O 0 0.0001248615444637835
Israelis O 0 6.355672667268664e-05
with O 0 6.0177142586326227e-05
familial O 1 0.9998781681060791
cancer B-Disease 1 0.9999997615814209
( O 0 0.0008018409716896713
P O 0 0.009773136116564274
= O 0 0.00018006112077273428
0 O 0 4.0825882024364546e-05
. O 0 1.3187989679863676e-05
02 O 0 0.0004499405331443995
) O 0 1.559208976686932e-05
and O 0 8.795721441856585e-06
was O 0 0.00012041103764204308
not O 0 9.439306268177461e-06
detected O 0 6.132476846687496e-05
in O 0 1.776018507371191e-05
51 O 0 8.875007188180462e-05
non O 0 9.889739885693416e-05
- O 0 6.59865399939008e-05
European O 0 5.907184458919801e-06
Jews O 0 4.3553573050303385e-05
at O 0 0.0002976747928187251
increased O 0 0.0006601802306249738
cancer B-Disease 1 0.9998782873153687
risk O 0 0.0010865672957152128
. O 0 0.00026442031958140433

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
occurred O 1 0.9997579455375671
personally O 0 0.003139960113912821
or O 0 5.183478424442001e-05
in O 0 3.177456892444752e-05
the O 0 2.2178566723596305e-05
families O 0 4.679596258938545e-06
of O 0 2.9554725188063458e-05
13 O 0 0.00010148428555112332
of O 0 0.00012411785428412259
20 O 0 0.0002102736762026325
Ashkenazi O 0 0.0003352670173626393
I1307K O 0 0.0007154259947128594
carriers O 0 5.3207651944831014e-05
, O 0 7.106333214323968e-06
8 O 0 3.702866524690762e-05
of O 0 4.8171223170356825e-05
whom O 0 0.00010496050526853651
also O 0 3.3557535061845556e-05
had O 0 6.628466508118436e-05
a O 0 4.0652608731761575e-05
personal O 0 0.00016439129831269383
or O 0 5.819112266181037e-05
family O 0 0.00012011104263365269
history O 0 0.0006007962510921061
of O 0 0.001945252064615488
noncolonic O 1 0.9999831914901733
neoplasia B-Disease 1 0.9999953508377075
. O 0 0.004419105593115091

CONCLUSIONS O 0 0.001395113649778068
The O 0 0.0005299379699863493
I1307K O 0 0.005955810192972422
APC O 0 0.003630109131336212
variant O 0 0.0002169884101022035
may O 0 5.710884215659462e-05
represent O 0 1.8243279555463232e-05
a O 0 3.484392800601199e-05
susceptibility O 0 0.00029247443308122456
gene O 0 6.212142761796713e-05
for O 0 0.00010553257743595168
colorectal B-Disease 1 1.0
, I-Disease 0 0.00018964453192893416
or I-Disease 0 3.877264680340886e-05
other I-Disease 0 2.6820183848030865e-05
, I-Disease 0 8.697590237716213e-05
cancers I-Disease 1 0.9986901879310608
in O 0 0.00014580068818759173
Ashkenazi O 0 0.00042071595089510083
Jews O 0 0.0009468098869547248
, O 0 7.155413186410442e-05
and O 0 4.487892147153616e-05
partially O 0 0.0002540524583309889
explains O 0 1.896301364467945e-05
the O 0 1.527681524748914e-05
higher O 0 6.911550008226186e-05
incidence O 0 0.4427599310874939
of O 1 0.9999812841415405
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.002477131551131606
European O 0 0.00025275745429098606
Israelis O 0 0.0004943220992572606
. O 0 0.00023884326219558716

Systematic O 0 0.00020326451340224594
analysis O 0 3.548433960531838e-05
of O 0 0.00025534824817441404
coproporphyrinogen O 1 0.9972841739654541
oxidase O 0 0.0015607152599841356
gene O 0 0.0016562483506277204
defects O 1 0.9993160963058472
in O 0 0.0005685891956090927
hereditary B-Disease 1 0.9999995231628418
coproporphyria I-Disease 1 0.9999970197677612
and O 0 0.0004000283661298454
mutation O 0 0.00018902278679888695
update O 0 0.00046906902571208775
. O 0 0.00027231057174503803

Hereditary B-Disease 1 0.9999994039535522
coproporphyria I-Disease 1 0.9999978542327881
( O 0 0.03943746164441109
HC B-Disease 1 1.0
) O 0 0.00038014937308616936
is O 0 4.6964167268015444e-05
an O 0 0.0001166067086160183
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999972581863403
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 1 0.9999995231628418
caused O 1 0.9999985694885254
by O 0 0.00016058808250818402
deficient B-Disease 0 0.005123194307088852
activity I-Disease 0 8.281235204776749e-05
of I-Disease 0 0.00021361281687859446
coproporphyrinogen I-Disease 1 0.9979104399681091
III I-Disease 1 0.9999997615814209
oxidase I-Disease 0 0.0008607504423707724
( O 0 0.00025933547294698656
CPO O 0 0.0077980863861739635
) O 0 0.00018575155991129577
. O 0 0.00014644245675299317

Clinical O 0 0.004560315515846014
manifestations O 1 0.6620303988456726
of O 1 0.8136918544769287
the O 1 0.9997883439064026
disease O 1 1.0
are O 0 1.835418152040802e-05
characterized O 0 0.00016016478184610605
by O 0 4.180619362159632e-05
acute O 1 1.0
attacks O 0 0.2056339681148529
of O 1 0.9999988079071045
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9997157454490662
precipitated O 1 0.9999988079071045
by O 0 0.0001675693056313321
drugs O 0 0.00033044020528905094
, O 0 2.1121868485352024e-05
fasting O 0 0.000168135084095411
, O 0 5.9306468756403774e-05
cyclical O 1 0.9999316930770874
hormonal O 1 0.999941349029541
changes O 0 0.0002590752555988729
, O 0 0.0002916165394708514
or O 1 0.9995474219322205
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 0 0.07203575223684311

Skin O 1 0.9999996423721313
photosensitivity O 1 0.9999984502792358
may O 0 0.06599917262792587
also O 0 0.0001688345510046929
be O 0 5.069274629931897e-05
present O 0 0.00014731526607647538
. O 0 0.00023197288101073354

The O 0 0.0003328672319184989
seven O 0 0.0001498069759691134
exons O 0 0.0003033028624486178
, O 0 3.961088805226609e-05
the O 0 7.777855353197083e-05
exon O 0 0.001400478184223175
/ O 0 0.0005611802916973829
intron O 0 0.0015718917129561305
boundaries O 0 2.823127397277858e-05
and O 0 8.682436600793153e-06
part O 0 3.3829233871074393e-05
of O 0 8.607128984294832e-05
3 O 0 0.00015834708756301552
noncoding O 0 0.0002354092721361667
sequence O 0 1.7752123312675394e-05
of O 0 4.864434595219791e-05
the O 0 6.700784433633089e-05
CPO O 0 0.0014154190430417657
gene O 0 2.5234321583411656e-05
were O 0 1.606210025784094e-05
systematically O 0 5.239526944933459e-05
analyzed O 0 2.0429999494808726e-05
by O 0 6.314436177490279e-06
an O 0 1.4419406397792045e-05
exon O 0 0.0008581602014601231
- O 0 0.00032423113589175045
by O 0 4.8150144721148536e-05
- O 0 0.000479524111142382
exon O 0 0.0005802482482977211
denaturing O 0 0.0012891563819721341
gradient O 0 0.0008890358149074018
gel O 0 0.0012688253773376346
electrophoresis O 0 0.0008392423624172807
( O 0 0.00018378946697339416
DGGE O 0 0.4127289056777954
) O 0 2.0742199922096916e-05
strategy O 0 2.735160342126619e-05
followed O 0 1.3682764802069869e-05
by O 0 4.5853666961193085e-06
direct O 0 1.3525989743357059e-05
sequencing O 0 3.683819159050472e-05
in O 0 2.6635923859430477e-05
seven O 0 5.900242103962228e-05
unrelated O 0 0.00035706235212273896
heterozygous O 0 0.00040260746027342975
HC B-Disease 1 0.9999991655349731
patients O 0 0.0022976079490035772
from O 0 0.000308595976093784
France O 0 0.0004788649966940284
, O 0 4.5482538553187624e-05
Holland O 0 0.0003506584616843611
, O 0 2.8882614060421474e-05
and O 0 2.7795300411526114e-05
Czech O 0 0.001232299953699112
Republic O 0 0.0015993675915524364
. O 0 0.0004268870980013162

Seven O 0 0.0009714748011901975
novel O 0 0.00038728152867406607
mutations O 0 9.816340752877295e-05
and O 0 1.3649478205479681e-05
two O 0 1.0497858056623954e-05
new O 0 3.4088607208104804e-05
polymorphisms O 0 0.0004380591562949121
were O 0 0.00022760168940294534
detected O 0 0.001093363156542182
. O 0 0.00024277734337374568

Among O 0 0.00029614425147883594
these O 0 2.3564434741274454e-05
mutations O 0 6.103335181251168e-05
two O 0 1.895601599244401e-05
are O 0 1.092866477847565e-05
missense O 0 0.00028712552739307284
( O 0 9.323772974312305e-05
G197W O 0 0.0009138314053416252
, O 0 4.403863204061054e-05
W427R O 0 0.0006184301455505192
) O 0 2.459354800521396e-05
, O 0 8.74869783729082e-06
two O 0 7.958283276821021e-06
are O 0 8.107294888759498e-06
nonsense O 0 0.0003794314106926322
( O 0 0.0001205071821459569
Q306X O 0 0.001950359670445323
, O 0 8.936398808145896e-05
Q385X O 0 0.0008008898585103452
) O 0 2.2747155526303686e-05
, O 0 6.429054337786511e-06
two O 0 5.8451892073208e-06
are O 0 5.263405910227448e-06
small O 0 2.5553985324222594e-05
deletions O 0 0.00036149780498817563
( O 0 0.0001721480512060225
662de14bp O 0 0.0019284631125628948
; O 0 5.366443292587064e-05
1168del3bp O 0 0.001704246154986322
removing O 0 0.0004239253466948867
a O 0 0.00010574026964604855
glycine O 0 0.00013069860870018601
at O 0 0.00027100523584522307
position O 0 0.0001609202299732715
390 O 0 0.0003178764891345054
) O 0 2.0436040358617902e-05
, O 0 7.991519851202611e-06
and O 0 6.092269359214697e-06
one O 0 5.6026456149993464e-06
is O 0 3.915145498467609e-06
a O 0 7.973842912178952e-06
splicing O 0 3.0183815397322178e-05
mutation O 0 3.176133395754732e-05
( O 0 7.65805525588803e-05
IVS1 O 1 0.8951868414878845
- O 0 0.000657895696349442
15c O 0 0.0014566322788596153
- O 0 0.0002327931288164109
- O 0 0.00011793562589446083
> O 0 7.686955359531567e-05
g O 0 6.700004450976849e-05
) O 0 1.5769579476909712e-05
which O 0 5.058376245870022e-06
creates O 0 3.4172415325883776e-05
a O 0 2.5646560970926657e-05
new O 0 2.5276760425185785e-05
acceptor O 0 6.763855344615877e-05
splice O 0 0.002484078984707594
site O 0 0.002141214907169342
. O 0 0.0005765825626440346

The O 0 0.0006561626796610653
pathological O 0 0.002720017684623599
significance O 0 0.00045644986676052213
of O 0 0.00022845742932986468
the O 0 0.00021072305389679968
point O 0 0.0005682760383933783
mutations O 0 0.0001559027878101915
G197W O 0 0.0010163786355406046
, O 0 4.103032188140787e-05
W427R O 0 0.00042210935498587787
, O 0 1.70810835697921e-05
and O 0 7.642133823537733e-06
the O 0 6.198744813445956e-05
in O 0 0.000142068209243007
- O 0 0.0006687985733151436
frame O 0 0.0004336416022852063
deletion O 0 0.000282031629467383
390delGly O 0 0.0012993990676477551
were O 0 6.590818520635366e-05
assessed O 0 7.386694778688252e-05
by O 0 7.996231033757795e-06
their O 0 5.563606009673094e-06
respective O 0 4.4138443627161905e-05
expression O 0 3.892624590662308e-05
in O 0 2.288432006025687e-05
a O 0 2.7932093871640973e-05
prokaryotic O 0 6.63916434859857e-05
system O 0 6.845902680652216e-05
using O 0 2.4580089302617125e-05
site O 0 0.00023156384122557938
- O 0 0.00027785025304183364
directed O 0 8.866463758749887e-05
mutagenesis O 0 0.0012293823529034853
. O 0 0.00032540850224904716

These O 0 0.00015916439588181674
mutations O 0 0.00015022953448351473
resulted O 0 0.0002746499376371503
in O 0 8.132474613375962e-05
the O 0 6.054824552848004e-05
absence O 0 0.00013030762784183025
or O 0 2.417385439912323e-05
a O 0 3.9747832488501444e-05
dramatic O 0 0.000274140591500327
decrease O 0 0.0005161784938536584
of O 0 0.001295139198191464
CPO O 1 0.9920424818992615
activity O 0 0.0007967329584062099
. O 0 0.00026939285453408957

The O 0 0.00023639330174773932
two O 0 5.04039999214001e-05
polymorphisms O 0 0.0001129003576352261
were O 0 4.7406210796907544e-05
localized O 0 0.0002097026736009866
in O 0 6.585805385839194e-05
noncoding O 0 0.0004617244703695178
part O 0 4.696331234299578e-05
of O 0 3.93450609408319e-05
the O 0 3.4399294236209244e-05
gene O 0 1.3119398317940067e-05
1 O 0 5.433804835774936e-05
) O 0 8.19488377601374e-06
a O 0 3.0514391255564988e-05
C O 0 0.0006456101546064019
/ O 0 0.0004180623509455472
G O 0 0.0006559282774105668
polymorphism O 0 6.592427962459624e-05
in O 0 3.540496982168406e-05
the O 0 6.574434519279748e-05
promotor O 0 0.0037804332096129656
region O 0 0.0002547306357882917
, O 0 2.4702449081814848e-05
142 O 0 8.617575076641515e-05
bp O 0 0.00011824641842395067
upstream O 0 7.035389717202634e-05
from O 0 4.64960430690553e-06
the O 0 4.625205292541068e-06
transcriptional O 0 5.142470763530582e-05
initiation O 0 0.00013470037083607167
site O 0 0.0001674171071499586
( O 0 4.5962333388160914e-05
- O 0 0.00017106464656535536
142C O 0 0.0007307278574444354
/ O 0 0.00031157617922872305
G O 0 0.0005830956506542861
) O 0 2.370951187913306e-05
, O 0 6.019271495460998e-06
and O 0 6.9358475229819305e-06
2 O 0 7.244752487167716e-05
) O 0 1.0623080925142858e-05
a O 0 2.8467344236560166e-05
6 O 0 0.00014105623995419592
bp O 0 0.00011960861593252048
deletion O 0 7.335124246310443e-05
polymorphism O 0 3.35388831445016e-05
in O 0 3.0575563869206235e-05
the O 0 5.0739559810608625e-05
3 O 0 8.51894001243636e-05
noncoding O 0 0.000349559064488858
part O 0 5.7577861298341304e-05
of O 0 0.0001354706473648548
the O 0 0.00040257503860630095
CPO O 0 0.0066164699383080006
gene O 0 0.0001021817879518494
, O 0 4.0893017285270616e-05
574 O 0 0.0005851176101714373
bp O 0 0.0004040930070914328
downstream O 0 0.0001471653231419623
of O 0 4.126674684812315e-05
the O 0 3.554150680429302e-05
last O 0 3.978218956035562e-05
base O 0 2.667756052687764e-05
of O 0 2.463370947225485e-05
the O 0 5.772284202976152e-05
normal O 0 6.793226930312812e-05
termination O 0 0.00011254951095907018
codon O 0 7.217968231998384e-05
( O 0 5.580674405791797e-05
+ O 0 0.00028901122277602553
574 O 0 0.0025149215944111347
delATTCTT O 0 0.007769533898681402
) O 0 0.00023510689788963646
. O 0 0.00021263335656840354

Five O 0 0.0013021716149523854
intragenic O 0 0.1907292604446411
dimorphisms O 0 0.010330653749406338
are O 0 2.2978965716902167e-05
now O 0 2.9814425943186507e-05
well O 0 1.2805302503693383e-05
characterized O 0 5.318654439179227e-05
and O 0 1.2750005225825589e-05
the O 0 3.24513457599096e-05
high O 0 0.00012442014121916145
degree O 0 0.00010680757986847311
of O 0 0.00012878085544798523
allelic O 0 0.0010438591707497835
heterogeneity O 0 0.0013604211853817105
in O 0 0.0003779766266234219
HC B-Disease 1 0.9999984502792358
is O 0 0.0001243954466190189
demonstrated O 0 9.911265806294978e-05
with O 0 5.904548743274063e-06
seven O 0 2.0670442609116435e-05
new O 0 5.096669156046119e-06
different O 0 1.2337870884948643e-06
mutations O 0 5.663223873852985e-06
making O 0 1.3697725989914034e-05
a O 0 1.1744880794140045e-05
total O 0 2.3971009795786813e-05
of O 0 9.874313400359824e-05
nineteen O 0 0.003817774821072817
CPO O 1 0.9988250136375427
gene B-Disease 0 0.0012192809954285622
defects I-Disease 1 0.8671340346336365
reported O 0 0.0001792990806279704
so O 0 4.1242947190767154e-05
far O 0 5.584539394476451e-05
. O 0 2.0938598026987165e-05
. O 0 9.38227167353034e-05

Coincidence O 0 0.0009304193663410842
of O 0 0.00020971184130758047
two O 0 5.525979577214457e-05
novel O 0 0.0001985191338462755
arylsulfatase O 0 0.0016941975336521864
A O 0 0.00022102321963757277
alleles O 0 2.6378413167549297e-05
and O 0 1.3793260222882964e-05
mutation O 0 2.435127680655569e-05
459 O 0 0.0004954093019478023
+ O 0 0.0008323172223754227
1G O 0 0.004221729468554258
> O 0 0.00029977806843817234
A O 0 0.00013439860776998103
within O 0 2.2629839804721996e-05
a O 0 3.2761949114501476e-05
family O 0 4.718624404631555e-05
with O 0 8.596031693741679e-05
metachromatic B-Disease 1 0.9999998807907104
leukodystrophy I-Disease 1 0.9999998807907104
: O 0 0.00010828348604263738
molecular O 0 7.029173139017075e-05
basis O 0 5.001062891096808e-05
of O 0 0.0001959104702109471
phenotypic O 0 0.001752776326611638
heterogeneity O 0 0.010910304263234138
. O 0 0.001913535175845027

In O 0 0.0005095306551083922
a O 0 0.00017737419693730772
family O 0 7.058391929604113e-05
with O 0 1.586870894243475e-05
three O 0 5.9369849623180926e-05
siblings O 0 0.00025066357920877635
, O 0 1.3261770618555602e-05
one O 0 1.3438839232549071e-05
developed O 0 8.34852980915457e-05
classical O 0 0.0005082826828584075
late O 1 0.980903685092926
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 0.4775795042514801
MLD B-Disease 1 1.0
) O 0 0.00024577713338658214
, O 0 7.707477925578132e-05
fatal O 0 0.002062298823148012
at O 0 0.0006111240945756435
age O 0 0.0002981576253660023
5 O 0 0.0001552030153106898
years O 0 7.154724153224379e-05
, O 0 1.0797491086123046e-05
with O 0 2.471479820087552e-05
deficient O 1 0.8182526230812073
arylsulfatase O 1 0.7316918969154358
A O 0 0.0021606581285595894
( O 0 0.00014425574045162648
ARSA O 0 0.05909932404756546
) O 0 1.8893229935201816e-05
activity O 0 1.7171532817883417e-05
and O 0 5.554095878324006e-06
increased O 0 6.845994357718155e-05
galactosylsulfatide O 0 0.009320644661784172
( O 0 0.0003301536780782044
GS O 1 0.9999713897705078
) O 0 0.00014582628500647843
excretion O 0 0.000735859910491854
. O 0 0.00029809484840370715

The O 0 0.00019473550491966307
two O 0 3.926983481505886e-05
other O 0 2.573441634012852e-05
siblings O 0 0.00025386069319210947
, O 0 2.8988213671254925e-05
apparently O 0 7.719621498836204e-05
healthy O 0 8.276286098407581e-05
at O 0 8.444779814453796e-05
12 O 0 4.243715375196189e-05
( O 0 1.401806093781488e-05
1 O 0 6.301664689090103e-05
/ O 0 6.602645589737222e-05
2 O 0 5.361378862289712e-05
) O 0 6.289830707828514e-06
and O 0 6.638581908191554e-06
15 O 0 4.458373223314993e-05
years O 0 5.3422969358507544e-05
, O 0 9.570367183187045e-06
respectively O 0 4.9283149564871565e-05
, O 0 1.2719036931230221e-05
and O 0 1.4134931916487403e-05
their O 0 3.6217388696968555e-05
father O 0 0.0008504570578224957
, O 0 7.498209743062034e-05
apparently O 0 0.0002586896880529821
healthy O 0 9.274124749936163e-05
as O 0 2.0571251297951676e-05
well O 0 2.9055881896056235e-05
, O 0 2.1238492990960367e-05
presented O 0 0.00035166816087439656
ARSA O 1 0.9987367987632751
and O 0 0.0003383575822226703
GS O 1 0.9996545314788818
values O 0 5.183458051760681e-05
within O 0 2.6061108655994758e-05
the O 0 2.9615384846692905e-05
range O 0 9.536123980069533e-05
of O 0 0.0009328412124887109
MLD B-Disease 1 1.0
patients O 0 0.03595797345042229
. O 0 0.000895084987860173

Mutation O 0 0.00015826302114874125
screening O 0 3.7047739169793203e-05
and O 0 7.717370863247197e-06
sequence O 0 9.475446859141812e-06
analysis O 0 6.426381787605351e-06
disclosed O 0 5.800950384582393e-05
the O 0 1.1515146979945712e-05
involvement O 0 6.0510323237394914e-05
of O 0 5.6580691307317466e-05
three O 0 2.934927397291176e-05
different O 0 1.7040894817910157e-05
ARSA O 1 0.9730073809623718
mutations O 0 9.131818660534918e-05
being O 0 3.1035608117235824e-05
the O 0 1.5137185982894152e-05
molecular O 0 2.4749986550887115e-05
basis O 0 2.3757449525874108e-05
of O 0 0.00022323599841911346
intrafamilial O 0 0.01424678135663271
phenotypic O 0 0.002967740409076214
heterogeneity O 0 0.006931826937943697
. O 0 0.001360080554150045

The O 0 0.0013539675856009126
late O 0 0.023459631949663162
infantile O 1 0.999984860420227
patient O 0 0.04747268185019493
inherited O 1 0.9999874830245972
from O 0 0.0009665124816820025
his O 0 0.0006653099553659558
mother O 0 0.00017820976790972054
the O 0 4.135171911912039e-05
frequent O 0 5.65220725547988e-05
0 O 0 0.0001199386824737303
- O 0 0.00015894416719675064
type O 0 4.769983570440672e-05
mutation O 0 1.6097832485684194e-05
459 O 0 0.0002521730202715844
+ O 0 0.0004478546907193959
1G O 0 0.0024599593598395586
> O 0 0.00020700902678072453
A O 0 0.00025182607350870967
, O 0 1.8881215510191396e-05
and O 0 1.2468534805520903e-05
from O 0 4.3261363316560164e-05
his O 0 0.00017870002193376422
father O 0 0.00045500154374167323
a O 0 7.227798050735146e-05
novel O 0 7.776506390655413e-05
, O 0 1.6571262676734477e-05
single O 0 2.425051570753567e-05
basepair O 0 0.0012379250256344676
microdeletion O 0 0.0012212975416332483
of O 0 0.0001688690244918689
guanine O 0 0.000142009012051858
at O 0 0.0002057109959423542
nucleotide O 0 5.0509181164670736e-05
7 O 0 0.00010697474499465898
in O 0 4.636099038179964e-05
exon O 0 0.000350979738868773
1 O 0 0.00033880205592140555
( O 0 0.00012266301200725138
7delG O 0 0.002798115834593773
) O 0 0.0002254971768707037
. O 0 0.0003193429729435593

The O 0 0.00055867456831038
two O 0 0.0001895342575153336
clinically O 0 0.2330150008201599
unaffected O 0 0.002528952434659004
siblings O 0 0.00035105450660921633
carried O 0 4.1115865315077826e-05
the O 0 4.695986717706546e-05
maternal O 0 0.00021339583327062428
mutation O 0 4.446119783096947e-05
459 O 0 0.0006593713769689202
+ O 0 0.0009802216663956642
1G O 0 0.004605486989021301
> O 0 0.00020987747120670974
A O 0 0.00023747942759655416
and O 0 7.860184268793091e-06
, O 0 7.096432000253117e-06
on O 0 1.4547832506650593e-05
their O 0 6.1218906921567395e-06
paternal O 0 8.676647848915309e-05
allele O 0 2.958311961265281e-05
, O 0 1.1699785318342037e-05
a O 0 2.230211248388514e-05
novel O 0 3.452997043495998e-05
cytosine O 0 2.2571301087737083e-05
to O 0 1.612301275599748e-05
thymidine O 0 0.00011719527537934482
transition O 0 0.0005108886398375034
at O 0 0.00035152302007190883
nucleotide O 0 0.0002322867076145485
2435 O 0 0.003562048776075244
in O 0 9.358520765090361e-05
exon O 0 0.0005227873916737735
8 O 0 0.00021975295385345817
, O 0 1.4127950635156594e-05
resulting O 0 3.4632073948159814e-05
in O 0 1.8251043002237566e-05
substitution O 0 3.2183310395339504e-05
of O 0 0.00011427124263718724
alanine O 0 0.0002170140651287511
464 O 0 0.0011859167134389281
by O 0 0.00021380416001193225
valine O 0 0.001751730334945023
( O 0 0.00034131764550693333
A464V O 0 0.002016820479184389
) O 0 0.00012331998732406646
. O 0 0.00018220199854113162

The O 0 0.0006004367605783045
fathers O 0 0.0005699548637494445
genotype O 0 0.0002928882313426584
thus O 0 0.00022649117454420775
was O 0 0.0008771630236878991
7delG O 0 0.008087665773928165
/ O 0 0.0036318362690508366
A464V O 0 0.007829412817955017
. O 0 0.0006645536632277071

Mutation O 0 0.0010772674577310681
A464V O 0 0.002524628071114421
was O 0 0.00032825517700985074
not O 0 7.898054718680214e-06
found O 0 3.8538632907147985e-06
in O 0 1.6888026948436163e-05
18 O 0 0.0002710954286158085
unrelated O 0 0.03255661204457283
MLD B-Disease 1 1.0
patients O 0 0.0015772141050547361
and O 0 0.00010510694119147956
50 O 0 0.0003369117039255798
controls O 0 0.00037089892430230975
. O 0 0.00023595913080498576

A464V O 0 0.009657437913119793
, O 0 0.0001137161161750555
although O 0 5.477950981003232e-05
clearly O 0 0.00019994271860923618
modifying O 0 0.0006915642297826707
ARSA O 1 0.9998642206192017
and O 0 0.0008405492408201098
GS O 1 1.0
levels O 0 0.0019311761716380715
, O 0 4.6952118282206357e-05
apparently O 0 0.00012581302144099027
bears O 0 0.00023207353660836816
little O 0 4.504176104092039e-05
significance O 0 9.572887938702479e-05
for O 0 2.7089108698419295e-05
clinical O 0 0.0004764504556078464
manifestation O 1 0.988501787185669
of O 1 0.9981897473335266
MLD B-Disease 1 1.0
, O 0 0.0008913360070437193
mimicking O 0 0.001771843177266419
the O 0 0.00034137311740778387
frequent O 0 0.0011117253452539444
ARSA O 1 0.9994682669639587
pseudodeficiency O 0 0.2400193214416504
allele O 0 0.0011929821921512485
. O 0 0.0007972983876243234

Our O 0 0.00022452895063906908
results O 0 2.74719550361624e-05
demonstrate O 0 5.369606878957711e-05
that O 0 2.9468751563399564e-06
in O 0 7.864412509661634e-06
certain O 0 1.7908456356963143e-05
genetic O 0 0.0005275563453324139
conditions O 1 0.5621680617332458
MLD B-Disease 1 1.0
- O 1 0.9500256776809692
like O 0 0.0002556674007792026
ARSA O 1 0.9989256262779236
and O 0 0.00010856305743800476
GS O 1 0.999923586845398
values O 0 3.965174255426973e-05
need O 0 1.0701314749894664e-05
not O 0 2.5283397917519324e-06
be O 0 3.728402589331381e-06
paralleled O 0 5.951848652330227e-05
by O 0 1.8907017874880694e-05
clinical O 0 0.31987378001213074
disease O 1 0.9999994039535522
, O 0 3.906089477823116e-05
a O 0 4.445602462510578e-05
finding O 0 6.600630877073854e-05
with O 0 2.8413429390639067e-05
serious O 0 0.2363101989030838
diagnostic O 0 0.007887661457061768
and O 0 0.0012368831085041165
prognostic O 1 0.9999866485595703
implications O 1 0.9952210783958435
. O 0 0.0010596874635666609

Moreover O 0 0.002302359091117978
, O 0 0.0001055792672559619
further O 0 0.00024790962925180793
ARSA O 0 0.021532148122787476
alleles O 0 8.453231566818431e-05
functionally O 0 0.00022899436589796096
similar O 0 2.0830511857639067e-05
to O 0 6.4667641709093e-05
A464V O 0 0.0007924387464299798
might O 0 3.763170388992876e-05
exist O 0 2.0754310753545724e-05
which O 0 5.472600150824292e-06
, O 0 3.581475993996719e-06
together O 0 5.686619715561392e-06
with O 0 6.099279744375963e-06
0 O 0 0.00010919596388703212
- O 0 0.0003097334410995245
type O 0 0.00011625287152128294
mutations O 0 9.139188478002325e-05
, O 0 5.0993156037293375e-05
may O 0 0.00028705268050543964
cause O 0 0.006788208615034819
pathological O 1 0.9999958276748657
ARSA O 1 0.9999998807907104
and O 0 0.0035080243833363056
GS O 1 1.0
levels O 0 0.000815206381957978
, O 0 1.0898005712078884e-05
but O 0 2.4053315428318456e-06
not O 0 2.3968225377757335e-06
clinical O 0 4.234425432514399e-05
outbreak O 0 0.0007135167834348977
of O 0 0.0004077197809237987
the O 0 0.08152421563863754
disease O 1 0.9999996423721313
. O 0 0.00017516805382911116
. O 0 0.00020540370314847678

Human O 1 0.9999611377716064
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999971389770508
to O 1 0.8296387195587158
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 0.0656227245926857
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9992954730987549
1 I-Disease 1 0.997810423374176
. O 0 0.0008008909644559026

Heterozygous O 0 0.006667475216090679
germ O 1 0.9999734163284302
- O 0 0.002716398099437356
line O 0 0.0003340870898682624
mutations O 0 2.2079591872170568e-05
in O 0 7.627251306985272e-06
the O 0 2.654227864695713e-05
DNA O 0 8.725169755052775e-05
mismatch O 0 0.3933614194393158
repair O 0 0.027604106813669205
genes O 0 5.346175021259114e-05
lead O 0 0.00010898304026341066
to O 0 0.00017131994536612183
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9978235960006714

The O 0 0.012478489428758621
disease O 1 0.9999996423721313
susceptibility O 0 0.026125725358724594
of O 0 0.0023009879514575005
individuals O 0 0.000196383087313734
who O 0 0.00015111280663404614
constitutionally O 0 0.0005218026344664395
lack O 0 0.0001666909083724022
both O 0 6.439890421461314e-05
wild O 0 0.0002379182114964351
- O 0 0.0002528439508751035
type O 0 6.284956907620654e-05
alleles O 0 4.35852307418827e-05
is O 0 6.853767263237387e-05
unknown O 0 0.0002858717634808272
. O 0 0.00019795398111455142

We O 0 7.963123061927035e-05
have O 0 7.770552656438667e-06
identified O 0 7.852579074096866e-06
three O 0 4.370996521174675e-06
offspring O 0 2.108716762450058e-05
in O 0 8.797794180281926e-06
a O 0 6.664435204584152e-05
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999576807022095
who O 0 0.0009387052268721163
developed O 1 0.7717998623847961
hematological B-Disease 1 0.9999977350234985
malignancy I-Disease 1 0.9999997615814209
at O 0 0.021964136511087418
a O 0 7.594175258418545e-05
very O 0 2.0738680177601054e-05
early O 0 3.850810753647238e-05
age O 0 8.688769594300538e-05
, O 0 1.1269984497630503e-05
and O 0 9.071766726265196e-06
at O 0 6.692967872368172e-05
least O 0 5.768860319221858e-06
two O 0 2.0932791358063696e-06
of O 0 1.3708324331673793e-05
them O 0 1.0276334251102526e-05
displayed O 0 0.00020016248163301498
signs O 0 0.0006071831448934972
of O 0 0.0007266654865816236
neurofibromatosis B-Disease 1 0.9999986886978149
type I-Disease 0 0.019220486283302307
1 I-Disease 0 0.21397903561592102
( O 0 0.0007578126969747245
NF1 B-Disease 1 0.9749021530151367
) O 0 0.0002582128799986094
. O 0 0.0002324699453311041

DNA O 0 0.00014871108578518033
sequence O 0 4.152487963438034e-05
analysis O 0 1.0469264452694915e-05
and O 0 1.1629480468400288e-05
allele O 0 2.4637796741444618e-05
- O 0 7.124229159671813e-05
specific O 0 5.396157575887628e-06
amplification O 0 8.267309021903202e-05
in O 0 3.085788557655178e-05
two O 0 1.3987427337269764e-05
siblings O 0 8.612695819465443e-05
revealed O 0 8.708959649084136e-05
a O 0 5.6104061513906345e-05
homozygous O 0 0.0003343419812154025
MLH1 O 0 0.06543351709842682
mutation O 0 0.00013741895963903517
( O 0 0.0001380689936922863
C676T O 0 0.0028401287272572517
- O 0 0.0009357285453006625
- O 0 0.00035100700915791094
> O 0 0.0003738568921107799
Arg226Stop O 0 0.007346583995968103
) O 0 0.00018576695583760738
. O 0 0.0001609392638783902

Thus O 0 0.0005557931726798415
, O 0 7.493820885429159e-05
a O 0 0.0001583359407959506
homozygous O 0 0.0015478719724342227
germ O 1 0.9999994039535522
- O 1 0.8574536442756653
line O 0 0.004560605622828007
MLH1 O 1 0.9988613128662109
mutation O 0 6.939393642824143e-05
and O 0 5.2873008826281875e-05
consequent O 1 0.9999632835388184
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.00068757648114115
in O 0 0.00019155052723363042
a O 0 0.00014829280553385615
mutator O 0 0.2170880138874054
phenotype O 0 0.0001675114908721298
characterized O 0 0.0003346653829794377
by O 0 0.00013117493654135615
leukemia B-Disease 1 1.0
and O 1 0.8398207426071167
/ O 1 0.9999998807907104
or O 1 0.9999945163726807
lymphoma B-Disease 1 1.0
associated O 1 0.999829888343811
with O 0 0.09478946030139923
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9992177486419678
1 I-Disease 1 0.9434948563575745
. O 0 0.00016164655971806496
. O 0 0.00016808731015771627

Missense O 0 0.007393202278763056
mutations O 0 0.00045835613855160773
in O 0 0.00010565340198809281
the O 0 5.815523400087841e-05
most O 0 1.7645350453676656e-05
ancient O 0 9.958178270608187e-05
residues O 0 7.228073809528723e-05
of O 0 9.021308505907655e-05
the O 0 0.00025620078667998314
PAX6 O 1 0.9991481304168701
paired O 0 0.0004356569261290133
domain O 0 0.00030290783615782857
underlie O 0 0.0015870498027652502
a O 0 0.00012447281915228814
spectrum O 0 0.002412018133327365
of O 1 0.9996911287307739
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9999160766601562

Mutations O 0 0.00018357738736085594
of O 0 0.0001287177437916398
the O 0 0.00013051839778199792
human O 0 0.00020004036196041852
PAX6 O 1 0.9999300241470337
gene O 0 0.002720767632126808
underlie O 1 0.9999990463256836
aniridia B-Disease 1 1.0
( O 1 0.9999799728393555
congenital B-Disease 1 1.0
absence I-Disease 1 0.9998668432235718
of I-Disease 1 0.9755653142929077
the I-Disease 0 0.04124046862125397
iris I-Disease 0 0.019510775804519653
) O 0 6.629117706324905e-05
, O 0 1.5677329429308884e-05
a O 0 7.31460822862573e-05
rare O 0 0.0014664834598079324
dominant O 1 0.9999678134918213
malformation B-Disease 1 1.0
of I-Disease 1 0.999951958656311
the I-Disease 1 0.9999551773071289
eye I-Disease 1 0.9999922513961792
. O 0 0.001467953436076641

The O 0 0.0004660324193537235
spectrum O 0 0.0010954326717182994
of O 0 0.0009910855442285538
PAX6 O 1 0.999950647354126
mutations O 0 0.0009561044280417264
in O 0 0.0006682684179395437
aniridia B-Disease 1 1.0
patients O 0 0.0004145616840105504
is O 0 3.690513767651282e-05
highly O 0 7.303192251129076e-05
biased O 0 3.277313953731209e-05
, O 0 4.613425062416354e-06
with O 0 2.990901748489705e-06
92 O 0 7.144272240111604e-05
% O 0 1.7830407159635797e-05
of O 0 3.007196391990874e-05
all O 0 2.660076461324934e-05
reported O 0 7.369942613877356e-05
mutations O 0 5.8678717323346063e-05
leading O 0 0.0002283668436575681
to O 0 4.998136137146503e-05
premature O 0 0.000244260038016364
truncation O 0 0.00021237664623185992
of O 0 0.00020813895389437675
the O 0 0.0001820530160330236
protein O 0 0.0001084318573703058
( O 0 3.337599991937168e-05
nonsense O 0 0.0001359930174658075
, O 0 1.6019726899685338e-05
splicing O 0 4.492747757467441e-05
, O 0 1.63306813192321e-05
insertions O 0 0.00014861044473946095
and O 0 3.249004657845944e-05
deletions O 0 0.00017266240320168436
) O 0 2.108913759002462e-05
and O 0 8.660051207698416e-06
just O 0 2.4622668206575327e-05
2 O 0 3.8618618418695405e-05
% O 0 9.963870979845524e-06
leading O 0 4.5775472244713455e-05
to O 0 1.0700416169129312e-05
substitution O 0 2.0329924154793844e-05
of O 0 6.144565850263461e-05
one O 0 4.249385165167041e-05
amino O 0 2.611952913866844e-05
acid O 0 2.821475027303677e-05
by O 0 2.123063495673705e-05
another O 0 8.96913988981396e-05
( O 0 0.0001098275461117737
missense O 0 0.0011638745199888945
) O 0 0.00017054348427336663
. O 0 0.00026213808450847864

The O 0 0.0003152574354317039
extraordinary O 0 0.00026219181017950177
conservation O 0 7.266803731909022e-05
of O 0 4.871411147178151e-05
the O 0 9.69691900536418e-05
PAX6 O 0 0.015356491319835186
protein O 0 7.297866250155494e-05
at O 0 0.00010121638479176909
the O 0 3.0075034374021925e-05
amino O 0 3.0084498575888574e-05
acid O 0 8.0575053289067e-05
level O 0 0.0005065483273938298
amongst O 0 0.0006189493578858674
vertebrates O 0 0.0008291181875392795
predicts O 0 0.0002917717501986772
that O 0 1.5588624592055567e-05
pathological O 0 0.004007405135780573
missense O 0 0.0012813378125429153
mutations O 0 0.00015540247841272503
should O 0 2.775048415060155e-05
in O 0 2.7184345526620746e-05
fact O 0 2.2266876840149052e-05
be O 0 1.2185387276986148e-05
common O 0 1.3383104487729724e-05
even O 0 2.3957114535733126e-05
though O 0 1.2105847417842597e-05
they O 0 3.3349751902278513e-06
are O 0 4.421731773618376e-06
hardly O 0 9.524464257992804e-05
ever O 0 0.00013556498743128031
seen O 0 0.000248502183239907
in O 0 0.0002768013218883425
aniridia B-Disease 1 0.9999994039535522
patients O 0 0.0025678619276732206
. O 0 0.0006156924646347761

This O 0 9.423651499673724e-05
indicates O 0 0.00012040771980537102
that O 0 6.278192358877277e-06
there O 0 9.638824849389493e-06
is O 0 9.507886716164649e-06
a O 0 4.228239777148701e-05
heavy O 0 0.0006972801638767123
ascertainment O 0 0.006852608639746904
bias O 0 0.00018541338795330375
in O 0 3.0236997190513648e-05
the O 0 2.00560170924291e-05
selection O 0 2.506179407646414e-05
of O 0 5.756715836469084e-05
patients O 0 6.0857946664327756e-05
for O 0 5.204895933275111e-05
PAX6 O 1 0.9209743142127991
mutation O 0 2.9659840947715566e-05
analysis O 0 6.612184733967297e-06
and O 0 9.920825505105313e-06
that O 0 5.180001153348712e-06
the O 0 5.881070319446735e-05
missing O 0 0.0003880738513544202
PAX6 O 1 0.9993133544921875
missense O 0 0.0027863585855811834
mutations O 0 0.0003121711779385805
frequently O 0 0.0002346816036151722
may O 0 0.0002834246843121946
underlie O 0 0.010913152247667313
phenotypes O 0 0.0006880733999423683
distinct O 0 0.00021049553470220417
from O 0 0.0008439400116913021
textbook O 1 0.8937662839889526
aniridia B-Disease 1 0.9999995231628418
. O 0 0.0022987788543105125

Here O 0 0.0007380770985037088
we O 0 3.224392276024446e-05
present O 0 2.4836452212184668e-05
four O 0 7.054206798784435e-05
novel O 0 0.00024303211830556393
PAX6 O 0 0.3454626202583313
missense O 0 0.0009237929480150342
mutations O 0 9.121670882450417e-05
, O 0 1.7497017324785702e-05
two O 0 9.590266017767135e-06
in O 0 1.7324306099908426e-05
association O 0 3.246010601287708e-05
with O 0 2.268944081151858e-05
atypical O 1 0.8882259130477905
phenotypes O 0 0.21257805824279785
ectopia B-Disease 1 0.9999854564666748
pupillae I-Disease 1 0.9996663331985474
( O 0 0.00013456826854962856
displaced B-Disease 0 0.00028207278228364885
pupils I-Disease 0 0.00031441819737665355
) O 0 0.00029755165451206267
and O 0 0.0015811597695574164
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999958276748657
( O 0 0.017707090824842453
searching B-Disease 0 0.001910705934278667
gaze I-Disease 0 0.003839949145913124
) O 0 4.7059158532647416e-05
, O 0 1.3920160199631937e-05
and O 0 7.819317033863626e-06
two O 0 1.0372093129262794e-05
in O 0 3.23786043736618e-05
association O 0 2.9013632229180075e-05
with O 0 2.349415808566846e-05
more O 0 6.448720523621887e-05
recognizable O 1 0.6492182016372681
aniridia B-Disease 1 0.9999997615814209
phenotypes O 0 0.00942243356257677
. O 0 0.001302176620811224

Strikingly O 0 0.0015550961252301931
, O 0 3.796353848883882e-05
all O 0 1.2170161426183768e-05
four O 0 2.463128839735873e-05
mutations O 0 2.2883883502800018e-05
are O 0 4.168325631326297e-06
located O 0 4.7867979446891695e-05
within O 0 2.57552346738521e-05
the O 0 9.538625454297289e-05
PAX6 O 0 0.03936248645186424
paired O 0 0.00018326938152313232
domain O 0 0.00018442179134581238
and O 0 3.6276156606618315e-05
affect O 0 5.868537482456304e-05
amino O 0 3.323808414279483e-05
acids O 0 1.65035598911345e-05
which O 0 4.932988758810097e-06
are O 0 1.7739229178914684e-06
highly O 0 1.755937046254985e-05
conserved O 0 4.965592233929783e-05
in O 0 1.2815467016480397e-05
all O 0 9.076527021534275e-06
known O 0 8.518924005329609e-05
paired O 0 0.00013081630459055305
domain O 0 0.00029151036869734526
proteins O 0 0.0001554688933538273
. O 0 0.00019120420620311052

Our O 0 0.0003137384192086756
results O 0 3.0999843147583306e-05
support O 0 3.5529643355403095e-05
the O 0 2.9694001568714157e-05
hypothesis O 0 2.056944686046336e-05
that O 0 2.3061670617607888e-06
the O 0 5.28415239386959e-06
under O 0 3.9636841393075883e-05
- O 0 5.589654028881341e-05
representation O 0 1.714186873869039e-05
of O 0 9.783987479750067e-05
missense O 0 0.0007727959309704602
mutations O 0 0.0002127560437656939
is O 0 7.82664938014932e-05
caused O 0 0.0005062827840447426
by O 0 4.078459460288286e-05
ascertainment O 0 0.006820982322096825
bias O 0 0.0003467848291620612
and O 0 2.973407208628487e-05
suggest O 0 3.604363155318424e-05
that O 0 4.420926416059956e-06
a O 0 1.782632534741424e-05
substantial O 0 0.0001117406427511014
burden O 0 0.0007605470600537956
of O 0 0.0011969637125730515
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999443292617798
related I-Disease 1 0.7456686496734619
disease I-Disease 1 0.9999955892562866
remains O 0 0.0007166628492996097
to O 0 2.992694680870045e-05
be O 0 2.596037302282639e-05
uncovered O 0 0.00043011645902879536
. O 0 4.183734563412145e-05
. O 0 8.341032662428916e-05

The O 0 0.00027106725610792637
chromosomal O 0 0.000733950815629214
order O 0 7.626062142662704e-05
of O 0 0.00016172365576494485
genes O 0 0.00010428420500829816
controlling O 0 0.0004168470040895045
the O 0 0.00010705964814405888
major O 0 0.008947523310780525
histocompatibility O 1 0.9999998807907104
complex O 1 0.9757752418518066
, O 0 4.646491288440302e-05
properdin O 0 0.0014909036690369248
factor O 0 0.00017592615040484816
B O 0 0.0016787074273452163
, O 0 2.6952176995109767e-05
and O 0 3.142422792734578e-05
deficiency B-Disease 1 0.9999767541885376
of I-Disease 0 0.0005231527029536664
the I-Disease 0 0.00027131210663355887
second I-Disease 0 0.0002654370036907494
component I-Disease 0 0.0002704649814404547
of I-Disease 0 0.0002516199310775846
complement I-Disease 0 0.0011499926913529634
. O 0 0.0005859558586962521

The O 0 0.00020869473519269377
relationship O 0 6.840695277787745e-05
of O 0 3.890450170729309e-05
the O 0 4.2688887333497405e-05
genes O 0 1.3667844541487284e-05
coding O 0 3.978719541919418e-05
for O 0 2.921765553764999e-05
HLA O 0 0.012493022717535496
to O 0 3.0128481739666313e-05
those O 0 6.132665930635994e-06
coding O 0 2.537694490456488e-05
for O 0 2.2519829144584946e-05
properdin O 0 0.0011082720011472702
Factor O 0 0.0001872954744612798
B O 0 0.0008820208022370934
allotypes O 0 0.0017600406426936388
and O 0 2.1254276362014934e-05
for O 0 5.859366137883626e-05
deficiency B-Disease 1 0.9999780654907227
of I-Disease 0 0.0002571159857325256
the I-Disease 0 6.62143575027585e-05
second I-Disease 0 5.214952034293674e-05
component I-Disease 0 4.1221555875381455e-05
of I-Disease 0 5.6228000175906345e-05
complement I-Disease 0 0.00014221823948901147
( O 0 0.00013213770580478013
C2 O 1 0.8794359564781189
) O 0 3.677893982967362e-05
was O 0 7.961969095049426e-05
studied O 0 2.479283830325585e-05
in O 0 5.179191703064134e-06
families O 0 3.715510729307425e-06
of O 0 6.19506899965927e-05
patients O 0 0.010592245496809483
with O 1 0.9993064403533936
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.999997615814209

Patients O 0 0.0008299227920360863
were O 0 0.0001127533832914196
selected O 0 5.5807009630370885e-05
because O 0 9.227288501278963e-06
they O 0 3.1416084311786108e-06
were O 0 7.759799700579606e-06
heterozygous O 0 1.3919482626079116e-05
or O 0 2.56128787441412e-05
homozygous O 0 0.0005880802636966109
for O 0 0.15146920084953308
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9970763921737671

12 O 0 0.00034284964203834534
families O 0 2.2746786271454766e-05
with O 0 1.3612430848297663e-05
15 O 0 0.00015558174345642328
matings O 0 0.0007103280513547361
informative O 0 0.00043613623711280525
for O 0 0.0020728292874991894
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 1 0.7230662703514099
found O 0 0.0006152624846436083
. O 0 0.0003539586905390024

Of O 0 0.0015287946444004774
57 O 0 0.0010977006750181317
informative O 0 0.0005185208865441382
meioses O 0 0.0022171649616211653
, O 0 1.6951909856288694e-05
two O 0 2.5108108729909873e-06
crossovers O 0 1.3075293281872291e-05
were O 0 8.378824531973805e-06
noted O 0 1.1496164916025009e-05
between O 0 9.575900912750512e-05
the O 0 0.0073263393715023994
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0002577912528067827
and O 0 3.6066492612008005e-05
the O 0 0.0001639032707316801
HLA O 1 0.999254047870636
- O 0 0.0010265889577567577
B O 0 0.0005875290371477604
gene O 0 8.158546734193806e-06
, O 0 1.3844876320945332e-06
with O 0 1.2157876199125894e-06
a O 0 7.342911430896493e-06
recombinant O 0 2.9486345738405362e-05
fraction O 0 9.83177887974307e-05
of O 0 0.00018620178161654621
0 O 0 0.0005537206889130175
. O 0 0.00033095190883614123

035 O 1 0.5568791627883911
. O 0 0.005666857119649649

A O 0 0.0026569634210318327
lod O 0 0.003485457506030798
score O 0 0.00012847028847318143
of O 0 9.483419125899673e-05
13 O 0 0.00012608262477442622
was O 0 7.292342343134806e-05
calculated O 0 1.6681779015925713e-05
for O 0 2.0630148355849087e-05
linkage O 0 0.0026661173906177282
between O 1 0.9999819993972778
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9927369356155396
HLA O 1 0.9999998807907104
- O 0 0.23268970847129822
B O 0 0.0009065959602594376
at O 0 7.706052565481514e-05
a O 0 6.470826519944239e-06
maximum O 0 7.342021945078159e-06
likelihood O 0 1.3436429981084075e-05
value O 0 7.494179499190068e-06
of O 0 1.3628564374812413e-05
the O 0 2.2444510250352323e-05
recombinant O 0 4.1217626858269796e-05
fraction O 0 6.118416786193848e-05
of O 0 0.00011509063915582374
0 O 0 0.00040485896170139313
. O 0 0.0002344002714380622

04 O 0 0.2292153686285019
. O 0 0.002775574568659067

18 O 0 0.0009892553789541125
families O 0 6.951674004085362e-05
with O 0 2.712757486733608e-05
21 O 0 0.00026660162257030606
informative O 0 0.00013532245066016912
matings O 0 0.0002539304259698838
for O 0 1.728707502479665e-05
both O 0 2.1179230316192843e-05
properdin O 0 0.0017024073749780655
Factor O 0 0.00041745862108655274
B O 0 0.0017231205711141229
allotype O 0 0.0022721090354025364
and O 0 8.943330612964928e-05
HLA O 1 0.9966891407966614
- O 0 0.0019059949554502964
B O 0 0.0014155228855088353
were O 0 6.838216359028593e-05
found O 0 4.922706284560263e-05
. O 0 8.87235946720466e-05

Of O 0 0.0016373207326978445
72 O 0 0.0018103583715856075
informative O 0 0.0010591045720502734
meioses O 0 0.004976660944521427
, O 0 7.303817983483896e-05
three O 0 3.0809020245214924e-05
recombinants O 0 0.002009160816669464
were O 0 8.121912105707452e-05
found O 0 1.6185853382921778e-05
, O 0 6.611005119339097e-06
giving O 0 6.57021337246988e-06
a O 0 2.8351660148473457e-05
recombinant O 0 6.753220077371225e-05
fraction O 0 8.806225378066301e-05
of O 0 0.0002114748494932428
0 O 0 0.000890315801370889
. O 0 0.0005476319347508252

042 O 0 0.4570389986038208
. O 0 0.0028579551726579666

A O 0 0.001892031286843121
lod O 0 0.0034066278021782637
score O 0 0.00015563025954179466
of O 0 0.00015714949404355139
16 O 0 0.0003458309802226722
between O 0 0.0013345718616619706
HLA O 1 0.9997062087059021
- O 0 0.001961171394214034
B O 0 0.0005393446772359312
and O 0 1.5872796211624518e-05
Factor O 0 9.766277798917145e-05
B O 0 0.0004889823612757027
allotypes O 0 0.0011239327723160386
was O 0 0.00014281290350481868
calculated O 0 1.2636146493605338e-05
at O 0 2.7909140044357628e-05
a O 0 4.432755304151215e-06
maximum O 0 8.657721991767175e-06
likelihood O 0 1.2367187991912942e-05
value O 0 8.02498652774375e-06
of O 0 1.916744622576516e-05
the O 0 2.3564098228234798e-05
recombinant O 0 4.540193913271651e-05
fraction O 0 7.255648233694956e-05
of O 0 0.0001495361066190526
0 O 0 0.00038512368337251246
. O 0 0.00032639282289892435

04 O 0 0.20161518454551697
. O 0 0.004962202627211809

A O 0 0.0009893901878967881
crossover O 0 0.0002621040912345052
was O 0 0.00010400889732409269
shown O 0 1.2103146218578331e-05
to O 0 4.754616838908987e-06
have O 0 2.542644779168768e-06
occurred O 0 2.663107261469122e-05
between O 0 1.268804680876201e-05
genes O 0 2.985774926855811e-06
for O 0 4.567328687699046e-06
Factor O 0 5.301391865941696e-05
B O 0 0.0003044896002393216
and O 0 3.345828372403048e-05
HLA O 1 0.9635756015777588
- O 0 0.0010273453081026673
D O 0 0.0009776587830856442
, O 0 9.260910701414105e-06
in O 0 1.4053237464395352e-05
which O 0 3.718620791914873e-05
HLA O 0 0.4712493419647217
- O 0 0.0019115136237815022
D O 0 0.00438544200733304
segregared O 0 0.0026179051492363214
with O 0 0.00010682551510399207
HLA O 1 0.9982773065567017
- O 0 0.001628213212825358
A O 0 0.0007507259724661708
and O 0 7.091978477546945e-05
B O 0 0.00373055599629879
. O 0 0.0003170625714119524

These O 0 6.764345016563311e-05
studies O 0 2.3567488824483007e-05
suggest O 0 1.527919084765017e-05
that O 0 1.2773706430380116e-06
the O 0 4.034797257190803e-06
genes O 0 2.6034579150291393e-06
for O 0 4.420217919687275e-06
Factor O 0 0.00016533542657271028
B O 1 0.9745219349861145
and O 0 0.004344254266470671
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.273460166994482e-05
located O 0 0.00010860343900276348
outside O 0 1.813888047763612e-05
those O 0 4.590340722643305e-06
for O 0 2.4378274247283116e-05
HLA O 1 0.9949363470077515
, O 0 2.3737022274872288e-05
that O 0 2.6488885396247497e-06
the O 0 5.335264177119825e-06
order O 0 6.153427420940716e-06
of O 0 6.0827198467450216e-05
genese O 0 0.003699340857565403
is O 0 9.599232726031914e-05
HLA O 0 0.20461273193359375
- O 0 0.0004179225070402026
A O 0 0.0002502602292224765
, O 0 1.3102719094604254e-05
- O 0 6.466259219450876e-05
B O 0 0.00018097115389537066
, O 0 1.6343037714250386e-05
- O 0 6.580418266821653e-05
D O 0 0.00017057129298336804
, O 0 5.190256615605904e-06
Factor O 0 4.8844922275748104e-05
B O 0 0.0018698569620028138
allotype O 1 0.9927380681037903
, O 0 0.0011753590079024434
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 7.291146175703034e-05
that O 0 2.2360452476277715e-06
the O 0 6.023767582519213e-06
genes O 0 6.680524165858515e-06
coding O 0 6.748313899151981e-05
for O 0 0.0002697680611163378
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 0.0009693870088085532
Factor O 0 0.0009118345333263278
B O 0 0.0011388714192435145
allotypes O 0 0.00042859313543885946
are O 0 3.0475016501441132e-06
approximately O 0 1.850520675361622e-05
3 O 0 6.289981683949009e-05
- O 0 8.380290091736242e-05
- O 0 5.0169550377177075e-05
5 O 0 2.657761433511041e-05
centimorgans O 0 0.0001548135478515178
from O 0 1.684276867308654e-05
the O 0 5.114334635436535e-05
HLA O 0 0.13660846650600433
- O 0 0.0003858719137497246
A O 0 0.0002594346588011831
and O 0 5.965030868537724e-05
HLA O 1 0.996709942817688
- O 0 0.002416952047497034
B O 0 0.0018065031617879868
loci O 0 0.0001218188481288962
, O 0 9.611158930056263e-06
and O 0 4.482380973058753e-06
that O 0 3.1517695333604934e-06
the O 0 2.1702075173379853e-05
apparent O 0 0.00022876916045788676
lack O 0 0.00015274314500857145
of O 0 0.00013982047676108778
recombinants O 0 0.0021497101988643408
between O 0 0.00011088511382695287
the O 0 3.7674439226975664e-05
Factor O 0 0.0001352419494651258
B O 0 0.00320173311047256
gene O 0 0.00015281597734428942
and O 0 0.0006914525874890387
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0007001887424848974
suggests O 0 8.600794535595924e-05
that O 0 4.4092125790484715e-06
these O 0 3.0240544219850563e-06
two O 0 6.816288077970967e-06
genes O 0 2.8842317988164723e-05
lie O 0 0.00023596611572429538
in O 0 4.265722964191809e-05
close O 0 0.00013799317821394652
proximity O 0 0.00014200359873939306
to O 0 4.968908251612447e-05
one O 0 5.3678253607358783e-05
another O 0 0.00021819044195581228
. O 0 0.0002459452080074698

Distribution O 0 0.0004097041964996606
of O 0 0.0008095194934867322
emerin O 1 0.6511138081550598
and O 0 0.00021289791038725525
lamins O 0 0.006522836163640022
in O 0 0.00010496831237105653
the O 0 0.00013506306277122349
heart O 0 0.23801453411579132
and O 0 4.139516022405587e-05
implications O 0 0.0004001088091172278
for O 0 0.00020324667275417596
Emery B-Disease 1 0.99989914894104
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8564615249633789

Emerin O 0 0.017812548205256462
is O 0 7.167473086155951e-05
a O 0 5.3632607887266204e-05
nuclear O 0 0.0006411768263205886
membrane O 0 0.00012997481098864228
protein O 0 2.9436361728585325e-05
which O 0 8.331764547619969e-06
is O 0 1.0343466783524491e-05
missing O 0 3.844488310278393e-05
or O 0 2.7174804927199148e-05
defective O 0 0.001175383571535349
in O 0 0.0006354515207931399
Emery B-Disease 1 0.9997096657752991
- I-Disease 1 0.9999990463256836
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999599456787109
EDMD B-Disease 1 1.0
) O 0 0.001531099434942007
. O 0 0.0004021327767986804

It O 0 9.66682200669311e-05
is O 0 1.6150759620359167e-05
one O 0 4.314777925173985e-06
member O 0 7.230793926282786e-06
of O 0 2.2309004634735174e-05
a O 0 6.74783150316216e-05
family O 0 5.020085154683329e-05
of O 0 0.00030249112751334906
lamina O 1 0.9997331500053406
- O 0 0.0017041618702933192
associated O 0 2.791425140458159e-05
proteins O 0 9.621357094147243e-06
which O 0 8.560889909858815e-06
includes O 0 3.34669639414642e-05
LAP1 O 1 0.9838812351226807
, O 0 0.00013322880840860307
LAP2 O 1 0.8831647634506226
and O 0 0.00014515013026539236
lamin O 0 0.002583964727818966
B O 0 0.0039492216892540455
receptor O 0 0.0010850292164832354
( O 0 0.0003876342670992017
LBR O 1 0.981734037399292
) O 0 0.00030824841815046966
. O 0 0.0002445718564558774

A O 0 0.0008490813197568059
panel O 0 7.247150642797351e-05
of O 0 7.13168628863059e-05
16 O 0 0.00023090442118700594
monoclonal O 0 0.00012311861792113632
antibodies O 0 8.428585715591908e-05
( O 0 5.469740062835626e-05
mAbs O 0 0.00046441348968073726
) O 0 1.1603855455177836e-05
has O 0 6.772163033019751e-06
been O 0 7.273453320522094e-06
mapped O 0 1.4417562852031551e-05
to O 0 7.549817382823676e-06
six O 0 9.483129360887688e-06
specific O 0 2.85793726106931e-06
sites O 0 1.2401450476318132e-05
throughout O 0 2.6432600861880928e-05
the O 0 4.139038355788216e-05
emerin O 0 0.0013326392509043217
molecule O 0 4.8886398872127756e-05
using O 0 2.059826147160493e-05
phage O 0 0.0006468748906627297
- O 0 0.00022412896214518696
displayed O 0 0.0001165762369055301
peptide O 0 0.00011579119018279016
libraries O 0 3.9133676182245836e-05
and O 0 9.254791621060576e-06
has O 0 9.765714821696747e-06
been O 0 7.501115760533139e-06
used O 0 7.827650733815972e-06
to O 0 4.366161010693759e-05
localize O 0 0.0023319367319345474
emerin O 0 0.012981202453374863
in O 0 0.00019790399528574198
human O 0 0.00015417172107845545
and O 0 0.0001716407568892464
rabbit O 0 0.01743902824819088
heart O 1 0.999371349811554
. O 0 0.0007193207857199013

Several O 0 0.0004214414511807263
mAbs O 0 0.0018551030661910772
against O 0 0.000169732331414707
different O 0 3.118608583463356e-05
emerin O 0 0.01201498880982399
epitopes O 0 0.0010497894836589694
did O 0 0.00011565502063604072
not O 0 2.2775418983655982e-05
recognize O 0 0.00011536940291989595
intercalated O 0 0.003915976732969284
discs O 0 0.003547094762325287
in O 0 9.195687744067982e-05
the O 0 0.0002247315424028784
heart O 1 0.7449204921722412
, O 0 2.5724797524162568e-05
though O 0 1.6319299902534112e-05
they O 0 8.626298040326219e-06
recognized O 0 8.016623905859888e-05
cardiomyocyte O 0 0.002870120806619525
nuclei O 0 0.0005298478063195944
strongly O 0 9.836955723585561e-05
, O 0 1.6965026588877663e-05
both O 0 1.2931545825267676e-05
at O 0 0.0002616314741317183
the O 0 0.00015902466839179397
rim O 0 0.0010197092778980732
and O 0 4.2274612496839836e-05
in O 0 0.00012837354734074324
intranuclear O 0 0.006903314497321844
spots O 0 0.00040074248681776226
or O 0 8.10548517620191e-05
channels O 0 0.00031750847119838
. O 0 0.00019860301108565181

A O 0 0.009847517125308514
polyclonal O 0 0.01795947179198265
rabbit O 0 0.002361185383051634
antiserum O 0 0.0018674430903047323
against O 0 0.00039396336069330573
emerin O 0 0.009198790416121483
did O 0 5.940949995419942e-05
recognize O 0 4.668797191698104e-05
both O 0 3.888602805091068e-05
nuclear O 0 0.0023344140499830246
membrane O 0 0.00024148801458068192
and O 0 4.469680061447434e-05
intercalated O 0 0.00242816680110991
discs O 0 0.0013519639614969492
but O 0 1.439291827409761e-05
, O 0 4.475376044865698e-06
after O 0 1.9194518245058134e-05
affinity O 0 3.127015952486545e-05
purification O 0 0.0002855827333405614
against O 0 0.0002026864094659686
a O 0 0.00021056056721135974
pure O 0 0.0019909250549972057
- O 0 0.0013913228176534176
emerin O 0 0.0032917854841798544
band O 0 0.0003622485091909766
on O 0 0.0001308050996158272
a O 0 5.189155854168348e-05
western O 0 0.00012970961688552052
blot O 0 0.0005388180143199861
, O 0 3.468082286417484e-05
it O 0 1.894241177069489e-05
stained O 0 0.0007880702614784241
only O 0 2.263579699501861e-05
the O 0 0.00016239398973993957
nuclear O 0 0.004915751051157713
membrane O 0 0.0010728798806667328
. O 0 0.0002864993002731353

These O 0 6.801770359743387e-05
results O 0 4.4605079892789945e-05
would O 0 2.029612187470775e-05
not O 0 4.09766789744026e-06
be O 0 4.632599939213833e-06
expected O 0 1.5843637811485678e-05
if O 0 1.2260150469955988e-05
immunostaining O 0 0.0008359719067811966
at O 0 0.000292319426080212
intercalated O 0 0.0021872094366699457
discs O 0 0.0018783878767862916
were O 0 9.611085260985419e-05
due O 0 0.00010609984019538388
to O 0 1.8181326595367864e-05
a O 0 1.266185336135095e-05
product O 0 8.029403034015559e-06
of O 0 2.846639290510211e-05
the O 0 9.027126361615956e-05
emerin O 0 0.04439743235707283
gene O 0 7.211487536551431e-05
and O 0 2.2293628717307e-05
, O 0 1.4894979358359706e-05
therefore O 0 1.9884802895830944e-05
, O 0 4.500569048104808e-06
cast O 0 1.2938834515807685e-05
some O 0 4.310722488298779e-06
doubt O 0 2.681381556612905e-05
upon O 0 1.6915446394705214e-05
the O 0 1.946130214491859e-05
hypothesis O 0 8.636182610644028e-05
that O 0 4.8366302507929504e-05
cardiac B-Disease 1 1.0
defects I-Disease 1 1.0
in O 1 0.9958009123802185
EDMD B-Disease 1 1.0
are O 0 5.1200830057496205e-05
caused O 0 0.0002226637734565884
by O 0 1.2146299923188053e-05
absence O 0 0.00013045707601122558
of O 0 0.0005427870783023536
emerin O 1 0.9996674060821533
from O 0 0.0016687909374013543
intercalated O 1 0.9934141635894775
discs O 1 0.9894060492515564
. O 0 0.001981896348297596

Although O 0 0.0006813197396695614
emerin O 0 0.021264059469103813
was O 0 0.0009606113308109343
abundant O 0 0.00012812481145374477
in O 0 2.242882692371495e-05
the O 0 4.9584377848077565e-05
membranes O 0 0.00012658305058721453
of O 0 0.00021777833171654493
cardiomyocyte O 1 0.9966490864753723
nuclei O 0 0.0014741001650691032
, O 0 4.4117990910308436e-05
it O 0 1.2219495147292037e-05
was O 0 0.00012226501712575555
absent O 0 0.00010621464025462046
from O 0 4.044426532345824e-05
many O 0 2.0848896383540705e-05
non O 0 0.0008962481515482068
- O 0 0.0031124581582844257
myocyte O 1 0.5615692734718323
cells O 0 0.00013983086682856083
in O 0 7.831516995793208e-05
the O 0 0.00024440587731078267
heart O 1 0.5782263278961182
. O 0 0.0005410556914284825

This O 0 6.182946526678279e-05
distribution O 0 4.296366751077585e-05
of O 0 0.00015153443382587284
emerin O 0 0.009525908157229424
was O 0 0.00024989640223793685
similar O 0 4.251283826306462e-06
to O 0 1.1156184882565867e-05
that O 0 6.093053343647625e-06
of O 0 7.238627586048096e-05
lamin O 0 0.0011964432196691632
A O 0 0.00034128426341339946
, O 0 9.757503903529141e-06
a O 0 8.310623343277257e-06
candidate O 0 1.2709601833194029e-05
gene O 0 8.174448339559603e-06
for O 0 3.7403544865810545e-06
an O 0 1.5746902136015706e-05
autosomal O 0 0.0003921500174328685
form O 0 0.0009463405585847795
of O 1 0.9999723434448242
EDMD B-Disease 1 1.0
. O 0 0.028166677802801132

In O 0 0.0005025169812142849
contrast O 0 0.00044120935490354896
, O 0 0.00016704351583030075
lamin O 0 0.016248000785708427
B1 O 1 0.9999834299087524
was O 0 0.005430285353213549
absent O 0 0.0005609561922028661
from O 0 0.0002448478771839291
cardiomyocyte O 0 0.007921597920358181
nuclei O 0 0.0009317806106992066
, O 0 4.419926699483767e-05
showing O 0 0.00011904231359949335
that O 0 4.9897917051566765e-05
lamin O 0 0.002980181248858571
B1 O 1 0.998601496219635
is O 0 1.9148537830915302e-05
not O 0 3.101175252595567e-06
essential O 0 1.4376099898072425e-05
for O 0 1.3282680811244063e-05
localization O 0 0.0004003957728855312
of O 0 0.00021764815028291196
emerin O 0 0.005709048826247454
to O 0 8.655178680783138e-05
the O 0 0.00029476708732545376
nuclear O 0 0.008057646453380585
lamina O 0 0.10910224914550781
. O 0 0.000489714031573385

Lamin O 1 0.9144145846366882
B1 O 1 0.9999539852142334
is O 0 0.0001179320242954418
also O 0 2.5452029149164446e-05
almost O 0 6.919042789377272e-05
completely O 0 0.0002691674162633717
absent O 0 0.0004669608606491238
from O 0 0.0007425541989505291
skeletal O 1 0.9999995231628418
muscle O 1 0.9999914169311523
nuclei O 1 0.9998778104782104
. O 0 0.006447464227676392

In O 0 0.0026827200781553984
EDMD B-Disease 1 0.9999992847442627
, O 0 6.284027767833322e-05
the O 0 2.2022981283953413e-05
additional O 0 1.9271919882157817e-05
absence O 0 0.00025291103520430624
of O 0 0.0008035623468458652
lamin O 1 0.9963847398757935
B1 O 1 0.9999998807907104
from O 0 0.04590475186705589
heart O 1 0.9999997615814209
and O 0 0.33684948086738586
skeletal O 1 1.0
muscle O 1 0.9999995231628418
nuclei O 1 0.9999232292175293
which O 0 0.0003903133620042354
already O 0 0.00011454081686679274
lack O 0 0.0002884842688217759
emerin O 0 0.005528887268155813
may O 0 7.703209121245891e-05
offer O 0 7.432783149852185e-06
an O 0 6.700342055410147e-06
alternative O 0 1.0044758710137103e-05
explanation O 0 3.092655970249325e-05
of O 0 0.00012719286314677447
why O 0 0.00016299806884489954
these O 0 3.3536547562107444e-05
tissues O 0 0.00026939439703710377
are O 0 1.8555461792857386e-05
particularly O 0 0.0001708055060589686
affected O 0 0.00020736362785100937
. O 0 8.520402479916811e-05
. O 0 0.00016032949497457594

Genetic O 0 0.00043503587949089706
mapping O 0 0.00032707126229070127
of O 0 0.0005444270791485906
the O 0 0.0022919364273548126
copper B-Disease 1 0.9999853372573853
toxicosis I-Disease 1 0.9993963241577148
locus O 0 0.0017097439849749207
in O 0 0.0004943486419506371
Bedlington O 0 0.014803824946284294
terriers O 0 0.003674935083836317
to O 0 0.00013890540867578238
dog O 0 0.00036019799881614745
chromosome O 0 0.0001571381144458428
10 O 0 5.195266203372739e-05
, O 0 1.2209828128106892e-05
in O 0 1.6352702004951425e-05
a O 0 5.9889185649808496e-05
region O 0 0.0002959192788694054
syntenic O 0 0.002890639007091522
to O 0 0.0001255708048120141
human O 0 0.00026274885749444366
chromosome O 0 0.0011785259703174233
region O 0 0.0012776306830346584
2p13 O 0 0.009497319348156452
- O 0 0.0026791756972670555
p16 O 0 0.0022581578232347965
. O 0 0.0002926194865722209

Abnormal O 1 0.9999980926513672
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.999958872795105
is O 0 7.821098552085459e-05
recognized O 0 2.8829585062339902e-05
as O 0 2.836155726981815e-05
an O 0 9.398372640134767e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9999983310699463
man O 1 0.9997701048851013
, O 0 0.00031124663655646145
mouse O 0 0.0005244478234089911
, O 0 0.00013224786380305886
rat O 0 0.0049721719697117805
and O 0 0.00012337764201220125
dog O 0 0.0016849866369739175
. O 0 0.0003829650522675365

The O 0 0.0005677362787537277
major O 0 0.06709794700145721
cause O 1 0.6197289824485779
of O 1 0.9979180693626404
hepatic B-Disease 1 1.0
copper I-Disease 1 1.0
accumulation I-Disease 1 0.9999995231628418
in O 0 0.001129751792177558
man O 0 0.0003042925673071295
is O 0 1.237818560184678e-05
a O 0 4.120956873521209e-05
dysfunctional O 0 0.0019291312200948596
ATP7B O 1 0.9999493360519409
gene O 0 0.0001918620109790936
, O 0 8.520613482687622e-05
causing O 1 0.9583823084831238
Wilson B-Disease 1 0.9999765157699585
disease I-Disease 1 0.9999998807907104
( O 0 0.0009571079281158745
WD B-Disease 1 0.9999594688415527
) O 0 0.0005695622530765831
. O 0 0.0003993124410044402

Mutations O 0 0.0002853927144315094
in O 0 9.13693947950378e-05
the O 0 0.00012525793863460422
ATP7B O 1 0.9982787370681763
genes O 0 3.0195618819561787e-05
have O 0 4.188189450360369e-06
also O 0 4.981530764780473e-06
been O 0 1.6715892343199812e-05
demonstrated O 0 0.00010386401845607907
in O 0 0.00010148002183996141
mouse O 0 0.00033445708686485887
and O 0 0.00012539190356619656
rat O 0 0.004502815194427967
. O 0 0.000274140591500327

The O 0 0.0013386415084823966
ATP7B O 1 0.9995864033699036
gene O 0 0.00011755791638279334
has O 0 2.248375676572323e-05
been O 0 1.7150910935015418e-05
excluded O 0 2.346858491364401e-05
in O 0 6.531337021442596e-06
the O 0 1.5598810932715423e-05
much O 0 5.143201633472927e-05
rarer O 0 0.00176888273563236
human O 0 0.003266572020947933
copper B-Disease 1 1.0
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9950976967811584
- I-Disease 0 0.020972255617380142
Indian I-Disease 0 0.00021847023162990808
childhood I-Disease 1 0.9012107253074646
cirrhosis I-Disease 1 1.0
, O 0 0.0002202774048782885
indicating O 0 0.000776139902882278
genetic O 0 0.0005654252017848194
heterogeneity O 0 0.0034845187328755856
. O 0 0.0009689531289041042

By O 0 8.29522468848154e-05
investigating O 0 0.0001041690120473504
the O 0 8.538190741091967e-05
common O 0 0.0003703678376041353
autosomal O 1 0.9999133348464966
recessive O 1 0.9999998807907104
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 0.010686006397008896
CT B-Disease 1 0.9970086216926575
) O 0 0.00010980104707414284
in O 0 0.0001369779638480395
Bedlington O 0 0.01050183642655611
terriers O 0 0.0023346582893282175
, O 0 2.0905319615849294e-05
we O 0 7.075815119605977e-06
have O 0 1.812840991988196e-06
identified O 0 4.884658210357884e-06
a O 0 3.8889738789293915e-06
new O 0 4.507845460466342e-06
locus O 0 8.009700832189992e-05
involved O 0 0.0001226939057232812
in O 0 0.0017392855370417237
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9779720306396484

We O 0 0.00017426312842871994
examined O 0 0.00011462843394838274
whether O 0 1.2057364983775187e-05
the O 0 6.182155630085617e-05
WD B-Disease 1 0.9625613689422607
gene O 0 0.0004305837210267782
ATP7B O 1 0.9987589120864868
was O 0 0.0006180954515002668
also O 0 2.2634696506429464e-05
causative O 0 0.00019503785006236285
for O 0 2.619606129883323e-05
CT B-Disease 0 0.001682028640061617
by O 0 1.2279938346182462e-05
investigating O 0 4.473679655347951e-05
the O 0 5.460812462843023e-05
chromosomal O 0 0.00674431212246418
co O 0 0.0033213100396096706
- O 0 0.0006884315516799688
localization O 0 0.0006404954474419355
of O 0 0.0003537168668117374
ATP7B O 1 0.9999046325683594
and O 0 8.428183355135843e-05
C04107 O 0 0.0008326362003572285
, O 0 1.2054282706230879e-05
using O 0 9.69767825154122e-06
fluorescence O 0 9.191383287543431e-05
in O 0 0.0001477316691307351
situ O 0 0.0026117144152522087
hybridization O 0 0.0001310721563640982
( O 0 0.00013498131011147052
FISH O 0 0.00033488558256067336
) O 0 3.9506659959442914e-05
. O 0 5.2900089940521866e-05

C04107 O 0 0.006422748323529959
is O 0 7.760342123219743e-05
an O 0 2.4341850803466514e-05
anonymous O 0 6.997418677201495e-05
microsatellite O 0 0.0007953414460644126
marker O 0 0.0007990516605786979
closely O 0 0.00029514305060729384
linked O 0 0.0008958835969679058
to O 0 0.0005182545864954591
CT B-Disease 1 0.979552686214447
. O 0 0.0007283390732482076

However O 0 0.0007007034146226943
, O 0 0.00028833665419369936
BAC O 0 0.3636024594306946
clones O 0 0.001408434472978115
containing O 0 0.0004552223836071789
ATP7B O 1 0.9955620765686035
and O 0 6.706466956529766e-05
C04107 O 0 0.000868999632075429
mapped O 0 0.00012934325786773115
to O 0 4.2853756895055994e-05
the O 0 0.0001400900655426085
canine O 0 0.0014922019327059388
chromosome O 0 0.0009444350725971162
regions O 0 0.0002761902869679034
CFA22q11 O 0 0.2379777878522873
and O 0 7.791841926518828e-05
CFA10q26 O 0 0.17465344071388245
, O 0 2.3901340682641603e-05
respectively O 0 4.566568532027304e-05
, O 0 1.2011411854473408e-05
demonstrating O 0 0.00015471084043383598
that O 0 2.907731141021941e-05
WD B-Disease 0 0.02344321273267269
cannot O 0 4.7380679461639374e-05
be O 0 2.0136239982093684e-05
homologous O 0 0.00014702518819831312
to O 0 0.00031476098229177296
CT B-Disease 0 0.4500594735145569
. O 0 0.0006946261273697019

The O 0 0.001866455189883709
copper O 1 0.8252551555633545
transport O 0 0.0009703526739031076
genes O 0 0.0004953395109623671
CTR1 O 1 0.99898761510849
and O 0 0.0001489622809458524
CTR2 O 1 0.9985559582710266
were O 0 6.56642732792534e-05
also O 0 1.263034027942922e-05
excluded O 0 3.288622247055173e-05
as O 0 1.6566855265409686e-05
candidate O 0 2.206679346272722e-05
genes O 0 1.1224206900806166e-05
for O 0 2.0698846128652804e-05
CT B-Disease 0 0.0029791679698973894
since O 0 8.637311839265749e-05
they O 0 3.5717137052415637e-06
both O 0 3.131832500002929e-06
mapped O 0 3.594178633647971e-05
to O 0 4.173055276623927e-05
canine O 0 0.0034347577020525932
chromosome O 0 0.003774746088311076
region O 0 0.004557657986879349
CFA11q22 O 1 0.9971344470977783
. O 0 0.0011150866048410535

2 O 0 0.0055551775731146336
- O 0 0.0028282080311328173
22 O 0 0.001266764011234045
. O 0 0.00039700089837424457

5 O 0 0.011978331953287125
. O 0 0.0023707072250545025

A O 0 0.0008649542578496039
transcribed O 0 0.0002601410378701985
sequence O 0 2.788817619148176e-05
identified O 0 3.441264925641008e-05
from O 0 1.4999392988102045e-05
the O 0 5.910998515901156e-05
C04107 O 0 0.0011913877679035068
- O 0 0.00041790056275203824
containing O 0 0.0001664472947595641
BAC O 0 0.0036239195615053177
was O 0 0.0001654253137530759
found O 0 6.5191024987143464e-06
to O 0 4.952020844939398e-06
be O 0 4.131543391849846e-06
homologous O 0 1.5631334463250823e-05
to O 0 7.685871423745994e-06
a O 0 1.5272589735104702e-05
gene O 0 1.1772196558013093e-05
expressed O 0 2.6165453164139763e-05
from O 0 7.145648851292208e-05
human O 0 0.00011462219845270738
chromosome O 0 0.000732697022613138
2p13 O 0 0.003248406806960702
- O 0 0.0009162898059003055
p16 O 0 0.00042539139394648373
, O 0 1.5408661056426354e-05
a O 0 3.524663770804182e-05
region O 0 0.00011366038233973086
devoid O 0 0.0005353149608708918
of O 0 9.126864460995421e-05
any O 0 7.159111555665731e-05
positional O 0 0.0014464943669736385
candidate O 0 0.000939065299462527
genes O 0 0.0005450898315757513
. O 0 0.00034484529169276357

Molecular O 0 0.00021755645866505802
analysis O 0 1.1279747013759334e-05
of O 0 5.224698907113634e-05
the O 0 0.00014376141189131886
APC B-Disease 0 0.0012425457825884223
gene O 0 3.838872362393886e-05
in O 0 2.846414099622052e-05
205 O 0 6.861948349978775e-05
families O 0 1.1803607776528224e-05
: O 0 1.3665746337210294e-05
extended O 0 0.00013639534881804138
genotype O 0 0.000515259278472513
- O 0 0.0006229651626199484
phenotype O 0 0.00013046029198449105
correlations O 0 0.0003789701440837234
in O 0 0.00016311623039655387
FAP B-Disease 0 0.004672539420425892
and O 0 1.730152143863961e-05
evidence O 0 2.238318666059058e-05
for O 0 4.843882379645947e-06
the O 0 1.447516569896834e-05
role O 0 5.2607807447202504e-05
of O 0 0.00011952834756812081
APC B-Disease 0 0.0016501459758728743
amino O 0 7.969154830789194e-05
acid O 0 0.00010555209155427292
changes O 0 0.0001099022410926409
in O 1 0.996639609336853
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.015998370945453644

BACKGROUND O 0 0.003945500589907169
/ O 0 0.0014623514143750072
AIMS O 0 0.000814317783806473
The O 0 6.286000279942527e-05
development O 0 0.00015264761168509722
of O 1 0.9875138401985168
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.00026199742569588125
a O 0 3.428251147852279e-05
variable O 0 1.3722411495109554e-05
range O 0 2.881814907595981e-05
of O 0 0.00012795437942259014
extracolonic O 1 0.9910592436790466
manifestations O 1 0.6068209409713745
in O 0 0.002123388461768627
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9998162388801575
FAP B-Disease 1 0.9999699592590332
) O 0 5.089288606541231e-05
is O 0 6.843762548669474e-06
the O 0 7.870745321270078e-06
result O 0 7.8933790064184e-06
of O 0 2.7093736207461916e-05
the O 0 5.495311779668555e-05
dominant O 0 0.00038468962884508073
inheritance O 0 0.0005864601116627455
of O 0 0.0648651272058487
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.005060989409685135
APC B-Disease 0 0.36132097244262695
) O 0 8.999656711239368e-05
gene O 0 0.00012124925706302747
mutations O 0 0.00018105587514583021
. O 0 0.00025981065118685365

In O 0 0.00031626890995539725
this O 0 2.063290412479546e-05
study O 0 1.343284202448558e-05
, O 0 4.106877440790413e-06
direct O 0 7.10621134203393e-06
mutation O 0 3.815486252278788e-06
analysis O 0 2.8512511107692262e-06
of O 0 2.3904942281660624e-05
the O 0 8.908203744795173e-05
APC B-Disease 0 0.0010389743838459253
gene O 0 4.328951399656944e-05
was O 0 0.00010263166768709198
performed O 0 4.083039311808534e-05
to O 0 1.2989698007004336e-05
determine O 0 4.0168586565414444e-05
genotype O 0 0.0002867818984668702
- O 0 0.0003415101673454046
phenotype O 0 2.7939260689890943e-05
correlations O 0 8.387997513636947e-05
for O 0 4.5296241296455264e-05
nine O 0 0.00029877087217755616
extracolonic O 0 0.04947776719927788
manifestations O 0 0.0017040888778865337
and O 0 5.156829138286412e-05
to O 0 3.574040601961315e-05
investigate O 0 8.598400017945096e-05
the O 0 7.990446465555578e-05
incidence O 0 0.0004923130618408322
of O 0 0.00023754037101753056
APC B-Disease 0 0.0034113505389541388
mutations O 0 8.223058830481023e-05
in O 0 0.00014475455100182444
non O 1 0.9912540316581726
- O 1 0.9999990463256836
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.014397666789591312

METHODS O 0 0.0011046214494854212
The O 0 0.0005843351245857775
APC B-Disease 0 0.002582430373877287
gene O 0 9.543965279590338e-05
was O 0 0.00015882706793490797
analysed O 0 7.19379386282526e-05
in O 0 2.4595494323875755e-05
190 O 0 7.92994032963179e-05
unrelated O 0 0.00015501768211834133
FAP B-Disease 0 0.0028521583881229162
and O 0 4.712742520496249e-05
15 O 0 0.00030598248122259974
non O 1 0.9933844208717346
- O 1 0.9999996423721313
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.05428304895758629
using O 0 7.226639718282968e-05
denaturing O 0 0.0018763185944408178
gradient O 0 0.0012683722889050841
gel O 0 0.0010007346281781793
electrophoresis O 0 0.0002047207235591486
, O 0 1.4060610737942625e-05
the O 0 2.524108458601404e-05
protein O 0 2.986804065585602e-05
truncation O 0 0.0001479702041251585
test O 0 2.4355549612664618e-05
, O 0 1.5374358554254286e-05
and O 0 8.169725333573297e-06
direct O 0 4.154595444560982e-05
sequencing O 0 0.00022971778525970876
. O 0 0.00023734885326121002

RESULTS O 0 0.003733649617061019
Chain O 0 0.0010710509959608316
terminating O 0 0.0007719223503954709
signals O 0 0.00033714139135554433
were O 0 6.190286512719467e-05
only O 0 1.3645782928506378e-05
identified O 0 1.8321650713915005e-05
in O 0 1.8462229490978643e-05
patients O 0 3.3411030017305166e-05
belonging O 0 5.7556619140086696e-05
to O 0 2.886807305912953e-05
the O 0 0.00012260266521479934
FAP B-Disease 0 0.008661782369017601
group O 0 2.7380698156775907e-05
( O 0 4.370893657323904e-05
105 O 0 0.0004974227631464601
patients O 0 0.0002558512205723673
) O 0 0.00017953927454072982
. O 0 0.00030942444573156536

Amino O 0 0.0010400379542261362
acid O 0 0.0003175096644554287
changes O 0 7.278294651769102e-05
were O 0 6.995363219175488e-05
identified O 0 3.5728375223698094e-05
in O 0 1.994116792047862e-05
four O 0 2.4640899937367067e-05
patients O 0 2.8219512387295254e-05
, O 0 7.625636953889625e-06
three O 0 9.11530150915496e-06
of O 0 5.4796957556391135e-05
whom O 0 0.0001822812482714653
belonged O 0 0.000519940338563174
to O 0 3.744513014680706e-05
the O 0 9.692851745057851e-05
non O 0 0.000844633555971086
- O 0 0.001961492234840989
FAP O 1 0.5475258231163025
group O 0 0.00013041812053415924
of O 1 0.9998352527618408
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999991774559021
. O 0 0.0020594920497387648

Genotype O 0 0.008585209026932716
- O 0 0.003212409559637308
phenotype O 0 0.00026104541029781103
correlations O 0 0.0006440046709030867
identified O 0 0.00011003572581103072
significant O 0 0.00010702044528443366
differences O 0 0.00017979110998567194
in O 0 3.223534440621734e-05
the O 0 3.252678652643226e-05
nature O 0 3.8121059333207086e-05
of O 0 4.737724884762429e-05
certain O 0 8.24556263978593e-05
extracolonic O 1 0.9995500445365906
manifestations O 1 0.9983617663383484
in O 0 0.003151340177282691
FAP B-Disease 1 0.9998860359191895
patients O 0 0.0002693139831535518
belonging O 0 0.00010767989442683756
to O 0 5.10496502101887e-05
three O 0 6.248819408938289e-05
mutation O 0 0.0001192310155602172
subgroups O 0 0.0011117227841168642
. O 0 0.00027961211162619293

CONCLUSIONS O 0 0.0015317993238568306
Extended O 0 0.0007808637456037104
genotype O 0 0.0009685616823844612
- O 0 0.0004365247441455722
phenotype O 0 5.6161126849474385e-05
correlations O 0 6.33247836958617e-05
made O 0 2.527333708712831e-05
in O 0 1.1789116797444876e-05
this O 0 3.0655160117021296e-06
study O 0 5.627191967505496e-06
may O 0 1.2982454791199416e-05
have O 0 1.492551518822438e-06
the O 0 6.287539690674748e-06
potential O 0 1.3462828064803034e-05
to O 0 2.585829861345701e-06
determine O 0 2.7350486107025063e-06
the O 0 4.572807029035175e-06
most O 0 3.174968242092291e-06
appropriate O 0 5.801045517728198e-06
surveillance O 0 7.699632260482758e-05
and O 0 2.1952024326310493e-05
prophylactic O 0 0.04826270788908005
treatment O 0 0.02446977235376835
regimens O 0 0.0008161748992279172
for O 0 4.365453060017899e-05
those O 0 3.500378807075322e-05
patients O 0 4.331693344283849e-05
with O 0 1.83812062459765e-05
mutations O 0 0.00014281782205216587
associated O 0 0.0001322035095654428
with O 0 9.774466889211908e-05
life O 0 0.05299016833305359
threatening O 0 0.13170477747917175
conditions O 0 0.005595870781689882
. O 0 0.0004694783710874617

This O 0 6.009450589772314e-05
study O 0 2.8199927328387275e-05
also O 0 9.167451025859918e-06
provided O 0 1.1308979992463719e-05
evidence O 0 2.9293374609551392e-05
for O 0 1.9303928638692014e-05
the O 0 7.196223305072635e-05
pathological O 0 0.014339461922645569
nature O 0 0.00013646480510942638
of O 0 0.0002089434419758618
amino O 0 0.00014183686289470643
acid O 0 9.410227357875556e-05
changes O 0 2.667031185410451e-05
in O 0 4.273646118235774e-05
APC O 0 0.0005199944134801626
associated O 0 2.2091810023994185e-05
with O 0 7.406701570289442e-06
both O 0 3.5907327401218936e-05
FAP B-Disease 1 0.995169460773468
and O 0 0.00014770629059057683
non O 1 0.9998778104782104
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9998856782913208
. O 0 0.00026311760302633047
. O 0 0.00022882192570250481

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999908208847046
cancer B-Disease 1 1.0
risk O 0 0.0020833632443100214
of O 0 0.0006615656311623752
the O 0 0.0009533772827126086
APC O 0 0.48388922214508057
I1307K O 0 0.006490101106464863
polymorphism O 0 0.0010536902118474245
. O 0 0.0003500642778817564

Germ O 1 0.9999996423721313
- O 0 0.015826202929019928
line O 0 0.000928889203350991
and O 0 5.083725045551546e-05
somatic O 0 0.00023062080435920507
truncating O 0 0.0005848129512742162
mutations O 0 4.158939918852411e-05
of O 0 7.29735111235641e-05
the O 0 0.00012646614050026983
APC B-Disease 0 0.0011432822793722153
gene O 0 1.8957280190079473e-05
are O 0 1.926673576235771e-06
thought O 0 1.196766515931813e-05
to O 0 1.383037852065172e-05
initiate O 0 0.0008887791773304343
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 1 0.999523401260376
in O 0 0.4506787657737732
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999986886978149
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.03483002260327339
respectively O 0 0.0028199779335409403
. O 0 0.0005700955516658723

Recently O 0 0.001826368854381144
, O 0 0.00010195413779001683
an O 0 8.578073175158352e-05
isoleucine O 0 0.0063371132127940655
- O 0 0.0037707046139985323
- O 0 0.0008973427466116846
> O 0 0.0004970668232999742
lysine O 0 0.00027185483486391604
polymorphism O 0 4.536514825304039e-05
at O 0 0.00019966972467955202
codon O 0 0.0001522545499028638
1307 O 0 0.0020401242654770613
( O 0 5.337087350198999e-05
I1307K O 0 0.00022226561850402504
) O 0 8.835319022182375e-06
of O 0 1.8574424757389352e-05
the O 0 0.00011039916716981679
APC B-Disease 0 0.001373572857119143
gene O 0 4.7152865590760484e-05
has O 0 1.370752761431504e-05
been O 0 1.303912176808808e-05
identified O 0 8.766921382630244e-06
in O 0 1.0696927347453311e-05
6 O 0 7.058634218992665e-05
% O 0 2.0624562239390798e-05
- O 0 8.567159966332838e-05
7 O 0 4.52816893812269e-05
% O 0 6.231498446140904e-06
of O 0 3.0922252335585654e-05
the O 0 6.325760477920994e-05
Ashkenazi O 0 0.0001386188087053597
Jewish O 0 0.00020147139730397612
population O 0 9.090350067708641e-05
. O 0 0.0002245739015052095

To O 0 0.00016033102292567492
assess O 0 0.00012113519915146753
the O 0 3.287706567789428e-05
risk O 0 4.603265188052319e-05
of O 0 3.113289858447388e-05
this O 0 1.867237369879149e-05
common O 0 7.4071365816053e-05
APC B-Disease 0 0.002117050811648369
allelic O 0 0.0011584145249798894
variant O 0 0.0012389312032610178
in O 0 0.004152363166213036
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.0001161438412964344
we O 0 1.216764394484926e-05
have O 0 2.66671759163728e-06
analyzed O 0 1.3346269952307921e-05
a O 0 1.2996018085686956e-05
large O 0 4.2061008571181446e-05
cohort O 0 0.00017661743913777173
of O 0 0.00011465905117802322
unselected O 0 0.007942989468574524
Ashkenazi O 0 0.0003574495785869658
Jewish O 0 0.000133817782625556
subjects O 0 0.0003182358341291547
with O 0 0.00015401125710923225
adenomatous B-Disease 1 0.9999933242797852
polyps I-Disease 1 0.9999016523361206
and O 0 0.00022858510783407837
. O 0 0.00016542593948543072
or O 1 0.9999021291732788
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.00026952693588100374
for O 0 5.7688717788551e-05
the O 0 0.00043166003888472915
APC O 0 0.01400739885866642
I1307K O 0 0.0036207272205501795
polymorphism O 0 0.0007010253611952066
. O 0 0.0003867144987452775

The O 0 0.0018678824417293072
APC O 0 0.00784068088978529
I1307K O 0 0.002374407136812806
allele O 0 8.985970634967089e-05
was O 0 0.00023214257089421153
identified O 0 3.1554343877360225e-05
in O 0 2.063869033008814e-05
48 O 0 2.3898792278487235e-05
( O 0 8.031463039515074e-06
10 O 0 9.909856999001931e-06
. O 0 2.249232920803479e-06
1 O 0 2.279084401379805e-05
% O 0 8.568657904106658e-06
) O 0 1.1045977771573234e-05
of O 0 0.00012168289686087519
476 O 0 0.004406181629747152
patients O 0 0.0021259989589452744
. O 0 0.0010305714095011353

Compared O 0 0.0004064570239279419
with O 0 2.1165458747418597e-05
the O 0 2.9459333745762706e-05
frequency O 0 1.916412111313548e-05
in O 0 9.839060112426523e-06
two O 0 2.344944505239255e-06
separate O 0 2.744726998571423e-06
population O 0 3.5648770335683366e-06
control O 0 2.5691624614410102e-05
groups O 0 2.5402478058822453e-06
, O 0 1.14479389594635e-05
the O 0 9.061452146852389e-05
APC O 0 0.0017908239969983697
I1307K O 0 0.000777341250795871
allele O 0 4.93874067615252e-05
is O 0 1.1869799891428556e-05
associated O 0 8.133826668199617e-06
with O 0 3.7929205518594244e-06
an O 0 1.2755526768160053e-05
estimated O 0 0.00010661240958143026
relative O 0 0.0001265498431166634
risk O 0 0.00010190853936364874
of O 0 0.0001578384981257841
1 O 0 0.0022594837937504053
. O 0 0.000271606637397781

5 O 0 0.0027655356097966433
- O 0 0.0018204499501734972
1 O 0 0.0012070868397131562
. O 0 0.00028069925610907376

7 O 0 0.002399660414084792
for O 0 0.0007380693568848073
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999915361404419
( O 0 0.000531040015630424
both O 0 0.00011208127398276702
P O 0 0.004182009492069483
= O 0 0.0003667327982839197
. O 0 3.354051659698598e-05
01 O 0 0.0017704175552353263
) O 0 0.0001461142674088478
. O 0 0.00022875324066262692

Furthermore O 0 0.0006637807819060981
, O 0 4.566237475955859e-05
compared O 0 5.755244637839496e-05
with O 0 3.566805389709771e-05
noncarriers O 0 0.1271354854106903
, O 0 0.00016617942310404032
APC O 0 0.0028402279131114483
I1307K O 0 0.0014167607296258211
carriers O 0 7.354938134085387e-05
had O 0 3.089439633185975e-05
increased O 0 1.755116682033986e-05
numbers O 0 1.8665661627892405e-05
of O 0 0.00016018890892155468
adenomas B-Disease 1 0.999997615814209
and O 1 0.8052215576171875
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.00030228932155296206
patient O 0 0.00019850305397994816
( O 0 3.651473525678739e-05
P O 0 0.0008223185432143509
= O 0 8.025290298974141e-05
. O 0 1.2618384971574415e-05
03 O 0 0.0002963749866466969
) O 0 9.701562703412492e-06
, O 0 3.919064511137549e-06
as O 0 1.4042667316971347e-05
well O 0 1.0302425835106988e-05
as O 0 2.551239413151052e-05
a O 0 5.554912786465138e-05
younger O 0 0.0002061515988316387
age O 0 0.0003137423191219568
at O 0 0.0014337267493829131
diagnosis O 0 0.05607734993100166
. O 0 0.0007567955181002617

We O 0 0.000117582363600377
conclude O 0 0.00012090877135051414
that O 0 7.412933882733341e-06
the O 0 6.128121458459646e-05
APC O 0 0.0019665099680423737
I1307K O 0 0.0012061754241585732
variant O 0 0.00025206172722391784
leads O 0 0.00016907573444768786
to O 0 8.976310346042737e-05
increased O 0 0.0013949602143839002
adenoma B-Disease 1 1.0
formation O 0 0.024830728769302368
and O 0 5.772074655396864e-05
directly O 0 2.9341967092477717e-05
contributes O 0 2.5001967514981516e-05
to O 0 7.640691364940722e-06
3 O 0 2.1339028535294347e-05
% O 0 7.299845492525492e-06
- O 0 2.2613377950619906e-05
4 O 0 1.1513917343108915e-05
% O 0 1.999222149606794e-06
of O 0 6.749602562194923e-06
all O 0 1.6449237591587007e-05
Ashkenazi O 0 0.0013486677780747414
Jewish O 1 0.9990875720977783
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.09768904000520706

The O 0 0.00028377026319503784
estimated O 0 0.00022821447055321187
relative O 0 0.0001704072637949139
risk O 0 9.231041622115299e-05
for O 0 3.546350126271136e-05
carriers O 0 9.413709631189704e-05
may O 0 5.036796210333705e-05
justify O 0 4.821323454962112e-05
specific O 0 4.0544814510212746e-06
clinical O 0 2.324067463632673e-05
screening O 0 1.4754606127098668e-05
for O 0 7.990712219907437e-06
the O 0 3.197943442501128e-05
360 O 0 6.199022755026817e-05
, O 0 6.292788839346031e-06
000 O 0 5.077382593299262e-05
Americans O 0 1.4392698176379781e-05
expected O 0 1.7033516996889375e-05
to O 0 2.1661713617504574e-05
harbor O 0 0.0005214232951402664
this O 0 9.553935342410114e-06
allele O 0 9.746148862177506e-06
, O 0 5.712046004191507e-06
and O 0 4.058171725773718e-06
genetic O 0 1.721537955745589e-05
testing O 0 9.804591172724031e-06
in O 0 9.417914952791762e-06
the O 0 2.450395368214231e-05
setting O 0 3.9731155993649736e-05
of O 0 7.551539601990953e-05
long O 0 0.0003476941492408514
- O 0 0.00020711208344437182
term O 0 6.345771544147283e-05
- O 0 3.538134478731081e-05
outcome O 0 1.0450869012856856e-05
studies O 0 4.810011887457222e-06
may O 0 1.1144594282086473e-05
impact O 0 6.225076504051685e-05
significantly O 0 0.00025264854775741696
on O 0 0.2546825408935547
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9990234375
in O 0 0.00016841621254570782
this O 0 3.098914385191165e-05
population O 0 3.459308936726302e-05
. O 0 8.53526871651411e-05

Localization O 0 0.007304019294679165
of O 0 0.0007810121169313788
human O 0 0.0004908765549771488
BRCA1 O 0 0.0006028393981978297
and O 0 2.9398093829513527e-05
its O 0 2.87167258647969e-05
loss O 0 0.0003549691173247993
in O 0 8.400821388931945e-05
high O 0 0.0004957849159836769
- O 0 0.00024577503791078925
grade O 0 0.00044641728163696826
, O 0 2.9467146305250935e-05
non B-Disease 0 0.0011571821523830295
- I-Disease 1 0.9984754920005798
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.018431805074214935

Although O 0 0.0001392916456097737
the O 0 8.130366040859371e-05
link O 0 0.0002080803969874978
between O 0 0.00015114682901185006
the O 0 0.0002836872008629143
BRCA1 O 1 0.9959681034088135
tumour B-Disease 1 1.0
- O 1 0.9859678745269775
suppressor O 0 0.0017097481759265065
gene O 0 3.994215512648225e-05
and O 0 3.240739897591993e-05
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 0.0006698376382701099
established O 0 0.00012621350469999015
, O 0 6.696828222629847e-06
the O 0 1.2085685739293694e-05
role O 0 3.387281685718335e-05
, O 0 6.1059495237714145e-06
if O 0 2.4685934931767406e-06
any O 0 3.876572463923367e-06
, O 0 7.789383744238876e-06
of O 0 8.130241621984169e-05
BRCA1 O 0 0.001425500842742622
in O 0 0.0003127681266050786
non B-Disease 1 0.8685004711151123
- I-Disease 1 0.9978440999984741
familial I-Disease 1 0.999969482421875
cancers I-Disease 1 0.9999986886978149
is O 0 0.0005490315961651504
unclear O 0 0.0004906567046418786
. O 0 0.00016072425933089107

BRCA1 O 0 0.004923695232719183
mutations O 0 0.00033090487704612315
are O 0 1.933207931870129e-05
rare O 0 0.0001326125639025122
in O 0 0.00017419352661818266
sporadic B-Disease 0 0.30077028274536133
cancers I-Disease 1 0.9999896287918091
, O 0 6.372197822201997e-05
but O 0 2.2779589926358312e-05
loss O 0 0.00044567108852788806
of O 0 0.0005157816340215504
BRCA1 O 0 0.0031613970641046762
resulting O 0 0.00029224809259176254
from O 0 9.866801701718941e-05
reduced O 0 0.00013221359404269606
expression O 0 5.127676558913663e-05
or O 0 2.8259855753276497e-05
incorrect O 0 9.688877617008984e-05
subcellular O 0 0.0004989661392755806
localization O 0 0.0010287560289725661
is O 0 4.718268974102102e-05
postulated O 0 0.0001361518370686099
to O 0 9.406820026924834e-06
be O 0 4.2108731577172875e-06
important O 0 1.4481171092484146e-05
in O 0 2.5545994503772818e-05
non B-Disease 0 0.00037546432577073574
- I-Disease 0 0.14423604309558868
familial I-Disease 1 0.9999918937683105
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.9991129040718079

Epigenetic O 0 0.40508347749710083
loss O 1 0.8932468295097351
, O 0 0.00011841634113807231
however O 0 4.8875768698053434e-05
, O 0 8.107805115287192e-06
has O 0 2.8142462724645156e-06
not O 0 1.5663690646761097e-06
received O 0 7.824456588423345e-06
general O 0 4.76281093142461e-05
acceptance O 0 0.00023827077529858798
due O 0 0.0003123026981484145
to O 0 6.15907774772495e-05
controversy O 0 0.0002896395744755864
regarding O 0 6.700254016323015e-05
the O 0 4.775973138748668e-05
subcellular O 0 0.0003809074987657368
localization O 0 0.0006916452548466623
of O 0 0.0003085321222897619
BRCA1 O 0 0.0007489538402296603
proteins O 0 3.793147698161192e-05
, O 0 7.787303729855921e-06
reports O 0 7.738492968201172e-06
of O 0 2.7473841328173876e-05
which O 0 1.3909265362599399e-05
have O 0 8.864538358466234e-06
ranged O 0 0.00019236686057411134
from O 0 3.4048865927616134e-05
exclusively O 0 6.114566349424422e-05
nuclear O 0 0.0002580287982709706
, O 0 5.7660222410049755e-06
to O 0 9.678819878899958e-06
conditionally O 0 0.00014732930867467076
nuclear O 0 0.00017665853374637663
, O 0 6.586330073332647e-06
to O 0 1.1410792467358988e-05
the O 0 0.00013158396177459508
ER O 1 0.9998757839202881
/ O 0 0.0020425296388566494
golgi O 0 0.004977842327207327
, O 0 4.520993752521463e-05
to O 0 4.528414865490049e-05
cytoplasmic O 0 0.0004214234068058431
invaginations O 0 0.0035664548631757498
into O 0 0.00015885900938883424
the O 0 0.0001697404368314892
nucleus O 0 0.001817270996980369
. O 0 0.00032197387190535665

In O 0 0.000357701675966382
an O 0 6.75510018481873e-05
attempt O 0 0.00020996334205847234
to O 0 4.5639560994459316e-05
resolve O 0 0.00025678426027297974
this O 0 1.2459157005650923e-05
issue O 0 3.343863136251457e-05
, O 0 6.849455985502573e-06
we O 0 4.440879820322152e-06
have O 0 4.090687070856802e-06
comprehensively O 0 0.0006447932682931423
characterized O 0 0.00023359933402389288
19 O 0 0.0012965945061296225
anti O 0 0.012851807288825512
- O 0 0.00607424508780241
BRCA1 O 0 0.0018666470423340797
antibodies O 0 0.0002501567068975419
. O 0 0.00015844135486986488

These O 0 0.00016600395611021668
reagents O 0 0.0004663917061407119
detect O 0 0.0005221324972808361
a O 0 0.00014662466128356755
220 O 0 0.0003386083117220551
- O 0 0.000451752042863518
kD O 0 0.00185842951759696
protein O 0 5.5379601690219715e-05
localized O 0 7.319751603063196e-05
in O 0 1.9597222490119748e-05
discrete O 0 4.5499196858145297e-05
nuclear O 0 0.0006338066887110472
foci O 0 0.0006361627019941807
in O 0 5.1999155402882025e-05
all O 0 5.5927572248037905e-05
epithelial O 1 0.9912660717964172
cell O 0 0.004004464019089937
lines O 0 0.00018695270409807563
, O 0 1.3756754924543202e-05
including O 0 9.383147698827088e-06
those O 0 1.8673157683224417e-05
derived O 0 8.797051850706339e-05
from O 0 0.0010659514227882028
breast B-Disease 1 0.9999774694442749
malignancies I-Disease 1 0.9999780654907227
. O 0 0.0018097060965374112

Immunohistochemical O 0 0.020345279946923256
staining O 0 0.004525326658040285
of O 0 0.0035861318465322256
human O 0 0.029981376603245735
breast O 1 0.9787908792495728
specimens O 0 0.00021340454986784607
also O 0 2.7818345188279636e-05
revealed O 0 0.0002880099636968225
BRCA1 O 0 0.0011879224330186844
nuclear O 0 0.0034357092808932066
foci O 0 0.015188412740826607
in O 0 0.0004044417873956263
benign O 1 0.9999988079071045
breast O 1 0.9999996423721313
, O 0 0.42474424839019775
invasive B-Disease 1 0.9999997615814209
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.00721080182120204
low B-Disease 1 0.9996157884597778
- I-Disease 1 0.9996247291564941
grade I-Disease 1 0.9999916553497314
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.003734520636498928

Conversely O 0 0.0038426078390330076
, O 0 0.00028198029031045735
BRCA1 O 0 0.0009368904866278172
expression O 0 0.00018043734598904848
was O 0 0.0005811110022477806
reduced O 0 0.00010268590995110571
or O 0 5.0472255679778755e-05
undetectable O 0 0.0005286151426844299
in O 0 1.0889756595133804e-05
the O 0 7.118271241779439e-06
majority O 0 5.9223862081125844e-06
of O 0 4.334721961640753e-05
high O 0 0.0017813991289585829
- O 0 0.0015834046062082052
grade O 1 0.9168380498886108
, O 0 0.0003071099636144936
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.00012044089817209169
suggesting O 0 6.786169251427054e-05
that O 0 7.021573765086941e-06
absence O 0 9.87240273389034e-05
of O 0 0.00026967190206050873
BRCA1 O 0 0.00223961821757257
may O 0 0.00014243375335354358
contribute O 0 5.25436807947699e-05
to O 0 2.425985803711228e-05
the O 0 4.721343066194095e-05
pathogenesis O 0 0.005431629251688719
of O 0 0.00011402556265238672
a O 0 4.991362584405579e-05
significant O 0 5.250616595731117e-05
percentage O 0 0.00015376268129330128
of O 0 0.00024138213484548032
sporadic B-Disease 1 0.9993529915809631
breast I-Disease 1 1.0
cancers I-Disease 1 0.9999997615814209
. O 0 0.0006085655768401921
. O 0 0.00031992714502848685

